data_2h45_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2h45 _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.017 0.437 . . . . 0.0 110.464 . . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.495 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 0.4 OUTLIER -65.52 -179.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 111.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.696 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 33.6 m-85 -141.52 140.03 33.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.985 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.7 t -113.68 101.07 11.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -111.16 133.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.322 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.7 p -122.24 153.02 39.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.648 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -143.15 -171.57 3.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.57 126.78 73.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.458 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.322 -0.611 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.797 -179.765 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.4 p . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 79' ' ' ILE . 19.5 m -94.44 -15.18 24.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.5 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.64 -179.23 47.74 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.18 154.9 44.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.958 0.409 . . . . 0.0 111.004 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.724 ' NE ' HE22 ' A' ' 85' ' ' GLN . 18.2 ttp180 -132.07 124.92 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.9 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.447 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' CB ' ' A' ' 49' ' ' PRO . 75.0 tt0 -125.85 129.8 50.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 22.5 p90 -137.51 130.97 31.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 17.1 pt-20 -144.51 161.92 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.863 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.507 HD21 ' CE2' ' A' ' 72' ' ' TYR . 87.6 mt -74.52 126.63 31.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.161 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.404 ' HG ' ' N ' ' A' ' 44' ' ' GLU . 19.3 p -73.14 -20.98 60.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.153 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' N ' ' HG ' ' A' ' 43' ' ' SER . 82.3 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.155 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 72.6 Cg_endo . . . . . 0 N--CA 1.489 1.228 0 CA-C-O 121.066 0.361 . . . . 0.0 112.769 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 19.7 mt-30 -114.47 146.18 40.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.441 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -123.09 137.13 55.0 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.437 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 76.7 mt -123.85 135.07 53.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.032 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -108.52 134.71 50.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.329 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.49 153.65 80.67 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.6 156.47 60.84 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.384 2.056 . . . . 0.0 112.344 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.6 p -57.56 -15.9 8.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.8 p -90.94 -7.6 51.64 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.539 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.43 137.18 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.1 p -134.51 13.82 3.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.227 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.7 p -164.79 145.22 7.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.634 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 62' ' ' ASN . 4.3 p -153.93 150.36 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.198 0.523 . . . . 0.0 111.942 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.495 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 9.2 t-20 -103.32 129.27 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.396 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.95 104.34 28.13 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.019 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -89.9 179.95 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.833 2.355 . . . . 0.0 113.153 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 59.62 37.03 22.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.7 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.546 ' O ' ' OG ' ' A' ' 20' ' ' SER . 29.5 mt -92.26 150.56 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.163 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.637 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 29.5 mt -89.04 111.27 43.88 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.777 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -57.97 143.6 95.83 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.155 1.903 . . . . 0.0 111.865 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.66 80.44 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.559 HH11 ' CG ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -123.22 146.58 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -95.28 134.36 38.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.244 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.637 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 12.3 m-85 -118.49 150.84 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.8 mt -108.54 121.64 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.94 131.37 66.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.095 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.523 ' OD1' ' OG ' ' A' ' 90' ' ' SER . 39.8 m-80 -133.73 131.46 39.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.701 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -105.1 131.43 54.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.554 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.472 ' CE1' HD12 ' A' ' 87' ' ' LEU . 66.4 m-85 -123.43 137.42 54.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.686 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.94 136.65 40.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.1 mt -99.29 125.26 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.38 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 47.3 p -84.64 169.25 14.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.74 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -59.9 -16.63 30.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.603 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.602 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 43.9 p30 -96.04 0.25 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.06 15.23 63.1 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.71 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.558 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 54.0 mm-40 -83.77 141.97 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.936 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.724 HE22 ' NE ' ' A' ' 37' ' ' ARG . 89.5 mt-30 -114.38 140.37 48.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.625 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -136.09 133.2 37.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.858 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.472 HD12 ' CE1' ' A' ' 77' ' ' TYR . 21.8 tp -72.17 116.59 12.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.1 pt -108.99 -21.36 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -155.67 126.24 6.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.574 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.523 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 28.6 t -131.53 122.15 25.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.877 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 t -154.08 153.82 32.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.617 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -112.99 154.75 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.106 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.696 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 31.6 mt-30 -142.09 157.07 45.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.278 0.561 . . . . 0.0 111.388 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.51 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -117.75 107.15 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.51 ' OXT' ' O ' ' A' ' 94' ' ' THR . 71.1 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.919 -1.038 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.708 0.289 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.459 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -59.07 176.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.541 0.686 . . . . 0.0 111.538 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.485 ' CZ ' HG23 ' A' ' 95' ' ' THR . 15.2 m-85 -148.19 146.59 28.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.041 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.96 102.2 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.2 t -110.17 136.93 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.484 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.8 p -123.46 151.72 42.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.846 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.422 ' CD2' HG13 ' A' ' 76' ' ' VAL . 35.4 p90 -143.99 -173.33 3.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.165 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.6 132.61 62.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 C--N 1.323 -0.557 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.783 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.0 p . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.944 0.402 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 79' ' ' ILE . 12.5 m -94.63 -14.11 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.583 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.67 176.81 46.01 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.59 151.21 46.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.069 0.462 . . . . 0.0 110.827 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.814 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.2 ttp180 -131.94 124.44 29.43 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.23 134.66 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.42 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 74.6 tt0 -121.96 127.08 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.978 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 52.6 p90 -135.54 133.98 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.63 165.69 29.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.229 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.502 HD21 ' CE2' ' A' ' 72' ' ' TYR . 85.2 mt -74.65 129.39 37.64 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.211 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.8 p -74.79 -15.75 60.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.307 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.274 -178.851 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 CA-C-O 120.959 0.316 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.423 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 20.0 mt-30 -116.18 151.11 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.42 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 63.8 m-85 -124.77 138.29 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.052 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.5 mt -125.02 131.35 53.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.73 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -104.63 133.04 50.15 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.917 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.6 mt -130.26 153.37 81.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.639 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.65 154.3 74.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.344 2.029 . . . . 0.0 112.622 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -56.77 -12.53 1.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.7 p -93.16 -9.67 38.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.646 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.54 136.27 34.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.514 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.9 p -128.03 10.62 6.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.01 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.5 p -164.07 150.41 11.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.539 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -151.37 153.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.186 0.517 . . . . 0.0 111.485 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.418 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 8.7 t-20 -103.4 126.57 50.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.723 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.02 101.84 24.0 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.926 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 69.1 Cg_endo -91.71 -175.24 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.995 2.463 . . . . 0.0 112.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 58.39 35.01 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.398 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.58 ' O ' ' OG ' ' A' ' 20' ' ' SER . 23.3 mt -88.5 153.14 21.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.36 109.97 41.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.206 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.47 ' CD ' ' HG ' ' A' ' 20' ' ' SER . 30.8 Cg_exo -56.02 138.5 82.68 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.234 1.956 . . . . 0.0 111.563 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.81 16.31 73.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 2.2 mmt-85 -126.13 148.19 49.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.86 0.362 . . . . 0.0 110.29 179.543 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -97.35 133.55 41.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.943 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CE2' HD21 ' A' ' 42' ' ' LEU . 60.3 m-85 -118.89 151.39 38.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.599 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 71.3 mt -108.91 125.45 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -113.59 131.71 64.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.059 0.457 . . . . 0.0 110.917 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -134.95 126.94 29.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.969 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 26' ' ' TRP . 26.3 t -105.4 128.56 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.463 ' CE1' HD11 ' A' ' 87' ' ' LEU . 77.8 m-85 -120.0 137.64 53.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.694 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 135.55 43.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.1 mt -98.91 122.31 50.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.2 0.524 . . . . 0.0 110.599 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 52.6 p -83.23 170.22 14.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.196 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.6 -19.63 50.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.374 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 44.6 p30 -91.99 -0.59 57.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.273 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.47 75.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 71.7 mm-40 -84.99 142.55 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 110.482 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.814 HE22 ' NE ' ' A' ' 37' ' ' ARG . 48.1 mt-30 -107.14 145.96 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.099 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 t -137.89 130.76 29.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.221 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.463 HD11 ' CE1' ' A' ' 77' ' ' TYR . 29.2 tp -73.01 117.93 15.33 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.232 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.3 pt -107.53 -21.66 5.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.773 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.2 tp -156.51 125.45 5.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.56 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.0 t -130.86 118.47 20.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -152.77 167.2 29.81 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.709 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 75.1 p -128.86 157.8 40.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 0.0 110.543 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -142.59 161.18 38.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.294 0.569 . . . . 0.0 111.024 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.49 115.23 21.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.538 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.485 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.609 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.4 p . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.611 ' HG ' HD22 ' A' ' 62' ' ' ASN . 79.6 p -62.87 140.21 58.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.386 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.516 ' CD1' ' CD1' ' A' ' 66' ' ' LEU . 5.7 m-30 -95.15 155.55 16.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.252 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -132.74 103.45 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.95 135.27 50.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 110.529 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -127.28 151.15 49.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.289 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.459 ' CE3' HG23 ' A' ' 76' ' ' VAL . 46.1 p90 -148.83 -164.99 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.1 t -120.49 133.71 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.446 -179.2 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 5.3 p . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.3 m -95.46 -12.96 25.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.24 177.26 46.01 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.26 151.51 49.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 110.288 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.635 ' NE ' HE22 ' A' ' 85' ' ' GLN . 27.8 ttp180 -129.71 126.09 37.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 t -107.56 134.66 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.523 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 68.5 tt0 -126.35 127.45 45.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.529 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.465 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 27.0 p90 -136.63 140.86 43.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 0.0 111.104 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.33 161.94 40.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.17 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.47 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 50.9 mt -75.63 127.75 33.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 111.503 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 20.3 p -75.81 -9.73 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.812 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.15 -178.313 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.893 0.289 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.465 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 mt-30 -114.31 147.03 39.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.586 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.453 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 91.4 m-85 -122.65 136.89 55.01 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.841 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.5 mt -124.8 127.15 46.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -99.06 131.96 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.956 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -127.87 154.29 78.16 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.82 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.58 159.64 52.78 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.619 2.213 . . . . 0.0 112.216 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p -60.61 -14.6 21.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.3 p -90.15 -5.44 56.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.328 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.43 139.29 31.64 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.498 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.6 p -129.72 9.54 5.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -167.55 150.2 5.95 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 62' ' ' ASN . 8.1 p -150.29 147.49 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.838 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.611 HD22 ' HG ' ' A' ' 21' ' ' SER . 17.6 t-20 -103.04 127.56 50.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.379 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -102.74 102.1 24.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.322 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 77.3 Cg_endo -86.8 -175.2 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.8 2.333 . . . . 0.0 113.278 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 57.87 39.15 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.611 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.516 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 25.8 mt -90.96 152.53 20.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.41 108.13 37.29 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.297 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -51.51 140.66 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.295 1.997 . . . . 0.0 111.647 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.425 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 83.33 14.76 73.35 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.414 ' H ' ' HG1' ' A' ' 95' ' ' THR . 7.3 mmm-85 -124.69 143.69 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.336 . . . . 0.0 110.385 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 74.7 tttt -99.19 134.88 41.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.47 ' CE2' ' CD2' ' A' ' 42' ' ' LEU . 83.8 m-85 -121.84 147.93 45.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.489 HG23 HD11 ' A' ' 73' ' ' ILE . 61.6 mt -106.04 128.05 60.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.64 136.49 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.149 0.499 . . . . 0.0 111.588 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -135.36 125.81 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.459 HG23 ' CE3' ' A' ' 26' ' ' TRP . 11.9 t -104.97 131.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.635 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -120.6 140.87 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.489 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.92 135.42 47.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' SER . 36.0 mt -100.23 121.6 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.439 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.621 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 44.4 p -82.49 171.91 13.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.782 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.06 -19.65 54.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.398 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.621 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 45.4 p30 -91.25 -2.8 57.37 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.389 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.17 67.23 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.319 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.54 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.2 mm-40 -83.33 145.23 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.635 HE22 ' NE ' ' A' ' 37' ' ' ARG . 57.4 mt-30 -111.69 140.73 46.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -137.79 135.27 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.637 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.5 tp -71.64 119.29 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.419 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.9 pt -109.36 -26.12 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.9 tp -156.94 122.77 4.78 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.48 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 t -134.22 121.1 20.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -150.73 162.35 40.88 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.972 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -121.18 152.12 39.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.289 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 23.2 mt-30 -144.56 160.26 41.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.234 0.54 . . . . 0.0 110.585 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -120.27 109.44 15.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.875 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.456 ' C ' ' O ' ' A' ' 94' ' ' THR . 69.3 p . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.042 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 121.141 0.496 . . . . 0.0 109.907 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.494 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 3.6 p -58.34 -178.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.22 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 21' ' ' SER . 16.1 m-85 -147.2 149.3 32.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.033 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.8 t -123.4 102.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -110.45 135.59 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.777 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.4 p -129.09 153.73 47.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.411 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CZ3' HG11 ' A' ' 76' ' ' VAL . 37.4 p90 -144.24 -171.61 3.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.37 128.42 73.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.1 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.506 ' H ' ' HG ' ' A' ' 28' ' ' SER . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 1.2 p . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.663 0.268 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -95.01 -18.53 20.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 109.413 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.451 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.28 179.65 47.68 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.77 151.17 45.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.834 0.35 . . . . 0.0 110.073 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.533 ' NE ' HE22 ' A' ' 85' ' ' GLN . 26.1 ttp180 -130.83 124.71 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.1 131.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.43 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.11 128.81 52.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 50' ' ' GLN . 51.5 p90 -136.96 140.29 42.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.203 0.525 . . . . 0.0 111.035 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.16 164.05 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.983 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 34.5 mt -73.96 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 0.0 111.104 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 p -71.05 -21.55 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.915 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.019 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 CA-C-O 120.969 0.321 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 18.0 mp0 -114.85 150.61 35.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -124.12 136.81 54.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.926 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.49 127.26 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -102.49 131.42 49.2 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.584 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mt -128.69 155.51 79.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.28 160.49 49.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.227 1.952 . . . . 0.0 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.451 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 p -60.19 -17.03 38.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.643 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.6 p -89.0 -9.54 50.97 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.066 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 130.26 35.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.5 p -127.02 13.07 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.467 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.8 p -165.06 148.09 8.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.267 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.89 148.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.494 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.777 HD21 ' N ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -104.42 127.29 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.842 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.777 ' N ' HD21 ' A' ' 62' ' ' ASN . 1.7 mt -101.92 103.69 30.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.114 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -90.52 -179.81 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.733 2.289 . . . . 0.0 112.342 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 59.98 38.13 21.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.69 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 33.2 mt -87.59 156.93 19.27 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 mt -94.04 108.33 34.69 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.151 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 30.7 Cg_exo -55.1 138.98 80.07 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.064 1.843 . . . . 0.0 111.874 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 14.75 76.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -126.36 148.95 49.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -100.66 133.77 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 110.431 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.492 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 77.5 m-85 -122.53 153.0 39.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.582 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.3 mt -111.05 128.82 67.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.44 130.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.878 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.09 122.72 27.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.036 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.446 HG11 ' CZ3' ' A' ' 26' ' ' TRP . 11.1 t -102.93 126.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.07 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.478 ' CE1' HD12 ' A' ' 87' ' ' LEU . 63.0 m-85 -116.4 140.6 49.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.77 133.64 46.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -97.61 122.29 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 110.591 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.593 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 73.2 p -82.18 168.0 18.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.307 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.22 -19.59 34.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.344 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.593 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 40.0 p30 -93.86 -0.42 55.76 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.472 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.04 66.26 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.993 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.5 mm-40 -83.84 138.94 32.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.851 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.533 HE22 ' NE ' ' A' ' 37' ' ' ARG . 37.4 mt-30 -103.44 142.82 33.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.619 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.9 t -136.36 127.38 27.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.871 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.478 HD12 ' CE1' ' A' ' 77' ' ' TYR . 13.7 tp -72.69 118.07 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.969 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.428 HD12 ' CD1' ' A' ' 26' ' ' TRP . 34.4 pt -112.26 -20.3 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -154.98 124.86 6.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.347 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -135.25 112.26 10.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.743 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -145.9 153.18 40.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.3 p -113.42 153.08 29.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.441 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 24.5 mt-30 -140.64 158.91 43.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.18 0.514 . . . . 0.0 110.906 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 106.14 11.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.452 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.477 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 70.9 p . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.74 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.558 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.96 0.409 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -63.51 163.32 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.585 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 18.2 m-30 -130.38 152.93 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.46 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.5 t -126.84 106.16 15.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.0 t -115.65 134.84 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.1 p -124.68 150.2 46.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.997 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CD1' HD12 ' A' ' 88' ' ' ILE . 42.2 p90 -144.4 -179.5 6.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.92 128.45 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.542 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 C--N 1.327 -0.408 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.484 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.7 m -94.58 -16.85 22.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.243 0.544 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.45 179.02 47.52 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.26 151.38 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.109 0.481 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HD3' ' NE2' ' A' ' 85' ' ' GLN . 60.8 ttt180 -130.89 124.4 31.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.4 t -107.01 131.11 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.924 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -123.1 122.8 39.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.932 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.56 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.1 p90 -135.7 138.17 42.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.384 0.612 . . . . 0.0 111.251 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -147.4 168.57 21.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.723 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.549 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -74.3 127.77 33.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.535 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 p -69.23 -21.06 63.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.719 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.255 -179.923 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.49 1.298 0 CA-C-O 120.737 0.224 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.56 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 17.2 mt-30 -116.93 146.82 42.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.04 136.7 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 61.5 mt -126.09 128.76 47.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -104.44 134.12 48.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.643 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mt -130.71 156.53 79.71 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.854 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -66.53 156.38 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.236 1.958 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 62.9 p -58.79 -13.3 5.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.115 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -92.79 -8.02 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.197 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.27 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.346 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -130.6 14.73 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.365 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.2 p -163.65 140.31 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.88 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.8 p -150.09 143.92 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.792 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.785 HD21 ' N ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -102.79 128.34 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.025 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.785 ' N ' HD21 ' A' ' 62' ' ' ASN . 1.9 mt -97.82 105.09 24.79 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.49 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.7 Cg_endo -91.16 177.35 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.589 2.193 . . . . 0.0 112.318 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.68 36.94 22.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.728 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.558 ' O ' ' OG ' ' A' ' 20' ' ' SER . 78.4 mt -89.48 146.1 24.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.55 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 34.4 mt -80.7 122.49 82.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.141 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 70' ' ' ARG . 45.6 Cg_exo -48.69 -174.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.994 1.796 . . . . 0.0 111.82 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 21.82 33.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.838 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.695 ' N ' ' O ' ' A' ' 68' ' ' PRO . 10.7 mmm-85 -126.89 144.54 50.96 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.758 0.779 . . . . 0.0 110.612 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -100.11 131.82 45.84 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.55 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 83.6 m-85 -121.75 149.86 42.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.286 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 85.4 mt -104.78 126.78 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.37 132.56 64.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.224 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -133.86 123.64 25.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.17 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.16 126.85 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.53 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.482 ' CE1' HD11 ' A' ' 87' ' ' LEU . 57.6 m-85 -118.45 138.03 52.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.756 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.05 135.86 40.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.1 mt -98.88 122.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.281 0.562 . . . . 0.0 110.711 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.607 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 100.0 p -84.02 167.5 16.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.755 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.14 -23.3 54.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.925 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.607 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 38.6 p30 -90.97 -0.8 57.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.747 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.62 70.79 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.165 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -83.01 136.47 34.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.43 ' NE2' ' HD3' ' A' ' 37' ' ' ARG . 92.4 mt-30 -105.92 144.29 32.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.151 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 t -139.87 133.05 29.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 77' ' ' TYR . 15.0 tp -71.51 117.56 13.21 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 26' ' ' TRP . 31.6 pt -108.9 -22.31 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.2 tp -156.14 121.18 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.3 t -127.03 122.99 35.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.583 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.3 t -154.28 157.78 39.21 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.575 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.8 p -115.73 153.26 31.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.415 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 31.6 mt-30 -138.06 157.29 46.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 111.071 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.69 108.19 10.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.181 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.465 -179.369 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.113 0.482 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.505 ' HG ' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -60.67 172.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.45 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.551 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 24.0 m-85 -135.61 151.91 50.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.25 105.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -114.12 136.34 50.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -124.59 152.2 43.85 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.281 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.419 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.2 p90 -145.83 -165.29 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.54 131.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.656 -179.555 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.6 p . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.917 0.389 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.4 m -95.63 -13.5 24.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.549 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.01 179.59 47.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.94 151.53 48.37 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.925 0.393 . . . . 0.0 110.681 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.442 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 18.6 ttp180 -130.5 122.16 27.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.416 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.8 t -108.9 132.58 56.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.271 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.469 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 20.0 tt0 -120.87 127.37 51.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.852 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 52.6 p90 -131.89 132.5 43.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.09 0.472 . . . . 0.0 110.019 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -148.68 165.15 32.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 72' ' ' TYR . 94.3 mt -73.27 128.54 35.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.942 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -70.82 -24.82 62.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.857 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 . . . . . 0 CA--C 1.519 -0.231 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.744 179.563 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 120.854 0.273 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -116.66 147.78 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.469 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 52.6 m-85 -125.66 141.69 51.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.819 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -127.91 134.65 49.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -106.92 134.12 50.55 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.164 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.45 155.93 80.33 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.044 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.25 154.12 75.41 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.945 1.763 . . . . 0.0 112.357 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 62.0 p -57.19 -15.75 6.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.5 p -91.06 -8.0 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.37 133.1 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.853 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.8 p -130.41 17.98 5.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.4 p -164.96 144.38 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.269 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 62' ' ' ASN . 9.8 p -149.13 147.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.232 0.539 . . . . 0.0 111.624 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.505 HD22 ' HG ' ' A' ' 21' ' ' SER . 2.2 t-20 -102.83 124.3 48.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.431 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.8 mt -95.44 109.9 47.9 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.317 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -90.99 178.9 1.77 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.88 2.387 . . . . 0.0 112.778 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 58.3 37.9 26.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.083 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.4 mt -91.11 143.94 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.213 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.571 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 17.9 mt -90.1 112.79 54.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -56.34 142.28 88.35 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.257 1.971 . . . . 0.0 111.86 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.58 82.32 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -121.9 150.94 41.26 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.75 130.84 46.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 0.0 110.107 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.571 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 59.8 m-85 -116.77 153.43 32.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.206 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 84.4 mt -108.51 122.8 63.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.21 131.63 64.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.672 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -137.49 126.53 24.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.591 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.419 HG11 ' CD2' ' A' ' 26' ' ' TRP . 15.6 t -103.35 130.85 52.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.506 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.5 ' CE2' HD12 ' A' ' 87' ' ' LEU . 71.7 m-85 -120.23 142.98 48.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.217 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.64 133.12 51.8 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' SER . 63.2 mt -96.23 122.83 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.61 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.597 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 20.7 p -81.19 168.11 18.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -58.75 -17.87 26.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.379 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.597 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.3 p30 -93.4 0.01 56.69 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.572 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.63 67.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.38 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.3 mm-40 -88.34 144.74 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.068 0.434 . . . . 0.0 110.652 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.442 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 29.7 mt-30 -103.47 143.32 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.96 125.21 36.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.996 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.5 HD12 ' CE2' ' A' ' 77' ' ' TYR . 25.1 tp -73.02 115.4 12.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.904 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.66 -23.52 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.581 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -156.61 128.08 7.08 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.977 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.6 t -131.66 125.65 32.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.735 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -153.97 156.4 37.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.49 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -116.25 155.48 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.144 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.551 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 25.5 mt-30 -142.31 157.96 44.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.324 0.583 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.64 104.81 9.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.911 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.472 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.536 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.452 ' HG ' ' HB2' ' A' ' 66' ' ' LEU . 79.4 p . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.946 0.403 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -60.34 149.41 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.551 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 22.2 m-30 -110.16 145.81 36.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.32 104.84 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.93 139.1 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.809 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.8 p -128.19 153.54 46.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.129 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -147.22 -166.32 2.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.079 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.06 133.1 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.256 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 C--N 1.321 -0.639 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.277 -179.4 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 m -96.16 -14.2 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.495 . . . . 0.0 110.24 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.53 174.92 43.43 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -123.33 150.73 43.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.063 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.791 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 37.7 ttp180 -130.51 122.52 27.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.27 132.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.824 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 81.4 tt0 -122.75 132.94 54.46 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.52 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 46.9 p90 -140.09 141.08 36.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.179 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -150.57 163.82 37.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.772 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.465 HD22 ' CE2' ' A' ' 72' ' ' TYR . 50.8 mt -75.35 131.98 40.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.474 ' HG ' ' HD3' ' A' ' 71' ' ' LYS . 17.3 p -78.78 -14.99 58.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.483 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.853 -178.259 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 121.092 0.371 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.484 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 24.7 mt-30 -122.75 148.2 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -126.37 137.03 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.188 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.7 mt -122.32 127.84 50.3 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -102.99 133.45 48.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.353 0.597 . . . . 0.0 112.17 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.38 157.2 78.79 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.3 160.5 48.65 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.789 1.66 . . . . 0.0 112.219 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.426 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 50.9 p -57.05 -11.82 1.76 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.183 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.2 p -91.49 -7.5 50.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.435 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.17 35.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.403 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.6 p -126.73 7.62 6.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.839 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -162.21 154.17 18.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.332 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -153.2 146.97 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.4 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 30.4 t30 -103.83 128.93 51.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.44 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.67 99.6 22.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.513 0.197 . . . . 0.0 111.055 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 66.9 Cg_endo -89.61 -169.41 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.921 2.414 . . . . 0.0 112.162 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 57.63 36.69 26.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.538 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.452 ' HB2' ' HG ' ' A' ' 20' ' ' SER . 42.7 mt -94.33 138.21 32.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.946 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.673 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 18.6 mt -84.71 113.96 52.54 Favored Pre-proline 0 C--N 1.333 -0.147 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.131 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -54.08 138.07 70.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.92 1.747 . . . . 0.0 111.534 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.405 ' H ' ' HG1' ' A' ' 95' ' ' THR . . . 84.32 14.95 70.18 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.861 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.87 148.61 48.17 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.474 ' HD3' ' HG ' ' A' ' 43' ' ' SER . 76.9 tttt -98.98 134.78 41.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.361 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.673 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 64.9 m-85 -121.5 153.55 37.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.588 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 85.7 mt -109.38 125.63 66.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.5 129.02 71.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 0.0 110.673 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -135.71 124.42 23.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.171 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.6 t -103.47 128.01 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.983 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.449 ' CE1' HD12 ' A' ' 87' ' ' LEU . 72.9 m-85 -117.37 142.21 47.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.547 ' CD ' ' HG ' ' A' ' 86' ' ' SER . 0.4 OUTLIER -103.41 133.75 47.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.0 mt -98.3 126.17 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 121.384 0.611 . . . . 0.0 110.789 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.604 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 30.0 p -82.87 168.55 16.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.974 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -19.3 62.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.147 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.604 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 36.3 p30 -93.69 2.8 56.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.451 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 11.8 66.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.425 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 70.5 mm-40 -87.34 142.6 27.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.979 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.791 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 83.7 mt-30 -105.2 147.23 28.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.018 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' SER . . . . . 0.547 ' HG ' ' CD ' ' A' ' 78' ' ' GLN . 0.9 OUTLIER -137.05 124.37 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.614 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.449 HD12 ' CE1' ' A' ' 77' ' ' TYR . 14.4 tp -73.71 115.57 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.147 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -109.87 -20.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.7 tp -155.17 123.12 5.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.657 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -131.87 119.13 20.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -153.37 162.26 41.47 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.601 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.7 p -120.33 153.1 36.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.347 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.551 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 20.7 mt-30 -138.13 157.1 47.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.945 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -123.09 115.7 22.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.474 HG21 ' CE1' ' A' ' 22' ' ' PHE . 40.2 p . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.781 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.837 0.351 . . . . 0.0 110.859 . . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.708 ' HG ' ' N ' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -62.96 -177.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.832 0.825 . . . . 0.0 112.059 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.708 ' N ' ' HG ' ' A' ' 21' ' ' SER . 16.1 m-85 -151.53 140.38 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.278 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.46 101.62 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.89 137.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.222 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.6 p -124.03 151.41 43.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.114 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CD2' HG11 ' A' ' 76' ' ' VAL . 40.6 p90 -145.04 -175.39 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.465 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -112.42 133.36 58.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.685 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 45.2 t . . . . . 0 C--N 1.324 -0.525 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.353 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.895 0.378 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.6 m -97.0 -14.52 21.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.421 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.94 178.54 46.77 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.44 153.04 46.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.483 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.662 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 42.5 ttp180 -131.07 129.25 41.7 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.834 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.37 133.65 57.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.526 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.16 127.71 50.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.091 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.8 p90 -135.25 130.63 35.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.32 0.581 . . . . 0.0 110.66 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -143.98 165.1 28.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.721 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.488 HD21 ' CE2' ' A' ' 72' ' ' TYR . 35.5 mt -74.78 127.14 32.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 0.0 111.505 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 p -69.9 -37.85 76.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.49 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.226 179.598 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.902 0.292 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 9.2 mt-30 -118.88 143.82 46.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.711 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.07 136.64 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.092 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.93 131.72 53.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -106.18 136.07 46.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.091 0.472 . . . . 0.0 111.457 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.8 mt -130.21 157.24 77.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.576 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -69.97 158.7 55.83 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.939 1.759 . . . . 0.0 112.098 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.7 p -59.31 -12.95 6.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.114 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.2 p -92.05 -8.56 45.57 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.69 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -131.02 11.21 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.0 p -164.43 143.89 7.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.01 149.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.465 HD21 ' N ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -103.9 123.41 47.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.069 178.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.465 ' N ' HD21 ' A' ' 62' ' ' ASN . 2.0 mt -100.38 102.82 19.96 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.003 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 63.1 Cg_endo -92.87 179.98 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.909 2.406 . . . . 0.0 113.207 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 62.31 37.3 14.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.901 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.563 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -92.47 152.34 19.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.291 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.405 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 19.3 mt -82.96 119.85 75.05 Favored Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.969 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.52 144.89 62.62 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.867 1.711 . . . . 0.0 112.082 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.76 15.45 75.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.543 HH11 ' CG ' ' A' ' 70' ' ' ARG . 0.1 OUTLIER -124.81 153.4 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.731 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.6 133.86 46.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.488 ' CE2' HD21 ' A' ' 42' ' ' LEU . 86.9 m-85 -120.4 151.12 39.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.74 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 77.1 mt -108.53 123.94 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.5 t -116.11 134.68 58.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.161 0.505 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -135.2 129.65 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 26' ' ' TRP . 28.6 t -106.61 128.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.355 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.471 ' CE1' HD11 ' A' ' 87' ' ' LEU . 60.1 m-85 -120.55 139.53 52.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.869 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.685 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -101.11 133.33 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 34' ' ' SER . 52.2 mt -98.33 122.69 50.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.292 0.567 . . . . 0.0 110.448 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.601 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 42.0 p -83.79 169.11 15.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.124 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -58.19 -20.81 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.09 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.601 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.5 p30 -91.35 -2.61 57.31 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.945 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.01 12.71 67.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.136 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.587 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.7 mm-40 -84.0 141.04 31.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.662 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 93.3 mt-30 -105.19 140.92 37.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -134.02 127.86 33.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.107 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.471 HD11 ' CE1' ' A' ' 77' ' ' TYR . 23.0 tp -72.06 116.28 12.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.553 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.3 pt -107.4 -23.1 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.4 tp -159.08 124.81 4.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.054 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.4 t -128.48 126.71 41.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.9 t -153.77 159.03 41.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.196 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -120.58 152.26 38.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.084 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.427 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 23.1 mt-30 -143.65 158.12 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.996 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 114.88 20.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.906 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.486 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 33.4 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.647 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.541 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.96 0.409 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.776 ' HG ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -63.29 -174.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.496 0.665 . . . . 0.0 112.15 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.759 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 21.1 m-85 -149.67 148.24 29.05 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.165 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.75 103.96 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -112.28 135.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -123.07 151.51 41.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.293 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -143.47 179.92 6.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.341 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -117.38 129.27 74.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.239 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.227 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.4 ' O ' ' CB ' ' A' ' 56' ' ' SER . 2.1 p . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 81' ' ' GLU . 70.8 m -95.36 -15.46 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.466 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.88 179.66 47.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -125.9 152.88 44.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 110.602 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' NH2' ' CD2' ' A' ' 51' ' ' TYR . 55.2 ttt180 -133.9 127.65 32.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.9 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.0 t -108.29 132.78 55.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.075 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.34 125.59 44.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.801 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 42.5 p90 -141.35 140.33 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.897 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -149.38 169.99 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.39 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' ' 72' ' ' TYR . 92.3 mt -74.28 126.66 31.13 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.42 ' HG ' ' N ' ' A' ' 44' ' ' GLU . 24.5 p -62.05 -33.92 75.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.388 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.42 ' N ' ' HG ' ' A' ' 43' ' ' SER . 93.8 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 N--CA 1.489 1.228 0 CA-C-O 120.983 0.326 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 32.5 mt-30 -119.91 140.78 50.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.778 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CD2' ' NH2' ' A' ' 37' ' ' ARG . 6.1 m-85 -121.64 141.28 51.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.588 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.5 mt -131.15 123.44 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -101.61 135.72 42.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.134 0.492 . . . . 0.0 111.578 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -132.86 159.43 72.63 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.842 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -72.52 160.17 47.31 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.094 1.863 . . . . 0.0 112.624 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.466 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 61.1 p -61.69 -15.48 40.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.696 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -88.34 -1.14 57.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.691 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.696 ' O ' ' CG2' ' A' ' 59' ' ' THR . . . -75.86 -146.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.595 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . 0.696 ' CG2' ' O ' ' A' ' 58' ' ' ALA . 1.9 p 143.45 4.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.8 p -163.75 141.89 7.54 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 62' ' ' ASN . 8.8 p -150.74 155.35 7.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.174 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.776 ' ND2' ' HG ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -106.1 122.88 47.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.217 178.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.609 ' N ' HD21 ' A' ' 62' ' ' ASN . 2.1 mt -95.87 106.67 29.26 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.175 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 64.7 Cg_endo -92.74 177.33 1.5 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 123.115 2.544 . . . . 0.0 113.393 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 60.19 38.33 20.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.958 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.541 ' O ' ' OG ' ' A' ' 20' ' ' SER . 39.8 mt -91.76 143.15 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.758 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 64.2 mt -83.86 112.82 43.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -55.29 143.12 77.43 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.675 ' H ' ' HG1' ' A' ' 95' ' ' THR . . . 76.51 17.37 79.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.441 ' NH1' ' HG3' ' A' ' 70' ' ' ARG . 8.9 mmm-85 -123.98 152.79 42.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.153 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -100.97 130.96 47.04 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.451 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.758 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 65.1 m-85 -118.5 144.59 45.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.091 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.2 mt -104.11 125.5 58.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.0 132.54 61.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.243 0.544 . . . . 0.0 111.154 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -134.78 128.13 32.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.514 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.11 128.45 57.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.416 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.474 ' CE1' HD12 ' A' ' 87' ' ' LEU . 79.6 m-85 -119.54 138.53 53.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -101.13 136.87 40.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -100.03 123.32 52.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.591 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 84.3 p -83.31 171.99 12.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.32 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 76.1 mm-40 -58.77 -19.96 45.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.496 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.591 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 48.8 p30 -95.08 -0.22 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.12 65.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.564 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.3 mm-40 -83.82 143.79 29.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.849 0.357 . . . . 0.0 110.53 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.91 142.78 45.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 111.686 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.7 t -138.24 134.54 34.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.86 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.474 HD12 ' CE1' ' A' ' 77' ' ' TYR . 53.5 tp -73.34 117.44 15.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.3 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.0 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.992 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.7 tp -156.84 125.44 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.325 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.2 t -132.13 122.53 25.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.819 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.8 t -151.7 158.69 43.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.75 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -118.04 152.55 35.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.759 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 23.6 mt-30 -140.51 156.77 46.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.268 0.556 . . . . 0.0 110.313 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -123.13 104.81 9.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.629 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.675 ' HG1' ' H ' ' A' ' 69' ' ' GLY . 81.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.051 -0.975 . . . . 0.0 110.435 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.461 ' HG ' HG22 ' A' ' 95' ' ' THR . 94.5 p . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 121.112 0.482 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.438 ' HG ' HD22 ' A' ' 62' ' ' ASN . 2.6 p -63.16 158.51 19.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.556 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.627 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 21.6 m-30 -125.69 155.92 40.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.776 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.4 t -128.83 106.3 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.7 t -111.94 137.48 44.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.71 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.1 p -129.14 153.56 47.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CE3' HG23 ' A' ' 76' ' ' VAL . 34.0 p90 -143.41 -165.88 2.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.023 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.0 t -127.73 124.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.902 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.4 p . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.716 0.293 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.645 ' N ' ' O ' ' A' ' 79' ' ' ILE . 53.1 m -94.0 -15.48 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.213 0.53 . . . . 0.0 109.803 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.2 176.46 45.32 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -125.41 152.91 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.906 0.384 . . . . 0.0 110.673 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.669 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.4 ttp180 -131.5 124.33 29.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.4 t -109.03 133.67 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -124.6 132.65 53.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.341 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.578 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 22.8 p90 -137.82 130.28 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.095 0.474 . . . . 0.0 110.284 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.71 166.61 26.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 87.1 mt -73.65 128.59 35.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.413 0.625 . . . . 0.0 111.969 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 p -68.23 -27.84 66.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HG3' HH22 ' A' ' 70' ' ' ARG . 88.1 mt-10 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.131 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.49 1.299 0 CA-C-O 120.883 0.285 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.578 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 11.4 mt-30 -120.29 144.0 48.04 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -124.41 140.38 53.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.506 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 mt -124.71 129.38 50.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.13 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -101.48 131.78 47.43 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.905 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.4 mt -130.08 155.64 80.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 57' ' ' THR . 22.7 Cg_endo -68.94 156.65 64.69 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.38 2.053 . . . . 0.0 112.5 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.452 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 30.4 p -55.74 -11.6 1.01 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 55' ' ' PRO . 29.5 p -92.0 -7.29 49.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.61 132.28 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -130.32 9.32 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.182 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.9 p -164.12 146.8 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.62 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.439 HG21 ' N ' ' A' ' 62' ' ' ASN . 5.2 p -151.0 152.69 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.772 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 11.7 t-20 -106.68 126.63 52.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.458 HG23 ' CG ' ' A' ' 40' ' ' TYR . 2.3 mt -100.94 104.94 35.36 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.148 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -91.35 -179.34 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.779 2.319 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 58.66 39.03 24.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.404 ' HB2' ' HG ' ' A' ' 20' ' ' SER . 41.5 mt -90.41 143.91 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.3 mt -78.02 129.81 74.65 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.043 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.49 140.94 44.98 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.529 2.153 . . . . 0.0 112.873 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.38 27.99 71.91 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.686 ' CZ ' ' H ' ' A' ' 71' ' ' LYS . 4.9 mmm180 -126.48 148.13 49.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.22 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.686 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 75.7 tttt -100.26 131.15 46.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 64.4 m-85 -119.82 151.26 39.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -104.99 123.7 59.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -111.69 131.15 63.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -133.98 125.86 29.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.507 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.47 HG23 ' CE3' ' A' ' 26' ' ' TRP . 5.7 t -104.42 126.57 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.03 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.466 ' CE1' HD12 ' A' ' 87' ' ' LEU . 81.4 m-85 -118.82 141.91 48.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.23 135.58 46.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.645 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.9 mt -98.38 122.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.172 0.511 . . . . 0.0 110.634 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.605 ' HG ' ' CG ' ' A' ' 82' ' ' ASP . 47.2 p -82.52 169.53 16.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.811 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.3 -20.47 43.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.126 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.605 ' CG ' ' HG ' ' A' ' 80' ' ' SER . 2.0 p-10 -92.04 -2.32 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.51 14.46 65.77 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CG ' ' OD2' ' A' ' 82' ' ' ASP . 60.2 mm-40 -86.2 144.17 27.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.121 0.46 . . . . 0.0 111.211 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.669 HE22 ' NE ' ' A' ' 37' ' ' ARG . 93.2 mt-30 -109.18 139.61 43.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 t -137.81 136.1 36.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.392 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.466 HD12 ' CE1' ' A' ' 77' ' ' TYR . 19.3 tp -72.88 116.73 13.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 pt -108.87 -22.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.29 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.1 tp -156.32 125.81 6.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.62 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.5 t -133.44 122.43 23.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.508 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -149.7 156.54 42.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.461 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -117.58 153.03 33.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.42 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 24.1 mt-30 -140.98 158.36 44.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.216 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.71 108.23 16.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.576 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.473 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 6.1 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.344 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.7 p . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.154 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.626 ' HG ' HD22 ' A' ' 62' ' ' ASN . 1.4 p -60.45 165.56 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.524 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.536 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 15.8 m-30 -133.51 154.76 50.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.818 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.43 104.32 8.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.43 136.8 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.43 150.92 43.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CE3' HG21 ' A' ' 76' ' ' VAL . 36.9 p90 -145.26 -174.15 4.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.373 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.5 t -109.55 135.38 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.412 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 85.2 p . . . . . 0 C--N 1.324 -0.512 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.544 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.0 p . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.678 0.275 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 79' ' ' ILE . 67.5 m -94.86 -14.65 24.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.27 0.557 . . . . 0.0 109.541 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.36 -179.87 47.93 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -127.31 150.57 49.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.003 0.43 . . . . 0.0 110.75 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -129.2 124.81 35.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.84 131.2 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.121 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.434 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.9 tt0 -123.27 133.57 54.17 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.579 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.7 p90 -140.65 138.7 34.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.446 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -148.02 165.54 30.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.706 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.488 HD22 ' CD2' ' A' ' 72' ' ' TYR . 56.3 mt -73.13 127.61 33.09 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.028 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.63 ' HG ' ' N ' ' A' ' 44' ' ' GLU . 18.6 p -70.34 -34.62 72.88 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.63 ' N ' ' HG ' ' A' ' 43' ' ' SER . 98.2 mt-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.825 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 120.92 0.3 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 16.2 mt-30 -123.36 146.02 48.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 80.4 m-85 -124.86 139.17 54.08 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.046 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.7 mt -123.2 129.16 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.231 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -102.21 130.92 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.831 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.25 154.72 80.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.795 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.15 156.76 64.59 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.143 1.895 . . . . 0.0 112.374 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.5 p -56.56 -11.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -93.76 -9.17 38.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.698 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.8 35.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.485 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 p -130.19 12.22 5.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.0 p -164.38 143.13 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.95 149.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.62 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.626 HD22 ' HG ' ' A' ' 21' ' ' SER . 8.9 t-20 -105.16 128.02 53.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.26 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mt -104.84 101.34 28.66 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.449 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -89.47 -174.58 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.773 2.315 . . . . 0.0 112.439 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 59.72 37.01 22.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.386 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.9 mt -90.36 151.88 21.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.769 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 30.4 mt -95.37 108.35 38.62 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.977 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.28 139.78 81.31 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.432 2.088 . . . . 0.0 111.839 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.58 14.69 67.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.449 ' HE ' HD12 ' A' ' 42' ' ' LEU . 5.7 mmm-85 -127.21 141.44 51.73 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.447 ' NZ ' ' HB2' ' A' ' 92' ' ' SER . 14.0 tttp -96.19 134.86 38.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.938 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.769 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 4.0 m-85 -117.85 151.79 36.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 0.0 111.718 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.5 mt -110.07 124.36 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.84 132.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.929 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -133.61 124.49 26.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.371 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.438 HG21 ' CE3' ' A' ' 26' ' ' TRP . 21.9 t -106.74 127.76 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.875 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.476 ' CE1' HD12 ' A' ' 87' ' ' LEU . 67.3 m-85 -119.01 137.36 53.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -100.65 136.25 40.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.0 mt -100.12 125.49 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.384 0.611 . . . . 0.0 110.934 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 89.7 p -84.89 165.2 17.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.206 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.31 -20.31 42.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.357 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.0 p-10 -91.98 -1.54 57.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.786 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.97 13.01 65.12 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.243 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.536 ' H ' ' HG ' ' A' ' 80' ' ' SER . 75.8 mm-40 -83.2 135.34 34.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -104.98 140.66 37.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.749 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.3 t -136.72 132.9 35.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.114 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.476 HD12 ' CE1' ' A' ' 77' ' ' TYR . 57.0 tp -71.83 118.98 15.35 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.736 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 pt -108.92 -22.97 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.2 tp -157.01 125.67 5.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.597 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 t -132.66 112.66 12.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.417 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -146.25 159.62 43.08 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.0 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.447 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 95.7 p -117.25 153.8 32.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.321 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.518 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 26.8 mt-30 -139.52 156.04 47.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -122.71 107.83 12.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.434 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 94' ' ' THR . 45.6 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.715 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 2.2 p . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 110.003 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.697 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -67.61 135.93 53.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.973 -179.32 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 23.9 m-85 -96.12 148.04 23.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.351 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.59 101.34 10.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.1 t -111.53 137.59 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -128.1 155.84 43.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.129 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.464 ' CD1' HD13 ' A' ' 88' ' ' ILE . 33.6 p90 -146.9 -164.95 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.049 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.08 129.62 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.471 ' H ' ' HG ' ' A' ' 28' ' ' SER . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.928 0.394 . . . . 0.0 110.365 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' ILE . 4.8 m -93.84 -15.4 25.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.667 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 175.62 -178.3 47.22 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -126.61 153.81 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.96 0.41 . . . . 0.0 110.376 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -132.44 123.01 25.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.083 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.7 t -107.48 132.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.504 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 68.3 tt0 -127.17 131.34 50.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.233 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 18.9 p90 -144.29 137.63 27.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.273 0.558 . . . . 0.0 111.259 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -144.36 167.91 21.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.149 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.485 HD21 ' CE2' ' A' ' 72' ' ' TYR . 76.7 mt -74.81 126.42 30.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.688 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -67.24 -25.03 65.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.458 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.979 -178.932 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.487 1.109 0 N-CA-C 111.269 -0.32 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.534 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 21.6 mt-30 -112.71 146.15 39.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.78 137.06 54.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.672 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.2 mt -129.68 130.48 45.59 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.71 132.75 50.58 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.477 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 mt -126.18 152.54 73.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.636 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.36 154.48 71.15 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.441 2.094 . . . . 0.0 112.777 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.524 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 24.9 p -57.8 -14.31 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.115 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.6 p -92.12 -6.7 50.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.234 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.82 138.78 31.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -130.71 13.98 5.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.2 p -163.68 148.68 10.81 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.18 144.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.856 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.697 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 2.4 t-20 -102.85 126.5 50.02 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -97.96 112.55 62.05 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.468 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -93.23 175.71 1.56 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.997 2.465 . . . . 0.0 113.637 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 59.91 38.4 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.619 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.1 mt -87.72 145.17 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.82 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.414 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 16.4 mt -86.73 112.12 44.69 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.28 134.26 62.8 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.963 1.775 . . . . 0.0 111.159 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.63 13.93 74.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.424 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -121.13 152.17 39.04 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.682 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -103.89 127.71 51.39 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.485 ' CE2' HD21 ' A' ' 42' ' ' LEU . 84.5 m-85 -115.36 156.98 24.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.096 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 61.9 mt -110.49 132.99 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.46 130.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.582 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -135.02 121.69 20.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.607 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.411 HG13 ' CD2' ' A' ' 26' ' ' TRP . 48.5 t -103.17 127.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.467 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.68 136.27 54.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -96.59 132.75 41.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' SER . 56.0 mt -97.18 125.94 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.346 0.593 . . . . 0.0 110.787 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.595 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 90.0 p -85.62 168.66 14.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.197 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.447 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 81.7 mm-40 -61.75 -18.43 59.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.595 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 32.8 p30 -92.87 -0.72 57.18 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.033 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.24 75.45 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.424 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 55.2 mm-40 -82.43 145.3 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.206 0.503 . . . . 0.0 110.971 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -109.87 139.16 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.722 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.1 t -133.88 130.39 37.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.187 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -73.45 121.72 20.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.042 0.449 . . . . 0.0 111.43 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.464 HD13 ' CD1' ' A' ' 26' ' ' TRP . 35.6 pt -109.59 -22.55 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -157.57 127.68 6.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.769 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.6 t -133.56 120.41 20.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -156.0 153.35 29.37 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.832 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.0 p -111.39 157.92 19.67 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.635 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 26.4 mt-30 -145.84 163.01 36.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.123 0.487 . . . . 0.0 111.112 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.84 105.23 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.149 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.486 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 81.3 p . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.315 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.689 ' HG ' ' N ' ' A' ' 21' ' ' SER . 4.3 p . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.691 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 38.81 -178.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.915 0.864 . . . . 0.0 112.023 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.698 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 25.2 m-85 -156.72 150.65 24.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.741 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.66 102.26 12.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.5 t -110.25 132.53 58.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.324 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.4 p -126.63 154.36 44.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.906 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.475 ' CD1' HD12 ' A' ' 88' ' ' ILE . 33.9 p90 -143.43 -165.48 2.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.724 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -130.68 128.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.286 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 28' ' ' SER . 1.3 p . . . . . 0 C--N 1.326 -0.422 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.692 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.6 m -94.86 -14.83 24.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.53 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.454 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.1 179.05 46.36 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.12 152.25 46.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 0.0 110.19 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.461 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 25.2 ttp180 -131.4 128.31 39.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.63 133.61 57.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.721 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 38.6 tt0 -123.1 130.67 53.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.794 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -133.69 135.78 44.28 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.709 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -144.96 161.52 39.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.239 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.576 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 43.8 mt -71.15 130.39 41.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.142 0.496 . . . . 0.0 111.332 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -65.32 -24.5 67.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.952 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.474 ' HB2' HH22 ' A' ' 70' ' ' ARG . 60.8 mm-40 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.384 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 N-CA-C 111.116 -0.378 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 mt-30 -119.57 144.09 47.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 59.2 m-85 -122.91 141.9 51.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.114 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . 0.455 HD12 ' HH ' ' A' ' 40' ' ' TYR . 85.5 mt -128.06 130.79 48.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.687 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -102.21 133.41 47.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.567 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.2 mt -128.67 156.39 77.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.55 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -71.51 159.3 51.72 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.454 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 47.4 p -60.2 -16.36 32.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.114 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -91.19 -7.92 50.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.704 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 133.74 34.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.222 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 p -128.84 11.36 6.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.584 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 144.22 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.284 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.24 147.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 18.6 t30 -101.4 126.23 48.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.358 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.66 105.65 31.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.08 -176.77 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 123.015 2.477 . . . . 0.0 112.773 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 56.41 35.92 26.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.441 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.519 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 44.4 mt -90.23 140.55 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -68.35 111.58 8.41 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 25.3 Cg_exo -57.71 138.67 87.22 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.191 1.928 . . . . 0.0 112.015 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.1 22.09 74.61 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.917 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.57 ' N ' ' OG1' ' A' ' 95' ' ' THR . 22.2 mmm180 -126.56 154.66 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.984 0.421 . . . . 0.0 111.548 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -100.05 132.44 45.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.694 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.576 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 52.4 m-85 -121.81 153.59 38.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.701 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 69.8 mt -108.1 125.41 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.87 133.87 58.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.044 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -136.36 124.25 22.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.751 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.423 HG21 ' CE3' ' A' ' 26' ' ' TRP . 34.0 t -105.06 129.75 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.599 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.472 ' CE2' HD11 ' A' ' 87' ' ' LEU . 60.8 m-85 -121.57 137.7 54.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.803 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -99.77 134.53 42.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.0 mt -98.27 125.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.399 0.619 . . . . 0.0 110.392 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 80.6 p -82.85 169.11 16.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.553 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.71 -22.32 57.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.936 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.598 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.4 p30 -93.72 0.02 56.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.303 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.51 63.51 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.421 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.35 144.45 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.995 0.397 . . . . 0.0 110.653 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.461 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 86.2 mt-30 -111.19 144.77 39.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.042 0.449 . . . . 0.0 111.431 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.8 t -138.02 132.04 31.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.314 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.472 HD11 ' CE2' ' A' ' 77' ' ' TYR . 26.3 tp -72.61 118.22 15.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.905 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 26' ' ' TRP . 36.3 pt -109.65 -25.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.822 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.7 tp -156.15 125.0 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.842 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 t -133.07 117.7 17.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 t -148.36 153.88 39.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.698 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.8 p -112.17 151.49 29.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.698 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 22.3 mt-30 -139.41 155.59 47.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.0 110.974 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.472 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -114.14 111.58 21.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.202 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 6.9 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.535 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.577 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 5.1 p . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.074 0.464 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -57.59 136.69 56.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.548 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 5.3 m-30 -101.66 147.03 26.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.876 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.461 HG23 ' ND2' ' A' ' 62' ' ' ASN . 16.1 t -130.45 103.77 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -113.78 138.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.456 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.8 p -127.58 151.54 48.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.725 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CZ3' HG22 ' A' ' 76' ' ' VAL . 32.4 p90 -144.37 -165.38 2.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.009 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.93 125.84 58.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.967 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.402 -179.787 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 56' ' ' SER . 2.3 p . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.817 0.342 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.5 m -96.19 -15.99 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.46 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.458 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.54 177.14 46.16 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.24 153.02 43.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.859 0.362 . . . . 0.0 110.54 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.769 ' NE ' HE22 ' A' ' 85' ' ' GLN . 42.3 ttp180 -132.18 132.09 42.83 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.728 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.4 t -113.0 135.09 53.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.53 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.8 133.5 50.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 4.4 p90 -143.56 143.05 31.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.282 0.563 . . . . 0.0 111.729 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -150.36 163.56 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.563 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 90.5 mt -74.07 125.47 28.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 p -64.3 -33.77 76.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.44 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.545 -178.948 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.486 1.076 0 CA-C-O 120.85 0.271 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.36 151.05 40.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.68 139.46 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.42 129.92 45.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.343 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -106.02 134.43 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.146 0.498 . . . . 0.0 111.963 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HB3' ' CB ' ' A' ' 58' ' ' ALA . 7.4 mt -129.71 155.75 79.89 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.686 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -68.06 159.89 51.06 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.195 1.93 . . . . 0.0 111.995 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.458 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 21.0 p -56.25 -12.83 1.75 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.241 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -93.58 -7.11 45.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 54' ' ' LEU . . . -79.6 130.13 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.248 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -130.98 12.65 5.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.861 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.2 p -165.13 147.56 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 p -149.87 147.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.81 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 4.7 t-20 -107.72 127.98 54.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.76 105.65 42.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.126 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.24 175.55 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.896 2.398 . . . . 0.0 112.715 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 60.48 39.1 18.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.994 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.577 ' O ' ' OG ' ' A' ' 20' ' ' SER . 56.9 mt -88.95 153.51 20.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.86 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 46.7 mt -90.72 110.56 42.36 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.873 -0.148 . . . . 0.0 110.836 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -58.95 145.1 98.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.307 2.005 . . . . 0.0 112.204 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.509 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 80.3 17.77 73.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.468 ' NH1' ' HG3' ' A' ' 70' ' ' ARG . 4.9 mmm-85 -128.78 147.54 50.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.547 0.213 . . . . 0.0 110.597 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -98.43 135.09 40.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.86 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 67.9 m-85 -121.02 152.87 38.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.378 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 79.0 mt -111.7 131.23 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.28 134.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.507 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -135.21 123.76 23.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.3 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.47 HG22 ' CZ3' ' A' ' 26' ' ' TRP . 17.2 t -103.62 130.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.462 ' CE1' HD11 ' A' ' 87' ' ' LEU . 49.7 m-85 -122.56 139.06 54.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.433 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.91 135.04 42.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 79' ' ' ILE . 54.0 mt -98.15 123.75 50.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.208 0.527 . . . . 0.0 110.634 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.613 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 59.3 p -83.76 166.18 18.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.498 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -57.48 -18.8 20.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.017 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.613 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 37.4 p30 -91.95 -1.1 57.44 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.747 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.75 13.7 66.63 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.032 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 63.8 mm-40 -85.47 143.3 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.65 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.769 HE22 ' NE ' ' A' ' 37' ' ' ARG . 78.5 mt-30 -108.06 140.41 41.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.742 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 t -135.15 132.68 38.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.035 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.462 HD11 ' CE1' ' A' ' 77' ' ' TYR . 38.7 tp -73.45 118.98 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.707 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 pt -112.09 -21.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.111 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 tp -157.04 124.41 5.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.905 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 t -132.18 120.82 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 t -153.56 155.51 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -121.63 154.27 37.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.181 0.515 . . . . 0.0 111.042 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.7 mt-30 -146.69 157.93 43.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.07 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.53 118.3 36.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.249 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 39.2 p . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.788 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p . . . . . 0 C--O 1.229 0.024 0 CA-C-O 120.957 0.408 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.423 ' HG ' ' N ' ' A' ' 22' ' ' PHE . 3.8 p -63.04 -177.58 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.378 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.491 ' CZ ' HG23 ' A' ' 95' ' ' THR . 17.7 m-85 -147.67 144.33 28.27 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.953 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.432 HG23 ' ND2' ' A' ' 62' ' ' ASN . 14.9 t -116.16 101.67 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.6 t -111.17 135.16 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.357 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.2 p -125.5 154.26 42.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.403 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.475 ' CE3' HG23 ' A' ' 76' ' ' VAL . 38.2 p90 -143.8 -179.19 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.01 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -118.8 129.36 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.045 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 p . . . . . 0 C--N 1.326 -0.435 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.422 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 79' ' ' ILE . 18.8 m -93.05 -15.99 25.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.558 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.502 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.41 -177.82 47.2 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 58' ' ' ALA . 73.8 m-85 -122.73 149.4 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.96 0.41 . . . . 0.0 110.523 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.59 ' NH2' HE22 ' A' ' 85' ' ' GLN . 13.7 ttp180 -127.49 118.71 24.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.49 132.39 49.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.209 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 80.8 tt0 -122.03 134.9 54.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.03 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CE1' ' NE2' ' A' ' 50' ' ' GLN . 54.3 p90 -140.86 137.08 32.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.836 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -149.08 160.86 42.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.203 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.441 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 47.3 mt -74.32 127.39 32.87 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.691 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 p -70.87 -24.01 62.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.027 -179.182 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 37.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.258 0.441 . . . . 0.0 112.851 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.506 ' NE2' ' CE1' ' A' ' 40' ' ' TYR . 6.1 mt-30 -114.88 145.0 42.65 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 39' ' ' GLU . 92.9 m-85 -124.09 136.41 54.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.153 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -119.92 131.37 55.2 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -103.6 132.03 50.22 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.521 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mt -129.72 155.5 80.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -66.68 160.42 46.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.232 1.955 . . . . 0.0 112.539 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.419 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 15.9 p -57.53 -14.19 4.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -90.82 -9.47 46.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 36' ' ' PHE . . . -83.41 128.81 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.938 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.9 p -132.81 14.22 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.339 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -163.16 141.62 8.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.152 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.22 146.43 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.654 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.432 ' ND2' HG23 ' A' ' 23' ' ' VAL . 9.1 t-20 -103.05 127.2 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.34 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -90.65 -179.12 1.53 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.919 2.413 . . . . 0.0 112.622 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 61.58 35.69 17.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.96 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 30.5 mt -89.51 152.88 21.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.11 111.73 40.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.508 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 23.5 Cg_exo -56.29 139.78 86.9 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.933 1.755 . . . . 0.0 111.358 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.83 18.83 69.2 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.685 HH11 ' CG ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -125.02 148.74 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -99.35 132.51 44.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.151 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.441 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 90.3 m-85 -121.56 150.92 40.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.189 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 87.4 mt -107.71 123.65 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -109.95 131.39 61.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 0.0 110.815 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.14 129.08 33.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.603 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.475 HG23 ' CE3' ' A' ' 26' ' ' TRP . 5.6 t -109.99 131.46 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.923 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.483 ' CE2' HD13 ' A' ' 87' ' ' LEU . 26.4 m-85 -123.47 143.37 50.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.288 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.6 136.58 39.32 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.686 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.5 mt -100.72 123.97 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.298 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.606 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 51.9 p -85.44 172.36 11.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.003 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.551 ' OE2' ' OG ' ' A' ' 34' ' ' SER . 78.1 mm-40 -61.48 -23.96 66.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.03 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.606 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.9 p30 -93.57 -1.66 55.18 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.35 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.97 60.05 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.411 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.4 mm-40 -84.79 131.82 34.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.14 0.47 . . . . 0.0 110.596 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.59 HE22 ' NH2' ' A' ' 37' ' ' ARG . 27.3 mt-30 -105.26 141.11 37.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.794 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.6 t -136.29 133.56 37.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.483 HD13 ' CE2' ' A' ' 77' ' ' TYR . 28.0 tp -72.3 118.41 15.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.3 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.06 -20.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.0 tp -155.0 124.89 6.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.422 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.9 t -131.93 123.03 26.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.562 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -154.14 152.76 30.78 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.034 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.6 p -118.19 153.37 33.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -142.59 160.5 40.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.838 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 115.92 25.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.015 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.491 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 81.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.662 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.903 0.383 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.631 ' HG ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -55.08 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.596 0.712 . . . . 0.0 111.862 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.51 ' N ' ' HG ' ' A' ' 21' ' ' SER . 18.7 m-85 -146.34 146.51 30.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.744 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.04 103.19 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.3 t -109.04 134.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.191 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.1 p -128.05 150.52 49.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.757 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.405 ' CD1' HD13 ' A' ' 88' ' ' ILE . 41.4 p90 -145.01 178.62 7.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 t -117.01 128.48 74.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.485 ' H ' ' HG ' ' A' ' 28' ' ' SER . 1.3 m . . . . . 0 C--N 1.325 -0.466 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.422 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.5 m -94.62 -14.77 24.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.469 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 174.9 177.3 43.9 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -124.77 152.86 43.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.624 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.781 ' NH1' ' CD1' ' A' ' 51' ' ' TYR . 14.8 ttp85 -128.59 126.06 39.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.72 132.34 52.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.463 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 73.3 tt0 -127.95 133.25 49.21 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.72 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.6 p90 -140.43 133.74 29.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.222 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -143.59 162.09 36.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 47.2 mt -72.9 134.95 45.01 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.997 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.7 p -73.55 -19.38 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.213 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HB2' ' NH2' ' A' ' 70' ' ' ARG . 73.5 mm-40 . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.936 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.64 ' CG ' ' HH ' ' A' ' 51' ' ' TYR . 61.2 Cg_endo . . . . . 0 N--CA 1.488 1.206 0 CA-C-O 120.745 0.227 . . . . 0.0 111.94 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -112.27 141.0 46.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.781 ' CD1' ' NH1' ' A' ' 37' ' ' ARG . 78.6 m-85 -123.43 138.8 54.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.872 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -126.6 132.18 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -100.91 134.38 43.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.882 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mt -128.64 154.7 79.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.558 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.08 159.39 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.245 1.963 . . . . 0.0 111.957 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.469 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 25.4 p -59.72 -11.99 6.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.672 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -91.23 -6.4 53.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.69 132.97 35.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.682 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 p -130.65 6.84 4.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.267 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.4 p -164.92 141.38 5.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.11 148.96 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.162 0.506 . . . . 0.0 111.667 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.631 ' ND2' ' HG ' ' A' ' 21' ' ' SER . 10.1 t-20 -102.63 125.45 49.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.908 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -99.03 108.17 47.95 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -93.36 -176.92 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 123.168 2.579 . . . . 0.0 112.705 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 59.59 35.55 22.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.233 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -89.6 148.11 23.53 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.191 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -86.49 113.31 51.97 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.034 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -57.66 140.95 95.14 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.236 1.957 . . . . 0.0 112.334 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.619 ' N ' ' HG1' ' A' ' 95' ' ' THR . . . 79.2 21.42 67.6 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.518 ' H ' ' HG1' ' A' ' 95' ' ' THR . 7.3 mmm180 -125.67 149.0 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.945 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.403 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 67.9 tttt -102.34 130.52 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.775 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 90.4 m-85 -122.72 154.05 38.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.3 mt -108.22 125.88 64.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 t -113.98 133.83 58.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.205 0.526 . . . . 0.0 111.401 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.569 ' CB ' ' HH ' ' A' ' 77' ' ' TYR . 40.7 m-80 -134.63 126.08 28.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.354 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.93 128.3 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.848 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.569 ' HH ' ' CB ' ' A' ' 75' ' ' ASN . 25.2 m-85 -121.36 137.94 54.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.01 136.0 41.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.3 mt -98.68 120.95 48.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.808 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 29.2 p -82.4 168.53 17.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.22 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.478 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 73.5 mm-40 -59.28 -18.22 35.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.825 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 38.7 p30 -93.07 -1.51 56.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.243 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.61 12.8 68.72 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.575 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.0 mm-40 -84.69 141.89 30.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.981 0.419 . . . . 0.0 111.082 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.449 HE22 ' NE ' ' A' ' 37' ' ' ARG . 94.4 mt-30 -110.12 141.93 42.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -136.5 131.22 33.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.034 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.488 HD12 ' CE2' ' A' ' 77' ' ' TYR . 30.4 tp -72.3 116.96 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.157 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 26' ' ' TRP . 36.5 pt -110.31 -21.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 tp -154.75 122.03 5.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.185 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.474 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 22.6 t -131.19 117.88 19.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -150.63 155.71 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.637 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.6 p -114.85 156.04 25.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.427 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.488 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 25.4 mt-30 -144.28 153.3 41.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 106.68 14.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.2 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.619 ' HG1' ' N ' ' A' ' 69' ' ' GLY . 20.6 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.595 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.054 0.454 . . . . 0.0 110.241 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.97 159.9 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.41 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.486 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 22.5 m-30 -127.23 151.97 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.806 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.76 106.56 15.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.24 145.48 20.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.109 0.48 . . . . 0.0 111.006 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.2 p -131.4 153.82 49.29 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.69 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.42 ' CD2' HG12 ' A' ' 76' ' ' VAL . 33.0 p90 -143.35 -166.38 2.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.45 129.23 74.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.079 -179.802 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' A' ' 56' ' ' SER . 3.9 p . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.621 ' N ' ' O ' ' A' ' 79' ' ' ILE . 39.0 m -95.45 -12.98 24.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 109.739 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.437 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.17 -179.88 47.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.86 151.53 48.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.749 0.309 . . . . 0.0 110.433 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.847 ' NE ' HE22 ' A' ' 85' ' ' GLN . 25.3 ttp180 -129.35 122.83 30.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.8 t -108.2 133.82 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.542 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 59.3 tt0 -124.46 137.06 54.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.548 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 24.9 p90 -141.81 130.66 22.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.937 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -143.11 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.324 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.488 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 83.0 mt -75.69 123.89 26.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.166 0.507 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.432 ' HG ' ' N ' ' A' ' 44' ' ' GLU . 24.0 p -66.14 -26.04 67.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.423 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.432 ' N ' ' HG ' ' A' ' 43' ' ' SER . 91.0 mt-10 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.299 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 N--CA 1.485 1.019 0 N-CA-C 111.163 -0.36 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.2 mt-30 -120.61 150.93 40.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -124.78 136.13 53.58 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.95 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -122.09 130.19 53.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -104.29 133.53 49.04 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.39 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.41 155.77 79.58 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.278 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 57' ' ' THR . 22.2 Cg_endo -69.49 151.24 70.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 121.63 1.553 . . . . 0.0 112.059 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.437 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 3.3 p -52.16 -13.03 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.491 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 55' ' ' PRO . 78.1 p -93.01 -7.06 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.45 136.79 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.352 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -129.62 8.9 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.5 p -164.57 149.84 10.01 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.85 153.06 10.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.244 0.545 . . . . 0.0 111.944 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 22' ' ' PHE . 50.8 t30 -105.51 128.5 53.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.927 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -102.13 103.36 29.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.808 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -89.95 -175.21 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.177 2.585 . . . . 0.0 112.211 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 58.86 36.63 24.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.234 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.4 mt -89.2 149.66 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.313 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.597 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 21.8 mt -92.67 112.06 53.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.076 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.34 132.84 48.74 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.875 1.717 . . . . 0.0 110.703 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.48 10.72 73.13 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 19.4 mmt85 -123.77 145.9 48.7 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -97.22 133.16 42.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.597 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 20.7 m-85 -115.27 156.19 25.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.225 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 62.5 mt -113.47 122.14 67.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.84 128.12 67.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.067 0.461 . . . . 0.0 110.948 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -133.86 127.17 32.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.599 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.42 HG12 ' CD2' ' A' ' 26' ' ' TRP . 19.5 t -106.99 128.25 61.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.446 ' CE1' HD13 ' A' ' 87' ' ' LEU . 67.9 m-85 -117.32 139.0 51.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.876 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -100.76 135.13 42.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.621 ' O ' ' N ' ' A' ' 34' ' ' SER . 60.0 mt -99.26 121.94 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.916 0.388 . . . . 0.0 110.984 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.595 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 93.0 p -85.2 168.98 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.008 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . 0.52 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 94.8 mt-10 -57.25 -20.8 29.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.643 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.595 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 50.0 p30 -93.38 2.67 56.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.17 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.95 72.62 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.944 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.4 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 69.7 mm-40 -85.13 144.35 28.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.984 0.421 . . . . 0.0 111.4 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.847 HE22 ' NE ' ' A' ' 37' ' ' ARG . 53.5 mt-30 -109.51 140.03 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.719 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 t -135.72 132.36 36.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.867 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.446 HD13 ' CE1' ' A' ' 77' ' ' TYR . 22.0 tp -73.16 117.07 14.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.424 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.0 pt -107.43 -22.84 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.096 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 tp -156.73 125.26 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.812 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.8 t -127.7 123.66 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.33 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 t -155.0 156.72 36.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.613 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.3 p -116.96 156.1 28.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.413 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.486 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 20.0 mt-30 -140.38 160.16 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 111.122 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.69 112.65 17.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.471 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 43.9 p . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.601 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.626 0.25 . . . . 0.0 110.683 . . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.49 164.3 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.164 0.507 . . . . 0.0 111.605 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.429 ' CZ ' HG23 ' A' ' 95' ' ' THR . 19.7 m-30 -128.71 144.26 51.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.58 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.7 101.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.27 136.59 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.509 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.8 p -124.41 152.76 42.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.497 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.458 ' CE3' HG22 ' A' ' 76' ' ' VAL . 38.8 p90 -144.28 -165.88 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 110.639 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 57.7 t -120.27 131.28 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.765 179.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.618 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 73.0 p . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.2 p . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.0 m -93.68 -16.52 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 109.761 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.97 178.82 47.01 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.73 150.82 49.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.658 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.692 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.0 ttp180 -130.09 122.26 27.95 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.98 131.17 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.806 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.432 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.6 tt0 -122.29 132.52 54.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.774 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 54.1 p90 -138.1 137.2 37.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.129 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.43 159.01 43.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.438 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.485 HD21 ' CD2' ' A' ' 72' ' ' TYR . 58.3 mt -73.91 124.43 26.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.197 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -67.14 -28.66 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.595 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.393 -179.193 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 121.006 0.336 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 mt-30 -114.59 146.38 40.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.3 m-85 -123.32 137.2 54.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.324 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.3 mt -121.93 126.81 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -100.69 130.62 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.146 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.9 mt -127.78 154.72 78.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.577 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.35 155.44 67.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.188 1.925 . . . . 0.0 112.503 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.417 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 5.3 p -56.89 -12.57 2.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -94.21 -9.45 36.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.848 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.1 136.05 34.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 110.67 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -129.34 12.6 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.89 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.2 p -164.32 149.32 10.11 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.516 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.41 150.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.178 0.514 . . . . 0.0 111.575 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.47 127.11 50.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.571 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.6 105.01 34.63 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.88 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -90.66 -178.54 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.922 2.414 . . . . 0.0 113.253 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 60.47 36.86 20.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.771 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.51 ' O ' ' OG ' ' A' ' 20' ' ' SER . 47.6 mt -92.62 144.88 24.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.603 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.574 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 19.4 mt -88.71 112.17 48.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.063 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HA ' ' HG1' ' A' ' 95' ' ' THR . 36.4 Cg_exo -53.92 141.67 66.29 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.102 1.868 . . . . 0.0 111.897 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 81.0 17.08 73.17 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.7 mmt-85 -124.01 146.39 48.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.467 ' HE2' ' HG ' ' A' ' 92' ' ' SER . 77.4 tttt -98.94 132.41 44.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.827 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.574 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 55.6 m-85 -118.89 155.6 30.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.762 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 70.8 mt -109.13 126.99 66.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -112.47 131.31 64.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.0 0.428 . . . . 0.0 111.075 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -138.05 125.68 22.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.898 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.458 HG22 ' CE3' ' A' ' 26' ' ' TRP . 46.5 t -105.04 127.85 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.893 0.378 . . . . 0.0 110.413 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.455 ' CE1' HD11 ' A' ' 87' ' ' LEU . 57.7 m-85 -119.45 136.07 54.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.618 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -101.57 135.18 43.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 34' ' ' SER . 64.0 mt -97.08 120.51 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 110.549 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.587 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.2 p -81.39 172.32 13.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.652 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -22.82 59.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.642 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.587 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 49.2 p30 -92.18 0.68 57.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 11.21 73.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.814 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.9 mm-40 -84.02 140.08 32.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.692 HE22 ' NE ' ' A' ' 37' ' ' ARG . 90.8 mt-30 -103.08 142.62 33.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.899 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.7 t -136.58 128.24 28.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.15 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.455 HD11 ' CE1' ' A' ' 77' ' ' TYR . 61.3 tp -73.14 119.16 17.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.0 pt -110.83 -20.89 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.099 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.0 tp -155.46 120.18 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.512 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.7 t -127.13 123.66 37.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 t -156.08 149.58 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.685 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' SER . . . . . 0.467 ' HG ' ' HE2' ' A' ' 71' ' ' LYS . 93.2 p -111.95 155.44 23.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.024 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -140.93 156.67 46.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.237 0.541 . . . . 0.0 110.954 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -119.14 110.94 17.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.252 178.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 94' ' ' THR . 75.6 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.583 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 18.7 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.569 0.224 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' SER . . . . . 0.525 ' HG ' HD22 ' A' ' 62' ' ' ASN . 1.2 p -61.65 131.59 50.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.264 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.632 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 6.6 m-30 -95.03 146.48 24.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.735 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . 0.442 HG22 ' ND2' ' A' ' 62' ' ' ASN . 37.1 t -131.49 103.99 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.903 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -116.05 138.11 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.0 p -124.71 152.58 43.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.821 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.469 ' CD1' HD12 ' A' ' 88' ' ' ILE . 42.1 p90 -146.24 -165.49 2.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.36 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 t -130.81 129.59 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.826 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 p . . . . . 0 C--N 1.324 -0.52 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.801 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.434 ' O ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 m -94.72 -18.74 21.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.209 0.528 . . . . 0.0 109.805 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.85 178.36 46.54 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -123.1 150.26 43.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.486 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.66 ' NE ' HE22 ' A' ' 85' ' ' GLN . 29.4 ttp180 -129.21 120.93 26.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.56 131.22 56.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.89 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.05 132.83 55.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.519 ' CE1' ' NE2' ' A' ' 50' ' ' GLN . 54.7 p90 -140.73 136.45 32.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.609 . . . . 0.0 111.267 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.0 164.72 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.989 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.5 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 79.3 mt -72.45 125.11 26.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.82 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.616 ' HG ' ' N ' ' A' ' 44' ' ' GLU . 18.4 p -62.08 -32.95 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.511 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . 0.616 ' N ' ' HG ' ' A' ' 43' ' ' SER . 71.8 mm-40 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.033 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 N--CA 1.492 1.393 0 CA-C-O 120.783 0.243 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.519 ' NE2' ' CE1' ' A' ' 40' ' ' TYR . 2.2 mt-30 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -126.15 138.92 53.71 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.763 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -127.06 133.05 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -106.65 134.29 50.02 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.693 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -131.83 156.14 80.49 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.669 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.25 158.13 58.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.05 1.834 . . . . 0.0 112.294 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 87.3 p -58.67 -13.04 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -92.97 -6.97 47.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.861 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.12 134.56 34.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.606 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -131.9 15.41 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.482 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -163.28 144.02 9.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.5 p -149.28 148.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.533 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 5.0 t-20 -106.04 127.13 52.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.546 178.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mt -98.34 104.77 25.15 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 94.3 Cg_endo -90.18 172.5 3.57 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.535 2.157 . . . . 0.0 112.587 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 62.45 39.53 11.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.725 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.484 ' O ' ' OG ' ' A' ' 20' ' ' SER . 32.9 mt -89.44 138.68 31.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.291 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.779 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 28.5 mt -68.76 129.34 92.51 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.851 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.05 138.06 27.53 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.508 2.139 . . . . 0.0 112.012 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.26 22.23 73.91 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.467 ' HE ' HD11 ' A' ' 42' ' ' LEU . 5.5 mmm-85 -125.71 148.59 49.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -98.64 134.03 42.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.183 0.516 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.779 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 49.9 m-85 -120.81 149.5 42.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.846 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 66.3 mt -108.18 128.71 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 t -116.58 129.26 73.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.42 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.572 ' OD1' ' OG ' ' A' ' 90' ' ' SER . 33.4 m-80 -134.43 124.41 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.712 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.468 HG21 ' CZ3' ' A' ' 26' ' ' TRP . 21.9 t -100.96 128.14 53.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.496 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.48 ' CE1' HD11 ' A' ' 87' ' ' LEU . 61.2 m-85 -120.12 136.59 54.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.698 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.88 137.5 40.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.759 -0.776 . . . . 0.0 108.969 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.8 mt -100.58 127.7 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 111.4 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 28.4 p -84.53 173.06 11.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.43 -18.06 48.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.868 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.605 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.3 p30 -94.56 -4.04 48.65 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.498 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 13.75 62.41 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.262 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.585 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 69.4 mm-40 -84.56 147.3 27.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.898 0.349 . . . . 0.0 110.335 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.66 HE22 ' NE ' ' A' ' 37' ' ' ARG . 50.0 mt-30 -112.44 147.7 35.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.124 0.488 . . . . 0.0 111.77 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -139.14 128.63 24.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.93 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.48 HD11 ' CE1' ' A' ' 77' ' ' TYR . 15.9 tp -73.3 118.96 16.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.964 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.469 HD12 ' CD1' ' A' ' 26' ' ' TRP . 41.2 pt -111.72 -22.69 4.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 tp -154.85 127.1 7.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.907 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.572 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 48.1 t -135.6 119.05 16.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.133 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -145.77 159.57 42.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.7 p -126.32 152.49 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.2 mt-30 -145.94 163.02 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.598 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.03 108.67 16.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.864 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.451 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 37.9 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.631 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.419 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.7 p . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.94 0.4 . . . . 0.0 109.962 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -61.16 142.37 56.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.37 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 93' ' ' GLN . 6.3 m-30 -96.78 148.38 22.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.34 107.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.21 135.54 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.051 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -123.35 150.58 43.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.693 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.442 ' CD1' HD13 ' A' ' 88' ' ' ILE . 43.0 p90 -146.88 -168.24 2.98 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.301 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.1 t -120.63 132.76 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.521 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.689 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 32.2 t . . . . . 0 C--N 1.323 -0.575 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.416 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 79' ' ' ILE . 8.4 m -94.83 -16.13 23.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.304 0.573 . . . . 0.0 109.682 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.05 175.29 45.08 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -124.28 152.25 43.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.613 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.489 ' HE ' ' HB3' ' A' ' 51' ' ' TYR . 70.7 ttt180 -132.78 122.87 25.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.756 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.2 t -109.58 130.41 62.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.886 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.51 ' OE1' ' C ' ' A' ' 39' ' ' GLU . 13.1 tm-20 -123.68 129.59 51.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 34.9 p90 -143.52 144.74 32.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.213 0.53 . . . . 0.0 111.599 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -148.65 168.14 23.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.464 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' ' 72' ' ' TYR . 67.3 mt -73.86 129.76 38.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.191 0.52 . . . . 0.0 111.532 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.419 ' HG ' ' HD3' ' A' ' 71' ' ' LYS . 35.3 p -70.83 -18.74 62.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.21 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.221 -179.339 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.489 1.25 0 CA-C-O 120.795 0.248 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -116.67 144.14 44.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.489 ' HB3' ' HE ' ' A' ' 37' ' ' ARG . 3.2 m-85 -123.7 139.22 54.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.909 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -127.35 127.67 44.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -100.86 132.1 46.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.354 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -128.0 155.5 77.67 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.456 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -68.33 155.98 67.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.037 1.824 . . . . 0.0 112.303 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.4 p -56.67 -12.59 1.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 37.7 p -91.84 -8.66 45.94 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.79 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.06 34.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -128.5 11.31 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.6 p -164.2 145.89 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.09 145.49 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.361 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -104.23 127.84 51.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.236 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.84 105.94 37.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -87.78 179.52 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.571 2.181 . . . . 0.0 112.492 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 58.37 38.58 25.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.299 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 22' ' ' PHE . 28.8 mt -87.77 150.23 23.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.8 mt -94.21 109.32 41.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.112 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -54.63 139.56 76.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.137 1.891 . . . . 0.0 111.627 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.574 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 84.95 15.92 66.36 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.462 ' NH1' ' HG3' ' A' ' 70' ' ' ARG . 7.6 mmm-85 -125.35 143.75 50.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 110.574 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.419 ' HD3' ' HG ' ' A' ' 43' ' ' SER . 64.8 tttt -100.81 132.0 46.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.512 ' CE2' HD23 ' A' ' 42' ' ' LEU . 80.1 m-85 -119.6 151.41 38.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.894 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 70.3 mt -108.54 131.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -119.68 134.18 64.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.827 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.02 125.7 30.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.48 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.1 t -104.15 128.95 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.765 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.478 ' CE1' HD13 ' A' ' 87' ' ' LEU . 92.2 m-85 -119.08 138.96 52.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.544 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -104.98 137.15 43.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.03 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.6 mt -100.1 121.75 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.195 0.521 . . . . 0.0 110.382 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 83.6 p -82.48 167.67 18.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.597 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -57.55 -19.91 28.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.244 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.61 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.9 p30 -92.24 0.04 57.43 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.188 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.4 9.2 73.06 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.054 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -82.71 143.93 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 111.074 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.461 ' NE2' HG12 ' A' ' 79' ' ' ILE . 3.1 mm-40 -109.53 141.91 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 t -138.27 133.95 33.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.557 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 77' ' ' TYR . 22.9 tp -73.56 118.55 16.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.648 -0.421 . . . . 0.0 109.947 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.442 HD13 ' CD1' ' A' ' 26' ' ' TRP . 45.3 pt -109.92 -23.25 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.211 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.9 tp -157.03 126.6 6.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.119 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 t -132.81 122.36 24.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.495 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -152.38 159.94 43.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.257 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.2 p -121.59 153.03 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.482 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.4 mt-30 -145.64 161.32 40.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.459 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.13 114.17 19.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.705 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 59.5 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.418 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 23.7 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.913 0.387 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -62.46 164.05 7.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.735 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 20.8 m-30 -129.37 147.9 51.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.47 178.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.04 101.9 10.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.953 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.09 137.76 43.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 -178.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -124.55 152.27 43.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.883 179.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.451 ' CD2' HG13 ' A' ' 76' ' ' VAL . 39.0 p90 -143.35 -177.93 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.5 -179.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -108.02 132.54 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.871 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.62 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 98.3 p . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.959 0.409 . . . . 0.0 110.49 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.4 p . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 79' ' ' ILE . 7.2 m -94.5 -17.14 22.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.248 0.547 . . . . 0.0 109.559 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.06 178.51 47.59 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -126.9 151.6 48.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.596 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.418 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 21.2 ttp180 -130.8 121.26 25.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.1 132.01 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.594 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 79.6 tt0 -121.07 133.65 55.24 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.61 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.542 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.4 p90 -139.04 130.48 27.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -142.72 161.63 37.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.573 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 56.8 mt -75.15 132.61 41.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 111.85 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -77.86 -14.67 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.124 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 -179.494 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo . . . . . 0 N--CA 1.489 1.247 0 CA-C-O 120.878 0.282 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.542 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 21.3 mt-30 -118.08 144.9 45.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.594 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.9 m-85 -125.17 137.37 54.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.627 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.5 mt -117.03 127.41 54.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -100.49 131.15 46.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.127 0.489 . . . . 0.0 111.093 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mt -129.12 155.79 79.26 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.59 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.69 158.61 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 112.167 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.427 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 27.8 p -58.69 -12.95 4.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.714 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.5 p -90.31 -10.23 44.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 134.74 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.7 p -126.83 7.51 6.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.563 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -165.76 147.08 7.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.232 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.7 p -148.91 150.43 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.043 0.449 . . . . 0.0 111.371 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 8.1 t-20 -101.49 130.48 47.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.925 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -107.29 97.01 17.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 85.3 Cg_endo -87.46 -171.52 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.664 2.243 . . . . 0.0 112.541 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 58.42 35.63 24.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.219 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.573 ' O ' ' OG ' ' A' ' 20' ' ' SER . 50.0 mt -90.53 142.01 28.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.554 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 27.2 mt -82.75 113.16 43.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.266 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -54.4 141.42 72.32 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.226 1.95 . . . . 0.0 112.204 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.26 20.09 70.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mmm-85 -123.05 146.91 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.716 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -100.15 131.54 46.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.554 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 76.9 m-85 -121.13 153.93 36.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.214 0.531 . . . . 0.0 111.625 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.0 mt -108.31 124.08 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.97 131.54 64.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -134.54 126.1 28.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.552 179.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.451 HG13 ' CD2' ' A' ' 26' ' ' TRP . 38.8 t -106.33 130.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.904 -179.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 87' ' ' LEU . 57.6 m-85 -123.5 136.59 54.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.025 179.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -100.93 134.74 43.46 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.207 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' SER . 59.2 mt -97.5 123.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.957 -178.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.679 ' HG ' ' CG ' ' A' ' 82' ' ' ASP . 52.1 p -83.34 170.97 14.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.97 -21.41 64.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.679 ' CG ' ' HG ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -91.3 -0.8 57.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.56 10.18 70.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.335 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.411 ' CG ' ' OD1' ' A' ' 82' ' ' ASP . 78.3 mm-40 -84.67 140.8 31.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.791 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.418 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 91.4 mt-30 -106.12 143.16 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.2 t -136.59 132.15 34.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.261 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.472 HD13 ' CE1' ' A' ' 77' ' ' TYR . 24.1 tp -72.96 118.37 15.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.349 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.5 pt -109.42 -22.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.401 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.7 tp -154.88 121.81 5.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 111.459 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.3 t -132.08 113.24 13.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.8 t -150.87 162.76 40.16 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.443 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -116.49 154.3 30.61 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.331 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.579 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 23.7 mt-30 -136.56 155.82 49.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.93 109.51 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.499 -179.203 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.525 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.951 0.405 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 p -61.18 165.87 4.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.24 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.675 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 17.3 m-30 -136.12 151.06 49.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.281 178.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.96 102.2 9.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.63 136.51 48.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.306 -178.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -121.88 153.18 38.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.687 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.4 ' CE3' HG23 ' A' ' 76' ' ' VAL . 29.0 p90 -143.58 -168.9 2.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 110.933 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.1 133.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.217 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.518 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 98.2 p . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.422 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.6 p . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.907 0.384 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 79' ' ' ILE . 59.7 m -95.37 -15.07 23.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.525 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.54 -178.89 48.37 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.34 152.73 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.549 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.755 ' NH2' HE22 ' A' ' 85' ' ' GLN . 27.4 ttp180 -130.8 122.68 27.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.594 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.32 134.32 51.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.948 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 83.2 tt0 -121.47 126.95 50.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.202 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.555 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 54.0 p90 -133.6 131.29 39.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.238 0.542 . . . . 0.0 110.502 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -147.44 161.56 40.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.442 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.496 HD23 ' CE2' ' A' ' 72' ' ' TYR . 67.6 mt -75.78 130.45 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.941 0.401 . . . . 0.0 111.702 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.402 ' HG ' ' HD3' ' A' ' 71' ' ' LYS . 27.0 p -74.87 -23.23 58.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.106 179.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.972 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 CA-C-O 120.906 0.294 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.555 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 32.7 mt-30 -116.81 147.82 41.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -123.95 139.59 53.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.943 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.7 mt -124.76 128.55 48.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.056 178.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -103.36 132.02 49.96 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.977 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mt -128.91 155.15 80.02 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.916 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.9 155.77 68.48 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 112.031 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.409 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 26.7 p -58.06 -14.66 7.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.639 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.8 p -89.41 -11.12 44.07 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.367 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.99 131.44 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.4 p -125.28 10.2 8.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.617 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -164.85 146.4 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.06 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . 0.453 HG21 ' N ' ' A' ' 62' ' ' ASN . 5.1 p -149.05 152.21 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.514 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.675 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 13.2 t-20 -102.42 124.76 48.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.762 178.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.421 HG22 ' CD2' ' A' ' 40' ' ' TYR . 2.4 mt -97.26 107.0 35.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -92.21 -178.65 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.802 2.335 . . . . 0.0 113.145 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 58.7 38.05 25.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.531 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.525 ' O ' ' OG ' ' A' ' 20' ' ' SER . 56.7 mt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.094 178.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.521 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 30.2 mt -86.44 123.77 70.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.249 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.81 143.36 55.29 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.226 1.95 . . . . 0.0 112.523 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.56 19.53 73.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.663 HH11 ' CG ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -126.44 151.55 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.302 . . . . 0.0 110.64 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.402 ' HD3' ' HG ' ' A' ' 43' ' ' SER . 77.7 tttt -100.37 130.65 46.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.029 0.442 . . . . 0.0 110.236 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.521 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 68.1 m-85 -117.25 158.52 24.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.017 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.4 mt -113.37 126.08 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.031 0.443 . . . . 0.0 110.642 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -133.36 125.76 29.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.421 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.4 HG23 ' CE3' ' A' ' 26' ' ' TRP . 14.3 t -104.65 128.51 58.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.583 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.465 ' CE1' HD11 ' A' ' 87' ' ' LEU . 54.0 m-85 -120.75 139.37 53.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -101.62 134.52 44.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.4 mt -99.06 119.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.39 0.614 . . . . 0.0 110.621 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.6 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 24.7 p -82.56 169.64 16.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.078 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.98 -19.3 51.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.48 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.6 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 47.3 p30 -93.14 -1.41 56.4 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.144 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.28 67.36 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.926 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 73.8 mm-40 -83.7 139.26 32.88 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.755 HE22 ' NH2' ' A' ' 37' ' ' ARG . 28.7 mt-30 -110.41 139.43 45.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -136.82 135.92 38.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.937 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.465 HD11 ' CE1' ' A' ' 77' ' ' TYR . 32.3 tp -73.28 118.45 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.05 -22.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.612 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -154.87 122.19 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.106 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.2 t -130.61 122.21 27.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -154.34 158.59 40.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.323 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.2 p -117.15 152.69 34.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.463 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 27.0 mt-30 -138.94 157.47 45.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.661 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 112.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.497 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 53.8 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.498 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.413 0.149 . . . . 0.0 111.313 . . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.77 129.57 42.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.182 0.515 . . . . 0.0 110.626 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 19.0 m-30 -95.65 144.87 25.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.266 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.31 102.87 13.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.87 137.88 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.079 0.466 . . . . 0.0 111.504 -178.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -126.52 153.02 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.711 179.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CD2' HG12 ' A' ' 76' ' ' VAL . 32.2 p90 -144.65 -172.52 3.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -113.76 131.15 66.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.629 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.678 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 27.3 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.683 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 56' ' ' SER . 2.1 p . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.8 m -95.31 -13.31 24.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.346 0.593 . . . . 0.0 109.831 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.96 177.02 44.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.57 151.71 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.904 0.383 . . . . 0.0 110.369 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.679 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 46.0 ttp180 -128.66 121.74 29.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.682 178.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.72 132.87 52.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.381 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 69.3 tt0 -123.46 134.28 53.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.763 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 54.6 p90 -140.14 137.18 34.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 110.714 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.62 158.94 44.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.907 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.644 ' CD1' HH21 ' A' ' 70' ' ' ARG . 39.9 mt -74.25 132.4 42.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.471 ' HG ' ' HB3' ' A' ' 71' ' ' LYS . 22.5 p -77.64 -13.67 59.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.317 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.976 -179.539 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.538 ' C ' ' OE1' ' A' ' 50' ' ' GLN . 57.7 Cg_endo . . . . . 0 N--CA 1.489 1.259 0 CA-C-O 120.846 0.269 . . . . 0.0 111.997 . . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.655 ' CD ' ' N ' ' A' ' 50' ' ' GLN . 2.4 mp0 -113.11 147.9 36.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -122.72 136.16 54.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.146 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -120.58 128.28 52.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.66 130.61 46.73 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.201 -178.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -127.82 155.95 76.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.468 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -68.21 156.16 66.77 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.274 1.983 . . . . 0.0 112.269 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 53.4 p -58.8 -14.11 7.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.3 p -90.01 -8.83 50.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.71 132.96 34.39 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 p -128.9 12.73 6.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.032 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.5 p -164.61 148.62 9.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -152.63 147.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.514 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 15.9 t-20 -102.88 127.96 49.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.366 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.21 104.6 27.33 Favored Pre-proline 0 C--N 1.332 -0.177 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.5 Cg_endo -89.42 174.66 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.785 2.323 . . . . 0.0 113.103 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 61.38 38.31 16.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.708 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -90.51 142.44 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.457 HD11 ' NH2' ' A' ' 70' ' ' ARG . 24.9 mt -78.66 130.8 69.69 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.287 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 70' ' ' ARG . 39.0 Cg_exo -51.35 -174.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.206 1.937 . . . . 0.0 111.812 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 17.02 40.29 0.01 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.373 179.068 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.709 ' N ' ' O ' ' A' ' 68' ' ' PRO . 16.2 mmm-85 -127.22 142.76 51.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.346 0.573 . . . . 0.0 110.417 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HB3' ' HG ' ' A' ' 43' ' ' SER . 77.4 tttt -101.19 132.4 46.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.468 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 67.8 m-85 -121.28 155.72 34.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.2 mt -110.68 123.77 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 62.7 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 0.0 111.565 -178.27 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . 0.496 ' OD1' ' OG ' ' A' ' 90' ' ' SER . 21.4 m-80 -133.07 126.14 31.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.523 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' A' ' 26' ' ' TRP . 6.6 t -107.57 131.36 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.471 ' CE1' HD12 ' A' ' 87' ' ' LEU . 46.2 m-85 -122.12 142.29 50.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.116 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.678 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -102.88 137.47 41.04 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.804 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.66 ' O ' ' N ' ' A' ' 34' ' ' SER . 45.2 mt -100.93 121.56 51.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.074 0.464 . . . . 0.0 110.437 -178.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.614 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 71.4 p -82.11 168.13 18.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.945 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -57.62 -22.25 44.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.614 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.5 p30 -92.82 -0.49 57.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.723 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.76 11.95 67.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.495 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.21 138.69 33.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.195 0.498 . . . . 0.0 111.037 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.679 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 94.0 mt-30 -107.03 142.24 36.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.224 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -138.3 135.34 35.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.135 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.471 HD12 ' CE1' ' A' ' 77' ' ' TYR . 36.8 tp -73.42 118.6 16.57 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.228 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.6 pt -110.99 -22.43 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.555 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -155.19 124.86 6.47 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.562 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 7.2 t -135.66 119.22 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.345 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 t -149.88 158.27 44.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.902 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -115.74 154.65 29.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.137 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.553 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 27.1 mt-30 -142.18 159.81 41.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.23 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.17 114.84 23.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.477 178.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.586 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 31.1 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.607 -179.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.536 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 2.6 p . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p -61.59 127.92 33.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -179.614 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 93' ' ' GLN . 5.5 m-30 -92.34 140.41 29.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.126 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.32 107.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.47 135.15 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.847 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -124.34 150.79 45.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.471 ' CD2' HG12 ' A' ' 76' ' ' VAL . 38.9 p90 -145.04 -164.99 2.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.75 133.37 65.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.345 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' SER . . . . . 0.426 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 61.1 p . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.595 -179.196 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 7.5 p . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.641 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.2 m -95.11 -16.51 22.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.83 178.34 47.29 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.19 151.27 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.895 0.379 . . . . 0.0 110.118 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.782 ' NE ' HE22 ' A' ' 85' ' ' GLN . 26.9 ttp180 -130.46 125.62 34.86 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.13 131.49 59.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.396 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -120.99 126.21 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 49.6 p90 -137.61 137.05 38.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.239 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -147.2 167.53 23.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 57.9 mt -77.1 128.59 34.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 111.213 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' SER . . . . . 0.451 ' HG ' ' HB3' ' A' ' 71' ' ' LYS . 18.4 p -76.4 -16.09 59.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.145 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -178.86 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 CA-C-O 121.316 0.465 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.432 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 42.9 mt-30 -118.65 144.7 46.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.904 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -121.1 143.04 49.3 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.054 -0.659 . . . . 0.0 112.203 -178.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 mt -129.38 125.74 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.869 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -100.54 133.52 44.85 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.367 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 160.43 63.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.512 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.61 158.99 39.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.989 1.793 . . . . 0.0 112.129 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.468 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 7.7 p -57.45 -12.23 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.296 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 p -93.8 -8.11 41.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.09 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.07 138.53 34.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -130.27 5.69 4.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.993 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 p -163.31 146.82 10.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.85 146.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.407 -179.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . 0.418 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 14.1 t-20 -103.51 128.49 50.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.296 179.315 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 ' CD1' ' A' ' 40' ' ' TYR . 1.4 mt -105.47 99.49 21.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.925 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 96.7 Cg_endo -88.83 174.46 3.92 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.579 2.186 . . . . 0.0 112.162 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 66.56 37.73 4.39 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.431 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.536 ' O ' ' OG ' ' A' ' 20' ' ' SER . 39.4 mt -89.74 157.42 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 mt -91.1 110.09 39.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.793 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HA ' ' HG1' ' A' ' 95' ' ' THR . 22.1 Cg_exo -56.39 143.33 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.192 1.928 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . 0.766 ' N ' ' HG1' ' A' ' 95' ' ' THR . . . 79.05 17.78 76.14 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -125.15 151.2 46.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HB3' ' HG ' ' A' ' 43' ' ' SER . 66.1 tttt -99.85 131.86 45.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.866 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.535 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 72.2 m-85 -118.84 153.05 35.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.457 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 75.0 mt -110.1 126.81 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.92 133.88 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.115 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -133.98 126.87 31.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.545 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 26' ' ' TRP . 23.9 t -105.44 126.96 60.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . 0.414 ' CE1' HD13 ' A' ' 87' ' ' LEU . 69.3 m-85 -119.35 139.74 51.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . 0.438 ' NE2' HG21 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -105.13 136.61 44.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.35 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.641 ' O ' ' N ' ' A' ' 34' ' ' SER . 46.4 mt -100.66 124.78 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.216 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.6 p -85.43 171.99 11.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.82 -19.45 41.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.8 p30 -92.34 -2.32 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.203 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.52 68.73 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.272 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 65.6 mm-40 -84.48 142.07 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.135 0.468 . . . . 0.0 111.097 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.782 HE22 ' NE ' ' A' ' 37' ' ' ARG . 81.2 mt-30 -108.64 139.81 42.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.832 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -136.92 137.81 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.866 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 77' ' ' TYR . 43.2 tp -74.07 118.46 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.377 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.438 HG21 ' NE2' ' A' ' 78' ' ' GLN . 43.3 pt -110.91 -23.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.0 tp -155.82 125.02 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.666 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.9 t -134.37 118.97 18.06 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 t -153.79 154.39 33.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.447 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -116.52 155.11 29.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.107 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 24.7 mt-30 -145.48 164.65 30.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.238 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 109.52 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.72 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.766 ' HG1' ' N ' ' A' ' 69' ' ' GLY . 72.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.389 -179.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.058 0.456 . . . . 0.0 109.957 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -61.22 172.1 1.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.801 -179.134 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . 0.436 ' CZ ' HG23 ' A' ' 95' ' ' THR . 23.3 m-85 -135.58 146.06 47.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.913 178.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.5 t -117.28 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.515 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.6 t -108.76 134.9 49.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.075 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.0 p -126.66 151.66 47.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.167 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CD2' HG13 ' A' ' 76' ' ' VAL . 36.9 p90 -144.37 -174.64 4.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.977 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.79 127.66 74.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' VAL . . . . . 0.428 ' O ' ' CB ' ' A' ' 56' ' ' SER . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 79' ' ' ILE . 32.1 m -94.46 -15.74 23.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 109.612 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' GLY . . . . . 0.457 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.04 176.68 45.37 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.33 151.48 44.27 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.29 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' ARG . . . . . 0.818 ' NE ' HE22 ' A' ' 85' ' ' GLN . 40.6 ttp180 -131.78 125.06 30.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.8 133.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.621 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.9 tt0 -123.82 132.24 53.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' TYR . . . . . 0.581 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 53.4 p90 -140.04 136.26 33.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.001 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -146.66 161.79 39.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.551 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' LEU . . . . . 0.536 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -75.0 125.14 28.29 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.848 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -69.57 -18.91 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 -179.002 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 N--CA 1.487 1.104 0 CA-C-O 120.872 0.28 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' GLN . . . . . 0.581 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 30.8 mt-30 -114.33 144.01 43.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -120.94 140.33 51.99 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.965 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -125.76 128.08 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.916 178.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -103.12 130.72 50.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.081 0.467 . . . . 0.0 111.43 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -129.77 154.55 81.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.651 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -69.54 157.73 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.371 2.047 . . . . 0.0 112.724 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' SER . . . . . 0.457 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 58.3 p -58.13 -14.65 7.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.701 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.4 p -89.61 -9.67 48.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.03 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.53 131.94 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.603 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.0 p -130.14 13.74 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.5 p -163.58 146.06 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.219 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.21 145.63 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 111.487 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -103.12 125.14 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.391 178.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.8 mt -97.98 107.59 41.59 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.179 -179.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -89.23 177.19 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.856 2.37 . . . . 0.0 112.682 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.47 38.18 19.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.717 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 34.1 mt -90.92 147.74 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LEU . . . . . 0.491 ' O ' ' OG1' ' A' ' 95' ' ' THR . 17.1 mt -89.09 114.25 59.44 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 31.6 Cg_exo -54.33 136.41 68.8 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.276 1.984 . . . . 0.0 111.465 178.031 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.73 26.75 66.47 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.864 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' ARG . . . . . 0.402 ' O ' ' HA ' ' A' ' 94' ' ' THR . 7.0 mmt180 -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -98.34 127.97 44.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' TYR . . . . . 0.536 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 74.6 m-85 -119.02 147.99 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.22 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 76.2 mt -103.87 124.83 58.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 t -111.17 130.57 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.671 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.91 123.08 24.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.507 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' VAL . . . . . 0.463 HG13 ' CD2' ' A' ' 26' ' ' TRP . 17.7 t -104.28 126.57 58.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -120.02 138.3 53.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.878 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.27 135.96 42.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.5 mt -99.26 122.26 50.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.229 0.537 . . . . 0.0 110.613 -178.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 94.5 p -83.5 169.45 15.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -21.15 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.878 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.5 p30 -91.74 -0.91 57.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.009 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.58 11.37 68.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.011 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' GLU . . . . . 0.575 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.0 mm-40 -82.81 140.39 32.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' GLN . . . . . 0.818 HE22 ' NE ' ' A' ' 37' ' ' ARG . 59.4 mt-30 -108.81 141.03 41.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.728 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.3 t -137.26 133.05 34.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.7 tp -71.31 119.05 14.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.695 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ILE . . . . . 0.463 HD12 ' CD1' ' A' ' 26' ' ' TRP . 40.9 pt -108.12 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.652 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -156.07 121.33 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.176 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.7 t -131.1 118.39 20.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.44 178.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -149.42 153.73 37.78 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.724 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.5 p -115.89 149.25 38.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.101 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -147.45 158.9 44.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.6 OUTLIER -119.04 111.5 18.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.739 178.318 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 67' ' ' LEU . 73.8 p . . . . . 0 C--N 1.321 -0.651 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.787 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.29 137.45 78.7 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.846 2.364 . . . . 0.0 111.987 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.6 tp -96.65 136.61 36.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.079 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.65 -12.64 55.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.536 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 6.3 t -111.61 137.96 48.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 5' ' ' SER . 97.6 m-70 -160.39 -13.79 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.203 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -47.47 97.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.393 -179.383 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.535 ' C ' ' H ' ' A' ' 10' ' ' THR . 5.0 p -112.08 -33.64 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.254 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 10' ' ' THR . . . 60.79 1.6 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.147 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.544 ' C ' ' O ' ' A' ' 9' ' ' ALA . 49.1 m 24.18 -97.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.273 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.614 ' O ' ' O ' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -136.76 50.59 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.409 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.614 ' O ' ' O ' ' A' ' 11' ' ' SER . 74.2 tt0 25.79 103.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.091 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 m -85.76 7.18 24.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.808 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 19.6 t -99.26 53.48 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.926 -179.729 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 84.3 m -89.0 138.57 31.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.189 0.519 . . . . 0.0 111.055 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.686 ' OE1' ' N ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -178.72 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.305 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.686 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 50.0 mt -19.0 -79.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.882 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.609 ' C ' ' O ' ' A' ' 17' ' ' ILE . 1.3 p 0.13 111.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.58 0.55 . . . . 0.0 111.163 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.55 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 65.34 24.94 12.11 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.554 -0.458 . . . . 0.0 109.92 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.55 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 59.0 23.87 12.04 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.464 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -65.52 -179.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 111.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.696 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 33.6 m-85 -141.52 140.03 33.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.985 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.449 ' CG2' ' HB3' ' A' ' 16' ' ' GLU . 24.7 t -113.68 101.07 11.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.004 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -111.16 133.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.322 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.7 p -122.24 153.02 39.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.648 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -143.15 -171.57 3.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.57 126.78 73.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.458 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -53.16 126.29 20.34 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.797 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.86 5.7 45.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.492 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.4 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 3.1 m -172.99 136.53 0.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.383 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.73 -3.52 58.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.1 0.476 . . . . 0.0 109.747 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.8 p -89.19 -4.63 58.17 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.013 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.4 p -59.34 138.37 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.102 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.465 ' N ' ' O ' ' A' ' 79' ' ' ILE . 19.5 m -94.44 -15.18 24.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.5 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.64 -179.23 47.74 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.18 154.9 44.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.958 0.409 . . . . 0.0 111.004 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.724 ' NE ' HE22 ' A' ' 85' ' ' GLN . 18.2 ttp180 -132.07 124.92 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 17.9 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.447 -179.506 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' CB ' ' A' ' 49' ' ' PRO . 75.0 tt0 -125.85 129.8 50.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.444 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 22.5 p90 -137.51 130.97 31.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . 0.423 ' O ' ' HA ' ' A' ' 72' ' ' TYR . 17.1 pt-20 -144.51 161.92 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.863 -179.667 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.507 HD21 ' CE2' ' A' ' 72' ' ' TYR . 87.6 mt -74.52 126.63 31.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.161 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.404 ' HG ' ' N ' ' A' ' 44' ' ' GLU . 19.3 p -73.14 -20.98 60.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.153 179.597 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' N ' ' HG ' ' A' ' 43' ' ' SER . 82.3 mt-10 -88.64 -73.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.155 -179.138 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.565 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 92.1 mt-10 -57.2 -35.51 69.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.319 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.48 21.34 75.34 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.504 ' OD2' ' OE1' ' A' ' 45' ' ' GLU . 81.0 m-20 -50.96 168.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.371 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.92 145.29 97.86 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.946 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 72.6 Cg_endo -76.24 151.82 34.5 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.739 2.293 . . . . 0.0 112.769 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.444 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 19.7 mt-30 -114.47 146.18 40.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.441 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -123.09 137.13 55.0 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.437 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 76.7 mt -123.85 135.07 53.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.032 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -108.52 134.71 50.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.329 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.49 153.65 80.67 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.6 156.47 60.84 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.384 2.056 . . . . 0.0 112.344 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 17.6 p -57.56 -15.9 8.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.028 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.8 p -90.94 -7.6 51.64 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.539 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.43 137.18 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.1 p -134.51 13.82 3.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.227 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.7 p -164.79 145.22 7.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.634 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.41 HG23 ' N ' ' A' ' 62' ' ' ASN . 4.3 p -153.93 150.36 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.198 0.523 . . . . 0.0 111.942 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.495 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 9.2 t-20 -103.32 129.27 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.396 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.95 104.34 28.13 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.019 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 94.7 Cg_endo -89.9 179.95 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.833 2.355 . . . . 0.0 113.153 -179.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 59.62 37.03 22.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.7 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.546 ' O ' ' OG ' ' A' ' 20' ' ' SER . 29.5 mt -92.26 150.56 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.163 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.637 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 29.5 mt -89.04 111.27 43.88 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.777 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_exo -57.97 143.6 95.83 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.155 1.903 . . . . 0.0 111.865 179.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.66 80.44 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.565 ' NH2' ' OE2' ' A' ' 45' ' ' GLU . 0.0 OUTLIER -123.22 146.58 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -95.28 134.36 38.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.244 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.637 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 12.3 m-85 -118.49 150.84 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.401 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.8 mt -108.54 121.64 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.94 131.37 66.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.095 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.523 ' OD1' ' OG ' ' A' ' 90' ' ' SER . 39.8 m-80 -133.73 131.46 39.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.701 179.853 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -105.1 131.43 54.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.554 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.472 ' CE1' HD12 ' A' ' 87' ' ' LEU . 66.4 m-85 -123.43 137.42 54.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.686 179.363 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.94 136.65 40.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.465 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.1 mt -99.29 125.26 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.38 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 47.3 p -84.64 169.25 14.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.74 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -59.9 -16.63 30.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.603 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.602 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 43.9 p30 -96.04 0.25 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.06 15.23 63.1 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.71 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.558 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 54.0 mm-40 -83.77 141.97 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.936 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.724 HE22 ' NE ' ' A' ' 37' ' ' ARG . 89.5 mt-30 -114.38 140.37 48.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.625 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -136.09 133.2 37.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.858 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD12 ' CE1' ' A' ' 77' ' ' TYR . 21.8 tp -72.17 116.59 12.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.1 pt -108.99 -21.36 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -155.67 126.24 6.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.574 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.523 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 28.6 t -131.53 122.15 25.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.877 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 t -154.08 153.82 32.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.617 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -112.99 154.75 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.106 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.696 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 31.6 mt-30 -142.09 157.07 45.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.278 0.561 . . . . 0.0 111.388 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.51 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -117.75 107.15 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.51 ' OXT' ' O ' ' A' ' 94' ' ' THR . 71.1 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.919 -1.038 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 48.0 Cg_exo -51.53 160.5 2.51 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.949 2.433 . . . . 0.0 111.938 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mp -55.82 -37.06 68.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.929 0.395 . . . . 0.0 110.434 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.07 -148.37 44.32 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.1 m -61.49 147.21 46.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.733 0.301 . . . . 0.0 110.254 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.78 127.02 18.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.67 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.655 ' O ' ' N ' ' A' ' 9' ' ' ALA . 57.0 mt -144.27 86.08 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.787 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.549 ' C ' ' O ' ' A' ' 7' ' ' LEU . 9.4 p 25.5 38.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 7' ' ' LEU . . . -64.55 149.16 49.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.2 OUTLIER 63.68 -1.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.553 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.634 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 10.0 p 39.14 -128.08 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.449 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.634 ' N ' ' OG ' ' A' ' 11' ' ' SER . 22.0 pt-20 -99.81 130.35 46.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.937 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.7 p -93.57 2.9 56.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.505 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 15' ' ' THR . 16.5 m -111.07 23.95 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.151 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.607 ' C ' ' H ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -33.97 -50.78 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.215 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.592 ' OE1' ' OG ' ' A' ' 21' ' ' SER . 0.0 OUTLIER -66.89 49.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.607 ' H ' ' C ' ' A' ' 15' ' ' THR . 64.1 mt -58.01 -12.82 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.957 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 20' ' ' SER . 78.9 p -53.6 157.52 2.16 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 36.48 28.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.841 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p 55.22 30.59 14.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.778 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.592 ' OG ' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -59.07 176.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.541 0.686 . . . . 0.0 111.538 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.485 ' CZ ' HG23 ' A' ' 95' ' ' THR . 15.2 m-85 -148.19 146.59 28.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.041 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.555 ' CG2' ' OE2' ' A' ' 16' ' ' GLU . 13.6 t -120.96 102.2 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.2 t -110.17 136.93 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.484 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.8 p -123.46 151.72 42.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.846 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.422 ' CD2' HG13 ' A' ' 76' ' ' VAL . 35.4 p90 -143.99 -173.33 3.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.165 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.436 ' C ' ' N ' ' A' ' 29' ' ' ALA . 61.6 t -113.6 132.61 62.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.684 ' O ' ' N ' ' A' ' 30' ' ' SER . 22.1 p -48.43 -20.95 0.47 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.783 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.436 ' N ' ' C ' ' A' ' 27' ' ' VAL . . . 43.84 5.93 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.479 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.684 ' N ' ' O ' ' A' ' 28' ' ' SER . 3.3 m -176.81 136.3 0.23 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.649 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.47 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 48.2 p30 -94.29 4.51 53.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.083 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.7 p -93.37 6.25 48.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.0 p -80.05 135.58 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.28 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 79' ' ' ILE . 12.5 m -94.63 -14.11 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.583 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.67 176.81 46.01 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.59 151.21 46.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.069 0.462 . . . . 0.0 110.827 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.814 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.2 ttp180 -131.94 124.44 29.43 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.23 134.66 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.42 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.41 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 74.6 tt0 -121.96 127.08 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.978 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.435 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 52.6 p90 -135.54 133.98 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.63 165.69 29.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.229 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.502 HD21 ' CE2' ' A' ' 72' ' ' TYR . 85.2 mt -74.65 129.39 37.64 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.211 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 16.8 p -74.79 -15.75 60.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.307 179.874 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -100.07 -65.56 0.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.274 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.518 ' OE1' ' OD2' ' A' ' 47' ' ' ASP . 93.2 mt-10 -62.55 -33.22 74.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.826 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.64 74.64 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.518 ' OD2' ' OE1' ' A' ' 45' ' ' GLU . 86.6 m-20 -48.1 171.01 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.87 0.366 . . . . 0.0 110.408 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.52 ' CD ' ' H ' ' A' ' 48' ' ' GLU . 1.9 pm0 -59.36 138.08 88.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.571 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.24 151.82 38.91 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.66 2.24 . . . . 0.0 112.098 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.423 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 20.0 mt-30 -116.18 151.11 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.42 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.41 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 63.8 m-85 -124.77 138.29 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.052 -178.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.5 mt -125.02 131.35 53.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.73 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -104.63 133.04 50.15 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.917 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.6 mt -130.26 153.37 81.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.639 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.65 154.3 74.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.344 2.029 . . . . 0.0 112.622 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -56.77 -12.53 1.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.7 p -93.16 -9.67 38.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.646 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.54 136.27 34.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.514 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.9 p -128.03 10.62 6.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.01 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.5 p -164.07 150.41 11.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.539 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -151.37 153.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.186 0.517 . . . . 0.0 111.485 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.418 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 8.7 t-20 -103.4 126.57 50.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.723 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -103.02 101.84 24.0 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.926 -179.507 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 69.1 Cg_endo -91.71 -175.24 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.995 2.463 . . . . 0.0 112.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 58.39 35.01 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.398 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.58 ' O ' ' OG ' ' A' ' 20' ' ' SER . 23.3 mt -88.5 153.14 21.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.36 109.97 41.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.206 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.47 ' CD ' ' HG ' ' A' ' 20' ' ' SER . 30.8 Cg_exo -56.02 138.5 82.68 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.234 1.956 . . . . 0.0 111.563 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.81 16.31 73.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.495 ' NH2' ' OE2' ' A' ' 45' ' ' GLU . 2.2 mmt-85 -126.13 148.19 49.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.86 0.362 . . . . 0.0 110.29 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -97.35 133.55 41.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.943 179.449 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.502 ' CE2' HD21 ' A' ' 42' ' ' LEU . 60.3 m-85 -118.89 151.39 38.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.599 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.435 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 71.3 mt -108.91 125.45 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -113.59 131.71 64.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.059 0.457 . . . . 0.0 110.917 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.2 m-80 -134.95 126.94 29.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.969 179.837 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.422 HG13 ' CD2' ' A' ' 26' ' ' TRP . 26.3 t -105.4 128.56 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.463 ' CE1' HD11 ' A' ' 87' ' ' LEU . 77.8 m-85 -120.0 137.64 53.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.694 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 135.55 43.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.1 mt -98.91 122.31 50.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.2 0.524 . . . . 0.0 110.599 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 52.6 p -83.23 170.22 14.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.196 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.6 -19.63 50.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.374 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 44.6 p30 -91.99 -0.59 57.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.273 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.47 75.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 71.7 mm-40 -84.99 142.55 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 110.482 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.814 HE22 ' NE ' ' A' ' 37' ' ' ARG . 48.1 mt-30 -107.14 145.96 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.099 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 t -137.89 130.76 29.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.221 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.463 HD11 ' CE1' ' A' ' 77' ' ' TYR . 29.2 tp -73.01 117.93 15.33 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.232 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.3 pt -107.53 -21.66 5.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.773 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.2 tp -156.51 125.45 5.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.56 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 24.0 t -130.86 118.47 20.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -152.77 167.2 29.81 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.709 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 75.1 p -128.86 157.8 40.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 0.0 110.543 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -142.59 161.18 38.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.294 0.569 . . . . 0.0 111.024 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.49 115.23 21.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.538 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.485 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.609 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.686 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -53.72 13.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.938 2.426 . . . . 0.0 112.104 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.686 ' H ' ' C ' ' A' ' 1' ' ' GLY . 41.9 mt -81.91 156.25 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.232 0.539 . . . . 0.0 111.51 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.75 -171.3 47.57 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.385 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 5.2 p 64.57 84.29 0.15 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -132.37 138.34 47.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.182 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.2 mt -148.62 68.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.386 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.572 ' O ' ' C ' ' A' ' 9' ' ' ALA . 86.8 t -90.5 -78.15 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.841 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . 19.86 59.42 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.2 p -92.51 0.67 57.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.275 -179.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.616 ' O ' ' C ' ' A' ' 12' ' ' GLU . 2.0 t -101.25 -37.95 8.3 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.968 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.616 ' C ' ' O ' ' A' ' 11' ' ' SER . 66.5 tt0 18.04 56.08 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 O-C-N 123.617 0.573 . . . . 0.0 110.182 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.563 ' C ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -14.45 -58.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.081 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.563 HG11 ' HG ' ' A' ' 13' ' ' SER . 33.0 m -92.56 128.64 44.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.688 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.602 ' CG2' ' H ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -123.19 -97.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.602 ' H ' ' CG2' ' A' ' 15' ' ' THR . 68.4 mm-40 -58.49 -37.15 74.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.619 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.595 ' O ' ' CG2' ' A' ' 17' ' ' ILE . 18.5 mt 50.04 6.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.269 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.529 ' H ' ' C ' ' A' ' 16' ' ' GLU . 26.7 m -59.37 128.61 37.96 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.588 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 63.58 27.34 14.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 4.4 p 55.21 31.3 16.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.138 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.611 ' HG ' HD22 ' A' ' 62' ' ' ASN . 79.6 p -62.87 140.21 58.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.386 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.516 ' CD1' ' CD1' ' A' ' 66' ' ' LEU . 5.7 m-30 -95.15 155.55 16.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.252 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -132.74 103.45 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.95 135.27 50.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 110.529 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -127.28 151.15 49.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.289 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.459 ' CE3' HG23 ' A' ' 76' ' ' VAL . 46.1 p90 -148.83 -164.99 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.682 ' C ' ' H ' ' A' ' 29' ' ' ALA . 49.1 t -120.49 133.71 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.586 ' O ' ' C ' ' A' ' 29' ' ' ALA . 36.8 p -50.18 -0.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.446 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.682 ' H ' ' C ' ' A' ' 27' ' ' VAL . . . 6.9 64.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.43 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.4 OUTLIER 164.67 -55.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.288 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 30' ' ' SER . 7.0 t70 77.43 -32.27 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.265 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.47 ' H ' ' C ' ' A' ' 30' ' ' SER . 43.0 p -81.13 0.03 38.07 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.304 0.573 . . . . 0.0 109.545 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.606 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 5.3 p -60.86 138.92 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.374 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.482 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.3 m -95.46 -12.96 25.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.24 177.26 46.01 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.4 m-85 -129.26 151.51 49.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 110.288 179.343 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.635 ' NE ' HE22 ' A' ' 85' ' ' GLN . 27.8 ttp180 -129.71 126.09 37.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 27.0 t -107.56 134.66 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.523 -179.501 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 68.5 tt0 -126.35 127.45 45.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.529 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.465 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 27.0 p90 -136.63 140.86 43.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 0.0 111.104 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.33 161.94 40.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.17 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.47 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 50.9 mt -75.63 127.75 33.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 111.503 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 20.3 p -75.81 -9.73 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.812 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.35 -75.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.15 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.07 -33.63 76.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.112 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.28 32.08 52.98 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.58 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 20.3 t0 -52.02 179.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.58 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -71.25 142.0 86.63 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.612 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.46 146.42 61.99 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.344 2.029 . . . . 0.0 111.83 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.465 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 mt-30 -114.31 147.03 39.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.586 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.453 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 91.4 m-85 -122.65 136.89 55.01 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.841 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.5 mt -124.8 127.15 46.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -99.06 131.96 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.956 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -127.87 154.29 78.16 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.82 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.58 159.64 52.78 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.619 2.213 . . . . 0.0 112.216 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p -60.61 -14.6 21.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.3 p -90.15 -5.44 56.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.328 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.43 139.29 31.64 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.498 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.6 p -129.72 9.54 5.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -167.55 150.2 5.95 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.462 HG23 ' N ' ' A' ' 62' ' ' ASN . 8.1 p -150.29 147.49 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.838 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.611 HD22 ' HG ' ' A' ' 21' ' ' SER . 17.6 t-20 -103.04 127.56 50.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.379 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -102.74 102.1 24.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.322 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 77.3 Cg_endo -86.8 -175.2 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.8 2.333 . . . . 0.0 113.278 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 57.87 39.15 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.611 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.516 ' CD1' ' CD1' ' A' ' 22' ' ' PHE . 25.8 mt -90.96 152.53 20.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.41 108.13 37.29 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.297 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.3 Cg_exo -51.51 140.66 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.295 1.997 . . . . 0.0 111.647 179.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.425 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 83.33 14.76 73.35 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.414 ' H ' ' HG1' ' A' ' 95' ' ' THR . 7.3 mmm-85 -124.69 143.69 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.336 . . . . 0.0 110.385 179.686 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 74.7 tttt -99.19 134.88 41.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.47 ' CE2' ' CD2' ' A' ' 42' ' ' LEU . 83.8 m-85 -121.84 147.93 45.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.489 HG23 HD11 ' A' ' 73' ' ' ILE . 61.6 mt -106.04 128.05 60.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.64 136.49 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.149 0.499 . . . . 0.0 111.588 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -135.36 125.81 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.459 HG23 ' CE3' ' A' ' 26' ' ' TRP . 11.9 t -104.97 131.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.635 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -120.6 140.87 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.489 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.495 ' OE1' ' OG ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -105.92 135.42 47.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.715 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.482 ' O ' ' N ' ' A' ' 34' ' ' SER . 36.0 mt -100.23 121.6 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.439 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.621 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 44.4 p -82.49 171.91 13.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.782 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.06 -19.65 54.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.398 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.621 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 45.4 p30 -91.25 -2.8 57.37 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.389 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.17 67.23 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.319 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.54 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.2 mm-40 -83.33 145.23 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.635 HE22 ' NE ' ' A' ' 37' ' ' ARG . 57.4 mt-30 -111.69 140.73 46.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -137.79 135.27 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.637 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 21.5 tp -71.64 119.29 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.419 -179.676 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.9 pt -109.36 -26.12 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 13.9 tp -156.94 122.77 4.78 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.48 -179.497 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 34.8 t -134.22 121.1 20.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.518 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -150.73 162.35 40.88 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.972 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -121.18 152.12 39.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.289 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.487 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 23.2 mt-30 -144.56 160.26 41.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.234 0.54 . . . . 0.0 110.585 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -120.27 109.44 15.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.875 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.456 ' C ' ' O ' ' A' ' 94' ' ' THR . 69.3 p . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.042 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -51.12 -35.54 51.94 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.913 2.409 . . . . 0.0 112.575 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.4 tp -90.81 140.27 29.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.74 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.79 174.2 21.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.4 p -68.89 165.02 20.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.361 . . . . 0.0 110.58 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 26.8 m80 -121.64 139.13 53.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.342 179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.778 ' H ' ' CD2' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -86.25 6.18 30.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.476 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' A' ' 9' ' ' ALA . 18.5 m -68.76 0.83 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 0.0 110.345 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.561 ' C ' ' H ' ' A' ' 11' ' ' SER . . . 33.15 39.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.529 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 3.4 m 68.24 -38.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.339 . . . . 0.0 111.2 179.308 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.561 ' H ' ' C ' ' A' ' 9' ' ' ALA . 9.9 t -62.83 172.85 1.52 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.78 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.441 ' H ' ' HG ' ' A' ' 11' ' ' SER . 77.2 mm-40 -53.49 142.15 23.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.362 -179.923 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -59.71 -39.42 84.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.845 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.1 t -147.63 118.04 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.685 ' O ' ' N ' ' A' ' 17' ' ' ILE . 14.5 m -117.87 -98.09 0.46 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.311 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.683 ' OE1' ' N ' ' A' ' 23' ' ' VAL . 24.5 pt-20 31.78 27.98 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.662 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 15' ' ' THR . 15.0 mt -78.52 -85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.318 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.626 ' C ' ' O ' ' A' ' 17' ' ' ILE . 30.1 p 7.1 109.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.626 0.579 . . . . 0.0 110.886 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.51 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 69.88 23.41 5.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 56.96 20.91 5.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.907 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 16' ' ' GLU . 3.6 p -58.34 -178.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.22 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 21' ' ' SER . 16.1 m-85 -147.2 149.3 32.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.033 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.683 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 37.8 t -123.4 102.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -110.45 135.59 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.777 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.4 p -129.09 153.73 47.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.411 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.446 ' CZ3' HG11 ' A' ' 76' ' ' VAL . 37.4 p90 -144.24 -171.61 3.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.37 128.42 73.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.1 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.506 ' H ' ' HG ' ' A' ' 28' ' ' SER . 0.0 OUTLIER -47.85 124.54 7.5 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.862 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.406 ' C ' HE22 ' A' ' 78' ' ' GLN . . . -112.42 28.68 8.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.243 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.692 ' C ' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -152.44 -36.81 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.109 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.2 t0 67.21 -28.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.692 ' H ' ' C ' ' A' ' 30' ' ' SER . 2.6 m -93.44 1.09 56.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 1.2 p -54.65 143.18 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.375 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -95.01 -18.53 20.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 109.413 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.451 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.28 179.65 47.68 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.77 151.17 45.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.834 0.35 . . . . 0.0 110.073 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.533 ' NE ' HE22 ' A' ' 85' ' ' GLN . 26.1 ttp180 -130.83 124.71 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 60.2 t -109.1 131.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.43 179.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.11 128.81 52.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 50' ' ' GLN . 51.5 p90 -136.96 140.29 42.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.203 0.525 . . . . 0.0 111.035 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.16 164.05 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.983 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.492 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 34.5 mt -73.96 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 0.0 111.104 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 p -71.05 -21.55 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.915 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -96.35 -63.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.019 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.465 ' HG3' HH21 ' A' ' 70' ' ' ARG . 78.6 mm-40 -63.62 -34.86 78.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.696 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 64.72 22.73 68.43 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.61 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 36.4 t0 -47.7 -170.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 110.567 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.61 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 1.6 pt-20 -73.03 139.1 79.37 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.993 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.65 150.58 45.47 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.554 2.169 . . . . 0.0 112.314 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 18.0 mp0 -114.85 150.61 35.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -124.12 136.81 54.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.926 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.49 127.26 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -102.49 131.42 49.2 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.584 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mt -128.69 155.51 79.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.28 160.49 49.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.227 1.952 . . . . 0.0 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.451 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 p -60.19 -17.03 38.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.643 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.6 p -89.0 -9.54 50.97 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.066 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 130.26 35.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.5 p -127.02 13.07 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.467 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.8 p -165.06 148.09 8.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.267 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -149.89 148.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.494 -179.758 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.777 HD21 ' N ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -104.42 127.29 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.842 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.777 ' N ' HD21 ' A' ' 62' ' ' ASN . 1.7 mt -101.92 103.69 30.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.114 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -90.52 -179.81 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.733 2.289 . . . . 0.0 112.342 179.508 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 59.98 38.13 21.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.69 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.414 ' O ' ' HD3' ' A' ' 68' ' ' PRO . 33.2 mt -87.59 156.93 19.27 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 28.7 mt -94.04 108.33 34.69 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.151 -179.083 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 30.7 Cg_exo -55.1 138.98 80.07 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.064 1.843 . . . . 0.0 111.874 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 14.75 76.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.465 HH21 ' HG3' ' A' ' 45' ' ' GLU . 11.1 mmm-85 -126.36 148.95 49.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -100.66 133.77 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 110.431 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.492 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 77.5 m-85 -122.53 153.0 39.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.582 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.402 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.3 mt -111.05 128.82 67.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.44 130.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.878 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.09 122.72 27.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.036 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.446 HG11 ' CZ3' ' A' ' 26' ' ' TRP . 11.1 t -102.93 126.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.07 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.478 ' CE1' HD12 ' A' ' 87' ' ' LEU . 63.0 m-85 -116.4 140.6 49.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.54 ' OE1' ' OG ' ' A' ' 30' ' ' SER . 0.5 OUTLIER -101.77 133.64 46.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.774 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -97.61 122.29 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 110.591 -178.408 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.593 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 73.2 p -82.18 168.0 18.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.307 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.22 -19.59 34.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.344 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.593 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 40.0 p30 -93.86 -0.42 55.76 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.472 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.04 66.26 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.993 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.5 mm-40 -83.84 138.94 32.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.851 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.533 HE22 ' NE ' ' A' ' 37' ' ' ARG . 37.4 mt-30 -103.44 142.82 33.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.619 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.9 t -136.36 127.38 27.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.871 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.478 HD12 ' CE1' ' A' ' 77' ' ' TYR . 13.7 tp -72.69 118.07 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.969 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.428 HD12 ' CD1' ' A' ' 26' ' ' TRP . 34.4 pt -112.26 -20.3 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -154.98 124.86 6.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.347 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -135.25 112.26 10.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.743 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -145.9 153.18 40.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.3 p -113.42 153.08 29.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.441 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 24.5 mt-30 -140.64 158.91 43.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.18 0.514 . . . . 0.0 110.906 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 106.14 11.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.452 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.477 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 70.9 p . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.74 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.553 ' O ' ' O ' ' A' ' 3' ' ' LEU . 10.7 Cg_endo -56.72 138.05 83.64 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.794 2.33 . . . . 0.0 111.933 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.553 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.9 OUTLIER -47.08 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.353 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.64 23.65 32.87 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 p -79.29 8.41 6.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.334 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 86.2 m-70 -113.73 142.56 45.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.316 -179.293 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.663 ' CD1' ' N ' ' A' ' 7' ' ' LEU . 4.2 mp -86.96 152.59 22.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.825 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.0 t -99.84 135.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.106 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.12 143.24 27.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.653 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.455 ' OG1' ' N ' ' A' ' 11' ' ' SER . 9.2 t -179.08 -157.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.455 ' N ' ' OG1' ' A' ' 10' ' ' THR . 24.0 p -63.11 -171.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.582 ' C ' ' H ' ' A' ' 14' ' ' VAL . 95.5 mt-10 -58.29 -31.56 67.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.21 -42.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.638 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.582 ' H ' ' C ' ' A' ' 12' ' ' GLU . 10.6 p -121.84 144.16 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.599 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.603 ' O ' ' O ' ' A' ' 16' ' ' GLU . 1.3 m -84.96 -82.25 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.005 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.674 ' OE1' ' N ' ' A' ' 23' ' ' VAL . 10.0 pt-20 32.09 105.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.216 0.531 . . . . 0.0 111.115 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.66 ' O ' ' N ' ' A' ' 20' ' ' SER . 46.1 mt -152.41 -77.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.79 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.622 ' C ' ' O ' ' A' ' 17' ' ' ILE . 5.6 p -11.34 126.01 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.539 0.525 . . . . 0.0 110.681 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.582 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 58.05 23.41 10.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER 59.16 29.58 19.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.124 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 17' ' ' ILE . 4.3 p -63.51 163.32 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.585 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 18.2 m-30 -130.38 152.93 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.46 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.674 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 41.5 t -126.84 106.16 15.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.0 t -115.65 134.84 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.1 p -124.68 150.2 46.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.997 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CD1' HD12 ' A' ' 88' ' ' ILE . 42.2 p90 -144.4 -179.5 6.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.915 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.92 128.45 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.542 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.5 t -50.08 133.86 22.61 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.595 ' H ' ' NE2' ' A' ' 78' ' ' GLN . . . -114.98 27.8 9.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.598 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.675 ' C ' ' H ' ' A' ' 32' ' ' THR . 1.3 m -159.55 -25.28 0.07 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.315 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 63.63 -40.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.675 ' H ' ' C ' ' A' ' 30' ' ' SER . 43.9 p -79.24 1.06 26.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.76 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER -53.19 142.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.93 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.7 m -94.58 -16.85 22.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.243 0.544 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.45 179.02 47.52 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.26 151.38 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.109 0.481 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.43 ' HD3' ' NE2' ' A' ' 85' ' ' GLN . 60.8 ttt180 -130.89 124.4 31.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 20.4 t -107.01 131.11 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.924 179.627 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -123.1 122.8 39.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.932 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.56 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.1 p90 -135.7 138.17 42.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.384 0.612 . . . . 0.0 111.251 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -147.4 168.57 21.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.723 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.549 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -74.3 127.77 33.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.535 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 p -69.23 -21.06 63.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.719 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -99.5 -74.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.255 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.645 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 70.6 mt-10 -66.76 150.73 48.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.557 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.7 43.1 1.86 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.509 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 93.1 m-20 -59.89 172.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.029 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.01 136.7 76.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.548 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.82 151.68 74.11 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.562 2.174 . . . . 0.0 111.628 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.56 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 17.2 mt-30 -116.93 146.82 42.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.04 136.7 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.411 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 61.5 mt -126.09 128.76 47.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -104.44 134.12 48.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.643 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mt -130.71 156.53 79.71 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.854 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -66.53 156.38 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.236 1.958 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 62.9 p -58.79 -13.3 5.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.115 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -92.79 -8.02 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.197 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.27 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.346 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -130.6 14.73 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.365 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.2 p -163.65 140.31 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.88 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.8 p -150.09 143.92 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.792 -179.828 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.785 HD21 ' N ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -102.79 128.34 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.025 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.785 ' N ' HD21 ' A' ' 62' ' ' ASN . 1.9 mt -97.82 105.09 24.79 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.49 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.7 Cg_endo -91.16 177.35 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.589 2.193 . . . . 0.0 112.318 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.68 36.94 22.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.728 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.558 ' O ' ' OG ' ' A' ' 20' ' ' SER . 78.4 mt -89.48 146.1 24.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.55 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 34.4 mt -80.7 122.49 82.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.141 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 70' ' ' ARG . 45.6 Cg_exo -48.69 -174.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.994 1.796 . . . . 0.0 111.82 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 21.82 33.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.838 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.695 ' N ' ' O ' ' A' ' 68' ' ' PRO . 10.7 mmm-85 -126.89 144.54 50.96 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.758 0.779 . . . . 0.0 110.612 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -100.11 131.82 45.84 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.55 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 83.6 m-85 -121.75 149.86 42.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.286 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 85.4 mt -104.78 126.78 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.37 132.56 64.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.224 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -133.86 123.64 25.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.17 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.16 126.85 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.53 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.482 ' CE1' HD11 ' A' ' 87' ' ' LEU . 57.6 m-85 -118.45 138.03 52.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.756 179.332 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.595 ' NE2' ' H ' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -100.05 135.86 40.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.489 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.1 mt -98.88 122.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.281 0.562 . . . . 0.0 110.711 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.607 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 100.0 p -84.02 167.5 16.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.755 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.14 -23.3 54.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.925 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.607 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 38.6 p30 -90.97 -0.8 57.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.747 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.62 70.79 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.165 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -83.01 136.47 34.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.43 ' NE2' ' HD3' ' A' ' 37' ' ' ARG . 92.4 mt-30 -105.92 144.29 32.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.151 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 t -139.87 133.05 29.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.482 HD11 ' CE1' ' A' ' 77' ' ' TYR . 15.0 tp -71.51 117.56 13.21 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.47 HD12 ' CD1' ' A' ' 26' ' ' TRP . 31.6 pt -108.9 -22.31 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 -179.447 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.2 tp -156.14 121.18 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 40.3 t -127.03 122.99 35.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.583 178.71 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.3 t -154.28 157.78 39.21 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.575 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.8 p -115.73 153.26 31.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.415 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 31.6 mt-30 -138.06 157.29 46.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 111.071 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.69 108.19 10.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.181 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 44.5 p . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.465 -179.369 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.431 ' H3 ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.431 ' HD2' ' H3 ' ' A' ' 1' ' ' GLY . 24.5 Cg_exo -57.79 148.6 74.08 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.733 2.289 . . . . 0.0 112.179 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.65 ' H ' ' CD2' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -57.39 -36.81 71.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.729 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.9 5.18 77.86 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -107.67 121.97 45.76 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.693 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -118.86 1.58 11.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.5 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.3 mt -68.07 174.61 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.13 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.563 ' O ' ' O ' ' A' ' 9' ' ' ALA . 42.0 t -54.2 144.95 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.077 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.563 ' O ' ' O ' ' A' ' 8' ' ' VAL . . . -32.52 155.94 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.8 m -66.09 136.19 55.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.032 0.444 . . . . 0.0 110.412 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.9 p -163.25 175.98 10.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.675 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.687 ' O ' ' N ' ' A' ' 14' ' ' VAL . 48.7 tt0 -80.58 7.37 10.18 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.6 -73.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.213 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.687 ' N ' ' O ' ' A' ' 12' ' ' GLU . 12.7 m -100.91 140.64 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.652 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.728 ' O ' ' N ' ' A' ' 17' ' ' ILE . 94.1 m -133.77 -119.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.463 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.724 ' H ' ' CG2' ' A' ' 15' ' ' THR . 72.7 mm-40 5.08 55.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.098 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.728 ' N ' ' O ' ' A' ' 15' ' ' THR . 86.6 mt -61.14 -29.17 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 17' ' ' ILE . 7.7 t -40.56 144.18 0.27 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.505 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.556 ' C ' ' OG ' ' A' ' 20' ' ' SER . . . 52.98 17.76 0.96 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.841 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.556 ' OG ' ' C ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 59.38 28.03 17.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.113 0.482 . . . . 0.0 110.016 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.505 ' HG ' HD22 ' A' ' 62' ' ' ASN . 0.0 OUTLIER -60.67 172.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.45 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.551 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 24.0 m-85 -135.61 151.91 50.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.25 105.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -114.12 136.34 50.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -124.59 152.2 43.85 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.281 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.419 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.2 p90 -145.83 -165.29 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.54 131.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.659 ' C ' ' H ' ' A' ' 30' ' ' SER . 19.3 m -52.36 -31.25 32.81 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.656 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 55.16 -8.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.047 178.588 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.659 ' H ' ' C ' ' A' ' 28' ' ' SER . 0.4 OUTLIER -158.36 127.4 5.61 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.15 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.99 4.66 40.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.899 0.38 . . . . 0.0 110.132 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.49 1.8 54.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.689 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.6 p -75.34 136.36 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.589 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.4 m -95.63 -13.5 24.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.549 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.01 179.59 47.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.94 151.53 48.37 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.925 0.393 . . . . 0.0 110.681 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.442 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 18.6 ttp180 -130.5 122.16 27.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.416 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 84.8 t -108.9 132.58 56.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.271 -179.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.469 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 20.0 tt0 -120.87 127.37 51.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.852 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.419 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 52.6 p90 -131.89 132.5 43.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.09 0.472 . . . . 0.0 110.019 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -148.68 165.15 32.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.518 HD22 ' CE2' ' A' ' 72' ' ' TYR . 94.3 mt -73.27 128.54 35.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.942 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -70.82 -24.82 62.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.857 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -92.24 -73.75 0.54 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.744 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.454 ' CD ' HH12 ' A' ' 70' ' ' ARG . 87.8 mt-10 -67.9 146.24 53.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.635 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -95.26 38.01 3.25 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.477 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -53.75 170.39 0.12 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.5 133.02 83.18 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.4 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.56 150.25 69.19 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.601 2.201 . . . . 0.0 112.167 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -116.66 147.78 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.469 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 52.6 m-85 -125.66 141.69 51.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.819 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -127.91 134.65 49.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -106.92 134.12 50.55 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.164 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.45 155.93 80.33 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.044 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.25 154.12 75.41 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.945 1.763 . . . . 0.0 112.357 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.421 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 62.0 p -57.19 -15.75 6.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.5 p -91.06 -8.0 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.37 133.1 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.853 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.8 p -130.41 17.98 5.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.4 p -164.96 144.38 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.269 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.466 HG23 ' N ' ' A' ' 62' ' ' ASN . 9.8 p -149.13 147.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.232 0.539 . . . . 0.0 111.624 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.505 HD22 ' HG ' ' A' ' 21' ' ' SER . 2.2 t-20 -102.83 124.3 48.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.431 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.8 mt -95.44 109.9 47.9 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.317 -179.236 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -90.99 178.9 1.77 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.88 2.387 . . . . 0.0 112.778 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 58.3 37.9 26.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.083 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 76.4 mt -91.11 143.94 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.213 178.665 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.571 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 17.9 mt -90.1 112.79 54.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -56.34 142.28 88.35 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.257 1.971 . . . . 0.0 111.86 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.58 82.32 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.454 HH12 ' CD ' ' A' ' 45' ' ' GLU . 14.6 mmt85 -121.9 150.94 41.26 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.75 130.84 46.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 0.0 110.107 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.571 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 59.8 m-85 -116.77 153.43 32.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.206 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.419 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 84.4 mt -108.51 122.8 63.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.21 131.63 64.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.672 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 44.8 m-80 -137.49 126.53 24.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.591 179.53 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.419 HG11 ' CD2' ' A' ' 26' ' ' TRP . 15.6 t -103.35 130.85 52.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.506 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.5 ' CE2' HD12 ' A' ' 87' ' ' LEU . 71.7 m-85 -120.23 142.98 48.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.217 179.644 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.422 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 0.5 OUTLIER -106.64 133.12 51.8 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' SER . 63.2 mt -96.23 122.83 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.61 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.597 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 20.7 p -81.19 168.11 18.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -58.75 -17.87 26.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.379 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.597 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.3 p30 -93.4 0.01 56.69 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.572 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.63 67.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.38 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.3 mm-40 -88.34 144.74 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.068 0.434 . . . . 0.0 110.652 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.442 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 29.7 mt-30 -103.47 143.32 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.96 125.21 36.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.996 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.5 HD12 ' CE2' ' A' ' 77' ' ' TYR . 25.1 tp -73.02 115.4 12.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.904 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.66 -23.52 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.581 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -156.61 128.08 7.08 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.977 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.6 t -131.66 125.65 32.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.735 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -153.97 156.4 37.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.49 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -116.25 155.48 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.144 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.551 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 25.5 mt-30 -142.31 157.96 44.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.324 0.583 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.64 104.81 9.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.911 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.472 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.536 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.5 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.76 3.35 0.52 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.9 2.4 . . . . 0.0 111.541 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.5 ' H ' ' C ' ' A' ' 1' ' ' GLY . 18.7 mt -77.06 146.66 37.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.748 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.57 -88.03 0.07 OUTLIER Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -60.02 -26.81 66.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.9 m170 60.8 158.17 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.476 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.48 ' H ' ' CD2' ' A' ' 7' ' ' LEU . 1.8 mm? -74.43 -3.48 30.83 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.153 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -119.0 139.63 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.631 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.41 129.6 36.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.285 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.635 ' C ' ' H ' ' A' ' 12' ' ' GLU . 2.4 t -132.65 154.49 50.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.737 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 12' ' ' GLU . 36.1 t 49.94 6.35 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.077 0.465 . . . . 0.0 110.133 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.635 ' H ' ' C ' ' A' ' 10' ' ' THR . 67.7 tt0 53.16 150.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.4 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 7.7 m -57.6 -54.15 50.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.342 -179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.49 132.7 50.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.175 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.449 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 46.5 m -111.7 169.38 8.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.681 ' CB ' ' HG ' ' A' ' 21' ' ' SER . 32.1 mm-40 62.75 17.41 9.81 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -177.95 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -37.94 -80.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.465 -178.712 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.689 ' OG1' ' N ' ' A' ' 19' ' ' ALA . 13.0 p 29.47 -99.57 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.689 ' N ' ' OG1' ' A' ' 18' ' ' THR . . . -69.11 32.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.85 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.644 ' H ' ' C ' ' A' ' 18' ' ' THR . 79.4 p 57.99 33.73 23.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.219 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.681 ' HG ' ' CB ' ' A' ' 16' ' ' GLU . 4.3 p -60.34 149.41 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.551 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 22.2 m-30 -110.16 145.81 36.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.32 104.84 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.93 139.1 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.809 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.8 p -128.19 153.54 46.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.129 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 39.8 p90 -147.22 -166.32 2.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.079 -179.608 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.06 133.1 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.256 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.626 ' C ' ' H ' ' A' ' 30' ' ' SER . 53.3 m -50.38 -30.91 13.35 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.277 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 51.07 2.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.366 179.267 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.626 ' H ' ' C ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -164.74 145.77 7.83 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.48 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.546 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 54.9 t0 -103.25 -12.38 17.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.5 p -86.78 -4.94 59.24 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.456 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.421 HG13 ' O ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -62.58 136.58 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 m -96.16 -14.2 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.495 . . . . 0.0 110.24 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.426 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.53 174.92 43.43 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -123.33 150.73 43.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.063 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.791 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 37.7 ttp180 -130.51 122.52 27.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 91.9 t -106.27 132.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.824 179.634 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.454 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 81.4 tt0 -122.75 132.94 54.46 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.52 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 46.9 p90 -140.09 141.08 36.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.179 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -150.57 163.82 37.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.772 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.465 HD22 ' CE2' ' A' ' 72' ' ' TYR . 50.8 mt -75.35 131.98 40.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.474 ' HG ' ' HD3' ' A' ' 71' ' ' LYS . 17.3 p -78.78 -14.99 58.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.483 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -102.14 -73.37 0.66 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.853 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -59.64 -28.33 67.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.473 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 40.13 86.91 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -60.36 -179.55 0.12 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.892 0.377 . . . . 0.0 110.408 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -74.11 143.33 80.31 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.138 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.7 151.76 58.19 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 122.696 2.264 . . . . 0.0 112.756 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.484 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 24.7 mt-30 -122.75 148.2 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -126.37 137.03 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.188 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.7 mt -122.32 127.84 50.3 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -102.99 133.45 48.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.353 0.597 . . . . 0.0 112.17 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.38 157.2 78.79 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.3 160.5 48.65 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.789 1.66 . . . . 0.0 112.219 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.426 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 50.9 p -57.05 -11.82 1.76 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.183 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.2 p -91.49 -7.5 50.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.435 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.17 35.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.403 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.6 p -126.73 7.62 6.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.839 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -162.21 154.17 18.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.332 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.1 p -153.2 146.97 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.246 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.4 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 30.4 t30 -103.83 128.93 51.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.44 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.67 99.6 22.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.513 0.197 . . . . 0.0 111.055 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 66.9 Cg_endo -89.61 -169.41 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.921 2.414 . . . . 0.0 112.162 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 57.63 36.69 26.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.538 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.452 ' HB2' ' HG ' ' A' ' 20' ' ' SER . 42.7 mt -94.33 138.21 32.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.946 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.673 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 18.6 mt -84.71 113.96 52.54 Favored Pre-proline 0 C--N 1.333 -0.147 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.131 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -54.08 138.07 70.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.92 1.747 . . . . 0.0 111.534 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.405 ' H ' ' HG1' ' A' ' 95' ' ' THR . . . 84.32 14.95 70.18 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.861 179.109 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.87 148.61 48.17 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.474 ' HD3' ' HG ' ' A' ' 43' ' ' SER . 76.9 tttt -98.98 134.78 41.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.361 179.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.673 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 64.9 m-85 -121.5 153.55 37.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.588 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.451 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 85.7 mt -109.38 125.63 66.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.5 129.02 71.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 0.0 110.673 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.3 m-80 -135.71 124.42 23.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.171 179.788 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 17.6 t -103.47 128.01 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.983 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.449 ' CE1' HD12 ' A' ' 87' ' ' LEU . 72.9 m-85 -117.37 142.21 47.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.445 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.547 ' CD ' ' HG ' ' A' ' 86' ' ' SER . 0.4 OUTLIER -103.41 133.75 47.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.865 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.0 mt -98.3 126.17 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 121.384 0.611 . . . . 0.0 110.789 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.604 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 30.0 p -82.87 168.55 16.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.974 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -19.3 62.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.147 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.604 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 36.3 p30 -93.69 2.8 56.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.451 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 11.8 66.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.425 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.458 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 70.5 mm-40 -87.34 142.6 27.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.979 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.791 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 83.7 mt-30 -105.2 147.23 28.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.018 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' SER . . . . . 0.547 ' HG ' ' CD ' ' A' ' 78' ' ' GLN . 0.9 OUTLIER -137.05 124.37 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.614 -179.933 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.449 HD12 ' CE1' ' A' ' 77' ' ' TYR . 14.4 tp -73.71 115.57 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.147 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -109.87 -20.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.7 tp -155.17 123.12 5.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.657 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.0 t -131.87 119.13 20.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -153.37 162.26 41.47 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.601 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.7 p -120.33 153.1 36.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.347 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.551 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 20.7 mt-30 -138.13 157.1 47.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.945 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -123.09 115.7 22.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.474 HG21 ' CE1' ' A' ' 22' ' ' PHE . 40.2 p . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.781 -179.199 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.1 150.22 10.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.641 2.227 . . . . 0.0 112.24 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.68 143.34 26.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.971 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.89 -168.03 34.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.527 ' O ' ' OG ' ' A' ' 5' ' ' SER . 0.0 OUTLIER 65.45 20.49 11.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.829 0.347 . . . . 0.0 110.873 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -93.45 10.9 30.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.648 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.693 ' O ' ' N ' ' A' ' 9' ' ' ALA . 23.1 mt -44.13 160.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.621 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.579 ' C ' ' O ' ' A' ' 7' ' ' LEU . 47.2 t -1.99 -60.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.288 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.693 ' N ' ' O ' ' A' ' 7' ' ' LEU . . . -52.54 129.42 28.97 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.254 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.534 ' O ' ' C ' ' A' ' 11' ' ' SER . 4.4 t -138.12 164.81 28.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.268 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.534 ' C ' ' O ' ' A' ' 10' ' ' THR . 17.7 m 32.36 -119.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -107.37 119.32 39.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.114 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.8 p -92.12 6.42 46.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -86.12 -75.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.559 -179.15 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.642 ' C ' ' H ' ' A' ' 17' ' ' ILE . 1.7 m 61.13 -45.75 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.584 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 14' ' ' VAL . 1.8 pt-20 -62.1 43.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.701 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.677 ' O ' ' N ' ' A' ' 20' ' ' SER . 0.3 OUTLIER -103.6 -11.67 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.833 -178.71 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.441 ' O ' ' HB3' ' A' ' 21' ' ' SER . 26.4 m -46.4 113.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.235 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 65.01 27.32 12.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER 64.34 29.06 13.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.859 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.708 ' HG ' ' N ' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -62.96 -177.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.832 0.825 . . . . 0.0 112.059 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.708 ' N ' ' HG ' ' A' ' 21' ' ' SER . 16.1 m-85 -151.53 140.38 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.278 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.46 101.62 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.89 137.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.222 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.6 p -124.03 151.41 43.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.114 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.48 ' CD2' HG11 ' A' ' 76' ' ' VAL . 40.6 p90 -145.04 -175.39 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.465 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -112.42 133.36 58.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.685 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 45.2 t -49.79 -34.59 19.89 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.353 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 58.34 -0.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.428 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.533 ' H ' ' C ' ' A' ' 28' ' ' SER . 3.2 m -170.99 133.63 0.91 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.118 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -89.68 1.66 55.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.742 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.0 p -92.37 1.55 57.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.301 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.412 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p -70.09 136.03 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.526 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.6 m -97.0 -14.52 21.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.421 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.94 178.54 46.77 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.44 153.04 46.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.483 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.662 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 42.5 ttp180 -131.07 129.25 41.7 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.834 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.37 133.65 57.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.526 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.16 127.71 50.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.091 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.414 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.8 p90 -135.25 130.63 35.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.32 0.581 . . . . 0.0 110.66 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -143.98 165.1 28.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.721 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.488 HD21 ' CE2' ' A' ' 72' ' ' TYR . 35.5 mt -74.78 127.14 32.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 0.0 111.505 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 p -69.9 -37.85 76.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.49 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -78.93 -56.6 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.226 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.675 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 81.9 mt-10 -85.85 152.45 22.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.973 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -99.5 26.78 23.03 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.513 ' CG ' ' N ' ' A' ' 48' ' ' GLU . 25.4 t70 -46.37 172.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.425 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.513 ' N ' ' CG ' ' A' ' 47' ' ' ASP . 1.3 pm0 -72.43 139.37 81.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.594 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.1 153.13 46.36 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.69 2.26 . . . . 0.0 112.291 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.404 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 9.2 mt-30 -118.88 143.82 46.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.711 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.07 136.64 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.092 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.93 131.72 53.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -106.18 136.07 46.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.091 0.472 . . . . 0.0 111.457 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.8 mt -130.21 157.24 77.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.576 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -69.97 158.7 55.83 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.939 1.759 . . . . 0.0 112.098 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 36.7 p -59.31 -12.95 6.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.114 -179.66 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.2 p -92.05 -8.56 45.57 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.69 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -131.02 11.21 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.0 p -164.43 143.89 7.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.01 149.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.465 HD21 ' N ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -103.9 123.41 47.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.069 178.832 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.465 ' N ' HD21 ' A' ' 62' ' ' ASN . 2.0 mt -100.38 102.82 19.96 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.003 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.431 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 63.1 Cg_endo -92.87 179.98 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.909 2.406 . . . . 0.0 113.207 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 62.31 37.3 14.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.901 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.563 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -92.47 152.34 19.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.291 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.405 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 19.3 mt -82.96 119.85 75.05 Favored Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.969 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.52 144.89 62.62 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.867 1.711 . . . . 0.0 112.082 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.76 15.45 75.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.675 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -124.81 153.4 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.731 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.6 133.86 46.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.488 ' CE2' HD21 ' A' ' 42' ' ' LEU . 86.9 m-85 -120.4 151.12 39.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.74 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 77.1 mt -108.53 123.94 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.5 t -116.11 134.68 58.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.161 0.505 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -135.2 129.65 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.48 HG11 ' CD2' ' A' ' 26' ' ' TRP . 28.6 t -106.61 128.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.355 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.471 ' CE1' HD11 ' A' ' 87' ' ' LEU . 60.1 m-85 -120.55 139.53 52.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.869 179.435 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.685 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -101.11 133.33 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.526 ' O ' ' N ' ' A' ' 34' ' ' SER . 52.2 mt -98.33 122.69 50.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.292 0.567 . . . . 0.0 110.448 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.601 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 42.0 p -83.79 169.11 15.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.124 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 77.6 mm-40 -58.19 -20.81 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.09 -179.71 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.601 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.5 p30 -91.35 -2.61 57.31 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.945 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.01 12.71 67.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.136 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.587 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.7 mm-40 -84.0 141.04 31.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.662 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 93.3 mt-30 -105.19 140.92 37.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -134.02 127.86 33.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.107 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.471 HD11 ' CE1' ' A' ' 77' ' ' TYR . 23.0 tp -72.06 116.28 12.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.553 179.549 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.3 pt -107.4 -23.1 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.4 tp -159.08 124.81 4.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.054 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.4 t -128.48 126.71 41.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.9 t -153.77 159.03 41.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.196 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -120.58 152.26 38.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.084 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.427 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 23.1 mt-30 -143.65 158.12 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.996 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 114.88 20.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.906 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.486 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 33.4 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.647 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.63 153.32 56.25 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.899 2.399 . . . . 0.0 111.96 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.3 mt -78.6 143.8 36.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.036 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.4 -136.66 12.83 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 38.78 56.45 1.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.642 ' H ' ' CD2' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -68.68 -46.84 68.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.493 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.525 ' N ' ' CD2' ' A' ' 7' ' ' LEU . 3.0 mm? -81.57 -154.68 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.274 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 6.1 m -48.46 132.73 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 110.253 -179.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.435 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -58.14 151.85 18.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.714 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.2 p -67.19 2.65 1.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.06 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.435 ' H ' ' C ' ' A' ' 9' ' ' ALA . 31.2 t -99.55 138.18 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.864 179.615 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -76.93 150.23 35.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.929 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 23' ' ' VAL . 61.8 m -71.45 -6.92 43.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.06 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.6 143.34 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.481 . . . . 0.0 111.076 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.672 ' O ' ' N ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -144.16 -52.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.199 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.404 ' HB2' ' OG ' ' A' ' 21' ' ' SER . 74.5 mm-40 -64.3 45.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 15' ' ' THR . 80.4 mt -43.64 -37.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.365 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.421 ' O ' ' CB ' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -43.26 124.99 3.57 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.639 ' C ' ' HG ' ' A' ' 20' ' ' SER . . . 74.84 20.13 2.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.471 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.639 ' HG ' ' C ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER 56.51 25.76 10.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.96 0.409 . . . . 0.0 110.455 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.776 ' HG ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -63.29 -174.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.496 0.665 . . . . 0.0 112.15 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.759 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 21.1 m-85 -149.67 148.24 29.05 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.165 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 13' ' ' SER . 43.4 t -118.75 103.96 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -112.28 135.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -123.07 151.51 41.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.293 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 41.0 p90 -143.47 179.92 6.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.341 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -117.38 129.27 74.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.239 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 p -50.39 133.12 24.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.431 ' C ' HE22 ' A' ' 78' ' ' GLN . . . -111.44 11.96 21.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.793 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.565 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 1.5 m -169.94 98.0 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.607 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.453 ' OD1' ' O ' ' A' ' 31' ' ' ASP . 66.0 t0 -50.28 -23.78 2.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.2 p -74.94 1.52 12.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.341 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.565 ' CG1' ' O ' ' A' ' 30' ' ' SER . 2.1 p -64.14 134.77 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.43 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 81' ' ' GLU . 70.8 m -95.36 -15.46 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.466 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.88 179.66 47.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -125.9 152.88 44.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 110.602 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' NH2' ' CD2' ' A' ' 51' ' ' TYR . 55.2 ttt180 -133.9 127.65 32.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.9 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.0 t -108.29 132.78 55.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.075 179.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.34 125.59 44.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.801 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.509 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 42.5 p90 -141.35 140.33 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.897 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -149.38 169.99 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.39 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' ' 72' ' ' TYR . 92.3 mt -74.28 126.66 31.13 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.42 ' HG ' ' N ' ' A' ' 44' ' ' GLU . 24.5 p -62.05 -33.92 75.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.388 179.64 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.42 ' N ' ' HG ' ' A' ' 43' ' ' SER . 93.8 mt-10 -86.19 -75.41 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 -179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.03 145.22 55.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.967 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.28 41.96 2.53 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.56 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -57.91 165.75 1.7 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.7 139.06 97.66 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.186 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.74 155.97 57.79 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.674 2.249 . . . . 0.0 111.824 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.509 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 32.5 mt-30 -119.91 140.78 50.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.778 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CD2' ' NH2' ' A' ' 37' ' ' ARG . 6.1 m-85 -121.64 141.28 51.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.588 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.5 mt -131.15 123.44 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -101.61 135.72 42.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.134 0.492 . . . . 0.0 111.578 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -132.86 159.43 72.63 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.842 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -72.52 160.17 47.31 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.094 1.863 . . . . 0.0 112.624 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.466 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 61.1 p -61.69 -15.48 40.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.696 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -88.34 -1.14 57.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.691 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.696 ' O ' ' CG2' ' A' ' 59' ' ' THR . . . -75.86 -146.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.595 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . 0.696 ' CG2' ' O ' ' A' ' 58' ' ' ALA . 1.9 p 143.45 4.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.8 p -163.75 141.89 7.54 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.405 HG23 ' N ' ' A' ' 62' ' ' ASN . 8.8 p -150.74 155.35 7.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.174 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.776 ' ND2' ' HG ' ' A' ' 21' ' ' SER . 0.7 OUTLIER -106.1 122.88 47.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.217 178.748 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.609 ' N ' HD21 ' A' ' 62' ' ' ASN . 2.1 mt -95.87 106.67 29.26 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.175 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.4 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 64.7 Cg_endo -92.74 177.33 1.5 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 123.115 2.544 . . . . 0.0 113.393 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 60.19 38.33 20.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.958 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.541 ' O ' ' OG ' ' A' ' 20' ' ' SER . 39.8 mt -91.76 143.15 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.758 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 64.2 mt -83.86 112.82 43.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -55.29 143.12 77.43 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.675 ' H ' ' HG1' ' A' ' 95' ' ' THR . . . 76.51 17.37 79.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.283 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.441 ' NH1' ' HG3' ' A' ' 70' ' ' ARG . 8.9 mmm-85 -123.98 152.79 42.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.153 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -100.97 130.96 47.04 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.451 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.758 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 65.1 m-85 -118.5 144.59 45.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.091 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.432 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.2 mt -104.11 125.5 58.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.0 132.54 61.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.243 0.544 . . . . 0.0 111.154 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -134.78 128.13 32.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.514 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -104.11 128.45 57.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.416 -179.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.474 ' CE1' HD12 ' A' ' 87' ' ' LEU . 79.6 m-85 -119.54 138.53 53.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.179 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.431 HE22 ' C ' ' A' ' 29' ' ' ALA . 1.6 pt20 -101.13 136.87 40.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -100.03 123.32 52.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.591 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 84.3 p -83.31 171.99 12.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.32 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 76.1 mm-40 -58.77 -19.96 45.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.496 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.591 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 48.8 p30 -95.08 -0.22 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.12 65.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.564 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.3 mm-40 -83.82 143.79 29.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.849 0.357 . . . . 0.0 110.53 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.91 142.78 45.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 111.686 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.7 t -138.24 134.54 34.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.86 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.474 HD12 ' CE1' ' A' ' 77' ' ' TYR . 53.5 tp -73.34 117.44 15.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.3 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.0 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.992 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.7 tp -156.84 125.44 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.325 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 38.2 t -132.13 122.53 25.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.819 179.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.8 t -151.7 158.69 43.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.75 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -118.04 152.55 35.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.759 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 23.6 mt-30 -140.51 156.77 46.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.268 0.556 . . . . 0.0 110.313 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -123.13 104.81 9.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.629 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.675 ' HG1' ' H ' ' A' ' 69' ' ' GLY . 81.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.051 -0.975 . . . . 0.0 110.435 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.546 ' O ' ' O ' ' A' ' 3' ' ' LEU . 1.0 OUTLIER -48.5 147.1 9.59 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.919 2.412 . . . . 0.0 111.978 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 2' ' ' PRO . 47.4 mt 54.2 128.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.616 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.695 ' O ' ' N ' ' A' ' 6' ' ' HIS . . . -170.16 152.36 18.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 t 55.35 -67.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.8 0.334 . . . . 0.0 110.704 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.695 ' N ' ' O ' ' A' ' 4' ' ' GLY . 1.8 p80 -80.75 152.86 28.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.249 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.3 mt 56.26 15.0 1.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -56.52 135.67 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.839 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.44 16.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.442 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -99.52 -0.33 40.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.634 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.557 ' O ' ' CB ' ' A' ' 12' ' ' GLU . 42.3 t -51.36 160.04 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.678 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.707 ' C ' ' H ' ' A' ' 14' ' ' VAL . 41.6 tt0 87.53 -3.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.485 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 p 60.09 -23.19 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.707 ' H ' ' C ' ' A' ' 12' ' ' GLU . 14.2 p -107.04 139.52 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.322 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.561 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 1.2 m -93.08 -79.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.561 ' N ' ' CG2' ' A' ' 15' ' ' THR . 60.1 mp0 -49.1 134.52 17.43 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.24 0.543 . . . . 0.0 110.399 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 20' ' ' SER . 5.9 mt -127.82 -25.25 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.401 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 17' ' ' ILE . 35.8 p -39.86 138.28 0.8 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.77 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.589 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 51.53 23.94 2.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.589 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 94.5 p 61.35 45.28 8.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.715 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.539 ' OG ' ' C ' ' A' ' 16' ' ' GLU . 2.6 p -63.16 158.51 19.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.556 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.627 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 21.6 m-30 -125.69 155.92 40.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.776 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.546 ' CG2' ' OE1' ' A' ' 16' ' ' GLU . 71.4 t -128.83 106.3 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.7 t -111.94 137.48 44.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.71 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.1 p -129.14 153.56 47.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CE3' HG23 ' A' ' 76' ' ' VAL . 34.0 p90 -143.41 -165.88 2.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.023 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.0 t -127.73 124.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.79 101.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.902 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.3 3.55 10.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.706 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.514 ' O ' ' CG1' ' A' ' 33' ' ' VAL . 3.3 m -168.92 116.96 0.66 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.781 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -71.73 -10.5 59.87 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.256 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.8 p -82.4 -0.68 47.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.456 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.514 ' CG1' ' O ' ' A' ' 30' ' ' SER . 2.4 p -64.04 137.84 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.25 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.645 ' N ' ' O ' ' A' ' 79' ' ' ILE . 53.1 m -94.0 -15.48 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.213 0.53 . . . . 0.0 109.803 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.456 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.2 176.46 45.32 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -125.41 152.91 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.906 0.384 . . . . 0.0 110.673 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.669 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.4 ttp180 -131.5 124.33 29.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 74.4 t -109.03 133.67 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.938 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -124.6 132.65 53.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.341 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.578 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 22.8 p90 -137.82 130.28 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.095 0.474 . . . . 0.0 110.284 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.71 166.61 26.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.609 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 87.1 mt -73.65 128.59 35.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.413 0.625 . . . . 0.0 111.969 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 p -68.23 -27.84 66.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.463 ' HG3' HH22 ' A' ' 70' ' ' ARG . 88.1 mt-10 -93.53 -75.19 0.51 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -64.73 144.0 57.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.05 41.31 2.44 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.343 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.26 169.72 1.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 48' ' ' GLU . 3.4 pm0 -69.17 137.17 89.24 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.577 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.82 156.2 48.47 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.783 2.322 . . . . 0.0 112.085 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.578 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 11.4 mt-30 -120.29 144.0 48.04 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -124.41 140.38 53.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.506 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 mt -124.71 129.38 50.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.13 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -101.48 131.78 47.43 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.905 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.4 mt -130.08 155.64 80.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.433 ' C ' ' H ' ' A' ' 57' ' ' THR . 22.7 Cg_endo -68.94 156.65 64.69 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.38 2.053 . . . . 0.0 112.5 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.452 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 30.4 p -55.74 -11.6 1.01 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.433 ' H ' ' C ' ' A' ' 55' ' ' PRO . 29.5 p -92.0 -7.29 49.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.61 132.28 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -130.32 9.32 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.182 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.9 p -164.12 146.8 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.62 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.439 HG21 ' N ' ' A' ' 62' ' ' ASN . 5.2 p -151.0 152.69 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.772 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 11.7 t-20 -106.68 126.63 52.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.458 HG23 ' CG ' ' A' ' 40' ' ' TYR . 2.3 mt -100.94 104.94 35.36 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.148 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -91.35 -179.34 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.779 2.319 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 58.66 39.03 24.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 19' ' ' ALA . 41.5 mt -90.41 143.91 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.3 mt -78.02 129.81 74.65 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.043 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.49 140.94 44.98 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.529 2.153 . . . . 0.0 112.873 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.38 27.99 71.91 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.686 ' CZ ' ' H ' ' A' ' 71' ' ' LYS . 4.9 mmm180 -126.48 148.13 49.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.22 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.686 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 75.7 tttt -100.26 131.15 46.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.609 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 64.4 m-85 -119.82 151.26 39.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -104.99 123.7 59.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -111.69 131.15 63.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -133.98 125.86 29.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.507 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.47 HG23 ' CE3' ' A' ' 26' ' ' TRP . 5.7 t -104.42 126.57 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.03 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.466 ' CE1' HD12 ' A' ' 87' ' ' LEU . 81.4 m-85 -118.82 141.91 48.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.809 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.23 135.58 46.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.645 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.9 mt -98.38 122.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.172 0.511 . . . . 0.0 110.634 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.605 ' HG ' ' CG ' ' A' ' 82' ' ' ASP . 47.2 p -82.52 169.53 16.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.811 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.3 -20.47 43.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.126 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' CG ' ' HG ' ' A' ' 80' ' ' SER . 2.0 p-10 -92.04 -2.32 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.51 14.46 65.77 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CG ' ' OD2' ' A' ' 82' ' ' ASP . 60.2 mm-40 -86.2 144.17 27.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.121 0.46 . . . . 0.0 111.211 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.669 HE22 ' NE ' ' A' ' 37' ' ' ARG . 93.2 mt-30 -109.18 139.61 43.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 t -137.81 136.1 36.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.392 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.466 HD12 ' CE1' ' A' ' 77' ' ' TYR . 19.3 tp -72.88 116.73 13.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 pt -108.87 -22.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.29 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.1 tp -156.32 125.81 6.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.62 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.5 t -133.44 122.43 23.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.508 178.857 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -149.7 156.54 42.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.461 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -117.58 153.03 33.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.42 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 24.1 mt-30 -140.98 158.36 44.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.216 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.71 108.23 16.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.576 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.473 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 6.1 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.344 -179.468 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -55.38 144.53 72.0 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.657 2.238 . . . . 0.0 112.006 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 88.9 mt -80.86 -4.26 54.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.167 179.923 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 5' ' ' SER . . . 130.35 145.77 5.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.619 ' OG ' ' N ' ' A' ' 6' ' ' HIS . 3.6 t 38.16 -171.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.752 0.31 . . . . 0.0 110.612 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.619 ' N ' ' OG ' ' A' ' 5' ' ' SER . 35.6 m170 -136.28 160.89 37.32 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.732 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.2 tp -83.75 139.8 32.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.698 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -87.82 139.93 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 110.699 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.516 ' O ' ' OG1' ' A' ' 10' ' ' THR . . . -44.72 147.55 0.61 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.625 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 9' ' ' ALA . 48.4 p 55.54 98.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.162 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.4 m -63.86 -76.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -57.08 143.45 38.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.109 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.4 p -63.22 -13.04 33.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.6 t -115.68 131.62 67.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.535 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.599 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 2.2 m -104.35 -86.37 0.46 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.086 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.599 ' N ' ' CG2' ' A' ' 15' ' ' THR . 76.7 mm-40 -45.04 130.95 7.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.314 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.442 HG13 ' O ' ' A' ' 15' ' ' THR . 6.0 mt -126.67 -24.16 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.664 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 59.6 m -54.34 136.79 43.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.812 -179.714 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.588 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 63.53 22.06 13.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.588 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 4.7 p 56.69 37.23 28.66 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.154 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.626 ' HG ' HD22 ' A' ' 62' ' ' ASN . 1.4 p -60.45 165.56 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.524 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.536 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 15.8 m-30 -133.51 154.76 50.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.818 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.43 104.32 8.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.43 136.8 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.43 150.92 43.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.438 ' CE3' HG21 ' A' ' 76' ' ' VAL . 36.9 p90 -145.26 -174.15 4.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.373 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.5 t -109.55 135.38 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.61 ' O ' ' N ' ' A' ' 30' ' ' SER . 85.2 p -53.53 -20.6 5.16 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.544 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.484 ' O ' ' CB ' ' A' ' 30' ' ' SER . . . 31.53 30.94 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.495 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.61 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.4 OUTLIER 164.71 122.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.907 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -87.18 -8.1 57.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.371 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.3 p -84.71 -4.4 59.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.0 p -64.64 136.45 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.275 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.506 ' N ' ' O ' ' A' ' 79' ' ' ILE . 67.5 m -94.86 -14.65 24.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.27 0.557 . . . . 0.0 109.541 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.36 -179.87 47.93 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -127.31 150.57 49.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.003 0.43 . . . . 0.0 110.75 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -129.2 124.81 35.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.84 131.2 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.121 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.434 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.9 tt0 -123.27 133.57 54.17 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.579 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.7 p90 -140.65 138.7 34.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.446 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -148.02 165.54 30.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.706 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.488 HD22 ' CD2' ' A' ' 72' ' ' TYR . 56.3 mt -73.13 127.61 33.09 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.028 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.63 ' HG ' ' N ' ' A' ' 44' ' ' GLU . 18.6 p -70.34 -34.62 72.88 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.63 ' N ' ' HG ' ' A' ' 43' ' ' SER . 98.2 mt-10 -80.05 -50.91 9.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.825 -179.933 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.621 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 90.5 mt-10 -94.39 144.99 25.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.651 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -84.96 23.88 7.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.69 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 52.3 t0 -43.61 177.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.993 0.425 . . . . 0.0 110.258 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.69 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 4.0 pm0 -83.11 143.06 44.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.089 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.43 153.57 39.86 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.838 2.359 . . . . 0.0 112.036 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.469 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 16.2 mt-30 -123.36 146.02 48.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 80.4 m-85 -124.86 139.17 54.08 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.046 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.7 mt -123.2 129.16 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.231 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -102.21 130.92 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.831 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.25 154.72 80.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.795 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.15 156.76 64.59 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.143 1.895 . . . . 0.0 112.374 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 14.5 p -56.56 -11.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -93.76 -9.17 38.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.698 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.8 35.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.485 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 p -130.19 12.22 5.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.0 p -164.38 143.13 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.95 149.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.62 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.626 HD22 ' HG ' ' A' ' 21' ' ' SER . 8.9 t-20 -105.16 128.02 53.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.26 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mt -104.84 101.34 28.66 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.449 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -89.47 -174.58 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.773 2.315 . . . . 0.0 112.439 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 59.72 37.01 22.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.386 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 45.9 mt -90.36 151.88 21.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 178.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.769 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 30.4 mt -95.37 108.35 38.62 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.977 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.28 139.78 81.31 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.432 2.088 . . . . 0.0 111.839 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.58 14.69 67.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.621 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 5.7 mmm-85 -127.21 141.44 51.73 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.447 ' NZ ' ' HB2' ' A' ' 92' ' ' SER . 14.0 tttp -96.19 134.86 38.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.938 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.769 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 4.0 m-85 -117.85 151.79 36.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 0.0 111.718 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.5 mt -110.07 124.36 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.648 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.84 132.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.929 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -133.61 124.49 26.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.371 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.438 HG21 ' CE3' ' A' ' 26' ' ' TRP . 21.9 t -106.74 127.76 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.875 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.476 ' CE1' HD12 ' A' ' 87' ' ' LEU . 67.3 m-85 -119.01 137.36 53.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.095 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.471 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 0.6 OUTLIER -100.65 136.25 40.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.973 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.506 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.0 mt -100.12 125.49 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.384 0.611 . . . . 0.0 110.934 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 89.7 p -84.89 165.2 17.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.206 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.31 -20.31 42.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.357 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.0 p-10 -91.98 -1.54 57.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.786 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.97 13.01 65.12 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.243 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.536 ' H ' ' HG ' ' A' ' 80' ' ' SER . 75.8 mm-40 -83.2 135.34 34.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -104.98 140.66 37.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.749 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.3 t -136.72 132.9 35.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.114 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.476 HD12 ' CE1' ' A' ' 77' ' ' TYR . 57.0 tp -71.83 118.98 15.35 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.736 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 pt -108.92 -22.97 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.2 tp -157.01 125.67 5.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.597 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.2 t -132.66 112.66 12.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.417 179.043 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -146.25 159.62 43.08 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.0 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.447 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 95.7 p -117.25 153.8 32.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.321 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.518 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 26.8 mt-30 -139.52 156.04 47.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -122.71 107.83 12.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.434 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 94' ' ' THR . 45.6 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.715 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.12 149.26 73.0 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.639 2.226 . . . . 0.0 111.735 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.9 mp -76.56 134.38 39.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.301 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.66 62.22 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.1 p -80.36 -5.34 56.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.351 . . . . 0.0 110.675 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -124.93 -168.36 1.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 mt -66.13 123.6 20.32 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.537 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.405 HG21 ' N ' ' A' ' 9' ' ' ALA . 9.8 p -128.55 146.33 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.482 -178.937 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.405 ' N ' HG21 ' A' ' 8' ' ' VAL . . . -91.2 -116.93 0.07 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.259 179.059 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.15 -4.94 21.21 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.762 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.6 t 33.58 81.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.421 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.52 144.74 55.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.051 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 p -78.85 -8.06 58.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.12 132.35 57.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.147 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.693 ' CG2' ' H ' ' A' ' 16' ' ' GLU . 85.6 m -104.59 -118.82 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.693 ' H ' ' CG2' ' A' ' 15' ' ' THR . 67.8 mm-40 -1.48 77.15 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.717 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.735 ' O ' ' N ' ' A' ' 20' ' ' SER . 60.1 mt -88.89 -78.01 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.598 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.602 ' C ' ' H ' ' A' ' 20' ' ' SER . 42.8 p 33.78 -97.71 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . -77.14 30.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.2 p 57.2 38.11 28.69 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.003 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.697 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -67.61 135.93 53.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.973 -179.32 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 23.9 m-85 -96.12 148.04 23.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.351 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.59 101.34 10.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.1 t -111.53 137.59 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -128.1 155.84 43.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.129 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.464 ' CD1' HD13 ' A' ' 88' ' ' ILE . 33.6 p90 -146.9 -164.95 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.049 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.08 129.62 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.471 ' H ' ' HG ' ' A' ' 28' ' ' SER . 1.0 OUTLIER -69.69 89.75 0.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.875 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.733 ' O ' ' NE2' ' A' ' 78' ' ' GLN . . . -89.92 104.31 16.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.649 ' CB ' ' O ' ' A' ' 29' ' ' ALA . 5.4 m 104.84 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.54 0.525 . . . . 0.0 110.337 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -58.99 -16.15 16.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.227 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.0 p -71.08 2.29 4.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.062 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 2.7 p -71.96 133.19 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.365 -179.848 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' ILE . 4.8 m -93.84 -15.4 25.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.667 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.524 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 175.62 -178.3 47.22 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -126.61 153.81 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.96 0.41 . . . . 0.0 110.376 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -132.44 123.01 25.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.083 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 77.7 t -107.48 132.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.504 179.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.414 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 68.3 tt0 -127.17 131.34 50.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.233 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 18.9 p90 -144.29 137.63 27.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.273 0.558 . . . . 0.0 111.259 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -144.36 167.91 21.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.149 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.485 HD21 ' CE2' ' A' ' 72' ' ' TYR . 76.7 mt -74.81 126.42 30.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.688 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -67.24 -25.03 65.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.458 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -92.29 -73.4 0.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.979 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.69 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 83.3 mt-10 -62.06 -31.23 71.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.944 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 83.34 -37.83 2.75 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 46' ' ' GLY . 32.3 t0 24.73 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.803 0.335 . . . . 0.0 111.044 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.539 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -104.37 138.57 19.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.424 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.11 142.74 38.72 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 121.982 1.788 . . . . 0.0 111.269 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.534 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 21.6 mt-30 -112.71 146.15 39.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.78 137.06 54.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.672 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.2 mt -129.68 130.48 45.59 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.71 132.75 50.58 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.477 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 mt -126.18 152.54 73.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.636 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.36 154.48 71.15 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.441 2.094 . . . . 0.0 112.777 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.524 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 24.9 p -57.8 -14.31 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.115 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.6 p -92.12 -6.7 50.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.234 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.82 138.78 31.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -130.71 13.98 5.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.2 p -163.68 148.68 10.81 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -149.18 144.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.856 -179.175 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.697 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 2.4 t-20 -102.85 126.5 50.02 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -97.96 112.55 62.05 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.468 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -93.23 175.71 1.56 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.997 2.465 . . . . 0.0 113.637 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 59.91 38.4 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.619 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 15.1 mt -87.72 145.17 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.82 178.679 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.414 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 16.4 mt -86.73 112.12 44.69 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.28 134.26 62.8 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.963 1.775 . . . . 0.0 111.159 178.378 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.63 13.93 74.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.424 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.69 ' NH2' ' OE2' ' A' ' 45' ' ' GLU . 13.0 mmt85 -121.13 152.17 39.04 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.682 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -103.89 127.71 51.39 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.485 ' CE2' HD21 ' A' ' 42' ' ' LEU . 84.5 m-85 -115.36 156.98 24.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.096 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 61.9 mt -110.49 132.99 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.46 130.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.582 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -135.02 121.69 20.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.607 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.411 HG13 ' CD2' ' A' ' 26' ' ' TRP . 48.5 t -103.17 127.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.467 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.68 136.27 54.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.733 ' NE2' ' O ' ' A' ' 29' ' ' ALA . 1.4 pt20 -96.59 132.75 41.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.466 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' SER . 56.0 mt -97.18 125.94 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.346 0.593 . . . . 0.0 110.787 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.595 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 90.0 p -85.62 168.66 14.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.197 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.447 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 81.7 mm-40 -61.75 -18.43 59.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.595 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 32.8 p30 -92.87 -0.72 57.18 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.033 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.24 75.45 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.424 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 55.2 mm-40 -82.43 145.3 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.206 0.503 . . . . 0.0 110.971 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -109.87 139.16 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.722 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.1 t -133.88 130.39 37.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.187 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -73.45 121.72 20.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.042 0.449 . . . . 0.0 111.43 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.464 HD13 ' CD1' ' A' ' 26' ' ' TRP . 35.6 pt -109.59 -22.55 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -157.57 127.68 6.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.769 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.6 t -133.56 120.41 20.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -156.0 153.35 29.37 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.832 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.0 p -111.39 157.92 19.67 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.635 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 26.4 mt-30 -145.84 163.01 36.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.123 0.487 . . . . 0.0 111.112 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.84 105.23 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.149 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.486 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 81.3 p . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.315 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.471 ' H3 ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 4' ' ' GLY . 13.1 Cg_endo -57.93 137.71 82.33 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.942 2.428 . . . . 0.0 112.134 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 2' ' ' PRO . 4.7 mp 31.92 26.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.969 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -108.86 154.36 16.51 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.378 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.733 ' HG ' ' H ' ' A' ' 6' ' ' HIS . 0.6 OUTLIER 48.99 -178.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.134 0.493 . . . . 0.0 111.284 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.733 ' H ' ' HG ' ' A' ' 5' ' ' SER . 81.9 m-70 57.79 -131.93 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.976 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.463 ' CD1' ' N ' ' A' ' 7' ' ' LEU . 6.6 mp -90.82 130.95 36.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.382 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -158.84 130.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.331 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.66 132.83 40.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.93 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.61 ' O ' ' O ' ' A' ' 11' ' ' SER . 1.5 t -109.27 -0.98 18.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.355 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 10' ' ' THR . 0.1 OUTLIER 25.05 104.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.15 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 11' ' ' SER . 42.0 mp0 38.2 101.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.205 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.4 m -78.04 -1.29 31.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.952 0.406 . . . . 0.0 110.019 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -120.48 132.08 71.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.712 ' O ' ' N ' ' A' ' 17' ' ' ILE . 54.3 m -123.27 -113.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.65 ' OE1' ' CG2' ' A' ' 23' ' ' VAL . 47.8 mp0 -13.69 75.55 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 O-C-N 123.628 0.58 . . . . 0.0 111.06 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.712 ' N ' ' O ' ' A' ' 15' ' ' THR . 35.0 mt -76.33 -9.45 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.698 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.638 ' O ' ' N ' ' A' ' 20' ' ' SER . 62.7 p -52.54 149.6 5.73 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 18' ' ' THR . . . 43.75 17.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.689 ' HG ' ' N ' ' A' ' 21' ' ' SER . 4.3 p 79.33 -55.63 0.42 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.519 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.691 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 38.81 -178.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.915 0.864 . . . . 0.0 112.023 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.698 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 25.2 m-85 -156.72 150.65 24.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.741 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.65 ' CG2' ' OE1' ' A' ' 16' ' ' GLU . 42.4 t -119.66 102.26 12.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.5 t -110.25 132.53 58.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.324 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.4 p -126.63 154.36 44.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.906 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.475 ' CD1' HD12 ' A' ' 88' ' ' ILE . 33.9 p90 -143.43 -165.48 2.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.724 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -130.68 128.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.286 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.405 ' O ' ' OG ' ' A' ' 28' ' ' SER . 1.3 p -49.67 111.61 0.53 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.692 179.926 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.96 5.27 22.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.116 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.444 ' HB2' ' NE2' ' A' ' 78' ' ' GLN . 4.0 m -174.46 140.71 0.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.781 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 51.3 p30 -87.23 2.36 50.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.253 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.3 p -93.22 1.07 57.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.356 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p -71.37 135.87 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.798 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 30.6 m -94.86 -14.83 24.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.53 179.637 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.454 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.1 179.05 46.36 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.12 152.25 46.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 0.0 110.19 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.461 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 25.2 ttp180 -131.4 128.31 39.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.63 133.61 57.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.721 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.462 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 38.6 tt0 -123.1 130.67 53.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.794 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -133.69 135.78 44.28 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.709 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -144.96 161.52 39.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.239 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.576 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 43.8 mt -71.15 130.39 41.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.142 0.496 . . . . 0.0 111.332 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -65.32 -24.5 67.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.952 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.474 ' HB2' HH22 ' A' ' 70' ' ' ARG . 60.8 mm-40 -97.44 -73.85 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.384 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.91 ' H ' HH22 ' A' ' 70' ' ' ARG . 80.5 mm-40 -68.72 147.1 52.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.282 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -93.07 28.42 9.59 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.104 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.574 ' O ' ' O ' ' A' ' 46' ' ' GLY . 13.7 t70 -41.64 171.45 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.733 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.521 ' N ' ' CG ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -73.42 134.93 79.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.747 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.64 148.99 73.29 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.486 2.124 . . . . 0.0 111.116 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.457 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 mt-30 -119.57 144.09 47.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.462 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 59.2 m-85 -122.91 141.9 51.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.114 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . 0.455 HD12 ' HH ' ' A' ' 40' ' ' TYR . 85.5 mt -128.06 130.79 48.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.687 177.748 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -102.21 133.41 47.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.567 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.2 mt -128.67 156.39 77.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.55 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -71.51 159.3 51.72 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.454 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 47.4 p -60.2 -16.36 32.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.114 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -91.19 -7.92 50.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.704 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 133.74 34.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.222 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 p -128.84 11.36 6.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.584 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 144.22 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.284 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.24 147.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.459 ' OD1' ' OE1' ' A' ' 16' ' ' GLU . 18.6 t30 -101.4 126.23 48.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.66 105.65 31.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 91.6 Cg_endo -90.08 -176.77 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 123.015 2.477 . . . . 0.0 112.773 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 56.41 35.92 26.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.441 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.519 ' CD1' ' CD2' ' A' ' 22' ' ' PHE . 44.4 mt -90.23 140.55 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -68.35 111.58 8.41 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 25.3 Cg_exo -57.71 138.67 87.22 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.191 1.928 . . . . 0.0 112.015 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.1 22.09 74.61 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.917 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.91 HH22 ' H ' ' A' ' 45' ' ' GLU . 22.2 mmm180 -126.56 154.66 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.984 0.421 . . . . 0.0 111.548 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -100.05 132.44 45.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.694 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.576 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 52.4 m-85 -121.81 153.59 38.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.701 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.413 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 69.8 mt -108.1 125.41 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.87 133.87 58.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.044 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -136.36 124.25 22.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.751 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.423 HG21 ' CE3' ' A' ' 26' ' ' TRP . 34.0 t -105.06 129.75 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.599 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.472 ' CE2' HD11 ' A' ' 87' ' ' LEU . 60.8 m-85 -121.57 137.7 54.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.803 179.51 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.444 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 3.5 pt20 -99.77 134.53 42.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 49.0 mt -98.27 125.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.399 0.619 . . . . 0.0 110.392 -178.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 80.6 p -82.85 169.11 16.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.553 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.71 -22.32 57.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.936 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.598 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.4 p30 -93.72 0.02 56.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.303 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.51 63.51 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.421 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.35 144.45 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.995 0.397 . . . . 0.0 110.653 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.461 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 86.2 mt-30 -111.19 144.77 39.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.042 0.449 . . . . 0.0 111.431 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.8 t -138.02 132.04 31.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.314 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD11 ' CE2' ' A' ' 77' ' ' TYR . 26.3 tp -72.61 118.22 15.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.905 179.662 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.475 HD12 ' CD1' ' A' ' 26' ' ' TRP . 36.3 pt -109.65 -25.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.822 -179.724 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.7 tp -156.15 125.0 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.842 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 t -133.07 117.7 17.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 t -148.36 153.88 39.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.698 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.8 p -112.17 151.49 29.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.698 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 22.3 mt-30 -139.41 155.59 47.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.0 110.974 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.472 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -114.14 111.58 21.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.202 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 6.9 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.535 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.698 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 6.6 Cg_endo -53.15 139.16 63.0 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.637 2.224 . . . . 0.0 111.749 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 2' ' ' PRO . 85.1 mt 51.11 162.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.386 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.22 2.76 56.8 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 m -80.9 15.02 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.375 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.672 ' C ' ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -113.03 167.08 10.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.4 tp 61.24 -5.5 0.12 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.456 0.646 . . . . 0.0 109.485 -179.376 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.672 ' H ' ' C ' ' A' ' 6' ' ' HIS . 6.2 m -120.74 22.13 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.469 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.26 175.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.242 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.559 ' O ' ' OG ' ' A' ' 11' ' ' SER . 26.4 p -80.53 169.63 17.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.003 0.43 . . . . 0.0 111.389 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 10' ' ' THR . 76.1 p 60.29 -122.27 0.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.493 ' N ' ' OG ' ' A' ' 11' ' ' SER . 44.1 mp0 -59.99 -23.73 63.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.525 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.624 ' HG ' ' H ' ' A' ' 14' ' ' VAL . 1.3 p 69.03 -55.65 0.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.624 ' H ' ' HG ' ' A' ' 13' ' ' SER . 63.1 t -111.98 129.64 67.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.965 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.48 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 53.4 m -133.89 -101.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.413 . . . . 0.0 110.664 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.695 ' OE1' ' N ' ' A' ' 23' ' ' VAL . 0.6 OUTLIER 35.78 73.36 0.09 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.952 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.579 ' O ' ' O ' ' A' ' 18' ' ' THR . 19.5 mt -129.03 -116.88 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.612 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.579 ' O ' ' O ' ' A' ' 17' ' ' ILE . 2.5 m 34.11 95.95 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.582 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 74.76 26.46 1.37 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.582 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 5.1 p 56.08 23.16 6.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.77 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.551 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.4 p -57.59 136.69 56.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.548 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 5.3 m-30 -101.66 147.03 26.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.876 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.695 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 16.1 t -130.45 103.77 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -113.78 138.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.456 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.8 p -127.58 151.54 48.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.725 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.47 ' CZ3' HG22 ' A' ' 76' ' ' VAL . 32.4 p90 -144.37 -165.38 2.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.009 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.93 125.84 58.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.967 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 p -46.01 117.27 1.46 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.402 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.02 4.04 35.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.363 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.411 ' N ' HE22 ' A' ' 78' ' ' GLN . 1.7 m -169.09 139.34 2.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.052 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -88.06 -2.21 58.47 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.805 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.4 p -92.56 -1.37 56.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.631 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.407 ' O ' ' HB3' ' A' ' 56' ' ' SER . 2.3 p -61.14 137.52 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.5 m -96.19 -15.99 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.46 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.458 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.54 177.14 46.16 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.24 153.02 43.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.859 0.362 . . . . 0.0 110.54 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.769 ' NE ' HE22 ' A' ' 85' ' ' GLN . 42.3 ttp180 -132.18 132.09 42.83 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.728 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 12.4 t -113.0 135.09 53.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.53 -179.869 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.8 133.5 50.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 4.4 p90 -143.56 143.05 31.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.282 0.563 . . . . 0.0 111.729 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -150.36 163.56 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.563 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 90.5 mt -74.07 125.47 28.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 p -64.3 -33.77 76.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.44 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.87 -71.07 0.57 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.545 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.651 ' CD ' HH21 ' A' ' 70' ' ' ARG . 89.1 mt-10 -62.73 -35.76 80.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.076 -178.428 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.583 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 85.35 -42.31 3.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.674 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 19.3 t70 28.98 -151.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.806 0.336 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.674 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 4.9 pt-20 -108.71 135.11 20.11 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.601 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.36 149.78 89.48 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.203 1.935 . . . . 0.0 111.826 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.36 151.05 40.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.68 139.46 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.42 129.92 45.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.343 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -106.02 134.43 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.146 0.498 . . . . 0.0 111.963 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . 0.427 ' HB3' ' CB ' ' A' ' 58' ' ' ALA . 7.4 mt -129.71 155.75 79.89 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.686 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -68.06 159.89 51.06 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.195 1.93 . . . . 0.0 111.995 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.458 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 21.0 p -56.25 -12.83 1.75 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.241 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -93.58 -7.11 45.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.427 ' CB ' ' HB3' ' A' ' 54' ' ' LEU . . . -79.6 130.13 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.248 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -130.98 12.65 5.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.861 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.2 p -165.13 147.56 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 p -149.87 147.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.81 -178.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 4.7 t-20 -107.72 127.98 54.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.76 105.65 42.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.126 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.24 175.55 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.896 2.398 . . . . 0.0 112.715 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 60.48 39.1 18.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.994 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.577 ' O ' ' OG ' ' A' ' 20' ' ' SER . 56.9 mt -88.95 153.51 20.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.86 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 46.7 mt -90.72 110.56 42.36 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.873 -0.148 . . . . 0.0 110.836 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -58.95 145.1 98.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.307 2.005 . . . . 0.0 112.204 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.509 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 80.3 17.77 73.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.651 HH21 ' CD ' ' A' ' 45' ' ' GLU . 4.9 mmm-85 -128.78 147.54 50.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.547 0.213 . . . . 0.0 110.597 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -98.43 135.09 40.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.86 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 67.9 m-85 -121.02 152.87 38.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.378 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 79.0 mt -111.7 131.23 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.14 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.28 134.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.507 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -135.21 123.76 23.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.3 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.47 HG22 ' CZ3' ' A' ' 26' ' ' TRP . 17.2 t -103.62 130.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.462 ' CE1' HD11 ' A' ' 87' ' ' LEU . 49.7 m-85 -122.56 139.06 54.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.433 179.873 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.411 HE22 ' N ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -100.91 135.04 42.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.098 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.437 HD13 HG22 ' A' ' 79' ' ' ILE . 54.0 mt -98.15 123.75 50.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.208 0.527 . . . . 0.0 110.634 -178.709 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.613 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 59.3 p -83.76 166.18 18.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.498 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -57.48 -18.8 20.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.017 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.613 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 37.4 p30 -91.95 -1.1 57.44 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.747 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.75 13.7 66.63 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.032 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 63.8 mm-40 -85.47 143.3 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.65 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.769 HE22 ' NE ' ' A' ' 37' ' ' ARG . 78.5 mt-30 -108.06 140.41 41.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.742 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 t -135.15 132.68 38.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.035 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.462 HD11 ' CE1' ' A' ' 77' ' ' TYR . 38.7 tp -73.45 118.98 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.707 -179.962 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 pt -112.09 -21.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.111 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 tp -157.04 124.41 5.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.905 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 t -132.18 120.82 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 t -153.56 155.51 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -121.63 154.27 37.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.181 0.515 . . . . 0.0 111.042 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.7 mt-30 -146.69 157.93 43.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.07 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.53 118.3 36.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.249 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.509 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 39.2 p . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.788 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.402 ' H1 ' ' HD2' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.402 ' HD2' ' H1 ' ' A' ' 1' ' ' GLY . 16.8 Cg_exo -63.81 133.59 39.76 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.453 2.102 . . . . 0.0 111.536 179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.6 mt -126.93 -134.87 0.25 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.292 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 5' ' ' SER . . . -115.96 37.18 3.52 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.559 ' O ' ' OG ' ' A' ' 5' ' ' SER . 4.7 p 33.31 63.73 0.33 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.016 0.436 . . . . 0.0 110.018 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.627 ' C ' ' HD1' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -97.62 -179.2 4.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.793 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.561 ' CD1' ' H ' ' A' ' 7' ' ' LEU . 5.2 mp -65.9 145.48 55.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.535 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.68 -15.62 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.579 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -176.98 150.15 0.75 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.792 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.605 ' O ' ' N ' ' A' ' 12' ' ' GLU . 1.8 m -67.94 10.66 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.579 ' H ' ' C ' ' A' ' 9' ' ' ALA . 1.2 p -35.11 89.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.022 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 10' ' ' THR . 61.7 tt0 -94.55 116.98 29.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.8 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 p -93.6 -10.38 34.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.588 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.612 ' O ' ' O ' ' A' ' 15' ' ' THR . 88.3 t -70.25 -21.31 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.093 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.661 ' O ' ' N ' ' A' ' 17' ' ' ILE . 27.5 m -33.28 -103.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.015 0.436 . . . . 0.0 111.027 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.595 ' O ' ' O ' ' A' ' 21' ' ' SER . 9.9 pt-20 32.41 28.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.442 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 15' ' ' THR . 8.9 mt -82.66 -81.25 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.027 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.601 ' C ' ' O ' ' A' ' 17' ' ' ILE . 1.5 p 11.43 100.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.474 0.484 . . . . 0.0 111.187 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.564 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 71.05 29.75 2.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 109.922 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p 55.56 23.47 6.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 17' ' ' ILE . 3.8 p -63.04 -177.58 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.378 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.491 ' CZ ' HG23 ' A' ' 95' ' ' THR . 17.7 m-85 -147.67 144.33 28.27 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.953 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.432 HG23 ' ND2' ' A' ' 62' ' ' ASN . 14.9 t -116.16 101.67 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.395 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.6 t -111.17 135.16 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.357 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.2 p -125.5 154.26 42.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.403 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.475 ' CE3' HG23 ' A' ' 76' ' ' VAL . 38.2 p90 -143.8 -179.19 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.01 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -118.8 129.36 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.045 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 p -49.88 126.92 15.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.422 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.63 3.31 54.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.059 0.457 . . . . 0.0 110.461 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.408 ' N ' HE22 ' A' ' 78' ' ' GLN . 5.9 m -174.22 153.7 2.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.002 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -98.07 1.68 47.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.6 p -95.35 -1.76 50.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.745 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p -60.04 138.77 20.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.507 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 79' ' ' ILE . 18.8 m -93.05 -15.99 25.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.558 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.502 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.41 -177.82 47.2 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 58' ' ' ALA . 73.8 m-85 -122.73 149.4 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.96 0.41 . . . . 0.0 110.523 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.59 ' NH2' HE22 ' A' ' 85' ' ' GLN . 13.7 ttp180 -127.49 118.71 24.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.49 132.39 49.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.209 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.445 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 80.8 tt0 -122.03 134.9 54.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.03 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CE1' ' NE2' ' A' ' 50' ' ' GLN . 54.3 p90 -140.86 137.08 32.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.836 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -149.08 160.86 42.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.203 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.441 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 47.3 mt -74.32 127.39 32.87 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.691 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 p -70.87 -24.01 62.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -86.6 -74.41 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.027 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -57.95 -35.3 70.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.93 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 70.24 17.33 73.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.646 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 27.2 t70 -46.5 -178.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.732 0.301 . . . . 0.0 110.591 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.646 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 2.8 pt-20 -68.8 139.18 90.82 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.76 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 37.3 Cg_endo -70.43 153.63 65.72 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.626 2.218 . . . . 0.0 112.851 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.506 ' NE2' ' CE1' ' A' ' 40' ' ' TYR . 6.1 mt-30 -114.88 145.0 42.65 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 39' ' ' GLU . 92.9 m-85 -124.09 136.41 54.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.153 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 88.6 mt -119.92 131.37 55.2 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.676 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -103.6 132.03 50.22 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.521 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mt -129.72 155.5 80.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -66.68 160.42 46.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.232 1.955 . . . . 0.0 112.539 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.419 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 15.9 p -57.53 -14.19 4.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -90.82 -9.47 46.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 36' ' ' PHE . . . -83.41 128.81 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.938 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.9 p -132.81 14.22 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.339 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -163.16 141.62 8.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.152 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.22 146.43 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.654 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.432 ' ND2' HG23 ' A' ' 23' ' ' VAL . 9.1 t-20 -103.05 127.2 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.34 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.0 Cg_endo -90.65 -179.12 1.53 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.919 2.413 . . . . 0.0 112.622 179.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 61.58 35.69 17.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.96 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 30.5 mt -89.51 152.88 21.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.11 111.73 40.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.508 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.407 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 23.5 Cg_exo -56.29 139.78 86.9 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.933 1.755 . . . . 0.0 111.358 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.83 18.83 69.2 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.685 HH11 ' CG ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -125.02 148.74 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.813 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -99.35 132.51 44.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.151 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.441 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 90.3 m-85 -121.56 150.92 40.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.189 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 87.4 mt -107.71 123.65 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -109.95 131.39 61.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 0.0 110.815 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.14 129.08 33.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.603 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.475 HG23 ' CE3' ' A' ' 26' ' ' TRP . 5.6 t -109.99 131.46 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.923 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.483 ' CE2' HD13 ' A' ' 87' ' ' LEU . 26.4 m-85 -123.47 143.37 50.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.288 179.553 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.408 HE22 ' N ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -99.6 136.58 39.32 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.806 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.686 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.5 mt -100.72 123.97 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.298 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.606 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 51.9 p -85.44 172.36 11.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.003 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.551 ' OE2' ' OG ' ' A' ' 34' ' ' SER . 78.1 mm-40 -61.48 -23.96 66.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.03 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.606 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.9 p30 -93.57 -1.66 55.18 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.35 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.97 60.05 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.411 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.489 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.4 mm-40 -84.79 131.82 34.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.14 0.47 . . . . 0.0 110.596 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.59 HE22 ' NH2' ' A' ' 37' ' ' ARG . 27.3 mt-30 -105.26 141.11 37.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.794 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.6 t -136.29 133.56 37.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.483 HD13 ' CE2' ' A' ' 77' ' ' TYR . 28.0 tp -72.3 118.41 15.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.3 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.06 -20.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.0 tp -155.0 124.89 6.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.422 -179.817 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 12.9 t -131.93 123.03 26.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.562 178.903 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -154.14 152.76 30.78 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.034 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.6 p -118.19 153.37 33.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -142.59 160.5 40.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.838 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 115.92 25.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.015 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.491 HG23 ' CZ ' ' A' ' 22' ' ' PHE . 81.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.662 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.417 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 . . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.11 34.11 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.978 2.452 . . . . 0.0 112.467 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.417 ' H ' ' C ' ' A' ' 1' ' ' GLY . 32.1 tp 44.35 84.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 110.511 -179.917 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.57 -131.27 4.33 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p -82.78 2.13 35.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.464 0.173 . . . . 0.0 110.94 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -58.85 -57.69 11.91 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.697 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.636 ' O ' ' O ' ' A' ' 8' ' ' VAL . 47.2 mt -95.05 0.07 54.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.298 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.636 ' O ' ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER 41.55 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.787 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.407 ' N ' HG12 ' A' ' 8' ' ' VAL . . . -70.43 147.39 49.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.658 ' O ' ' N ' ' A' ' 12' ' ' GLU . 40.8 p -80.02 3.87 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.703 ' HG ' ' N ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER 55.99 -69.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.759 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.703 ' N ' ' HG ' ' A' ' 11' ' ' SER . 24.4 tp10 -108.92 -137.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.31 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 14' ' ' VAL . 1.4 t 178.68 69.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.986 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.727 ' CG1' ' H ' ' A' ' 23' ' ' VAL . 2.0 t 53.39 129.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.688 ' CG2' ' H ' ' A' ' 16' ' ' GLU . 7.4 m -81.95 -140.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.828 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.688 ' H ' ' CG2' ' A' ' 15' ' ' THR . 81.0 mm-40 26.04 47.53 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.034 0.445 . . . . 0.0 110.029 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.489 ' N ' ' O ' ' A' ' 15' ' ' THR . 43.9 mt -65.6 -5.36 2.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.253 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' SER . 68.8 p -62.63 151.09 39.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.568 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 43.34 23.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.672 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.568 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 60.56 27.57 17.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.383 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.631 ' HG ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -55.08 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.596 0.712 . . . . 0.0 111.862 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.51 ' N ' ' HG ' ' A' ' 21' ' ' SER . 18.7 m-85 -146.34 146.51 30.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.744 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.727 ' H ' ' CG1' ' A' ' 14' ' ' VAL . 54.1 t -119.04 103.19 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.3 t -109.04 134.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.191 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.1 p -128.05 150.52 49.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.757 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.405 ' CD1' HD13 ' A' ' 88' ' ' ILE . 41.4 p90 -145.01 178.62 7.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.949 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 t -117.01 128.48 74.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.485 ' H ' ' HG ' ' A' ' 28' ' ' SER . 1.3 m -48.1 148.98 1.55 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.422 -179.447 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.621 ' C ' HE22 ' A' ' 78' ' ' GLN . . . -138.51 55.15 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.659 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.753 ' C ' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER 178.21 -27.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.614 179.334 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 60.86 -26.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.893 0.378 . . . . 0.0 110.128 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.753 ' H ' ' C ' ' A' ' 30' ' ' SER . 1.9 m -92.04 -0.85 57.46 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . . . . . . . . . 1.5 p -52.78 137.08 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.656 179.509 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.5 m -94.62 -14.77 24.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.469 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 174.9 177.3 43.9 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -124.77 152.86 43.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.624 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.781 ' NH1' ' CD1' ' A' ' 51' ' ' TYR . 14.8 ttp85 -128.59 126.06 39.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 41.6 t -105.72 132.34 52.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.373 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.463 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 73.3 tt0 -127.95 133.25 49.21 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.72 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.6 p90 -140.43 133.74 29.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.222 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -143.59 162.09 36.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.514 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 47.2 mt -72.9 134.95 45.01 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.997 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.7 p -73.55 -19.38 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.213 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HB2' ' NH2' ' A' ' 70' ' ' ARG . 73.5 mm-40 -98.5 -65.0 0.99 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.936 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -64.16 -31.07 72.13 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.423 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 55.27 22.72 30.96 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' O ' ' O ' ' A' ' 46' ' ' GLY . 34.1 t0 -49.59 -169.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.929 0.395 . . . . 0.0 110.297 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.536 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 1.7 pt-20 -68.7 138.13 90.69 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.217 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.64 ' CG ' ' HH ' ' A' ' 51' ' ' TYR . 61.2 Cg_endo -73.43 151.09 47.45 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.62 2.213 . . . . 0.0 111.94 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -112.27 141.0 46.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.781 ' CD1' ' NH1' ' A' ' 37' ' ' ARG . 78.6 m-85 -123.43 138.8 54.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.872 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -126.6 132.18 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -100.91 134.38 43.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.882 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mt -128.64 154.7 79.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.558 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.08 159.39 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.245 1.963 . . . . 0.0 111.957 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.469 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 25.4 p -59.72 -11.99 6.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.672 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -91.23 -6.4 53.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.69 132.97 35.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.682 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 p -130.65 6.84 4.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.267 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.4 p -164.92 141.38 5.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.0 p -148.11 148.96 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.162 0.506 . . . . 0.0 111.667 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.631 ' ND2' ' HG ' ' A' ' 21' ' ' SER . 10.1 t-20 -102.63 125.45 49.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.908 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -99.03 108.17 47.95 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -93.36 -176.92 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 123.168 2.579 . . . . 0.0 112.705 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 59.59 35.55 22.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.233 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -89.6 148.11 23.53 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.191 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -86.49 113.31 51.97 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.034 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -57.66 140.95 95.14 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.236 1.957 . . . . 0.0 112.334 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.619 ' N ' ' HG1' ' A' ' 95' ' ' THR . . . 79.2 21.42 67.6 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 179.563 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.518 ' H ' ' HG1' ' A' ' 95' ' ' THR . 7.3 mmm180 -125.67 149.0 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.945 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.403 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 67.9 tttt -102.34 130.52 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.775 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.514 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 90.4 m-85 -122.72 154.05 38.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.3 mt -108.22 125.88 64.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 t -113.98 133.83 58.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.205 0.526 . . . . 0.0 111.401 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.569 ' CB ' ' HH ' ' A' ' 77' ' ' TYR . 40.7 m-80 -134.63 126.08 28.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.354 179.048 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.93 128.3 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.848 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.569 ' HH ' ' CB ' ' A' ' 75' ' ' ASN . 25.2 m-85 -121.36 137.94 54.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 -179.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.621 HE22 ' C ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -101.01 136.0 41.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.3 mt -98.68 120.95 48.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.808 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 29.2 p -82.4 168.53 17.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.22 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.478 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 73.5 mm-40 -59.28 -18.22 35.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.825 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 38.7 p30 -93.07 -1.51 56.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.243 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.61 12.8 68.72 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.575 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.0 mm-40 -84.69 141.89 30.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.981 0.419 . . . . 0.0 111.082 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.449 HE22 ' NE ' ' A' ' 37' ' ' ARG . 94.4 mt-30 -110.12 141.93 42.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -136.5 131.22 33.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.034 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.488 HD12 ' CE2' ' A' ' 77' ' ' TYR . 30.4 tp -72.3 116.96 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.157 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.405 HD13 ' CD1' ' A' ' 26' ' ' TRP . 36.5 pt -110.31 -21.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 -179.424 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 tp -154.75 122.03 5.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.185 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.474 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 22.6 t -131.19 117.88 19.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -150.63 155.71 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.637 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.6 p -114.85 156.04 25.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.427 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.488 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 25.4 mt-30 -144.28 153.3 41.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 106.68 14.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.2 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.619 ' HG1' ' N ' ' A' ' 69' ' ' GLY . 20.6 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.595 -179.24 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.499 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.69 6.7 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.24 1.96 . . . . 0.0 111.317 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.499 ' H ' ' C ' ' A' ' 1' ' ' GLY . 2.3 tt 73.19 -55.23 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.659 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.67 -148.95 20.73 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.44 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t 71.34 15.22 6.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.195 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.41 -40.24 61.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.674 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.481 ' HG ' ' H ' ' A' ' 9' ' ' ALA . 12.2 tp -90.35 124.69 35.13 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.427 ' C ' ' H ' ' A' ' 10' ' ' THR . 3.6 t -82.95 -13.32 12.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.481 ' H ' ' HG ' ' A' ' 7' ' ' LEU . . . 74.98 -37.74 0.36 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.555 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.753 ' O ' ' N ' ' A' ' 12' ' ' GLU . 88.8 m -79.28 136.83 37.15 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.544 ' C ' ' O ' ' A' ' 10' ' ' THR . 7.0 t -26.25 80.15 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 123.341 0.4 . . . . 0.0 110.672 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.753 ' N ' ' O ' ' A' ' 10' ' ' THR . 50.9 mt-10 59.45 150.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.783 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 15.4 t -60.92 -36.41 79.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.029 0.442 . . . . 0.0 110.112 179.527 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.69 143.76 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.589 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 3.1 m -91.07 -93.45 0.13 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.146 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.589 ' N ' ' CG2' ' A' ' 15' ' ' THR . 74.3 mm-40 -30.86 114.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.195 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.482 ' CG1' ' O ' ' A' ' 15' ' ' THR . 11.7 mt -112.05 -18.19 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.225 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.464 ' C ' ' N ' ' A' ' 20' ' ' SER . 71.8 p -58.48 156.37 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 46.35 21.61 0.13 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.526 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 57.97 36.3 26.04 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.241 -179.604 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.544 ' OG ' ' CB ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -61.97 159.9 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.41 -179.161 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.486 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 22.5 m-30 -127.23 151.97 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.806 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.76 106.56 15.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.24 145.48 20.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.109 0.48 . . . . 0.0 111.006 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.2 p -131.4 153.82 49.29 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.69 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.42 ' CD2' HG12 ' A' ' 76' ' ' VAL . 33.0 p90 -143.35 -166.38 2.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.45 129.23 74.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -50.55 -33.98 23.8 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.079 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.495 ' O ' ' OG ' ' A' ' 30' ' ' SER . . . 51.11 12.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.909 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.495 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 5.3 m -175.57 148.34 0.9 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.89 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -103.79 -12.36 16.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.387 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.3 p -79.68 -1.12 36.92 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.075 0.464 . . . . 0.0 109.827 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.401 ' O ' ' HB3' ' A' ' 56' ' ' SER . 3.9 p -73.72 130.42 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.226 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.621 ' N ' ' O ' ' A' ' 79' ' ' ILE . 39.0 m -95.45 -12.98 24.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 109.739 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.437 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.17 -179.88 47.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.86 151.53 48.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.749 0.309 . . . . 0.0 110.433 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.847 ' NE ' HE22 ' A' ' 85' ' ' GLN . 25.3 ttp180 -129.35 122.83 30.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 80.8 t -108.2 133.82 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.542 -179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.413 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 59.3 tt0 -124.46 137.06 54.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.548 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.43 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 24.9 p90 -141.81 130.66 22.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.937 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -143.11 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.324 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.488 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 83.0 mt -75.69 123.89 26.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.166 0.507 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.432 ' HG ' ' N ' ' A' ' 44' ' ' GLU . 24.0 p -66.14 -26.04 67.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.423 179.657 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.432 ' N ' ' HG ' ' A' ' 43' ' ' SER . 91.0 mt-10 -87.88 -73.54 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.299 -179.162 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.547 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 81.3 mt-10 -83.54 148.56 27.13 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.627 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -61.4 -23.54 62.57 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.415 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.675 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 16.1 t70 33.01 -161.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 110.093 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.675 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER -119.07 126.01 27.31 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.15 137.2 31.0 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 121.815 1.677 . . . . 0.0 111.163 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.43 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.2 mt-30 -120.61 150.93 40.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -124.78 136.13 53.58 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.95 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -122.09 130.19 53.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 67.3 m-20 -104.29 133.53 49.04 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.39 -179.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.41 155.77 79.58 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.278 -179.983 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . 0.429 ' C ' ' H ' ' A' ' 57' ' ' THR . 22.2 Cg_endo -69.49 151.24 70.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 121.63 1.553 . . . . 0.0 112.059 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.437 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 3.3 p -52.16 -13.03 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.491 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' THR . . . . . 0.429 ' H ' ' C ' ' A' ' 55' ' ' PRO . 78.1 p -93.01 -7.06 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.45 136.79 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.352 179.754 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -129.62 8.9 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.5 p -164.57 149.84 10.01 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 p -151.85 153.06 10.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.244 0.545 . . . . 0.0 111.944 -179.822 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 22' ' ' PHE . 50.8 t30 -105.51 128.5 53.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.927 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -102.13 103.36 29.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.808 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 64.2 Cg_endo -89.95 -175.21 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.177 2.585 . . . . 0.0 112.211 179.782 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 58.86 36.63 24.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.234 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 16.4 mt -89.2 149.66 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.313 179.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.597 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 21.8 mt -92.67 112.06 53.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.076 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.34 132.84 48.74 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.875 1.717 . . . . 0.0 110.703 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.48 10.72 73.13 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.547 ' NH2' ' OE2' ' A' ' 45' ' ' GLU . 19.4 mmt85 -123.77 145.9 48.7 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -97.22 133.16 42.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.597 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 20.7 m-85 -115.27 156.19 25.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.225 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.412 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 62.5 mt -113.47 122.14 67.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.84 128.12 67.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.067 0.461 . . . . 0.0 110.948 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.7 m-80 -133.86 127.17 32.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.599 179.52 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.42 HG12 ' CD2' ' A' ' 26' ' ' TRP . 19.5 t -106.99 128.25 61.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.446 ' CE1' HD13 ' A' ' 87' ' ' LEU . 67.9 m-85 -117.32 139.0 51.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.876 179.314 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -100.76 135.13 42.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.621 ' O ' ' N ' ' A' ' 34' ' ' SER . 60.0 mt -99.26 121.94 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.916 0.388 . . . . 0.0 110.984 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.595 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 93.0 p -85.2 168.98 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.008 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . 0.52 ' HA ' ' HG ' ' A' ' 34' ' ' SER . 94.8 mt-10 -57.25 -20.8 29.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.643 -179.645 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.595 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 50.0 p30 -93.38 2.67 56.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.17 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.95 72.62 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.944 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.4 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 69.7 mm-40 -85.13 144.35 28.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.984 0.421 . . . . 0.0 111.4 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.847 HE22 ' NE ' ' A' ' 37' ' ' ARG . 53.5 mt-30 -109.51 140.03 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.719 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 t -135.72 132.36 36.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.867 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.446 HD13 ' CE1' ' A' ' 77' ' ' TYR . 22.0 tp -73.16 117.07 14.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.424 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.0 pt -107.43 -22.84 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.096 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 tp -156.73 125.26 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.812 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 47.8 t -127.7 123.66 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.33 178.424 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 t -155.0 156.72 36.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.613 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.3 p -116.96 156.1 28.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.413 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.486 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 20.0 mt-30 -140.38 160.16 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 111.122 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.69 112.65 17.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.471 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 43.9 p . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.601 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 1' ' ' GLY . 37.9 Cg_exo -52.82 -136.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.877 2.385 . . . . 0.0 112.134 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.5 tp -92.96 125.64 37.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.733 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.24 -175.08 46.41 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 p -71.86 157.6 37.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.939 0.399 . . . . 0.0 110.8 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.683 ' O ' ' N ' ' A' ' 8' ' ' VAL . 80.5 m-70 -133.71 -64.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.374 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.514 ' C ' ' O ' ' A' ' 6' ' ' HIS . 6.1 mp 30.98 30.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.057 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 6' ' ' HIS . 2.1 t 48.53 13.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.64 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' H ' ' C ' ' A' ' 7' ' ' LEU . . . -78.3 -3.27 42.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.089 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.517 ' CG2' ' H ' ' A' ' 11' ' ' SER . 1.5 m -78.39 -169.98 1.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.517 ' H ' ' CG2' ' A' ' 10' ' ' THR . 7.2 p -60.04 170.05 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.13 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -56.74 126.93 29.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.399 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 m -90.07 1.33 56.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.227 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.432 HG21 ' N ' ' A' ' 15' ' ' THR . 12.5 p -124.83 143.78 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.793 -179.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.695 ' CG2' ' H ' ' A' ' 16' ' ' GLU . 59.4 m -132.42 -125.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.702 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.695 ' H ' ' CG2' ' A' ' 15' ' ' THR . 47.4 mp0 15.25 48.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.128 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 15' ' ' THR . 77.7 mt -69.87 -4.25 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.756 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 79.6 m -67.21 139.58 57.4 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.792 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.58 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 63.74 15.95 9.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 59.38 34.11 22.66 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.683 -179.57 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.574 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -64.49 164.3 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.164 0.507 . . . . 0.0 111.605 -179.509 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.429 ' CZ ' HG23 ' A' ' 95' ' ' THR . 19.7 m-30 -128.71 144.26 51.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.58 178.665 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.7 101.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.27 136.59 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.509 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.8 p -124.41 152.76 42.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.497 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.458 ' CE3' HG22 ' A' ' 76' ' ' VAL . 38.8 p90 -144.28 -165.88 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 110.639 -179.318 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.488 HG11 ' H ' ' A' ' 29' ' ' ALA . 57.7 t -120.27 131.28 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.765 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.68 ' C ' ' H ' ' A' ' 30' ' ' SER . 73.0 p -52.66 -27.45 17.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.488 ' H ' HG11 ' A' ' 27' ' ' VAL . . . 45.53 5.63 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.006 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.68 ' H ' ' C ' ' A' ' 28' ' ' SER . 1.6 m -168.34 110.77 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.85 0.357 . . . . 0.0 110.685 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -76.43 -7.04 54.23 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.3 p -87.31 -3.27 59.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.195 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.492 ' CG1' ' O ' ' A' ' 30' ' ' SER . 3.2 p -62.33 138.24 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.17 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.0 m -93.68 -16.52 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 109.761 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.97 178.82 47.01 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.73 150.82 49.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.658 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.692 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.0 ttp180 -130.09 122.26 27.95 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.98 131.17 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.806 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.432 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.6 tt0 -122.29 132.52 54.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.774 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.408 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 54.1 p90 -138.1 137.2 37.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.129 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.43 159.01 43.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.438 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.485 HD21 ' CD2' ' A' ' 72' ' ' TYR . 58.3 mt -73.91 124.43 26.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.197 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -67.14 -28.66 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.595 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -86.41 -69.1 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.393 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -60.3 -35.95 76.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.882 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.22 30.92 64.37 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -58.48 171.48 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 0.0 110.719 -179.669 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.7 141.37 95.05 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.13 147.71 48.89 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.391 2.061 . . . . 0.0 112.47 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.407 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 mt-30 -114.59 146.38 40.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.3 m-85 -123.32 137.2 54.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.324 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 91.3 mt -121.93 126.81 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -100.69 130.62 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.146 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.9 mt -127.78 154.72 78.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.577 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.35 155.44 67.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.188 1.925 . . . . 0.0 112.503 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.417 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 5.3 p -56.89 -12.57 2.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -94.21 -9.45 36.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.848 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.1 136.05 34.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 110.67 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -129.34 12.6 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.89 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.2 p -164.32 149.32 10.11 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.516 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.41 150.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.178 0.514 . . . . 0.0 111.575 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.47 127.11 50.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.571 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.6 105.01 34.63 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.88 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -90.66 -178.54 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.922 2.414 . . . . 0.0 113.253 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 60.47 36.86 20.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.771 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' O ' ' OG ' ' A' ' 20' ' ' SER . 47.6 mt -92.62 144.88 24.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.603 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.574 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 19.4 mt -88.71 112.17 48.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.063 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.437 ' HA ' ' HG1' ' A' ' 95' ' ' THR . 36.4 Cg_exo -53.92 141.67 66.29 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.102 1.868 . . . . 0.0 111.897 179.104 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 81.0 17.08 73.17 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.7 mmt-85 -124.01 146.39 48.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.741 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.467 ' HE2' ' HG ' ' A' ' 92' ' ' SER . 77.4 tttt -98.94 132.41 44.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.827 179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.574 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 55.6 m-85 -118.89 155.6 30.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.762 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.408 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 70.8 mt -109.13 126.99 66.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -112.47 131.31 64.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.0 0.428 . . . . 0.0 111.075 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 32.7 m-80 -138.05 125.68 22.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.898 179.489 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.458 HG22 ' CE3' ' A' ' 26' ' ' TRP . 46.5 t -105.04 127.85 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.893 0.378 . . . . 0.0 110.413 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.455 ' CE1' HD11 ' A' ' 87' ' ' LEU . 57.7 m-85 -119.45 136.07 54.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.459 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.618 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -101.57 135.18 43.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.82 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 34' ' ' SER . 64.0 mt -97.08 120.51 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 110.549 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.587 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.2 p -81.39 172.32 13.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.652 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -22.82 59.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.642 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.587 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 49.2 p30 -92.18 0.68 57.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 11.21 73.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.814 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.9 mm-40 -84.02 140.08 32.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.692 HE22 ' NE ' ' A' ' 37' ' ' ARG . 90.8 mt-30 -103.08 142.62 33.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.899 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.7 t -136.58 128.24 28.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.15 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.455 HD11 ' CE1' ' A' ' 77' ' ' TYR . 61.3 tp -73.14 119.16 17.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.0 pt -110.83 -20.89 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.099 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.0 tp -155.46 120.18 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.512 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 33.7 t -127.13 123.66 37.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.384 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 t -156.08 149.58 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.685 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' SER . . . . . 0.467 ' HG ' ' HE2' ' A' ' 71' ' ' LYS . 93.2 p -111.95 155.44 23.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.024 179.388 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -140.93 156.67 46.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.237 0.541 . . . . 0.0 110.954 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -119.14 110.94 17.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.252 178.908 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 94' ' ' THR . 75.6 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.583 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.468 ' N ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.468 ' HD3' ' N ' ' A' ' 1' ' ' GLY . 22.2 Cg_exo -56.79 146.0 80.34 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.652 2.234 . . . . 0.0 111.998 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.8 mt -82.66 137.78 34.36 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.549 ' O ' ' C ' ' A' ' 5' ' ' SER . . . 171.52 -176.68 44.68 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.549 ' C ' ' O ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 27.85 85.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.889 0.376 . . . . 0.0 110.227 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -159.06 134.36 8.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.556 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.96 133.56 34.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.029 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -111.33 123.79 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.342 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.94 -85.97 0.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.595 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.2 m -105.01 138.02 41.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.6 -31.01 8.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 14' ' ' VAL . 25.5 tt0 -89.22 5.84 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.858 0.361 . . . . 0.0 110.764 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.56 -78.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.364 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.577 ' N ' ' O ' ' A' ' 12' ' ' GLU . 11.0 m -101.5 133.83 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.354 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.559 ' CG2' ' N ' ' A' ' 16' ' ' GLU . 1.1 m -88.18 -77.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.534 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.615 ' CB ' ' HG ' ' A' ' 21' ' ' SER . 51.3 mp0 -49.71 132.37 21.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.065 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' SER . 2.1 mt -131.01 -22.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.445 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.497 ' C ' ' O ' ' A' ' 17' ' ' ILE . 44.0 p -35.01 140.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.601 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 38.98 38.9 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.707 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.601 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 18.7 p 56.92 43.69 24.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.615 ' HG ' ' CB ' ' A' ' 16' ' ' GLU . 1.2 p -61.65 131.59 50.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.264 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.632 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 6.6 m-30 -95.03 146.48 24.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.735 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.442 HG22 ' ND2' ' A' ' 62' ' ' ASN . 37.1 t -131.49 103.99 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.903 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -116.05 138.11 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.0 p -124.71 152.58 43.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.821 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.469 ' CD1' HD12 ' A' ' 88' ' ' ILE . 42.1 p90 -146.24 -165.49 2.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.36 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 t -130.81 129.59 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.826 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 p -50.02 155.38 0.93 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.801 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.473 ' H ' HE22 ' A' ' 78' ' ' GLN . . . -142.46 44.65 1.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.113 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.689 ' C ' ' H ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -170.93 -30.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.897 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t0 64.49 -33.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.689 ' H ' ' C ' ' A' ' 30' ' ' SER . 81.0 p -86.85 2.33 49.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.665 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.434 ' O ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER -55.56 142.2 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.836 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 5.6 m -94.72 -18.74 21.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.209 0.528 . . . . 0.0 109.805 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.85 178.36 46.54 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -123.1 150.26 43.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.486 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.66 ' NE ' HE22 ' A' ' 85' ' ' GLN . 29.4 ttp180 -129.21 120.93 26.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 13.7 t -106.56 131.22 56.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.89 -179.799 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.401 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.05 132.83 55.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.519 ' CE1' ' NE2' ' A' ' 50' ' ' GLN . 54.7 p90 -140.73 136.45 32.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.609 . . . . 0.0 111.267 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.0 164.72 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.989 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.5 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 79.3 mt -72.45 125.11 26.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.82 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.616 ' HG ' ' N ' ' A' ' 44' ' ' GLU . 18.4 p -62.08 -32.95 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.511 179.816 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . 0.616 ' N ' ' HG ' ' A' ' 43' ' ' SER . 71.8 mm-40 -87.41 -75.07 0.42 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.033 179.735 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.68 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 90.4 mt-10 -63.84 143.59 57.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.39 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.14 29.57 8.02 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.43 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' A' ' 48' ' ' GLU . 21.8 t70 -46.93 170.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.51 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 47' ' ' ASP . 2.5 pt-20 -70.69 139.4 86.12 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.542 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.64 153.29 69.68 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.693 2.262 . . . . 0.0 111.952 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.519 ' NE2' ' CE1' ' A' ' 40' ' ' TYR . 2.2 mt-30 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -126.15 138.92 53.71 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.763 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -127.06 133.05 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.1 m-20 -106.65 134.29 50.02 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.693 -179.059 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -131.83 156.14 80.49 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.669 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.25 158.13 58.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.05 1.834 . . . . 0.0 112.294 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.434 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 87.3 p -58.67 -13.04 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -92.97 -6.97 47.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.861 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.12 134.56 34.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.606 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -131.9 15.41 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.482 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -163.28 144.02 9.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.5 p -149.28 148.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.533 -179.486 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 5.0 t-20 -106.04 127.13 52.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.546 178.533 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mt -98.34 104.77 25.15 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.893 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.408 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 94.3 Cg_endo -90.18 172.5 3.57 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.535 2.157 . . . . 0.0 112.587 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 62.45 39.53 11.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.725 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.484 ' O ' ' OG ' ' A' ' 20' ' ' SER . 32.9 mt -89.44 138.68 31.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.291 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.779 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 28.5 mt -68.76 129.34 92.51 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.851 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.05 138.06 27.53 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.508 2.139 . . . . 0.0 112.012 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.26 22.23 73.91 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.68 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 5.5 mmm-85 -125.71 148.59 49.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -98.64 134.03 42.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.183 0.516 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.779 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 49.9 m-85 -120.81 149.5 42.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.846 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.409 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 66.3 mt -108.18 128.71 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 t -116.58 129.26 73.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.42 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.572 ' OD1' ' OG ' ' A' ' 90' ' ' SER . 33.4 m-80 -134.43 124.41 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.712 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.468 HG21 ' CZ3' ' A' ' 26' ' ' TRP . 21.9 t -100.96 128.14 53.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.496 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.48 ' CE1' HD11 ' A' ' 87' ' ' LEU . 61.2 m-85 -120.12 136.59 54.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.698 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.473 HE22 ' H ' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -101.88 137.5 40.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.759 -0.776 . . . . 0.0 108.969 178.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 58.8 mt -100.58 127.7 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 111.4 -178.405 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 28.4 p -84.53 173.06 11.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.43 -18.06 48.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.868 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.3 p30 -94.56 -4.04 48.65 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.498 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 13.75 62.41 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.262 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.585 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 69.4 mm-40 -84.56 147.3 27.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.898 0.349 . . . . 0.0 110.335 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.66 HE22 ' NE ' ' A' ' 37' ' ' ARG . 50.0 mt-30 -112.44 147.7 35.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.124 0.488 . . . . 0.0 111.77 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -139.14 128.63 24.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.93 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.48 HD11 ' CE1' ' A' ' 77' ' ' TYR . 15.9 tp -73.3 118.96 16.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.964 179.528 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.469 HD12 ' CD1' ' A' ' 26' ' ' TRP . 41.2 pt -111.72 -22.69 4.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 -179.425 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 16.6 tp -154.85 127.1 7.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.907 -179.427 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.572 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 48.1 t -135.6 119.05 16.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.133 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -145.77 159.57 42.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.7 p -126.32 152.49 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.424 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.2 mt-30 -145.94 163.02 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.598 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.03 108.67 16.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.864 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.451 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 37.9 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.631 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.426 ' H3 ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.426 ' HD3' ' H3 ' ' A' ' 1' ' ' GLY . 46.6 Cg_endo -73.64 8.21 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.737 2.291 . . . . 0.0 111.981 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.0 mt -54.3 -23.68 16.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.276 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 6' ' ' HIS . . . -163.43 15.39 0.11 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.513 ' C ' ' O ' ' A' ' 4' ' ' GLY . 41.4 t 28.6 35.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.679 0.276 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 4' ' ' GLY . 91.3 m-70 -52.52 -39.22 61.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.513 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 6' ' ' HIS . 7.7 mp 31.1 102.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.632 ' O ' ' CB ' ' A' ' 9' ' ' ALA . 94.2 t -100.55 125.57 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.817 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.632 ' CB ' ' O ' ' A' ' 8' ' ' VAL . . . 150.28 80.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.685 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -90.93 130.09 36.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.608 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.2 p -76.4 161.96 28.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.373 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.39 133.21 55.54 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.578 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 m -100.24 -6.33 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.406 ' C ' ' CG2' ' A' ' 15' ' ' THR . 33.7 m -74.32 -10.07 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.093 0.473 . . . . 0.0 110.483 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.63 ' OG1' ' N ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER 33.39 -112.12 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.832 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.692 ' C ' ' H ' ' A' ' 18' ' ' THR . 95.1 mt-10 -61.85 -33.48 74.26 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.561 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.591 ' O ' ' C ' ' A' ' 18' ' ' THR . 6.0 mt 63.44 -27.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.934 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.692 ' H ' ' C ' ' A' ' 16' ' ' GLU . 13.2 t -19.96 116.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.676 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . 67.08 34.57 5.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.756 -179.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 17' ' ' ILE . 1.7 p 47.18 24.97 0.47 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.962 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -61.16 142.37 56.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.37 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' HB2' ' A' ' 93' ' ' GLN . 6.3 m-30 -96.78 148.38 22.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.34 107.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.21 135.54 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.051 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -123.35 150.58 43.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.693 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.442 ' CD1' HD13 ' A' ' 88' ' ' ILE . 43.0 p90 -146.88 -168.24 2.98 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.301 -179.523 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.473 HG11 ' H ' ' A' ' 29' ' ' ALA . 34.1 t -120.63 132.76 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.521 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.689 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 32.2 t -45.49 -33.11 2.51 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.416 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.473 ' H ' HG11 ' A' ' 27' ' ' VAL . . . 56.69 5.22 0.2 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.661 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 31' ' ' ASP . 1.4 t -143.36 -59.38 0.42 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.445 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 30' ' ' SER . 2.9 m-20 86.39 -22.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.889 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 m -95.21 -3.82 47.02 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER -54.11 144.15 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.167 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.479 ' N ' ' O ' ' A' ' 79' ' ' ILE . 8.4 m -94.83 -16.13 23.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.304 0.573 . . . . 0.0 109.682 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.05 175.29 45.08 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.9 m-85 -124.28 152.25 43.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.613 179.545 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.489 ' HE ' ' HB3' ' A' ' 51' ' ' TYR . 70.7 ttt180 -132.78 122.87 25.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.756 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.2 t -109.58 130.41 62.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.886 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.51 ' OE1' ' C ' ' A' ' 39' ' ' GLU . 13.1 tm-20 -123.68 129.59 51.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.407 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 34.9 p90 -143.52 144.74 32.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.213 0.53 . . . . 0.0 111.599 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -148.65 168.14 23.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.464 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.512 HD23 ' CE2' ' A' ' 72' ' ' TYR . 67.3 mt -73.86 129.76 38.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.191 0.52 . . . . 0.0 111.532 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.419 ' HG ' ' HD3' ' A' ' 71' ' ' LYS . 35.3 p -70.83 -18.74 62.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.21 179.514 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -101.06 -75.01 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.221 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.677 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 89.0 mt-10 -62.2 -36.71 82.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.262 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 83.6 -39.18 2.8 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 46' ' ' GLY . 35.4 t0 27.98 -151.39 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.865 0.364 . . . . 0.0 110.41 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.566 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.8 OUTLIER -101.62 134.13 20.39 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.897 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.27 144.05 73.0 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.129 1.886 . . . . 0.0 111.858 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 22.6 mt-30 -116.67 144.14 44.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.678 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.489 ' HB3' ' HE ' ' A' ' 37' ' ' ARG . 3.2 m-85 -123.7 139.22 54.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.909 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -127.35 127.67 44.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -100.86 132.1 46.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.354 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -128.0 155.5 77.67 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.456 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -68.33 155.98 67.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.037 1.824 . . . . 0.0 112.303 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.4 p -56.67 -12.59 1.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 37.7 p -91.84 -8.66 45.94 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.79 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.06 34.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -128.5 11.31 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.6 p -164.2 145.89 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.09 145.49 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.361 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -104.23 127.84 51.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.236 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.84 105.94 37.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -87.78 179.52 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.571 2.181 . . . . 0.0 112.492 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 58.37 38.58 25.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.299 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.456 HD12 ' N ' ' A' ' 22' ' ' PHE . 28.8 mt -87.77 150.23 23.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.8 mt -94.21 109.32 41.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.112 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -54.63 139.56 76.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.137 1.891 . . . . 0.0 111.627 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.574 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 84.95 15.92 66.36 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.677 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 7.6 mmm-85 -125.35 143.75 50.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 110.574 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.419 ' HD3' ' HG ' ' A' ' 43' ' ' SER . 64.8 tttt -100.81 132.0 46.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.156 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.512 ' CE2' HD23 ' A' ' 42' ' ' LEU . 80.1 m-85 -119.6 151.41 38.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.894 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.407 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 70.3 mt -108.54 131.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -119.68 134.18 64.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.827 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.02 125.7 30.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.48 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.1 t -104.15 128.95 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.765 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.478 ' CE1' HD13 ' A' ' 87' ' ' LEU . 92.2 m-85 -119.08 138.96 52.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.544 179.394 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -104.98 137.15 43.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.03 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.479 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.6 mt -100.1 121.75 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.195 0.521 . . . . 0.0 110.382 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 83.6 p -82.48 167.67 18.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.597 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -57.55 -19.91 28.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.244 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.9 p30 -92.24 0.04 57.43 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.188 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.4 9.2 73.06 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.054 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -82.71 143.93 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 111.074 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.461 ' NE2' HG12 ' A' ' 79' ' ' ILE . 3.1 mm-40 -109.53 141.91 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 t -138.27 133.95 33.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.557 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.478 HD13 ' CE1' ' A' ' 77' ' ' TYR . 22.9 tp -73.56 118.55 16.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.648 -0.421 . . . . 0.0 109.947 179.527 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.442 HD13 ' CD1' ' A' ' 26' ' ' TRP . 45.3 pt -109.92 -23.25 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.211 -179.531 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.9 tp -157.03 126.6 6.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.119 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 t -132.81 122.36 24.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.495 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -152.38 159.94 43.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.257 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.2 p -121.59 153.03 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.482 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.4 mt-30 -145.64 161.32 40.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.459 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.13 114.17 19.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.705 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 59.5 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.418 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.479 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -57.58 -2.73 0.74 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.79 2.327 . . . . 0.0 112.016 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.658 ' C ' ' H ' ' A' ' 5' ' ' SER . 50.3 mt -103.97 -38.72 6.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.88 -31.21 0.06 OUTLIER Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.658 ' H ' ' C ' ' A' ' 3' ' ' LEU . 94.0 p -76.68 -7.71 55.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.75 0.31 . . . . 0.0 111.028 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.516 ' NE2' ' CD1' ' A' ' 3' ' ' LEU . 6.0 m-70 -76.21 -24.54 54.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.454 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.629 ' CD1' ' N ' ' A' ' 7' ' ' LEU . 4.1 mp -90.57 134.56 34.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.632 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 27.6 m -135.12 69.83 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.282 179.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.673 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -63.5 -48.63 76.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.311 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.572 ' C ' ' O ' ' A' ' 9' ' ' ALA . 20.1 p 26.51 36.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.924 0.392 . . . . 0.0 110.25 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.701 ' C ' ' H ' ' A' ' 13' ' ' SER . 66.8 m -78.26 2.18 19.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.363 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.665 ' C ' ' H ' ' A' ' 14' ' ' VAL . 48.6 mt-10 60.96 -11.1 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.356 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.701 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.6 OUTLIER 68.36 -22.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.97 -179.374 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.665 ' H ' ' C ' ' A' ' 12' ' ' GLU . 39.4 t -135.0 133.97 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.112 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.74 ' C ' ' H ' ' A' ' 17' ' ' ILE . 1.4 m -130.14 -56.98 1.1 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.25 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.573 ' O ' ' OG ' ' A' ' 21' ' ' SER . 61.2 mp0 -66.04 32.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.74 ' H ' ' C ' ' A' ' 15' ' ' THR . 49.1 mt -31.48 -35.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.886 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.512 ' N ' ' O ' ' A' ' 16' ' ' GLU . 5.2 t -44.35 127.67 5.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 70.68 26.8 3.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 23.7 p 52.57 35.55 18.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.691 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 p -62.46 164.05 7.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.735 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 20.8 m-30 -129.37 147.9 51.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.47 178.495 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' CG2' ' OE1' ' A' ' 16' ' ' GLU . 38.9 t -124.04 101.9 10.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.09 137.76 43.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 -178.561 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -124.55 152.27 43.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.883 179.356 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.451 ' CD2' HG13 ' A' ' 76' ' ' VAL . 39.0 p90 -143.35 -177.93 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.5 -179.489 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.5 HG11 ' H ' ' A' ' 29' ' ' ALA . 55.8 t -108.02 132.54 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.871 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.665 ' C ' ' H ' ' A' ' 30' ' ' SER . 98.3 p -54.68 -33.21 60.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.959 0.409 . . . . 0.0 110.49 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.5 ' H ' HG11 ' A' ' 27' ' ' VAL . . . 54.69 -6.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.528 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.665 ' H ' ' C ' ' A' ' 28' ' ' SER . 2.2 m -166.05 122.88 1.37 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.07 -179.633 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -80.34 -4.07 52.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.129 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.8 p -85.14 -5.58 59.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.59 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.4 p -63.3 138.83 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.485 ' N ' ' O ' ' A' ' 79' ' ' ILE . 7.2 m -94.5 -17.14 22.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.248 0.547 . . . . 0.0 109.559 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.06 178.51 47.59 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -126.9 151.6 48.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.596 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.418 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 21.2 ttp180 -130.8 121.26 25.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.984 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.1 132.01 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.594 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 79.6 tt0 -121.07 133.65 55.24 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.61 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.542 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.4 p90 -139.04 130.48 27.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.155 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -142.72 161.63 37.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.573 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.515 ' CD2' ' CE2' ' A' ' 72' ' ' TYR . 56.8 mt -75.15 132.61 41.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 111.85 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -77.86 -14.67 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.124 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -100.19 -74.91 0.59 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.658 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 89.3 mt-10 -63.65 -34.57 78.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.93 -179.224 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 84.75 -39.6 2.95 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.323 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.649 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 32.4 t0 29.43 -153.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.888 0.375 . . . . 0.0 110.45 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.649 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -102.6 134.93 19.63 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.429 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.66 142.13 62.93 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.166 1.911 . . . . 0.0 111.511 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.542 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 21.3 mt-30 -118.08 144.9 45.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.594 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.9 m-85 -125.17 137.37 54.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.627 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.5 mt -117.03 127.41 54.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -100.49 131.15 46.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.127 0.489 . . . . 0.0 111.093 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mt -129.12 155.79 79.26 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.59 -179.474 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.69 158.61 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 112.167 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.427 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 27.8 p -58.69 -12.95 4.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.714 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.5 p -90.31 -10.23 44.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 134.74 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.7 p -126.83 7.51 6.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.563 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -165.76 147.08 7.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.232 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.7 p -148.91 150.43 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.043 0.449 . . . . 0.0 111.371 -179.516 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.437 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 8.1 t-20 -101.49 130.48 47.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.925 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -107.29 97.01 17.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 85.3 Cg_endo -87.46 -171.52 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.664 2.243 . . . . 0.0 112.541 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 58.42 35.63 24.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.219 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.573 ' O ' ' OG ' ' A' ' 20' ' ' SER . 50.0 mt -90.53 142.01 28.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.554 ' H ' ' HH ' ' A' ' 72' ' ' TYR . 27.2 mt -82.75 113.16 43.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.266 -179.939 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -54.4 141.42 72.32 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.226 1.95 . . . . 0.0 112.204 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.26 20.09 70.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.658 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 13.3 mmm-85 -123.05 146.91 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.716 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -100.15 131.54 46.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.554 ' HH ' ' H ' ' A' ' 67' ' ' LEU . 76.9 m-85 -121.13 153.93 36.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.214 0.531 . . . . 0.0 111.625 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.417 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.0 mt -108.31 124.08 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.206 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.97 131.54 64.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -134.54 126.1 28.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.552 179.517 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.451 HG13 ' CD2' ' A' ' 26' ' ' TRP . 38.8 t -106.33 130.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.904 -179.461 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.472 ' CE1' HD13 ' A' ' 87' ' ' LEU . 57.6 m-85 -123.5 136.59 54.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.025 179.179 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -100.93 134.74 43.46 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.207 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.485 ' O ' ' N ' ' A' ' 34' ' ' SER . 59.2 mt -97.5 123.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.957 -178.4 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.679 ' HG ' ' CG ' ' A' ' 82' ' ' ASP . 52.1 p -83.34 170.97 14.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.97 -21.41 64.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.679 ' CG ' ' HG ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -91.3 -0.8 57.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.56 10.18 70.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.335 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.411 ' CG ' ' OD1' ' A' ' 82' ' ' ASP . 78.3 mm-40 -84.67 140.8 31.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.791 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.418 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 91.4 mt-30 -106.12 143.16 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.2 t -136.59 132.15 34.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.261 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.472 HD13 ' CE1' ' A' ' 77' ' ' TYR . 24.1 tp -72.96 118.37 15.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.349 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.5 pt -109.42 -22.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.401 179.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.7 tp -154.88 121.81 5.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 111.459 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 39.3 t -132.08 113.24 13.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.666 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.8 t -150.87 162.76 40.16 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.443 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -116.49 154.3 30.61 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.331 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.579 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 23.7 mt-30 -136.56 155.82 49.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.93 109.51 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 18.4 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.499 -179.203 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.41 141.51 97.13 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.778 2.318 . . . . 0.0 111.518 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 tt -91.29 121.8 33.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.505 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.685 ' O ' ' N ' ' A' ' 6' ' ' HIS . . . 154.67 179.44 29.91 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.429 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 35.3 t 49.54 -73.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.568 0.223 . . . . 0.0 110.972 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.685 ' N ' ' O ' ' A' ' 4' ' ' GLY . 27.8 m80 76.51 -60.93 0.46 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.463 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 6' ' ' HIS . 3.1 mt 33.02 63.77 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.666 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.546 ' O ' ' C ' ' A' ' 9' ' ' ALA . 14.7 p -84.23 150.22 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.674 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.546 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . -28.3 113.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.005 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 m -112.59 141.01 46.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.645 -178.91 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -82.18 155.65 24.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.465 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -54.46 137.51 42.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 110.606 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.91 -18.71 13.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.505 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.8 t -103.71 122.28 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.125 0.488 . . . . 0.0 111.108 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.706 ' O ' ' N ' ' A' ' 17' ' ' ILE . 2.5 m -111.69 -167.52 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.983 179.108 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.66 ' O ' ' N ' ' A' ' 18' ' ' THR . 3.1 mp0 33.37 28.34 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.706 ' N ' ' O ' ' A' ' 15' ' ' THR . 80.1 mt -37.14 -21.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.584 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.66 ' N ' ' O ' ' A' ' 16' ' ' GLU . 69.8 p -58.34 151.97 18.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.682 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.567 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 55.58 21.75 4.72 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.484 -0.487 . . . . 0.0 109.947 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.567 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER 58.03 33.84 23.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.234 -179.879 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.569 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 3.5 p -61.18 165.87 4.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.24 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.675 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 17.3 m-30 -136.12 151.06 49.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.281 178.765 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.96 102.2 9.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.677 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.63 136.51 48.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.306 -178.557 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -121.88 153.18 38.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.687 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.4 ' CE3' HG23 ' A' ' 76' ' ' VAL . 29.0 p90 -143.58 -168.9 2.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 110.933 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 79.7 t -115.1 133.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.217 179.635 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.666 ' C ' ' H ' ' A' ' 30' ' ' SER . 98.2 p -51.9 -29.69 21.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.422 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 50.77 0.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.251 179.844 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.666 ' H ' ' C ' ' A' ' 28' ' ' SER . 3.0 m -173.03 134.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.912 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.54 -8.39 54.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.57 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 44.6 p -83.35 -2.83 56.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.632 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.6 p -65.09 135.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.297 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.531 ' N ' ' O ' ' A' ' 79' ' ' ILE . 59.7 m -95.37 -15.07 23.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.525 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.54 -178.89 48.37 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.34 152.73 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.549 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.755 ' NH2' HE22 ' A' ' 85' ' ' GLN . 27.4 ttp180 -130.8 122.68 27.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.594 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.32 134.32 51.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.948 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 83.2 tt0 -121.47 126.95 50.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.202 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.555 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 54.0 p90 -133.6 131.29 39.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.238 0.542 . . . . 0.0 110.502 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -147.44 161.56 40.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.442 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.496 HD23 ' CE2' ' A' ' 72' ' ' TYR . 67.6 mt -75.78 130.45 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.941 0.401 . . . . 0.0 111.702 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.402 ' HG ' ' HD3' ' A' ' 71' ' ' LYS . 27.0 p -74.87 -23.23 58.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.106 179.018 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -89.63 -71.04 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 94.1 mt-10 -59.11 -37.98 78.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.698 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 70.4 21.91 77.56 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.557 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 27.1 t0 -46.29 -176.74 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.963 0.411 . . . . 0.0 110.333 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.557 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -69.76 140.2 89.01 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.93 179.773 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -72.44 148.78 49.04 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.483 2.122 . . . . 0.0 111.856 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.555 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 32.7 mt-30 -116.81 147.82 41.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -123.95 139.59 53.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.943 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.7 mt -124.76 128.55 48.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.056 178.348 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -103.36 132.02 49.96 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.977 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mt -128.91 155.15 80.02 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.916 -179.391 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.9 155.77 68.48 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 112.031 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.409 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 26.7 p -58.06 -14.66 7.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.639 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.8 p -89.41 -11.12 44.07 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.367 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.99 131.44 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.4 p -125.28 10.2 8.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.617 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -164.85 146.4 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.06 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . 0.453 HG21 ' N ' ' A' ' 62' ' ' ASN . 5.1 p -149.05 152.21 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.514 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.675 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 13.2 t-20 -102.42 124.76 48.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.762 178.86 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.421 HG22 ' CD2' ' A' ' 40' ' ' TYR . 2.4 mt -97.26 107.0 35.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.971 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -92.21 -178.65 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.802 2.335 . . . . 0.0 113.145 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 58.7 38.05 25.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.531 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.525 ' O ' ' OG ' ' A' ' 20' ' ' SER . 56.7 mt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.094 178.988 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.521 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 30.2 mt -86.44 123.77 70.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.249 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.81 143.36 55.29 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.226 1.95 . . . . 0.0 112.523 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.56 19.53 73.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.663 HH11 ' CG ' ' A' ' 70' ' ' ARG . 0.0 OUTLIER -126.44 151.55 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.302 . . . . 0.0 110.64 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.402 ' HD3' ' HG ' ' A' ' 43' ' ' SER . 77.7 tttt -100.37 130.65 46.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.029 0.442 . . . . 0.0 110.236 179.232 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.521 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 68.1 m-85 -117.25 158.52 24.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.017 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.4 mt -113.37 126.08 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.031 0.443 . . . . 0.0 110.642 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -133.36 125.76 29.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.421 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.4 HG23 ' CE3' ' A' ' 26' ' ' TRP . 14.3 t -104.65 128.51 58.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.583 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.465 ' CE1' HD11 ' A' ' 87' ' ' LEU . 54.0 m-85 -120.75 139.37 53.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.262 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -101.62 134.52 44.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.531 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.4 mt -99.06 119.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.39 0.614 . . . . 0.0 110.621 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.6 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 24.7 p -82.56 169.64 16.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.078 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.98 -19.3 51.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.48 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.6 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 47.3 p30 -93.14 -1.41 56.4 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.144 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.28 67.36 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.926 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 73.8 mm-40 -83.7 139.26 32.88 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.755 HE22 ' NH2' ' A' ' 37' ' ' ARG . 28.7 mt-30 -110.41 139.43 45.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -136.82 135.92 38.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.937 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.465 HD11 ' CE1' ' A' ' 77' ' ' TYR . 32.3 tp -73.28 118.45 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 44.1 pt -109.05 -22.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.612 179.949 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -154.87 122.19 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.106 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.2 t -130.61 122.21 27.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.886 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -154.34 158.59 40.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.323 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.2 p -117.15 152.69 34.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.463 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 27.0 mt-30 -138.94 157.47 45.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.661 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 112.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.497 HG21 ' CZ ' ' A' ' 22' ' ' PHE . 53.8 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.498 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . 0.604 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.23 18.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.851 2.368 . . . . 0.0 111.653 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . 0.604 ' H ' ' C ' ' A' ' 1' ' ' GLY . 1.0 OUTLIER -70.28 144.14 51.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.013 -179.713 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.55 11.48 81.81 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.7 p -84.95 -4.06 58.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.915 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 8' ' ' VAL . 76.6 m-70 -73.36 -113.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.105 0.478 . . . . 0.0 110.552 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . 0.412 ' C ' ' O ' ' A' ' 6' ' ' HIS . 6.5 mp 36.31 23.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.991 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.684 ' C ' ' H ' ' A' ' 10' ' ' THR . 36.9 t -70.05 -11.71 15.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.98 -27.95 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.363 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.684 ' H ' ' C ' ' A' ' 8' ' ' VAL . 63.8 m -103.91 139.21 39.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.937 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 p -130.85 -90.87 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.446 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.513 ' C ' ' H ' ' A' ' 14' ' ' VAL . 39.4 tp10 -72.69 -44.03 62.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.165 0.507 . . . . 0.0 109.899 178.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.521 ' HG ' ' CG2' ' A' ' 10' ' ' THR . 1.1 m 69.8 -40.64 0.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.947 179.925 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.513 ' H ' ' C ' ' A' ' 12' ' ' GLU . 47.3 t -115.01 131.34 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.978 0.418 . . . . 0.0 111.94 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.724 ' CG2' ' H ' ' A' ' 16' ' ' GLU . 9.5 m -134.67 -143.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.954 178.615 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.724 ' H ' ' CG2' ' A' ' 15' ' ' THR . 77.4 mm-40 8.14 56.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.529 0.518 . . . . 0.0 110.777 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.711 ' N ' ' O ' ' A' ' 15' ' ' THR . 67.4 mt -64.1 -21.5 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.991 -178.73 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' THR . . . . . . . . . . . . . 18.4 m -53.33 135.0 39.63 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.39 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 65.4 17.38 10.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.597 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER 60.41 29.14 18.78 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.313 -179.879 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.615 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -60.77 129.57 42.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.182 0.515 . . . . 0.0 110.626 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 19.0 m-30 -95.65 144.87 25.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.266 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.31 102.87 13.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.87 137.88 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.079 0.466 . . . . 0.0 111.504 -178.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -126.52 153.02 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.711 179.32 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.487 ' CD2' HG12 ' A' ' 76' ' ' VAL . 32.2 p90 -144.65 -172.52 3.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . 0.448 HG12 ' H ' ' A' ' 29' ' ' ALA . 39.4 t -113.76 131.15 66.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.629 179.235 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.678 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 27.3 t -52.76 -34.64 54.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.683 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . 0.448 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 60.59 -7.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.082 179.507 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.624 ' H ' ' C ' ' A' ' 28' ' ' SER . 3.1 m -167.48 132.77 1.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.798 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -90.06 6.55 41.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.483 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.49 -4.39 48.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.231 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 56' ' ' SER . 2.1 p -63.29 138.49 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.106 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.8 m -95.31 -13.31 24.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.346 0.593 . . . . 0.0 109.831 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.96 177.02 44.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.57 151.71 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.904 0.383 . . . . 0.0 110.369 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.679 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 46.0 ttp180 -128.66 121.74 29.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.682 178.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 47.9 t -106.72 132.87 52.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.381 -179.679 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.437 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 69.3 tt0 -123.46 134.28 53.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.763 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.467 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 54.6 p90 -140.14 137.18 34.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 110.714 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.62 158.94 44.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.907 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.644 ' CD1' HH21 ' A' ' 70' ' ' ARG . 39.9 mt -74.25 132.4 42.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.471 ' HG ' ' HB3' ' A' ' 71' ' ' LYS . 22.5 p -77.64 -13.67 59.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.317 179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -98.8 -73.19 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.976 -179.539 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -60.1 -34.4 73.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.155 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 74.96 18.48 80.18 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.675 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 37.8 t0 -41.32 173.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.0 110.462 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . 0.675 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -67.18 140.23 95.51 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.125 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.538 ' C ' ' OE1' ' A' ' 50' ' ' GLN . 57.7 Cg_endo -73.3 146.35 40.11 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.575 2.183 . . . . 0.0 111.997 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.655 ' CD ' ' N ' ' A' ' 50' ' ' GLN . 2.4 mp0 -113.11 147.9 36.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -122.72 136.16 54.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.146 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -120.58 128.28 52.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.465 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.66 130.61 46.73 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.201 -178.928 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -127.82 155.95 76.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.468 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -68.21 156.16 66.77 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.274 1.983 . . . . 0.0 112.269 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 53.4 p -58.8 -14.11 7.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.3 p -90.01 -8.83 50.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.71 132.96 34.39 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 p -128.9 12.73 6.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.032 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.5 p -164.61 148.62 9.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -152.63 147.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.514 -179.571 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.404 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 15.9 t-20 -102.88 127.96 49.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.366 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.9 mt -99.21 104.6 27.33 Favored Pre-proline 0 C--N 1.332 -0.177 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.684 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.404 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.5 Cg_endo -89.42 174.66 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.785 2.323 . . . . 0.0 113.103 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 61.38 38.31 16.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.708 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -90.51 142.44 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.793 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.457 HD11 ' NH2' ' A' ' 70' ' ' ARG . 24.9 mt -78.66 130.8 69.69 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.287 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 70' ' ' ARG . 39.0 Cg_exo -51.35 -174.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.206 1.937 . . . . 0.0 111.812 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 17.02 40.29 0.01 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.373 179.068 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.709 ' N ' ' O ' ' A' ' 68' ' ' PRO . 16.2 mmm-85 -127.22 142.76 51.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.346 0.573 . . . . 0.0 110.417 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.471 ' HB3' ' HG ' ' A' ' 43' ' ' SER . 77.4 tttt -101.19 132.4 46.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.441 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.468 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 67.8 m-85 -121.28 155.72 34.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.415 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.2 mt -110.68 123.77 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.816 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . 0.401 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 62.7 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 0.0 111.565 -178.27 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . 0.496 ' OD1' ' OG ' ' A' ' 90' ' ' SER . 21.4 m-80 -133.07 126.14 31.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.523 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.487 HG12 ' CD2' ' A' ' 26' ' ' TRP . 6.6 t -107.57 131.36 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.471 ' CE1' HD12 ' A' ' 87' ' ' LEU . 46.2 m-85 -122.12 142.29 50.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.116 179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.678 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -102.88 137.47 41.04 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.804 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.66 ' O ' ' N ' ' A' ' 34' ' ' SER . 45.2 mt -100.93 121.56 51.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.074 0.464 . . . . 0.0 110.437 -178.587 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.614 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 71.4 p -82.11 168.13 18.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.945 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -57.62 -22.25 44.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.614 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.5 p30 -92.82 -0.49 57.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.723 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.76 11.95 67.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.495 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.21 138.69 33.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.195 0.498 . . . . 0.0 111.037 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.679 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 94.0 mt-30 -107.03 142.24 36.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.224 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -138.3 135.34 35.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.135 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.471 HD12 ' CE1' ' A' ' 77' ' ' TYR . 36.8 tp -73.42 118.6 16.57 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.228 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 32.6 pt -110.99 -22.43 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.555 -179.849 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -155.19 124.86 6.47 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.562 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' SER . . . . . 0.496 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 7.2 t -135.66 119.22 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.345 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 t -149.88 158.27 44.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.902 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -115.74 154.65 29.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.137 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.553 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 27.1 mt-30 -142.18 159.81 41.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.23 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.17 114.84 23.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.477 178.597 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.586 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 31.1 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.607 -179.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.463 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.541 ' HA ' ' HE2' ' A' ' 6' ' ' HIS . 95.8 Cg_endo -88.34 -9.8 4.94 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.475 2.783 . . . . 0.0 113.9 -179.239 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.1 mt -59.51 -36.22 75.66 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.093 -178.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' SER . . . -108.44 -140.73 9.31 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 4' ' ' GLY . 13.2 m 36.5 -157.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 110.667 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.541 ' HE2' ' HA ' ' A' ' 2' ' ' PRO . 79.5 m-70 60.66 45.46 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 110.048 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.0 tt -53.44 -37.74 62.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.487 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.477 HG12 ' H ' ' A' ' 9' ' ' ALA . 7.4 p -137.96 -42.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.512 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.477 ' H ' HG12 ' A' ' 8' ' ' VAL . . . -61.95 148.1 44.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 0.0 110.809 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.412 ' CG2' ' C ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER 166.63 -33.63 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.478 0.656 . . . . 0.0 109.484 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 8.0 p -163.62 -138.62 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.408 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' C ' ' H ' ' A' ' 14' ' ' VAL . 85.6 mt-10 -67.95 -31.86 71.89 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.877 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.37 4.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.241 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.578 ' H ' ' C ' ' A' ' 12' ' ' GLU . 39.2 t -135.02 -59.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.384 . . . . 0.0 110.837 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.556 ' O ' ' CG ' ' A' ' 16' ' ' GLU . 59.6 m 45.89 -102.64 0.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.625 ' O ' ' O ' ' A' ' 21' ' ' SER . 17.4 pt-20 46.79 43.47 13.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.7 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.622 ' O ' ' O ' ' A' ' 18' ' ' THR . 30.3 mt -110.05 -118.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.571 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.622 ' O ' ' O ' ' A' ' 17' ' ' ILE . 71.3 p 36.15 102.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.608 ' C ' ' HG ' ' A' ' 20' ' ' SER . . . 68.16 22.64 8.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.297 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.608 ' HG ' ' C ' ' A' ' 19' ' ' ALA . 2.6 p 55.26 22.59 4.87 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.324 -178.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.625 ' O ' ' O ' ' A' ' 16' ' ' GLU . 2.3 p -61.59 127.92 33.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.427 ' CE2' ' HB2' ' A' ' 93' ' ' GLN . 5.5 m-30 -92.34 140.41 29.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.126 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.32 107.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.47 135.15 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.847 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -124.34 150.79 45.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.142 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.471 ' CD2' HG12 ' A' ' 76' ' ' VAL . 38.9 p90 -145.04 -164.99 2.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.75 133.37 65.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.345 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 30' ' ' SER . 61.1 p -50.56 -28.83 9.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.595 -179.196 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . 42.81 9.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.666 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.7 OUTLIER -169.08 116.96 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.82 -179.896 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -84.44 -7.46 59.28 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.8 p -88.25 -0.7 57.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.017 179.305 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 7.5 p -66.94 137.22 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.8 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.641 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.2 m -95.11 -16.51 22.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.83 178.34 47.29 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.19 151.27 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.895 0.379 . . . . 0.0 110.118 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.782 ' NE ' HE22 ' A' ' 85' ' ' GLN . 26.9 ttp180 -130.46 125.62 34.86 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.557 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 46.2 t -109.13 131.49 59.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.396 -179.662 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 78.2 tt0 -120.99 126.21 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.48 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.471 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 49.6 p90 -137.61 137.05 38.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.239 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -147.2 167.53 23.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.535 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 57.9 mt -77.1 128.59 34.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 111.213 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' SER . . . . . 0.451 ' HG ' ' HB3' ' A' ' 71' ' ' LYS . 18.4 p -76.4 -16.09 59.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.145 179.684 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -92.31 -74.82 0.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -62.84 -34.29 77.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.998 -179.43 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.68 34.96 59.28 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -57.56 169.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -61.11 137.47 94.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.85 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.71 152.47 81.84 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.603 2.202 . . . . 0.0 112.846 -179.281 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.432 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 42.9 mt-30 -118.65 144.7 46.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.904 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -121.1 143.04 49.3 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.054 -0.659 . . . . 0.0 112.203 -178.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 mt -129.38 125.74 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.869 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -100.54 133.52 44.85 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.367 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 160.43 63.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.512 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.9 Cg_endo -75.61 158.99 39.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.989 1.793 . . . . 0.0 112.129 179.794 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.468 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 7.7 p -57.45 -12.23 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.296 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 p -93.8 -8.11 41.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.09 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.07 138.53 34.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.752 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -130.27 5.69 4.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.993 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 p -163.31 146.82 10.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.7 p -146.85 146.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.407 -179.171 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . 0.418 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 14.1 t-20 -103.51 128.49 50.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.296 179.315 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . 0.405 HD12 ' CD1' ' A' ' 40' ' ' TYR . 1.4 mt -105.47 99.49 21.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.925 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . 0.418 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 96.7 Cg_endo -88.83 174.46 3.92 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.579 2.186 . . . . 0.0 112.162 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 66.56 37.73 4.39 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.431 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.536 ' O ' ' OG ' ' A' ' 20' ' ' SER . 39.4 mt -89.74 157.42 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 mt -91.1 110.09 39.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.793 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.419 ' HA ' ' HG1' ' A' ' 95' ' ' THR . 22.1 Cg_exo -56.39 143.33 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.192 1.928 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . 0.766 ' N ' ' HG1' ' A' ' 95' ' ' THR . . . 79.05 17.78 76.14 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -125.15 151.2 46.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . 0.451 ' HB3' ' HG ' ' A' ' 43' ' ' SER . 66.1 tttt -99.85 131.86 45.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.866 179.353 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.535 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 72.2 m-85 -118.84 153.05 35.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.457 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.471 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 75.0 mt -110.1 126.81 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.369 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.92 133.88 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.115 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -133.98 126.87 31.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.545 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.471 HG12 ' CD2' ' A' ' 26' ' ' TRP . 23.9 t -105.44 126.96 60.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . 0.414 ' CE1' HD13 ' A' ' 87' ' ' LEU . 69.3 m-85 -119.35 139.74 51.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.938 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . 0.484 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 0.5 OUTLIER -105.13 136.61 44.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.35 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.641 ' O ' ' N ' ' A' ' 34' ' ' SER . 46.4 mt -100.66 124.78 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.216 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.6 p -85.43 171.99 11.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.82 -19.45 41.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.8 p30 -92.34 -2.32 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.203 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.52 68.73 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.272 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 65.6 mm-40 -84.48 142.07 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.135 0.468 . . . . 0.0 111.097 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.782 HE22 ' NE ' ' A' ' 37' ' ' ARG . 81.2 mt-30 -108.64 139.81 42.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.832 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -136.92 137.81 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.866 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . 0.414 HD13 ' CE1' ' A' ' 77' ' ' TYR . 43.2 tp -74.07 118.46 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.377 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.438 HG21 ' NE2' ' A' ' 78' ' ' GLN . 43.3 pt -110.91 -23.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.616 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.0 tp -155.82 125.02 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.666 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 25.9 t -134.37 118.97 18.06 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.494 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 t -153.79 154.39 33.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.447 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -116.52 155.11 29.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.107 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . 0.427 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 24.7 mt-30 -145.48 164.65 30.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.238 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 109.52 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.72 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.766 ' HG1' ' N ' ' A' ' 69' ' ' GLY . 72.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.389 -179.4 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PRO . . . . . 0.647 ' C ' ' H ' ' A' ' 4' ' ' GLY . 10.9 Cg_endo -57.24 149.5 63.87 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.519 2.146 . . . . 0.0 111.829 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -64.14 16.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.696 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLY . . . . . 0.647 ' H ' ' C ' ' A' ' 2' ' ' PRO . . . -57.4 136.79 50.28 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' SER . . . . . 0.54 ' O ' ' C ' ' A' ' 6' ' ' HIS . 60.0 p -86.32 -2.64 58.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.23 -0.188 . . . . 0.0 111.272 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' HIS . . . . . 0.699 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER 29.46 55.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.605 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -52.34 71.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.147 -179.408 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' VAL . . . . . 0.699 ' N ' ' O ' ' A' ' 6' ' ' HIS . 18.8 m -111.28 5.59 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.81 179.364 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . 37.29 -121.29 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.926 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' THR . . . . . 0.727 ' HG1' ' H ' ' A' ' 11' ' ' SER . 15.0 t -103.86 175.05 5.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.051 -179.557 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' SER . . . . . 0.727 ' H ' ' HG1' ' A' ' 10' ' ' THR . 4.4 p -60.63 -163.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.126 179.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' GLU . . . . . 0.708 ' C ' ' H ' ' A' ' 14' ' ' VAL . 97.0 mt-10 -57.89 -35.94 71.71 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.547 -179.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' SER . . . . . 0.522 ' OG ' ' O ' ' A' ' 12' ' ' GLU . 51.2 p 60.45 -19.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.074 179.861 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' VAL . . . . . 0.708 ' H ' ' C ' ' A' ' 12' ' ' GLU . 63.4 t -107.53 132.03 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.715 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' THR . . . . . 0.437 ' O ' HG13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -109.49 -43.73 4.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.939 179.675 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' GLU . . . . . 0.505 ' OE1' ' CG2' ' A' ' 23' ' ' VAL . 43.8 mp0 -74.78 92.57 2.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ILE . . . . . 0.678 ' O ' ' N ' ' A' ' 20' ' ' SER . 12.6 mt -112.88 -22.92 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.431 -179.056 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 19' ' ' ALA . 35.0 p -32.66 -71.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.03 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . -81.71 26.53 0.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.39 179.019 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER 60.91 21.47 11.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.957 -179.834 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' SER . . . . . 0.473 ' OG ' ' CB ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER -61.22 172.1 1.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.801 -179.134 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . 0.436 ' CZ ' HG23 ' A' ' 95' ' ' THR . 23.3 m-85 -135.58 146.06 47.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.913 178.166 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . 0.505 ' CG2' ' OE1' ' A' ' 16' ' ' GLU . 41.5 t -117.28 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.515 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.6 t -108.76 134.9 49.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.075 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.0 p -126.66 151.66 47.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.167 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CD2' HG13 ' A' ' 76' ' ' VAL . 36.9 p90 -144.37 -174.64 4.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.977 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.79 127.66 74.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.62 129.08 8.8 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.71 28.17 8.99 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.745 -178.706 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' SER . . . . . 0.647 ' C ' ' H ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -163.47 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.392 179.974 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' ASP . . . . . 0.433 ' C ' ' H ' ' A' ' 33' ' ' VAL . 91.2 m-20 61.51 -41.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.073 -179.438 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' THR . . . . . 0.647 ' H ' ' C ' ' A' ' 30' ' ' SER . 40.1 p -74.19 5.24 4.61 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.053 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' VAL . . . . . 0.433 ' H ' ' C ' ' A' ' 31' ' ' ASP . 0.8 OUTLIER -60.1 138.1 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.006 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 79' ' ' ILE . 32.1 m -94.46 -15.74 23.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 109.612 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' GLY . . . . . 0.457 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.04 176.68 45.37 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.33 151.48 44.27 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.29 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' ARG . . . . . 0.818 ' NE ' HE22 ' A' ' 85' ' ' GLN . 40.6 ttp180 -131.78 125.06 30.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 48.2 t -110.8 133.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.621 -179.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.9 tt0 -123.82 132.24 53.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' TYR . . . . . 0.581 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 53.4 p90 -140.04 136.26 33.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.001 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -146.66 161.79 39.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.551 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' LEU . . . . . 0.536 ' CD2' ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -75.0 125.14 28.29 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.848 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -69.57 -18.91 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -94.23 -73.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 94.8 mt-10 -57.55 -34.59 69.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.993 -178.992 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.25 34.23 69.26 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' ASP . . . . . 0.454 ' C ' ' OD1' ' A' ' 47' ' ' ASP . 48.5 p30 -58.22 -175.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.382 . . . . 0.0 110.417 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -71.54 135.95 83.71 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.3 146.45 69.32 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.267 1.978 . . . . 0.0 111.703 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' GLN . . . . . 0.581 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 30.8 mt-30 -114.33 144.01 43.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -120.94 140.33 51.99 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.965 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -125.76 128.08 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.916 178.612 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -103.12 130.72 50.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.081 0.467 . . . . 0.0 111.43 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -129.77 154.55 81.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.651 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -69.54 157.73 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.371 2.047 . . . . 0.0 112.724 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' SER . . . . . 0.457 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 58.3 p -58.13 -14.65 7.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.701 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.4 p -89.61 -9.67 48.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.03 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.53 131.94 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.603 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.0 p -130.14 13.74 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.5 p -163.58 146.06 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.219 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.6 p -149.21 145.63 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 111.487 -179.675 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -103.12 125.14 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.391 178.962 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.8 mt -97.98 107.59 41.59 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.179 -179.326 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -89.23 177.19 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.856 2.37 . . . . 0.0 112.682 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.47 38.18 19.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.717 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 34.1 mt -90.92 147.74 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.779 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LEU . . . . . 0.491 ' O ' ' OG1' ' A' ' 95' ' ' THR . 17.1 mt -89.09 114.25 59.44 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.893 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' PRO . . . . . 0.413 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 31.6 Cg_exo -54.33 136.41 68.8 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.276 1.984 . . . . 0.0 111.465 178.031 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.73 26.75 66.47 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.864 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 45' ' ' GLU . 7.0 mmt180 -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -98.34 127.97 44.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' TYR . . . . . 0.536 ' CZ ' ' CD2' ' A' ' 42' ' ' LEU . 74.6 m-85 -119.02 147.99 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.22 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 76.2 mt -103.87 124.83 58.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.585 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 t -111.17 130.57 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.671 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.91 123.08 24.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.507 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' VAL . . . . . 0.463 HG13 ' CD2' ' A' ' 26' ' ' TRP . 17.7 t -104.28 126.57 58.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -120.02 138.3 53.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.878 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.27 135.96 42.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.896 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.5 mt -99.26 122.26 50.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.229 0.537 . . . . 0.0 110.613 -178.739 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 94.5 p -83.5 169.45 15.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -21.15 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.878 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.5 p30 -91.74 -0.91 57.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.009 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.58 11.37 68.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.011 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' GLU . . . . . 0.575 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.0 mm-40 -82.81 140.39 32.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLN . . . . . 0.818 HE22 ' NE ' ' A' ' 37' ' ' ARG . 59.4 mt-30 -108.81 141.03 41.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.728 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.3 t -137.26 133.05 34.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 13.7 tp -71.31 119.05 14.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.695 179.72 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ILE . . . . . 0.463 HD12 ' CD1' ' A' ' 26' ' ' TRP . 40.9 pt -108.12 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.652 -179.508 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -156.07 121.33 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.176 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 15.7 t -131.1 118.39 20.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.44 178.94 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -149.42 153.73 37.78 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.724 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.5 p -115.89 149.25 38.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.101 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -147.45 158.9 44.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.6 OUTLIER -119.04 111.5 18.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.739 178.318 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' THR . . . . . 0.491 ' OG1' ' O ' ' A' ' 67' ' ' LEU . 73.8 p . . . . . 0 C--N 1.321 -0.651 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.787 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.017 0.437 . . . . 0.0 110.464 . . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.433 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.4 OUTLIER -65.52 -179.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 111.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.696 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 33.6 m-85 -141.52 140.03 33.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.985 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.7 t -113.68 101.07 11.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -111.16 133.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.322 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.7 p -122.24 153.02 39.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.648 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -143.15 -171.57 3.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.57 126.78 73.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.458 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.322 -0.611 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.797 -179.765 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.4 p . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 79' ' ' ILE . 19.5 m -94.44 -15.18 24.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.5 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.64 -179.23 47.74 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.18 154.9 44.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.958 0.409 . . . . 0.0 111.004 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 18.2 ttp180 -132.07 124.92 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 61' ' ' VAL . 17.9 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.447 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' CB ' ' A' ' 49' ' ' PRO . 75.0 tt0 -125.85 129.8 50.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 22.5 p90 -137.51 130.97 31.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -144.51 161.92 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.863 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.74 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 87.6 mt -74.52 126.63 31.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.161 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.3 p -73.14 -20.98 60.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.153 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.155 -179.138 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 72.6 Cg_endo . . . . . 0 N--CA 1.489 1.228 0 CA-C-O 121.066 0.361 . . . . 0.0 112.769 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 19.7 mt-30 -114.47 146.18 40.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.441 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -123.09 137.13 55.0 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.437 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 76.7 mt -123.85 135.07 53.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.032 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -108.52 134.71 50.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.329 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.49 153.65 80.67 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.6 156.47 60.84 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.384 2.056 . . . . 0.0 112.344 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 17.6 p -57.56 -15.9 8.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.028 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.8 p -90.94 -7.6 51.64 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.539 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.43 137.18 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.1 p -134.51 13.82 3.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.227 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.7 p -164.79 145.22 7.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.634 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 38' ' ' VAL . 4.3 p -153.93 150.36 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.198 0.523 . . . . 0.0 111.942 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.414 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 30.7 t30 -103.32 129.27 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.396 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.95 104.34 28.13 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.019 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 94.7 Cg_endo -89.9 179.95 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.833 2.355 . . . . 0.0 113.153 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 59.62 37.03 22.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.7 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.546 ' O ' ' OG ' ' A' ' 20' ' ' SER . 29.5 mt -92.26 150.56 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.163 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.637 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 29.5 mt -89.04 111.27 43.88 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.777 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 20.4 Cg_exo -57.97 143.6 95.83 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.155 1.903 . . . . 0.0 111.865 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.66 80.44 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -123.22 146.58 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -95.28 134.36 38.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.244 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.74 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 12.3 m-85 -118.49 150.84 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.8 mt -108.54 121.64 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.94 131.37 66.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.095 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -133.73 131.46 39.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.701 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -105.1 131.43 54.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.554 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -123.43 137.42 54.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.686 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.9 pt20 -100.94 136.65 40.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.702 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.1 mt -99.29 125.26 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.38 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 47.3 p -84.64 169.25 14.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.74 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -59.9 -16.63 30.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.603 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.602 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 43.9 p30 -96.04 0.25 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.06 15.23 63.1 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.71 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.558 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 54.0 mm-40 -83.77 141.97 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.936 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -114.38 140.37 48.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.625 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -136.09 133.2 37.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.858 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 90' ' ' SER . 21.8 tp -72.17 116.59 12.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.1 pt -108.99 -21.36 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -155.67 126.24 6.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.574 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 87' ' ' LEU . 28.6 t -131.53 122.15 25.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.877 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 t -154.08 153.82 32.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.617 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -112.99 154.75 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.106 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.696 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 31.6 mt-30 -142.09 157.07 45.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.278 0.561 . . . . 0.0 111.388 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.51 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -117.75 107.15 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.51 ' OXT' ' O ' ' A' ' 94' ' ' THR . 71.1 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.919 -1.038 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.708 0.289 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.459 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -59.07 176.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.541 0.686 . . . . 0.0 111.538 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.587 ' CZ ' HG22 ' A' ' 95' ' ' THR . 15.2 m-85 -148.19 146.59 28.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.041 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.96 102.2 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.2 t -110.17 136.93 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.484 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.8 p -123.46 151.72 42.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.846 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CD2' HG11 ' A' ' 76' ' ' VAL . 35.4 p90 -143.99 -173.33 3.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.165 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.6 132.61 62.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 C--N 1.323 -0.557 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.783 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.0 p . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.944 0.402 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 79' ' ' ILE . 12.5 m -94.63 -14.11 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.583 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.67 176.81 46.01 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.59 151.21 46.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.069 0.462 . . . . 0.0 110.827 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -131.94 124.44 29.43 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.23 134.66 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.42 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 74.6 tt0 -121.96 127.08 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.978 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.6 p90 -135.54 133.98 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.63 165.69 29.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.229 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.766 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 85.2 mt -74.65 129.39 37.64 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.211 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 16.8 p -74.79 -15.75 60.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.307 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.274 -178.851 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 CA-C-O 120.959 0.316 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.473 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 20.0 mt-30 -116.18 151.11 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.42 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -124.77 138.29 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.052 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.5 mt -125.02 131.35 53.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.73 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -104.63 133.04 50.15 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.917 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.6 mt -130.26 153.37 81.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.639 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.65 154.3 74.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.344 2.029 . . . . 0.0 112.622 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -56.77 -12.53 1.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.7 p -93.16 -9.67 38.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.646 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.54 136.27 34.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.514 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.9 p -128.03 10.62 6.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.01 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.5 p -164.07 150.41 11.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.539 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -151.37 153.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.186 0.517 . . . . 0.0 111.485 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.434 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.9 t30 -103.4 126.57 50.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.723 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.485 HG22 HD21 ' A' ' 66' ' ' LEU . 3.1 mt -103.02 101.84 24.0 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.926 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 69.1 Cg_endo -91.71 -175.24 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.995 2.463 . . . . 0.0 112.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 58.39 35.01 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.398 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.58 ' O ' ' OG ' ' A' ' 20' ' ' SER . 23.3 mt -88.5 153.14 21.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.36 109.97 41.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.206 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 30.8 Cg_exo -56.02 138.5 82.68 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.234 1.956 . . . . 0.0 111.563 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.81 16.31 73.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.2 mmt-85 -126.13 148.19 49.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.86 0.362 . . . . 0.0 110.29 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 70.1 tttt -97.35 133.55 41.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.943 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.766 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 60.3 m-85 -118.89 151.39 38.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.599 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.466 HG22 HD21 ' A' ' 75' ' ' ASN . 71.3 mt -108.91 125.45 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -113.59 131.71 64.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.059 0.457 . . . . 0.0 110.917 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.466 HD21 HG22 ' A' ' 73' ' ' ILE . 35.2 m-80 -134.95 126.94 29.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.969 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.489 HG11 ' CD2' ' A' ' 26' ' ' TRP . 26.3 t -105.4 128.56 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -120.0 137.64 53.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.694 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -101.84 135.55 43.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.1 mt -98.91 122.31 50.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.2 0.524 . . . . 0.0 110.599 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 52.6 p -83.23 170.22 14.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.196 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.6 -19.63 50.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.374 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 44.6 p30 -91.99 -0.59 57.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.273 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.47 75.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 71.7 mm-40 -84.99 142.55 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 110.482 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -107.14 145.96 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.099 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 t -137.89 130.76 29.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.221 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 90' ' ' SER . 29.2 tp -73.01 117.93 15.33 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.232 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.3 pt -107.53 -21.66 5.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.773 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.2 tp -156.51 125.45 5.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.56 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.692 ' HB2' HD21 ' A' ' 87' ' ' LEU . 24.0 t -130.86 118.47 20.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -152.77 167.2 29.81 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.709 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 75.1 p -128.86 157.8 40.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 0.0 110.543 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -142.59 161.18 38.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.294 0.569 . . . . 0.0 111.024 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.49 115.23 21.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.538 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.587 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.609 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.465 ' O ' HD12 ' A' ' 66' ' ' LEU . 4.4 p . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.6 p -62.87 140.21 58.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.386 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.557 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.7 m-30 -95.15 155.55 16.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.252 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -132.74 103.45 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.95 135.27 50.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 110.529 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -127.28 151.15 49.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.289 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.505 ' HB3' HD22 ' A' ' 89' ' ' LEU . 46.1 p90 -148.83 -164.99 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.1 t -120.49 133.71 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.446 -179.2 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.734 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 5.3 p . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.3 m -95.46 -12.96 25.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.24 177.26 46.01 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.734 ' CZ ' HG11 ' A' ' 33' ' ' VAL . 92.4 m-85 -129.26 151.51 49.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 110.288 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -129.71 126.09 37.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.595 HG21 HG11 ' A' ' 61' ' ' VAL . 27.0 t -107.56 134.66 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.523 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 68.5 tt0 -126.35 127.45 45.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.529 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.465 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 27.0 p90 -136.63 140.86 43.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 0.0 111.104 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.33 161.94 40.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.17 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.72 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 50.9 mt -75.63 127.75 33.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 111.503 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 20.3 p -75.81 -9.73 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.812 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.15 -178.313 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.893 0.289 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.465 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 mt-30 -114.31 147.03 39.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.586 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 91.4 m-85 -122.65 136.89 55.01 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.841 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.5 mt -124.8 127.15 46.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -99.06 131.96 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.956 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -127.87 154.29 78.16 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.82 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.58 159.64 52.78 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.619 2.213 . . . . 0.0 112.216 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p -60.61 -14.6 21.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.3 p -90.15 -5.44 56.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.328 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.43 139.29 31.64 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.498 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.6 p -129.72 9.54 5.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -167.55 150.2 5.95 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.595 HG11 HG21 ' A' ' 38' ' ' VAL . 8.1 p -150.29 147.49 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.838 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.428 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 7.5 t30 -103.04 127.56 50.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.379 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -102.74 102.1 24.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.322 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 77.3 Cg_endo -86.8 -175.2 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.8 2.333 . . . . 0.0 113.278 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 57.87 39.15 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.611 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' CD1' ' A' ' 22' ' ' PHE . 25.8 mt -90.96 152.53 20.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.41 108.13 37.29 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.297 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 39.3 Cg_exo -51.51 140.66 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.295 1.997 . . . . 0.0 111.647 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.425 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 83.33 14.76 73.35 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -124.69 143.69 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.336 . . . . 0.0 110.385 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 74.7 tttt -99.19 134.88 41.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.72 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 83.8 m-85 -121.84 147.93 45.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 61.6 mt -106.04 128.05 60.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.64 136.49 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.149 0.499 . . . . 0.0 111.588 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -135.36 125.81 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.442 HG11 ' CD2' ' A' ' 26' ' ' TRP . 11.9 t -104.97 131.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.635 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -120.6 140.87 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.489 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.6 pt20 -105.92 135.42 47.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.715 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 34' ' ' SER . 36.0 mt -100.23 121.6 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.439 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.621 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 44.4 p -82.49 171.91 13.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.782 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.06 -19.65 54.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.398 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.621 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 45.4 p30 -91.25 -2.8 57.37 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.389 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.17 67.23 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.319 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.514 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.2 mm-40 -83.33 145.23 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -111.69 140.73 46.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -137.79 135.27 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.637 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 90' ' ' SER . 21.5 tp -71.64 119.29 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.419 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.9 pt -109.36 -26.12 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 26' ' ' TRP . 13.9 tp -156.94 122.77 4.78 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.48 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.403 ' HB2' HD21 ' A' ' 87' ' ' LEU . 34.8 t -134.22 121.1 20.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -150.73 162.35 40.88 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.972 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -121.18 152.12 39.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.289 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 72.7 mt-30 -144.56 160.26 41.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.234 0.54 . . . . 0.0 110.585 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -120.27 109.44 15.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.875 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.557 HG22 ' CE1' ' A' ' 22' ' ' PHE . 69.3 p . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.042 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.539 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 121.141 0.496 . . . . 0.0 109.907 . . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.494 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 3.6 p -58.34 -178.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.22 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 21' ' ' SER . 16.1 m-85 -147.2 149.3 32.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.033 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.8 t -123.4 102.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -110.45 135.59 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.777 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.4 p -129.09 153.73 47.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.411 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.702 ' CD2' HG11 ' A' ' 76' ' ' VAL . 37.4 p90 -144.24 -171.61 3.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.37 128.42 73.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.1 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 1.2 p . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.663 0.268 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -95.01 -18.53 20.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 109.413 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.28 179.65 47.68 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.77 151.17 45.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.834 0.35 . . . . 0.0 110.073 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.407 ' HB2' HD11 ' A' ' 79' ' ' ILE . 26.1 ttp180 -130.83 124.71 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG21 HG11 ' A' ' 61' ' ' VAL . 60.2 t -109.1 131.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.43 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.11 128.81 52.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 50' ' ' GLN . 51.5 p90 -136.96 140.29 42.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.203 0.525 . . . . 0.0 111.035 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.16 164.05 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.983 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.726 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 34.5 mt -73.96 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 0.0 111.104 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 p -71.05 -21.55 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.915 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.019 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 CA-C-O 120.969 0.321 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 18.0 mp0 -114.85 150.61 35.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -124.12 136.81 54.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.926 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.49 127.26 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -102.49 131.42 49.2 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.584 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mt -128.69 155.51 79.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.28 160.49 49.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.227 1.952 . . . . 0.0 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.459 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 p -60.19 -17.03 38.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.643 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.6 p -89.0 -9.54 50.97 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.066 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 130.26 35.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.5 p -127.02 13.07 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.467 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.8 p -165.06 148.09 8.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.267 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 38' ' ' VAL . 12.6 p -149.89 148.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.494 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 46.9 t-20 -104.42 127.29 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.842 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mt -101.92 103.69 30.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.114 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 97.2 Cg_endo -90.52 -179.81 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.733 2.289 . . . . 0.0 112.342 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 59.98 38.13 21.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.69 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 20' ' ' SER . 33.2 mt -87.59 156.93 19.27 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' OH ' ' A' ' 72' ' ' TYR . 28.7 mt -94.04 108.33 34.69 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.151 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 30.7 Cg_exo -55.1 138.98 80.07 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.064 1.843 . . . . 0.0 111.874 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 14.75 76.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -126.36 148.95 49.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -100.66 133.77 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 110.431 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.726 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 77.5 m-85 -122.53 153.0 39.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.582 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.3 mt -111.05 128.82 67.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.44 130.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.878 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.09 122.72 27.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.036 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.702 HG11 ' CD2' ' A' ' 26' ' ' TRP . 11.1 t -102.93 126.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.07 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CE1' HD13 ' A' ' 87' ' ' LEU . 63.0 m-85 -116.4 140.6 49.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.5 pt20 -101.77 133.64 46.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 37' ' ' ARG . 54.0 mt -97.61 122.29 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 110.591 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.593 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 73.2 p -82.18 168.0 18.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.307 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.22 -19.59 34.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.344 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.593 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 40.0 p30 -93.86 -0.42 55.76 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.472 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.04 66.26 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.993 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.5 mm-40 -83.84 138.94 32.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.851 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -103.44 142.82 33.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.619 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.9 t -136.36 127.38 27.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.871 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 77' ' ' TYR . 13.7 tp -72.69 118.07 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.969 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.484 HD11 ' CD1' ' A' ' 26' ' ' TRP . 34.4 pt -112.26 -20.3 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -154.98 124.86 6.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.347 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -135.25 112.26 10.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.743 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -145.9 153.18 40.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.3 p -113.42 153.08 29.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -140.64 158.91 43.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.18 0.514 . . . . 0.0 110.906 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 106.14 11.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.452 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 70.9 p . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.74 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.558 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.96 0.409 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -63.51 163.32 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 93' ' ' GLN . 18.2 m-30 -130.38 152.93 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.46 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.5 t -126.84 106.16 15.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.0 t -115.65 134.84 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.1 p -124.68 150.2 46.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.997 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -144.4 -179.5 6.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.92 128.45 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.542 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 C--N 1.327 -0.408 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.484 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.7 m -94.58 -16.85 22.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.243 0.544 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.45 179.02 47.52 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.26 151.38 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.109 0.481 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.447 ' HD3' ' NE2' ' A' ' 85' ' ' GLN . 60.8 ttt180 -130.89 124.4 31.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 61' ' ' VAL . 20.4 t -107.01 131.11 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.924 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -123.1 122.8 39.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.932 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.552 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.1 p90 -135.7 138.17 42.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.384 0.612 . . . . 0.0 111.251 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -147.4 168.57 21.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.723 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.759 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -74.3 127.77 33.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.535 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 p -69.23 -21.06 63.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.719 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.255 -179.923 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.49 1.298 0 CA-C-O 120.737 0.224 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.552 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 17.2 mt-30 -116.93 146.82 42.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.04 136.7 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 61.5 mt -126.09 128.76 47.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -104.44 134.12 48.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.643 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mt -130.71 156.53 79.71 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.854 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -66.53 156.38 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.236 1.958 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 62.9 p -58.79 -13.3 5.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.115 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -92.79 -8.02 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.197 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.27 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.346 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -130.6 14.73 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.365 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.2 p -163.65 140.31 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.88 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 38' ' ' VAL . 4.8 p -150.09 143.92 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.792 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.443 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 46.2 t-20 -102.79 128.34 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.442 ' HB ' HD11 ' A' ' 66' ' ' LEU . 1.9 mt -97.82 105.09 24.79 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.49 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.7 Cg_endo -91.16 177.35 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.589 2.193 . . . . 0.0 112.318 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.68 36.94 22.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.728 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.558 ' O ' ' OG ' ' A' ' 20' ' ' SER . 78.4 mt -89.48 146.1 24.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' PRO . 34.4 mt -80.7 122.49 82.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.141 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 70' ' ' ARG . 45.6 Cg_exo -48.69 -174.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.994 1.796 . . . . 0.0 111.82 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 21.82 33.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.838 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.695 ' N ' ' O ' ' A' ' 68' ' ' PRO . 10.7 mmm-85 -126.89 144.54 50.96 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.758 0.779 . . . . 0.0 110.612 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -100.11 131.82 45.84 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.759 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 83.6 m-85 -121.75 149.86 42.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.286 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 85.4 mt -104.78 126.78 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.37 132.56 64.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.224 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -133.86 123.64 25.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.17 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.16 126.85 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.53 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -118.45 138.03 52.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.756 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.0 pt20 -100.05 135.86 40.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.1 mt -98.88 122.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.281 0.562 . . . . 0.0 110.711 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.607 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 100.0 p -84.02 167.5 16.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.755 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.14 -23.3 54.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.925 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.607 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 38.6 p30 -90.97 -0.8 57.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.747 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.62 70.79 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.165 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -83.01 136.47 34.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' A' ' 37' ' ' ARG . 92.4 mt-30 -105.92 144.29 32.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.151 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 t -139.87 133.05 29.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 90' ' ' SER . 15.0 tp -71.51 117.56 13.21 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.9 -22.31 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.2 tp -156.14 121.18 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.504 ' HB2' HD21 ' A' ' 87' ' ' LEU . 40.3 t -127.03 122.99 35.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.583 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.3 t -154.28 157.78 39.21 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.575 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.8 p -115.73 153.26 31.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.437 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 31.6 mt-30 -138.06 157.29 46.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 111.071 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.69 108.19 10.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.181 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.41 HG22 ' CE1' ' A' ' 22' ' ' PHE . 44.5 p . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.465 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.113 0.482 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.556 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -60.67 172.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.45 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 95' ' ' THR . 24.0 m-85 -135.61 151.91 50.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.25 105.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -114.12 136.34 50.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -124.59 152.2 43.85 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.281 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.2 p90 -145.83 -165.29 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.54 131.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.656 -179.555 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.6 p . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.917 0.389 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.4 m -95.63 -13.5 24.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.549 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.01 179.59 47.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.94 151.53 48.37 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.925 0.393 . . . . 0.0 110.681 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.478 ' NH2' HE22 ' A' ' 85' ' ' GLN . 18.6 ttp180 -130.5 122.16 27.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.416 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 61' ' ' VAL . 84.8 t -108.9 132.58 56.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.271 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.46 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 20.0 tt0 -120.87 127.37 51.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.852 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 52.6 p90 -131.89 132.5 43.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.09 0.472 . . . . 0.0 110.019 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -148.68 165.15 32.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.612 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 94.3 mt -73.27 128.54 35.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.942 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -70.82 -24.82 62.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.857 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 . . . . . 0 CA--C 1.519 -0.231 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.744 179.563 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 120.854 0.273 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -116.66 147.78 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 52.6 m-85 -125.66 141.69 51.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.819 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -127.91 134.65 49.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -106.92 134.12 50.55 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.164 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.45 155.93 80.33 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.044 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.25 154.12 75.41 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.945 1.763 . . . . 0.0 112.357 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.473 ' HB2' HG13 ' A' ' 33' ' ' VAL . 62.0 p -57.19 -15.75 6.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.5 p -91.06 -8.0 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.37 133.1 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.853 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.8 p -130.41 17.98 5.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.4 p -164.96 144.38 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.269 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 38' ' ' VAL . 9.8 p -149.13 147.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.232 0.539 . . . . 0.0 111.624 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 31.0 t30 -102.83 124.3 48.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.431 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.409 HG21 ' CG ' ' A' ' 40' ' ' TYR . 1.8 mt -95.44 109.9 47.9 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.317 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -90.99 178.9 1.77 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.88 2.387 . . . . 0.0 112.778 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 58.3 37.9 26.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.083 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 21' ' ' SER . 76.4 mt -91.11 143.94 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.213 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.571 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 17.9 mt -90.1 112.79 54.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -56.34 142.28 88.35 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.257 1.971 . . . . 0.0 111.86 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.58 82.32 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -121.9 150.94 41.26 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.75 130.84 46.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 0.0 110.107 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.612 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 59.8 m-85 -116.77 153.43 32.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.206 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.534 HG22 ' ND2' ' A' ' 75' ' ' ASN . 84.4 mt -108.51 122.8 63.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.21 131.63 64.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.672 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.534 ' ND2' HG22 ' A' ' 73' ' ' ILE . 44.8 m-80 -137.49 126.53 24.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.591 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 26' ' ' TRP . 15.6 t -103.35 130.85 52.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.506 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -120.23 142.98 48.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.217 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -106.64 133.12 51.8 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 34' ' ' SER . 63.2 mt -96.23 122.83 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.61 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.597 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 20.7 p -81.19 168.11 18.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -58.75 -17.87 26.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.379 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.597 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.3 p30 -93.4 0.01 56.69 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.572 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.63 67.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.38 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.3 mm-40 -88.34 144.74 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.068 0.434 . . . . 0.0 110.652 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.478 HE22 ' NH2' ' A' ' 37' ' ' ARG . 29.7 mt-30 -103.47 143.32 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.96 125.21 36.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.996 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.1 tp -73.02 115.4 12.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.904 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.66 -23.52 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.581 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -156.61 128.08 7.08 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.977 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.6 t -131.66 125.65 32.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.735 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -153.97 156.4 37.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.49 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -116.25 155.48 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.144 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.404 ' OE1' ' CG ' ' A' ' 22' ' ' PHE . 81.4 mt-30 -142.31 157.96 44.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.324 0.583 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.64 104.81 9.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.911 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.43 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.536 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.425 ' O ' HD12 ' A' ' 66' ' ' LEU . 79.4 p . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.946 0.403 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -60.34 149.41 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.401 ' CG ' ' OE1' ' A' ' 93' ' ' GLN . 22.2 m-30 -110.16 145.81 36.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.32 104.84 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.93 139.1 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.809 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.8 p -128.19 153.54 46.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.129 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.546 ' CE3' HG21 ' A' ' 76' ' ' VAL . 39.8 p90 -147.22 -166.32 2.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.079 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.06 133.1 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.256 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 C--N 1.321 -0.639 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.277 -179.4 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.406 ' O ' ' HB3' ' A' ' 56' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 m -96.16 -14.2 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.495 . . . . 0.0 110.24 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.53 174.92 43.43 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -123.33 150.73 43.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.063 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -130.51 122.52 27.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.73 HG21 HG11 ' A' ' 61' ' ' VAL . 91.9 t -106.27 132.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.824 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 81.4 tt0 -122.75 132.94 54.46 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.52 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 46.9 p90 -140.09 141.08 36.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.179 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -150.57 163.82 37.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.772 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.557 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 50.8 mt -75.35 131.98 40.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.3 p -78.78 -14.99 58.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.483 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.853 -178.259 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 121.092 0.371 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.484 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 24.7 mt-30 -122.75 148.2 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -126.37 137.03 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.188 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.7 mt -122.32 127.84 50.3 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -102.99 133.45 48.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.353 0.597 . . . . 0.0 112.17 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.38 157.2 78.79 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.3 160.5 48.65 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.789 1.66 . . . . 0.0 112.219 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.431 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 50.9 p -57.05 -11.82 1.76 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.183 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.2 p -91.49 -7.5 50.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.435 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.17 35.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.403 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.6 p -126.73 7.62 6.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.839 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -162.21 154.17 18.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.332 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 38' ' ' VAL . 9.1 p -153.2 146.97 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.421 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 30.4 t30 -103.83 128.93 51.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.44 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.67 99.6 22.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.513 0.197 . . . . 0.0 111.055 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 66.9 Cg_endo -89.61 -169.41 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.921 2.414 . . . . 0.0 112.162 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 57.63 36.69 26.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.538 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 20' ' ' SER . 42.7 mt -94.33 138.21 32.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.946 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.673 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 18.6 mt -84.71 113.96 52.54 Favored Pre-proline 0 C--N 1.333 -0.147 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.131 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -54.08 138.07 70.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.92 1.747 . . . . 0.0 111.534 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.32 14.95 70.18 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.861 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.87 148.61 48.17 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -98.98 134.78 41.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.361 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.673 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 64.9 m-85 -121.5 153.55 37.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.588 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.608 HG22 HD21 ' A' ' 75' ' ' ASN . 85.7 mt -109.38 125.63 66.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.5 129.02 71.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 0.0 110.673 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.608 HD21 HG22 ' A' ' 73' ' ' ILE . 14.3 m-80 -135.71 124.42 23.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.171 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.546 HG21 ' CE3' ' A' ' 26' ' ' TRP . 17.6 t -103.47 128.01 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.983 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -117.37 142.21 47.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -103.41 133.75 47.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.0 mt -98.3 126.17 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 121.384 0.611 . . . . 0.0 110.789 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.604 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 30.0 p -82.87 168.55 16.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.974 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -19.3 62.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.147 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.604 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 36.3 p30 -93.69 2.8 56.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.451 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 11.8 66.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.425 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.448 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 70.5 mm-40 -87.34 142.6 27.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.979 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -105.2 147.23 28.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.018 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.05 124.37 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.614 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 90' ' ' SER . 14.4 tp -73.71 115.57 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.147 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -109.87 -20.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.7 tp -155.17 123.12 5.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.657 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.423 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.0 t -131.87 119.13 20.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -153.37 162.26 41.47 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.601 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.7 p -120.33 153.1 36.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.347 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.401 ' OE1' ' CG ' ' A' ' 22' ' ' PHE . 64.3 mt-30 -138.13 157.1 47.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.945 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -123.09 115.7 22.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.781 -179.199 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.837 0.351 . . . . 0.0 110.859 . . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.564 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -62.96 -177.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.832 0.825 . . . . 0.0 112.059 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 21' ' ' SER . 16.1 m-85 -151.53 140.38 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.278 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.46 101.62 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.89 137.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.222 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.6 p -124.03 151.41 43.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.114 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.466 ' CD2' HG11 ' A' ' 76' ' ' VAL . 40.6 p90 -145.04 -175.39 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.465 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -112.42 133.36 58.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.535 ' O ' ' OE1' ' A' ' 78' ' ' GLN . 45.2 t . . . . . 0 C--N 1.324 -0.525 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.353 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 56' ' ' SER . 2.5 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.895 0.378 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.6 m -97.0 -14.52 21.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.421 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.94 178.54 46.77 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.44 153.04 46.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.483 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.431 ' NH2' HE22 ' A' ' 85' ' ' GLN . 42.5 ttp180 -131.07 129.25 41.7 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.834 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.37 133.65 57.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.526 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.16 127.71 50.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.091 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.8 p90 -135.25 130.63 35.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.32 0.581 . . . . 0.0 110.66 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -143.98 165.1 28.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.721 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.611 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 35.5 mt -74.78 127.14 32.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 0.0 111.505 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 p -69.9 -37.85 76.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.49 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.226 179.598 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.902 0.292 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 9.2 mt-30 -118.88 143.82 46.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.711 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.07 136.64 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.092 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.93 131.72 53.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -106.18 136.07 46.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.091 0.472 . . . . 0.0 111.457 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.8 mt -130.21 157.24 77.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.576 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -69.97 158.7 55.83 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.939 1.759 . . . . 0.0 112.098 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' HG13 ' A' ' 33' ' ' VAL . 36.7 p -59.31 -12.95 6.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.114 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.2 p -92.05 -8.56 45.57 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.69 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -131.02 11.21 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.0 p -164.43 143.89 7.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.01 149.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.445 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 53.7 t-20 -103.9 123.41 47.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.069 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -100.38 102.82 19.96 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.003 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 63.1 Cg_endo -92.87 179.98 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.909 2.406 . . . . 0.0 113.207 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 62.31 37.3 14.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.901 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.563 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -92.47 152.34 19.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.291 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 19.3 mt -82.96 119.85 75.05 Favored Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.969 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.52 144.89 62.62 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.867 1.711 . . . . 0.0 112.082 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.76 15.45 75.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.553 ' CB ' HH11 ' A' ' 70' ' ' ARG . 0.1 OUTLIER -124.81 153.4 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.731 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.6 133.86 46.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.611 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 86.9 m-85 -120.4 151.12 39.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.74 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 77.1 mt -108.53 123.94 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.5 t -116.11 134.68 58.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.161 0.505 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -135.2 129.65 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' A' ' 26' ' ' TRP . 28.6 t -106.61 128.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.355 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -120.55 139.53 52.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.869 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.535 ' OE1' ' O ' ' A' ' 28' ' ' SER . 7.4 pt20 -101.11 133.33 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 34' ' ' SER . 52.2 mt -98.33 122.69 50.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.292 0.567 . . . . 0.0 110.448 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.601 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 42.0 p -83.79 169.11 15.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.124 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.524 ' CD ' ' HG ' ' A' ' 34' ' ' SER . 77.6 mm-40 -58.19 -20.81 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.09 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.601 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.5 p30 -91.35 -2.61 57.31 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.945 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.01 12.71 67.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.136 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.587 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.7 mm-40 -84.0 141.04 31.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.431 HE22 ' NH2' ' A' ' 37' ' ' ARG . 25.9 mt-30 -105.19 140.92 37.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -134.02 127.86 33.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.107 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.0 tp -72.06 116.28 12.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.553 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.3 pt -107.4 -23.1 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.4 tp -159.08 124.81 4.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.054 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.4 t -128.48 126.71 41.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.9 t -153.77 159.03 41.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.196 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -120.58 152.26 38.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.084 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -143.65 158.12 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.996 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 114.88 20.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.906 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.553 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 33.4 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.647 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.539 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.96 0.409 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -63.29 -174.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.496 0.665 . . . . 0.0 112.15 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.609 ' CD1' ' OE1' ' A' ' 93' ' ' GLN . 21.1 m-85 -149.67 148.24 29.05 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.165 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.75 103.96 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -112.28 135.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -123.07 151.51 41.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.293 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.405 ' CD2' HG11 ' A' ' 76' ' ' VAL . 41.0 p90 -143.47 179.92 6.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.341 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -117.38 129.27 74.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.239 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.227 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' A' ' 56' ' ' SER . 2.1 p . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 81' ' ' GLU . 70.8 m -95.36 -15.46 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.88 179.66 47.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -125.9 152.88 44.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 110.602 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' NH2' ' CD2' ' A' ' 51' ' ' TYR . 55.2 ttt180 -133.9 127.65 32.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.9 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.586 HG21 HG11 ' A' ' 61' ' ' VAL . 47.0 t -108.29 132.78 55.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.075 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.34 125.59 44.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.801 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 42.5 p90 -141.35 140.33 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.897 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -149.38 169.99 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.39 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.72 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 92.3 mt -74.28 126.66 31.13 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.5 p -62.05 -33.92 75.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.388 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 -179.862 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 N--CA 1.489 1.228 0 CA-C-O 120.983 0.326 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 32.5 mt-30 -119.91 140.78 50.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.778 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CD2' ' NH2' ' A' ' 37' ' ' ARG . 6.1 m-85 -121.64 141.28 51.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.588 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.5 mt -131.15 123.44 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -101.61 135.72 42.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.134 0.492 . . . . 0.0 111.578 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -132.86 159.43 72.63 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.842 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -72.52 160.17 47.31 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.094 1.863 . . . . 0.0 112.624 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.477 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 61.1 p -61.69 -15.48 40.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.696 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -88.34 -1.14 57.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.691 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.908 ' O ' HG23 ' A' ' 59' ' ' THR . . . -75.86 -146.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.595 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 58' ' ' ALA . 1.9 p 143.45 4.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.8 p -163.75 141.89 7.54 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 38' ' ' VAL . 8.8 p -150.74 155.35 7.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.174 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.415 ' N ' HG22 ' A' ' 61' ' ' VAL . 7.0 t30 -106.1 122.88 47.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.217 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -95.87 106.67 29.26 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.175 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 64.7 Cg_endo -92.74 177.33 1.5 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 123.115 2.544 . . . . 0.0 113.393 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 60.19 38.33 20.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.958 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.539 ' O ' ' OG ' ' A' ' 20' ' ' SER . 39.8 mt -91.76 143.15 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.473 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 64.2 mt -83.86 112.82 43.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -55.29 143.12 77.43 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.37 79.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.479 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.9 mmm-85 -123.98 152.79 42.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.153 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -100.97 130.96 47.04 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.451 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.72 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 65.1 m-85 -118.5 144.59 45.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.091 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.2 mt -104.11 125.5 58.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.0 132.54 61.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.243 0.544 . . . . 0.0 111.154 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -134.78 128.13 32.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.514 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' ' 26' ' ' TRP . 21.3 t -104.11 128.45 57.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.416 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -119.54 138.53 53.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -101.13 136.87 40.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -100.03 123.32 52.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.591 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 84.3 p -83.31 171.99 12.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.32 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 76.1 mm-40 -58.77 -19.96 45.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.496 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.591 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 48.8 p30 -95.08 -0.22 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.12 65.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.564 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.3 mm-40 -83.82 143.79 29.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.849 0.357 . . . . 0.0 110.53 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.91 142.78 45.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 111.686 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.7 t -138.24 134.54 34.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.86 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 90' ' ' SER . 53.5 tp -73.34 117.44 15.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.3 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.0 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.992 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.7 tp -156.84 125.44 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.325 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 87' ' ' LEU . 38.2 t -132.13 122.53 25.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.819 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.8 t -151.7 158.69 43.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.75 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -118.04 152.55 35.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.609 ' OE1' ' CD1' ' A' ' 22' ' ' PHE . 74.9 mt-30 -140.51 156.77 46.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.268 0.556 . . . . 0.0 110.313 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -123.13 104.81 9.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.629 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.473 ' OXT' ' O ' ' A' ' 94' ' ' THR . 81.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.051 -0.975 . . . . 0.0 110.435 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.497 ' O ' HD12 ' A' ' 66' ' ' LEU . 94.5 p . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 121.112 0.482 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 p -63.16 158.51 19.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.556 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.627 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 21.6 m-30 -125.69 155.92 40.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.776 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.4 t -128.83 106.3 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.7 t -111.94 137.48 44.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.71 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.1 p -129.14 153.56 47.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CD2' HG11 ' A' ' 76' ' ' VAL . 34.0 p90 -143.41 -165.88 2.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.023 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.0 t -127.73 124.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.902 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.4 p . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.716 0.293 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 79' ' ' ILE . 53.1 m -94.0 -15.48 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.213 0.53 . . . . 0.0 109.803 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.2 176.46 45.32 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -125.41 152.91 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.906 0.384 . . . . 0.0 110.673 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -131.5 124.33 29.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 61' ' ' VAL . 74.4 t -109.03 133.67 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -124.6 132.65 53.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.341 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.578 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 22.8 p90 -137.82 130.28 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.095 0.474 . . . . 0.0 110.284 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.71 166.61 26.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.833 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 87.1 mt -73.65 128.59 35.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.413 0.625 . . . . 0.0 111.969 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 p -68.23 -27.84 66.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.469 ' HG3' HH22 ' A' ' 70' ' ' ARG . 88.1 mt-10 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.131 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.49 1.299 0 CA-C-O 120.883 0.285 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.578 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 11.4 mt-30 -120.29 144.0 48.04 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -124.41 140.38 53.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.506 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 mt -124.71 129.38 50.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.13 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -101.48 131.78 47.43 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.905 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.4 mt -130.08 155.64 80.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 57' ' ' THR . 22.7 Cg_endo -68.94 156.65 64.69 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.38 2.053 . . . . 0.0 112.5 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.459 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 30.4 p -55.74 -11.6 1.01 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.4 ' N ' ' C ' ' A' ' 55' ' ' PRO . 29.5 p -92.0 -7.29 49.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.61 132.28 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -130.32 9.32 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.182 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.9 p -164.12 146.8 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.62 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 38' ' ' VAL . 5.2 p -151.0 152.69 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.772 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 11.7 t-20 -106.68 126.63 52.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.513 HG21 ' CG ' ' A' ' 40' ' ' TYR . 2.3 mt -100.94 104.94 35.36 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.148 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -91.35 -179.34 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.779 2.319 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 58.66 39.03 24.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 20' ' ' SER . 41.5 mt -90.41 143.91 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.3 mt -78.02 129.81 74.65 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.043 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.49 140.94 44.98 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.529 2.153 . . . . 0.0 112.873 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.38 27.99 71.91 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.773 ' HE ' HD22 ' A' ' 42' ' ' LEU . 4.9 mmm180 -126.48 148.13 49.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.22 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.685 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 75.7 tttt -100.26 131.15 46.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.833 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 64.4 m-85 -119.82 151.26 39.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -104.99 123.7 59.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -111.69 131.15 63.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -133.98 125.86 29.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.507 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.64 HG11 ' CD2' ' A' ' 26' ' ' TRP . 5.7 t -104.42 126.57 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.03 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -118.82 141.91 48.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -105.23 135.58 46.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.688 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.9 mt -98.38 122.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.172 0.511 . . . . 0.0 110.634 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.726 ' HG ' ' CG ' ' A' ' 82' ' ' ASP . 47.2 p -82.52 169.53 16.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.811 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.3 -20.47 43.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.126 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.726 ' CG ' ' HG ' ' A' ' 80' ' ' SER . 2.0 p-10 -92.04 -2.32 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.51 14.46 65.77 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CG ' ' OD2' ' A' ' 82' ' ' ASP . 60.2 mm-40 -86.2 144.17 27.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.121 0.46 . . . . 0.0 111.211 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.18 139.61 43.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 t -137.81 136.1 36.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.392 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 90' ' ' SER . 19.3 tp -72.88 116.73 13.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 pt -108.87 -22.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.29 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.1 tp -156.32 125.81 6.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.62 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.437 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.5 t -133.44 122.43 23.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.508 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -149.7 156.54 42.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.461 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -117.58 153.03 33.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -140.98 158.36 44.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.216 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.71 108.23 16.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.576 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.344 -179.468 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.567 ' O ' HD12 ' A' ' 66' ' ' LEU . 4.7 p . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 p -60.45 165.56 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.524 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.536 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 15.8 m-30 -133.51 154.76 50.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.818 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.43 104.32 8.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.43 136.8 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.43 150.92 43.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CE3' HG21 ' A' ' 76' ' ' VAL . 36.9 p90 -145.26 -174.15 4.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.373 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.5 t -109.55 135.38 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 85.2 p . . . . . 0 C--N 1.324 -0.512 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.544 -179.648 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.0 p . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.678 0.275 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 79' ' ' ILE . 67.5 m -94.86 -14.65 24.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.27 0.557 . . . . 0.0 109.541 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.36 -179.87 47.93 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -127.31 150.57 49.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.003 0.43 . . . . 0.0 110.75 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -129.2 124.81 35.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.84 131.2 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.121 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 80.9 tt0 -123.27 133.57 54.17 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.579 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.7 p90 -140.65 138.7 34.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.446 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -148.02 165.54 30.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.706 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.533 HD13 ' HE ' ' A' ' 70' ' ' ARG . 56.3 mt -73.13 127.61 33.09 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.028 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 18.6 p -70.34 -34.62 72.88 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.825 -179.933 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 120.92 0.3 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 16.2 mt-30 -123.36 146.02 48.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 80.4 m-85 -124.86 139.17 54.08 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.046 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.7 mt -123.2 129.16 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.231 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -102.21 130.92 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.831 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.25 154.72 80.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.795 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.15 156.76 64.59 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.143 1.895 . . . . 0.0 112.374 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 14.5 p -56.56 -11.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -93.76 -9.17 38.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.698 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.8 35.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.485 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 p -130.19 12.22 5.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.0 p -164.38 143.13 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.95 149.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.62 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 8.9 t-20 -105.16 128.02 53.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.26 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mt -104.84 101.34 28.66 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.449 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -89.47 -174.58 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.773 2.315 . . . . 0.0 112.439 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 59.72 37.01 22.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.386 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 20' ' ' SER . 45.9 mt -90.36 151.88 21.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.648 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 30.4 mt -95.37 108.35 38.62 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.977 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.28 139.78 81.31 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.432 2.088 . . . . 0.0 111.839 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.58 14.69 67.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HE ' HD13 ' A' ' 42' ' ' LEU . 5.7 mmm-85 -127.21 141.44 51.73 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 92' ' ' SER . 14.0 tttp -96.19 134.86 38.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.938 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 4.0 m-85 -117.85 151.79 36.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 0.0 111.718 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.5 mt -110.07 124.36 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.648 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.84 132.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.929 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -133.61 124.49 26.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.371 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.463 HG21 ' CE3' ' A' ' 26' ' ' TRP . 21.9 t -106.74 127.76 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.875 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -119.01 137.36 53.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -100.65 136.25 40.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.0 mt -100.12 125.49 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.384 0.611 . . . . 0.0 110.934 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.597 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 89.7 p -84.89 165.2 17.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.206 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.31 -20.31 42.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.357 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.0 p-10 -91.98 -1.54 57.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.786 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.97 13.01 65.12 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.243 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.455 ' CG ' ' OD2' ' A' ' 82' ' ' ASP . 75.8 mm-40 -83.2 135.34 34.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -104.98 140.66 37.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.749 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.3 t -136.72 132.9 35.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.114 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 90' ' ' SER . 57.0 tp -71.83 118.98 15.35 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.736 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 pt -108.92 -22.97 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.2 tp -157.01 125.67 5.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.597 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.613 ' HB2' HD21 ' A' ' 87' ' ' LEU . 15.2 t -132.66 112.66 12.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.417 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -146.25 159.62 43.08 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.0 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' SER . . . . . 0.431 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 95.7 p -117.25 153.8 32.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.321 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -139.52 156.04 47.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -122.71 107.83 12.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.434 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 94' ' ' THR . 45.6 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.715 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.481 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.2 p . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.485 ' OG ' ' OD1' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -67.61 135.93 53.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.973 -179.32 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.485 ' CD1' ' OE1' ' A' ' 93' ' ' GLN . 23.9 m-85 -96.12 148.04 23.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.351 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.59 101.34 10.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.1 t -111.53 137.59 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -128.1 155.84 43.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.129 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.465 ' CE3' HG21 ' A' ' 76' ' ' VAL . 33.6 p90 -146.9 -164.95 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.049 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.08 129.62 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 56' ' ' SER . 2.7 p . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.928 0.394 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' ILE . 4.8 m -93.84 -15.4 25.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.667 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.535 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 175.62 -178.3 47.22 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -126.61 153.81 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.96 0.41 . . . . 0.0 110.376 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -132.44 123.01 25.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.083 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.617 HG21 HG11 ' A' ' 61' ' ' VAL . 77.7 t -107.48 132.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.504 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 68.3 tt0 -127.17 131.34 50.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.233 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 18.9 p90 -144.29 137.63 27.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.273 0.558 . . . . 0.0 111.259 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -144.36 167.91 21.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.149 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.764 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 76.7 mt -74.81 126.42 30.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.688 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -67.24 -25.03 65.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.458 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.979 -178.932 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.487 1.109 0 N-CA-C 111.269 -0.32 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.534 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 21.6 mt-30 -112.71 146.15 39.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.78 137.06 54.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.672 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.2 mt -129.68 130.48 45.59 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.71 132.75 50.58 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.477 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 mt -126.18 152.54 73.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.636 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.36 154.48 71.15 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.441 2.094 . . . . 0.0 112.777 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.535 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 24.9 p -57.8 -14.31 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.115 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.6 p -92.12 -6.7 50.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.234 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.82 138.78 31.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -130.71 13.98 5.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.2 p -163.68 148.68 10.81 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 38' ' ' VAL . 9.4 p -149.18 144.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.856 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.485 ' OD1' ' OG ' ' A' ' 21' ' ' SER . 52.2 t30 -102.85 126.5 50.02 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -97.96 112.55 62.05 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.468 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -93.23 175.71 1.56 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.997 2.465 . . . . 0.0 113.637 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 59.91 38.4 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.619 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 20' ' ' SER . 15.1 mt -87.72 145.17 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.82 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.406 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 16.4 mt -86.73 112.12 44.69 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 32.1 Cg_exo -55.28 134.26 62.8 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.963 1.775 . . . . 0.0 111.159 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.63 13.93 74.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.424 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -121.13 152.17 39.04 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.682 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -103.89 127.71 51.39 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.764 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 84.5 m-85 -115.36 156.98 24.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.096 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 61.9 mt -110.49 132.99 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.46 130.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.582 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -135.02 121.69 20.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.607 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.465 HG21 ' CE3' ' A' ' 26' ' ' TRP . 48.5 t -103.17 127.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.467 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.68 136.27 54.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 11.6 pt20 -96.59 132.75 41.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' SER . 56.0 mt -97.18 125.94 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.346 0.593 . . . . 0.0 110.787 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.595 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 90.0 p -85.62 168.66 14.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.197 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.447 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 81.7 mm-40 -61.75 -18.43 59.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.595 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 32.8 p30 -92.87 -0.72 57.18 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.033 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.24 75.45 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.424 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 55.2 mm-40 -82.43 145.3 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.206 0.503 . . . . 0.0 110.971 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -109.87 139.16 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.722 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.1 t -133.88 130.39 37.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.187 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -73.45 121.72 20.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.042 0.449 . . . . 0.0 111.43 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.459 HD11 ' CG1' ' A' ' 76' ' ' VAL . 35.6 pt -109.59 -22.55 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -157.57 127.68 6.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.769 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.6 t -133.56 120.41 20.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -156.0 153.35 29.37 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.832 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.0 p -111.39 157.92 19.67 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.485 ' OE1' ' CD1' ' A' ' 22' ' ' PHE . 80.9 mt-30 -145.84 163.01 36.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.123 0.487 . . . . 0.0 111.112 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.84 105.23 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.149 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 81.3 p . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.315 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.625 ' O ' ' O ' ' A' ' 21' ' ' SER . 4.3 p . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.691 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 38.81 -178.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.915 0.864 . . . . 0.0 112.023 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.691 ' CD1' ' O ' ' A' ' 21' ' ' SER . 25.2 m-85 -156.72 150.65 24.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.741 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.66 102.26 12.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.5 t -110.25 132.53 58.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.324 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.4 p -126.63 154.36 44.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.906 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.414 ' CE3' HG21 ' A' ' 76' ' ' VAL . 33.9 p90 -143.43 -165.48 2.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.724 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -130.68 128.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.286 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.326 -0.422 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.692 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 79' ' ' ILE . 30.6 m -94.86 -14.83 24.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.53 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.1 179.05 46.36 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.12 152.25 46.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 0.0 110.19 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -131.4 128.31 39.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.63 133.61 57.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.721 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 38.6 tt0 -123.1 130.67 53.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.794 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -133.69 135.78 44.28 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.709 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -144.96 161.52 39.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.239 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.772 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 43.8 mt -71.15 130.39 41.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.142 0.496 . . . . 0.0 111.332 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -65.32 -24.5 67.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.952 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.486 ' HB2' HH22 ' A' ' 70' ' ' ARG . 60.8 mm-40 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.384 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 N-CA-C 111.116 -0.378 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 mt-30 -119.57 144.09 47.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 59.2 m-85 -122.91 141.9 51.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.114 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -128.06 130.79 48.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.687 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -102.21 133.41 47.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.567 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.2 mt -128.67 156.39 77.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.55 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -71.51 159.3 51.72 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.462 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 47.4 p -60.2 -16.36 32.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.114 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -91.19 -7.92 50.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.704 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 133.74 34.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.222 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 p -128.84 11.36 6.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.584 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 144.22 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.284 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.24 147.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.413 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 18.6 t30 -101.4 126.23 48.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.66 105.65 31.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.6 Cg_endo -90.08 -176.77 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 123.015 2.477 . . . . 0.0 112.773 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 56.41 35.92 26.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.441 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 22' ' ' PHE . 44.4 mt -90.23 140.55 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -68.35 111.58 8.41 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 25.3 Cg_exo -57.71 138.67 87.22 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.191 1.928 . . . . 0.0 112.015 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.1 22.09 74.61 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.917 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.59 ' HE ' HD22 ' A' ' 42' ' ' LEU . 22.2 mmm180 -126.56 154.66 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.984 0.421 . . . . 0.0 111.548 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -100.05 132.44 45.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.694 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.772 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 52.4 m-85 -121.81 153.59 38.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.701 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 69.8 mt -108.1 125.41 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.87 133.87 58.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.044 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -136.36 124.25 22.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.751 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.414 HG21 ' CE3' ' A' ' 26' ' ' TRP . 34.0 t -105.06 129.75 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.599 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -121.57 137.7 54.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.803 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -99.77 134.53 42.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' SER . 49.0 mt -98.27 125.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.399 0.619 . . . . 0.0 110.392 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 80.6 p -82.85 169.11 16.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.553 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.71 -22.32 57.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.936 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.598 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.4 p30 -93.72 0.02 56.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.303 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.51 63.51 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.421 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.35 144.45 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.995 0.397 . . . . 0.0 110.653 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -111.19 144.77 39.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.042 0.449 . . . . 0.0 111.431 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.8 t -138.02 132.04 31.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.314 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.3 tp -72.61 118.22 15.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.905 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.3 pt -109.65 -25.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.822 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.7 tp -156.15 125.0 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.842 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 t -133.07 117.7 17.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 t -148.36 153.88 39.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.698 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.8 p -112.17 151.49 29.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.548 ' OE1' ' CD1' ' A' ' 22' ' ' PHE . 70.7 mt-30 -139.41 155.59 47.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.0 110.974 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.472 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -114.14 111.58 21.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.202 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 6.9 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.535 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.707 ' O ' HD12 ' A' ' 66' ' ' LEU . 5.1 p . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.074 0.464 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -57.59 136.69 56.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.584 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.3 m-30 -101.66 147.03 26.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.876 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.1 t -130.45 103.77 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -113.78 138.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.456 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.8 p -127.58 151.54 48.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.725 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.639 ' CE3' HG21 ' A' ' 76' ' ' VAL . 32.4 p90 -144.37 -165.38 2.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.009 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.93 125.84 58.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.967 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.402 -179.787 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 56' ' ' SER . 2.3 p . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.817 0.342 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.5 m -96.19 -15.99 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.46 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.54 177.14 46.16 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.24 153.02 43.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.859 0.362 . . . . 0.0 110.54 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -132.18 132.09 42.83 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.728 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.645 HG21 HG11 ' A' ' 61' ' ' VAL . 12.4 t -113.0 135.09 53.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.53 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.8 133.5 50.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 4.4 p90 -143.56 143.05 31.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.282 0.563 . . . . 0.0 111.729 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -150.36 163.56 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.869 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 90.5 mt -74.07 125.47 28.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 p -64.3 -33.77 76.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.44 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.545 -178.948 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.486 1.076 0 CA-C-O 120.85 0.271 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.36 151.05 40.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.68 139.46 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.42 129.92 45.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.343 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -106.02 134.43 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.146 0.498 . . . . 0.0 111.963 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HB3' ' CB ' ' A' ' 58' ' ' ALA . 7.4 mt -129.71 155.75 79.89 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.686 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -68.06 159.89 51.06 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.195 1.93 . . . . 0.0 111.995 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.467 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 21.0 p -56.25 -12.83 1.75 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.241 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -93.58 -7.11 45.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 54' ' ' LEU . . . -79.6 130.13 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.248 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -130.98 12.65 5.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.861 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.2 p -165.13 147.56 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.645 HG11 HG21 ' A' ' 38' ' ' VAL . 6.2 p -149.87 147.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.81 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 4.7 t-20 -107.72 127.98 54.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.76 105.65 42.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.126 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.24 175.55 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.896 2.398 . . . . 0.0 112.715 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 60.48 39.1 18.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.994 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 20' ' ' SER . 56.9 mt -88.95 153.51 20.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.466 HD13 ' NH2' ' A' ' 70' ' ' ARG . 46.7 mt -90.72 110.56 42.36 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.873 -0.148 . . . . 0.0 110.836 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -58.95 145.1 98.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.307 2.005 . . . . 0.0 112.204 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.509 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 80.3 17.77 73.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.484 ' HB3' HD22 ' A' ' 42' ' ' LEU . 4.9 mmm-85 -128.78 147.54 50.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.547 0.213 . . . . 0.0 110.597 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -98.43 135.09 40.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.869 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 67.9 m-85 -121.02 152.87 38.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.378 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 79.0 mt -111.7 131.23 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.14 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.28 134.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.507 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -135.21 123.76 23.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.3 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.639 HG21 ' CE3' ' A' ' 26' ' ' TRP . 17.2 t -103.62 130.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -122.56 139.06 54.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.433 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 9.7 pt20 -100.91 135.04 42.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.098 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -98.15 123.75 50.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.208 0.527 . . . . 0.0 110.634 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.613 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 59.3 p -83.76 166.18 18.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.498 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -57.48 -18.8 20.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.017 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.613 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 37.4 p30 -91.95 -1.1 57.44 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.747 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.75 13.7 66.63 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.032 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 63.8 mm-40 -85.47 143.3 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.65 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -108.06 140.41 41.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.742 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 t -135.15 132.68 38.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.035 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.7 tp -73.45 118.98 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.707 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 pt -112.09 -21.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.111 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 tp -157.04 124.41 5.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.905 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 t -132.18 120.82 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 t -153.56 155.51 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -121.63 154.27 37.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.181 0.515 . . . . 0.0 111.042 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.461 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 81.5 mt-30 -146.69 157.93 43.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.07 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.53 118.3 36.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.249 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.584 HG22 ' CE1' ' A' ' 22' ' ' PHE . 39.2 p . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.788 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p . . . . . 0 C--O 1.229 0.024 0 CA-C-O 120.957 0.408 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 p -63.04 -177.58 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.378 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 95' ' ' THR . 17.7 m-85 -147.67 144.33 28.27 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.953 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 t -116.16 101.67 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.6 t -111.17 135.16 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.357 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.2 p -125.5 154.26 42.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.403 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.623 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.2 p90 -143.8 -179.19 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.01 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -118.8 129.36 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.045 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 p . . . . . 0 C--N 1.326 -0.435 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.422 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 79' ' ' ILE . 18.8 m -93.05 -15.99 25.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.558 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.502 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.41 -177.82 47.2 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 58' ' ' ALA . 73.8 m-85 -122.73 149.4 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.96 0.41 . . . . 0.0 110.523 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.6 ' HB2' HD11 ' A' ' 79' ' ' ILE . 13.7 ttp180 -127.49 118.71 24.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.49 132.39 49.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.209 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 80.8 tt0 -122.03 134.9 54.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.03 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CE1' ' NE2' ' A' ' 50' ' ' GLN . 54.3 p90 -140.86 137.08 32.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.836 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -149.08 160.86 42.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.203 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.69 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 47.3 mt -74.32 127.39 32.87 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.691 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 p -70.87 -24.01 62.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.027 -179.182 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 37.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.258 0.441 . . . . 0.0 112.851 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.506 ' NE2' ' CE1' ' A' ' 40' ' ' TYR . 6.1 mt-30 -114.88 145.0 42.65 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 39' ' ' GLU . 92.9 m-85 -124.09 136.41 54.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.153 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 52' ' ' LEU . 88.6 mt -119.92 131.37 55.2 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -103.6 132.03 50.22 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.521 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mt -129.72 155.5 80.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -66.68 160.42 46.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.232 1.955 . . . . 0.0 112.539 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.427 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 15.9 p -57.53 -14.19 4.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -90.82 -9.47 46.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 36' ' ' PHE . . . -83.41 128.81 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.938 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.9 p -132.81 14.22 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.339 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -163.16 141.62 8.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.152 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.22 146.43 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.654 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.406 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.1 t-20 -103.05 127.2 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.34 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 95.0 Cg_endo -90.65 -179.12 1.53 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.919 2.413 . . . . 0.0 112.622 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 61.58 35.69 17.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.96 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 30.5 mt -89.51 152.88 21.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.11 111.73 40.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.508 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 23.5 Cg_exo -56.29 139.78 86.9 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.933 1.755 . . . . 0.0 111.358 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.83 18.83 69.2 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.695 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -125.02 148.74 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.813 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -99.35 132.51 44.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.151 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 90.3 m-85 -121.56 150.92 40.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.189 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 87.4 mt -107.71 123.65 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -109.95 131.39 61.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 0.0 110.815 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.14 129.08 33.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.603 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 26' ' ' TRP . 5.6 t -109.99 131.46 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.923 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -123.47 143.37 50.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.288 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -99.6 136.58 39.32 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.686 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.5 mt -100.72 123.97 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.298 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.606 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 51.9 p -85.44 172.36 11.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.003 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' OE2' ' OG ' ' A' ' 34' ' ' SER . 78.1 mm-40 -61.48 -23.96 66.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.03 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.606 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.9 p30 -93.57 -1.66 55.18 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.35 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.97 60.05 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.411 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.459 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.4 mm-40 -84.79 131.82 34.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.14 0.47 . . . . 0.0 110.596 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -105.26 141.11 37.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.794 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.6 t -136.29 133.56 37.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.76 HD21 ' HB2' ' A' ' 90' ' ' SER . 28.0 tp -72.3 118.41 15.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.3 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.06 -20.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 26' ' ' TRP . 15.0 tp -155.0 124.89 6.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.422 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.76 ' HB2' HD21 ' A' ' 87' ' ' LEU . 12.9 t -131.93 123.03 26.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.562 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -154.14 152.76 30.78 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.034 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.6 p -118.19 153.37 33.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -142.59 160.5 40.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.838 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 115.92 25.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.015 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.465 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 81.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.662 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.903 0.383 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.469 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -55.08 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.596 0.712 . . . . 0.0 111.862 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.469 ' N ' ' OG ' ' A' ' 21' ' ' SER . 18.7 m-85 -146.34 146.51 30.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.744 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.04 103.19 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.3 t -109.04 134.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.191 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.1 p -128.05 150.52 49.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.757 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -145.01 178.62 7.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.949 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 t -117.01 128.48 74.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.325 -0.466 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.422 -179.447 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 56' ' ' SER . 1.5 p . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.5 m -94.62 -14.77 24.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 174.9 177.3 43.9 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -124.77 152.86 43.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.624 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.781 ' NH1' ' CD1' ' A' ' 51' ' ' TYR . 14.8 ttp85 -128.59 126.06 39.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.657 HG21 HG11 ' A' ' 61' ' ' VAL . 41.6 t -105.72 132.34 52.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' OE2' ' CB ' ' A' ' 49' ' ' PRO . 73.3 tt0 -127.95 133.25 49.21 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.72 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.6 p90 -140.43 133.74 29.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.222 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -143.59 162.09 36.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.726 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 47.2 mt -72.9 134.95 45.01 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.997 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.7 p -73.55 -19.38 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.213 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HG2' HH22 ' A' ' 70' ' ' ARG . 73.5 mm-40 . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.936 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 61.2 Cg_endo . . . . . 0 N--CA 1.488 1.206 0 CA-C-O 120.745 0.227 . . . . 0.0 111.94 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -112.27 141.0 46.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.781 ' CD1' ' NH1' ' A' ' 37' ' ' ARG . 78.6 m-85 -123.43 138.8 54.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.872 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -126.6 132.18 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -100.91 134.38 43.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.882 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mt -128.64 154.7 79.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.558 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.08 159.39 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.245 1.963 . . . . 0.0 111.957 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.475 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 25.4 p -59.72 -11.99 6.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.672 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -91.23 -6.4 53.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.69 132.97 35.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.682 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 p -130.65 6.84 4.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.267 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.4 p -164.92 141.38 5.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.657 HG11 HG21 ' A' ' 38' ' ' VAL . 8.0 p -148.11 148.96 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.162 0.506 . . . . 0.0 111.667 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -102.63 125.45 49.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.908 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -99.03 108.17 47.95 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -93.36 -176.92 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 123.168 2.579 . . . . 0.0 112.705 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 59.59 35.55 22.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.233 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -89.6 148.11 23.53 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.191 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -86.49 113.31 51.97 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.034 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -57.66 140.95 95.14 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.236 1.957 . . . . 0.0 112.334 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.2 21.42 67.6 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.682 ' HE ' HD22 ' A' ' 42' ' ' LEU . 7.3 mmm180 -125.67 149.0 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.945 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 67.9 tttt -102.34 130.52 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.775 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.726 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 90.4 m-85 -122.72 154.05 38.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.3 mt -108.22 125.88 64.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 t -113.98 133.83 58.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.205 0.526 . . . . 0.0 111.401 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -134.63 126.08 28.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.354 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.93 128.3 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.848 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -121.36 137.94 54.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 8.3 pt20 -101.01 136.0 41.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.476 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.3 mt -98.68 120.95 48.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.808 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 29.2 p -82.4 168.53 17.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.22 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' GLU . . . . . 0.478 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 73.5 mm-40 -59.28 -18.22 35.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.825 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 38.7 p30 -93.07 -1.51 56.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.243 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.61 12.8 68.72 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.575 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.0 mm-40 -84.69 141.89 30.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.981 0.419 . . . . 0.0 111.082 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.12 141.93 42.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -136.5 131.22 33.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.034 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 90' ' ' SER . 30.4 tp -72.3 116.96 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.157 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 pt -110.31 -21.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 tp -154.75 122.03 5.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.185 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.569 ' HB2' HD21 ' A' ' 87' ' ' LEU . 22.6 t -131.19 117.88 19.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -150.63 155.71 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.637 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.6 p -114.85 156.04 25.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.427 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -144.28 153.3 41.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 106.68 14.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.2 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.595 -179.24 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.472 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.054 0.454 . . . . 0.0 110.241 . . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.97 159.9 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.41 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 93' ' ' GLN . 22.5 m-30 -127.23 151.97 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.806 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.76 106.56 15.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.24 145.48 20.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.109 0.48 . . . . 0.0 111.006 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.2 p -131.4 153.82 49.29 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.69 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.479 ' CD2' HG11 ' A' ' 76' ' ' VAL . 33.0 p90 -143.35 -166.38 2.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.45 129.23 74.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.079 -179.802 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 56' ' ' SER . 3.9 p . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.687 ' N ' ' O ' ' A' ' 79' ' ' ILE . 39.0 m -95.45 -12.98 24.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 109.739 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.17 -179.88 47.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.86 151.53 48.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.749 0.309 . . . . 0.0 110.433 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -129.35 122.83 30.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 61' ' ' VAL . 80.8 t -108.2 133.82 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.542 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 59.3 tt0 -124.46 137.06 54.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.548 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 24.9 p90 -141.81 130.66 22.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.937 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -143.11 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.324 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.82 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 83.0 mt -75.69 123.89 26.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.166 0.507 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.0 p -66.14 -26.04 67.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.423 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.299 -179.162 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 N--CA 1.485 1.019 0 N-CA-C 111.163 -0.36 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.2 mt-30 -120.61 150.93 40.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -124.78 136.13 53.58 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.95 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -122.09 130.19 53.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.479 ' O ' HD23 ' A' ' 54' ' ' LEU . 67.3 m-20 -104.29 133.53 49.04 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.39 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 53' ' ' ASP . 7.2 mt -129.41 155.77 79.58 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.278 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 58' ' ' ALA . 22.2 Cg_endo -69.49 151.24 70.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 121.63 1.553 . . . . 0.0 112.059 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.443 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 3.3 p -52.16 -13.03 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.491 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' THR . . . . . 0.406 ' N ' ' C ' ' A' ' 55' ' ' PRO . 78.1 p -93.01 -7.06 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . . . -80.45 136.79 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.352 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -129.62 8.9 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.5 p -164.57 149.84 10.01 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.486 HG11 HG21 ' A' ' 38' ' ' VAL . 9.9 p -151.85 153.06 10.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.244 0.545 . . . . 0.0 111.944 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 22' ' ' PHE . 50.8 t30 -105.51 128.5 53.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.927 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.415 HG22 HD21 ' A' ' 66' ' ' LEU . 2.0 mt -102.13 103.36 29.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 64.2 Cg_endo -89.95 -175.21 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.177 2.585 . . . . 0.0 112.211 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 58.86 36.63 24.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.234 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 20' ' ' SER . 16.4 mt -89.2 149.66 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.313 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.597 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 21.8 mt -92.67 112.06 53.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.076 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.34 132.84 48.74 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.875 1.717 . . . . 0.0 110.703 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.48 10.72 73.13 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.426 ' HB3' HD22 ' A' ' 42' ' ' LEU . 19.4 mmt85 -123.77 145.9 48.7 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -97.22 133.16 42.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.82 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 20.7 m-85 -115.27 156.19 25.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.225 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.564 HG22 HD21 ' A' ' 75' ' ' ASN . 62.5 mt -113.47 122.14 67.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.84 128.12 67.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.067 0.461 . . . . 0.0 110.948 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.564 HD21 HG22 ' A' ' 73' ' ' ILE . 39.7 m-80 -133.86 127.17 32.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.599 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 26' ' ' TRP . 19.5 t -106.99 128.25 61.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -117.32 139.0 51.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.876 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -100.76 135.13 42.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.687 ' O ' ' N ' ' A' ' 34' ' ' SER . 60.0 mt -99.26 121.94 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.916 0.388 . . . . 0.0 110.984 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.593 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 93.0 p -85.2 168.98 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.008 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -57.25 -20.8 29.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.643 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.593 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 50.0 p30 -93.38 2.67 56.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.17 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.95 72.62 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.944 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 69.7 mm-40 -85.13 144.35 28.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.984 0.421 . . . . 0.0 111.4 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -109.51 140.03 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.719 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 t -135.72 132.36 36.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.867 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 90' ' ' SER . 22.0 tp -73.16 117.07 14.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.424 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.0 pt -107.43 -22.84 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.096 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 tp -156.73 125.26 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.812 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.448 ' HB2' HD21 ' A' ' 87' ' ' LEU . 47.8 t -127.7 123.66 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.33 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 t -155.0 156.72 36.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.613 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.3 p -116.96 156.1 28.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.413 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 63.9 mt-30 -140.38 160.16 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 111.122 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.69 112.65 17.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 43.9 p . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.601 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.626 0.25 . . . . 0.0 110.683 . . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.49 164.3 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.164 0.507 . . . . 0.0 111.605 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -128.71 144.26 51.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.58 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.7 101.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.27 136.59 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.509 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.8 p -124.41 152.76 42.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.497 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -144.28 -165.88 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 110.639 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.577 ' O ' HD12 ' A' ' 88' ' ' ILE . 57.7 t -120.27 131.28 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.765 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.466 ' O ' ' OE1' ' A' ' 78' ' ' GLN . 73.0 p . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.2 p . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.0 m -93.68 -16.52 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 109.761 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.97 178.82 47.01 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.73 150.82 49.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.658 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -130.09 122.26 27.95 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.98 131.17 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.806 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.432 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.6 tt0 -122.29 132.52 54.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.774 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 54.1 p90 -138.1 137.2 37.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.129 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.43 159.01 43.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.438 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.71 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 58.3 mt -73.91 124.43 26.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.197 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -67.14 -28.66 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.595 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.393 -179.193 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 121.006 0.336 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 mt-30 -114.59 146.38 40.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.3 m-85 -123.32 137.2 54.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.324 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 52' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 52' ' ' LEU . 91.3 mt -121.93 126.81 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -100.69 130.62 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.146 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.9 mt -127.78 154.72 78.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.577 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.35 155.44 67.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.188 1.925 . . . . 0.0 112.503 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.426 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 5.3 p -56.89 -12.57 2.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -94.21 -9.45 36.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.848 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.1 136.05 34.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 110.67 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -129.34 12.6 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.89 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.2 p -164.32 149.32 10.11 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.516 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.41 150.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.178 0.514 . . . . 0.0 111.575 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.2 t30 -103.47 127.11 50.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.571 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.6 105.01 34.63 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.88 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -90.66 -178.54 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.922 2.414 . . . . 0.0 113.253 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 60.47 36.86 20.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.771 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.51 ' O ' ' OG ' ' A' ' 20' ' ' SER . 47.6 mt -92.62 144.88 24.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.603 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.541 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 19.4 mt -88.71 112.17 48.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.063 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -53.92 141.67 66.29 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.102 1.868 . . . . 0.0 111.897 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 81.0 17.08 73.17 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.424 ' HB3' HD22 ' A' ' 42' ' ' LEU . 7.7 mmt-85 -124.01 146.39 48.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -98.94 132.41 44.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.827 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.71 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 55.6 m-85 -118.89 155.6 30.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.762 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.468 HG22 HD21 ' A' ' 75' ' ' ASN . 70.8 mt -109.13 126.99 66.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -112.47 131.31 64.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.0 0.428 . . . . 0.0 111.075 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.468 HD21 HG22 ' A' ' 73' ' ' ILE . 32.7 m-80 -138.05 125.68 22.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.898 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.471 ' O ' HD12 ' A' ' 87' ' ' LEU . 46.5 t -105.04 127.85 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.893 0.378 . . . . 0.0 110.413 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -119.45 136.07 54.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 28' ' ' SER . 5.5 pt20 -101.57 135.18 43.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 34' ' ' SER . 64.0 mt -97.08 120.51 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 110.549 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.587 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.2 p -81.39 172.32 13.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.652 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -22.82 59.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.642 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.587 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 49.2 p30 -92.18 0.68 57.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 11.21 73.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.814 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.9 mm-40 -84.02 140.08 32.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -103.08 142.62 33.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.7 t -136.58 128.24 28.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.15 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 90' ' ' SER . 61.3 tp -73.14 119.16 17.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 27' ' ' VAL . 45.0 pt -110.83 -20.89 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.099 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.0 tp -155.46 120.18 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.512 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.711 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.7 t -127.13 123.66 37.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 t -156.08 149.58 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.685 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.2 p -111.95 155.44 23.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.024 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -140.93 156.67 46.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.237 0.541 . . . . 0.0 110.954 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -119.14 110.94 17.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.252 178.908 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 94' ' ' THR . 75.6 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.583 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 18.7 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.569 0.224 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -61.65 131.59 50.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.264 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.632 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 6.6 m-30 -95.03 146.48 24.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.735 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.1 t -131.49 103.99 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.903 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -116.05 138.11 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.0 p -124.71 152.58 43.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.821 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.621 ' CE3' HG21 ' A' ' 76' ' ' VAL . 42.1 p90 -146.24 -165.49 2.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.36 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 t -130.81 129.59 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.826 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 p . . . . . 0 C--N 1.324 -0.52 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.801 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 56' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.6 m -94.72 -18.74 21.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.209 0.528 . . . . 0.0 109.805 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.85 178.36 46.54 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -123.1 150.26 43.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.486 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.68 ' NH2' HE22 ' A' ' 85' ' ' GLN . 29.4 ttp180 -129.21 120.93 26.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.527 HG21 HG11 ' A' ' 61' ' ' VAL . 13.7 t -106.56 131.22 56.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.89 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.05 132.83 55.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 54.7 p90 -140.73 136.45 32.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.609 . . . . 0.0 111.267 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.0 164.72 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.989 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.768 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 79.3 mt -72.45 125.11 26.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.82 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 p -62.08 -32.95 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.511 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.033 179.735 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 N--CA 1.492 1.393 0 CA-C-O 120.783 0.243 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.0 mt-30 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -126.15 138.92 53.71 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.763 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -127.06 133.05 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' ASP . . . . . 0.406 ' O ' HD23 ' A' ' 54' ' ' LEU . 56.1 m-20 -106.65 134.29 50.02 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.693 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 53' ' ' ASP . 7.2 mt -131.83 156.14 80.49 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.669 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.25 158.13 58.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.05 1.834 . . . . 0.0 112.294 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.618 ' HB2' HG13 ' A' ' 33' ' ' VAL . 87.3 p -58.67 -13.04 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -92.97 -6.97 47.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.861 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.12 134.56 34.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.606 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -131.9 15.41 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.482 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -163.28 144.02 9.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 38' ' ' VAL . 9.5 p -149.28 148.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.533 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 5.0 t-20 -106.04 127.13 52.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.546 178.533 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.411 HG22 HD21 ' A' ' 66' ' ' LEU . 1.7 mt -98.34 104.77 25.15 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 94.3 Cg_endo -90.18 172.5 3.57 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.535 2.157 . . . . 0.0 112.587 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 62.45 39.53 11.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.725 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.547 HD12 ' CD1' ' A' ' 22' ' ' PHE . 32.9 mt -89.44 138.68 31.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.291 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.565 HD13 ' NH2' ' A' ' 70' ' ' ARG . 28.5 mt -68.76 129.34 92.51 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.851 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.05 138.06 27.53 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.508 2.139 . . . . 0.0 112.012 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.26 22.23 73.91 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.565 ' NH2' HD13 ' A' ' 67' ' ' LEU . 5.5 mmm-85 -125.71 148.59 49.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -98.64 134.03 42.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.183 0.516 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.768 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 49.9 m-85 -120.81 149.5 42.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.846 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.478 HG22 HD21 ' A' ' 75' ' ' ASN . 66.3 mt -108.18 128.71 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 t -116.58 129.26 73.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.42 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.478 HD21 HG22 ' A' ' 73' ' ' ILE . 33.4 m-80 -134.43 124.41 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.712 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.621 HG21 ' CE3' ' A' ' 26' ' ' TRP . 21.9 t -100.96 128.14 53.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.496 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -120.12 136.59 54.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.698 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -101.88 137.5 40.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.759 -0.776 . . . . 0.0 108.969 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.8 mt -100.58 127.7 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 111.4 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 28.4 p -84.53 173.06 11.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.43 -18.06 48.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.868 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.605 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.3 p30 -94.56 -4.04 48.65 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.498 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 13.75 62.41 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.262 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.585 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 69.4 mm-40 -84.56 147.3 27.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.898 0.349 . . . . 0.0 110.335 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.68 HE22 ' NH2' ' A' ' 37' ' ' ARG . 43.6 mt-30 -112.44 147.7 35.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.124 0.488 . . . . 0.0 111.77 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -139.14 128.63 24.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.93 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 tp -73.3 118.96 16.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.964 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.2 pt -111.72 -22.69 4.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 26' ' ' TRP . 16.6 tp -154.85 127.1 7.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.907 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 48.1 t -135.6 119.05 16.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.133 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -145.77 159.57 42.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.7 p -126.32 152.49 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.447 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 81.9 mt-30 -145.94 163.02 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.598 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.03 108.67 16.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.864 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.482 ' HG1' ' H ' ' A' ' 70' ' ' ARG . 37.9 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.631 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.519 ' O ' HD12 ' A' ' 66' ' ' LEU . 1.7 p . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.94 0.4 . . . . 0.0 109.962 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -61.16 142.37 56.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.37 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 95' ' ' THR . 6.3 m-30 -96.78 148.38 22.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.34 107.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.21 135.54 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.051 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -123.35 150.58 43.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.693 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -146.88 -168.24 2.98 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.301 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.1 t -120.63 132.76 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.521 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.524 ' O ' ' OE1' ' A' ' 78' ' ' GLN . 32.2 t . . . . . 0 C--N 1.323 -0.575 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.416 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 79' ' ' ILE . 8.4 m -94.83 -16.13 23.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.304 0.573 . . . . 0.0 109.682 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.05 175.29 45.08 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CZ ' HG11 ' A' ' 33' ' ' VAL . 93.9 m-85 -124.28 152.25 43.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.613 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.534 ' HE ' ' HB3' ' A' ' 51' ' ' TYR . 70.7 ttt180 -132.78 122.87 25.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.756 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.2 t -109.58 130.41 62.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.886 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.51 ' C ' ' OE1' ' A' ' 39' ' ' GLU . 13.1 tm-20 -123.68 129.59 51.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 34.9 p90 -143.52 144.74 32.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.213 0.53 . . . . 0.0 111.599 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -148.65 168.14 23.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.464 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.745 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 67.3 mt -73.86 129.76 38.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.191 0.52 . . . . 0.0 111.532 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.3 p -70.83 -18.74 62.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.21 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.221 -179.339 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.489 1.25 0 CA-C-O 120.795 0.248 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 22.6 mt-30 -116.67 144.14 44.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' HB3' ' HE ' ' A' ' 37' ' ' ARG . 3.2 m-85 -123.7 139.22 54.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.909 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -127.35 127.67 44.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -100.86 132.1 46.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.354 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -128.0 155.5 77.67 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.456 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -68.33 155.98 67.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.037 1.824 . . . . 0.0 112.303 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.4 p -56.67 -12.59 1.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 37.7 p -91.84 -8.66 45.94 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.79 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.06 34.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -128.5 11.31 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.6 p -164.2 145.89 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.09 145.49 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.361 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -104.23 127.84 51.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.236 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.84 105.94 37.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -87.78 179.52 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.571 2.181 . . . . 0.0 112.492 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 58.37 38.58 25.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.299 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 20' ' ' SER . 28.8 mt -87.77 150.23 23.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.8 mt -94.21 109.32 41.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.112 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -54.63 139.56 76.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.137 1.891 . . . . 0.0 111.627 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.574 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 84.95 15.92 66.36 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.471 ' HG3' ' NH1' ' A' ' 70' ' ' ARG . 7.6 mmm-85 -125.35 143.75 50.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 110.574 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -100.81 132.0 46.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.745 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 80.1 m-85 -119.6 151.41 38.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.894 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 70.3 mt -108.54 131.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -119.68 134.18 64.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.827 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.02 125.7 30.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.48 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.1 t -104.15 128.95 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.765 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -119.08 138.96 52.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.544 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.524 ' OE1' ' O ' ' A' ' 28' ' ' SER . 6.5 pt20 -104.98 137.15 43.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.6 mt -100.1 121.75 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.195 0.521 . . . . 0.0 110.382 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 83.6 p -82.48 167.67 18.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.597 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -57.55 -19.91 28.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.244 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.61 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.9 p30 -92.24 0.04 57.43 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.188 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.4 9.2 73.06 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.054 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -82.71 143.93 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 111.074 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.484 ' NE2' HG12 ' A' ' 79' ' ' ILE . 3.1 mm-40 -109.53 141.91 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 t -138.27 133.95 33.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.557 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 tp -73.56 118.55 16.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.648 -0.421 . . . . 0.0 109.947 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.3 pt -109.92 -23.25 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.211 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.9 tp -157.03 126.6 6.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.119 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 t -132.81 122.36 24.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.495 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -152.38 159.94 43.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.257 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.2 p -121.59 153.03 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.505 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 80.2 mt-30 -145.64 161.32 40.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.459 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.13 114.17 19.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.705 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 59.5 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.418 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 23.7 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.913 0.387 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -62.46 164.05 7.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.735 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.437 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 20.8 m-30 -129.37 147.9 51.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.47 178.495 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.04 101.9 10.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.953 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.09 137.76 43.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 -178.561 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -124.55 152.27 43.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.883 179.356 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.473 ' CD2' HG11 ' A' ' 76' ' ' VAL . 39.0 p90 -143.35 -177.93 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.5 -179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -108.02 132.54 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.871 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.47 ' O ' ' OE1' ' A' ' 78' ' ' GLN . 98.3 p . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.959 0.409 . . . . 0.0 110.49 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.4 p . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 79' ' ' ILE . 7.2 m -94.5 -17.14 22.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.248 0.547 . . . . 0.0 109.559 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.06 178.51 47.59 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -126.9 151.6 48.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.596 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -130.8 121.26 25.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.1 132.01 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.594 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 79.6 tt0 -121.07 133.65 55.24 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.61 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.465 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.4 p90 -139.04 130.48 27.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.155 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -142.72 161.63 37.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.573 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.654 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 56.8 mt -75.15 132.61 41.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 111.85 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -77.86 -14.67 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.124 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 -179.494 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo . . . . . 0 N--CA 1.489 1.247 0 CA-C-O 120.878 0.282 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.465 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 21.3 mt-30 -118.08 144.9 45.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.594 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.9 m-85 -125.17 137.37 54.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.627 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.5 mt -117.03 127.41 54.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -100.49 131.15 46.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.127 0.489 . . . . 0.0 111.093 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 61' ' ' VAL . 4.5 mt -129.12 155.79 79.26 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.59 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.69 158.61 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 112.167 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.433 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 27.8 p -58.69 -12.95 4.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.714 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.5 p -90.31 -10.23 44.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 134.74 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.7 p -126.83 7.51 6.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.563 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -165.76 147.08 7.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.232 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 54' ' ' LEU . 5.7 p -148.91 150.43 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.043 0.449 . . . . 0.0 111.371 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.439 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 8.1 t-20 -101.49 130.48 47.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.925 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -107.29 97.01 17.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 85.3 Cg_endo -87.46 -171.52 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.664 2.243 . . . . 0.0 112.541 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 58.42 35.63 24.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.219 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.573 ' O ' ' OG ' ' A' ' 20' ' ' SER . 50.0 mt -90.53 142.01 28.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.2 mt -82.75 113.16 43.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.266 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -54.4 141.42 72.32 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.226 1.95 . . . . 0.0 112.204 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.26 20.09 70.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mmm-85 -123.05 146.91 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.716 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -100.15 131.54 46.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 76.9 m-85 -121.13 153.93 36.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.214 0.531 . . . . 0.0 111.625 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.0 mt -108.31 124.08 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.206 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.97 131.54 64.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -134.54 126.1 28.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.552 179.517 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 26' ' ' TRP . 38.8 t -106.33 130.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.904 -179.461 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -123.5 136.59 54.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.025 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.47 ' OE1' ' O ' ' A' ' 28' ' ' SER . 7.2 pt20 -100.93 134.74 43.46 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.207 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 34' ' ' SER . 59.2 mt -97.5 123.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.957 -178.4 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.579 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 52.1 p -83.34 170.97 14.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.97 -21.41 64.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.579 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -91.3 -0.8 57.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.56 10.18 70.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.335 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 78.3 mm-40 -84.67 140.8 31.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.791 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -106.12 143.16 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.2 t -136.59 132.15 34.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.261 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 90' ' ' SER . 24.1 tp -72.96 118.37 15.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.349 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.435 HD11 ' CD1' ' A' ' 26' ' ' TRP . 41.5 pt -109.42 -22.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.401 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.7 tp -154.88 121.81 5.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 111.459 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.575 ' HB2' HD21 ' A' ' 87' ' ' LEU . 39.3 t -132.08 113.24 13.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.666 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.8 t -150.87 162.76 40.16 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.443 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -116.49 154.3 30.61 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.331 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.433 ' OE1' ' CG ' ' A' ' 22' ' ' PHE . 76.0 mt-30 -136.56 155.82 49.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.93 109.51 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.4 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 18.4 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.499 -179.203 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.525 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.951 0.405 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 p -61.18 165.87 4.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.24 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.521 ' O ' ' OD1' ' A' ' 62' ' ' ASN . 17.3 m-30 -136.12 151.06 49.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.281 178.765 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.96 102.2 9.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.677 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.63 136.51 48.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.306 -178.557 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -121.88 153.18 38.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.687 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.62 ' CD2' HG11 ' A' ' 76' ' ' VAL . 29.0 p90 -143.58 -168.9 2.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 110.933 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' VAL . . . . . 0.652 ' O ' HD12 ' A' ' 88' ' ' ILE . 79.7 t -115.1 133.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.217 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 98.2 p . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.422 -179.833 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.6 p . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.907 0.384 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 79' ' ' ILE . 59.7 m -95.37 -15.07 23.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.525 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.54 -178.89 48.37 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.34 152.73 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.549 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 ttp180 -130.8 122.68 27.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.594 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.32 134.32 51.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.948 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 83.2 tt0 -121.47 126.95 50.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.202 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.457 ' CE1' ' OE1' ' A' ' 50' ' ' GLN . 54.0 p90 -133.6 131.29 39.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.238 0.542 . . . . 0.0 110.502 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -147.44 161.56 40.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.442 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.78 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 67.6 mt -75.78 130.45 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.941 0.401 . . . . 0.0 111.702 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.0 p -74.87 -23.23 58.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.106 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.972 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 CA-C-O 120.906 0.294 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.457 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 32.7 mt-30 -116.81 147.82 41.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -123.95 139.59 53.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.943 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.7 mt -124.76 128.55 48.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.056 178.348 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -103.36 132.02 49.96 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.977 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' LEU . . . . . 0.449 HD21 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -128.91 155.15 80.02 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.916 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.9 155.77 68.48 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 112.031 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.413 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 26.7 p -58.06 -14.66 7.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.639 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.8 p -89.41 -11.12 44.07 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.367 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.99 131.44 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.4 p -125.28 10.2 8.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.617 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -164.85 146.4 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.06 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.449 HG21 HD21 ' A' ' 54' ' ' LEU . 5.1 p -149.05 152.21 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.514 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.521 ' OD1' ' O ' ' A' ' 22' ' ' PHE . 41.8 t30 -102.42 124.76 48.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.762 178.86 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 mt -97.26 107.0 35.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -92.21 -178.65 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.802 2.335 . . . . 0.0 113.145 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 58.7 38.05 25.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.531 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.525 ' O ' ' OG ' ' A' ' 20' ' ' SER . 56.7 mt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.094 178.988 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.493 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 30.2 mt -86.44 123.77 70.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.249 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.81 143.36 55.29 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.226 1.95 . . . . 0.0 112.523 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.56 19.53 73.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.673 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -126.44 151.55 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.302 . . . . 0.0 110.64 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -100.37 130.65 46.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.029 0.442 . . . . 0.0 110.236 179.232 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.78 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 68.1 m-85 -117.25 158.52 24.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.017 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.4 mt -113.37 126.08 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.031 0.443 . . . . 0.0 110.642 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -133.36 125.76 29.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.421 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.62 HG11 ' CD2' ' A' ' 26' ' ' TRP . 14.3 t -104.65 128.51 58.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.583 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -120.75 139.37 53.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -101.62 134.52 44.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.963 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.4 mt -99.06 119.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.39 0.614 . . . . 0.0 110.621 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.6 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 24.7 p -82.56 169.64 16.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.078 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.98 -19.3 51.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.48 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.6 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 47.3 p30 -93.14 -1.41 56.4 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.144 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.28 67.36 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.926 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 73.8 mm-40 -83.7 139.26 32.88 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -110.41 139.43 45.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -136.82 135.92 38.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.937 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.819 HD21 ' HB2' ' A' ' 90' ' ' SER . 32.3 tp -73.28 118.45 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 27' ' ' VAL . 44.1 pt -109.05 -22.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.612 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -154.87 122.19 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.106 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.819 ' HB2' HD21 ' A' ' 87' ' ' LEU . 35.2 t -130.61 122.21 27.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -154.34 158.59 40.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.323 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.2 p -117.15 152.69 34.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -138.94 157.47 45.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.661 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 112.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 53.8 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.498 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.413 0.149 . . . . 0.0 111.313 . . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.77 129.57 42.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.182 0.515 . . . . 0.0 110.626 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 93' ' ' GLN . 19.0 m-30 -95.65 144.87 25.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.266 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.31 102.87 13.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.87 137.88 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.079 0.466 . . . . 0.0 111.504 -178.457 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -126.52 153.02 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.711 179.32 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.577 ' CD2' HG11 ' A' ' 76' ' ' VAL . 32.2 p90 -144.65 -172.52 3.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -113.76 131.15 66.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.629 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' SER . . . . . 0.528 ' O ' ' OE1' ' A' ' 78' ' ' GLN . 27.3 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.683 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 56' ' ' SER . 2.1 p . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.8 m -95.31 -13.31 24.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.346 0.593 . . . . 0.0 109.831 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.96 177.02 44.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.57 151.71 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.904 0.383 . . . . 0.0 110.369 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.561 ' NH2' HE22 ' A' ' 85' ' ' GLN . 46.0 ttp180 -128.66 121.74 29.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.682 178.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 61' ' ' VAL . 47.9 t -106.72 132.87 52.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.381 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 69.3 tt0 -123.46 134.28 53.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.763 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 54.6 p90 -140.14 137.18 34.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 110.714 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.62 158.94 44.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.907 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.685 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 39.9 mt -74.25 132.4 42.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.5 p -77.64 -13.67 59.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.317 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.976 -179.539 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.538 ' C ' ' OE1' ' A' ' 50' ' ' GLN . 57.7 Cg_endo . . . . . 0 N--CA 1.489 1.259 0 CA-C-O 120.846 0.269 . . . . 0.0 111.997 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.655 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.4 mp0 -113.11 147.9 36.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -122.72 136.16 54.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.146 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -120.58 128.28 52.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.465 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.66 130.61 46.73 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.201 -178.928 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -127.82 155.95 76.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.468 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -68.21 156.16 66.77 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.274 1.983 . . . . 0.0 112.269 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 53.4 p -58.8 -14.11 7.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.3 p -90.01 -8.83 50.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.71 132.96 34.39 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 p -128.9 12.73 6.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.032 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.5 p -164.61 148.62 9.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 38' ' ' VAL . 5.3 p -152.63 147.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.514 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 42.0 t30 -102.88 127.96 49.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.366 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.455 HG22 HD21 ' A' ' 66' ' ' LEU . 1.9 mt -99.21 104.6 27.33 Favored Pre-proline 0 C--N 1.332 -0.177 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.5 Cg_endo -89.42 174.66 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.785 2.323 . . . . 0.0 113.103 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 61.38 38.31 16.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.708 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -90.51 142.44 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.793 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.417 HD13 ' NH2' ' A' ' 70' ' ' ARG . 24.9 mt -78.66 130.8 69.69 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.287 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 70' ' ' ARG . 39.0 Cg_exo -51.35 -174.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.206 1.937 . . . . 0.0 111.812 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 17.02 40.29 0.01 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.373 179.068 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.709 ' N ' ' O ' ' A' ' 68' ' ' PRO . 16.2 mmm-85 -127.22 142.76 51.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.346 0.573 . . . . 0.0 110.417 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -101.19 132.4 46.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.685 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 67.8 m-85 -121.28 155.72 34.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.2 mt -110.68 123.77 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.816 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 62.7 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 0.0 111.565 -178.27 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 75' ' ' ASN . . . . . 0.496 ' OD1' ' OG ' ' A' ' 90' ' ' SER . 21.4 m-80 -133.07 126.14 31.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.523 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' A' ' 26' ' ' TRP . 6.6 t -107.57 131.36 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.12 142.29 50.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.116 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' GLN . . . . . 0.528 ' OE1' ' O ' ' A' ' 28' ' ' SER . 9.3 pt20 -102.88 137.47 41.04 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.804 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.663 ' O ' ' N ' ' A' ' 34' ' ' SER . 45.2 mt -100.93 121.56 51.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.074 0.464 . . . . 0.0 110.437 -178.587 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.614 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 71.4 p -82.11 168.13 18.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.945 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -57.62 -22.25 44.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.614 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.5 p30 -92.82 -0.49 57.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.723 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.76 11.95 67.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.495 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.21 138.69 33.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.195 0.498 . . . . 0.0 111.037 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.561 HE22 ' NH2' ' A' ' 37' ' ' ARG . 22.9 mt-30 -107.03 142.24 36.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.224 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -138.3 135.34 35.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.135 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 90' ' ' SER . 36.8 tp -73.42 118.6 16.57 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.228 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 88' ' ' ILE . 32.6 pt -110.99 -22.43 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.555 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -155.19 124.86 6.47 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.562 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.614 ' HB2' HD21 ' A' ' 87' ' ' LEU . 7.2 t -135.66 119.22 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.345 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 t -149.88 158.27 44.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.902 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -115.74 154.65 29.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.137 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.408 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 82.6 mt-30 -142.18 159.81 41.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.23 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.17 114.84 23.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.477 178.597 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.586 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 31.1 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.607 -179.191 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.64 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.6 p . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.3 p -61.59 127.92 33.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -179.614 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.524 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.5 m-30 -92.34 140.41 29.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.126 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.32 107.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.47 135.15 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.847 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -124.34 150.79 45.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.142 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.57 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.9 p90 -145.04 -164.99 2.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.75 133.37 65.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.345 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 61.1 p . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.595 -179.196 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG22 ' H ' ' A' ' 35' ' ' GLY . 7.5 p . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.2 m -95.11 -16.51 22.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.83 178.34 47.29 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.19 151.27 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.895 0.379 . . . . 0.0 110.118 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -130.46 125.62 34.86 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.525 HG21 HG11 ' A' ' 61' ' ' VAL . 46.2 t -109.13 131.49 59.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.396 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.2 tt0 -120.99 126.21 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 49.6 p90 -137.61 137.05 38.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.239 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -147.2 167.53 23.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.811 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 57.9 mt -77.1 128.59 34.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 111.213 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 p -76.4 -16.09 59.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.145 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -178.86 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 CA-C-O 121.316 0.465 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 42.9 mt-30 -118.65 144.7 46.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.904 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -121.1 143.04 49.3 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.054 -0.659 . . . . 0.0 112.203 -178.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 mt -129.38 125.74 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.869 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -100.54 133.52 44.85 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.367 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 160.43 63.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.512 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 58' ' ' ALA . 35.9 Cg_endo -75.61 158.99 39.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.989 1.793 . . . . 0.0 112.129 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.477 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 7.7 p -57.45 -12.23 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.296 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 p -93.8 -8.11 41.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.09 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' ALA . . . . . 0.467 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . . . -82.07 138.53 34.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -130.27 5.69 4.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.993 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 p -163.31 146.82 10.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 38' ' ' VAL . 9.7 p -146.85 146.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.407 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' ASN . . . . . 0.436 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 19.4 t30 -103.51 128.49 50.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.296 179.315 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.457 HD13 ' CD1' ' A' ' 40' ' ' TYR . 1.4 mt -105.47 99.49 21.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.925 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 96.7 Cg_endo -88.83 174.46 3.92 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.579 2.186 . . . . 0.0 112.162 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 66.56 37.73 4.39 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.431 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.64 HD12 ' O ' ' A' ' 20' ' ' SER . 39.4 mt -89.74 157.42 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 mt -91.1 110.09 39.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.793 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 22.1 Cg_exo -56.39 143.33 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.192 1.928 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' GLY . . . . . 0.602 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 79.05 17.78 76.14 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -125.15 151.2 46.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -99.85 131.86 45.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.866 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.811 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 72.2 m-85 -118.84 153.05 35.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.457 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 75.0 mt -110.1 126.81 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.369 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.92 133.88 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.115 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -133.98 126.87 31.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.545 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.57 HG11 ' CD2' ' A' ' 26' ' ' TRP . 23.9 t -105.44 126.96 60.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -119.35 139.74 51.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -105.13 136.61 44.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.35 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.681 ' O ' ' N ' ' A' ' 34' ' ' SER . 46.4 mt -100.66 124.78 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.216 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.6 p -85.43 171.99 11.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.82 -19.45 41.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.8 p30 -92.34 -2.32 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.203 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.52 68.73 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.272 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 65.6 mm-40 -84.48 142.07 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.135 0.468 . . . . 0.0 111.097 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -108.64 139.81 42.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.832 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -136.92 137.81 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.866 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' A' ' 90' ' ' SER . 43.2 tp -74.07 118.46 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.377 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.3 pt -110.91 -23.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.0 tp -155.82 125.02 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.666 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.605 ' HB2' HD21 ' A' ' 87' ' ' LEU . 25.9 t -134.37 118.97 18.06 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 t -153.79 154.39 33.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.447 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -116.52 155.11 29.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.107 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 93' ' ' GLN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 78.2 mt-30 -145.48 164.65 30.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.238 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 109.52 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.72 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 72.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.389 -179.4 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.058 0.456 . . . . 0.0 109.957 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' SER . . . . . 0.485 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -61.22 172.1 1.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.801 -179.134 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CZ ' HG22 ' A' ' 95' ' ' THR . 23.3 m-85 -135.58 146.06 47.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.913 178.166 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.5 t -117.28 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.515 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.6 t -108.76 134.9 49.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.075 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.0 p -126.66 151.66 47.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.167 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' TRP . . . . . 0.565 ' CD2' HG11 ' A' ' 76' ' ' VAL . 36.9 p90 -144.37 -174.64 4.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.977 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.79 127.66 74.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 33' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 79' ' ' ILE . 32.1 m -94.46 -15.74 23.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 109.612 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.04 176.68 45.37 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.33 151.48 44.27 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.29 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' ARG . . . . . 0.484 ' NH2' HE22 ' A' ' 85' ' ' GLN . 40.6 ttp180 -131.78 125.06 30.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.817 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' VAL . . . . . 0.529 HG21 HG11 ' A' ' 61' ' ' VAL . 48.2 t -110.8 133.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.621 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.9 tt0 -123.82 132.24 53.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' TYR . . . . . 0.52 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 53.4 p90 -140.04 136.26 33.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.001 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -146.66 161.79 39.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.551 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' LEU . . . . . 0.786 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -75.0 125.14 28.29 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.848 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -69.57 -18.91 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 -179.002 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 N--CA 1.487 1.104 0 CA-C-O 120.872 0.28 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 50' ' ' GLN . . . . . 0.52 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 30.8 mt-30 -114.33 144.01 43.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -120.94 140.33 51.99 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.965 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -125.76 128.08 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.916 178.612 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -103.12 130.72 50.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.081 0.467 . . . . 0.0 111.43 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -129.77 154.55 81.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.651 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -69.54 157.73 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.371 2.047 . . . . 0.0 112.724 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' SER . . . . . 0.464 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 58.3 p -58.13 -14.65 7.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.701 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.4 p -89.61 -9.67 48.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.03 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.53 131.94 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.603 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.0 p -130.14 13.74 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.5 p -163.58 146.06 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.219 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.529 HG11 HG21 ' A' ' 38' ' ' VAL . 7.6 p -149.21 145.63 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 111.487 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -103.12 125.14 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.391 178.962 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.426 ' HB ' HD11 ' A' ' 66' ' ' LEU . 1.8 mt -97.98 107.59 41.59 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.179 -179.326 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -89.23 177.19 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.856 2.37 . . . . 0.0 112.682 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.47 38.18 19.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.717 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 34.1 mt -90.92 147.74 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.779 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LEU . . . . . 0.428 ' O ' ' OG1' ' A' ' 95' ' ' THR . 17.1 mt -89.09 114.25 59.44 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.893 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 31.6 Cg_exo -54.33 136.41 68.8 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.276 1.984 . . . . 0.0 111.465 178.031 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.73 26.75 66.47 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.864 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 94' ' ' THR . 7.0 mmt180 -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -98.34 127.97 44.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 72' ' ' TYR . . . . . 0.786 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 74.6 m-85 -119.02 147.99 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.22 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 76.2 mt -103.87 124.83 58.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.585 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 t -111.17 130.57 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.671 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.91 123.08 24.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.507 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' VAL . . . . . 0.565 HG11 ' CD2' ' A' ' 26' ' ' TRP . 17.7 t -104.28 126.57 58.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -120.02 138.3 53.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.878 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.0 pt20 -102.27 135.96 42.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.896 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.5 mt -99.26 122.26 50.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.229 0.537 . . . . 0.0 110.613 -178.739 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 94.5 p -83.5 169.45 15.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -21.15 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.878 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.5 p30 -91.74 -0.91 57.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.009 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.58 11.37 68.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.011 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' GLU . . . . . 0.575 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.0 mm-40 -82.81 140.39 32.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' GLN . . . . . 0.484 HE22 ' NH2' ' A' ' 37' ' ' ARG . 36.5 mt-30 -108.81 141.03 41.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.728 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.3 t -137.26 133.05 34.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 87' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' A' ' 90' ' ' SER . 13.7 tp -71.31 119.05 14.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.695 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.9 pt -108.12 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.652 -179.508 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -156.07 121.33 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.176 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' SER . . . . . 0.743 ' HB2' HD21 ' A' ' 87' ' ' LEU . 15.7 t -131.1 118.39 20.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.44 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -149.42 153.73 37.78 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.724 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.5 p -115.89 149.25 38.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.101 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -147.45 158.9 44.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.6 OUTLIER -119.04 111.5 18.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.739 178.318 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 95' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 73.8 p . . . . . 0 C--N 1.321 -0.651 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.787 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.29 137.45 78.7 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.846 2.364 . . . . 0.0 111.987 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.6 tp -96.65 136.61 36.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.079 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.65 -12.64 55.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.536 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 6.3 t -111.61 137.96 48.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 5' ' ' SER . 97.6 m-70 -160.39 -13.79 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.203 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.418 ' H ' ' H ' ' A' ' 6' ' ' HIS . 0.7 OUTLIER -47.47 97.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.393 -179.383 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.649 HG22 ' H ' ' A' ' 10' ' ' THR . 5.0 p -112.08 -33.64 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.254 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 10' ' ' THR . . . 60.79 1.6 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.147 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.649 ' H ' HG22 ' A' ' 8' ' ' VAL . 49.1 m 24.18 -97.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.273 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.614 ' O ' ' O ' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -136.76 50.59 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.409 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.614 ' O ' ' O ' ' A' ' 11' ' ' SER . 74.2 tt0 25.79 103.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.091 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 m -85.76 7.18 24.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.808 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 14' ' ' VAL . 19.6 t -99.26 53.48 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.926 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 84.3 m -89.0 138.57 31.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.189 0.519 . . . . 0.0 111.055 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.686 ' OE1' ' N ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -178.72 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.305 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.686 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 50.0 mt -19.0 -79.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.882 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.609 ' C ' ' O ' ' A' ' 17' ' ' ILE . 1.3 p 0.13 111.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.58 0.55 . . . . 0.0 111.163 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.545 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 65.34 24.94 12.11 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.554 -0.458 . . . . 0.0 109.92 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.548 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER 59.0 23.87 12.04 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.464 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -65.52 -179.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 111.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.696 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 33.6 m-85 -141.52 140.03 33.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.985 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.643 HG23 ' HB3' ' A' ' 16' ' ' GLU . 24.7 t -113.68 101.07 11.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.004 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -111.16 133.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.322 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.7 p -122.24 153.02 39.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.648 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -143.15 -171.57 3.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.57 126.78 73.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.458 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -53.16 126.29 20.34 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.797 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.86 5.7 45.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.492 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.741 ' O ' HG12 ' A' ' 33' ' ' VAL . 3.1 m -172.99 136.53 0.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.383 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.73 -3.52 58.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.1 0.476 . . . . 0.0 109.747 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.8 p -89.19 -4.63 58.17 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.013 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 30' ' ' SER . 2.4 p -59.34 138.37 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.102 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 79' ' ' ILE . 19.5 m -94.44 -15.18 24.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.5 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.64 -179.23 47.74 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.18 154.9 44.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.958 0.409 . . . . 0.0 111.004 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.405 ' HA ' ' O ' ' A' ' 52' ' ' LEU . 18.2 ttp180 -132.07 124.92 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 61' ' ' VAL . 17.9 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.447 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' CB ' ' A' ' 49' ' ' PRO . 75.0 tt0 -125.85 129.8 50.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 22.5 p90 -137.51 130.97 31.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -144.51 161.92 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.863 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.74 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 87.6 mt -74.52 126.63 31.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.161 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.3 p -73.14 -20.98 60.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.153 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -88.64 -73.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.155 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.565 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 92.1 mt-10 -57.2 -35.51 69.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.319 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.48 21.34 75.34 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.504 ' OD2' ' OE1' ' A' ' 45' ' ' GLU . 81.0 m-20 -50.96 168.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.371 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.92 145.29 97.86 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.946 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 72.6 Cg_endo -76.24 151.82 34.5 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.739 2.293 . . . . 0.0 112.769 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 19.7 mt-30 -114.47 146.18 40.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.441 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -123.09 137.13 55.0 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.437 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 76.7 mt -123.85 135.07 53.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.032 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -108.52 134.71 50.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.329 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.49 153.65 80.67 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.6 156.47 60.84 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.384 2.056 . . . . 0.0 112.344 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 17.6 p -57.56 -15.9 8.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.028 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.8 p -90.94 -7.6 51.64 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.539 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.43 137.18 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.1 p -134.51 13.82 3.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.227 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.7 p -164.79 145.22 7.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.634 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 38' ' ' VAL . 4.3 p -153.93 150.36 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.198 0.523 . . . . 0.0 111.942 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.495 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 9.2 t-20 -103.32 129.27 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.396 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.95 104.34 28.13 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.019 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 94.7 Cg_endo -89.9 179.95 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.833 2.355 . . . . 0.0 113.153 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 59.62 37.03 22.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.7 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.548 ' O ' ' OG ' ' A' ' 20' ' ' SER . 29.5 mt -92.26 150.56 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.163 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.637 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 29.5 mt -89.04 111.27 43.88 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.777 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 20.4 Cg_exo -57.97 143.6 95.83 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.155 1.903 . . . . 0.0 111.865 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.66 80.44 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -123.22 146.58 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -95.28 134.36 38.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.244 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.74 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 12.3 m-85 -118.49 150.84 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.8 mt -108.54 121.64 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.94 131.37 66.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.095 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -133.73 131.46 39.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.701 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -105.1 131.43 54.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.554 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -123.43 137.42 54.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.686 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.461 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 8.9 pt20 -100.94 136.65 40.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.1 mt -99.29 125.26 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.38 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 47.3 p -84.64 169.25 14.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.74 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -59.9 -16.63 30.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.603 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.602 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 43.9 p30 -96.04 0.25 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.06 15.23 63.1 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.71 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.558 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 54.0 mm-40 -83.77 141.97 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.936 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.6 mt-30 -114.38 140.37 48.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.625 179.53 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -136.09 133.2 37.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.858 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 90' ' ' SER . 21.8 tp -72.17 116.59 12.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.1 pt -108.99 -21.36 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -155.67 126.24 6.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.574 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 87' ' ' LEU . 28.6 t -131.53 122.15 25.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.877 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 t -154.08 153.82 32.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.617 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -112.99 154.75 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.106 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.696 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 31.6 mt-30 -142.09 157.07 45.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.278 0.561 . . . . 0.0 111.388 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.51 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -117.75 107.15 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.51 ' OXT' ' O ' ' A' ' 94' ' ' THR . 71.1 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.919 -1.038 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 48.0 Cg_exo -51.53 160.5 2.51 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.949 2.433 . . . . 0.0 111.938 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mp -55.82 -37.06 68.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.929 0.395 . . . . 0.0 110.434 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.07 -148.37 44.32 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.1 m -61.49 147.21 46.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.733 0.301 . . . . 0.0 110.254 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.78 127.02 18.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.67 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.655 ' O ' ' N ' ' A' ' 9' ' ' ALA . 57.0 mt -144.27 86.08 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.787 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.786 ' O ' HG22 ' A' ' 8' ' ' VAL . 9.4 p 25.5 38.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 7' ' ' LEU . . . -64.55 149.16 49.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.2 OUTLIER 63.68 -1.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.553 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.634 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 10.0 p 39.14 -128.08 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.449 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.634 ' N ' ' OG ' ' A' ' 11' ' ' SER . 22.0 pt-20 -99.81 130.35 46.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.937 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.7 p -93.57 2.9 56.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.505 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 15' ' ' THR . 16.5 m -111.07 23.95 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.151 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.657 ' O ' ' N ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -33.97 -50.78 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.215 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.717 ' OE2' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -66.89 49.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 15' ' ' THR . 64.1 mt -58.01 -12.82 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.957 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 20' ' ' SER . 78.9 p -53.6 157.52 2.16 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.548 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 36.48 28.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.841 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p 55.22 30.59 14.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.778 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.592 ' OG ' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -59.07 176.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.541 0.686 . . . . 0.0 111.538 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.587 ' CZ ' HG22 ' A' ' 95' ' ' THR . 15.2 m-85 -148.19 146.59 28.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.041 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.717 HG23 ' OE2' ' A' ' 16' ' ' GLU . 13.6 t -120.96 102.2 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.2 t -110.17 136.93 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.484 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.8 p -123.46 151.72 42.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.846 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CD2' HG11 ' A' ' 76' ' ' VAL . 35.4 p90 -143.99 -173.33 3.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.165 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.794 HG12 ' H ' ' A' ' 29' ' ' ALA . 61.6 t -113.6 132.61 62.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.684 ' O ' ' N ' ' A' ' 30' ' ' SER . 22.1 p -48.43 -20.95 0.47 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.783 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.794 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 43.84 5.93 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.479 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.684 ' N ' ' O ' ' A' ' 28' ' ' SER . 3.3 m -176.81 136.3 0.23 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.649 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.47 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 48.2 p30 -94.29 4.51 53.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.083 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.7 p -93.37 6.25 48.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.0 p -80.05 135.58 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.28 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 79' ' ' ILE . 12.5 m -94.63 -14.11 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.583 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.67 176.81 46.01 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.59 151.21 46.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.069 0.462 . . . . 0.0 110.827 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.2 ttp180 -131.94 124.44 29.43 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.862 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.23 134.66 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.42 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 74.6 tt0 -121.96 127.08 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.978 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.6 p90 -135.54 133.98 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.63 165.69 29.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.229 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.766 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 85.2 mt -74.65 129.39 37.64 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.211 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 16.8 p -74.79 -15.75 60.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.307 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -100.07 -65.56 0.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.274 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.518 ' OE1' ' OD2' ' A' ' 47' ' ' ASP . 93.2 mt-10 -62.55 -33.22 74.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.826 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.64 74.64 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.518 ' OD2' ' OE1' ' A' ' 45' ' ' GLU . 86.6 m-20 -48.1 171.01 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.87 0.366 . . . . 0.0 110.408 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.9 pm0 -59.36 138.08 88.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.571 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.24 151.82 38.91 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.66 2.24 . . . . 0.0 112.098 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.473 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 20.0 mt-30 -116.18 151.11 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.42 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -124.77 138.29 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.052 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.5 mt -125.02 131.35 53.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.73 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -104.63 133.04 50.15 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.917 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.6 mt -130.26 153.37 81.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.639 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.65 154.3 74.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.344 2.029 . . . . 0.0 112.622 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -56.77 -12.53 1.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.7 p -93.16 -9.67 38.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.646 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.54 136.27 34.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.514 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.9 p -128.03 10.62 6.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.01 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.5 p -164.07 150.41 11.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.539 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -151.37 153.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.186 0.517 . . . . 0.0 111.485 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.434 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 8.7 t-20 -103.4 126.57 50.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.723 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.485 HG22 HD21 ' A' ' 66' ' ' LEU . 3.1 mt -103.02 101.84 24.0 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.926 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 69.1 Cg_endo -91.71 -175.24 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.995 2.463 . . . . 0.0 112.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 58.39 35.01 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.398 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.58 ' O ' ' OG ' ' A' ' 20' ' ' SER . 23.3 mt -88.5 153.14 21.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.36 109.97 41.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.206 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 30.8 Cg_exo -56.02 138.5 82.68 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.234 1.956 . . . . 0.0 111.563 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.81 16.31 73.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.2 mmt-85 -126.13 148.19 49.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.86 0.362 . . . . 0.0 110.29 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 70.1 tttt -97.35 133.55 41.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.943 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.766 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 60.3 m-85 -118.89 151.39 38.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.599 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.466 HG22 HD21 ' A' ' 75' ' ' ASN . 71.3 mt -108.91 125.45 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -113.59 131.71 64.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.059 0.457 . . . . 0.0 110.917 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.466 HD21 HG22 ' A' ' 73' ' ' ILE . 35.2 m-80 -134.95 126.94 29.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.969 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.489 HG11 ' CD2' ' A' ' 26' ' ' TRP . 26.3 t -105.4 128.56 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 77.8 m-85 -120.0 137.64 53.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.694 179.212 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.9 pt20 -101.84 135.55 43.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.92 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.1 mt -98.91 122.31 50.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.2 0.524 . . . . 0.0 110.599 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 52.6 p -83.23 170.22 14.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.196 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.6 -19.63 50.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.374 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 44.6 p30 -91.99 -0.59 57.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.273 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.47 75.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 71.7 mm-40 -84.99 142.55 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 110.482 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -107.14 145.96 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.099 179.821 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 t -137.89 130.76 29.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.221 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 90' ' ' SER . 29.2 tp -73.01 117.93 15.33 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.232 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.3 pt -107.53 -21.66 5.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.773 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.2 tp -156.51 125.45 5.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.56 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.692 ' HB2' HD21 ' A' ' 87' ' ' LEU . 24.0 t -130.86 118.47 20.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -152.77 167.2 29.81 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.709 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 75.1 p -128.86 157.8 40.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 0.0 110.543 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.6 mt-30 -142.59 161.18 38.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.294 0.569 . . . . 0.0 111.024 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.49 115.23 21.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.538 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.587 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.609 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.704 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -53.72 13.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.938 2.426 . . . . 0.0 112.104 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.704 ' H ' ' C ' ' A' ' 1' ' ' GLY . 41.9 mt -81.91 156.25 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.232 0.539 . . . . 0.0 111.51 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.75 -171.3 47.57 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.385 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.555 ' O ' ' OG ' ' A' ' 5' ' ' SER . 5.2 p 64.57 84.29 0.15 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -132.37 138.34 47.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.182 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.2 mt -148.62 68.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.386 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.572 ' O ' ' C ' ' A' ' 9' ' ' ALA . 86.8 t -90.5 -78.15 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.841 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . 19.86 59.42 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 8' ' ' VAL . 74.2 p -92.51 0.67 57.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.275 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.616 ' O ' ' C ' ' A' ' 12' ' ' GLU . 2.0 t -101.25 -37.95 8.3 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.968 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.616 ' C ' ' O ' ' A' ' 11' ' ' SER . 66.5 tt0 18.04 56.08 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 O-C-N 123.617 0.573 . . . . 0.0 110.182 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.563 ' C ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -14.45 -58.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.081 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' GLU . 33.0 m -92.56 128.64 44.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.688 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -123.19 -97.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.76 ' H ' HG23 ' A' ' 15' ' ' THR . 68.4 mm-40 -58.49 -37.15 74.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.619 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.799 ' O ' HG22 ' A' ' 17' ' ' ILE . 18.5 mt 50.04 6.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.269 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.494 ' H ' ' C ' ' A' ' 16' ' ' GLU . 26.7 m -59.37 128.61 37.96 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.588 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.57 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 63.58 27.34 14.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 4.4 p 55.21 31.3 16.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.138 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 79.6 p -62.87 140.21 58.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.386 -178.91 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.557 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.7 m-30 -95.15 155.55 16.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.252 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -132.74 103.45 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.95 135.27 50.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 110.529 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -127.28 151.15 49.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.289 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.505 ' HB3' HD22 ' A' ' 89' ' ' LEU . 46.1 p90 -148.83 -164.99 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.663 ' C ' ' H ' ' A' ' 29' ' ' ALA . 49.1 t -120.49 133.71 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.586 ' O ' ' C ' ' A' ' 29' ' ' ALA . 36.8 p -50.18 -0.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.446 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 27' ' ' VAL . . . 6.9 64.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.43 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.4 OUTLIER 164.67 -55.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.288 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 30' ' ' SER . 7.0 t70 77.43 -32.27 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.265 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 30' ' ' SER . 43.0 p -81.13 0.03 38.07 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.304 0.573 . . . . 0.0 109.545 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.734 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 5.3 p -60.86 138.92 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.374 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.3 m -95.46 -12.96 25.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.24 177.26 46.01 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.734 ' CZ ' HG11 ' A' ' 33' ' ' VAL . 92.4 m-85 -129.26 151.51 49.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 110.288 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.8 ttp180 -129.71 126.09 37.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.057 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.595 HG21 HG11 ' A' ' 61' ' ' VAL . 27.0 t -107.56 134.66 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.523 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 68.5 tt0 -126.35 127.45 45.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.529 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.465 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 27.0 p90 -136.63 140.86 43.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 0.0 111.104 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.33 161.94 40.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.17 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.72 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 50.9 mt -75.63 127.75 33.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 111.503 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 20.3 p -75.81 -9.73 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.812 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.35 -75.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.15 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.07 -33.63 76.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.112 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.28 32.08 52.98 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 20.3 t0 -52.02 179.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.547 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -71.25 142.0 86.63 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.612 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.46 146.42 61.99 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.344 2.029 . . . . 0.0 111.83 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.465 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 mt-30 -114.31 147.03 39.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.586 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 91.4 m-85 -122.65 136.89 55.01 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.841 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.5 mt -124.8 127.15 46.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -99.06 131.96 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.956 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -127.87 154.29 78.16 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.82 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.58 159.64 52.78 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.619 2.213 . . . . 0.0 112.216 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p -60.61 -14.6 21.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.3 p -90.15 -5.44 56.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.328 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.43 139.29 31.64 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.498 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.6 p -129.72 9.54 5.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -167.55 150.2 5.95 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.595 HG11 HG21 ' A' ' 38' ' ' VAL . 8.1 p -150.29 147.49 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.838 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.428 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 7.5 t30 -103.04 127.56 50.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.379 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -102.74 102.1 24.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.322 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 77.3 Cg_endo -86.8 -175.2 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.8 2.333 . . . . 0.0 113.278 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 57.87 39.15 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.611 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' CD1' ' A' ' 22' ' ' PHE . 25.8 mt -90.96 152.53 20.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.41 108.13 37.29 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.297 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 39.3 Cg_exo -51.51 140.66 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.295 1.997 . . . . 0.0 111.647 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.425 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 83.33 14.76 73.35 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -124.69 143.69 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.336 . . . . 0.0 110.385 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 74.7 tttt -99.19 134.88 41.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.72 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 83.8 m-85 -121.84 147.93 45.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 61.6 mt -106.04 128.05 60.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.64 136.49 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.149 0.499 . . . . 0.0 111.588 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -135.36 125.81 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.442 HG11 ' CD2' ' A' ' 26' ' ' TRP . 11.9 t -104.97 131.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.635 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -120.6 140.87 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.489 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.483 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 0.5 OUTLIER -105.92 135.42 47.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.715 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 34' ' ' SER . 36.0 mt -100.23 121.6 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.439 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.621 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 44.4 p -82.49 171.91 13.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.782 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.06 -19.65 54.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.398 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.621 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 45.4 p30 -91.25 -2.8 57.37 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.389 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.17 67.23 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.319 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.2 mm-40 -83.33 145.23 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -111.69 140.73 46.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 179.466 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -137.79 135.27 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.637 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 90' ' ' SER . 21.5 tp -71.64 119.29 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.419 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.9 pt -109.36 -26.12 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 26' ' ' TRP . 13.9 tp -156.94 122.77 4.78 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.48 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.403 ' HB2' HD21 ' A' ' 87' ' ' LEU . 34.8 t -134.22 121.1 20.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -150.73 162.35 40.88 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.972 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -121.18 152.12 39.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.289 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 72.7 mt-30 -144.56 160.26 41.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.234 0.54 . . . . 0.0 110.585 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -120.27 109.44 15.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.875 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.557 HG22 ' CE1' ' A' ' 22' ' ' PHE . 69.3 p . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.042 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -51.12 -35.54 51.94 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.913 2.409 . . . . 0.0 112.575 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.4 tp -90.81 140.27 29.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.74 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.79 174.2 21.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.4 p -68.89 165.02 20.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.361 . . . . 0.0 110.58 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.545 ' C ' HD13 ' A' ' 7' ' ' LEU . 26.8 m80 -121.64 139.13 53.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.342 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 1.061 HD22 ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -86.25 6.18 30.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.476 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' A' ' 9' ' ' ALA . 18.5 m -68.76 0.83 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 0.0 110.345 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 11' ' ' SER . . . 33.15 39.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.529 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 8' ' ' VAL . 3.4 m 68.24 -38.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.339 . . . . 0.0 111.2 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 9' ' ' ALA . 9.9 t -62.83 172.85 1.52 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.78 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -53.49 142.15 23.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.362 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -59.71 -39.42 84.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.845 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.1 t -147.63 118.04 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.838 HG22 ' N ' ' A' ' 16' ' ' GLU . 14.5 m -117.87 -98.09 0.46 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.311 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.838 ' N ' HG22 ' A' ' 15' ' ' THR . 24.5 pt-20 31.78 27.98 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.662 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 15' ' ' THR . 15.0 mt -78.52 -85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.318 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.626 ' C ' ' O ' ' A' ' 17' ' ' ILE . 30.1 p 7.1 109.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.626 0.579 . . . . 0.0 110.886 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 69.88 23.41 5.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.539 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER 56.96 20.91 5.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.907 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 16' ' ' GLU . 3.6 p -58.34 -178.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.22 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 21' ' ' SER . 16.1 m-85 -147.2 149.3 32.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.033 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.683 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 37.8 t -123.4 102.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -110.45 135.59 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.777 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.4 p -129.09 153.73 47.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.411 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.702 ' CD2' HG11 ' A' ' 76' ' ' VAL . 37.4 p90 -144.24 -171.61 3.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.37 128.42 73.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.1 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.85 124.54 7.5 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' C ' HE22 ' A' ' 78' ' ' GLN . . . -112.42 28.68 8.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.243 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.664 ' C ' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -152.44 -36.81 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.109 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.2 t0 67.21 -28.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.664 ' H ' ' C ' ' A' ' 30' ' ' SER . 2.6 m -93.44 1.09 56.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.2 p -54.65 143.18 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.375 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -95.01 -18.53 20.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 109.413 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.28 179.65 47.68 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.77 151.17 45.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.834 0.35 . . . . 0.0 110.073 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.407 ' HB2' HD11 ' A' ' 79' ' ' ILE . 26.1 ttp180 -130.83 124.71 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG21 HG11 ' A' ' 61' ' ' VAL . 60.2 t -109.1 131.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.43 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.11 128.81 52.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 50' ' ' GLN . 51.5 p90 -136.96 140.29 42.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.203 0.525 . . . . 0.0 111.035 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.16 164.05 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.983 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.726 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 34.5 mt -73.96 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 0.0 111.104 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 p -71.05 -21.55 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.915 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -96.35 -63.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.019 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.499 ' HG3' HH21 ' A' ' 70' ' ' ARG . 78.6 mm-40 -63.62 -34.86 78.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.696 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 64.72 22.73 68.43 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.581 ' O ' ' O ' ' A' ' 46' ' ' GLY . 36.4 t0 -47.7 -170.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 110.567 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.577 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 1.6 pt-20 -73.03 139.1 79.37 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.993 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.65 150.58 45.47 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.554 2.169 . . . . 0.0 112.314 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 18.0 mp0 -114.85 150.61 35.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -124.12 136.81 54.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.926 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.49 127.26 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -102.49 131.42 49.2 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.584 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mt -128.69 155.51 79.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.28 160.49 49.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.227 1.952 . . . . 0.0 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.459 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 p -60.19 -17.03 38.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.643 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.6 p -89.0 -9.54 50.97 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.066 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 130.26 35.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.5 p -127.02 13.07 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.467 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.8 p -165.06 148.09 8.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.267 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 38' ' ' VAL . 12.6 p -149.89 148.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.494 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.412 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 46.9 t-20 -104.42 127.29 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.842 179.224 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mt -101.92 103.69 30.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.114 -179.662 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 97.2 Cg_endo -90.52 -179.81 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.733 2.289 . . . . 0.0 112.342 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 59.98 38.13 21.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.69 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 20' ' ' SER . 33.2 mt -87.59 156.93 19.27 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' OH ' ' A' ' 72' ' ' TYR . 28.7 mt -94.04 108.33 34.69 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.151 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 30.7 Cg_exo -55.1 138.98 80.07 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.064 1.843 . . . . 0.0 111.874 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 14.75 76.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.499 HH21 ' HG3' ' A' ' 45' ' ' GLU . 11.1 mmm-85 -126.36 148.95 49.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -100.66 133.77 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 110.431 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.726 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 77.5 m-85 -122.53 153.0 39.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.582 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.3 mt -111.05 128.82 67.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.44 130.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.878 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.09 122.72 27.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.036 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.702 HG11 ' CD2' ' A' ' 26' ' ' TRP . 11.1 t -102.93 126.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.07 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' TYR . . . . . 0.419 ' CE1' HD13 ' A' ' 87' ' ' LEU . 63.0 m-85 -116.4 140.6 49.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.441 HE22 ' C ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -101.77 133.64 46.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.774 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 37' ' ' ARG . 54.0 mt -97.61 122.29 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 110.591 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.593 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 73.2 p -82.18 168.0 18.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.307 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.22 -19.59 34.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.344 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.593 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 40.0 p30 -93.86 -0.42 55.76 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.472 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.04 66.26 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.993 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.5 mm-40 -83.84 138.94 32.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.851 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 53.2 mt-30 -103.44 142.82 33.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.619 179.326 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.9 t -136.36 127.38 27.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.871 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 77' ' ' TYR . 13.7 tp -72.69 118.07 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.969 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.484 HD11 ' CD1' ' A' ' 26' ' ' TRP . 34.4 pt -112.26 -20.3 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -154.98 124.86 6.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.347 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -135.25 112.26 10.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.743 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -145.9 153.18 40.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.3 p -113.42 153.08 29.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -140.64 158.91 43.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.18 0.514 . . . . 0.0 110.906 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 106.14 11.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.452 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 70.9 p . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.74 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.553 ' O ' ' O ' ' A' ' 3' ' ' LEU . 10.7 Cg_endo -56.72 138.05 83.64 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.794 2.33 . . . . 0.0 111.933 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.553 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.9 OUTLIER -47.08 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.353 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.64 23.65 32.87 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 p -79.29 8.41 6.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.334 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.421 ' C ' HD12 ' A' ' 7' ' ' LEU . 86.2 m-70 -113.73 142.56 45.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.316 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.82 ' N ' HD12 ' A' ' 7' ' ' LEU . 4.2 mp -86.96 152.59 22.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.825 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.0 t -99.84 135.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.106 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.12 143.24 27.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.653 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 11' ' ' SER . 9.2 t -179.08 -157.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.508 ' N ' ' OG1' ' A' ' 10' ' ' THR . 24.0 p -63.11 -171.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 14' ' ' VAL . 95.5 mt-10 -58.29 -31.56 67.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.21 -42.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.638 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' A' ' 12' ' ' GLU . 10.6 p -121.84 144.16 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.599 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.81 HG22 ' N ' ' A' ' 16' ' ' GLU . 1.3 m -84.96 -82.25 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.005 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.81 ' N ' HG22 ' A' ' 15' ' ' THR . 10.0 pt-20 32.09 105.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.216 0.531 . . . . 0.0 111.115 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.66 ' O ' ' N ' ' A' ' 20' ' ' SER . 46.1 mt -152.41 -77.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.79 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.622 ' C ' ' O ' ' A' ' 17' ' ' ILE . 5.6 p -11.34 126.01 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.539 0.525 . . . . 0.0 110.681 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.582 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 58.05 23.41 10.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER 59.16 29.58 19.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.124 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 17' ' ' ILE . 4.3 p -63.51 163.32 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.437 ' CE2' ' HB2' ' A' ' 93' ' ' GLN . 18.2 m-30 -130.38 152.93 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.46 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.674 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 41.5 t -126.84 106.16 15.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.0 t -115.65 134.84 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.1 p -124.68 150.2 46.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.997 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -144.4 -179.5 6.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.92 128.45 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.542 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.5 t -50.08 133.86 22.61 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -114.98 27.8 9.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.598 -179.003 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.65 ' C ' ' H ' ' A' ' 32' ' ' THR . 1.3 m -159.55 -25.28 0.07 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.315 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 63.63 -40.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.65 ' H ' ' C ' ' A' ' 30' ' ' SER . 43.9 p -79.24 1.06 26.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.76 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER -53.19 142.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.93 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.7 m -94.58 -16.85 22.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.243 0.544 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.45 179.02 47.52 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.26 151.38 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.109 0.481 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.447 ' HD3' ' NE2' ' A' ' 85' ' ' GLN . 60.8 ttt180 -130.89 124.4 31.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 61' ' ' VAL . 20.4 t -107.01 131.11 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.924 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -123.1 122.8 39.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.932 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.552 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.1 p90 -135.7 138.17 42.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.384 0.612 . . . . 0.0 111.251 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -147.4 168.57 21.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.723 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.759 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -74.3 127.77 33.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.535 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 p -69.23 -21.06 63.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.719 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -99.5 -74.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.255 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.645 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 70.6 mt-10 -66.76 150.73 48.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.557 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.7 43.1 1.86 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.509 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD2' HD12 ' A' ' 42' ' ' LEU . 93.1 m-20 -59.89 172.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.01 136.7 76.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.548 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.82 151.68 74.11 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.562 2.174 . . . . 0.0 111.628 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.552 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 17.2 mt-30 -116.93 146.82 42.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.04 136.7 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 61.5 mt -126.09 128.76 47.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -104.44 134.12 48.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.643 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mt -130.71 156.53 79.71 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.854 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -66.53 156.38 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.236 1.958 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 62.9 p -58.79 -13.3 5.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.115 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -92.79 -8.02 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.197 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.27 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.346 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -130.6 14.73 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.365 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.2 p -163.65 140.31 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.88 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 38' ' ' VAL . 4.8 p -150.09 143.92 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.792 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.443 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 46.2 t-20 -102.79 128.34 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.442 ' HB ' HD11 ' A' ' 66' ' ' LEU . 1.9 mt -97.82 105.09 24.79 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.49 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.7 Cg_endo -91.16 177.35 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.589 2.193 . . . . 0.0 112.318 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.68 36.94 22.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.728 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.558 ' O ' ' OG ' ' A' ' 20' ' ' SER . 78.4 mt -89.48 146.1 24.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' PRO . 34.4 mt -80.7 122.49 82.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.141 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 70' ' ' ARG . 45.6 Cg_exo -48.69 -174.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.994 1.796 . . . . 0.0 111.82 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 21.82 33.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.838 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.695 ' N ' ' O ' ' A' ' 68' ' ' PRO . 10.7 mmm-85 -126.89 144.54 50.96 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.758 0.779 . . . . 0.0 110.612 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -100.11 131.82 45.84 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.759 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 83.6 m-85 -121.75 149.86 42.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.286 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 85.4 mt -104.78 126.78 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.37 132.56 64.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.224 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -133.86 123.64 25.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.17 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.16 126.85 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.53 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -118.45 138.03 52.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.756 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.591 ' NE2' ' OG ' ' A' ' 30' ' ' SER . 9.0 pt20 -100.05 135.86 40.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.1 mt -98.88 122.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.281 0.562 . . . . 0.0 110.711 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.607 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 100.0 p -84.02 167.5 16.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.755 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.14 -23.3 54.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.925 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.607 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 38.6 p30 -90.97 -0.8 57.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.747 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.62 70.79 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.165 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -83.01 136.47 34.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' A' ' 37' ' ' ARG . 92.4 mt-30 -105.92 144.29 32.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.151 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 t -139.87 133.05 29.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 90' ' ' SER . 15.0 tp -71.51 117.56 13.21 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.9 -22.31 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.2 tp -156.14 121.18 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.504 ' HB2' HD21 ' A' ' 87' ' ' LEU . 40.3 t -127.03 122.99 35.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.583 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.3 t -154.28 157.78 39.21 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.575 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.8 p -115.73 153.26 31.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.437 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 31.6 mt-30 -138.06 157.29 46.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 111.071 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.69 108.19 10.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.181 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.41 HG22 ' CE1' ' A' ' 22' ' ' PHE . 44.5 p . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.465 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 24.5 Cg_exo -57.79 148.6 74.08 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.733 2.289 . . . . 0.0 112.179 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -57.39 -36.81 71.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.729 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.9 5.18 77.86 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -107.67 121.97 45.76 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.693 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -118.86 1.58 11.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.5 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.3 mt -68.07 174.61 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.13 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.563 ' O ' ' O ' ' A' ' 9' ' ' ALA . 42.0 t -54.2 144.95 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.077 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.563 ' O ' ' O ' ' A' ' 8' ' ' VAL . . . -32.52 155.94 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.8 m -66.09 136.19 55.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.032 0.444 . . . . 0.0 110.412 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.9 p -163.25 175.98 10.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.675 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.687 ' O ' ' N ' ' A' ' 14' ' ' VAL . 48.7 tt0 -80.58 7.37 10.18 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.6 -73.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.213 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.687 ' N ' ' O ' ' A' ' 12' ' ' GLU . 12.7 m -100.91 140.64 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.652 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.865 HG22 ' N ' ' A' ' 16' ' ' GLU . 94.1 m -133.77 -119.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.463 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.865 ' N ' HG22 ' A' ' 15' ' ' THR . 72.7 mm-40 5.08 55.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.098 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.728 ' N ' ' O ' ' A' ' 15' ' ' THR . 86.6 mt -61.14 -29.17 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 17' ' ' ILE . 7.7 t -40.56 144.18 0.27 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.505 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.556 ' C ' ' OG ' ' A' ' 20' ' ' SER . . . 52.98 17.76 0.96 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.841 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.556 ' OG ' ' C ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 59.38 28.03 17.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.113 0.482 . . . . 0.0 110.016 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.556 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -60.67 172.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.45 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.43 ' CZ ' HG22 ' A' ' 95' ' ' THR . 24.0 m-85 -135.61 151.91 50.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.25 105.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -114.12 136.34 50.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -124.59 152.2 43.85 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.281 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.2 p90 -145.83 -165.29 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 29' ' ' ALA . 21.7 t -118.54 131.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 30' ' ' SER . 19.3 m -52.36 -31.25 32.81 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.656 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.591 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 55.16 -8.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.047 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.775 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -158.36 127.4 5.61 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.15 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.99 4.66 40.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.899 0.38 . . . . 0.0 110.132 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.49 1.8 54.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.689 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 30' ' ' SER . 2.6 p -75.34 136.36 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.589 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.4 m -95.63 -13.5 24.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.549 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.01 179.59 47.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.94 151.53 48.37 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.925 0.393 . . . . 0.0 110.681 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' NH2' HE22 ' A' ' 85' ' ' GLN . 18.6 ttp180 -130.5 122.16 27.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.416 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 61' ' ' VAL . 84.8 t -108.9 132.58 56.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.271 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.46 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 20.0 tt0 -120.87 127.37 51.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.852 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 52.6 p90 -131.89 132.5 43.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.09 0.472 . . . . 0.0 110.019 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -148.68 165.15 32.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.612 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 94.3 mt -73.27 128.54 35.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.942 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -70.82 -24.82 62.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.857 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -92.24 -73.75 0.54 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.744 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' CD ' HH12 ' A' ' 70' ' ' ARG . 87.8 mt-10 -67.9 146.24 53.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.635 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -95.26 38.01 3.25 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.477 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -53.75 170.39 0.12 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.5 133.02 83.18 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.4 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.56 150.25 69.19 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.601 2.201 . . . . 0.0 112.167 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -116.66 147.78 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 52.6 m-85 -125.66 141.69 51.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.819 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -127.91 134.65 49.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -106.92 134.12 50.55 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.164 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.45 155.93 80.33 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.044 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.25 154.12 75.41 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.945 1.763 . . . . 0.0 112.357 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.473 ' HB2' HG13 ' A' ' 33' ' ' VAL . 62.0 p -57.19 -15.75 6.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.5 p -91.06 -8.0 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.37 133.1 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.853 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.8 p -130.41 17.98 5.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.4 p -164.96 144.38 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.269 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 38' ' ' VAL . 9.8 p -149.13 147.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.232 0.539 . . . . 0.0 111.624 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.2 t-20 -102.83 124.3 48.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.431 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.409 HG21 ' CG ' ' A' ' 40' ' ' TYR . 1.8 mt -95.44 109.9 47.9 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.317 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -90.99 178.9 1.77 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.88 2.387 . . . . 0.0 112.778 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 58.3 37.9 26.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.083 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 21' ' ' SER . 76.4 mt -91.11 143.94 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.213 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.571 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 17.9 mt -90.1 112.79 54.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -56.34 142.28 88.35 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.257 1.971 . . . . 0.0 111.86 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.58 82.32 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.471 HH12 ' CD ' ' A' ' 45' ' ' GLU . 14.6 mmt85 -121.9 150.94 41.26 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.75 130.84 46.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 0.0 110.107 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.612 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 59.8 m-85 -116.77 153.43 32.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.206 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.534 HG22 ' ND2' ' A' ' 75' ' ' ASN . 84.4 mt -108.51 122.8 63.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.21 131.63 64.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.672 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.534 ' ND2' HG22 ' A' ' 73' ' ' ILE . 44.8 m-80 -137.49 126.53 24.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.591 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 26' ' ' TRP . 15.6 t -103.35 130.85 52.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.506 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -120.23 142.98 48.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.217 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -106.64 133.12 51.8 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.642 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 34' ' ' SER . 63.2 mt -96.23 122.83 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.61 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.597 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 20.7 p -81.19 168.11 18.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -58.75 -17.87 26.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.379 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.597 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.3 p30 -93.4 0.01 56.69 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.572 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.63 67.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.38 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.3 mm-40 -88.34 144.74 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.068 0.434 . . . . 0.0 110.652 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.478 HE22 ' NH2' ' A' ' 37' ' ' ARG . 29.7 mt-30 -103.47 143.32 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.96 125.21 36.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.996 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.1 tp -73.02 115.4 12.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.904 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.66 -23.52 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.581 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -156.61 128.08 7.08 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.977 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.6 t -131.66 125.65 32.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.735 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -153.97 156.4 37.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.49 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -116.25 155.48 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.144 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.404 ' OE1' ' CG ' ' A' ' 22' ' ' PHE . 81.4 mt-30 -142.31 157.96 44.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.324 0.583 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.64 104.81 9.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.911 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.43 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.536 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.76 3.35 0.52 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.9 2.4 . . . . 0.0 111.541 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 1' ' ' GLY . 18.7 mt -77.06 146.66 37.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.748 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.57 -88.03 0.07 OUTLIER Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -60.02 -26.81 66.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.9 m170 60.8 158.17 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.476 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.789 HD22 ' H ' ' A' ' 7' ' ' LEU . 1.8 mm? -74.43 -3.48 30.83 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.153 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -119.0 139.63 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.631 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.41 129.6 36.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.285 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.586 ' C ' ' H ' ' A' ' 12' ' ' GLU . 2.4 t -132.65 154.49 50.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.737 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 12' ' ' GLU . 36.1 t 49.94 6.35 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.077 0.465 . . . . 0.0 110.133 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' H ' ' C ' ' A' ' 10' ' ' THR . 67.7 tt0 53.16 150.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.4 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.404 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 7.7 m -57.6 -54.15 50.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.342 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.49 132.7 50.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.175 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.66 HG22 ' N ' ' A' ' 16' ' ' GLU . 46.5 m -111.7 169.38 8.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.66 ' N ' HG22 ' A' ' 15' ' ' THR . 32.1 mm-40 62.75 17.41 9.81 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -177.95 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -37.94 -80.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.465 -178.712 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.689 ' OG1' ' N ' ' A' ' 19' ' ' ALA . 13.0 p 29.47 -99.57 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.689 ' N ' ' OG1' ' A' ' 18' ' ' THR . . . -69.11 32.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.85 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 18' ' ' THR . 79.4 p 57.99 33.73 23.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.219 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 4.3 p -60.34 149.41 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.401 ' CG ' ' OE1' ' A' ' 93' ' ' GLN . 22.2 m-30 -110.16 145.81 36.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.32 104.84 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.93 139.1 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.809 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.8 p -128.19 153.54 46.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.129 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.546 ' CE3' HG21 ' A' ' 76' ' ' VAL . 39.8 p90 -147.22 -166.32 2.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.079 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.705 HG12 ' H ' ' A' ' 29' ' ' ALA . 49.0 t -118.06 133.1 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.256 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 30' ' ' SER . 53.3 m -50.38 -30.91 13.35 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.277 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.705 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 51.07 2.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.366 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.582 ' H ' ' C ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -164.74 145.77 7.83 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.48 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.546 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 54.9 t0 -103.25 -12.38 17.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.5 p -86.78 -4.94 59.24 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.456 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.432 ' H ' HG12 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -62.58 136.58 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 m -96.16 -14.2 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.495 . . . . 0.0 110.24 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.53 174.92 43.43 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -123.33 150.73 43.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.063 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 37.7 ttp180 -130.51 122.52 27.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.385 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.73 HG21 HG11 ' A' ' 61' ' ' VAL . 91.9 t -106.27 132.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.824 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 81.4 tt0 -122.75 132.94 54.46 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.52 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 46.9 p90 -140.09 141.08 36.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.179 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -150.57 163.82 37.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.772 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.557 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 50.8 mt -75.35 131.98 40.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.3 p -78.78 -14.99 58.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.483 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -102.14 -73.37 0.66 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.853 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -59.64 -28.33 67.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.473 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 40.13 86.91 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -60.36 -179.55 0.12 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.892 0.377 . . . . 0.0 110.408 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -74.11 143.33 80.31 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.138 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.7 151.76 58.19 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 122.696 2.264 . . . . 0.0 112.756 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.484 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 24.7 mt-30 -122.75 148.2 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -126.37 137.03 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.188 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.7 mt -122.32 127.84 50.3 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -102.99 133.45 48.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.353 0.597 . . . . 0.0 112.17 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.38 157.2 78.79 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.3 160.5 48.65 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.789 1.66 . . . . 0.0 112.219 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.431 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 50.9 p -57.05 -11.82 1.76 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.183 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.2 p -91.49 -7.5 50.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.435 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.17 35.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.403 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.6 p -126.73 7.62 6.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.839 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -162.21 154.17 18.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.332 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 38' ' ' VAL . 9.1 p -153.2 146.97 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.421 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 30.4 t30 -103.83 128.93 51.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.44 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.67 99.6 22.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.513 0.197 . . . . 0.0 111.055 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 66.9 Cg_endo -89.61 -169.41 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.921 2.414 . . . . 0.0 112.162 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 57.63 36.69 26.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.538 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.513 ' HB2' ' HG ' ' A' ' 20' ' ' SER . 42.7 mt -94.33 138.21 32.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.946 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.673 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 18.6 mt -84.71 113.96 52.54 Favored Pre-proline 0 C--N 1.333 -0.147 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.131 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -54.08 138.07 70.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.92 1.747 . . . . 0.0 111.534 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.32 14.95 70.18 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.861 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.87 148.61 48.17 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -98.98 134.78 41.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.361 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.673 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 64.9 m-85 -121.5 153.55 37.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.588 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.608 HG22 HD21 ' A' ' 75' ' ' ASN . 85.7 mt -109.38 125.63 66.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.5 129.02 71.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 0.0 110.673 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.608 HD21 HG22 ' A' ' 73' ' ' ILE . 14.3 m-80 -135.71 124.42 23.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.171 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.546 HG21 ' CE3' ' A' ' 26' ' ' TRP . 17.6 t -103.47 128.01 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.983 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -117.37 142.21 47.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.5 pt20 -103.41 133.75 47.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.865 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.0 mt -98.3 126.17 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 121.384 0.611 . . . . 0.0 110.789 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.604 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 30.0 p -82.87 168.55 16.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.974 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -19.3 62.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.147 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.604 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 36.3 p30 -93.69 2.8 56.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.451 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 11.8 66.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.425 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.448 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 70.5 mm-40 -87.34 142.6 27.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.979 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 23.9 mt-30 -105.2 147.23 28.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.018 179.503 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.05 124.37 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.614 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 90' ' ' SER . 14.4 tp -73.71 115.57 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.147 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -109.87 -20.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.7 tp -155.17 123.12 5.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.657 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.423 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.0 t -131.87 119.13 20.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -153.37 162.26 41.47 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.601 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.7 p -120.33 153.1 36.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.347 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.401 ' OE1' ' CG ' ' A' ' 22' ' ' PHE . 64.3 mt-30 -138.13 157.1 47.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.945 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -123.09 115.7 22.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.781 -179.199 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.1 150.22 10.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.641 2.227 . . . . 0.0 112.24 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.444 ' HB2' ' CE1' ' A' ' 6' ' ' HIS . 24.9 mt -90.68 143.34 26.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.971 -179.759 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.89 -168.03 34.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.523 ' O ' ' OG ' ' A' ' 5' ' ' SER . 0.0 OUTLIER 65.45 20.49 11.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.829 0.347 . . . . 0.0 110.873 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.444 ' CE1' ' HB2' ' A' ' 3' ' ' LEU . 0.9 OUTLIER -93.45 10.9 30.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.648 179.672 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.693 ' O ' ' N ' ' A' ' 9' ' ' ALA . 23.1 mt -44.13 160.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.621 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.579 ' C ' ' O ' ' A' ' 7' ' ' LEU . 47.2 t -1.99 -60.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.288 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.693 ' N ' ' O ' ' A' ' 7' ' ' LEU . . . -52.54 129.42 28.97 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.254 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.534 ' O ' ' C ' ' A' ' 11' ' ' SER . 4.4 t -138.12 164.81 28.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.268 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.534 ' C ' ' O ' ' A' ' 10' ' ' THR . 17.7 m 32.36 -119.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -107.37 119.32 39.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.114 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.8 p -92.12 6.42 46.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -86.12 -75.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.559 -179.15 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.687 ' O ' ' N ' ' A' ' 17' ' ' ILE . 1.7 m 61.13 -45.75 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.584 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 14' ' ' VAL . 1.8 pt-20 -62.1 43.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.701 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -103.6 -11.67 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.833 -178.71 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 26.4 m -46.4 113.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.235 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 65.01 27.32 12.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER 64.34 29.06 13.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.859 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -62.96 -177.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.832 0.825 . . . . 0.0 112.059 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 21' ' ' SER . 16.1 m-85 -151.53 140.38 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.278 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.46 101.62 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.89 137.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.222 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.6 p -124.03 151.41 43.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.114 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.466 ' CD2' HG11 ' A' ' 76' ' ' VAL . 40.6 p90 -145.04 -175.39 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.465 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 29' ' ' ALA . 41.3 t -112.42 133.36 58.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.535 ' O ' ' OE1' ' A' ' 78' ' ' GLN . 45.2 t -49.79 -34.59 19.89 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.353 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.582 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 58.34 -0.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.428 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.532 ' O ' HG12 ' A' ' 33' ' ' VAL . 3.2 m -170.99 133.63 0.91 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.118 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -89.68 1.66 55.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.742 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.0 p -92.37 1.55 57.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.301 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 30' ' ' SER . 2.5 p -70.09 136.03 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.6 m -97.0 -14.52 21.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.421 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.94 178.54 46.77 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.44 153.04 46.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.483 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.431 ' NH2' HE22 ' A' ' 85' ' ' GLN . 42.5 ttp180 -131.07 129.25 41.7 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.834 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.37 133.65 57.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.526 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.16 127.71 50.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.091 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.8 p90 -135.25 130.63 35.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.32 0.581 . . . . 0.0 110.66 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -143.98 165.1 28.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.721 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.611 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 35.5 mt -74.78 127.14 32.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 0.0 111.505 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 p -69.9 -37.85 76.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.49 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -78.93 -56.6 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.226 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.675 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 81.9 mt-10 -85.85 152.45 22.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.973 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -99.5 26.78 23.03 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.513 ' CG ' ' N ' ' A' ' 48' ' ' GLU . 25.4 t70 -46.37 172.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.425 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.578 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.3 pm0 -72.43 139.37 81.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.594 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.1 153.13 46.36 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.69 2.26 . . . . 0.0 112.291 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 9.2 mt-30 -118.88 143.82 46.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.711 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.07 136.64 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.092 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.93 131.72 53.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -106.18 136.07 46.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.091 0.472 . . . . 0.0 111.457 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.8 mt -130.21 157.24 77.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.576 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -69.97 158.7 55.83 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.939 1.759 . . . . 0.0 112.098 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' HG13 ' A' ' 33' ' ' VAL . 36.7 p -59.31 -12.95 6.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.114 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.2 p -92.05 -8.56 45.57 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.69 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -131.02 11.21 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.0 p -164.43 143.89 7.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.01 149.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.445 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 53.7 t-20 -103.9 123.41 47.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.069 178.832 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -100.38 102.82 19.96 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.003 -179.554 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 63.1 Cg_endo -92.87 179.98 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.909 2.406 . . . . 0.0 113.207 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 62.31 37.3 14.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.901 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.563 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -92.47 152.34 19.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.291 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 19.3 mt -82.96 119.85 75.05 Favored Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.969 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.52 144.89 62.62 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.867 1.711 . . . . 0.0 112.082 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.76 15.45 75.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.675 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -124.81 153.4 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.731 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.6 133.86 46.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.611 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 86.9 m-85 -120.4 151.12 39.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.74 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 77.1 mt -108.53 123.94 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.5 t -116.11 134.68 58.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.161 0.505 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -135.2 129.65 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' A' ' 26' ' ' TRP . 28.6 t -106.61 128.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.355 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -120.55 139.53 52.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.869 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.535 ' OE1' ' O ' ' A' ' 28' ' ' SER . 7.4 pt20 -101.11 133.33 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 34' ' ' SER . 52.2 mt -98.33 122.69 50.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.292 0.567 . . . . 0.0 110.448 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.601 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 42.0 p -83.79 169.11 15.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.124 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.524 ' CD ' ' HG ' ' A' ' 34' ' ' SER . 77.6 mm-40 -58.19 -20.81 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.09 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.601 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.5 p30 -91.35 -2.61 57.31 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.945 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.01 12.71 67.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.136 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.587 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.7 mm-40 -84.0 141.04 31.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.431 HE22 ' NH2' ' A' ' 37' ' ' ARG . 25.9 mt-30 -105.19 140.92 37.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -134.02 127.86 33.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.107 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.0 tp -72.06 116.28 12.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.553 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.3 pt -107.4 -23.1 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.4 tp -159.08 124.81 4.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.054 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.4 t -128.48 126.71 41.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.9 t -153.77 159.03 41.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.196 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -120.58 152.26 38.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.084 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 73.1 mt-30 -143.65 158.12 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.996 179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 114.88 20.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.906 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.553 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 33.4 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.647 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.63 153.32 56.25 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.899 2.399 . . . . 0.0 111.96 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.3 mt -78.6 143.8 36.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.036 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.4 -136.66 12.83 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 38.78 56.45 1.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -68.68 -46.84 68.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.493 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 3.0 mm? -81.57 -154.68 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.274 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.438 ' H ' ' HB3' ' A' ' 7' ' ' LEU . 6.1 m -48.46 132.73 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 110.253 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.14 151.85 18.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.2 p -67.19 2.65 1.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.06 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.2 t -99.55 138.18 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.864 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -76.93 150.23 35.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.929 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 23' ' ' VAL . 61.8 m -71.45 -6.92 43.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.06 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.6 143.34 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.481 . . . . 0.0 111.076 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.672 ' O ' ' N ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -144.16 -52.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.199 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' N ' HG22 ' A' ' 15' ' ' THR . 74.5 mm-40 -64.3 45.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 15' ' ' THR . 80.4 mt -43.64 -37.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.365 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.604 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -43.26 124.99 3.57 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 74.84 20.13 2.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.471 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.541 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 56.51 25.76 10.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.96 0.409 . . . . 0.0 110.455 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -63.29 -174.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.496 0.665 . . . . 0.0 112.15 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.609 ' CD1' ' OE1' ' A' ' 93' ' ' GLN . 21.1 m-85 -149.67 148.24 29.05 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.165 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 13' ' ' SER . 43.4 t -118.75 103.96 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -112.28 135.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -123.07 151.51 41.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.293 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.405 ' CD2' HG11 ' A' ' 76' ' ' VAL . 41.0 p90 -143.47 179.92 6.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.341 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -117.38 129.27 74.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.239 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 p -50.39 133.12 24.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.44 11.96 21.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.793 -179.921 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.938 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.5 m -169.94 98.0 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.607 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 66.0 t0 -50.28 -23.78 2.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.2 p -74.94 1.52 12.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.341 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.938 HG12 ' O ' ' A' ' 30' ' ' SER . 2.1 p -64.14 134.77 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.43 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 81' ' ' GLU . 70.8 m -95.36 -15.46 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.88 179.66 47.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -125.9 152.88 44.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 110.602 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' NH2' ' CD2' ' A' ' 51' ' ' TYR . 55.2 ttt180 -133.9 127.65 32.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.9 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.586 HG21 HG11 ' A' ' 61' ' ' VAL . 47.0 t -108.29 132.78 55.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.075 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.34 125.59 44.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.801 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 42.5 p90 -141.35 140.33 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.897 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -149.38 169.99 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.39 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.72 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 92.3 mt -74.28 126.66 31.13 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.5 p -62.05 -33.92 75.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.388 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -86.19 -75.41 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.03 145.22 55.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.967 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.28 41.96 2.53 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.56 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -57.91 165.75 1.7 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.7 139.06 97.66 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.186 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.74 155.97 57.79 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.674 2.249 . . . . 0.0 111.824 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 32.5 mt-30 -119.91 140.78 50.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.778 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CD2' ' NH2' ' A' ' 37' ' ' ARG . 6.1 m-85 -121.64 141.28 51.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.588 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.5 mt -131.15 123.44 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -101.61 135.72 42.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.134 0.492 . . . . 0.0 111.578 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -132.86 159.43 72.63 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.842 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -72.52 160.17 47.31 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.094 1.863 . . . . 0.0 112.624 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.477 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 61.1 p -61.69 -15.48 40.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.696 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -88.34 -1.14 57.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.691 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.908 ' O ' HG23 ' A' ' 59' ' ' THR . . . -75.86 -146.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.595 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 58' ' ' ALA . 1.9 p 143.45 4.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.8 p -163.75 141.89 7.54 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 38' ' ' VAL . 8.8 p -150.74 155.35 7.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.174 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.415 ' N ' HG22 ' A' ' 61' ' ' VAL . 7.0 t30 -106.1 122.88 47.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.217 178.748 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -95.87 106.67 29.26 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.175 -179.205 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 64.7 Cg_endo -92.74 177.33 1.5 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 123.115 2.544 . . . . 0.0 113.393 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 60.19 38.33 20.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.958 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.541 ' O ' ' OG ' ' A' ' 20' ' ' SER . 39.8 mt -91.76 143.15 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.473 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 64.2 mt -83.86 112.82 43.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -55.29 143.12 77.43 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.37 79.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.479 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.9 mmm-85 -123.98 152.79 42.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.153 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -100.97 130.96 47.04 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.451 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.72 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 65.1 m-85 -118.5 144.59 45.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.091 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.2 mt -104.11 125.5 58.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.0 132.54 61.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.243 0.544 . . . . 0.0 111.154 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -134.78 128.13 32.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.514 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' ' 26' ' ' TRP . 21.3 t -104.11 128.45 57.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.416 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -119.54 138.53 53.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.6 pt20 -101.13 136.87 40.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -100.03 123.32 52.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.591 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 84.3 p -83.31 171.99 12.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.32 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 76.1 mm-40 -58.77 -19.96 45.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.496 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.591 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 48.8 p30 -95.08 -0.22 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.12 65.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.564 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.3 mm-40 -83.82 143.79 29.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.849 0.357 . . . . 0.0 110.53 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.91 142.78 45.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 111.686 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.7 t -138.24 134.54 34.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.86 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 90' ' ' SER . 53.5 tp -73.34 117.44 15.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.3 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.0 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.992 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.7 tp -156.84 125.44 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.325 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 87' ' ' LEU . 38.2 t -132.13 122.53 25.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.819 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.8 t -151.7 158.69 43.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.75 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -118.04 152.55 35.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.609 ' OE1' ' CD1' ' A' ' 22' ' ' PHE . 74.9 mt-30 -140.51 156.77 46.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.268 0.556 . . . . 0.0 110.313 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -123.13 104.81 9.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.629 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.473 ' OXT' ' O ' ' A' ' 94' ' ' THR . 81.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.051 -0.975 . . . . 0.0 110.435 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.546 ' O ' ' O ' ' A' ' 3' ' ' LEU . 1.0 OUTLIER -48.5 147.1 9.59 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.919 2.412 . . . . 0.0 111.978 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 2' ' ' PRO . 47.4 mt 54.2 128.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.616 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.695 ' O ' ' N ' ' A' ' 6' ' ' HIS . . . -170.16 152.36 18.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 t 55.35 -67.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.8 0.334 . . . . 0.0 110.704 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.695 ' N ' ' O ' ' A' ' 4' ' ' GLY . 2.1 p-80 -80.75 152.86 28.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.249 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.3 mt 56.26 15.0 1.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -56.52 135.67 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.839 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.44 16.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.442 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -99.52 -0.33 40.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.634 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.557 ' O ' ' CB ' ' A' ' 12' ' ' GLU . 42.3 t -51.36 160.04 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.678 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.669 ' C ' ' H ' ' A' ' 14' ' ' VAL . 41.6 tt0 87.53 -3.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.485 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 p 60.09 -23.19 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.669 ' H ' ' C ' ' A' ' 12' ' ' GLU . 14.2 p -107.04 139.52 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.322 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.839 HG22 ' N ' ' A' ' 16' ' ' GLU . 1.2 m -93.08 -79.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.839 ' N ' HG22 ' A' ' 15' ' ' THR . 60.1 mp0 -49.1 134.52 17.43 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.24 0.543 . . . . 0.0 110.399 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 20' ' ' SER . 5.9 mt -127.82 -25.25 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.401 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 17' ' ' ILE . 35.8 p -39.86 138.28 0.8 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.77 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 51.53 23.94 2.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 94.5 p 61.35 45.28 8.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.715 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.539 ' OG ' ' C ' ' A' ' 16' ' ' GLU . 2.6 p -63.16 158.51 19.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.556 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.627 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 21.6 m-30 -125.69 155.92 40.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.776 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.546 ' CG2' ' OE1' ' A' ' 16' ' ' GLU . 71.4 t -128.83 106.3 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.7 t -111.94 137.48 44.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.71 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.1 p -129.14 153.56 47.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CD2' HG11 ' A' ' 76' ' ' VAL . 34.0 p90 -143.41 -165.88 2.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.023 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.0 t -127.73 124.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.79 101.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.902 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -76.3 3.55 10.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.706 -179.59 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.888 ' O ' HG12 ' A' ' 33' ' ' VAL . 3.3 m -168.92 116.96 0.66 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.781 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -71.73 -10.5 59.87 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.256 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.8 p -82.4 -0.68 47.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.456 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.888 HG12 ' O ' ' A' ' 30' ' ' SER . 2.4 p -64.04 137.84 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.25 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 79' ' ' ILE . 53.1 m -94.0 -15.48 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.213 0.53 . . . . 0.0 109.803 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.2 176.46 45.32 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -125.41 152.91 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.906 0.384 . . . . 0.0 110.673 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.4 ttp180 -131.5 124.33 29.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.7 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 61' ' ' VAL . 74.4 t -109.03 133.67 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -124.6 132.65 53.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.341 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.578 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 22.8 p90 -137.82 130.28 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.095 0.474 . . . . 0.0 110.284 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.71 166.61 26.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.833 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 87.1 mt -73.65 128.59 35.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.413 0.625 . . . . 0.0 111.969 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 p -68.23 -27.84 66.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.469 ' HG3' HH22 ' A' ' 70' ' ' ARG . 88.1 mt-10 -93.53 -75.19 0.51 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -64.73 144.0 57.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.05 41.31 2.44 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.343 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.26 169.72 1.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 48' ' ' GLU . 3.4 pm0 -69.17 137.17 89.24 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.577 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.82 156.2 48.47 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.783 2.322 . . . . 0.0 112.085 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.578 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 11.4 mt-30 -120.29 144.0 48.04 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -124.41 140.38 53.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.506 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 mt -124.71 129.38 50.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.13 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -101.48 131.78 47.43 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.905 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.4 mt -130.08 155.64 80.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 57' ' ' THR . 22.7 Cg_endo -68.94 156.65 64.69 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.38 2.053 . . . . 0.0 112.5 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.459 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 30.4 p -55.74 -11.6 1.01 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.4 ' N ' ' C ' ' A' ' 55' ' ' PRO . 29.5 p -92.0 -7.29 49.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.61 132.28 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -130.32 9.32 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.182 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.9 p -164.12 146.8 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.62 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 38' ' ' VAL . 5.2 p -151.0 152.69 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.772 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 11.7 t-20 -106.68 126.63 52.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.513 HG21 ' CG ' ' A' ' 40' ' ' TYR . 2.3 mt -100.94 104.94 35.36 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.148 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -91.35 -179.34 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.779 2.319 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 58.66 39.03 24.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 19' ' ' ALA . 41.5 mt -90.41 143.91 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.3 mt -78.02 129.81 74.65 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.043 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.49 140.94 44.98 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.529 2.153 . . . . 0.0 112.873 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.38 27.99 71.91 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.773 ' HE ' HD22 ' A' ' 42' ' ' LEU . 4.9 mmm180 -126.48 148.13 49.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.22 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.685 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 75.7 tttt -100.26 131.15 46.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.833 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 64.4 m-85 -119.82 151.26 39.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -104.99 123.7 59.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -111.69 131.15 63.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -133.98 125.86 29.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.507 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.64 HG11 ' CD2' ' A' ' 26' ' ' TRP . 5.7 t -104.42 126.57 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.03 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -118.82 141.91 48.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.8 pt20 -105.23 135.58 46.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.688 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.9 mt -98.38 122.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.172 0.511 . . . . 0.0 110.634 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.726 ' HG ' ' CG ' ' A' ' 82' ' ' ASP . 47.2 p -82.52 169.53 16.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.811 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.3 -20.47 43.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.126 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.726 ' CG ' ' HG ' ' A' ' 80' ' ' SER . 2.0 p-10 -92.04 -2.32 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.51 14.46 65.77 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CG ' ' OD2' ' A' ' 82' ' ' ASP . 60.2 mm-40 -86.2 144.17 27.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.121 0.46 . . . . 0.0 111.211 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 26.2 mt-30 -109.18 139.61 43.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 179.477 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 t -137.81 136.1 36.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.392 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 90' ' ' SER . 19.3 tp -72.88 116.73 13.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 pt -108.87 -22.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.29 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.1 tp -156.32 125.81 6.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.62 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.437 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.5 t -133.44 122.43 23.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.508 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -149.7 156.54 42.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.461 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -117.58 153.03 33.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.5 mt-30 -140.98 158.36 44.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.216 -179.769 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.71 108.23 16.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.576 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.344 -179.468 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -55.38 144.53 72.0 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.657 2.238 . . . . 0.0 112.006 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 3' ' ' LEU . 88.9 mt -80.86 -4.26 54.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.167 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 5' ' ' SER . . . 130.35 145.77 5.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.622 ' OG ' ' N ' ' A' ' 6' ' ' HIS . 3.6 t 38.16 -171.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.752 0.31 . . . . 0.0 110.612 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.622 ' N ' ' OG ' ' A' ' 5' ' ' SER . 63.9 m-70 -136.28 160.89 37.32 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.732 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.2 tp -83.75 139.8 32.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.698 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -87.82 139.93 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 110.699 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.516 ' O ' ' OG1' ' A' ' 10' ' ' THR . . . -44.72 147.55 0.61 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.625 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 9' ' ' ALA . 48.4 p 55.54 98.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.162 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.4 m -63.86 -76.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -57.08 143.45 38.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.109 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.4 p -63.22 -13.04 33.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.6 t -115.68 131.62 67.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.535 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.836 HG22 ' N ' ' A' ' 16' ' ' GLU . 2.2 m -104.35 -86.37 0.46 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.086 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.836 ' N ' HG22 ' A' ' 15' ' ' THR . 76.7 mm-40 -45.04 130.95 7.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.314 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 15' ' ' THR . 6.0 mt -126.67 -24.16 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.664 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 59.6 m -54.34 136.79 43.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.812 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.588 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 63.53 22.06 13.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.588 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 4.7 p 56.69 37.23 28.66 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.154 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 16' ' ' GLU . 1.4 p -60.45 165.56 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.524 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.536 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 15.8 m-30 -133.51 154.76 50.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.818 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.43 104.32 8.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.43 136.8 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.43 150.92 43.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CE3' HG21 ' A' ' 76' ' ' VAL . 36.9 p90 -145.26 -174.15 4.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.373 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.749 HG12 ' H ' ' A' ' 29' ' ' ALA . 44.5 t -109.55 135.38 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.61 ' O ' ' N ' ' A' ' 30' ' ' SER . 85.2 p -53.53 -20.6 5.16 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.544 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.749 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 31.53 30.94 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.495 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.692 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER 164.71 122.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.907 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -87.18 -8.1 57.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.371 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.3 p -84.71 -4.4 59.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 30' ' ' SER . 3.0 p -64.64 136.45 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.275 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 79' ' ' ILE . 67.5 m -94.86 -14.65 24.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.27 0.557 . . . . 0.0 109.541 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.36 -179.87 47.93 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -127.31 150.57 49.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.003 0.43 . . . . 0.0 110.75 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -129.2 124.81 35.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.84 131.2 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.121 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 80.9 tt0 -123.27 133.57 54.17 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.579 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.7 p90 -140.65 138.7 34.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.446 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -148.02 165.54 30.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.706 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.533 HD13 ' HE ' ' A' ' 70' ' ' ARG . 56.3 mt -73.13 127.61 33.09 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.028 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 18.6 p -70.34 -34.62 72.88 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.05 -50.91 9.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.825 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.621 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 90.5 mt-10 -94.39 144.99 25.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.651 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -84.96 23.88 7.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.69 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 52.3 t0 -43.61 177.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.993 0.425 . . . . 0.0 110.258 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.69 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 4.0 pm0 -83.11 143.06 44.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.089 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.43 153.57 39.86 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.838 2.359 . . . . 0.0 112.036 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 16.2 mt-30 -123.36 146.02 48.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 80.4 m-85 -124.86 139.17 54.08 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.046 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.7 mt -123.2 129.16 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.231 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -102.21 130.92 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.831 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.25 154.72 80.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.795 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.15 156.76 64.59 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.143 1.895 . . . . 0.0 112.374 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 14.5 p -56.56 -11.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -93.76 -9.17 38.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.698 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.8 35.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.485 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 p -130.19 12.22 5.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.0 p -164.38 143.13 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.95 149.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.62 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 8.9 t-20 -105.16 128.02 53.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.26 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mt -104.84 101.34 28.66 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.449 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -89.47 -174.58 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.773 2.315 . . . . 0.0 112.439 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 59.72 37.01 22.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.386 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 20' ' ' SER . 45.9 mt -90.36 151.88 21.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.648 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 30.4 mt -95.37 108.35 38.62 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.977 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.28 139.78 81.31 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.432 2.088 . . . . 0.0 111.839 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.58 14.69 67.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.621 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 5.7 mmm-85 -127.21 141.44 51.73 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 92' ' ' SER . 14.0 tttp -96.19 134.86 38.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.938 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 4.0 m-85 -117.85 151.79 36.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 0.0 111.718 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.5 mt -110.07 124.36 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.648 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.84 132.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.929 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -133.61 124.49 26.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.371 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.463 HG21 ' CE3' ' A' ' 26' ' ' TRP . 21.9 t -106.74 127.76 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.875 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -119.01 137.36 53.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.6 pt20 -100.65 136.25 40.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.0 mt -100.12 125.49 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.384 0.611 . . . . 0.0 110.934 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.597 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 89.7 p -84.89 165.2 17.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.206 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.31 -20.31 42.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.357 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.0 p-10 -91.98 -1.54 57.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.786 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.97 13.01 65.12 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.243 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.455 ' CG ' ' OD2' ' A' ' 82' ' ' ASP . 75.8 mm-40 -83.2 135.34 34.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -104.98 140.66 37.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.749 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.3 t -136.72 132.9 35.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.114 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 90' ' ' SER . 57.0 tp -71.83 118.98 15.35 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.736 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 pt -108.92 -22.97 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.2 tp -157.01 125.67 5.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.597 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.613 ' HB2' HD21 ' A' ' 87' ' ' LEU . 15.2 t -132.66 112.66 12.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.417 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -146.25 159.62 43.08 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.0 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' SER . . . . . 0.431 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 95.7 p -117.25 153.8 32.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.321 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 81.5 mt-30 -139.52 156.04 47.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 179.626 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -122.71 107.83 12.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.434 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 94' ' ' THR . 45.6 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.715 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.12 149.26 73.0 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.639 2.226 . . . . 0.0 111.735 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.732 ' H ' HD12 ' A' ' 3' ' ' LEU . 4.9 mp -76.56 134.38 39.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.301 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.66 62.22 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.1 p -80.36 -5.34 56.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.351 . . . . 0.0 110.675 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -124.93 -168.36 1.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 mt -66.13 123.6 20.32 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.537 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -128.55 146.33 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.482 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.2 -116.93 0.07 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.259 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.15 -4.94 21.21 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.762 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.6 t 33.58 81.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.421 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.52 144.74 55.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.051 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 p -78.85 -8.06 58.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.12 132.35 57.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.147 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.882 HG22 ' N ' ' A' ' 16' ' ' GLU . 85.6 m -104.59 -118.82 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.882 ' N ' HG22 ' A' ' 15' ' ' THR . 67.8 mm-40 -1.48 77.15 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.717 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.735 ' O ' ' N ' ' A' ' 20' ' ' SER . 60.1 mt -88.89 -78.01 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.598 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.563 ' C ' ' H ' ' A' ' 20' ' ' SER . 42.8 p 33.78 -97.71 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . -77.14 30.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.2 p 57.2 38.11 28.69 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.003 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.697 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -67.61 135.93 53.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.973 -179.32 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.485 ' CD1' ' OE1' ' A' ' 93' ' ' GLN . 23.9 m-85 -96.12 148.04 23.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.351 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.59 101.34 10.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.1 t -111.53 137.59 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -128.1 155.84 43.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.129 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.465 ' CE3' HG21 ' A' ' 76' ' ' VAL . 33.6 p90 -146.9 -164.95 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.049 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.08 129.62 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.69 89.75 0.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.733 ' O ' ' NE2' ' A' ' 78' ' ' GLN . . . -89.92 104.31 16.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.649 ' CB ' ' O ' ' A' ' 29' ' ' ALA . 5.4 m 104.84 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.54 0.525 . . . . 0.0 110.337 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -58.99 -16.15 16.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.227 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.0 p -71.08 2.29 4.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.062 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 30' ' ' SER . 2.7 p -71.96 133.19 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.365 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' ILE . 4.8 m -93.84 -15.4 25.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.667 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.535 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 175.62 -178.3 47.22 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -126.61 153.81 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.96 0.41 . . . . 0.0 110.376 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -132.44 123.01 25.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.083 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.617 HG21 HG11 ' A' ' 61' ' ' VAL . 77.7 t -107.48 132.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.504 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 68.3 tt0 -127.17 131.34 50.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.233 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 18.9 p90 -144.29 137.63 27.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.273 0.558 . . . . 0.0 111.259 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -144.36 167.91 21.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.149 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.764 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 76.7 mt -74.81 126.42 30.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.688 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -67.24 -25.03 65.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.458 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -92.29 -73.4 0.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.979 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.69 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 83.3 mt-10 -62.06 -31.23 71.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.944 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 83.34 -37.83 2.75 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 46' ' ' GLY . 32.3 t0 24.73 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.803 0.335 . . . . 0.0 111.044 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.511 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -104.37 138.57 19.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.424 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.11 142.74 38.72 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 121.982 1.788 . . . . 0.0 111.269 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.534 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 21.6 mt-30 -112.71 146.15 39.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.78 137.06 54.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.672 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.2 mt -129.68 130.48 45.59 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.71 132.75 50.58 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.477 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 mt -126.18 152.54 73.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.636 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.36 154.48 71.15 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.441 2.094 . . . . 0.0 112.777 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.535 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 24.9 p -57.8 -14.31 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.115 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.6 p -92.12 -6.7 50.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.234 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.82 138.78 31.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -130.71 13.98 5.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.2 p -163.68 148.68 10.81 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 38' ' ' VAL . 9.4 p -149.18 144.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.856 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.697 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 2.4 t-20 -102.85 126.5 50.02 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -97.96 112.55 62.05 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.468 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -93.23 175.71 1.56 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.997 2.465 . . . . 0.0 113.637 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 59.91 38.4 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.619 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 20' ' ' SER . 15.1 mt -87.72 145.17 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.82 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.406 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 16.4 mt -86.73 112.12 44.69 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 32.1 Cg_exo -55.28 134.26 62.8 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.963 1.775 . . . . 0.0 111.159 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.63 13.93 74.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.424 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.69 ' NH2' ' OE2' ' A' ' 45' ' ' GLU . 13.0 mmt85 -121.13 152.17 39.04 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.682 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -103.89 127.71 51.39 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.764 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 84.5 m-85 -115.36 156.98 24.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.096 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 61.9 mt -110.49 132.99 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.46 130.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.582 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -135.02 121.69 20.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.607 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.465 HG21 ' CE3' ' A' ' 26' ' ' TRP . 48.5 t -103.17 127.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.467 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.68 136.27 54.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.733 ' NE2' ' O ' ' A' ' 29' ' ' ALA . 1.4 pt20 -96.59 132.75 41.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.466 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' SER . 56.0 mt -97.18 125.94 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.346 0.593 . . . . 0.0 110.787 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.595 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 90.0 p -85.62 168.66 14.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.197 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.447 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 81.7 mm-40 -61.75 -18.43 59.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.595 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 32.8 p30 -92.87 -0.72 57.18 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.033 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.24 75.45 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.424 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 55.2 mm-40 -82.43 145.3 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.206 0.503 . . . . 0.0 110.971 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -109.87 139.16 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.722 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.1 t -133.88 130.39 37.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.187 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -73.45 121.72 20.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.042 0.449 . . . . 0.0 111.43 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.459 HD11 ' CG1' ' A' ' 76' ' ' VAL . 35.6 pt -109.59 -22.55 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -157.57 127.68 6.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.769 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.6 t -133.56 120.41 20.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -156.0 153.35 29.37 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.832 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.0 p -111.39 157.92 19.67 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.485 ' OE1' ' CD1' ' A' ' 22' ' ' PHE . 80.9 mt-30 -145.84 163.01 36.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.123 0.487 . . . . 0.0 111.112 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.84 105.23 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.149 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 81.3 p . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.315 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 4' ' ' GLY . 13.1 Cg_endo -57.93 137.71 82.33 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.942 2.428 . . . . 0.0 112.134 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 2' ' ' PRO . 4.7 mp 31.92 26.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.969 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -108.86 154.36 16.51 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.378 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 6' ' ' HIS . 0.6 OUTLIER 48.99 -178.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.134 0.493 . . . . 0.0 111.284 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.597 ' N ' ' OG ' ' A' ' 5' ' ' SER . 40.4 m80 57.79 -131.93 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.976 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 7' ' ' LEU . 6.6 mp -90.82 130.95 36.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.382 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -158.84 130.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.331 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.66 132.83 40.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.93 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.61 ' O ' ' O ' ' A' ' 11' ' ' SER . 1.5 t -109.27 -0.98 18.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.355 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 10' ' ' THR . 0.1 OUTLIER 25.05 104.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.15 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 11' ' ' SER . 42.0 mp0 38.2 101.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.205 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.4 m -78.04 -1.29 31.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.952 0.406 . . . . 0.0 110.019 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -120.48 132.08 71.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.865 HG22 ' N ' ' A' ' 16' ' ' GLU . 54.3 m -123.27 -113.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.865 ' N ' HG22 ' A' ' 15' ' ' THR . 47.8 mp0 -13.69 75.55 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 O-C-N 123.628 0.58 . . . . 0.0 111.06 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.712 ' N ' ' O ' ' A' ' 15' ' ' THR . 35.0 mt -76.33 -9.45 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.698 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.638 ' O ' ' N ' ' A' ' 20' ' ' SER . 62.7 p -52.54 149.6 5.73 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 18' ' ' THR . . . 43.75 17.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.638 ' N ' ' O ' ' A' ' 18' ' ' THR . 4.3 p 79.33 -55.63 0.42 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.519 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.691 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 38.81 -178.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.915 0.864 . . . . 0.0 112.023 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.691 ' CD1' ' O ' ' A' ' 21' ' ' SER . 25.2 m-85 -156.72 150.65 24.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.741 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.65 ' CG2' ' OE1' ' A' ' 16' ' ' GLU . 42.4 t -119.66 102.26 12.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.5 t -110.25 132.53 58.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.324 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.4 p -126.63 154.36 44.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.906 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.414 ' CE3' HG21 ' A' ' 76' ' ' VAL . 33.9 p90 -143.43 -165.48 2.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.724 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -130.68 128.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.286 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 p -49.67 111.61 0.53 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.692 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.96 5.27 22.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.116 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.654 ' O ' HG12 ' A' ' 33' ' ' VAL . 4.0 m -174.46 140.71 0.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.781 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 51.3 p30 -87.23 2.36 50.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.253 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.3 p -93.22 1.07 57.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.356 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 30' ' ' SER . 2.5 p -71.37 135.87 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.798 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 79' ' ' ILE . 30.6 m -94.86 -14.83 24.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.53 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.1 179.05 46.36 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.12 152.25 46.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 0.0 110.19 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.2 ttp180 -131.4 128.31 39.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.839 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.63 133.61 57.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.721 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 38.6 tt0 -123.1 130.67 53.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.794 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -133.69 135.78 44.28 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.709 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -144.96 161.52 39.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.239 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.772 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 43.8 mt -71.15 130.39 41.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.142 0.496 . . . . 0.0 111.332 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -65.32 -24.5 67.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.952 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.486 ' HB2' HH22 ' A' ' 70' ' ' ARG . 60.8 mm-40 -97.44 -73.85 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.384 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.913 ' H ' HH22 ' A' ' 70' ' ' ARG . 80.5 mm-40 -68.72 147.1 52.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.282 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -93.07 28.42 9.59 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.104 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.574 ' O ' ' O ' ' A' ' 46' ' ' GLY . 13.7 t70 -41.64 171.45 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.733 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.521 ' N ' ' CG ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -73.42 134.93 79.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.747 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.64 148.99 73.29 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.486 2.124 . . . . 0.0 111.116 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 mt-30 -119.57 144.09 47.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 59.2 m-85 -122.91 141.9 51.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.114 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -128.06 130.79 48.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.687 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -102.21 133.41 47.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.567 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.2 mt -128.67 156.39 77.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.55 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -71.51 159.3 51.72 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.462 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 47.4 p -60.2 -16.36 32.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.114 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -91.19 -7.92 50.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.704 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 133.74 34.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.222 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 p -128.84 11.36 6.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.584 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 144.22 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.284 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.24 147.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.459 ' OD1' ' OE1' ' A' ' 16' ' ' GLU . 18.6 t30 -101.4 126.23 48.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.66 105.65 31.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.6 Cg_endo -90.08 -176.77 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 123.015 2.477 . . . . 0.0 112.773 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 56.41 35.92 26.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.441 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 22' ' ' PHE . 44.4 mt -90.23 140.55 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -68.35 111.58 8.41 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 25.3 Cg_exo -57.71 138.67 87.22 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.191 1.928 . . . . 0.0 112.015 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.1 22.09 74.61 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.917 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.913 HH22 ' H ' ' A' ' 45' ' ' GLU . 22.2 mmm180 -126.56 154.66 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.984 0.421 . . . . 0.0 111.548 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -100.05 132.44 45.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.694 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.772 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 52.4 m-85 -121.81 153.59 38.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.701 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 69.8 mt -108.1 125.41 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.87 133.87 58.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.044 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -136.36 124.25 22.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.751 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.414 HG21 ' CE3' ' A' ' 26' ' ' TRP . 34.0 t -105.06 129.75 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.599 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -121.57 137.7 54.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.803 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.447 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 3.5 pt20 -99.77 134.53 42.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' SER . 49.0 mt -98.27 125.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.399 0.619 . . . . 0.0 110.392 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 80.6 p -82.85 169.11 16.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.553 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.71 -22.32 57.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.936 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.598 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.4 p30 -93.72 0.02 56.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.303 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.51 63.51 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.421 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.35 144.45 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.995 0.397 . . . . 0.0 110.653 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 24.1 mt-30 -111.19 144.77 39.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.042 0.449 . . . . 0.0 111.431 -179.882 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.8 t -138.02 132.04 31.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.314 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.3 tp -72.61 118.22 15.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.905 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.3 pt -109.65 -25.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.822 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.7 tp -156.15 125.0 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.842 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 t -133.07 117.7 17.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 t -148.36 153.88 39.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.698 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.8 p -112.17 151.49 29.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.548 ' OE1' ' CD1' ' A' ' 22' ' ' PHE . 70.7 mt-30 -139.41 155.59 47.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.0 110.974 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.472 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -114.14 111.58 21.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.202 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 6.9 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.535 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.698 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 6.6 Cg_endo -53.15 139.16 63.0 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.637 2.224 . . . . 0.0 111.749 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 2' ' ' PRO . 85.1 mt 51.11 162.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.386 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.22 2.76 56.8 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 m -80.9 15.02 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.375 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -113.03 167.08 10.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 7' ' ' LEU . 17.4 tp 61.24 -5.5 0.12 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.456 0.646 . . . . 0.0 109.485 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.64 ' H ' ' C ' ' A' ' 6' ' ' HIS . 6.2 m -120.74 22.13 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.469 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.26 175.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.242 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.478 ' O ' ' OG ' ' A' ' 11' ' ' SER . 26.4 p -80.53 169.63 17.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.003 0.43 . . . . 0.0 111.389 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 76.1 p 60.29 -122.27 0.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' VAL . 44.1 mp0 -59.99 -23.73 63.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.525 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.493 ' OG ' HG23 ' A' ' 14' ' ' VAL . 1.3 p 69.03 -55.65 0.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 12' ' ' GLU . 63.1 t -111.98 129.64 67.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.965 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.702 HG22 ' N ' ' A' ' 16' ' ' GLU . 53.4 m -133.89 -101.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.413 . . . . 0.0 110.664 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.702 ' N ' HG22 ' A' ' 15' ' ' THR . 0.6 OUTLIER 35.78 73.36 0.09 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.952 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.579 ' O ' ' O ' ' A' ' 18' ' ' THR . 19.5 mt -129.03 -116.88 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.612 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 2.5 m 34.11 95.95 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 74.76 26.46 1.37 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.707 ' O ' HD12 ' A' ' 66' ' ' LEU . 5.1 p 56.08 23.16 6.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.77 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.551 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.4 p -57.59 136.69 56.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.584 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.3 m-30 -101.66 147.03 26.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.876 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.695 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 16.1 t -130.45 103.77 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -113.78 138.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.456 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.8 p -127.58 151.54 48.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.725 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.639 ' CE3' HG21 ' A' ' 76' ' ' VAL . 32.4 p90 -144.37 -165.38 2.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.009 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.93 125.84 58.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.967 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 p -46.01 117.27 1.46 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.402 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.02 4.04 35.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.363 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.618 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.7 m -169.09 139.34 2.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.052 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -88.06 -2.21 58.47 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.805 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.4 p -92.56 -1.37 56.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.631 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 30' ' ' SER . 2.3 p -61.14 137.52 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.5 m -96.19 -15.99 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.46 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.54 177.14 46.16 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.24 153.02 43.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.859 0.362 . . . . 0.0 110.54 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 42.3 ttp180 -132.18 132.09 42.83 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.728 178.661 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.645 HG21 HG11 ' A' ' 61' ' ' VAL . 12.4 t -113.0 135.09 53.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.53 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.8 133.5 50.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 4.4 p90 -143.56 143.05 31.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.282 0.563 . . . . 0.0 111.729 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -150.36 163.56 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.869 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 90.5 mt -74.07 125.47 28.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 p -64.3 -33.77 76.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.44 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.87 -71.07 0.57 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.545 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.662 ' CD ' HH21 ' A' ' 70' ' ' ARG . 89.1 mt-10 -62.73 -35.76 80.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.076 -178.428 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.583 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 85.35 -42.31 3.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.684 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 19.3 t70 28.98 -151.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.806 0.336 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.684 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 4.9 pt-20 -108.71 135.11 20.11 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.601 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.36 149.78 89.48 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.203 1.935 . . . . 0.0 111.826 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.36 151.05 40.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.68 139.46 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.42 129.92 45.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.343 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -106.02 134.43 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.146 0.498 . . . . 0.0 111.963 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HB3' ' CB ' ' A' ' 58' ' ' ALA . 7.4 mt -129.71 155.75 79.89 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.686 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -68.06 159.89 51.06 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.195 1.93 . . . . 0.0 111.995 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.467 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 21.0 p -56.25 -12.83 1.75 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.241 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -93.58 -7.11 45.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 54' ' ' LEU . . . -79.6 130.13 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.248 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -130.98 12.65 5.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.861 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.2 p -165.13 147.56 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.645 HG11 HG21 ' A' ' 38' ' ' VAL . 6.2 p -149.87 147.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.81 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 4.7 t-20 -107.72 127.98 54.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.76 105.65 42.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.126 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.24 175.55 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.896 2.398 . . . . 0.0 112.715 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 60.48 39.1 18.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.994 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 20' ' ' SER . 56.9 mt -88.95 153.51 20.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.466 HD13 ' NH2' ' A' ' 70' ' ' ARG . 46.7 mt -90.72 110.56 42.36 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.873 -0.148 . . . . 0.0 110.836 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -58.95 145.1 98.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.307 2.005 . . . . 0.0 112.204 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.509 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 80.3 17.77 73.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.662 HH21 ' CD ' ' A' ' 45' ' ' GLU . 4.9 mmm-85 -128.78 147.54 50.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.547 0.213 . . . . 0.0 110.597 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -98.43 135.09 40.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.869 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 67.9 m-85 -121.02 152.87 38.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.378 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 79.0 mt -111.7 131.23 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.14 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.28 134.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.507 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -135.21 123.76 23.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.3 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.639 HG21 ' CE3' ' A' ' 26' ' ' TRP . 17.2 t -103.62 130.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -122.56 139.06 54.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.433 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.452 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 9.7 pt20 -100.91 135.04 42.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -98.15 123.75 50.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.208 0.527 . . . . 0.0 110.634 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.613 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 59.3 p -83.76 166.18 18.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.498 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -57.48 -18.8 20.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.017 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.613 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 37.4 p30 -91.95 -1.1 57.44 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.747 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.75 13.7 66.63 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.032 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 63.8 mm-40 -85.47 143.3 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.65 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.3 mt-30 -108.06 140.41 41.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.742 178.935 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 t -135.15 132.68 38.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.035 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.7 tp -73.45 118.98 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.707 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 pt -112.09 -21.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.111 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 tp -157.04 124.41 5.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.905 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 t -132.18 120.82 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 t -153.56 155.51 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -121.63 154.27 37.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.181 0.515 . . . . 0.0 111.042 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.461 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 81.5 mt-30 -146.69 157.93 43.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.07 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.53 118.3 36.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.249 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.584 HG22 ' CE1' ' A' ' 22' ' ' PHE . 39.2 p . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.788 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.81 133.59 39.76 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.453 2.102 . . . . 0.0 111.536 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.6 mt -126.93 -134.87 0.25 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.292 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 5' ' ' SER . . . -115.96 37.18 3.52 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.559 ' O ' ' OG ' ' A' ' 5' ' ' SER . 4.7 p 33.31 63.73 0.33 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.016 0.436 . . . . 0.0 110.018 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.508 ' C ' ' ND1' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -97.62 -179.2 4.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.793 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.787 ' H ' HD12 ' A' ' 7' ' ' LEU . 5.2 mp -65.9 145.48 55.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.535 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.68 -15.62 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -176.98 150.15 0.75 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.792 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.605 ' O ' ' N ' ' A' ' 12' ' ' GLU . 1.8 m -67.94 10.66 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.541 ' O ' ' OG ' ' A' ' 11' ' ' SER . 1.2 p -35.11 89.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.022 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 10' ' ' THR . 61.7 tt0 -94.55 116.98 29.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.8 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 p -93.6 -10.38 34.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.588 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.612 ' O ' ' O ' ' A' ' 15' ' ' THR . 88.3 t -70.25 -21.31 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.093 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.807 HG22 ' N ' ' A' ' 16' ' ' GLU . 27.5 m -33.28 -103.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.015 0.436 . . . . 0.0 111.027 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.807 ' N ' HG22 ' A' ' 15' ' ' THR . 9.9 pt-20 32.41 28.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.442 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 15' ' ' THR . 8.9 mt -82.66 -81.25 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.027 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.601 ' C ' ' O ' ' A' ' 17' ' ' ILE . 1.5 p 11.43 100.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.474 0.484 . . . . 0.0 111.187 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 71.05 29.75 2.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 109.922 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p 55.56 23.47 6.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 17' ' ' ILE . 3.8 p -63.04 -177.58 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.378 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 95' ' ' THR . 17.7 m-85 -147.67 144.33 28.27 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.953 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 t -116.16 101.67 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.6 t -111.17 135.16 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.357 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.2 p -125.5 154.26 42.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.403 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.623 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.2 p90 -143.8 -179.19 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.01 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -118.8 129.36 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.045 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 p -49.88 126.92 15.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.422 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.63 3.31 54.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.059 0.457 . . . . 0.0 110.461 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' SER . . . . . . . . . . . . . 5.9 m -174.22 153.7 2.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.002 -179.515 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -98.07 1.68 47.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.6 p -95.35 -1.76 50.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.745 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p -60.04 138.77 20.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.507 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 79' ' ' ILE . 18.8 m -93.05 -15.99 25.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.558 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.502 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.41 -177.82 47.2 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 58' ' ' ALA . 73.8 m-85 -122.73 149.4 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.96 0.41 . . . . 0.0 110.523 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.6 ' HB2' HD11 ' A' ' 79' ' ' ILE . 13.7 ttp180 -127.49 118.71 24.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.49 132.39 49.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.209 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 80.8 tt0 -122.03 134.9 54.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.03 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CE1' ' NE2' ' A' ' 50' ' ' GLN . 54.3 p90 -140.86 137.08 32.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.836 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -149.08 160.86 42.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.203 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.69 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 47.3 mt -74.32 127.39 32.87 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.691 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 p -70.87 -24.01 62.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -86.6 -74.41 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.027 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -57.95 -35.3 70.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.93 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 70.24 17.33 73.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.613 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 27.2 t70 -46.5 -178.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.732 0.301 . . . . 0.0 110.591 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.613 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 2.8 pt-20 -68.8 139.18 90.82 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.76 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 37.3 Cg_endo -70.43 153.63 65.72 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.626 2.218 . . . . 0.0 112.851 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.506 ' NE2' ' CE1' ' A' ' 40' ' ' TYR . 6.1 mt-30 -114.88 145.0 42.65 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 39' ' ' GLU . 92.9 m-85 -124.09 136.41 54.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.153 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 52' ' ' LEU . 88.6 mt -119.92 131.37 55.2 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -103.6 132.03 50.22 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.521 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mt -129.72 155.5 80.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -66.68 160.42 46.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.232 1.955 . . . . 0.0 112.539 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.427 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 15.9 p -57.53 -14.19 4.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -90.82 -9.47 46.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 36' ' ' PHE . . . -83.41 128.81 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.938 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.9 p -132.81 14.22 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.339 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -163.16 141.62 8.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.152 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.22 146.43 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.654 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.406 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.1 t-20 -103.05 127.2 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.34 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 95.0 Cg_endo -90.65 -179.12 1.53 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.919 2.413 . . . . 0.0 112.622 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 61.58 35.69 17.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.96 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 30.5 mt -89.51 152.88 21.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.11 111.73 40.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.508 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 23.5 Cg_exo -56.29 139.78 86.9 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.933 1.755 . . . . 0.0 111.358 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.83 18.83 69.2 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.695 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -125.02 148.74 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.813 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -99.35 132.51 44.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.151 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 90.3 m-85 -121.56 150.92 40.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.189 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 87.4 mt -107.71 123.65 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -109.95 131.39 61.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 0.0 110.815 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.14 129.08 33.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.603 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 26' ' ' TRP . 5.6 t -109.99 131.46 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.923 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -123.47 143.37 50.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.288 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 10.5 pt20 -99.6 136.58 39.32 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.806 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.686 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.5 mt -100.72 123.97 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.298 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.606 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 51.9 p -85.44 172.36 11.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.003 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' OE2' ' OG ' ' A' ' 34' ' ' SER . 78.1 mm-40 -61.48 -23.96 66.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.03 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.606 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.9 p30 -93.57 -1.66 55.18 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.35 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.97 60.05 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.411 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.459 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.4 mm-40 -84.79 131.82 34.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.14 0.47 . . . . 0.0 110.596 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 85.0 mt-30 -105.26 141.11 37.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.794 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.6 t -136.29 133.56 37.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.76 HD21 ' HB2' ' A' ' 90' ' ' SER . 28.0 tp -72.3 118.41 15.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.3 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.06 -20.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 26' ' ' TRP . 15.0 tp -155.0 124.89 6.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.422 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.76 ' HB2' HD21 ' A' ' 87' ' ' LEU . 12.9 t -131.93 123.03 26.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.562 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -154.14 152.76 30.78 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.034 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.6 p -118.19 153.37 33.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 70.8 mt-30 -142.59 160.5 40.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.838 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 115.92 25.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.015 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.465 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 81.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.662 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.11 34.11 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.978 2.452 . . . . 0.0 112.467 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 32.1 tp 44.35 84.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 110.511 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.57 -131.27 4.33 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p -82.78 2.13 35.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.464 0.173 . . . . 0.0 110.94 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -58.85 -57.69 11.91 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.697 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.636 ' O ' ' O ' ' A' ' 8' ' ' VAL . 47.2 mt -95.05 0.07 54.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.298 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.636 ' O ' ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER 41.55 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.787 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.478 ' H ' HG22 ' A' ' 8' ' ' VAL . . . -70.43 147.39 49.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.658 ' O ' ' N ' ' A' ' 12' ' ' GLU . 40.8 p -80.02 3.87 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.59 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER 55.99 -69.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.759 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.658 ' N ' ' O ' ' A' ' 10' ' ' THR . 24.4 tp10 -108.92 -137.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.31 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 14' ' ' VAL . 1.4 t 178.68 69.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.986 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.763 ' CG1' ' H ' ' A' ' 23' ' ' VAL . 2.0 t 53.39 129.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.911 HG22 ' H ' ' A' ' 16' ' ' GLU . 7.4 m -81.95 -140.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.828 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.911 ' H ' HG22 ' A' ' 15' ' ' THR . 81.0 mm-40 26.04 47.53 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.034 0.445 . . . . 0.0 110.029 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.503 ' O ' HG22 ' A' ' 17' ' ' ILE . 43.9 mt -65.6 -5.36 2.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.253 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' SER . 68.8 p -62.63 151.09 39.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.559 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 43.34 23.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.672 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 60.56 27.57 17.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.383 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.578 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -55.08 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.596 0.712 . . . . 0.0 111.862 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.469 ' N ' ' OG ' ' A' ' 21' ' ' SER . 18.7 m-85 -146.34 146.51 30.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.744 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.763 ' H ' ' CG1' ' A' ' 14' ' ' VAL . 54.1 t -119.04 103.19 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.3 t -109.04 134.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.191 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.1 p -128.05 150.52 49.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.757 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -145.01 178.62 7.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.949 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 t -117.01 128.48 74.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -48.1 148.98 1.55 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.422 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.554 ' O ' ' NE2' ' A' ' 78' ' ' GLN . . . -138.51 55.15 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.659 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.73 ' C ' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER 178.21 -27.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.614 179.334 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 60.86 -26.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.893 0.378 . . . . 0.0 110.128 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.73 ' H ' ' C ' ' A' ' 30' ' ' SER . 1.9 m -92.04 -0.85 57.46 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 56' ' ' SER . 1.5 p -52.78 137.08 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.656 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.5 m -94.62 -14.77 24.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 174.9 177.3 43.9 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -124.77 152.86 43.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.624 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.781 ' NH1' ' CD1' ' A' ' 51' ' ' TYR . 14.8 ttp85 -128.59 126.06 39.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.657 HG21 HG11 ' A' ' 61' ' ' VAL . 41.6 t -105.72 132.34 52.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' OE2' ' CB ' ' A' ' 49' ' ' PRO . 73.3 tt0 -127.95 133.25 49.21 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.72 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.6 p90 -140.43 133.74 29.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.222 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -143.59 162.09 36.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.726 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 47.2 mt -72.9 134.95 45.01 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.997 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.7 p -73.55 -19.38 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.213 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HG2' HH22 ' A' ' 70' ' ' ARG . 73.5 mm-40 -98.5 -65.0 0.99 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.936 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -64.16 -31.07 72.13 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.423 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 55.27 22.72 30.96 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' O ' ' O ' ' A' ' 46' ' ' GLY . 34.1 t0 -49.59 -169.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.929 0.395 . . . . 0.0 110.297 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.498 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 1.7 pt-20 -68.7 138.13 90.69 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.217 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 61.2 Cg_endo -73.43 151.09 47.45 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.62 2.213 . . . . 0.0 111.94 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -112.27 141.0 46.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.781 ' CD1' ' NH1' ' A' ' 37' ' ' ARG . 78.6 m-85 -123.43 138.8 54.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.872 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -126.6 132.18 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -100.91 134.38 43.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.882 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mt -128.64 154.7 79.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.558 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.08 159.39 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.245 1.963 . . . . 0.0 111.957 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.475 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 25.4 p -59.72 -11.99 6.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.672 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -91.23 -6.4 53.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.69 132.97 35.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.682 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 p -130.65 6.84 4.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.267 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.4 p -164.92 141.38 5.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.657 HG11 HG21 ' A' ' 38' ' ' VAL . 8.0 p -148.11 148.96 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.162 0.506 . . . . 0.0 111.667 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 8.6 t30 -102.63 125.45 49.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.908 178.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -99.03 108.17 47.95 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -93.36 -176.92 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 123.168 2.579 . . . . 0.0 112.705 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 59.59 35.55 22.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.233 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -89.6 148.11 23.53 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.191 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -86.49 113.31 51.97 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.034 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -57.66 140.95 95.14 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.236 1.957 . . . . 0.0 112.334 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.2 21.42 67.6 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.682 ' HE ' HD22 ' A' ' 42' ' ' LEU . 7.3 mmm180 -125.67 149.0 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.945 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 67.9 tttt -102.34 130.52 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.775 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.726 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 90.4 m-85 -122.72 154.05 38.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.3 mt -108.22 125.88 64.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 t -113.98 133.83 58.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.205 0.526 . . . . 0.0 111.401 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -134.63 126.08 28.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.354 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.93 128.3 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.848 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -121.36 137.94 54.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.554 ' NE2' ' O ' ' A' ' 29' ' ' ALA . 8.3 pt20 -101.01 136.0 41.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.3 mt -98.68 120.95 48.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.808 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 29.2 p -82.4 168.53 17.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.22 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' GLU . . . . . 0.555 ' HG2' HG22 ' A' ' 32' ' ' THR . 73.5 mm-40 -59.28 -18.22 35.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.825 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 38.7 p30 -93.07 -1.51 56.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.243 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.61 12.8 68.72 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.575 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.0 mm-40 -84.69 141.89 30.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.981 0.419 . . . . 0.0 111.082 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 25.1 mt-30 -110.12 141.93 42.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.471 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -136.5 131.22 33.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.034 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 90' ' ' SER . 30.4 tp -72.3 116.96 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.157 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 pt -110.31 -21.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 tp -154.75 122.03 5.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.185 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.569 ' HB2' HD21 ' A' ' 87' ' ' LEU . 22.6 t -131.19 117.88 19.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -150.63 155.71 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.637 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.6 p -114.85 156.04 25.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.427 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 80.9 mt-30 -144.28 153.3 41.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 106.68 14.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.2 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.595 -179.24 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.69 6.7 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.24 1.96 . . . . 0.0 111.317 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 3' ' ' LEU . 2.3 tt 73.19 -55.23 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.659 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.67 -148.95 20.73 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.44 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t 71.34 15.22 6.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.195 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.41 -40.24 61.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.674 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.537 ' HG ' ' H ' ' A' ' 9' ' ' ALA . 12.2 tp -90.35 124.69 35.13 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.601 HG21 ' HB2' ' A' ' 13' ' ' SER . 3.6 t -82.95 -13.32 12.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 8' ' ' VAL . . . 74.98 -37.74 0.36 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.555 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.753 ' O ' ' N ' ' A' ' 12' ' ' GLU . 88.8 m -79.28 136.83 37.15 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.544 ' C ' ' O ' ' A' ' 10' ' ' THR . 7.0 t -26.25 80.15 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 123.341 0.4 . . . . 0.0 110.672 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.753 ' N ' ' O ' ' A' ' 10' ' ' THR . 50.9 mt-10 59.45 150.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.783 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.601 ' HB2' HG21 ' A' ' 8' ' ' VAL . 15.4 t -60.92 -36.41 79.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.029 0.442 . . . . 0.0 110.112 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.69 143.76 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.849 HG22 ' N ' ' A' ' 16' ' ' GLU . 3.1 m -91.07 -93.45 0.13 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.146 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.849 ' N ' HG22 ' A' ' 15' ' ' THR . 74.3 mm-40 -30.86 114.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.195 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 15' ' ' THR . 11.7 mt -112.05 -18.19 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.225 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.464 ' C ' ' N ' ' A' ' 20' ' ' SER . 71.8 p -58.48 156.37 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 46.35 21.61 0.13 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.526 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 57.97 36.3 26.04 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.241 -179.604 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.544 ' OG ' ' CB ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -61.97 159.9 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.41 -179.161 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.484 ' CE2' ' HB2' ' A' ' 93' ' ' GLN . 22.5 m-30 -127.23 151.97 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.806 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.76 106.56 15.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.24 145.48 20.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.109 0.48 . . . . 0.0 111.006 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.2 p -131.4 153.82 49.29 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.69 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.479 ' CD2' HG11 ' A' ' 76' ' ' VAL . 33.0 p90 -143.35 -166.38 2.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 29' ' ' ALA . 25.4 t -117.45 129.23 74.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -50.55 -33.98 23.8 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.079 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.565 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 51.11 12.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.909 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 5.3 m -175.57 148.34 0.9 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.89 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -103.79 -12.36 16.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.387 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.3 p -79.68 -1.12 36.92 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.075 0.464 . . . . 0.0 109.827 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 56' ' ' SER . 3.9 p -73.72 130.42 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.226 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.687 ' N ' ' O ' ' A' ' 79' ' ' ILE . 39.0 m -95.45 -12.98 24.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 109.739 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.17 -179.88 47.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.86 151.53 48.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.749 0.309 . . . . 0.0 110.433 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 25.3 ttp180 -129.35 122.83 30.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.317 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 61' ' ' VAL . 80.8 t -108.2 133.82 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.542 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 59.3 tt0 -124.46 137.06 54.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.548 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 24.9 p90 -141.81 130.66 22.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.937 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -143.11 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.324 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.82 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 83.0 mt -75.69 123.89 26.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.166 0.507 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.0 p -66.14 -26.04 67.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.423 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -87.88 -73.54 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.299 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.547 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 81.3 mt-10 -83.54 148.56 27.13 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.627 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -61.4 -23.54 62.57 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.415 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.684 ' HB2' HD12 ' A' ' 42' ' ' LEU . 16.1 t70 33.01 -161.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 110.093 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.644 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER -119.07 126.01 27.31 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.15 137.2 31.0 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 121.815 1.677 . . . . 0.0 111.163 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.2 mt-30 -120.61 150.93 40.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -124.78 136.13 53.58 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.95 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -122.09 130.19 53.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.479 ' O ' HD23 ' A' ' 54' ' ' LEU . 67.3 m-20 -104.29 133.53 49.04 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.39 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 53' ' ' ASP . 7.2 mt -129.41 155.77 79.58 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.278 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 58' ' ' ALA . 22.2 Cg_endo -69.49 151.24 70.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 121.63 1.553 . . . . 0.0 112.059 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.443 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 3.3 p -52.16 -13.03 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.491 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' THR . . . . . 0.406 ' N ' ' C ' ' A' ' 55' ' ' PRO . 78.1 p -93.01 -7.06 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . . . -80.45 136.79 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.352 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -129.62 8.9 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.5 p -164.57 149.84 10.01 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.486 HG11 HG21 ' A' ' 38' ' ' VAL . 9.9 p -151.85 153.06 10.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.244 0.545 . . . . 0.0 111.944 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 22' ' ' PHE . 50.8 t30 -105.51 128.5 53.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.927 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.415 HG22 HD21 ' A' ' 66' ' ' LEU . 2.0 mt -102.13 103.36 29.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 64.2 Cg_endo -89.95 -175.21 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.177 2.585 . . . . 0.0 112.211 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 58.86 36.63 24.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.234 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 20' ' ' SER . 16.4 mt -89.2 149.66 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.313 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.597 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 21.8 mt -92.67 112.06 53.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.076 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.34 132.84 48.74 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.875 1.717 . . . . 0.0 110.703 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.48 10.72 73.13 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.547 ' NH2' ' OE2' ' A' ' 45' ' ' GLU . 19.4 mmt85 -123.77 145.9 48.7 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -97.22 133.16 42.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.82 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 20.7 m-85 -115.27 156.19 25.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.225 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.564 HG22 HD21 ' A' ' 75' ' ' ASN . 62.5 mt -113.47 122.14 67.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.84 128.12 67.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.067 0.461 . . . . 0.0 110.948 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.564 HD21 HG22 ' A' ' 73' ' ' ILE . 39.7 m-80 -133.86 127.17 32.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.599 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 26' ' ' TRP . 19.5 t -106.99 128.25 61.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -117.32 139.0 51.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.876 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.2 pt20 -100.76 135.13 42.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.856 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.687 ' O ' ' N ' ' A' ' 34' ' ' SER . 60.0 mt -99.26 121.94 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.916 0.388 . . . . 0.0 110.984 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.593 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 93.0 p -85.2 168.98 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.008 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -57.25 -20.8 29.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.643 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.593 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 50.0 p30 -93.38 2.67 56.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.17 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.95 72.62 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.944 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 69.7 mm-40 -85.13 144.35 28.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.984 0.421 . . . . 0.0 111.4 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 41.0 mt-30 -109.51 140.03 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.719 179.115 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 t -135.72 132.36 36.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.867 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 90' ' ' SER . 22.0 tp -73.16 117.07 14.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.424 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.0 pt -107.43 -22.84 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.096 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 tp -156.73 125.26 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.812 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.448 ' HB2' HD21 ' A' ' 87' ' ' LEU . 47.8 t -127.7 123.66 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.33 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 t -155.0 156.72 36.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.613 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.3 p -116.96 156.1 28.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.413 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 63.9 mt-30 -140.38 160.16 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 111.122 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.69 112.65 17.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 43.9 p . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.601 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 1' ' ' GLY . 37.9 Cg_exo -52.82 -136.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.877 2.385 . . . . 0.0 112.134 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.5 tp -92.96 125.64 37.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.733 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.24 -175.08 46.41 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 p -71.86 157.6 37.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.939 0.399 . . . . 0.0 110.8 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.683 ' O ' ' N ' ' A' ' 8' ' ' VAL . 80.5 m-70 -133.71 -64.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.374 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 7' ' ' LEU . 6.1 mp 30.98 30.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.057 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 6' ' ' HIS . 2.1 t 48.53 13.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.64 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.467 ' N ' ' C ' ' A' ' 7' ' ' LEU . . . -78.3 -3.27 42.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.089 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.842 HG22 ' H ' ' A' ' 11' ' ' SER . 1.5 m -78.39 -169.98 1.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.842 ' H ' HG22 ' A' ' 10' ' ' THR . 7.2 p -60.04 170.05 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.13 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -56.74 126.93 29.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.399 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 m -90.07 1.33 56.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.227 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 p -124.83 143.78 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.793 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.813 HG22 ' H ' ' A' ' 16' ' ' GLU . 59.4 m -132.42 -125.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.702 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.813 ' H ' HG22 ' A' ' 15' ' ' THR . 47.4 mp0 15.25 48.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.128 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 15' ' ' THR . 77.7 mt -69.87 -4.25 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.756 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 79.6 m -67.21 139.58 57.4 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 63.74 15.95 9.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 59.38 34.11 22.66 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.683 -179.57 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.607 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -64.49 164.3 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.164 0.507 . . . . 0.0 111.605 -179.509 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -128.71 144.26 51.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.58 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.7 101.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.27 136.59 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.509 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.8 p -124.41 152.76 42.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.497 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -144.28 -165.88 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 110.639 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 29' ' ' ALA . 57.7 t -120.27 131.28 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.765 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.661 ' O ' ' N ' ' A' ' 30' ' ' SER . 73.0 p -52.66 -27.45 17.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.75 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 45.53 5.63 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.006 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.836 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.6 m -168.34 110.77 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.85 0.357 . . . . 0.0 110.685 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -76.43 -7.04 54.23 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.3 p -87.31 -3.27 59.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.195 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.836 HG12 ' O ' ' A' ' 30' ' ' SER . 3.2 p -62.33 138.24 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.17 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.0 m -93.68 -16.52 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 109.761 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.97 178.82 47.01 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.73 150.82 49.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.658 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 31.0 ttp180 -130.09 122.26 27.95 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.521 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.98 131.17 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.806 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.432 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.6 tt0 -122.29 132.52 54.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.774 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 54.1 p90 -138.1 137.2 37.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.129 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.43 159.01 43.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.438 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.71 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 58.3 mt -73.91 124.43 26.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.197 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -67.14 -28.66 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.595 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -86.41 -69.1 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.393 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -60.3 -35.95 76.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.882 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.22 30.92 64.37 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' OD2' HD12 ' A' ' 42' ' ' LEU . 76.1 m-20 -58.48 171.48 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 0.0 110.719 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.7 141.37 95.05 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.13 147.71 48.89 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.391 2.061 . . . . 0.0 112.47 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 mt-30 -114.59 146.38 40.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.3 m-85 -123.32 137.2 54.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.324 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 52' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 52' ' ' LEU . 91.3 mt -121.93 126.81 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -100.69 130.62 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.146 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.9 mt -127.78 154.72 78.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.577 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.35 155.44 67.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.188 1.925 . . . . 0.0 112.503 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.426 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 5.3 p -56.89 -12.57 2.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -94.21 -9.45 36.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.848 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.1 136.05 34.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 110.67 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -129.34 12.6 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.89 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.2 p -164.32 149.32 10.11 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.516 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.41 150.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.178 0.514 . . . . 0.0 111.575 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.47 127.11 50.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.571 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.6 105.01 34.63 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.88 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -90.66 -178.54 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.922 2.414 . . . . 0.0 113.253 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 60.47 36.86 20.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.771 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' O ' ' OG ' ' A' ' 20' ' ' SER . 47.6 mt -92.62 144.88 24.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.603 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.541 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 19.4 mt -88.71 112.17 48.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.063 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -53.92 141.67 66.29 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.102 1.868 . . . . 0.0 111.897 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 81.0 17.08 73.17 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.424 ' HB3' HD22 ' A' ' 42' ' ' LEU . 7.7 mmt-85 -124.01 146.39 48.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -98.94 132.41 44.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.827 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.71 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 55.6 m-85 -118.89 155.6 30.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.762 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.468 HG22 HD21 ' A' ' 75' ' ' ASN . 70.8 mt -109.13 126.99 66.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -112.47 131.31 64.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.0 0.428 . . . . 0.0 111.075 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.468 HD21 HG22 ' A' ' 73' ' ' ILE . 32.7 m-80 -138.05 125.68 22.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.898 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.471 ' O ' HD12 ' A' ' 87' ' ' LEU . 46.5 t -105.04 127.85 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.893 0.378 . . . . 0.0 110.413 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -119.45 136.07 54.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.466 ' OE1' ' O ' ' A' ' 28' ' ' SER . 5.5 pt20 -101.57 135.18 43.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.82 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 34' ' ' SER . 64.0 mt -97.08 120.51 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 110.549 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.587 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.2 p -81.39 172.32 13.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.652 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -22.82 59.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.642 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.587 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 49.2 p30 -92.18 0.68 57.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 11.21 73.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.814 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.9 mm-40 -84.02 140.08 32.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 22.3 mt-30 -103.08 142.62 33.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.899 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.7 t -136.58 128.24 28.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.15 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 90' ' ' SER . 61.3 tp -73.14 119.16 17.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 27' ' ' VAL . 45.0 pt -110.83 -20.89 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.099 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.0 tp -155.46 120.18 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.512 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.711 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.7 t -127.13 123.66 37.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 t -156.08 149.58 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.685 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.2 p -111.95 155.44 23.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.024 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 69.1 mt-30 -140.93 156.67 46.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.237 0.541 . . . . 0.0 110.954 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -119.14 110.94 17.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.252 178.908 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 94' ' ' THR . 75.6 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.583 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 1' ' ' GLY . 22.2 Cg_exo -56.79 146.0 80.34 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.652 2.234 . . . . 0.0 111.998 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.8 mt -82.66 137.78 34.36 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.549 ' O ' ' C ' ' A' ' 5' ' ' SER . . . 171.52 -176.68 44.68 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.549 ' C ' ' O ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 27.85 85.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.889 0.376 . . . . 0.0 110.227 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -159.06 134.36 8.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.556 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.96 133.56 34.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.029 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -111.33 123.79 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.342 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.94 -85.97 0.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.595 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.2 m -105.01 138.02 41.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.6 -31.01 8.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 14' ' ' VAL . 25.5 tt0 -89.22 5.84 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.858 0.361 . . . . 0.0 110.764 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.56 -78.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.364 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 23' ' ' VAL . 11.0 m -101.5 133.83 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.354 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.807 HG22 ' N ' ' A' ' 16' ' ' GLU . 1.1 m -88.18 -77.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.534 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.807 ' N ' HG22 ' A' ' 15' ' ' THR . 51.3 mp0 -49.71 132.37 21.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.065 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' SER . 2.1 mt -131.01 -22.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.445 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.497 ' C ' ' O ' ' A' ' 17' ' ' ILE . 44.0 p -35.01 140.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.601 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 38.98 38.9 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.707 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.601 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 18.7 p 56.92 43.69 24.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.546 ' OG ' ' C ' ' A' ' 16' ' ' GLU . 1.2 p -61.65 131.59 50.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.264 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.632 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 6.6 m-30 -95.03 146.48 24.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.735 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 14' ' ' VAL . 37.1 t -131.49 103.99 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.903 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -116.05 138.11 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.0 p -124.71 152.58 43.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.821 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.621 ' CE3' HG21 ' A' ' 76' ' ' VAL . 42.1 p90 -146.24 -165.49 2.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.36 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 t -130.81 129.59 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.826 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 p -50.02 155.38 0.93 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.801 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -142.46 44.65 1.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.113 -179.424 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.664 ' C ' ' H ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -170.93 -30.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.897 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t0 64.49 -33.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.664 ' H ' ' C ' ' A' ' 30' ' ' SER . 81.0 p -86.85 2.33 49.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.665 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 56' ' ' SER . 0.9 OUTLIER -55.56 142.2 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.836 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.6 m -94.72 -18.74 21.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.209 0.528 . . . . 0.0 109.805 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.85 178.36 46.54 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -123.1 150.26 43.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.486 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.68 ' NH2' HE22 ' A' ' 85' ' ' GLN . 29.4 ttp180 -129.21 120.93 26.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG21 HG11 ' A' ' 61' ' ' VAL . 13.7 t -106.56 131.22 56.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.89 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.05 132.83 55.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.48 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 54.7 p90 -140.73 136.45 32.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.609 . . . . 0.0 111.267 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.0 164.72 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.989 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.768 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 79.3 mt -72.45 125.11 26.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.82 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 p -62.08 -32.95 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.511 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -87.41 -75.07 0.42 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.033 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.68 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 90.4 mt-10 -63.84 143.59 57.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.39 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.14 29.57 8.02 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.43 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' A' ' 48' ' ' GLU . 21.8 t70 -46.93 170.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.51 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 47' ' ' ASP . 2.5 pt-20 -70.69 139.4 86.12 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.542 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.64 153.29 69.68 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.693 2.262 . . . . 0.0 111.952 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.48 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.0 mt-30 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -126.15 138.92 53.71 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.763 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -127.06 133.05 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ASP . . . . . 0.406 ' O ' HD23 ' A' ' 54' ' ' LEU . 56.1 m-20 -106.65 134.29 50.02 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.693 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 53' ' ' ASP . 7.2 mt -131.83 156.14 80.49 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.669 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.25 158.13 58.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.05 1.834 . . . . 0.0 112.294 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.618 ' HB2' HG13 ' A' ' 33' ' ' VAL . 87.3 p -58.67 -13.04 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -92.97 -6.97 47.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.861 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.12 134.56 34.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.606 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -131.9 15.41 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.482 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -163.28 144.02 9.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 38' ' ' VAL . 9.5 p -149.28 148.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.533 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 5.0 t-20 -106.04 127.13 52.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.546 178.533 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.411 HG22 HD21 ' A' ' 66' ' ' LEU . 1.7 mt -98.34 104.77 25.15 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 94.3 Cg_endo -90.18 172.5 3.57 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.535 2.157 . . . . 0.0 112.587 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 62.45 39.53 11.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.725 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.547 HD12 ' CD1' ' A' ' 22' ' ' PHE . 32.9 mt -89.44 138.68 31.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.291 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.565 HD13 ' NH2' ' A' ' 70' ' ' ARG . 28.5 mt -68.76 129.34 92.51 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.851 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.05 138.06 27.53 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.508 2.139 . . . . 0.0 112.012 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.26 22.23 73.91 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.68 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 5.5 mmm-85 -125.71 148.59 49.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -98.64 134.03 42.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.183 0.516 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.768 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 49.9 m-85 -120.81 149.5 42.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.846 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.478 HG22 HD21 ' A' ' 75' ' ' ASN . 66.3 mt -108.18 128.71 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 t -116.58 129.26 73.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.42 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.478 HD21 HG22 ' A' ' 73' ' ' ILE . 33.4 m-80 -134.43 124.41 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.712 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.621 HG21 ' CE3' ' A' ' 26' ' ' TRP . 21.9 t -100.96 128.14 53.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.496 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 61.2 m-85 -120.12 136.59 54.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.698 179.616 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 6.4 pt20 -101.88 137.5 40.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.759 -0.776 . . . . 0.0 108.969 178.992 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.8 mt -100.58 127.7 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 111.4 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 28.4 p -84.53 173.06 11.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.43 -18.06 48.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.868 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.3 p30 -94.56 -4.04 48.65 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.498 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 13.75 62.41 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.262 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.585 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 69.4 mm-40 -84.56 147.3 27.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.898 0.349 . . . . 0.0 110.335 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.68 HE22 ' NH2' ' A' ' 37' ' ' ARG . 43.6 mt-30 -112.44 147.7 35.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.124 0.488 . . . . 0.0 111.77 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -139.14 128.63 24.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.93 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 tp -73.3 118.96 16.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.964 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.2 pt -111.72 -22.69 4.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 26' ' ' TRP . 16.6 tp -154.85 127.1 7.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.907 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 48.1 t -135.6 119.05 16.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.133 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -145.77 159.57 42.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.7 p -126.32 152.49 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.447 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 81.9 mt-30 -145.94 163.02 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.598 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.03 108.67 16.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.864 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.482 ' HG1' ' H ' ' A' ' 70' ' ' ARG . 37.9 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.631 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.64 8.21 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.737 2.291 . . . . 0.0 111.981 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.0 mt -54.3 -23.68 16.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.276 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 6' ' ' HIS . . . -163.43 15.39 0.11 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.513 ' C ' ' O ' ' A' ' 4' ' ' GLY . 41.4 t 28.6 35.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.679 0.276 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 4' ' ' GLY . 91.3 m-70 -52.52 -39.22 61.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.513 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 6' ' ' HIS . 7.7 mp 31.1 102.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.755 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 94.2 t -100.55 125.57 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.817 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 8' ' ' VAL . . . 150.28 80.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.685 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -90.93 130.09 36.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.608 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.2 p -76.4 161.96 28.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.373 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.39 133.21 55.54 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.578 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 m -100.24 -6.33 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.406 ' C ' ' CG2' ' A' ' 15' ' ' THR . 33.7 m -74.32 -10.07 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.093 0.473 . . . . 0.0 110.483 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.63 ' OG1' ' N ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER 33.39 -112.12 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.832 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.653 ' C ' ' H ' ' A' ' 18' ' ' THR . 95.1 mt-10 -61.85 -33.48 74.26 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.561 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.591 ' O ' ' C ' ' A' ' 18' ' ' THR . 6.0 mt 63.44 -27.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.934 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.653 ' H ' ' C ' ' A' ' 16' ' ' GLU . 13.2 t -19.96 116.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.676 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 67.08 34.57 5.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.756 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 17' ' ' ILE . 1.7 p 47.18 24.97 0.47 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.962 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -61.16 142.37 56.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.37 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 95' ' ' THR . 6.3 m-30 -96.78 148.38 22.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.34 107.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.21 135.54 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.051 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -123.35 150.58 43.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.693 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -146.88 -168.24 2.98 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.301 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 29' ' ' ALA . 34.1 t -120.63 132.76 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.521 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.524 ' O ' ' OE1' ' A' ' 78' ' ' GLN . 32.2 t -45.49 -33.11 2.51 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.416 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.533 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 56.69 5.22 0.2 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.661 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 31' ' ' ASP . 1.4 t -143.36 -59.38 0.42 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.445 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 30' ' ' SER . 2.9 m-20 86.39 -22.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.889 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 m -95.21 -3.82 47.02 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' H ' HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -54.11 144.15 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.167 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 79' ' ' ILE . 8.4 m -94.83 -16.13 23.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.304 0.573 . . . . 0.0 109.682 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.05 175.29 45.08 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CZ ' HG11 ' A' ' 33' ' ' VAL . 93.9 m-85 -124.28 152.25 43.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.613 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.534 ' HE ' ' HB3' ' A' ' 51' ' ' TYR . 70.7 ttt180 -132.78 122.87 25.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.756 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.2 t -109.58 130.41 62.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.886 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.51 ' C ' ' OE1' ' A' ' 39' ' ' GLU . 13.1 tm-20 -123.68 129.59 51.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 34.9 p90 -143.52 144.74 32.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.213 0.53 . . . . 0.0 111.599 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -148.65 168.14 23.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.464 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.745 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 67.3 mt -73.86 129.76 38.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.191 0.52 . . . . 0.0 111.532 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.3 p -70.83 -18.74 62.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.21 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -101.06 -75.01 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.221 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.677 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 89.0 mt-10 -62.2 -36.71 82.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.262 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 83.6 -39.18 2.8 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 46' ' ' GLY . 35.4 t0 27.98 -151.39 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.865 0.364 . . . . 0.0 110.41 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.557 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.8 OUTLIER -101.62 134.13 20.39 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.897 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.27 144.05 73.0 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.129 1.886 . . . . 0.0 111.858 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 22.6 mt-30 -116.67 144.14 44.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' HB3' ' HE ' ' A' ' 37' ' ' ARG . 3.2 m-85 -123.7 139.22 54.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.909 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -127.35 127.67 44.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -100.86 132.1 46.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.354 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -128.0 155.5 77.67 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.456 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -68.33 155.98 67.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.037 1.824 . . . . 0.0 112.303 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.4 p -56.67 -12.59 1.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 37.7 p -91.84 -8.66 45.94 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.79 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.06 34.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -128.5 11.31 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.6 p -164.2 145.89 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.09 145.49 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.361 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -104.23 127.84 51.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.236 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.84 105.94 37.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -87.78 179.52 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.571 2.181 . . . . 0.0 112.492 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 58.37 38.58 25.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.299 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 20' ' ' SER . 28.8 mt -87.77 150.23 23.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.8 mt -94.21 109.32 41.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.112 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -54.63 139.56 76.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.137 1.891 . . . . 0.0 111.627 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.574 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 84.95 15.92 66.36 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.677 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 7.6 mmm-85 -125.35 143.75 50.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 110.574 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -100.81 132.0 46.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.745 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 80.1 m-85 -119.6 151.41 38.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.894 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 70.3 mt -108.54 131.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -119.68 134.18 64.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.827 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.02 125.7 30.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.48 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.1 t -104.15 128.95 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.765 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -119.08 138.96 52.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.544 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.524 ' OE1' ' O ' ' A' ' 28' ' ' SER . 6.5 pt20 -104.98 137.15 43.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.03 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.6 mt -100.1 121.75 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.195 0.521 . . . . 0.0 110.382 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 83.6 p -82.48 167.67 18.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.597 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -57.55 -19.91 28.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.244 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.9 p30 -92.24 0.04 57.43 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.188 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.4 9.2 73.06 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.054 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -82.71 143.93 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 111.074 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.484 ' NE2' HG12 ' A' ' 79' ' ' ILE . 3.1 mm-40 -109.53 141.91 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 t -138.27 133.95 33.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.557 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 tp -73.56 118.55 16.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.648 -0.421 . . . . 0.0 109.947 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.3 pt -109.92 -23.25 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.211 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.9 tp -157.03 126.6 6.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.119 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 t -132.81 122.36 24.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.495 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -152.38 159.94 43.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.257 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.2 p -121.59 153.03 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.505 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 80.2 mt-30 -145.64 161.32 40.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.459 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.13 114.17 19.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.705 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 59.5 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.418 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -57.58 -2.73 0.74 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.79 2.327 . . . . 0.0 112.016 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.624 ' C ' ' H ' ' A' ' 5' ' ' SER . 50.3 mt -103.97 -38.72 6.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.88 -31.21 0.06 OUTLIER Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.624 ' H ' ' C ' ' A' ' 3' ' ' LEU . 94.0 p -76.68 -7.71 55.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.75 0.31 . . . . 0.0 111.028 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.516 ' NE2' ' CD1' ' A' ' 3' ' ' LEU . 6.0 m-70 -76.21 -24.54 54.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.454 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.891 ' N ' HD12 ' A' ' 7' ' ' LEU . 4.1 mp -90.57 134.56 34.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.632 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 8' ' ' VAL . 27.6 m -135.12 69.83 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.282 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.673 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -63.5 -48.63 76.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.311 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.572 ' C ' ' O ' ' A' ' 9' ' ' ALA . 20.1 p 26.51 36.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.924 0.392 . . . . 0.0 110.25 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.673 ' N ' ' O ' ' A' ' 9' ' ' ALA . 66.8 m -78.26 2.18 19.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.363 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.63 ' C ' ' H ' ' A' ' 14' ' ' VAL . 48.6 mt-10 60.96 -11.1 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.356 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 13' ' ' SER . . . . . 0.655 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.6 OUTLIER 68.36 -22.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.97 -179.374 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.63 ' H ' ' C ' ' A' ' 12' ' ' GLU . 39.4 t -135.0 133.97 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.112 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.717 ' C ' ' H ' ' A' ' 17' ' ' ILE . 1.4 m -130.14 -56.98 1.1 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.25 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.573 ' O ' ' OG ' ' A' ' 21' ' ' SER . 61.2 mp0 -66.04 32.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.717 ' H ' ' C ' ' A' ' 15' ' ' THR . 49.1 mt -31.48 -35.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.886 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 5.2 t -44.35 127.67 5.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 70.68 26.8 3.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 23.7 p 52.57 35.55 18.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.691 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 p -62.46 164.05 7.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.735 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.437 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 20.8 m-30 -129.37 147.9 51.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.47 178.495 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' CG2' ' OE1' ' A' ' 16' ' ' GLU . 38.9 t -124.04 101.9 10.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.09 137.76 43.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 -178.561 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -124.55 152.27 43.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.883 179.356 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.473 ' CD2' HG11 ' A' ' 76' ' ' VAL . 39.0 p90 -143.35 -177.93 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.5 -179.489 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 29' ' ' ALA . 55.8 t -108.02 132.54 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.871 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.644 ' C ' ' H ' ' A' ' 30' ' ' SER . 98.3 p -54.68 -33.21 60.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.959 0.409 . . . . 0.0 110.49 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.619 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 54.69 -6.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.528 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.787 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.2 m -166.05 122.88 1.37 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.07 -179.633 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -80.34 -4.07 52.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.129 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.8 p -85.14 -5.58 59.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.59 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 30' ' ' SER . 2.4 p -63.3 138.83 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 79' ' ' ILE . 7.2 m -94.5 -17.14 22.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.248 0.547 . . . . 0.0 109.559 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.06 178.51 47.59 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -126.9 151.6 48.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.596 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 21.2 ttp180 -130.8 121.26 25.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.984 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.1 132.01 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.594 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 79.6 tt0 -121.07 133.65 55.24 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.61 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.465 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.4 p90 -139.04 130.48 27.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.155 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -142.72 161.63 37.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.573 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.654 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 56.8 mt -75.15 132.61 41.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 111.85 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -77.86 -14.67 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.124 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -100.19 -74.91 0.59 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.658 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 89.3 mt-10 -63.65 -34.57 78.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.93 -179.224 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 84.75 -39.6 2.95 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.323 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.64 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 32.4 t0 29.43 -153.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.888 0.375 . . . . 0.0 110.45 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.64 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -102.6 134.93 19.63 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.429 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.66 142.13 62.93 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.166 1.911 . . . . 0.0 111.511 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.465 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 21.3 mt-30 -118.08 144.9 45.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.594 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.9 m-85 -125.17 137.37 54.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.627 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.5 mt -117.03 127.41 54.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -100.49 131.15 46.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.127 0.489 . . . . 0.0 111.093 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 61' ' ' VAL . 4.5 mt -129.12 155.79 79.26 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.59 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.69 158.61 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 112.167 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.433 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 27.8 p -58.69 -12.95 4.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.714 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.5 p -90.31 -10.23 44.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 134.74 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.7 p -126.83 7.51 6.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.563 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -165.76 147.08 7.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.232 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 54' ' ' LEU . 5.7 p -148.91 150.43 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.043 0.449 . . . . 0.0 111.371 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.439 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 8.1 t-20 -101.49 130.48 47.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.925 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -107.29 97.01 17.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 85.3 Cg_endo -87.46 -171.52 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.664 2.243 . . . . 0.0 112.541 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 58.42 35.63 24.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.219 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.573 ' O ' ' OG ' ' A' ' 20' ' ' SER . 50.0 mt -90.53 142.01 28.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.2 mt -82.75 113.16 43.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.266 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -54.4 141.42 72.32 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.226 1.95 . . . . 0.0 112.204 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.26 20.09 70.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.658 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 13.3 mmm-85 -123.05 146.91 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.716 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -100.15 131.54 46.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 76.9 m-85 -121.13 153.93 36.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.214 0.531 . . . . 0.0 111.625 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.0 mt -108.31 124.08 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.206 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.97 131.54 64.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -134.54 126.1 28.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.552 179.517 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 26' ' ' TRP . 38.8 t -106.33 130.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.904 -179.461 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -123.5 136.59 54.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.025 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.47 ' OE1' ' O ' ' A' ' 28' ' ' SER . 7.2 pt20 -100.93 134.74 43.46 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.207 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 34' ' ' SER . 59.2 mt -97.5 123.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.957 -178.4 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.579 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 52.1 p -83.34 170.97 14.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.97 -21.41 64.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.579 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -91.3 -0.8 57.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.56 10.18 70.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.335 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 78.3 mm-40 -84.67 140.8 31.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.791 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -106.12 143.16 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.504 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.2 t -136.59 132.15 34.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.261 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 90' ' ' SER . 24.1 tp -72.96 118.37 15.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.349 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.435 HD11 ' CD1' ' A' ' 26' ' ' TRP . 41.5 pt -109.42 -22.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.401 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.7 tp -154.88 121.81 5.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 111.459 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.575 ' HB2' HD21 ' A' ' 87' ' ' LEU . 39.3 t -132.08 113.24 13.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.666 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.8 t -150.87 162.76 40.16 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.443 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -116.49 154.3 30.61 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.331 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.433 ' OE1' ' CG ' ' A' ' 22' ' ' PHE . 76.0 mt-30 -136.56 155.82 49.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.93 109.51 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.4 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 18.4 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.499 -179.203 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.41 141.51 97.13 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.778 2.318 . . . . 0.0 111.518 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 tt -91.29 121.8 33.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.505 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.685 ' O ' ' N ' ' A' ' 6' ' ' HIS . . . 154.67 179.44 29.91 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 35.3 t 49.54 -73.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.568 0.223 . . . . 0.0 110.972 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.685 ' N ' ' O ' ' A' ' 4' ' ' GLY . 27.8 m80 76.51 -60.93 0.46 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.463 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 6' ' ' HIS . 3.1 mt 33.02 63.77 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.666 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.546 ' O ' ' C ' ' A' ' 9' ' ' ALA . 14.7 p -84.23 150.22 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.674 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.546 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . -28.3 113.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.005 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 m -112.59 141.01 46.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.645 -178.91 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -82.18 155.65 24.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.465 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -54.46 137.51 42.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 110.606 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.91 -18.71 13.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.505 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.8 t -103.71 122.28 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.125 0.488 . . . . 0.0 111.108 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.949 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.5 m -111.69 -167.52 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.983 179.108 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.949 ' H ' HG22 ' A' ' 15' ' ' THR . 3.1 mp0 33.37 28.34 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.706 ' N ' ' O ' ' A' ' 15' ' ' THR . 80.1 mt -37.14 -21.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.584 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.66 ' N ' ' O ' ' A' ' 16' ' ' GLU . 69.8 p -58.34 151.97 18.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.682 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.567 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 55.58 21.75 4.72 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.484 -0.487 . . . . 0.0 109.947 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.567 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER 58.03 33.84 23.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.234 -179.879 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.569 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 3.5 p -61.18 165.87 4.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.24 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.521 ' O ' ' OD1' ' A' ' 62' ' ' ASN . 17.3 m-30 -136.12 151.06 49.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.281 178.765 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.96 102.2 9.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.677 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.63 136.51 48.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.306 -178.557 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -121.88 153.18 38.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.687 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.62 ' CD2' HG11 ' A' ' 76' ' ' VAL . 29.0 p90 -143.58 -168.9 2.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 110.933 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.841 HG12 ' H ' ' A' ' 29' ' ' ALA . 79.7 t -115.1 133.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.217 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 30' ' ' SER . 98.2 p -51.9 -29.69 21.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.422 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.841 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 50.77 0.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.251 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.625 ' H ' ' C ' ' A' ' 28' ' ' SER . 3.0 m -173.03 134.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.912 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.54 -8.39 54.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.57 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 44.6 p -83.35 -2.83 56.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.632 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 30' ' ' SER . 2.6 p -65.09 135.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.297 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 79' ' ' ILE . 59.7 m -95.37 -15.07 23.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.525 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.54 -178.89 48.37 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.34 152.73 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.549 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 27.4 ttp180 -130.8 122.68 27.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.594 179.396 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.32 134.32 51.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.948 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 83.2 tt0 -121.47 126.95 50.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.202 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.457 ' CE1' ' OE1' ' A' ' 50' ' ' GLN . 54.0 p90 -133.6 131.29 39.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.238 0.542 . . . . 0.0 110.502 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -147.44 161.56 40.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.442 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.78 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 67.6 mt -75.78 130.45 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.941 0.401 . . . . 0.0 111.702 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.0 p -74.87 -23.23 58.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.106 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -89.63 -71.04 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 94.1 mt-10 -59.11 -37.98 78.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.698 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 70.4 21.91 77.56 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.55 ' O ' ' O ' ' A' ' 46' ' ' GLY . 27.1 t0 -46.29 -176.74 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.963 0.411 . . . . 0.0 110.333 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.511 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -69.76 140.2 89.01 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.93 179.773 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -72.44 148.78 49.04 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.483 2.122 . . . . 0.0 111.856 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.457 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 32.7 mt-30 -116.81 147.82 41.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -123.95 139.59 53.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.943 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.7 mt -124.76 128.55 48.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.056 178.348 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -103.36 132.02 49.96 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.977 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' LEU . . . . . 0.449 HD21 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -128.91 155.15 80.02 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.916 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.9 155.77 68.48 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 112.031 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.413 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 26.7 p -58.06 -14.66 7.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.639 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.8 p -89.41 -11.12 44.07 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.367 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.99 131.44 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.4 p -125.28 10.2 8.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.617 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -164.85 146.4 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.06 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.449 HG21 HD21 ' A' ' 54' ' ' LEU . 5.1 p -149.05 152.21 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.514 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.521 ' OD1' ' O ' ' A' ' 22' ' ' PHE . 41.8 t30 -102.42 124.76 48.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.762 178.86 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 mt -97.26 107.0 35.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -92.21 -178.65 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.802 2.335 . . . . 0.0 113.145 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 58.7 38.05 25.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.531 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.525 ' O ' ' OG ' ' A' ' 20' ' ' SER . 56.7 mt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.094 178.988 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.493 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 30.2 mt -86.44 123.77 70.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.249 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.81 143.36 55.29 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.226 1.95 . . . . 0.0 112.523 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.56 19.53 73.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.673 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -126.44 151.55 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.302 . . . . 0.0 110.64 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -100.37 130.65 46.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.029 0.442 . . . . 0.0 110.236 179.232 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.78 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 68.1 m-85 -117.25 158.52 24.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.017 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.4 mt -113.37 126.08 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.031 0.443 . . . . 0.0 110.642 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -133.36 125.76 29.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.421 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.62 HG11 ' CD2' ' A' ' 26' ' ' TRP . 14.3 t -104.65 128.51 58.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.583 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -120.75 139.37 53.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 7.2 pt20 -101.62 134.52 44.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.963 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.4 mt -99.06 119.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.39 0.614 . . . . 0.0 110.621 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.6 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 24.7 p -82.56 169.64 16.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.078 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.98 -19.3 51.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.48 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.6 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 47.3 p30 -93.14 -1.41 56.4 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.144 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.28 67.36 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.926 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 73.8 mm-40 -83.7 139.26 32.88 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 67.7 mt-30 -110.41 139.43 45.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.791 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -136.82 135.92 38.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.937 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.819 HD21 ' HB2' ' A' ' 90' ' ' SER . 32.3 tp -73.28 118.45 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 27' ' ' VAL . 44.1 pt -109.05 -22.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.612 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -154.87 122.19 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.106 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.819 ' HB2' HD21 ' A' ' 87' ' ' LEU . 35.2 t -130.61 122.21 27.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -154.34 158.59 40.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.323 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.2 p -117.15 152.69 34.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 82.2 mt-30 -138.94 157.47 45.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.661 179.809 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 112.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 53.8 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.498 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.23 18.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.851 2.368 . . . . 0.0 111.653 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.554 ' H ' ' C ' ' A' ' 1' ' ' GLY . 1.0 OUTLIER -70.28 144.14 51.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.013 -179.713 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.55 11.48 81.81 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.7 p -84.95 -4.06 58.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.915 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 8' ' ' VAL . 76.6 m-70 -73.36 -113.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.105 0.478 . . . . 0.0 110.552 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 7' ' ' LEU . 6.5 mp 36.31 23.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.991 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.69 ' C ' ' H ' ' A' ' 10' ' ' THR . 36.9 t -70.05 -11.71 15.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.98 -27.95 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.363 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.69 ' H ' ' C ' ' A' ' 8' ' ' VAL . 63.8 m -103.91 139.21 39.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.937 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 p -130.85 -90.87 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.446 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 14' ' ' VAL . 39.4 tp10 -72.69 -44.03 62.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.165 0.507 . . . . 0.0 109.899 178.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m 69.8 -40.64 0.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.947 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.476 ' H ' ' C ' ' A' ' 12' ' ' GLU . 47.3 t -115.01 131.34 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.978 0.418 . . . . 0.0 111.94 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.964 HG22 ' H ' ' A' ' 16' ' ' GLU . 9.5 m -134.67 -143.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.954 178.615 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.964 ' H ' HG22 ' A' ' 15' ' ' THR . 77.4 mm-40 8.14 56.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.529 0.518 . . . . 0.0 110.777 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.711 ' N ' ' O ' ' A' ' 15' ' ' THR . 67.4 mt -64.1 -21.5 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.991 -178.73 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 18.4 m -53.33 135.0 39.63 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.39 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 65.4 17.38 10.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.597 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER 60.41 29.14 18.78 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.313 -179.879 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.607 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -60.77 129.57 42.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.182 0.515 . . . . 0.0 110.626 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.408 ' CE2' ' HB2' ' A' ' 93' ' ' GLN . 19.0 m-30 -95.65 144.87 25.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.266 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.31 102.87 13.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.87 137.88 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.079 0.466 . . . . 0.0 111.504 -178.457 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -126.52 153.02 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.711 179.32 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.577 ' CD2' HG11 ' A' ' 76' ' ' VAL . 32.2 p90 -144.65 -172.52 3.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 29' ' ' ALA . 39.4 t -113.76 131.15 66.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.629 179.235 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.592 ' C ' ' H ' ' A' ' 30' ' ' SER . 27.3 t -52.76 -34.64 54.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.683 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.537 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 60.59 -7.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.082 179.507 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 28' ' ' SER . 3.1 m -167.48 132.77 1.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.798 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -90.06 6.55 41.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.483 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.49 -4.39 48.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.231 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 30' ' ' SER . 2.1 p -63.29 138.49 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.106 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.8 m -95.31 -13.31 24.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.346 0.593 . . . . 0.0 109.831 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.96 177.02 44.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.57 151.71 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.904 0.383 . . . . 0.0 110.369 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.561 ' NH2' HE22 ' A' ' 85' ' ' GLN . 46.0 ttp180 -128.66 121.74 29.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.682 178.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 61' ' ' VAL . 47.9 t -106.72 132.87 52.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.381 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 69.3 tt0 -123.46 134.28 53.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.763 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 54.6 p90 -140.14 137.18 34.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 110.714 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.62 158.94 44.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.907 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.685 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 39.9 mt -74.25 132.4 42.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.5 p -77.64 -13.67 59.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.317 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -98.8 -73.19 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.976 -179.539 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -60.1 -34.4 73.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.155 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 74.96 18.48 80.18 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.677 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 37.8 t0 -41.32 173.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.0 110.462 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 48' ' ' GLU . . . . . 0.677 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -67.18 140.23 95.51 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.125 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.538 ' C ' ' OE1' ' A' ' 50' ' ' GLN . 57.7 Cg_endo -73.3 146.35 40.11 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.575 2.183 . . . . 0.0 111.997 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.655 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.4 mp0 -113.11 147.9 36.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -122.72 136.16 54.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.146 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -120.58 128.28 52.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.465 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.66 130.61 46.73 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.201 -178.928 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -127.82 155.95 76.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.468 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -68.21 156.16 66.77 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.274 1.983 . . . . 0.0 112.269 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 53.4 p -58.8 -14.11 7.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.3 p -90.01 -8.83 50.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.71 132.96 34.39 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 p -128.9 12.73 6.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.032 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.5 p -164.61 148.62 9.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 38' ' ' VAL . 5.3 p -152.63 147.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.514 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 15.9 t-20 -102.88 127.96 49.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.366 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.455 HG22 HD21 ' A' ' 66' ' ' LEU . 1.9 mt -99.21 104.6 27.33 Favored Pre-proline 0 C--N 1.332 -0.177 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.5 Cg_endo -89.42 174.66 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.785 2.323 . . . . 0.0 113.103 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 61.38 38.31 16.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.708 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -90.51 142.44 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.793 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.417 HD13 ' NH2' ' A' ' 70' ' ' ARG . 24.9 mt -78.66 130.8 69.69 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.287 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 70' ' ' ARG . 39.0 Cg_exo -51.35 -174.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.206 1.937 . . . . 0.0 111.812 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 17.02 40.29 0.01 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.373 179.068 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.709 ' N ' ' O ' ' A' ' 68' ' ' PRO . 16.2 mmm-85 -127.22 142.76 51.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.346 0.573 . . . . 0.0 110.417 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -101.19 132.4 46.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.685 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 67.8 m-85 -121.28 155.72 34.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.2 mt -110.68 123.77 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.816 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 62.7 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 0.0 111.565 -178.27 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 75' ' ' ASN . . . . . 0.496 ' OD1' ' OG ' ' A' ' 90' ' ' SER . 21.4 m-80 -133.07 126.14 31.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.523 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' A' ' 26' ' ' TRP . 6.6 t -107.57 131.36 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.12 142.29 50.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.116 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.528 ' OE1' ' O ' ' A' ' 28' ' ' SER . 9.3 pt20 -102.88 137.47 41.04 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.804 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.663 ' O ' ' N ' ' A' ' 34' ' ' SER . 45.2 mt -100.93 121.56 51.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.074 0.464 . . . . 0.0 110.437 -178.587 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.614 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 71.4 p -82.11 168.13 18.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.945 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -57.62 -22.25 44.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.614 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.5 p30 -92.82 -0.49 57.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.723 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.76 11.95 67.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.495 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.21 138.69 33.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.195 0.498 . . . . 0.0 111.037 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.561 HE22 ' NH2' ' A' ' 37' ' ' ARG . 22.9 mt-30 -107.03 142.24 36.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.224 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -138.3 135.34 35.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.135 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 90' ' ' SER . 36.8 tp -73.42 118.6 16.57 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.228 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 88' ' ' ILE . 32.6 pt -110.99 -22.43 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.555 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -155.19 124.86 6.47 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.562 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.614 ' HB2' HD21 ' A' ' 87' ' ' LEU . 7.2 t -135.66 119.22 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.345 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 t -149.88 158.27 44.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.902 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -115.74 154.65 29.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.137 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.408 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 82.6 mt-30 -142.18 159.81 41.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.23 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.17 114.84 23.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.477 178.597 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.586 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 31.1 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.607 -179.191 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.463 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -88.34 -9.8 4.94 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.475 2.783 . . . . 0.0 113.9 -179.239 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.1 mt -59.51 -36.22 75.66 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.093 -178.778 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' SER . . . -108.44 -140.73 9.31 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 4' ' ' GLY . 13.2 m 36.5 -157.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 110.667 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 60.66 45.46 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 110.048 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.0 tt -53.44 -37.74 62.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.487 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 10' ' ' THR . 7.4 p -137.96 -42.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.512 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.653 ' C ' HG22 ' A' ' 10' ' ' THR . . . -61.95 148.1 44.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 0.0 110.809 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' THR . . . . . 0.653 HG22 ' C ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER 166.63 -33.63 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.478 0.656 . . . . 0.0 109.484 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 11' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 8.0 p -163.62 -138.62 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.408 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' N ' ' OG ' ' A' ' 11' ' ' SER . 85.6 mt-10 -67.95 -31.86 71.89 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.877 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.37 4.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.241 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 12' ' ' GLU . 39.2 t -135.02 -59.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.384 . . . . 0.0 110.837 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.7 HG22 ' N ' ' A' ' 16' ' ' GLU . 59.6 m 45.89 -102.64 0.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.7 ' N ' HG22 ' A' ' 15' ' ' THR . 17.4 pt-20 46.79 43.47 13.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.7 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.675 HG22 ' N ' ' A' ' 18' ' ' THR . 30.3 mt -110.05 -118.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.571 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.675 ' N ' HG22 ' A' ' 17' ' ' ILE . 71.3 p 36.15 102.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.565 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 68.16 22.64 8.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.297 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.64 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.6 p 55.26 22.59 4.87 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.324 -178.923 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.625 ' O ' ' O ' ' A' ' 16' ' ' GLU . 2.3 p -61.59 127.92 33.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.524 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.5 m-30 -92.34 140.41 29.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.126 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.32 107.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.47 135.15 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.847 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -124.34 150.79 45.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.142 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.57 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.9 p90 -145.04 -164.99 2.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' VAL . . . . . 0.654 HG12 ' H ' ' A' ' 29' ' ' ALA . 47.0 t -118.75 133.37 65.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.345 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 30' ' ' SER . 61.1 p -50.56 -28.83 9.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.595 -179.196 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 29' ' ' ALA . . . . . 0.654 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 42.81 9.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 179.486 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.678 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -169.08 116.96 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.82 -179.896 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -84.44 -7.46 59.28 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.8 p -88.25 -0.7 57.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.017 179.305 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 30' ' ' SER . 7.5 p -66.94 137.22 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.8 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.2 m -95.11 -16.51 22.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.83 178.34 47.29 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.19 151.27 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.895 0.379 . . . . 0.0 110.118 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 26.9 ttp180 -130.46 125.62 34.86 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.557 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.525 HG21 HG11 ' A' ' 61' ' ' VAL . 46.2 t -109.13 131.49 59.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.396 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.2 tt0 -120.99 126.21 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 49.6 p90 -137.61 137.05 38.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.239 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -147.2 167.53 23.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.811 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 57.9 mt -77.1 128.59 34.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 111.213 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 p -76.4 -16.09 59.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.145 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -92.31 -74.82 0.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -62.84 -34.29 77.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.998 -179.43 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.68 34.96 59.28 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -57.56 169.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -61.11 137.47 94.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.85 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.71 152.47 81.84 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.603 2.202 . . . . 0.0 112.846 -179.281 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 42.9 mt-30 -118.65 144.7 46.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.904 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -121.1 143.04 49.3 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.054 -0.659 . . . . 0.0 112.203 -178.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 mt -129.38 125.74 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.869 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -100.54 133.52 44.85 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.367 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 160.43 63.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.512 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 58' ' ' ALA . 35.9 Cg_endo -75.61 158.99 39.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.989 1.793 . . . . 0.0 112.129 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.477 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 7.7 p -57.45 -12.23 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.296 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 p -93.8 -8.11 41.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.09 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' ALA . . . . . 0.467 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . . . -82.07 138.53 34.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -130.27 5.69 4.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.993 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 p -163.31 146.82 10.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 38' ' ' VAL . 9.7 p -146.85 146.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.407 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' ASN . . . . . 0.436 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 19.4 t30 -103.51 128.49 50.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.296 179.315 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.457 HD13 ' CD1' ' A' ' 40' ' ' TYR . 1.4 mt -105.47 99.49 21.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.925 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 96.7 Cg_endo -88.83 174.46 3.92 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.579 2.186 . . . . 0.0 112.162 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 66.56 37.73 4.39 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.431 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.64 HD12 ' O ' ' A' ' 20' ' ' SER . 39.4 mt -89.74 157.42 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 mt -91.1 110.09 39.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.793 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 22.1 Cg_exo -56.39 143.33 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.192 1.928 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' GLY . . . . . 0.602 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 79.05 17.78 76.14 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -125.15 151.2 46.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -99.85 131.86 45.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.866 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.811 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 72.2 m-85 -118.84 153.05 35.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.457 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 75.0 mt -110.1 126.81 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.369 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.92 133.88 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.115 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -133.98 126.87 31.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.545 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.57 HG11 ' CD2' ' A' ' 26' ' ' TRP . 23.9 t -105.44 126.96 60.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -119.35 139.74 51.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 5.5 pt20 -105.13 136.61 44.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.35 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.681 ' O ' ' N ' ' A' ' 34' ' ' SER . 46.4 mt -100.66 124.78 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.216 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.6 p -85.43 171.99 11.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.82 -19.45 41.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.8 p30 -92.34 -2.32 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.203 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.52 68.73 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.272 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 65.6 mm-40 -84.48 142.07 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.135 0.468 . . . . 0.0 111.097 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 32.0 mt-30 -108.64 139.81 42.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.832 179.68 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -136.92 137.81 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.866 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' A' ' 90' ' ' SER . 43.2 tp -74.07 118.46 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.377 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 43.3 pt -110.91 -23.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.616 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.0 tp -155.82 125.02 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.666 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.605 ' HB2' HD21 ' A' ' 87' ' ' LEU . 25.9 t -134.37 118.97 18.06 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 t -153.79 154.39 33.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.447 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -116.52 155.11 29.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.107 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 78.2 mt-30 -145.48 164.65 30.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.238 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 109.52 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.72 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 72.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.389 -179.4 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PRO . . . . . 0.618 ' C ' ' H ' ' A' ' 4' ' ' GLY . 10.9 Cg_endo -57.24 149.5 63.87 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.519 2.146 . . . . 0.0 111.829 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 3' ' ' LEU . 1.1 mm? -64.14 16.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLY . . . . . 0.767 ' O ' ' CE1' ' A' ' 6' ' ' HIS . . . -57.4 136.79 50.28 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' SER . . . . . 0.54 ' O ' ' C ' ' A' ' 6' ' ' HIS . 60.0 p -86.32 -2.64 58.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.23 -0.188 . . . . 0.0 111.272 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 6' ' ' HIS . . . . . 0.767 ' CE1' ' O ' ' A' ' 4' ' ' GLY . 0.1 OUTLIER 29.46 55.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.605 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 7' ' ' LEU . . . . . 0.419 HD23 ' H ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -52.34 71.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.147 -179.408 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 8' ' ' VAL . . . . . 0.699 ' N ' ' O ' ' A' ' 6' ' ' HIS . 18.8 m -111.28 5.59 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.81 179.364 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . 37.29 -121.29 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.926 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.0 t -103.86 175.05 5.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.051 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -60.63 -163.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.126 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 12' ' ' GLU . . . . . 0.676 ' C ' ' H ' ' A' ' 14' ' ' VAL . 97.0 mt-10 -57.89 -35.94 71.71 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.547 -179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 p 60.45 -19.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.074 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' VAL . . . . . 0.676 ' H ' ' C ' ' A' ' 12' ' ' GLU . 63.4 t -107.53 132.03 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.715 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 15' ' ' THR . . . . . 0.443 ' O ' HG13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -109.49 -43.73 4.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.939 179.675 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 16' ' ' GLU . . . . . 0.56 ' OE1' HG21 ' A' ' 23' ' ' VAL . 43.8 mp0 -74.78 92.57 2.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ILE . . . . . 0.678 ' O ' ' N ' ' A' ' 20' ' ' SER . 12.6 mt -112.88 -22.92 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.431 -179.056 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 19' ' ' ALA . 35.0 p -32.66 -71.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.03 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . -81.71 26.53 0.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.39 179.019 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER 60.91 21.47 11.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.957 -179.834 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 21' ' ' SER . . . . . 0.485 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -61.22 172.1 1.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.801 -179.134 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CZ ' HG22 ' A' ' 95' ' ' THR . 23.3 m-85 -135.58 146.06 47.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.913 178.166 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.56 HG21 ' OE1' ' A' ' 16' ' ' GLU . 41.5 t -117.28 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.515 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.6 t -108.76 134.9 49.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.075 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.0 p -126.66 151.66 47.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.167 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' TRP . . . . . 0.565 ' CD2' HG11 ' A' ' 76' ' ' VAL . 36.9 p90 -144.37 -174.64 4.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.977 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.79 127.66 74.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.62 129.08 8.8 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -111.71 28.17 8.99 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.745 -178.706 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -163.47 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.392 179.974 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 61.51 -41.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.073 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' THR . . . . . 0.681 ' N ' ' O ' ' A' ' 30' ' ' SER . 40.1 p -74.19 5.24 4.61 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.053 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' H ' HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -60.1 138.1 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.006 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 34' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 79' ' ' ILE . 32.1 m -94.46 -15.74 23.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 109.612 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.04 176.68 45.37 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.33 151.48 44.27 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.29 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' ARG . . . . . 0.484 ' NH2' HE22 ' A' ' 85' ' ' GLN . 40.6 ttp180 -131.78 125.06 30.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.817 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' VAL . . . . . 0.529 HG21 HG11 ' A' ' 61' ' ' VAL . 48.2 t -110.8 133.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.621 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.9 tt0 -123.82 132.24 53.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' TYR . . . . . 0.52 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 53.4 p90 -140.04 136.26 33.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.001 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -146.66 161.79 39.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.551 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' LEU . . . . . 0.786 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -75.0 125.14 28.29 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.848 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -69.57 -18.91 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -94.23 -73.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 45' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 94.8 mt-10 -57.55 -34.59 69.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.993 -178.992 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.25 34.23 69.26 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' ASP . . . . . 0.454 ' C ' ' OD1' ' A' ' 47' ' ' ASP . 48.5 p30 -58.22 -175.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.382 . . . . 0.0 110.417 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -71.54 135.95 83.71 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.3 146.45 69.32 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.267 1.978 . . . . 0.0 111.703 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' GLN . . . . . 0.52 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 30.8 mt-30 -114.33 144.01 43.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -120.94 140.33 51.99 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.965 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -125.76 128.08 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.916 178.612 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -103.12 130.72 50.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.081 0.467 . . . . 0.0 111.43 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -129.77 154.55 81.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.651 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -69.54 157.73 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.371 2.047 . . . . 0.0 112.724 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' SER . . . . . 0.464 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 58.3 p -58.13 -14.65 7.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.701 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.4 p -89.61 -9.67 48.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.03 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.53 131.94 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.603 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.0 p -130.14 13.74 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.5 p -163.58 146.06 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.219 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.529 HG11 HG21 ' A' ' 38' ' ' VAL . 7.6 p -149.21 145.63 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 111.487 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -103.12 125.14 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.391 178.962 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.426 ' HB ' HD11 ' A' ' 66' ' ' LEU . 1.8 mt -97.98 107.59 41.59 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.179 -179.326 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -89.23 177.19 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.856 2.37 . . . . 0.0 112.682 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.47 38.18 19.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.717 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 34.1 mt -90.92 147.74 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.779 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LEU . . . . . 0.428 ' O ' ' OG1' ' A' ' 95' ' ' THR . 17.1 mt -89.09 114.25 59.44 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.893 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 31.6 Cg_exo -54.33 136.41 68.8 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.276 1.984 . . . . 0.0 111.465 178.031 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.73 26.75 66.47 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.864 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 45' ' ' GLU . 7.0 mmt180 -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -98.34 127.97 44.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 72' ' ' TYR . . . . . 0.786 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 74.6 m-85 -119.02 147.99 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.22 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 76.2 mt -103.87 124.83 58.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.585 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 t -111.17 130.57 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.671 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.91 123.08 24.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.507 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' VAL . . . . . 0.565 HG11 ' CD2' ' A' ' 26' ' ' TRP . 17.7 t -104.28 126.57 58.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -120.02 138.3 53.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.878 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' GLN . . . . . 0.484 ' NE2' ' OG ' ' A' ' 30' ' ' SER . 7.0 pt20 -102.27 135.96 42.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.896 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.5 mt -99.26 122.26 50.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.229 0.537 . . . . 0.0 110.613 -178.739 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 94.5 p -83.5 169.45 15.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -21.15 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.878 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.5 p30 -91.74 -0.91 57.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.009 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.58 11.37 68.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.011 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' GLU . . . . . 0.575 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.0 mm-40 -82.81 140.39 32.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLN . . . . . 0.484 HE22 ' NH2' ' A' ' 37' ' ' ARG . 36.5 mt-30 -108.81 141.03 41.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.728 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.3 t -137.26 133.05 34.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 87' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' A' ' 90' ' ' SER . 13.7 tp -71.31 119.05 14.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.695 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.9 pt -108.12 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.652 -179.508 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -156.07 121.33 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.176 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' SER . . . . . 0.743 ' HB2' HD21 ' A' ' 87' ' ' LEU . 15.7 t -131.1 118.39 20.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.44 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -149.42 153.73 37.78 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.724 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.5 p -115.89 149.25 38.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.101 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 76.4 mt-30 -147.45 158.9 44.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.6 OUTLIER -119.04 111.5 18.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.739 178.318 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 95' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 73.8 p . . . . . 0 C--N 1.321 -0.651 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.787 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.546 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER . . . . . 0 C--O 1.231 0.09 0 CA-C-O 121.017 0.437 . . . . 0.0 110.464 . . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.496 ' HG ' HD21 ' A' ' 62' ' ' ASN . 0.4 OUTLIER -65.52 -179.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 111.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.696 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 33.6 m-85 -141.52 140.03 33.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.985 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.7 t -113.68 101.07 11.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -111.16 133.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.322 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.7 p -122.24 153.02 39.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.648 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -143.15 -171.57 3.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.57 126.78 73.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.458 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m . . . . . 0 C--N 1.322 -0.611 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.797 -179.765 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.5 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.4 p . . . . . 0 N--CA 1.455 -0.224 0 N-CA-C 110.102 -0.332 . . . . 0.0 110.102 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 79' ' ' ILE . 19.5 m -94.44 -15.18 24.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.5 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.64 -179.23 47.74 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.18 154.9 44.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.958 0.409 . . . . 0.0 111.004 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.751 ' NE ' HE22 ' A' ' 85' ' ' GLN . 18.2 ttp180 -132.07 124.92 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 61' ' ' VAL . 17.9 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.447 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' CB ' ' A' ' 49' ' ' PRO . 75.0 tt0 -125.85 129.8 50.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 22.5 p90 -137.51 130.97 31.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -144.51 161.92 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.863 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.74 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 87.6 mt -74.52 126.63 31.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.161 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.3 p -73.14 -20.98 60.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.153 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 . . . . . 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.155 -179.138 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.451 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 72.6 Cg_endo . . . . . 0 N--CA 1.489 1.228 0 CA-C-O 121.066 0.361 . . . . 0.0 112.769 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 19.7 mt-30 -114.47 146.18 40.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.441 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -123.09 137.13 55.0 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.437 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 76.7 mt -123.85 135.07 53.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.032 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -108.52 134.71 50.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.329 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.49 153.65 80.67 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.6 156.47 60.84 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.384 2.056 . . . . 0.0 112.344 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 17.6 p -57.56 -15.9 8.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.028 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.8 p -90.94 -7.6 51.64 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.539 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.43 137.18 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.1 p -134.51 13.82 3.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.227 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.7 p -164.79 145.22 7.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.634 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 38' ' ' VAL . 4.3 p -153.93 150.36 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.198 0.523 . . . . 0.0 111.942 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.496 HD21 ' HG ' ' A' ' 21' ' ' SER . 9.2 t-20 -103.32 129.27 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.396 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.95 104.34 28.13 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.019 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 94.7 Cg_endo -89.9 179.95 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.833 2.355 . . . . 0.0 113.153 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 59.62 37.03 22.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.7 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.546 ' O ' ' OG ' ' A' ' 20' ' ' SER . 29.5 mt -92.26 150.56 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.163 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.637 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 29.5 mt -89.04 111.27 43.88 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.777 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 20.4 Cg_exo -57.97 143.6 95.83 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.155 1.903 . . . . 0.0 111.865 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.66 80.44 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -123.22 146.58 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -95.28 134.36 38.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.244 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.74 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 12.3 m-85 -118.49 150.84 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.8 mt -108.54 121.64 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.94 131.37 66.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.095 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -133.73 131.46 39.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.701 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -105.1 131.43 54.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.554 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -123.43 137.42 54.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.686 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.94 136.65 40.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.1 mt -99.29 125.26 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.38 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 47.3 p -84.64 169.25 14.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.74 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -59.9 -16.63 30.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.603 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.602 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 43.9 p30 -96.04 0.25 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.06 15.23 63.1 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.71 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.558 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 54.0 mm-40 -83.77 141.97 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.936 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.751 HE22 ' NE ' ' A' ' 37' ' ' ARG . 89.5 mt-30 -114.38 140.37 48.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.625 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -136.09 133.2 37.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.858 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 90' ' ' SER . 21.8 tp -72.17 116.59 12.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.1 pt -108.99 -21.36 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -155.67 126.24 6.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.574 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 87' ' ' LEU . 28.6 t -131.53 122.15 25.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.877 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 t -154.08 153.82 32.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.617 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -112.99 154.75 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.106 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.696 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 31.6 mt-30 -142.09 157.07 45.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.278 0.561 . . . . 0.0 111.388 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.51 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -117.75 107.15 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.51 ' OXT' ' O ' ' A' ' 94' ' ' THR . 71.1 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.919 -1.038 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.708 0.289 . . . . 0.0 110.778 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.459 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -59.07 176.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.541 0.686 . . . . 0.0 111.538 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.587 ' CZ ' HG22 ' A' ' 95' ' ' THR . 15.2 m-85 -148.19 146.59 28.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.041 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 13.6 t -120.96 102.2 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.131 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.2 t -110.17 136.93 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.484 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.8 p -123.46 151.72 42.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.846 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CD2' HG11 ' A' ' 76' ' ' VAL . 35.4 p90 -143.99 -173.33 3.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.165 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 61.6 t -113.6 132.61 62.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.36 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 22.1 p . . . . . 0 C--N 1.323 -0.557 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.783 -179.72 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.0 p . . . . . 0 N--CA 1.453 -0.287 0 CA-C-O 120.944 0.402 . . . . 0.0 111.28 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 79' ' ' ILE . 12.5 m -94.63 -14.11 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.583 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.67 176.81 46.01 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.59 151.21 46.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.069 0.462 . . . . 0.0 110.827 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.847 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.2 ttp180 -131.94 124.44 29.43 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.23 134.66 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.42 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 74.6 tt0 -121.96 127.08 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.978 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.6 p90 -135.54 133.98 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.63 165.69 29.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.229 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.766 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 85.2 mt -74.65 129.39 37.64 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.211 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 16.8 p -74.79 -15.75 60.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.307 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 . . . . . 0 C--N 1.328 -0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.274 -178.851 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.489 1.227 0 CA-C-O 120.959 0.316 . . . . 0.0 112.098 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.473 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 20.0 mt-30 -116.18 151.11 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.42 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -124.77 138.29 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.052 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.5 mt -125.02 131.35 53.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.73 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -104.63 133.04 50.15 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.917 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.6 mt -130.26 153.37 81.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.639 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.65 154.3 74.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.344 2.029 . . . . 0.0 112.622 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -56.77 -12.53 1.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.7 p -93.16 -9.67 38.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.646 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.54 136.27 34.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.514 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.9 p -128.03 10.62 6.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.01 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.5 p -164.07 150.41 11.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.539 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -151.37 153.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.186 0.517 . . . . 0.0 111.485 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.434 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 8.7 t-20 -103.4 126.57 50.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.723 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.485 HG22 HD21 ' A' ' 66' ' ' LEU . 3.1 mt -103.02 101.84 24.0 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.926 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 69.1 Cg_endo -91.71 -175.24 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.995 2.463 . . . . 0.0 112.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 58.39 35.01 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.398 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.58 ' O ' ' OG ' ' A' ' 20' ' ' SER . 23.3 mt -88.5 153.14 21.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.36 109.97 41.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.206 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 30.8 Cg_exo -56.02 138.5 82.68 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.234 1.956 . . . . 0.0 111.563 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.81 16.31 73.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.5 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.2 mmt-85 -126.13 148.19 49.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.86 0.362 . . . . 0.0 110.29 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 70.1 tttt -97.35 133.55 41.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.943 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.766 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 60.3 m-85 -118.89 151.39 38.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.599 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.466 HG22 HD21 ' A' ' 75' ' ' ASN . 71.3 mt -108.91 125.45 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -113.59 131.71 64.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.059 0.457 . . . . 0.0 110.917 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.466 HD21 HG22 ' A' ' 73' ' ' ILE . 35.2 m-80 -134.95 126.94 29.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.969 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.489 HG11 ' CD2' ' A' ' 26' ' ' TRP . 26.3 t -105.4 128.56 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.407 ' HB2' HE21 ' A' ' 85' ' ' GLN . 77.8 m-85 -120.0 137.64 53.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.694 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 135.55 43.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.1 mt -98.91 122.31 50.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.2 0.524 . . . . 0.0 110.599 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 52.6 p -83.23 170.22 14.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.196 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.6 -19.63 50.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.374 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 44.6 p30 -91.99 -0.59 57.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.273 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.47 75.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 71.7 mm-40 -84.99 142.55 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 110.482 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.847 HE22 ' NE ' ' A' ' 37' ' ' ARG . 48.1 mt-30 -107.14 145.96 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.099 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 t -137.89 130.76 29.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.221 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 90' ' ' SER . 29.2 tp -73.01 117.93 15.33 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.232 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.3 pt -107.53 -21.66 5.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.773 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.2 tp -156.51 125.45 5.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.56 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.692 ' HB2' HD21 ' A' ' 87' ' ' LEU . 24.0 t -130.86 118.47 20.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -152.77 167.2 29.81 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.709 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 75.1 p -128.86 157.8 40.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 0.0 110.543 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -142.59 161.18 38.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.294 0.569 . . . . 0.0 111.024 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.49 115.23 21.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.538 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.587 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.609 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.465 ' O ' HD12 ' A' ' 66' ' ' LEU . 4.4 p . . . . . 0 N--CA 1.454 -0.243 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.429 ' CB ' HD21 ' A' ' 62' ' ' ASN . 79.6 p -62.87 140.21 58.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.386 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.557 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.7 m-30 -95.15 155.55 16.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.252 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -132.74 103.45 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.95 135.27 50.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 110.529 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -127.28 151.15 49.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.289 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.505 ' HB3' HD22 ' A' ' 89' ' ' LEU . 46.1 p90 -148.83 -164.99 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.1 t -120.49 133.71 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.371 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 36.8 p . . . . . 0 C--N 1.327 -0.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.446 -179.2 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.734 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 5.3 p . . . . . 0 N--CA 1.45 -0.458 0 N-CA-C 110.374 -0.232 . . . . 0.0 110.374 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.3 m -95.46 -12.96 25.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.24 177.26 46.01 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.734 ' CZ ' HG11 ' A' ' 33' ' ' VAL . 92.4 m-85 -129.26 151.51 49.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 110.288 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.671 ' NE ' HE22 ' A' ' 85' ' ' GLN . 27.8 ttp180 -129.71 126.09 37.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.595 HG21 HG11 ' A' ' 61' ' ' VAL . 27.0 t -107.56 134.66 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.523 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 68.5 tt0 -126.35 127.45 45.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.529 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.465 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 27.0 p90 -136.63 140.86 43.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 0.0 111.104 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.33 161.94 40.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.17 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.72 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 50.9 mt -75.63 127.75 33.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 111.503 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 20.3 p -75.81 -9.73 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.812 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.15 -178.313 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo . . . . . 0 N--CA 1.489 1.222 0 CA-C-O 120.893 0.289 . . . . 0.0 111.83 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.465 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 mt-30 -114.31 147.03 39.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.586 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 91.4 m-85 -122.65 136.89 55.01 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.841 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.5 mt -124.8 127.15 46.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -99.06 131.96 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.956 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -127.87 154.29 78.16 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.82 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.58 159.64 52.78 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.619 2.213 . . . . 0.0 112.216 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p -60.61 -14.6 21.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.3 p -90.15 -5.44 56.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.328 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.43 139.29 31.64 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.498 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.6 p -129.72 9.54 5.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -167.55 150.2 5.95 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.595 HG11 HG21 ' A' ' 38' ' ' VAL . 8.1 p -150.29 147.49 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.838 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.429 HD21 ' CB ' ' A' ' 21' ' ' SER . 17.6 t-20 -103.04 127.56 50.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.379 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -102.74 102.1 24.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.322 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 77.3 Cg_endo -86.8 -175.2 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.8 2.333 . . . . 0.0 113.278 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 57.87 39.15 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.611 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' CD1' ' A' ' 22' ' ' PHE . 25.8 mt -90.96 152.53 20.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.41 108.13 37.29 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.297 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 39.3 Cg_exo -51.51 140.66 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.295 1.997 . . . . 0.0 111.647 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.425 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 83.33 14.76 73.35 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -124.69 143.69 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.336 . . . . 0.0 110.385 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 74.7 tttt -99.19 134.88 41.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.72 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 83.8 m-85 -121.84 147.93 45.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 61.6 mt -106.04 128.05 60.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.64 136.49 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.149 0.499 . . . . 0.0 111.588 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -135.36 125.81 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.442 HG11 ' CD2' ' A' ' 26' ' ' TRP . 11.9 t -104.97 131.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.635 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -120.6 140.87 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.489 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -105.92 135.42 47.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.715 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 34' ' ' SER . 36.0 mt -100.23 121.6 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.439 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.621 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 44.4 p -82.49 171.91 13.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.782 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.06 -19.65 54.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.398 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.621 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 45.4 p30 -91.25 -2.8 57.37 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.389 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.17 67.23 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.319 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.514 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.2 mm-40 -83.33 145.23 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.671 HE22 ' NE ' ' A' ' 37' ' ' ARG . 57.4 mt-30 -111.69 140.73 46.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -137.79 135.27 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.637 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 90' ' ' SER . 21.5 tp -71.64 119.29 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.419 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.9 pt -109.36 -26.12 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 26' ' ' TRP . 13.9 tp -156.94 122.77 4.78 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.48 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.403 ' HB2' HD21 ' A' ' 87' ' ' LEU . 34.8 t -134.22 121.1 20.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -150.73 162.35 40.88 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.972 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -121.18 152.12 39.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.289 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 23.2 mt-30 -144.56 160.26 41.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.234 0.54 . . . . 0.0 110.585 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -120.27 109.44 15.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.875 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.557 HG22 ' CE1' ' A' ' 22' ' ' PHE . 69.3 p . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.042 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.539 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.175 0 CA-C-O 121.141 0.496 . . . . 0.0 109.907 . . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.494 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 3.6 p -58.34 -178.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.22 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 21' ' ' SER . 16.1 m-85 -147.2 149.3 32.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.033 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.8 t -123.4 102.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.742 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -110.45 135.59 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.777 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.4 p -129.09 153.73 47.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.411 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.702 ' CD2' HG11 ' A' ' 76' ' ' VAL . 37.4 p90 -144.24 -171.61 3.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.37 128.42 73.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.1 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--N 1.326 -0.415 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.862 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.41 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 1.2 p . . . . . 0 N--CA 1.452 -0.368 0 CA-C-O 120.663 0.268 . . . . 0.0 110.375 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -95.01 -18.53 20.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 109.413 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.28 179.65 47.68 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.77 151.17 45.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.834 0.35 . . . . 0.0 110.073 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.556 ' NE ' HE22 ' A' ' 85' ' ' GLN . 26.1 ttp180 -130.83 124.71 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.493 HG21 HG11 ' A' ' 61' ' ' VAL . 60.2 t -109.1 131.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.43 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.11 128.81 52.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 50' ' ' GLN . 51.5 p90 -136.96 140.29 42.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.203 0.525 . . . . 0.0 111.035 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.16 164.05 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.983 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.726 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 34.5 mt -73.96 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 0.0 111.104 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 p -71.05 -21.55 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.915 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 . . . . . 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.019 -179.509 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo . . . . . 0 N--CA 1.489 1.23 0 CA-C-O 120.969 0.321 . . . . 0.0 112.314 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 18.0 mp0 -114.85 150.61 35.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -124.12 136.81 54.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.926 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.49 127.26 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -102.49 131.42 49.2 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.584 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mt -128.69 155.51 79.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.28 160.49 49.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.227 1.952 . . . . 0.0 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.459 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 p -60.19 -17.03 38.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.643 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.6 p -89.0 -9.54 50.97 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.066 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 130.26 35.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.5 p -127.02 13.07 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.467 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.8 p -165.06 148.09 8.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.267 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 38' ' ' VAL . 12.6 p -149.89 148.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.494 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.816 HD22 ' N ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -104.42 127.29 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.842 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.816 ' N ' HD22 ' A' ' 62' ' ' ASN . 1.7 mt -101.92 103.69 30.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.114 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 97.2 Cg_endo -90.52 -179.81 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.733 2.289 . . . . 0.0 112.342 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 59.98 38.13 21.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.69 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 20' ' ' SER . 33.2 mt -87.59 156.93 19.27 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' OH ' ' A' ' 72' ' ' TYR . 28.7 mt -94.04 108.33 34.69 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.151 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 30.7 Cg_exo -55.1 138.98 80.07 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.064 1.843 . . . . 0.0 111.874 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 14.75 76.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 11.1 mmm-85 -126.36 148.95 49.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.788 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -100.66 133.77 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 110.431 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.726 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 77.5 m-85 -122.53 153.0 39.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.582 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.3 mt -111.05 128.82 67.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.44 130.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.878 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.09 122.72 27.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.036 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.702 HG11 ' CD2' ' A' ' 26' ' ' TRP . 11.1 t -102.93 126.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.07 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.481 ' HB2' HE21 ' A' ' 85' ' ' GLN . 63.0 m-85 -116.4 140.6 49.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.77 133.64 46.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.774 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 37' ' ' ARG . 54.0 mt -97.61 122.29 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 110.591 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.593 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 73.2 p -82.18 168.0 18.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.307 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.22 -19.59 34.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.344 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.593 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 40.0 p30 -93.86 -0.42 55.76 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.472 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.04 66.26 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.993 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.5 mm-40 -83.84 138.94 32.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.851 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.556 HE22 ' NE ' ' A' ' 37' ' ' ARG . 37.4 mt-30 -103.44 142.82 33.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.619 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.9 t -136.36 127.38 27.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.871 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 77' ' ' TYR . 13.7 tp -72.69 118.07 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.969 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.484 HD11 ' CD1' ' A' ' 26' ' ' TRP . 34.4 pt -112.26 -20.3 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -154.98 124.86 6.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.347 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -135.25 112.26 10.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.743 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -145.9 153.18 40.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.3 p -113.42 153.08 29.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.441 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 24.5 mt-30 -140.64 158.91 43.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.18 0.514 . . . . 0.0 110.906 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 106.14 11.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.452 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 70.9 p . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.74 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.558 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER . . . . . 0 N--CA 1.455 -0.18 0 CA-C-O 120.96 0.409 . . . . 0.0 110.124 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -63.51 163.32 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 -179.363 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.585 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 18.2 m-30 -130.38 152.93 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.46 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.5 t -126.84 106.16 15.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.732 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.0 t -115.65 134.84 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.1 p -124.68 150.2 46.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.997 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -144.4 -179.5 6.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.92 128.45 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.542 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.5 t . . . . . 0 C--N 1.327 -0.408 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.484 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.45 -0.473 0 N-CA-C 109.93 -0.396 . . . . 0.0 109.93 . . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.7 m -94.58 -16.85 22.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.243 0.544 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.45 179.02 47.52 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.26 151.38 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.109 0.481 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.447 ' HD3' ' NE2' ' A' ' 85' ' ' GLN . 60.8 ttt180 -130.89 124.4 31.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 61' ' ' VAL . 20.4 t -107.01 131.11 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.924 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -123.1 122.8 39.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.932 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.552 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.1 p90 -135.7 138.17 42.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.384 0.612 . . . . 0.0 111.251 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -147.4 168.57 21.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.723 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.759 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -74.3 127.77 33.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.535 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 p -69.23 -21.06 63.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.719 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.255 -179.923 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo . . . . . 0 N--CA 1.49 1.298 0 CA-C-O 120.737 0.224 . . . . 0.0 111.628 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.552 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 17.2 mt-30 -116.93 146.82 42.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.04 136.7 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 61.5 mt -126.09 128.76 47.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -104.44 134.12 48.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.643 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mt -130.71 156.53 79.71 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.854 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -66.53 156.38 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.236 1.958 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 62.9 p -58.79 -13.3 5.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.115 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -92.79 -8.02 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.197 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.27 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.346 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -130.6 14.73 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.365 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.2 p -163.65 140.31 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.88 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 38' ' ' VAL . 4.8 p -150.09 143.92 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.792 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.826 HD22 ' N ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -102.79 128.34 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.826 ' N ' HD22 ' A' ' 62' ' ' ASN . 1.9 mt -97.82 105.09 24.79 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.49 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.7 Cg_endo -91.16 177.35 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.589 2.193 . . . . 0.0 112.318 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.68 36.94 22.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.728 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.558 ' O ' ' OG ' ' A' ' 20' ' ' SER . 78.4 mt -89.48 146.1 24.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' PRO . 34.4 mt -80.7 122.49 82.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.141 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 70' ' ' ARG . 45.6 Cg_exo -48.69 -174.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.994 1.796 . . . . 0.0 111.82 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 21.82 33.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.838 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.695 ' N ' ' O ' ' A' ' 68' ' ' PRO . 10.7 mmm-85 -126.89 144.54 50.96 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.758 0.779 . . . . 0.0 110.612 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -100.11 131.82 45.84 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.759 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 83.6 m-85 -121.75 149.86 42.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.286 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 85.4 mt -104.78 126.78 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.37 132.56 64.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.224 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -133.86 123.64 25.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.17 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.16 126.85 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.53 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -118.45 138.03 52.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.756 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.05 135.86 40.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.489 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.1 mt -98.88 122.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.281 0.562 . . . . 0.0 110.711 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.607 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 100.0 p -84.02 167.5 16.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.755 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.14 -23.3 54.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.925 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.607 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 38.6 p30 -90.97 -0.8 57.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.747 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.62 70.79 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.165 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -83.01 136.47 34.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' A' ' 37' ' ' ARG . 92.4 mt-30 -105.92 144.29 32.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.151 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 t -139.87 133.05 29.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 90' ' ' SER . 15.0 tp -71.51 117.56 13.21 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.9 -22.31 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.2 tp -156.14 121.18 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.504 ' HB2' HD21 ' A' ' 87' ' ' LEU . 40.3 t -127.03 122.99 35.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.583 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.3 t -154.28 157.78 39.21 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.575 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.8 p -115.73 153.26 31.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.437 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 31.6 mt-30 -138.06 157.29 46.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 111.071 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.69 108.19 10.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.181 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.41 HG22 ' CE1' ' A' ' 22' ' ' PHE . 44.5 p . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.465 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.243 0 CA-C-O 121.113 0.482 . . . . 0.0 110.016 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.556 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -60.67 172.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.45 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.551 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 24.0 m-85 -135.61 151.91 50.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.25 105.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -114.12 136.34 50.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -124.59 152.2 43.85 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.281 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.2 p90 -145.83 -165.29 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.7 t -118.54 131.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.273 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 19.3 m . . . . . 0 C--N 1.321 -0.671 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.656 -179.555 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.519 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.6 p . . . . . 0 N--CA 1.455 -0.178 0 CA-C-O 120.917 0.389 . . . . 0.0 110.589 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.4 m -95.63 -13.5 24.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.549 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.519 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.01 179.59 47.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.94 151.53 48.37 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.925 0.393 . . . . 0.0 110.681 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.478 ' NH2' HE22 ' A' ' 85' ' ' GLN . 18.6 ttp180 -130.5 122.16 27.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.416 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 61' ' ' VAL . 84.8 t -108.9 132.58 56.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.271 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.46 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 20.0 tt0 -120.87 127.37 51.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.852 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 52.6 p90 -131.89 132.5 43.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.09 0.472 . . . . 0.0 110.019 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -148.68 165.15 32.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.612 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 94.3 mt -73.27 128.54 35.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.942 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -70.82 -24.82 62.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.857 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 . . . . . 0 CA--C 1.519 -0.231 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.744 179.563 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo . . . . . 0 N--CA 1.493 1.444 0 CA-C-O 120.854 0.273 . . . . 0.0 112.167 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -116.66 147.78 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 52.6 m-85 -125.66 141.69 51.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.819 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -127.91 134.65 49.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -106.92 134.12 50.55 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.164 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.45 155.93 80.33 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.044 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.25 154.12 75.41 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.945 1.763 . . . . 0.0 112.357 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.473 ' HB2' HG13 ' A' ' 33' ' ' VAL . 62.0 p -57.19 -15.75 6.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.5 p -91.06 -8.0 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.37 133.1 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.853 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.8 p -130.41 17.98 5.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.4 p -164.96 144.38 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.269 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 38' ' ' VAL . 9.8 p -149.13 147.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.232 0.539 . . . . 0.0 111.624 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.2 t-20 -102.83 124.3 48.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.431 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.409 HG21 ' CG ' ' A' ' 40' ' ' TYR . 1.8 mt -95.44 109.9 47.9 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.317 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -90.99 178.9 1.77 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.88 2.387 . . . . 0.0 112.778 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 58.3 37.9 26.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.083 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 21' ' ' SER . 76.4 mt -91.11 143.94 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.213 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.571 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 17.9 mt -90.1 112.79 54.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -56.34 142.28 88.35 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.257 1.971 . . . . 0.0 111.86 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.58 82.32 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 14.6 mmt85 -121.9 150.94 41.26 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.56 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.75 130.84 46.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 0.0 110.107 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.612 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 59.8 m-85 -116.77 153.43 32.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.206 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.534 HG22 ' ND2' ' A' ' 75' ' ' ASN . 84.4 mt -108.51 122.8 63.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.21 131.63 64.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.672 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.534 ' ND2' HG22 ' A' ' 73' ' ' ILE . 44.8 m-80 -137.49 126.53 24.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.591 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 26' ' ' TRP . 15.6 t -103.35 130.85 52.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.506 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -120.23 142.98 48.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.217 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -106.64 133.12 51.8 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.642 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 34' ' ' SER . 63.2 mt -96.23 122.83 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.61 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.597 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 20.7 p -81.19 168.11 18.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -58.75 -17.87 26.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.379 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.597 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.3 p30 -93.4 0.01 56.69 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.572 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.63 67.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.38 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.3 mm-40 -88.34 144.74 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.068 0.434 . . . . 0.0 110.652 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.478 HE22 ' NH2' ' A' ' 37' ' ' ARG . 29.7 mt-30 -103.47 143.32 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.96 125.21 36.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.996 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.1 tp -73.02 115.4 12.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.904 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.66 -23.52 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.581 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -156.61 128.08 7.08 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.977 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.6 t -131.66 125.65 32.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.735 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -153.97 156.4 37.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.49 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -116.25 155.48 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.144 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.551 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 25.5 mt-30 -142.31 157.96 44.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.324 0.583 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.64 104.81 9.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.911 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.43 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.536 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.425 ' O ' HD12 ' A' ' 66' ' ' LEU . 79.4 p . . . . . 0 CA--C 1.521 -0.146 0 CA-C-O 120.946 0.403 . . . . 0.0 110.219 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.3 p -60.34 149.41 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 -179.532 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.551 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 22.2 m-30 -110.16 145.81 36.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.32 104.84 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.93 139.1 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.809 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.8 p -128.19 153.54 46.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.129 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.546 ' CE3' HG21 ' A' ' 76' ' ' VAL . 39.8 p90 -147.22 -166.32 2.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.079 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 49.0 t -118.06 133.1 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.256 179.175 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 53.3 m . . . . . 0 C--N 1.321 -0.639 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.277 -179.4 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.406 ' O ' ' HB3' ' A' ' 56' ' ' SER . 0.6 OUTLIER . . . . . 0 N--CA 1.452 -0.342 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 . . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 m -96.16 -14.2 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.495 . . . . 0.0 110.24 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.53 174.92 43.43 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -123.33 150.73 43.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.063 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.834 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 37.7 ttp180 -130.51 122.52 27.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.73 HG21 HG11 ' A' ' 61' ' ' VAL . 91.9 t -106.27 132.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.824 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 81.4 tt0 -122.75 132.94 54.46 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.52 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 46.9 p90 -140.09 141.08 36.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.179 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -150.57 163.82 37.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.772 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.557 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 50.8 mt -75.35 131.98 40.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.3 p -78.78 -14.99 58.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.483 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 . . . . . 0 C--N 1.327 -0.38 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.853 -178.259 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo . . . . . 0 N--CA 1.49 1.304 0 CA-C-O 121.092 0.371 . . . . 0.0 112.756 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.484 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 24.7 mt-30 -122.75 148.2 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -126.37 137.03 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.188 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.7 mt -122.32 127.84 50.3 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -102.99 133.45 48.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.353 0.597 . . . . 0.0 112.17 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.38 157.2 78.79 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.3 160.5 48.65 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.789 1.66 . . . . 0.0 112.219 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.431 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 50.9 p -57.05 -11.82 1.76 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.183 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.2 p -91.49 -7.5 50.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.435 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.17 35.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.403 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.6 p -126.73 7.62 6.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.839 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -162.21 154.17 18.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.332 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 38' ' ' VAL . 9.1 p -153.2 146.97 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.421 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 30.4 t30 -103.83 128.93 51.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.44 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.67 99.6 22.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.513 0.197 . . . . 0.0 111.055 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 66.9 Cg_endo -89.61 -169.41 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.921 2.414 . . . . 0.0 112.162 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 57.63 36.69 26.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.538 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.425 HD12 ' O ' ' A' ' 20' ' ' SER . 42.7 mt -94.33 138.21 32.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.946 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.673 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 18.6 mt -84.71 113.96 52.54 Favored Pre-proline 0 C--N 1.333 -0.147 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.131 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -54.08 138.07 70.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.92 1.747 . . . . 0.0 111.534 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.32 14.95 70.18 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.861 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.87 148.61 48.17 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -98.98 134.78 41.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.361 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.673 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 64.9 m-85 -121.5 153.55 37.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.588 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.608 HG22 HD21 ' A' ' 75' ' ' ASN . 85.7 mt -109.38 125.63 66.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.5 129.02 71.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 0.0 110.673 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.608 HD21 HG22 ' A' ' 73' ' ' ILE . 14.3 m-80 -135.71 124.42 23.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.171 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.546 HG21 ' CE3' ' A' ' 26' ' ' TRP . 17.6 t -103.47 128.01 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.983 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -117.37 142.21 47.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.41 133.75 47.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.0 mt -98.3 126.17 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 121.384 0.611 . . . . 0.0 110.789 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.604 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 30.0 p -82.87 168.55 16.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.974 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -19.3 62.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.147 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.604 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 36.3 p30 -93.69 2.8 56.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.451 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 11.8 66.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.425 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.448 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 70.5 mm-40 -87.34 142.6 27.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.979 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.834 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 83.7 mt-30 -105.2 147.23 28.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.018 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.05 124.37 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.614 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 90' ' ' SER . 14.4 tp -73.71 115.57 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.147 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -109.87 -20.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.7 tp -155.17 123.12 5.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.657 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.423 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.0 t -131.87 119.13 20.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -153.37 162.26 41.47 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.601 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.7 p -120.33 153.1 36.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.347 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.551 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 20.7 mt-30 -138.13 157.1 47.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.945 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -123.09 115.7 22.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.781 -179.199 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.563 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.0 OUTLIER . . . . . 0 CA--C 1.528 0.128 0 CA-C-O 120.837 0.351 . . . . 0.0 110.859 . . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.564 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.3 OUTLIER -62.96 -177.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.832 0.825 . . . . 0.0 112.059 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 21' ' ' SER . 16.1 m-85 -151.53 140.38 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.278 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.46 101.62 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.89 137.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.222 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.6 p -124.03 151.41 43.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.114 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.466 ' CD2' HG11 ' A' ' 76' ' ' VAL . 40.6 p90 -145.04 -175.39 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.465 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.3 t -112.42 133.36 58.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.266 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.685 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 45.2 t . . . . . 0 C--N 1.324 -0.525 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.353 -179.47 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.434 HG13 ' HB2' ' A' ' 56' ' ' SER . 2.5 p . . . . . 0 N--CA 1.453 -0.279 0 CA-C-O 120.895 0.378 . . . . 0.0 111.083 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.6 m -97.0 -14.52 21.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.421 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.412 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.94 178.54 46.77 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.44 153.04 46.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.483 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.701 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 42.5 ttp180 -131.07 129.25 41.7 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.834 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.37 133.65 57.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.526 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.16 127.71 50.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.091 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.8 p90 -135.25 130.63 35.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.32 0.581 . . . . 0.0 110.66 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -143.98 165.1 28.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.721 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.611 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 35.5 mt -74.78 127.14 32.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 0.0 111.505 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 p -69.9 -37.85 76.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.49 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 . . . . . 0 C--N 1.33 -0.258 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.226 179.598 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo . . . . . 0 N--CA 1.491 1.356 0 CA-C-O 120.902 0.292 . . . . 0.0 112.291 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 9.2 mt-30 -118.88 143.82 46.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.711 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.07 136.64 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.092 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.93 131.72 53.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -106.18 136.07 46.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.091 0.472 . . . . 0.0 111.457 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.8 mt -130.21 157.24 77.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.576 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -69.97 158.7 55.83 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.939 1.759 . . . . 0.0 112.098 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' HG13 ' A' ' 33' ' ' VAL . 36.7 p -59.31 -12.95 6.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.114 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.2 p -92.05 -8.56 45.57 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.69 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -131.02 11.21 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.0 p -164.43 143.89 7.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.01 149.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.5 HD22 ' N ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -103.9 123.41 47.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.069 178.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.5 ' N ' HD22 ' A' ' 62' ' ' ASN . 2.0 mt -100.38 102.82 19.96 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.003 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 63.1 Cg_endo -92.87 179.98 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.909 2.406 . . . . 0.0 113.207 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 62.31 37.3 14.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.901 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.563 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -92.47 152.34 19.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.291 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 19.3 mt -82.96 119.85 75.05 Favored Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.969 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.52 144.89 62.62 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.867 1.711 . . . . 0.0 112.082 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.76 15.45 75.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.553 ' CB ' HH11 ' A' ' 70' ' ' ARG . 0.1 OUTLIER -124.81 153.4 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.731 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.6 133.86 46.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.611 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 86.9 m-85 -120.4 151.12 39.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.74 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 77.1 mt -108.53 123.94 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.5 t -116.11 134.68 58.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.161 0.505 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -135.2 129.65 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' A' ' 26' ' ' TRP . 28.6 t -106.61 128.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.355 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -120.55 139.53 52.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.869 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.685 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -101.11 133.33 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 34' ' ' SER . 52.2 mt -98.33 122.69 50.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.292 0.567 . . . . 0.0 110.448 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.601 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 42.0 p -83.79 169.11 15.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.124 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.524 ' CD ' ' HG ' ' A' ' 34' ' ' SER . 77.6 mm-40 -58.19 -20.81 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.09 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.601 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.5 p30 -91.35 -2.61 57.31 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.945 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.01 12.71 67.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.136 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.587 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.7 mm-40 -84.0 141.04 31.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.701 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 93.3 mt-30 -105.19 140.92 37.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -134.02 127.86 33.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.107 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.0 tp -72.06 116.28 12.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.553 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.3 pt -107.4 -23.1 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.4 tp -159.08 124.81 4.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.054 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.4 t -128.48 126.71 41.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.9 t -153.77 159.03 41.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.196 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -120.58 152.26 38.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.084 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.427 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 23.1 mt-30 -143.65 158.12 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.996 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 114.88 20.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.906 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.553 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 33.4 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.647 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.539 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER . . . . . 0 CA--C 1.528 0.118 0 CA-C-O 120.96 0.409 . . . . 0.0 110.455 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -63.29 -174.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.496 0.665 . . . . 0.0 112.15 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.759 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 21.1 m-85 -149.67 148.24 29.05 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.165 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 43.4 t -118.75 103.96 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.482 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -112.28 135.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -123.07 151.51 41.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.293 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.405 ' CD2' HG11 ' A' ' 76' ' ' VAL . 41.0 p90 -143.47 179.92 6.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.341 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -117.38 129.27 74.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.239 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 p . . . . . 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.227 -179.903 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.43 HG13 ' HB2' ' A' ' 56' ' ' SER . 2.1 p . . . . . 0 N--CA 1.453 -0.283 0 CA-C-O 120.847 0.356 . . . . 0.0 110.43 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 81' ' ' GLU . 70.8 m -95.36 -15.46 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.88 179.66 47.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -125.9 152.88 44.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 110.602 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.47 ' NH2' ' CD2' ' A' ' 51' ' ' TYR . 55.2 ttt180 -133.9 127.65 32.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.9 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.586 HG21 HG11 ' A' ' 61' ' ' VAL . 47.0 t -108.29 132.78 55.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.075 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.34 125.59 44.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.801 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 42.5 p90 -141.35 140.33 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.897 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -149.38 169.99 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.39 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.72 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 92.3 mt -74.28 126.66 31.13 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.5 p -62.05 -33.92 75.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.388 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 . . . . . 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 -179.862 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo . . . . . 0 N--CA 1.489 1.228 0 CA-C-O 120.983 0.326 . . . . 0.0 111.824 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 32.5 mt-30 -119.91 140.78 50.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.778 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CD2' ' NH2' ' A' ' 37' ' ' ARG . 6.1 m-85 -121.64 141.28 51.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.588 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.5 mt -131.15 123.44 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -101.61 135.72 42.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.134 0.492 . . . . 0.0 111.578 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -132.86 159.43 72.63 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.842 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -72.52 160.17 47.31 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.094 1.863 . . . . 0.0 112.624 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.477 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 61.1 p -61.69 -15.48 40.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.696 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -88.34 -1.14 57.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.691 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.908 ' O ' HG23 ' A' ' 59' ' ' THR . . . -75.86 -146.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.595 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 58' ' ' ALA . 1.9 p 143.45 4.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.8 p -163.75 141.89 7.54 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 38' ' ' VAL . 8.8 p -150.74 155.35 7.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.174 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.642 HD22 ' N ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -106.1 122.88 47.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.217 178.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.642 ' N ' HD22 ' A' ' 62' ' ' ASN . 2.1 mt -95.87 106.67 29.26 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.175 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 64.7 Cg_endo -92.74 177.33 1.5 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 123.115 2.544 . . . . 0.0 113.393 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 60.19 38.33 20.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.958 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.539 ' O ' ' OG ' ' A' ' 20' ' ' SER . 39.8 mt -91.76 143.15 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.473 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 64.2 mt -83.86 112.82 43.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -55.29 143.12 77.43 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.37 79.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.479 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.9 mmm-85 -123.98 152.79 42.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.153 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -100.97 130.96 47.04 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.451 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.72 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 65.1 m-85 -118.5 144.59 45.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.091 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.2 mt -104.11 125.5 58.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.0 132.54 61.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.243 0.544 . . . . 0.0 111.154 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -134.78 128.13 32.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.514 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' ' 26' ' ' TRP . 21.3 t -104.11 128.45 57.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.416 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -119.54 138.53 53.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.6 pt20 -101.13 136.87 40.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.768 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -100.03 123.32 52.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.591 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 84.3 p -83.31 171.99 12.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.32 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.47 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 76.1 mm-40 -58.77 -19.96 45.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.496 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.591 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 48.8 p30 -95.08 -0.22 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.12 65.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.564 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.3 mm-40 -83.82 143.79 29.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.849 0.357 . . . . 0.0 110.53 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.91 142.78 45.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 111.686 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.7 t -138.24 134.54 34.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.86 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 90' ' ' SER . 53.5 tp -73.34 117.44 15.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.3 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.0 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.992 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.7 tp -156.84 125.44 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.325 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 87' ' ' LEU . 38.2 t -132.13 122.53 25.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.819 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.8 t -151.7 158.69 43.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.75 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -118.04 152.55 35.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.759 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 23.6 mt-30 -140.51 156.77 46.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.268 0.556 . . . . 0.0 110.313 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -123.13 104.81 9.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.629 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.473 ' OXT' ' O ' ' A' ' 94' ' ' THR . 81.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.051 -0.975 . . . . 0.0 110.435 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.497 ' O ' HD12 ' A' ' 66' ' ' LEU . 94.5 p . . . . . 0 N--CA 1.457 -0.083 0 CA-C-O 121.112 0.482 . . . . 0.0 109.715 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.6 p -63.16 158.51 19.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.556 -179.415 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.627 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 21.6 m-30 -125.69 155.92 40.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.776 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.4 t -128.83 106.3 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.757 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.7 t -111.94 137.48 44.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.71 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.1 p -129.14 153.56 47.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CD2' HG11 ' A' ' 76' ' ' VAL . 34.0 p90 -143.41 -165.88 2.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.023 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.0 t -127.73 124.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--N 1.327 -0.385 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.902 -179.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.456 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.4 p . . . . . 0 N--CA 1.454 -0.254 0 CA-C-O 120.716 0.293 . . . . 0.0 110.25 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 79' ' ' ILE . 53.1 m -94.0 -15.48 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.213 0.53 . . . . 0.0 109.803 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.2 176.46 45.32 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -125.41 152.91 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.906 0.384 . . . . 0.0 110.673 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.7 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.4 ttp180 -131.5 124.33 29.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 61' ' ' VAL . 74.4 t -109.03 133.67 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -124.6 132.65 53.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.341 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.578 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 22.8 p90 -137.82 130.28 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.095 0.474 . . . . 0.0 110.284 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.71 166.61 26.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.833 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 87.1 mt -73.65 128.59 35.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.413 0.625 . . . . 0.0 111.969 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 p -68.23 -27.84 66.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.469 ' HG3' HH22 ' A' ' 70' ' ' ARG . 88.1 mt-10 . . . . . 0 C--N 1.331 -0.238 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.131 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo . . . . . 0 N--CA 1.49 1.299 0 CA-C-O 120.883 0.285 . . . . 0.0 112.085 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.578 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 11.4 mt-30 -120.29 144.0 48.04 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -124.41 140.38 53.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.506 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 mt -124.71 129.38 50.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.13 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -101.48 131.78 47.43 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.905 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.4 mt -130.08 155.64 80.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 57' ' ' THR . 22.7 Cg_endo -68.94 156.65 64.69 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.38 2.053 . . . . 0.0 112.5 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.459 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 30.4 p -55.74 -11.6 1.01 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.4 ' N ' ' C ' ' A' ' 55' ' ' PRO . 29.5 p -92.0 -7.29 49.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.61 132.28 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -130.32 9.32 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.182 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.9 p -164.12 146.8 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.62 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 38' ' ' VAL . 5.2 p -151.0 152.69 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.772 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 11.7 t-20 -106.68 126.63 52.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.513 HG21 ' CG ' ' A' ' 40' ' ' TYR . 2.3 mt -100.94 104.94 35.36 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.148 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -91.35 -179.34 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.779 2.319 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 58.66 39.03 24.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.497 HD12 ' O ' ' A' ' 20' ' ' SER . 41.5 mt -90.41 143.91 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.3 mt -78.02 129.81 74.65 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.043 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.49 140.94 44.98 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.529 2.153 . . . . 0.0 112.873 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.38 27.99 71.91 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.773 ' HE ' HD22 ' A' ' 42' ' ' LEU . 4.9 mmm180 -126.48 148.13 49.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.22 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.685 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 75.7 tttt -100.26 131.15 46.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.833 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 64.4 m-85 -119.82 151.26 39.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -104.99 123.7 59.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -111.69 131.15 63.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -133.98 125.86 29.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.507 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.64 HG11 ' CD2' ' A' ' 26' ' ' TRP . 5.7 t -104.42 126.57 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.03 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -118.82 141.91 48.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -105.23 135.58 46.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.973 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.688 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.9 mt -98.38 122.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.172 0.511 . . . . 0.0 110.634 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.726 ' HG ' ' CG ' ' A' ' 82' ' ' ASP . 47.2 p -82.52 169.53 16.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.811 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.3 -20.47 43.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.126 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.726 ' CG ' ' HG ' ' A' ' 80' ' ' SER . 2.0 p-10 -92.04 -2.32 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.51 14.46 65.77 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CG ' ' OD2' ' A' ' 82' ' ' ASP . 60.2 mm-40 -86.2 144.17 27.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.121 0.46 . . . . 0.0 111.211 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.7 HE22 ' NE ' ' A' ' 37' ' ' ARG . 93.2 mt-30 -109.18 139.61 43.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 t -137.81 136.1 36.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.392 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 90' ' ' SER . 19.3 tp -72.88 116.73 13.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 pt -108.87 -22.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.29 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.1 tp -156.32 125.81 6.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.62 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.437 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.5 t -133.44 122.43 23.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.508 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -149.7 156.54 42.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.461 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -117.58 153.03 33.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.42 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 24.1 mt-30 -140.98 158.36 44.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.216 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.71 108.23 16.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.576 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.344 -179.468 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.567 ' O ' HD12 ' A' ' 66' ' ' LEU . 4.7 p . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 120.94 0.4 . . . . 0.0 110.154 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.4 p -60.45 165.56 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.524 -179.679 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.536 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 15.8 m-30 -133.51 154.76 50.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.818 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.43 104.32 8.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.43 136.8 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.43 150.92 43.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CE3' HG21 ' A' ' 76' ' ' VAL . 36.9 p90 -145.26 -174.15 4.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.373 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 44.5 t -109.55 135.38 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.944 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.412 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 85.2 p . . . . . 0 C--N 1.324 -0.512 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.544 -179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.515 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.0 p . . . . . 0 N--CA 1.453 -0.311 0 CA-C-O 120.678 0.275 . . . . 0.0 110.275 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 79' ' ' ILE . 67.5 m -94.86 -14.65 24.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.27 0.557 . . . . 0.0 109.541 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.36 -179.87 47.93 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -127.31 150.57 49.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.003 0.43 . . . . 0.0 110.75 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -129.2 124.81 35.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.84 131.2 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.121 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 80.9 tt0 -123.27 133.57 54.17 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.579 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.7 p90 -140.65 138.7 34.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.446 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -148.02 165.54 30.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.706 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.533 HD13 ' HE ' ' A' ' 70' ' ' ARG . 56.3 mt -73.13 127.61 33.09 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.028 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 18.6 p -70.34 -34.62 72.88 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 . . . . . 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.825 -179.933 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 N--CA 1.489 1.224 0 CA-C-O 120.92 0.3 . . . . 0.0 112.036 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 16.2 mt-30 -123.36 146.02 48.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 80.4 m-85 -124.86 139.17 54.08 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.046 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.7 mt -123.2 129.16 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.231 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -102.21 130.92 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.831 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.25 154.72 80.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.795 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.15 156.76 64.59 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.143 1.895 . . . . 0.0 112.374 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 14.5 p -56.56 -11.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -93.76 -9.17 38.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.698 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.8 35.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.485 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 p -130.19 12.22 5.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.0 p -164.38 143.13 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.95 149.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.62 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 8.9 t-20 -105.16 128.02 53.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.26 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mt -104.84 101.34 28.66 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.449 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -89.47 -174.58 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.773 2.315 . . . . 0.0 112.439 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 59.72 37.01 22.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.386 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 20' ' ' SER . 45.9 mt -90.36 151.88 21.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.648 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 30.4 mt -95.37 108.35 38.62 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.977 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.28 139.78 81.31 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.432 2.088 . . . . 0.0 111.839 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.58 14.69 67.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.533 ' HE ' HD13 ' A' ' 42' ' ' LEU . 5.7 mmm-85 -127.21 141.44 51.73 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 92' ' ' SER . 14.0 tttp -96.19 134.86 38.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.938 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 4.0 m-85 -117.85 151.79 36.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 0.0 111.718 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.5 mt -110.07 124.36 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.84 132.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.929 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -133.61 124.49 26.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.371 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.463 HG21 ' CE3' ' A' ' 26' ' ' TRP . 21.9 t -106.74 127.76 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.875 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -119.01 137.36 53.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.412 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -100.65 136.25 40.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.0 mt -100.12 125.49 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.384 0.611 . . . . 0.0 110.934 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.597 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 89.7 p -84.89 165.2 17.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.206 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.31 -20.31 42.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.357 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.0 p-10 -91.98 -1.54 57.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.786 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.97 13.01 65.12 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.243 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.455 ' CG ' ' OD2' ' A' ' 82' ' ' ASP . 75.8 mm-40 -83.2 135.34 34.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -104.98 140.66 37.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.749 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.3 t -136.72 132.9 35.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.114 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 90' ' ' SER . 57.0 tp -71.83 118.98 15.35 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.736 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 pt -108.92 -22.97 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.2 tp -157.01 125.67 5.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.597 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.613 ' HB2' HD21 ' A' ' 87' ' ' LEU . 15.2 t -132.66 112.66 12.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.417 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -146.25 159.62 43.08 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.0 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . 0.431 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 95.7 p -117.25 153.8 32.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.321 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.518 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 26.8 mt-30 -139.52 156.04 47.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -122.71 107.83 12.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.434 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 94' ' ' THR . 45.6 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.715 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.481 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.2 p . . . . . 0 CA--C 1.52 -0.208 0 CA-C-O 120.978 0.418 . . . . 0.0 110.003 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.697 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -67.61 135.93 53.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.973 -179.32 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 23.9 m-85 -96.12 148.04 23.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.351 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.59 101.34 10.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.1 t -111.53 137.59 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -128.1 155.84 43.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.129 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.465 ' CE3' HG21 ' A' ' 76' ' ' VAL . 33.6 p90 -146.9 -164.95 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.049 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.08 129.62 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.324 -0.543 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.875 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.458 HG13 ' HB2' ' A' ' 56' ' ' SER . 2.7 p . . . . . 0 N--CA 1.452 -0.374 0 CA-C-O 120.928 0.394 . . . . 0.0 110.365 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' ILE . 4.8 m -93.84 -15.4 25.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.667 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.535 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 175.62 -178.3 47.22 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -126.61 153.81 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.96 0.41 . . . . 0.0 110.376 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -132.44 123.01 25.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.083 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.617 HG21 HG11 ' A' ' 61' ' ' VAL . 77.7 t -107.48 132.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.504 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 68.3 tt0 -127.17 131.34 50.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.233 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 18.9 p90 -144.29 137.63 27.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.273 0.558 . . . . 0.0 111.259 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -144.36 167.91 21.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.149 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.764 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 76.7 mt -74.81 126.42 30.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.688 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -67.24 -25.03 65.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.458 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 . . . . . 0 C--N 1.327 -0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.979 -178.932 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo . . . . . 0 N--CA 1.487 1.109 0 N-CA-C 111.269 -0.32 . . . . 0.0 111.269 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.534 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 21.6 mt-30 -112.71 146.15 39.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.78 137.06 54.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.672 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.2 mt -129.68 130.48 45.59 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.71 132.75 50.58 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.477 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 mt -126.18 152.54 73.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.636 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.36 154.48 71.15 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.441 2.094 . . . . 0.0 112.777 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.535 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 24.9 p -57.8 -14.31 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.115 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.6 p -92.12 -6.7 50.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.234 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.82 138.78 31.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -130.71 13.98 5.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.2 p -163.68 148.68 10.81 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 38' ' ' VAL . 9.4 p -149.18 144.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.856 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.697 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 2.4 t-20 -102.85 126.5 50.02 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -97.96 112.55 62.05 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.468 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -93.23 175.71 1.56 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.997 2.465 . . . . 0.0 113.637 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 59.91 38.4 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.619 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 20' ' ' SER . 15.1 mt -87.72 145.17 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.82 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.406 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 16.4 mt -86.73 112.12 44.69 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 32.1 Cg_exo -55.28 134.26 62.8 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.963 1.775 . . . . 0.0 111.159 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.63 13.93 74.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.424 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.0 mmt85 -121.13 152.17 39.04 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.682 -179.947 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -103.89 127.71 51.39 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.764 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 84.5 m-85 -115.36 156.98 24.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.096 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 61.9 mt -110.49 132.99 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.46 130.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.582 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -135.02 121.69 20.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.607 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.465 HG21 ' CE3' ' A' ' 26' ' ' TRP . 48.5 t -103.17 127.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.467 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.68 136.27 54.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 1.4 pt20 -96.59 132.75 41.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.466 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' SER . 56.0 mt -97.18 125.94 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.346 0.593 . . . . 0.0 110.787 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.595 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 90.0 p -85.62 168.66 14.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.197 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.447 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 81.7 mm-40 -61.75 -18.43 59.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.595 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 32.8 p30 -92.87 -0.72 57.18 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.033 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.24 75.45 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.424 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 55.2 mm-40 -82.43 145.3 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.206 0.503 . . . . 0.0 110.971 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -109.87 139.16 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.722 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.1 t -133.88 130.39 37.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.187 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -73.45 121.72 20.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.042 0.449 . . . . 0.0 111.43 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.459 HD11 ' CG1' ' A' ' 76' ' ' VAL . 35.6 pt -109.59 -22.55 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -157.57 127.68 6.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.769 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.6 t -133.56 120.41 20.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -156.0 153.35 29.37 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.832 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.0 p -111.39 157.92 19.67 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.635 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 26.4 mt-30 -145.84 163.01 36.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.123 0.487 . . . . 0.0 111.112 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.84 105.23 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.149 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 81.3 p . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.315 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.625 ' O ' ' O ' ' A' ' 21' ' ' SER . 4.3 p . . . . . 0 CA--C 1.519 -0.235 0 N-CA-C 109.519 -0.549 . . . . 0.0 109.519 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.691 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 38.81 -178.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.915 0.864 . . . . 0.0 112.023 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.698 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 25.2 m-85 -156.72 150.65 24.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.741 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.4 t -119.66 102.26 12.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 176.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.5 t -110.25 132.53 58.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.324 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.4 p -126.63 154.36 44.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.906 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.414 ' CE3' HG21 ' A' ' 76' ' ' VAL . 33.9 p90 -143.43 -165.48 2.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.724 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -130.68 128.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.286 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 p . . . . . 0 C--N 1.326 -0.422 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.692 179.926 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.441 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.455 -0.209 0 CA-C-O 120.935 0.397 . . . . 0.0 110.798 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 79' ' ' ILE . 30.6 m -94.86 -14.83 24.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.53 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.462 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.1 179.05 46.36 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.12 152.25 46.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 0.0 110.19 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.499 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 25.2 ttp180 -131.4 128.31 39.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.63 133.61 57.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.721 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 38.6 tt0 -123.1 130.67 53.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.794 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -133.69 135.78 44.28 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.709 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -144.96 161.52 39.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.239 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.772 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 43.8 mt -71.15 130.39 41.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.142 0.496 . . . . 0.0 111.332 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -65.32 -24.5 67.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.952 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.486 ' HB2' HH22 ' A' ' 70' ' ' ARG . 60.8 mm-40 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.384 -179.792 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo . . . . . 0 N--CA 1.489 1.214 0 N-CA-C 111.116 -0.378 . . . . 0.0 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 mt-30 -119.57 144.09 47.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 59.2 m-85 -122.91 141.9 51.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.114 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -128.06 130.79 48.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.687 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -102.21 133.41 47.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.567 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.2 mt -128.67 156.39 77.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.55 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -71.51 159.3 51.72 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.462 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 47.4 p -60.2 -16.36 32.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.114 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -91.19 -7.92 50.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.704 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 133.74 34.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.222 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 p -128.84 11.36 6.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.584 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 144.22 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.284 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.24 147.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.413 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 18.6 t30 -101.4 126.23 48.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.66 105.65 31.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.6 Cg_endo -90.08 -176.77 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 123.015 2.477 . . . . 0.0 112.773 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 56.41 35.92 26.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.441 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 22' ' ' PHE . 44.4 mt -90.23 140.55 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -68.35 111.58 8.41 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 25.3 Cg_exo -57.71 138.67 87.22 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.191 1.928 . . . . 0.0 112.015 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.1 22.09 74.61 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.917 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.59 ' HE ' HD22 ' A' ' 42' ' ' LEU . 22.2 mmm180 -126.56 154.66 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.984 0.421 . . . . 0.0 111.548 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -100.05 132.44 45.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.694 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.772 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 52.4 m-85 -121.81 153.59 38.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.701 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 69.8 mt -108.1 125.41 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.87 133.87 58.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.044 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -136.36 124.25 22.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.751 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.414 HG21 ' CE3' ' A' ' 26' ' ' TRP . 34.0 t -105.06 129.75 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.599 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -121.57 137.7 54.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.803 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 3.5 pt20 -99.77 134.53 42.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' SER . 49.0 mt -98.27 125.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.399 0.619 . . . . 0.0 110.392 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 80.6 p -82.85 169.11 16.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.553 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.71 -22.32 57.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.936 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.598 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.4 p30 -93.72 0.02 56.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.303 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.51 63.51 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.421 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.484 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.35 144.45 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.995 0.397 . . . . 0.0 110.653 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.499 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 86.2 mt-30 -111.19 144.77 39.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.042 0.449 . . . . 0.0 111.431 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.8 t -138.02 132.04 31.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.314 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.3 tp -72.61 118.22 15.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.905 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.3 pt -109.65 -25.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.822 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.7 tp -156.15 125.0 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.842 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 t -133.07 117.7 17.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 t -148.36 153.88 39.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.698 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.8 p -112.17 151.49 29.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.698 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 22.3 mt-30 -139.41 155.59 47.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.0 110.974 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.472 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -114.14 111.58 21.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.202 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 6.9 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.535 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.707 ' O ' HD12 ' A' ' 66' ' ' LEU . 5.1 p . . . . . 0 N--CA 1.456 -0.173 0 CA-C-O 121.074 0.464 . . . . 0.0 109.77 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 2.4 p -57.59 136.69 56.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.217 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.584 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.3 m-30 -101.66 147.03 26.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.876 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 16.1 t -130.45 103.77 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.005 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -113.78 138.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.456 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.8 p -127.58 151.54 48.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.725 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.639 ' CE3' HG21 ' A' ' 76' ' ' VAL . 32.4 p90 -144.37 -165.38 2.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.009 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.93 125.84 58.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.967 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 p . . . . . 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.402 -179.787 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.419 ' O ' ' HB3' ' A' ' 56' ' ' SER . 2.3 p . . . . . 0 N--CA 1.454 -0.249 0 CA-C-O 120.817 0.342 . . . . 0.0 110.802 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.5 m -96.19 -15.99 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.46 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.467 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.54 177.14 46.16 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.24 153.02 43.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.859 0.362 . . . . 0.0 110.54 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.803 ' NE ' HE22 ' A' ' 85' ' ' GLN . 42.3 ttp180 -132.18 132.09 42.83 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.728 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.645 HG21 HG11 ' A' ' 61' ' ' VAL . 12.4 t -113.0 135.09 53.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.53 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.8 133.5 50.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 4.4 p90 -143.56 143.05 31.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.282 0.563 . . . . 0.0 111.729 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -150.36 163.56 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.869 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 90.5 mt -74.07 125.47 28.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 p -64.3 -33.77 76.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.44 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 . . . . . 0 C--N 1.323 -0.562 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.545 -178.948 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo . . . . . 0 N--CA 1.486 1.076 0 CA-C-O 120.85 0.271 . . . . 0.0 111.826 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.36 151.05 40.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.68 139.46 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.42 129.92 45.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.343 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -106.02 134.43 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.146 0.498 . . . . 0.0 111.963 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HB3' ' CB ' ' A' ' 58' ' ' ALA . 7.4 mt -129.71 155.75 79.89 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.686 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -68.06 159.89 51.06 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.195 1.93 . . . . 0.0 111.995 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.467 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 21.0 p -56.25 -12.83 1.75 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.241 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -93.58 -7.11 45.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 54' ' ' LEU . . . -79.6 130.13 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.248 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -130.98 12.65 5.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.861 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.2 p -165.13 147.56 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.645 HG11 HG21 ' A' ' 38' ' ' VAL . 6.2 p -149.87 147.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.81 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 4.7 t-20 -107.72 127.98 54.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.76 105.65 42.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.126 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.24 175.55 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.896 2.398 . . . . 0.0 112.715 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 60.48 39.1 18.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.994 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 20' ' ' SER . 56.9 mt -88.95 153.51 20.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.466 HD13 ' NH2' ' A' ' 70' ' ' ARG . 46.7 mt -90.72 110.56 42.36 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.873 -0.148 . . . . 0.0 110.836 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -58.95 145.1 98.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.307 2.005 . . . . 0.0 112.204 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.509 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 80.3 17.77 73.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.484 ' HB3' HD22 ' A' ' 42' ' ' LEU . 4.9 mmm-85 -128.78 147.54 50.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.547 0.213 . . . . 0.0 110.597 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -98.43 135.09 40.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.869 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 67.9 m-85 -121.02 152.87 38.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.378 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 79.0 mt -111.7 131.23 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.28 134.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.507 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -135.21 123.76 23.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.3 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.639 HG21 ' CE3' ' A' ' 26' ' ' TRP . 17.2 t -103.62 130.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -122.56 139.06 54.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.433 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.91 135.04 42.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.098 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -98.15 123.75 50.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.208 0.527 . . . . 0.0 110.634 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.613 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 59.3 p -83.76 166.18 18.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.498 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -57.48 -18.8 20.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.017 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.613 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 37.4 p30 -91.95 -1.1 57.44 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.747 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.75 13.7 66.63 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.032 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 63.8 mm-40 -85.47 143.3 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.65 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.803 HE22 ' NE ' ' A' ' 37' ' ' ARG . 78.5 mt-30 -108.06 140.41 41.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.742 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 t -135.15 132.68 38.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.035 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.7 tp -73.45 118.98 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.707 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 pt -112.09 -21.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.111 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 tp -157.04 124.41 5.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.905 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 t -132.18 120.82 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 t -153.56 155.51 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -121.63 154.27 37.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.181 0.515 . . . . 0.0 111.042 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.461 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.7 mt-30 -146.69 157.93 43.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.07 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.53 118.3 36.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.249 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.584 HG22 ' CE1' ' A' ' 22' ' ' PHE . 39.2 p . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.788 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p . . . . . 0 C--O 1.229 0.024 0 CA-C-O 120.957 0.408 . . . . 0.0 110.476 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.8 p -63.04 -177.58 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.378 -179.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 95' ' ' THR . 17.7 m-85 -147.67 144.33 28.27 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.953 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 t -116.16 101.67 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.6 t -111.17 135.16 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.357 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.2 p -125.5 154.26 42.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.403 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.623 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.2 p90 -143.8 -179.19 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.01 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -118.8 129.36 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.045 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 p . . . . . 0 C--N 1.326 -0.435 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.422 -179.859 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p . . . . . 0 N--CA 1.453 -0.318 0 CA-C-O 120.83 0.348 . . . . 0.0 110.507 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 79' ' ' ILE . 18.8 m -93.05 -15.99 25.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.558 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.502 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.41 -177.82 47.2 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 58' ' ' ALA . 73.8 m-85 -122.73 149.4 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.96 0.41 . . . . 0.0 110.523 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.631 ' NH2' HE22 ' A' ' 85' ' ' GLN . 13.7 ttp180 -127.49 118.71 24.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.49 132.39 49.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.209 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 80.8 tt0 -122.03 134.9 54.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.03 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CE1' ' NE2' ' A' ' 50' ' ' GLN . 54.3 p90 -140.86 137.08 32.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.836 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -149.08 160.86 42.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.203 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.69 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 47.3 mt -74.32 127.39 32.87 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.691 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 p -70.87 -24.01 62.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 . . . . . 0 C--N 1.328 -0.366 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.027 -179.182 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.437 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 37.3 Cg_endo . . . . . 0 N--CA 1.489 1.257 0 CA-C-O 121.258 0.441 . . . . 0.0 112.851 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.506 ' NE2' ' CE1' ' A' ' 40' ' ' TYR . 6.1 mt-30 -114.88 145.0 42.65 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 39' ' ' GLU . 92.9 m-85 -124.09 136.41 54.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.153 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 52' ' ' LEU . 88.6 mt -119.92 131.37 55.2 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -103.6 132.03 50.22 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.521 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mt -129.72 155.5 80.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -66.68 160.42 46.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.232 1.955 . . . . 0.0 112.539 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.427 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 15.9 p -57.53 -14.19 4.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -90.82 -9.47 46.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 36' ' ' PHE . . . -83.41 128.81 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.938 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.9 p -132.81 14.22 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.339 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -163.16 141.62 8.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.152 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.22 146.43 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.654 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.406 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.1 t-20 -103.05 127.2 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.34 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 95.0 Cg_endo -90.65 -179.12 1.53 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.919 2.413 . . . . 0.0 112.622 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 61.58 35.69 17.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.96 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 30.5 mt -89.51 152.88 21.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.11 111.73 40.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.508 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 23.5 Cg_exo -56.29 139.78 86.9 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.933 1.755 . . . . 0.0 111.358 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.83 18.83 69.2 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.695 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -125.02 148.74 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -99.35 132.51 44.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.151 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 90.3 m-85 -121.56 150.92 40.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.189 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 87.4 mt -107.71 123.65 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -109.95 131.39 61.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 0.0 110.815 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.14 129.08 33.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.603 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 26' ' ' TRP . 5.6 t -109.99 131.46 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.923 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -123.47 143.37 50.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.288 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -99.6 136.58 39.32 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.686 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.5 mt -100.72 123.97 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.298 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.606 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 51.9 p -85.44 172.36 11.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.003 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.549 ' OE2' ' OG ' ' A' ' 34' ' ' SER . 78.1 mm-40 -61.48 -23.96 66.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.03 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.606 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.9 p30 -93.57 -1.66 55.18 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.35 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.97 60.05 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.411 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.459 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.4 mm-40 -84.79 131.82 34.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.14 0.47 . . . . 0.0 110.596 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.631 HE22 ' NH2' ' A' ' 37' ' ' ARG . 27.3 mt-30 -105.26 141.11 37.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.794 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.6 t -136.29 133.56 37.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.76 HD21 ' HB2' ' A' ' 90' ' ' SER . 28.0 tp -72.3 118.41 15.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.3 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.06 -20.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 26' ' ' TRP . 15.0 tp -155.0 124.89 6.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.422 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.76 ' HB2' HD21 ' A' ' 87' ' ' LEU . 12.9 t -131.93 123.03 26.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.562 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -154.14 152.76 30.78 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.034 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.6 p -118.19 153.37 33.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -142.59 160.5 40.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.838 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 115.92 25.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.015 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.465 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 81.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.662 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.456 -0.151 0 CA-C-O 120.903 0.383 . . . . 0.0 110.383 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.488 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -55.08 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.596 0.712 . . . . 0.0 111.862 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.488 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 18.7 m-85 -146.34 146.51 30.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.744 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 54.1 t -119.04 103.19 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.509 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.3 t -109.04 134.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.191 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.1 p -128.05 150.52 49.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.757 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -145.01 178.62 7.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.949 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 t -117.01 128.48 74.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m . . . . . 0 C--N 1.325 -0.466 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.422 -179.447 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 56' ' ' SER . 1.5 p . . . . . 0 N--CA 1.448 -0.531 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.5 m -94.62 -14.77 24.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 174.9 177.3 43.9 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -124.77 152.86 43.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.624 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.781 ' NH1' ' CD1' ' A' ' 51' ' ' TYR . 14.8 ttp85 -128.59 126.06 39.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.657 HG21 HG11 ' A' ' 61' ' ' VAL . 41.6 t -105.72 132.34 52.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.453 ' OE2' ' CB ' ' A' ' 49' ' ' PRO . 73.3 tt0 -127.95 133.25 49.21 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.72 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.6 p90 -140.43 133.74 29.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.222 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -143.59 162.09 36.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.726 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 47.2 mt -72.9 134.95 45.01 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.997 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.7 p -73.55 -19.38 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.213 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HG2' HH22 ' A' ' 70' ' ' ARG . 73.5 mm-40 . . . . . 0 C--N 1.331 -0.207 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.936 -179.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.453 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 61.2 Cg_endo . . . . . 0 N--CA 1.488 1.206 0 CA-C-O 120.745 0.227 . . . . 0.0 111.94 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -112.27 141.0 46.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.781 ' CD1' ' NH1' ' A' ' 37' ' ' ARG . 78.6 m-85 -123.43 138.8 54.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.872 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -126.6 132.18 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -100.91 134.38 43.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.882 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mt -128.64 154.7 79.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.558 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.08 159.39 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.245 1.963 . . . . 0.0 111.957 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.475 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 25.4 p -59.72 -11.99 6.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.672 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -91.23 -6.4 53.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.69 132.97 35.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.682 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 p -130.65 6.84 4.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.267 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.4 p -164.92 141.38 5.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.657 HG11 HG21 ' A' ' 38' ' ' VAL . 8.0 p -148.11 148.96 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.162 0.506 . . . . 0.0 111.667 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.488 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 10.1 t-20 -102.63 125.45 49.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.908 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -99.03 108.17 47.95 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -93.36 -176.92 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 123.168 2.579 . . . . 0.0 112.705 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 59.59 35.55 22.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.233 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -89.6 148.11 23.53 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.191 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -86.49 113.31 51.97 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.034 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -57.66 140.95 95.14 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.236 1.957 . . . . 0.0 112.334 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.2 21.42 67.6 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.682 ' HE ' HD22 ' A' ' 42' ' ' LEU . 7.3 mmm180 -125.67 149.0 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.945 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . 0.4 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 67.9 tttt -102.34 130.52 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.775 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.726 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 90.4 m-85 -122.72 154.05 38.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.3 mt -108.22 125.88 64.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 t -113.98 133.83 58.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.205 0.526 . . . . 0.0 111.401 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -134.63 126.08 28.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.354 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.93 128.3 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.848 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -121.36 137.94 54.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -101.01 136.0 41.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.476 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.3 mt -98.68 120.95 48.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.808 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 29.2 p -82.4 168.53 17.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.22 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . 0.478 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 73.5 mm-40 -59.28 -18.22 35.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.825 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 38.7 p30 -93.07 -1.51 56.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.243 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.61 12.8 68.72 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.575 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.0 mm-40 -84.69 141.89 30.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.981 0.419 . . . . 0.0 111.082 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.484 HE22 ' NE ' ' A' ' 37' ' ' ARG . 94.4 mt-30 -110.12 141.93 42.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -136.5 131.22 33.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.034 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 90' ' ' SER . 30.4 tp -72.3 116.96 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.157 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 pt -110.31 -21.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 tp -154.75 122.03 5.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.185 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.569 ' HB2' HD21 ' A' ' 87' ' ' LEU . 22.6 t -131.19 117.88 19.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -150.63 155.71 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.637 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.6 p -114.85 156.04 25.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.427 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.488 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 25.4 mt-30 -144.28 153.3 41.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 106.68 14.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.2 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.595 -179.24 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.472 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.455 -0.186 0 CA-C-O 121.054 0.454 . . . . 0.0 110.241 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.97 159.9 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.41 -179.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.486 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 22.5 m-30 -127.23 151.97 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.806 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.76 106.56 15.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.24 145.48 20.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.109 0.48 . . . . 0.0 111.006 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.2 p -131.4 153.82 49.29 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.69 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.479 ' CD2' HG11 ' A' ' 76' ' ' VAL . 33.0 p90 -143.35 -166.38 2.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 25.4 t -117.45 129.23 74.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.146 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m . . . . . 0 C--N 1.325 -0.471 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.079 -179.802 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 56' ' ' SER . 3.9 p . . . . . 0 N--CA 1.452 -0.349 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.687 ' N ' ' O ' ' A' ' 79' ' ' ILE . 39.0 m -95.45 -12.98 24.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 109.739 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.17 -179.88 47.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.86 151.53 48.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.749 0.309 . . . . 0.0 110.433 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.889 ' NE ' HE22 ' A' ' 85' ' ' GLN . 25.3 ttp180 -129.35 122.83 30.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 61' ' ' VAL . 80.8 t -108.2 133.82 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.542 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 59.3 tt0 -124.46 137.06 54.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.548 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 24.9 p90 -141.81 130.66 22.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.937 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -143.11 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.324 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.82 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 83.0 mt -75.69 123.89 26.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.166 0.507 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.0 p -66.14 -26.04 67.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.423 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 . . . . . 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.299 -179.162 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo . . . . . 0 N--CA 1.485 1.019 0 N-CA-C 111.163 -0.36 . . . . 0.0 111.163 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.2 mt-30 -120.61 150.93 40.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -124.78 136.13 53.58 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.95 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -122.09 130.19 53.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.479 ' O ' HD23 ' A' ' 54' ' ' LEU . 67.3 m-20 -104.29 133.53 49.04 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.39 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 53' ' ' ASP . 7.2 mt -129.41 155.77 79.58 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.278 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 58' ' ' ALA . 22.2 Cg_endo -69.49 151.24 70.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 121.63 1.553 . . . . 0.0 112.059 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.443 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 3.3 p -52.16 -13.03 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.491 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . 0.406 ' N ' ' C ' ' A' ' 55' ' ' PRO . 78.1 p -93.01 -7.06 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . . . -80.45 136.79 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.352 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -129.62 8.9 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.5 p -164.57 149.84 10.01 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.486 HG11 HG21 ' A' ' 38' ' ' VAL . 9.9 p -151.85 153.06 10.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.244 0.545 . . . . 0.0 111.944 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 22' ' ' PHE . 50.8 t30 -105.51 128.5 53.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.927 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.415 HG22 HD21 ' A' ' 66' ' ' LEU . 2.0 mt -102.13 103.36 29.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 64.2 Cg_endo -89.95 -175.21 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.177 2.585 . . . . 0.0 112.211 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 58.86 36.63 24.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.234 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 20' ' ' SER . 16.4 mt -89.2 149.66 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.313 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.597 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 21.8 mt -92.67 112.06 53.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.076 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.34 132.84 48.74 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.875 1.717 . . . . 0.0 110.703 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.48 10.72 73.13 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.426 ' HB3' HD22 ' A' ' 42' ' ' LEU . 19.4 mmt85 -123.77 145.9 48.7 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -97.22 133.16 42.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.82 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 20.7 m-85 -115.27 156.19 25.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.225 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.564 HG22 HD21 ' A' ' 75' ' ' ASN . 62.5 mt -113.47 122.14 67.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.84 128.12 67.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.067 0.461 . . . . 0.0 110.948 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.564 HD21 HG22 ' A' ' 73' ' ' ILE . 39.7 m-80 -133.86 127.17 32.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.599 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 26' ' ' TRP . 19.5 t -106.99 128.25 61.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -117.32 139.0 51.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.876 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -100.76 135.13 42.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.687 ' O ' ' N ' ' A' ' 34' ' ' SER . 60.0 mt -99.26 121.94 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.916 0.388 . . . . 0.0 110.984 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.593 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 93.0 p -85.2 168.98 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.008 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -57.25 -20.8 29.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.643 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.593 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 50.0 p30 -93.38 2.67 56.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.17 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.95 72.62 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.944 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 69.7 mm-40 -85.13 144.35 28.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.984 0.421 . . . . 0.0 111.4 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.889 HE22 ' NE ' ' A' ' 37' ' ' ARG . 53.5 mt-30 -109.51 140.03 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.719 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 t -135.72 132.36 36.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.867 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 90' ' ' SER . 22.0 tp -73.16 117.07 14.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.424 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.0 pt -107.43 -22.84 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.096 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 tp -156.73 125.26 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.812 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.448 ' HB2' HD21 ' A' ' 87' ' ' LEU . 47.8 t -127.7 123.66 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.33 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 t -155.0 156.72 36.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.613 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.3 p -116.96 156.1 28.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.413 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.486 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 20.0 mt-30 -140.38 160.16 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 111.122 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.69 112.65 17.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 43.9 p . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.601 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.51 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.9 OUTLIER . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.626 0.25 . . . . 0.0 110.683 . . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -64.49 164.3 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.164 0.507 . . . . 0.0 111.605 -179.509 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -128.71 144.26 51.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.58 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.7 101.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.27 136.59 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.509 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.8 p -124.41 152.76 42.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.497 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -144.28 -165.88 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 110.639 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.577 ' O ' HD12 ' A' ' 88' ' ' ILE . 57.7 t -120.27 131.28 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.765 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.618 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 73.0 p . . . . . 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 -179.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.438 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.2 p . . . . . 0 N--CA 1.453 -0.294 0 N-CA-C 110.17 -0.308 . . . . 0.0 110.17 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.0 m -93.68 -16.52 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 109.761 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.97 178.82 47.01 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.73 150.82 49.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.658 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.722 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.0 ttp180 -130.09 122.26 27.95 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.98 131.17 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.806 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.432 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.6 tt0 -122.29 132.52 54.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.774 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 54.1 p90 -138.1 137.2 37.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.129 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.43 159.01 43.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.438 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.71 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 58.3 mt -73.91 124.43 26.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.197 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -67.14 -28.66 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.595 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 . . . . . 0 C--N 1.327 -0.4 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.393 -179.193 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo . . . . . 0 N--CA 1.489 1.217 0 CA-C-O 121.006 0.336 . . . . 0.0 112.47 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 mt-30 -114.59 146.38 40.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.3 m-85 -123.32 137.2 54.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.324 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 52' ' ' LEU . 91.3 mt -121.93 126.81 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -100.69 130.62 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.146 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.9 mt -127.78 154.72 78.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.577 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.35 155.44 67.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.188 1.925 . . . . 0.0 112.503 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.426 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 5.3 p -56.89 -12.57 2.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -94.21 -9.45 36.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.848 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.1 136.05 34.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 110.67 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -129.34 12.6 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.89 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.2 p -164.32 149.32 10.11 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.516 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.41 150.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.178 0.514 . . . . 0.0 111.575 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.47 127.11 50.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.571 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.6 105.01 34.63 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.88 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -90.66 -178.54 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.922 2.414 . . . . 0.0 113.253 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 60.47 36.86 20.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.771 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.51 ' O ' ' OG ' ' A' ' 20' ' ' SER . 47.6 mt -92.62 144.88 24.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.603 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.541 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 19.4 mt -88.71 112.17 48.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.063 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -53.92 141.67 66.29 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.102 1.868 . . . . 0.0 111.897 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 81.0 17.08 73.17 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.424 ' HB3' HD22 ' A' ' 42' ' ' LEU . 7.7 mmt-85 -124.01 146.39 48.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -98.94 132.41 44.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.827 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.71 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 55.6 m-85 -118.89 155.6 30.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.762 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.468 HG22 HD21 ' A' ' 75' ' ' ASN . 70.8 mt -109.13 126.99 66.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -112.47 131.31 64.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.0 0.428 . . . . 0.0 111.075 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.468 HD21 HG22 ' A' ' 73' ' ' ILE . 32.7 m-80 -138.05 125.68 22.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.898 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.471 ' O ' HD12 ' A' ' 87' ' ' LEU . 46.5 t -105.04 127.85 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.893 0.378 . . . . 0.0 110.413 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -119.45 136.07 54.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.618 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -101.57 135.18 43.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 34' ' ' SER . 64.0 mt -97.08 120.51 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 110.549 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.587 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.2 p -81.39 172.32 13.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.652 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -22.82 59.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.642 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.587 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 49.2 p30 -92.18 0.68 57.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 11.21 73.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.814 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.9 mm-40 -84.02 140.08 32.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.722 HE22 ' NE ' ' A' ' 37' ' ' ARG . 90.8 mt-30 -103.08 142.62 33.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.899 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.7 t -136.58 128.24 28.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.15 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 90' ' ' SER . 61.3 tp -73.14 119.16 17.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 27' ' ' VAL . 45.0 pt -110.83 -20.89 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.099 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.0 tp -155.46 120.18 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.512 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.711 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.7 t -127.13 123.66 37.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 t -156.08 149.58 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.685 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.2 p -111.95 155.44 23.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.024 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -140.93 156.67 46.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.237 0.541 . . . . 0.0 110.954 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -119.14 110.94 17.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.252 178.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 94' ' ' THR . 75.6 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.583 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.484 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 18.7 p . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.569 0.224 . . . . 0.0 111.05 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 1.2 p -61.65 131.59 50.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.264 179.86 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.632 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 6.6 m-30 -95.03 146.48 24.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.735 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.1 t -131.49 103.99 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.903 178.376 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -116.05 138.11 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.0 p -124.71 152.58 43.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.821 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.621 ' CE3' HG21 ' A' ' 76' ' ' VAL . 42.1 p90 -146.24 -165.49 2.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.36 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 t -130.81 129.59 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.826 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 p . . . . . 0 C--N 1.324 -0.52 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.801 -179.978 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 56' ' ' SER . 0.9 OUTLIER . . . . . 0 N--CA 1.451 -0.41 0 N-CA-C 109.836 -0.431 . . . . 0.0 109.836 . . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.6 m -94.72 -18.74 21.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.209 0.528 . . . . 0.0 109.805 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.85 178.36 46.54 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -123.1 150.26 43.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.486 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.685 ' NE ' HE22 ' A' ' 85' ' ' GLN . 29.4 ttp180 -129.21 120.93 26.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.527 HG21 HG11 ' A' ' 61' ' ' VAL . 13.7 t -106.56 131.22 56.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.89 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.05 132.83 55.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.519 ' CE1' ' NE2' ' A' ' 50' ' ' GLN . 54.7 p90 -140.73 136.45 32.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.609 . . . . 0.0 111.267 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.0 164.72 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.989 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.768 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 79.3 mt -72.45 125.11 26.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.82 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 p -62.08 -32.95 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.511 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 . . . . . 0 C--N 1.328 -0.358 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.033 179.735 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo . . . . . 0 N--CA 1.492 1.393 0 CA-C-O 120.783 0.243 . . . . 0.0 111.952 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.519 ' NE2' ' CE1' ' A' ' 40' ' ' TYR . 2.2 mt-30 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -126.15 138.92 53.71 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.763 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -127.06 133.05 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . 0.406 ' O ' HD23 ' A' ' 54' ' ' LEU . 56.1 m-20 -106.65 134.29 50.02 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.693 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 53' ' ' ASP . 7.2 mt -131.83 156.14 80.49 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.669 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.25 158.13 58.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.05 1.834 . . . . 0.0 112.294 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.618 ' HB2' HG13 ' A' ' 33' ' ' VAL . 87.3 p -58.67 -13.04 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -92.97 -6.97 47.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.861 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.12 134.56 34.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.606 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -131.9 15.41 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.482 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -163.28 144.02 9.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 38' ' ' VAL . 9.5 p -149.28 148.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.533 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 5.0 t-20 -106.04 127.13 52.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.546 178.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.411 HG22 HD21 ' A' ' 66' ' ' LEU . 1.7 mt -98.34 104.77 25.15 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 94.3 Cg_endo -90.18 172.5 3.57 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.535 2.157 . . . . 0.0 112.587 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 62.45 39.53 11.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.725 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.547 HD12 ' CD1' ' A' ' 22' ' ' PHE . 32.9 mt -89.44 138.68 31.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.291 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.565 HD13 ' NH2' ' A' ' 70' ' ' ARG . 28.5 mt -68.76 129.34 92.51 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.851 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.05 138.06 27.53 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.508 2.139 . . . . 0.0 112.012 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.26 22.23 73.91 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.565 ' NH2' HD13 ' A' ' 67' ' ' LEU . 5.5 mmm-85 -125.71 148.59 49.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -98.64 134.03 42.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.183 0.516 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.768 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 49.9 m-85 -120.81 149.5 42.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.846 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.478 HG22 HD21 ' A' ' 75' ' ' ASN . 66.3 mt -108.18 128.71 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 t -116.58 129.26 73.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.42 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.478 HD21 HG22 ' A' ' 73' ' ' ILE . 33.4 m-80 -134.43 124.41 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.712 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.621 HG21 ' CE3' ' A' ' 26' ' ' TRP . 21.9 t -100.96 128.14 53.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.496 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . 0.468 ' HB2' HE21 ' A' ' 85' ' ' GLN . 61.2 m-85 -120.12 136.59 54.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.698 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.88 137.5 40.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.759 -0.776 . . . . 0.0 108.969 178.992 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.8 mt -100.58 127.7 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 111.4 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 28.4 p -84.53 173.06 11.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.43 -18.06 48.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.868 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.605 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.3 p30 -94.56 -4.04 48.65 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.498 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 13.75 62.41 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.262 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.585 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 69.4 mm-40 -84.56 147.3 27.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.898 0.349 . . . . 0.0 110.335 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.685 HE22 ' NE ' ' A' ' 37' ' ' ARG . 50.0 mt-30 -112.44 147.7 35.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.124 0.488 . . . . 0.0 111.77 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -139.14 128.63 24.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.93 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 tp -73.3 118.96 16.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.964 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.2 pt -111.72 -22.69 4.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 26' ' ' TRP . 16.6 tp -154.85 127.1 7.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.907 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 48.1 t -135.6 119.05 16.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.133 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -145.77 159.57 42.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.7 p -126.32 152.49 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.447 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.2 mt-30 -145.94 163.02 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.598 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.03 108.67 16.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.864 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.482 ' HG1' ' H ' ' A' ' 70' ' ' ARG . 37.9 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.631 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.519 ' O ' HD12 ' A' ' 66' ' ' LEU . 1.7 p . . . . . 0 N--CA 1.456 -0.16 0 CA-C-O 120.94 0.4 . . . . 0.0 109.962 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -61.16 142.37 56.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.37 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 95' ' ' THR . 6.3 m-30 -96.78 148.38 22.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.34 107.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.21 135.54 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.051 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -123.35 150.58 43.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.693 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -146.88 -168.24 2.98 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.301 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.1 t -120.63 132.76 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.521 179.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.689 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 32.2 t . . . . . 0 C--N 1.323 -0.575 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.416 -179.347 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.447 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 0.7 OUTLIER . . . . . 0 N--CA 1.449 -0.482 0 N-CA-C 110.167 -0.308 . . . . 0.0 110.167 . . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 79' ' ' ILE . 8.4 m -94.83 -16.13 23.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.304 0.573 . . . . 0.0 109.682 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.447 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.05 175.29 45.08 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CZ ' HG11 ' A' ' 33' ' ' VAL . 93.9 m-85 -124.28 152.25 43.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.613 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.534 ' HE ' ' HB3' ' A' ' 51' ' ' TYR . 70.7 ttt180 -132.78 122.87 25.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.756 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.2 t -109.58 130.41 62.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.886 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.51 ' C ' ' OE1' ' A' ' 39' ' ' GLU . 13.1 tm-20 -123.68 129.59 51.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 34.9 p90 -143.52 144.74 32.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.213 0.53 . . . . 0.0 111.599 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -148.65 168.14 23.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.464 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.745 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 67.3 mt -73.86 129.76 38.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.191 0.52 . . . . 0.0 111.532 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.3 p -70.83 -18.74 62.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.21 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 . . . . . 0 C--N 1.331 -0.226 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.221 -179.339 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo . . . . . 0 N--CA 1.489 1.25 0 CA-C-O 120.795 0.248 . . . . 0.0 111.858 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 22.6 mt-30 -116.67 144.14 44.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.534 ' HB3' ' HE ' ' A' ' 37' ' ' ARG . 3.2 m-85 -123.7 139.22 54.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.909 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -127.35 127.67 44.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -100.86 132.1 46.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.354 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -128.0 155.5 77.67 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.456 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -68.33 155.98 67.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.037 1.824 . . . . 0.0 112.303 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.4 p -56.67 -12.59 1.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 37.7 p -91.84 -8.66 45.94 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.79 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.06 34.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -128.5 11.31 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.6 p -164.2 145.89 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.09 145.49 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.361 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -104.23 127.84 51.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.236 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.84 105.94 37.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -87.78 179.52 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.571 2.181 . . . . 0.0 112.492 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 58.37 38.58 25.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.299 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 20' ' ' SER . 28.8 mt -87.77 150.23 23.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.8 mt -94.21 109.32 41.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.112 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -54.63 139.56 76.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.137 1.891 . . . . 0.0 111.627 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.574 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 84.95 15.92 66.36 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.471 ' HG3' ' NH1' ' A' ' 70' ' ' ARG . 7.6 mmm-85 -125.35 143.75 50.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 110.574 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -100.81 132.0 46.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.745 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 80.1 m-85 -119.6 151.41 38.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.894 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 70.3 mt -108.54 131.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -119.68 134.18 64.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.827 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.02 125.7 30.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.48 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.1 t -104.15 128.95 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.765 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -119.08 138.96 52.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.544 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -104.98 137.15 43.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.03 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.6 mt -100.1 121.75 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.195 0.521 . . . . 0.0 110.382 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 83.6 p -82.48 167.67 18.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.597 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -57.55 -19.91 28.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.244 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.61 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.9 p30 -92.24 0.04 57.43 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.188 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.4 9.2 73.06 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.054 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -82.71 143.93 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 111.074 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.484 ' NE2' HG12 ' A' ' 79' ' ' ILE . 3.1 mm-40 -109.53 141.91 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 t -138.27 133.95 33.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.557 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 tp -73.56 118.55 16.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.648 -0.421 . . . . 0.0 109.947 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.3 pt -109.92 -23.25 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.211 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.9 tp -157.03 126.6 6.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.119 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 t -132.81 122.36 24.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.495 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -152.38 159.94 43.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.257 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.2 p -121.59 153.03 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.505 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.4 mt-30 -145.64 161.32 40.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.459 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.13 114.17 19.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.705 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 59.5 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.418 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 23.7 p . . . . . 0 C--O 1.23 0.075 0 CA-C-O 120.913 0.387 . . . . 0.0 110.691 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 4.9 p -62.46 164.05 7.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.735 -179.68 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 20.8 m-30 -129.37 147.9 51.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.47 178.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.9 t -124.04 101.9 10.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.953 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.09 137.76 43.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 -178.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -124.55 152.27 43.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.883 179.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.473 ' CD2' HG11 ' A' ' 76' ' ' VAL . 39.0 p90 -143.35 -177.93 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.5 -179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 55.8 t -108.02 132.54 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.871 179.622 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.62 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 98.3 p . . . . . 0 C--N 1.326 -0.438 0 CA-C-O 120.959 0.409 . . . . 0.0 110.49 -179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.434 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.4 p . . . . . 0 N--CA 1.455 -0.22 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 79' ' ' ILE . 7.2 m -94.5 -17.14 22.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.248 0.547 . . . . 0.0 109.559 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.06 178.51 47.59 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -126.9 151.6 48.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.596 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.455 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 21.2 ttp180 -130.8 121.26 25.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.1 132.01 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.594 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 79.6 tt0 -121.07 133.65 55.24 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.61 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.465 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.4 p90 -139.04 130.48 27.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -142.72 161.63 37.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.573 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.654 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 56.8 mt -75.15 132.61 41.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 111.85 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -77.86 -14.67 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.124 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 . . . . . 0 C--N 1.331 -0.216 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 -179.494 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo . . . . . 0 N--CA 1.489 1.247 0 CA-C-O 120.878 0.282 . . . . 0.0 111.511 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.465 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 21.3 mt-30 -118.08 144.9 45.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.594 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.9 m-85 -125.17 137.37 54.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.627 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.5 mt -117.03 127.41 54.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -100.49 131.15 46.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.127 0.489 . . . . 0.0 111.093 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 61' ' ' VAL . 4.5 mt -129.12 155.79 79.26 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.59 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.69 158.61 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 112.167 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.433 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 27.8 p -58.69 -12.95 4.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.714 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.5 p -90.31 -10.23 44.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 134.74 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.7 p -126.83 7.51 6.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.563 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -165.76 147.08 7.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.232 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 54' ' ' LEU . 5.7 p -148.91 150.43 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.043 0.449 . . . . 0.0 111.371 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.439 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 8.1 t-20 -101.49 130.48 47.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.925 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -107.29 97.01 17.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 85.3 Cg_endo -87.46 -171.52 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.664 2.243 . . . . 0.0 112.541 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 58.42 35.63 24.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.219 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.573 ' O ' ' OG ' ' A' ' 20' ' ' SER . 50.0 mt -90.53 142.01 28.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.2 mt -82.75 113.16 43.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.266 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -54.4 141.42 72.32 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.226 1.95 . . . . 0.0 112.204 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.26 20.09 70.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 13.3 mmm-85 -123.05 146.91 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.716 -179.959 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -100.15 131.54 46.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 76.9 m-85 -121.13 153.93 36.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.214 0.531 . . . . 0.0 111.625 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.0 mt -108.31 124.08 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.97 131.54 64.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -134.54 126.1 28.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.552 179.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 26' ' ' TRP . 38.8 t -106.33 130.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.904 -179.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -123.5 136.59 54.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.025 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -100.93 134.74 43.46 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.207 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 34' ' ' SER . 59.2 mt -97.5 123.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.957 -178.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.579 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 52.1 p -83.34 170.97 14.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.97 -21.41 64.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.579 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -91.3 -0.8 57.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.56 10.18 70.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.335 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.419 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 78.3 mm-40 -84.67 140.8 31.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.791 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.455 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 91.4 mt-30 -106.12 143.16 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.2 t -136.59 132.15 34.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.261 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 90' ' ' SER . 24.1 tp -72.96 118.37 15.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.349 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.435 HD11 ' CD1' ' A' ' 26' ' ' TRP . 41.5 pt -109.42 -22.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.401 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.7 tp -154.88 121.81 5.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 111.459 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.575 ' HB2' HD21 ' A' ' 87' ' ' LEU . 39.3 t -132.08 113.24 13.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.8 t -150.87 162.76 40.16 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.443 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -116.49 154.3 30.61 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.331 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.579 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 23.7 mt-30 -136.56 155.82 49.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.93 109.51 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.4 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 18.4 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.499 -179.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.525 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.2 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.951 0.405 . . . . 0.0 110.234 . . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 3.5 p -61.18 165.87 4.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.24 -179.212 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.675 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 17.3 m-30 -136.12 151.06 49.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.281 178.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.96 102.2 9.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.63 136.51 48.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.306 -178.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -121.88 153.18 38.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.687 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.62 ' CD2' HG11 ' A' ' 76' ' ' VAL . 29.0 p90 -143.58 -168.9 2.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 110.933 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . 0.652 ' O ' HD12 ' A' ' 88' ' ' ILE . 79.7 t -115.1 133.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.217 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.518 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 98.2 p . . . . . 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.422 -179.833 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.468 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.6 p . . . . . 0 N--CA 1.452 -0.358 0 CA-C-O 120.907 0.384 . . . . 0.0 110.297 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 79' ' ' ILE . 59.7 m -95.37 -15.07 23.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.525 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.54 -178.89 48.37 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.34 152.73 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.549 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.793 ' NH2' HE22 ' A' ' 85' ' ' GLN . 27.4 ttp180 -130.8 122.68 27.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.594 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.32 134.32 51.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.948 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 83.2 tt0 -121.47 126.95 50.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.202 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.457 ' CE1' ' OE1' ' A' ' 50' ' ' GLN . 54.0 p90 -133.6 131.29 39.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.238 0.542 . . . . 0.0 110.502 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -147.44 161.56 40.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.442 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.78 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 67.6 mt -75.78 130.45 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.941 0.401 . . . . 0.0 111.702 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.0 p -74.87 -23.23 58.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.106 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 . . . . . 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.972 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo . . . . . 0 N--CA 1.488 1.2 0 CA-C-O 120.906 0.294 . . . . 0.0 111.856 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.457 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 32.7 mt-30 -116.81 147.82 41.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -123.95 139.59 53.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.943 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.7 mt -124.76 128.55 48.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.056 178.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -103.36 132.02 49.96 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.977 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . 0.449 HD21 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -128.91 155.15 80.02 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.916 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.9 155.77 68.48 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 112.031 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.413 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 26.7 p -58.06 -14.66 7.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.639 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.8 p -89.41 -11.12 44.07 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.367 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.99 131.44 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.4 p -125.28 10.2 8.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.617 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -164.85 146.4 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.06 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.449 HG21 HD21 ' A' ' 54' ' ' LEU . 5.1 p -149.05 152.21 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.514 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.675 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 13.2 t-20 -102.42 124.76 48.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.762 178.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 mt -97.26 107.0 35.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -92.21 -178.65 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.802 2.335 . . . . 0.0 113.145 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 58.7 38.05 25.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.531 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.525 ' O ' ' OG ' ' A' ' 20' ' ' SER . 56.7 mt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.094 178.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.493 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 30.2 mt -86.44 123.77 70.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.249 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.81 143.36 55.29 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.226 1.95 . . . . 0.0 112.523 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.56 19.53 73.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.673 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -126.44 151.55 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.302 . . . . 0.0 110.64 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -100.37 130.65 46.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.029 0.442 . . . . 0.0 110.236 179.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.78 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 68.1 m-85 -117.25 158.52 24.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.017 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.4 mt -113.37 126.08 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.031 0.443 . . . . 0.0 110.642 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -133.36 125.76 29.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.421 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.62 HG11 ' CD2' ' A' ' 26' ' ' TRP . 14.3 t -104.65 128.51 58.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.583 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -120.75 139.37 53.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -101.62 134.52 44.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.4 mt -99.06 119.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.39 0.614 . . . . 0.0 110.621 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.6 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 24.7 p -82.56 169.64 16.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.078 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.98 -19.3 51.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.48 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.6 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 47.3 p30 -93.14 -1.41 56.4 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.144 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.28 67.36 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.926 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 73.8 mm-40 -83.7 139.26 32.88 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.793 HE22 ' NH2' ' A' ' 37' ' ' ARG . 28.7 mt-30 -110.41 139.43 45.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -136.82 135.92 38.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.937 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.819 HD21 ' HB2' ' A' ' 90' ' ' SER . 32.3 tp -73.28 118.45 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 27' ' ' VAL . 44.1 pt -109.05 -22.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.612 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -154.87 122.19 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.106 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.819 ' HB2' HD21 ' A' ' 87' ' ' LEU . 35.2 t -130.61 122.21 27.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -154.34 158.59 40.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.323 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.2 p -117.15 152.69 34.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.463 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 27.0 mt-30 -138.94 157.47 45.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.661 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 112.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 53.8 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.498 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.413 0.149 . . . . 0.0 111.313 . . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -60.77 129.57 42.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.182 0.515 . . . . 0.0 110.626 -179.994 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 19.0 m-30 -95.65 144.87 25.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.266 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.31 102.87 13.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.87 137.88 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.079 0.466 . . . . 0.0 111.504 -178.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -126.52 153.02 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.711 179.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.577 ' CD2' HG11 ' A' ' 76' ' ' VAL . 32.2 p90 -144.65 -172.52 3.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 39.4 t -113.76 131.15 66.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.629 179.235 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.678 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 27.3 t . . . . . 0 C--N 1.327 -0.393 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.683 -179.376 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.505 ' O ' ' CB ' ' A' ' 56' ' ' SER . 2.1 p . . . . . 0 N--CA 1.454 -0.26 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.8 m -95.31 -13.31 24.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.346 0.593 . . . . 0.0 109.831 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.96 177.02 44.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.57 151.71 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.904 0.383 . . . . 0.0 110.369 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.708 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 46.0 ttp180 -128.66 121.74 29.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.682 178.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 61' ' ' VAL . 47.9 t -106.72 132.87 52.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.381 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 69.3 tt0 -123.46 134.28 53.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.763 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 54.6 p90 -140.14 137.18 34.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 110.714 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.62 158.94 44.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.907 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.685 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 39.9 mt -74.25 132.4 42.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.5 p -77.64 -13.67 59.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.317 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.976 -179.539 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.538 ' C ' ' OE1' ' A' ' 50' ' ' GLN . 57.7 Cg_endo . . . . . 0 N--CA 1.489 1.259 0 CA-C-O 120.846 0.269 . . . . 0.0 111.997 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.655 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.4 mp0 -113.11 147.9 36.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -122.72 136.16 54.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.146 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -120.58 128.28 52.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.66 130.61 46.73 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.201 -178.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -127.82 155.95 76.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.468 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -68.21 156.16 66.77 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.274 1.983 . . . . 0.0 112.269 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 53.4 p -58.8 -14.11 7.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.3 p -90.01 -8.83 50.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.71 132.96 34.39 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 p -128.9 12.73 6.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.032 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.5 p -164.61 148.62 9.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 38' ' ' VAL . 5.3 p -152.63 147.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.514 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 15.9 t-20 -102.88 127.96 49.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.366 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.455 HG22 HD21 ' A' ' 66' ' ' LEU . 1.9 mt -99.21 104.6 27.33 Favored Pre-proline 0 C--N 1.332 -0.177 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.5 Cg_endo -89.42 174.66 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.785 2.323 . . . . 0.0 113.103 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 61.38 38.31 16.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.708 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.517 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -90.51 142.44 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.417 HD13 ' NH2' ' A' ' 70' ' ' ARG . 24.9 mt -78.66 130.8 69.69 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.287 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 70' ' ' ARG . 39.0 Cg_exo -51.35 -174.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.206 1.937 . . . . 0.0 111.812 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 17.02 40.29 0.01 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.373 179.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.709 ' N ' ' O ' ' A' ' 68' ' ' PRO . 16.2 mmm-85 -127.22 142.76 51.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.346 0.573 . . . . 0.0 110.417 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -101.19 132.4 46.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.685 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 67.8 m-85 -121.28 155.72 34.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.2 mt -110.68 123.77 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 62.7 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 0.0 111.565 -178.27 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . 0.496 ' OD1' ' OG ' ' A' ' 90' ' ' SER . 21.4 m-80 -133.07 126.14 31.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.523 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' A' ' 26' ' ' TRP . 6.6 t -107.57 131.36 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.12 142.29 50.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.116 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.678 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -102.88 137.47 41.04 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.663 ' O ' ' N ' ' A' ' 34' ' ' SER . 45.2 mt -100.93 121.56 51.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.074 0.464 . . . . 0.0 110.437 -178.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.614 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 71.4 p -82.11 168.13 18.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.945 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -57.62 -22.25 44.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.614 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.5 p30 -92.82 -0.49 57.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.723 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.76 11.95 67.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.495 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.21 138.69 33.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.195 0.498 . . . . 0.0 111.037 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.708 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 94.0 mt-30 -107.03 142.24 36.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.224 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -138.3 135.34 35.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.135 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 90' ' ' SER . 36.8 tp -73.42 118.6 16.57 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.228 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 88' ' ' ILE . 32.6 pt -110.99 -22.43 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.555 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -155.19 124.86 6.47 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.562 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.614 ' HB2' HD21 ' A' ' 87' ' ' LEU . 7.2 t -135.66 119.22 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.345 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 t -149.88 158.27 44.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.902 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -115.74 154.65 29.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.137 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.553 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 27.1 mt-30 -142.18 159.81 41.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.23 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.17 114.84 23.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.477 178.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.586 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 31.1 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.607 -179.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.64 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.6 p . . . . . 0 N--CA 1.454 -0.257 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.412 ' CB ' HD21 ' A' ' 62' ' ' ASN . 2.3 p -61.59 127.92 33.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.524 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.5 m-30 -92.34 140.41 29.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.126 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.32 107.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.47 135.15 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.847 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -124.34 150.79 45.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.57 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.9 p90 -145.04 -164.99 2.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 47.0 t -118.75 133.37 65.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.345 179.392 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . 0.426 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 61.1 p . . . . . 0 C--N 1.324 -0.501 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.595 -179.196 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.453 HG22 ' H ' ' A' ' 35' ' ' GLY . 7.5 p . . . . . 0 N--CA 1.453 -0.299 0 CA-C-O 120.838 0.351 . . . . 0.0 110.8 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.2 m -95.11 -16.51 22.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.83 178.34 47.29 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.19 151.27 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.895 0.379 . . . . 0.0 110.118 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.819 ' NE ' HE22 ' A' ' 85' ' ' GLN . 26.9 ttp180 -130.46 125.62 34.86 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.525 HG21 HG11 ' A' ' 61' ' ' VAL . 46.2 t -109.13 131.49 59.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.396 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.2 tt0 -120.99 126.21 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 49.6 p90 -137.61 137.05 38.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.239 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -147.2 167.53 23.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.811 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 57.9 mt -77.1 128.59 34.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 111.213 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 p -76.4 -16.09 59.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.145 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 . . . . . 0 C--N 1.328 -0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -178.86 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo . . . . . 0 N--CA 1.491 1.365 0 CA-C-O 121.316 0.465 . . . . 0.0 112.846 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 42.9 mt-30 -118.65 144.7 46.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.904 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -121.1 143.04 49.3 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.054 -0.659 . . . . 0.0 112.203 -178.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 mt -129.38 125.74 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.869 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -100.54 133.52 44.85 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.367 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 160.43 63.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.512 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 58' ' ' ALA . 35.9 Cg_endo -75.61 158.99 39.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.989 1.793 . . . . 0.0 112.129 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.477 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 7.7 p -57.45 -12.23 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.296 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 p -93.8 -8.11 41.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.09 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . 0.467 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . . . -82.07 138.53 34.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -130.27 5.69 4.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.993 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 p -163.31 146.82 10.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 38' ' ' VAL . 9.7 p -146.85 146.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.407 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . 0.436 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 14.1 t-20 -103.51 128.49 50.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.296 179.315 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.457 HD13 ' CD1' ' A' ' 40' ' ' TYR . 1.4 mt -105.47 99.49 21.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.925 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 96.7 Cg_endo -88.83 174.46 3.92 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.579 2.186 . . . . 0.0 112.162 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 66.56 37.73 4.39 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.431 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.64 HD12 ' O ' ' A' ' 20' ' ' SER . 39.4 mt -89.74 157.42 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 mt -91.1 110.09 39.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.793 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 22.1 Cg_exo -56.39 143.33 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.192 1.928 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . 0.602 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 79.05 17.78 76.14 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -125.15 151.2 46.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -99.85 131.86 45.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.866 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.811 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 72.2 m-85 -118.84 153.05 35.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.457 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 75.0 mt -110.1 126.81 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.92 133.88 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.115 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -133.98 126.87 31.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.545 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.57 HG11 ' CD2' ' A' ' 26' ' ' TRP . 23.9 t -105.44 126.96 60.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -119.35 139.74 51.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . 0.487 ' NE2' HG21 ' A' ' 88' ' ' ILE . 0.5 OUTLIER -105.13 136.61 44.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.35 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.681 ' O ' ' N ' ' A' ' 34' ' ' SER . 46.4 mt -100.66 124.78 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.216 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.6 p -85.43 171.99 11.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.82 -19.45 41.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.8 p30 -92.34 -2.32 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.203 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.52 68.73 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.272 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 65.6 mm-40 -84.48 142.07 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.135 0.468 . . . . 0.0 111.097 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.819 HE22 ' NE ' ' A' ' 37' ' ' ARG . 81.2 mt-30 -108.64 139.81 42.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.832 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -136.92 137.81 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.866 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' A' ' 90' ' ' SER . 43.2 tp -74.07 118.46 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.377 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . 0.487 HG21 ' NE2' ' A' ' 78' ' ' GLN . 43.3 pt -110.91 -23.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.0 tp -155.82 125.02 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.666 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.605 ' HB2' HD21 ' A' ' 87' ' ' LEU . 25.9 t -134.37 118.97 18.06 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 t -153.79 154.39 33.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.447 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -116.52 155.11 29.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.107 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 24.7 mt-30 -145.48 164.65 30.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.238 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 109.52 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.72 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 72.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.389 -179.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER . . . . . 0 N--CA 1.454 -0.255 0 CA-C-O 121.058 0.456 . . . . 0.0 109.957 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' SER . . . . . 0.485 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -61.22 172.1 1.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.801 -179.134 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CZ ' HG22 ' A' ' 95' ' ' THR . 23.3 m-85 -135.58 146.06 47.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.913 178.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 41.5 t -117.28 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.515 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.6 t -108.76 134.9 49.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.075 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.0 p -126.66 151.66 47.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.167 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' TRP . . . . . 0.565 ' CD2' HG11 ' A' ' 76' ' ' VAL . 36.9 p90 -144.37 -174.64 4.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.977 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.79 127.66 74.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.326 -0.431 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.958 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' VAL . . . . . 0.429 HG23 ' O ' ' A' ' 35' ' ' GLY . 0.8 OUTLIER . . . . . 0 N--CA 1.449 -0.497 0 N-CA-C 110.006 -0.368 . . . . 0.0 110.006 . . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 79' ' ' ILE . 32.1 m -94.46 -15.74 23.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 109.612 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.04 176.68 45.37 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.33 151.48 44.27 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.29 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' ARG . . . . . 0.855 ' NE ' HE22 ' A' ' 85' ' ' GLN . 40.6 ttp180 -131.78 125.06 30.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' VAL . . . . . 0.529 HG21 HG11 ' A' ' 61' ' ' VAL . 48.2 t -110.8 133.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.621 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLU . . . . . 0.436 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.9 tt0 -123.82 132.24 53.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' TYR . . . . . 0.52 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 53.4 p90 -140.04 136.26 33.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.001 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -146.66 161.79 39.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.551 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' LEU . . . . . 0.786 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -75.0 125.14 28.29 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.848 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -69.57 -18.91 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 . . . . . 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 -179.002 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo . . . . . 0 N--CA 1.487 1.104 0 CA-C-O 120.872 0.28 . . . . 0.0 111.703 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' GLN . . . . . 0.52 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 30.8 mt-30 -114.33 144.01 43.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -120.94 140.33 51.99 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.965 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -125.76 128.08 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.916 178.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -103.12 130.72 50.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.081 0.467 . . . . 0.0 111.43 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -129.77 154.55 81.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.651 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -69.54 157.73 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.371 2.047 . . . . 0.0 112.724 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' SER . . . . . 0.464 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 58.3 p -58.13 -14.65 7.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.701 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.4 p -89.61 -9.67 48.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.03 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.53 131.94 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.603 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.0 p -130.14 13.74 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.5 p -163.58 146.06 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.219 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.529 HG11 HG21 ' A' ' 38' ' ' VAL . 7.6 p -149.21 145.63 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 111.487 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -103.12 125.14 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.391 178.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.426 ' HB ' HD11 ' A' ' 66' ' ' LEU . 1.8 mt -97.98 107.59 41.59 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.179 -179.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -89.23 177.19 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.856 2.37 . . . . 0.0 112.682 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.47 38.18 19.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.717 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 34.1 mt -90.92 147.74 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LEU . . . . . 0.428 ' O ' ' OG1' ' A' ' 95' ' ' THR . 17.1 mt -89.09 114.25 59.44 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 31.6 Cg_exo -54.33 136.41 68.8 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.276 1.984 . . . . 0.0 111.465 178.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.73 26.75 66.47 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.864 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 94' ' ' THR . 7.0 mmt180 -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -98.34 127.97 44.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' TYR . . . . . 0.786 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 74.6 m-85 -119.02 147.99 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.22 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 76.2 mt -103.87 124.83 58.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 t -111.17 130.57 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.671 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.91 123.08 24.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.507 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' VAL . . . . . 0.565 HG11 ' CD2' ' A' ' 26' ' ' TRP . 17.7 t -104.28 126.57 58.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -120.02 138.3 53.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.878 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -102.27 135.96 42.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.896 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.5 mt -99.26 122.26 50.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.229 0.537 . . . . 0.0 110.613 -178.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 94.5 p -83.5 169.45 15.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -21.15 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.878 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.5 p30 -91.74 -0.91 57.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.009 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.58 11.37 68.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.011 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' GLU . . . . . 0.575 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.0 mm-40 -82.81 140.39 32.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' GLN . . . . . 0.855 HE22 ' NE ' ' A' ' 37' ' ' ARG . 59.4 mt-30 -108.81 141.03 41.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.728 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.3 t -137.26 133.05 34.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' A' ' 90' ' ' SER . 13.7 tp -71.31 119.05 14.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.695 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.9 pt -108.12 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.652 -179.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -156.07 121.33 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.176 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' SER . . . . . 0.743 ' HB2' HD21 ' A' ' 87' ' ' LEU . 15.7 t -131.1 118.39 20.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.44 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -149.42 153.73 37.78 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.724 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.5 p -115.89 149.25 38.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.101 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -147.45 158.9 44.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.6 OUTLIER -119.04 111.5 18.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.739 178.318 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 73.8 p . . . . . 0 C--N 1.321 -0.651 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.787 -179.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.372 0 N-CA-C 109.537 -1.425 . . . . 0.0 109.537 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 27.0 Cg_exo -59.29 137.45 78.7 Favored 'Trans proline' 0 C--N 1.304 -1.784 0 C-N-CA 122.846 2.364 . . . . 0.0 111.987 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.6 tp -96.65 136.61 36.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.321 -0.4 . . . . 0.0 111.079 -179.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 84.65 -12.64 55.82 Favored Glycine 0 CA--C 1.522 0.511 0 N-CA-C 110.75 -0.94 . . . . 0.0 110.75 179.609 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.536 ' O ' ' CG ' ' A' ' 6' ' ' HIS . 6.3 t -111.61 137.96 48.79 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-O 120.979 0.418 . . . . 0.0 111.054 -179.869 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.536 ' CG ' ' O ' ' A' ' 5' ' ' SER . 97.6 m-70 -160.39 -13.79 0.05 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.911 -0.586 . . . . 0.0 110.203 179.676 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.418 ' H ' ' H ' ' A' ' 6' ' ' HIS . 0.7 OUTLIER -47.47 97.97 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.393 -179.383 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.649 HG22 ' H ' ' A' ' 10' ' ' THR . 5.0 p -112.08 -33.64 2.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.254 179.14 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.544 ' O ' ' C ' ' A' ' 10' ' ' THR . . . 60.79 1.6 0.45 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.147 -179.57 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.649 ' H ' HG22 ' A' ' 8' ' ' VAL . 49.1 m 24.18 -97.54 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 115.767 -0.651 . . . . 0.0 111.273 179.782 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.614 ' O ' ' O ' ' A' ' 12' ' ' GLU . 0.4 OUTLIER -136.76 50.59 2.02 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.883 -0.327 . . . . 0.0 111.409 -179.314 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.614 ' O ' ' O ' ' A' ' 11' ' ' SER . 74.2 tt0 25.79 103.06 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.952 0.406 . . . . 0.0 111.091 179.436 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 33.6 m -85.76 7.18 24.7 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 115.97 -0.559 . . . . 0.0 111.808 -179.63 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.467 ' O ' HG12 ' A' ' 14' ' ' VAL . 19.6 t -99.26 53.48 0.13 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 C-N-CA 120.523 -0.471 . . . . 0.0 110.926 -179.729 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . . . . . . . . . 84.3 m -89.0 138.57 31.28 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 121.189 0.519 . . . . 0.0 111.055 179.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.686 ' OE1' ' N ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -178.72 -32.73 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.357 -0.838 . . . . 0.0 109.305 179.735 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.686 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 50.0 mt -19.0 -79.58 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.326 -0.449 0 CA-C-N 114.962 -1.017 . . . . 0.0 111.882 -179.758 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.609 ' C ' ' O ' ' A' ' 17' ' ' ILE . 1.3 p 0.13 111.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.481 0 O-C-N 123.58 0.55 . . . . 0.0 111.163 -179.322 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.545 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 65.34 24.94 12.11 Favored 'General case' 0 C--N 1.325 -0.459 0 C-N-CA 120.554 -0.458 . . . . 0.0 109.92 -179.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.548 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.1 OUTLIER 59.0 23.87 12.04 Favored 'General case' 0 C--O 1.231 0.09 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.464 179.902 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.606 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.4 OUTLIER -65.52 -179.44 0.64 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 121.574 0.702 . . . . 0.0 111.635 -179.259 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.696 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 33.6 m-85 -141.52 140.03 33.38 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 114.638 -1.165 . . . . 0.0 108.985 178.257 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.643 HG23 ' HB3' ' A' ' 16' ' ' GLU . 24.7 t -113.68 101.07 11.93 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 N-CA-C 106.931 -1.507 . . . . 0.0 106.931 176.004 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.0 t -111.16 133.76 55.7 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.557 0 CA-C-N 115.633 -0.712 . . . . 0.0 111.322 -177.689 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.7 p -122.24 153.02 39.41 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.442 -0.799 . . . . 0.0 109.648 179.391 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.8 p90 -143.15 -171.57 3.5 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-O 121.007 0.432 . . . . 0.0 110.617 -179.583 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.1 t -123.57 126.78 73.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 CA-C-N 115.819 -0.628 . . . . 0.0 109.458 179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.1 m -53.16 126.29 20.34 Favored 'General case' 0 C--N 1.322 -0.611 0 C-N-CA 120.151 -0.62 . . . . 0.0 109.797 -179.765 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -89.86 5.7 45.1 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.968 0.413 . . . . 0.0 110.492 179.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.741 ' O ' HG12 ' A' ' 33' ' ' VAL . 3.1 m -172.99 136.53 0.67 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.862 -0.608 . . . . 0.0 110.383 -179.511 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 97.6 m-20 -85.73 -3.52 58.92 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-O 121.1 0.476 . . . . 0.0 109.747 179.248 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 78.8 p -89.19 -4.63 58.17 Favored 'General case' 0 N--CA 1.452 -0.339 0 CA-C-N 115.651 -0.704 . . . . 0.0 110.013 179.394 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.741 HG12 ' O ' ' A' ' 30' ' ' SER . 2.4 p -59.34 138.37 20.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.102 179.496 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.554 ' N ' ' O ' ' A' ' 79' ' ' ILE . 19.5 m -94.44 -15.18 24.49 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-O 121.269 0.557 . . . . 0.0 109.849 -179.923 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.5 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.64 -179.23 47.74 Favored Glycine 0 CA--C 1.524 0.602 0 N-CA-C 109.889 -1.284 . . . . 0.0 109.889 179.706 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 86.6 m-85 -127.18 154.9 44.21 Favored 'General case' 0 C--N 1.325 -0.489 0 CA-C-O 120.958 0.409 . . . . 0.0 111.004 179.578 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.751 ' NE ' HE22 ' A' ' 85' ' ' GLN . 18.2 ttp180 -132.07 124.92 30.17 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.232 -0.655 . . . . 0.0 109.232 178.015 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.478 HG21 HG11 ' A' ' 61' ' ' VAL . 17.9 t -107.14 135.37 45.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 CA-C-N 116.187 -0.46 . . . . 0.0 110.447 -179.506 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.451 ' OE2' ' CB ' ' A' ' 49' ' ' PRO . 75.0 tt0 -125.85 129.8 50.1 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.375 -0.53 . . . . 0.0 110.587 -179.608 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.464 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 22.5 p90 -137.51 130.97 31.12 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.125 179.472 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -144.51 161.92 37.88 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.876 -0.602 . . . . 0.0 109.863 -179.667 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.74 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 87.6 mt -74.52 126.63 31.19 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 120.618 -0.433 . . . . 0.0 111.161 179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.3 p -73.14 -20.98 60.8 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.804 -0.634 . . . . 0.0 110.153 179.597 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 82.3 mt-10 -88.64 -73.14 0.51 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.744 -0.662 . . . . 0.0 111.155 -179.138 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.565 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 92.1 mt-10 -57.2 -35.51 69.7 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.892 -0.594 . . . . 0.0 111.319 -179.001 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.48 21.34 75.34 Favored Glycine 0 CA--C 1.523 0.586 0 N-CA-C 109.698 -1.361 . . . . 0.0 109.698 -179.058 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.504 ' OD2' ' OE1' ' A' ' 45' ' ' GLU . 81.0 m-20 -50.96 168.43 0.06 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.839 0.352 . . . . 0.0 110.371 -179.614 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -63.92 145.29 97.86 Favored Pre-proline 0 C--N 1.325 -0.476 0 CA-C-N 116.189 -0.46 . . . . 0.0 109.946 179.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.451 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 72.6 Cg_endo -76.24 151.82 34.5 Favored 'Trans proline' 0 C--N 1.303 -1.841 0 C-N-CA 122.739 2.293 . . . . 0.0 112.769 -179.701 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 19.7 mt-30 -114.47 146.18 40.97 Favored 'General case' 0 C--N 1.325 -0.481 0 N-CA-C 108.312 -0.995 . . . . 0.0 108.312 178.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.441 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -123.09 137.13 55.0 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 119.787 -0.765 . . . . 0.0 112.437 -178.596 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.405 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 76.7 mt -123.85 135.07 53.52 Favored 'General case' 0 C--N 1.332 -0.153 0 CA-C-N 115.114 -0.948 . . . . 0.0 109.032 178.612 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 65.0 m-20 -108.52 134.71 50.92 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.301 -0.56 . . . . 0.0 112.329 -178.576 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.9 mt -129.49 153.65 80.67 Favored Pre-proline 0 C--N 1.333 -0.141 0 CA-C-N 115.759 -0.655 . . . . 0.0 109.993 179.47 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -64.6 156.47 60.84 Favored 'Trans proline' 0 C--N 1.307 -1.637 0 C-N-CA 122.384 2.056 . . . . 0.0 112.344 179.569 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 17.6 p -57.56 -15.9 8.56 Favored 'General case' 0 C--N 1.332 -0.18 0 CA-C-N 115.98 -0.555 . . . . 0.0 111.028 -179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 21.8 p -90.94 -7.6 51.64 Favored 'General case' 0 C--N 1.328 -0.334 0 C-N-CA 120.808 -0.357 . . . . 0.0 110.539 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.43 137.18 33.52 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.227 -0.442 . . . . 0.0 110.759 179.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.1 p -134.51 13.82 3.76 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.801 -0.36 . . . . 0.0 111.227 179.844 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 58.7 p -164.79 145.22 7.5 Favored 'General case' 0 C--N 1.331 -0.211 0 C-N-CA 120.854 -0.338 . . . . 0.0 110.634 179.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.478 HG11 HG21 ' A' ' 38' ' ' VAL . 4.3 p -153.93 150.36 12.23 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.201 0 CA-C-O 121.198 0.523 . . . . 0.0 111.942 -179.55 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.495 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 9.2 t-20 -103.32 129.27 50.31 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.447 -0.797 . . . . 0.0 109.396 178.527 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.3 mt -99.95 104.34 28.13 Favored Pre-proline 0 N--CA 1.466 0.331 0 C-N-CA 121.176 -0.21 . . . . 0.0 111.019 -179.37 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.414 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 94.7 Cg_endo -89.9 179.95 1.96 Allowed 'Trans proline' 0 C--N 1.313 -1.314 0 C-N-CA 122.833 2.355 . . . . 0.0 113.153 -179.567 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 59.62 37.03 22.68 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.763 -1.108 . . . . 0.0 111.7 179.535 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.548 ' O ' ' OG ' ' A' ' 20' ' ' SER . 29.5 mt -92.26 150.56 20.8 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 116.327 -0.397 . . . . 0.0 110.163 178.918 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.637 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 29.5 mt -89.04 111.27 43.88 Favored Pre-proline 0 CA--C 1.531 0.233 0 CA-C-N 116.69 -0.232 . . . . 0.0 110.777 -179.686 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 20.4 Cg_exo -57.97 143.6 95.83 Favored 'Trans proline' 0 N--CA 1.493 1.499 0 C-N-CA 122.155 1.903 . . . . 0.0 111.865 179.305 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.2 11.66 80.44 Favored Glycine 0 CA--C 1.526 0.746 0 N-CA-C 111.441 -0.664 . . . . 0.0 111.441 179.378 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.567 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -123.22 146.58 47.71 Favored 'General case' 0 C--N 1.329 -0.287 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 179.348 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.0 tttt -95.28 134.36 38.14 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 120.531 -0.468 . . . . 0.0 110.244 -179.727 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.74 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 12.3 m-85 -118.49 150.84 38.92 Favored 'General case' 0 C--N 1.323 -0.574 0 CA-C-N 116.014 -0.539 . . . . 0.0 111.691 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.416 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.8 mt -108.54 121.64 61.89 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.473 0 N-CA-C 107.068 -1.456 . . . . 0.0 107.068 176.333 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 48.7 t -113.94 131.37 66.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.802 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.095 -178.943 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 39.8 m-80 -133.73 131.46 39.44 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.701 179.853 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 15.2 t -105.1 131.43 54.33 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.554 -179.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.4 m-85 -123.43 137.42 54.81 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.686 179.363 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -100.94 136.65 40.45 Favored 'General case' 0 C--N 1.322 -0.622 0 N-CA-C 108.603 -0.888 . . . . 0.0 108.603 178.702 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.554 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.1 mt -99.29 125.26 52.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-O 121.312 0.577 . . . . 0.0 111.38 -178.34 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 47.3 p -84.64 169.25 14.54 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.74 179.315 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -59.9 -16.63 30.99 Favored 'General case' 0 C--N 1.322 -0.592 0 CA-C-N 116.218 -0.446 . . . . 0.0 111.603 -179.246 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.602 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 43.9 p30 -96.04 0.25 51.35 Favored 'General case' 0 C--N 1.33 -0.279 0 C-N-CA 120.538 -0.465 . . . . 0.0 110.999 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.06 15.23 63.1 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 120.959 -0.639 . . . . 0.0 111.71 179.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.558 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 54.0 mm-40 -83.77 141.97 31.02 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.857 0.36 . . . . 0.0 110.936 179.485 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.751 HE22 ' NE ' ' A' ' 37' ' ' ARG . 89.5 mt-30 -114.38 140.37 48.72 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.004 -0.544 . . . . 0.0 110.625 179.53 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -136.09 133.2 37.06 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.971 -0.559 . . . . 0.0 109.858 179.396 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.485 HD21 ' HB2' ' A' ' 90' ' ' SER . 21.8 tp -72.17 116.59 12.78 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.645 -0.422 . . . . 0.0 110.303 -179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.1 pt -108.99 -21.36 5.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.369 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.841 -179.428 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -155.67 126.24 6.84 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.574 -0.45 . . . . 0.0 111.574 -179.889 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.485 ' HB2' HD21 ' A' ' 87' ' ' LEU . 28.6 t -131.53 122.15 25.65 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.098 -0.501 . . . . 0.0 109.877 179.005 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.5 t -154.08 153.82 32.56 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.86 -0.336 . . . . 0.0 110.617 -179.921 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 85.0 p -112.99 154.75 25.98 Favored 'General case' 0 C--N 1.325 -0.46 0 C-N-CA 120.754 -0.378 . . . . 0.0 110.106 179.409 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.696 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 31.6 mt-30 -142.09 157.07 45.33 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-O 121.278 0.561 . . . . 0.0 111.388 -179.804 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.51 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -117.75 107.15 13.82 Favored 'General case' 0 C--N 1.325 -0.486 0 CA-C-N 115.251 -0.886 . . . . 0.0 109.43 179.267 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.51 ' OXT' ' O ' ' A' ' 94' ' ' THR . 71.1 p . . . . . 0 C--O 1.221 -0.431 0 CA-C-O 117.919 -1.038 . . . . 0.0 110.764 -179.456 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.411 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.338 0 N-CA-C 109.503 -1.439 . . . . 0.0 109.503 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.411 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 48.0 Cg_exo -51.53 160.5 2.51 Favored 'Trans proline' 0 C--N 1.303 -1.816 0 C-N-CA 122.949 2.433 . . . . 0.0 111.938 179.932 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 3.0 mp -55.82 -37.06 68.18 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.929 0.395 . . . . 0.0 110.434 -179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 71.07 -148.37 44.32 Favored Glycine 0 CA--C 1.525 0.661 0 N-CA-C 110.557 -1.017 . . . . 0.0 110.557 -179.912 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 67.1 m -61.49 147.21 46.02 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-O 120.733 0.301 . . . . 0.0 110.254 179.627 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -141.78 127.02 18.58 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.67 179.888 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.655 ' O ' ' N ' ' A' ' 9' ' ' ALA . 57.0 mt -144.27 86.08 1.82 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.243 -0.435 . . . . 0.0 110.787 179.685 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.786 ' O ' HG22 ' A' ' 8' ' ' VAL . 9.4 p 25.5 38.04 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.331 -0.208 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.897 179.721 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.655 ' N ' ' O ' ' A' ' 7' ' ' LEU . . . -64.55 149.16 49.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.3 -0.409 . . . . 0.0 110.894 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.408 ' O ' ' C ' ' A' ' 11' ' ' SER . 0.2 OUTLIER 63.68 -1.39 0.62 Allowed 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.018 -0.537 . . . . 0.0 111.553 179.443 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.634 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 10.0 p 39.14 -128.08 0.3 Allowed 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.82 -0.352 . . . . 0.0 110.449 -179.884 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.634 ' N ' ' OG ' ' A' ' 11' ' ' SER . 22.0 pt-20 -99.81 130.35 46.0 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.387 -0.37 . . . . 0.0 110.937 179.803 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 92.7 p -93.57 2.9 56.24 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.114 -0.494 . . . . 0.0 111.505 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.461 ' O ' ' C ' ' A' ' 15' ' ' THR . 16.5 m -111.07 23.95 4.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 C-N-CA 120.956 -0.298 . . . . 0.0 111.151 -179.569 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.657 ' O ' ' N ' ' A' ' 17' ' ' ILE . 0.8 OUTLIER -33.97 -50.78 0.39 Allowed 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.416 -0.357 . . . . 0.0 111.215 -179.691 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.717 ' OE2' HG23 ' A' ' 23' ' ' VAL . 0.0 OUTLIER -66.89 49.1 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 -179.742 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.657 ' N ' ' O ' ' A' ' 15' ' ' THR . 64.1 mt -58.01 -12.82 2.21 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 CA-C-N 114.508 -1.224 . . . . 0.0 110.957 -178.787 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.574 ' O ' ' N ' ' A' ' 20' ' ' SER . 78.9 p -53.6 157.52 2.16 Favored 'General case' 0 C--N 1.329 -0.284 0 N-CA-C 109.64 -0.504 . . . . 0.0 109.64 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.548 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 36.48 28.43 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.431 0 C-N-CA 120.575 -0.45 . . . . 0.0 109.841 -179.278 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.58 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p 55.22 30.59 14.87 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.778 179.931 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.592 ' OG ' ' OE1' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -59.07 176.54 0.21 Allowed 'General case' 0 C--N 1.325 -0.479 0 CA-C-O 121.541 0.686 . . . . 0.0 111.538 -179.387 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.587 ' CZ ' HG22 ' A' ' 95' ' ' THR . 15.2 m-85 -148.19 146.59 28.77 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 114.877 -1.056 . . . . 0.0 110.041 178.636 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.717 HG23 ' OE2' ' A' ' 16' ' ' GLU . 13.6 t -120.96 102.2 11.86 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.131 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 90.2 t -110.17 136.93 44.64 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.484 -178.209 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 82.8 p -123.46 151.72 42.42 Favored 'General case' 0 N--CA 1.451 -0.416 0 CA-C-N 115.611 -0.722 . . . . 0.0 109.846 179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.489 ' CD2' HG11 ' A' ' 76' ' ' VAL . 35.4 p90 -143.99 -173.33 3.96 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 116.063 -0.517 . . . . 0.0 110.165 -179.641 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.794 HG12 ' H ' ' A' ' 29' ' ' ALA . 61.6 t -113.6 132.61 62.03 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.553 0 N-CA-C 109.372 -0.603 . . . . 0.0 109.372 179.36 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.684 ' O ' ' N ' ' A' ' 30' ' ' SER . 22.1 p -48.43 -20.95 0.47 Allowed 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.291 -0.564 . . . . 0.0 109.783 -179.72 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.794 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 43.84 5.93 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.544 -0.753 . . . . 0.0 111.479 179.314 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.684 ' N ' ' O ' ' A' ' 28' ' ' SER . 3.3 m -176.81 136.3 0.23 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 120.823 -0.351 . . . . 0.0 110.649 -179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.47 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 48.2 p30 -94.29 4.51 53.78 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.083 179.511 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 61.7 p -93.37 6.25 48.79 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-N 115.885 -0.598 . . . . 0.0 110.34 179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.511 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 3.0 p -80.05 135.58 25.15 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 115.96 -0.564 . . . . 0.0 111.28 -179.262 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.627 ' N ' ' O ' ' A' ' 79' ' ' ILE . 12.5 m -94.63 -14.11 25.24 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.77 -0.65 . . . . 0.0 109.583 179.509 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.511 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.67 176.81 46.01 Favored Glycine 0 CA--C 1.522 0.488 0 N-CA-C 109.655 -1.378 . . . . 0.0 109.655 179.639 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.4 m-85 -125.59 151.21 46.74 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-O 121.069 0.462 . . . . 0.0 110.827 179.679 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.847 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.2 ttp180 -131.94 124.44 29.43 Favored 'General case' 0 C--N 1.322 -0.615 0 N-CA-C 109.083 -0.71 . . . . 0.0 109.083 178.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 19.1 t -108.23 134.66 49.41 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.42 -179.62 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.411 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 74.6 tt0 -121.96 127.08 49.93 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.222 -0.445 . . . . 0.0 109.978 179.838 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.473 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.6 p90 -135.54 133.98 38.96 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 121.141 0.496 . . . . 0.0 110.821 179.383 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.8 pt-20 -147.63 165.69 29.64 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.229 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.766 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 85.2 mt -74.65 129.39 37.64 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.651 -0.42 . . . . 0.0 111.211 179.696 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.4 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 16.8 p -74.79 -15.75 60.74 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 115.828 -0.623 . . . . 0.0 110.307 179.874 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 90.9 mt-10 -100.07 -65.56 0.96 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.068 -0.515 . . . . 0.0 111.274 -178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.518 ' OE1' ' OD2' ' A' ' 47' ' ' ASP . 93.2 mt-10 -62.55 -33.22 74.51 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.826 -179.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 69.95 18.64 74.64 Favored Glycine 0 CA--C 1.522 0.516 0 N-CA-C 109.906 -1.278 . . . . 0.0 109.906 -179.544 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.518 ' OD2' ' OE1' ' A' ' 45' ' ' GLU . 86.6 m-20 -48.1 171.01 0.02 OUTLIER 'General case' 0 N--CA 1.453 -0.31 0 CA-C-O 120.87 0.366 . . . . 0.0 110.408 -179.62 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.596 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.9 pm0 -59.36 138.08 88.84 Favored Pre-proline 0 C--N 1.326 -0.427 0 CA-C-N 116.021 -0.536 . . . . 0.0 110.571 -179.604 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -75.24 151.82 38.91 Favored 'Trans proline' 0 C--N 1.306 -1.671 0 C-N-CA 122.66 2.24 . . . . 0.0 112.098 179.609 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.473 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 20.0 mt-30 -116.18 151.11 36.34 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-N 115.889 -0.596 . . . . 0.0 109.42 179.465 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 63.8 m-85 -124.77 138.29 54.28 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.132 -0.627 . . . . 0.0 112.052 -178.852 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 76.5 mt -125.02 131.35 53.41 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.329 -0.85 . . . . 0.0 108.73 178.137 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 46.4 m-20 -104.63 133.04 50.15 Favored 'General case' 0 C--N 1.325 -0.493 0 C-N-CA 120.535 -0.466 . . . . 0.0 111.917 -178.566 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.6 mt -130.26 153.37 81.2 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.639 179.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 13.4 Cg_endo -66.65 154.3 74.9 Favored 'Trans proline' 0 C--N 1.308 -1.583 0 C-N-CA 122.344 2.029 . . . . 0.0 112.622 -179.812 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 28.5 p -56.77 -12.53 1.95 Allowed 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.001 -0.545 . . . . 0.0 110.89 -179.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 33.7 p -93.16 -9.67 38.53 Favored 'General case' 0 C--N 1.328 -0.333 0 C-N-CA 120.673 -0.411 . . . . 0.0 110.646 -179.888 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.54 136.27 34.89 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.514 179.624 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.9 p -128.03 10.62 6.44 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.323 -0.398 . . . . 0.0 111.01 179.939 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 71.5 p -164.07 150.41 11.3 Favored 'General case' 0 C--N 1.331 -0.22 0 C-N-CA 120.842 -0.343 . . . . 0.0 110.539 179.655 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.6 p -151.37 153.17 10.28 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-O 121.186 0.517 . . . . 0.0 111.485 -179.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.434 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 8.7 t-20 -103.4 126.57 50.63 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.45 -0.795 . . . . 0.0 109.723 179.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.485 HG22 HD21 ' A' ' 66' ' ' LEU . 3.1 mt -103.02 101.84 24.0 Favored Pre-proline 0 CA--C 1.531 0.222 0 CA-C-N 116.776 -0.193 . . . . 0.0 110.926 -179.507 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.434 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 69.1 Cg_endo -91.71 -175.24 0.67 Allowed 'Trans proline' 0 C--N 1.311 -1.409 0 C-N-CA 122.995 2.463 . . . . 0.0 112.98 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.8 m-20 58.39 35.01 24.5 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-N 115.079 -0.964 . . . . 0.0 111.398 179.388 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.58 ' O ' ' OG ' ' A' ' 20' ' ' SER . 23.3 mt -88.5 153.14 21.39 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.835 -0.431 . . . . 0.0 109.835 178.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 25.7 mt -92.36 109.97 41.6 Favored Pre-proline 0 C--N 1.33 -0.271 0 CA-C-N 116.694 -0.23 . . . . 0.0 111.206 -179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 30.8 Cg_exo -56.02 138.5 82.68 Favored 'Trans proline' 0 C--N 1.311 -1.438 0 C-N-CA 122.234 1.956 . . . . 0.0 111.563 178.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.81 16.31 73.12 Favored Glycine 0 CA--C 1.524 0.619 0 N-CA-C 110.973 -0.851 . . . . 0.0 110.973 179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.5 ' HB3' HD22 ' A' ' 42' ' ' LEU . 2.2 mmt-85 -126.13 148.19 49.45 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.86 0.362 . . . . 0.0 110.29 179.543 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 70.1 tttt -97.35 133.55 41.81 Favored 'General case' 0 C--N 1.326 -0.437 0 CA-C-N 116.185 -0.461 . . . . 0.0 109.943 179.449 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.766 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 60.3 m-85 -118.89 151.39 38.22 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.898 -0.592 . . . . 0.0 111.599 -179.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.466 HG22 HD21 ' A' ' 75' ' ' ASN . 71.3 mt -108.91 125.45 65.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 N-CA-C 107.523 -1.288 . . . . 0.0 107.523 176.742 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 17.9 t -113.59 131.71 64.62 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.849 0 CA-C-O 121.059 0.457 . . . . 0.0 110.917 -178.67 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.466 HD21 HG22 ' A' ' 73' ' ' ILE . 35.2 m-80 -134.95 126.94 29.63 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.969 179.837 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.489 HG11 ' CD2' ' A' ' 26' ' ' TRP . 26.3 t -105.4 128.56 59.29 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 C-N-CA 120.447 -0.501 . . . . 0.0 110.669 179.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.407 ' HB2' HE21 ' A' ' 85' ' ' GLN . 77.8 m-85 -120.0 137.64 53.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.004 -0.543 . . . . 0.0 109.694 179.212 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -101.84 135.55 43.21 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.433 -0.951 . . . . 0.0 108.433 178.92 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.627 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.1 mt -98.91 122.31 50.49 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.549 0 CA-C-O 121.2 0.524 . . . . 0.0 110.599 -178.693 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.602 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 52.6 p -83.23 170.22 14.91 Favored 'General case' 0 N--CA 1.447 -0.58 0 CA-C-N 115.425 -0.807 . . . . 0.0 110.196 -179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 51.9 mp0 -59.6 -19.63 50.22 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.877 -0.601 . . . . 0.0 111.374 -179.463 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.636 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 44.6 p30 -91.99 -0.59 57.48 Favored 'General case' 0 C--N 1.33 -0.244 0 C-N-CA 120.757 -0.377 . . . . 0.0 111.273 -179.403 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 10.47 75.26 Favored Glycine 0 CA--C 1.526 0.752 0 N-CA-C 111.448 -0.661 . . . . 0.0 111.448 179.761 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.636 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 71.7 mm-40 -84.99 142.55 29.53 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.73 0.3 . . . . 0.0 110.482 179.446 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.847 HE22 ' NE ' ' A' ' 37' ' ' ARG . 48.1 mt-30 -107.14 145.96 31.88 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.043 0.449 . . . . 0.0 111.099 179.821 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 20.5 t -137.89 130.76 29.98 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.221 179.434 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.692 HD21 ' HB2' ' A' ' 90' ' ' SER . 29.2 tp -73.01 117.93 15.33 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.517 -0.473 . . . . 0.0 110.232 179.667 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 48.3 pt -107.53 -21.66 5.4 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.773 -179.612 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.2 tp -156.51 125.45 5.97 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.499 -0.48 . . . . 0.0 111.56 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.692 ' HB2' HD21 ' A' ' 87' ' ' LEU . 24.0 t -130.86 118.47 20.8 Favored 'General case' 0 C--N 1.328 -0.337 0 N-CA-C 109.43 -0.581 . . . . 0.0 109.43 178.498 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -152.77 167.2 29.81 Favored 'General case' 0 C--O 1.224 -0.289 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.709 -179.188 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 75.1 p -128.86 157.8 40.53 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.889 0.376 . . . . 0.0 110.543 179.51 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 22.9 mt-30 -142.59 161.18 38.74 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 121.294 0.569 . . . . 0.0 111.024 179.492 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.49 115.23 21.85 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.222 -0.899 . . . . 0.0 109.538 179.054 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.587 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.118 -0.944 . . . . 0.0 110.609 -179.397 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.704 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.259 0 N-CA-C 109.882 -1.287 . . . . 0.0 109.882 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 32.7 Cg_exo -53.72 13.71 0.02 OUTLIER 'Trans proline' 0 C--N 1.308 -1.569 0 C-N-CA 122.938 2.426 . . . . 0.0 112.104 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.704 ' H ' ' C ' ' A' ' 1' ' ' GLY . 41.9 mt -81.91 156.25 24.88 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 121.232 0.539 . . . . 0.0 111.51 -179.398 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -83.75 -171.3 47.57 Favored Glycine 0 CA--C 1.526 0.753 0 CA-C-N 115.323 -0.853 . . . . 0.0 111.385 -179.668 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.555 ' O ' ' OG ' ' A' ' 5' ' ' SER . 5.2 p 64.57 84.29 0.15 Allowed 'General case' 0 C--N 1.332 -0.176 0 CA-C-O 120.921 0.391 . . . . 0.0 110.758 -179.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 11.3 m-70 -132.37 138.34 47.7 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.182 179.524 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 40.2 mt -148.62 68.59 1.07 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.536 -0.302 . . . . 0.0 110.386 179.14 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.572 ' O ' ' C ' ' A' ' 9' ' ' ALA . 86.8 t -90.5 -78.15 0.26 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.327 -0.549 . . . . 0.0 110.841 179.836 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.572 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . 19.86 59.42 0.02 OUTLIER 'General case' 0 N--CA 1.463 0.202 0 CA-C-N 116.313 -0.403 . . . . 0.0 111.174 179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.428 HG23 ' O ' ' A' ' 8' ' ' VAL . 74.2 p -92.51 0.67 57.46 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.693 -0.403 . . . . 0.0 111.275 -179.805 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.616 ' O ' ' C ' ' A' ' 12' ' ' GLU . 2.0 t -101.25 -37.95 8.3 Favored 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 120.267 -0.573 . . . . 0.0 110.968 -179.825 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.616 ' C ' ' O ' ' A' ' 11' ' ' SER . 66.5 tt0 18.04 56.08 0.01 OUTLIER 'General case' 0 C--O 1.232 0.138 0 O-C-N 123.617 0.573 . . . . 0.0 110.182 -179.828 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.563 ' C ' ' O ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER -14.45 -58.24 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 115.525 -0.762 . . . . 0.0 112.081 -179.064 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.485 ' N ' ' O ' ' A' ' 12' ' ' GLU . 33.0 m -92.56 128.64 44.01 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 C-N-CA 120.593 -0.443 . . . . 0.0 110.688 -179.886 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.76 HG23 ' H ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -123.19 -97.77 0.44 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.823 -179.788 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.76 ' H ' HG23 ' A' ' 15' ' ' THR . 68.4 mm-40 -58.49 -37.15 74.96 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.222 -0.899 . . . . 0.0 110.619 -179.655 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.799 ' O ' HG22 ' A' ' 17' ' ' ILE . 18.5 mt 50.04 6.95 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.024 -0.535 . . . . 0.0 111.269 179.885 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.494 ' H ' ' C ' ' A' ' 16' ' ' GLU . 26.7 m -59.37 128.61 37.96 Favored 'General case' 0 C--N 1.331 -0.232 0 C-N-CA 120.063 -0.655 . . . . 0.0 109.588 -179.772 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.57 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 63.58 27.34 14.95 Favored 'General case' 0 C--N 1.329 -0.3 0 N-CA-C 109.016 -0.735 . . . . 0.0 109.016 -178.727 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.57 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 4.4 p 55.21 31.3 16.21 Favored 'General case' 0 N--CA 1.454 -0.243 0 CA-C-N 115.666 -0.697 . . . . 0.0 109.138 -178.69 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.429 ' CB ' HD21 ' A' ' 62' ' ' ASN . 79.6 p -62.87 140.21 58.79 Favored 'General case' 0 C--O 1.233 0.209 0 CA-C-N 115.322 -0.854 . . . . 0.0 111.386 -178.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.557 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.7 m-30 -95.15 155.55 16.69 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.185 -0.916 . . . . 0.0 111.252 179.407 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 55.2 t -132.74 103.45 6.14 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.576 0 N-CA-C 109.203 -0.665 . . . . 0.0 109.203 176.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 61.9 t -110.95 135.27 50.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.948 0.404 . . . . 0.0 110.529 -179.474 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.3 p -127.28 151.15 49.12 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.289 179.726 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.505 ' HB3' HD22 ' A' ' 89' ' ' LEU . 46.1 p90 -148.83 -164.99 2.16 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.218 -0.446 . . . . 0.0 110.525 -179.816 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.663 ' C ' ' H ' ' A' ' 29' ' ' ALA . 49.1 t -120.49 133.71 66.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 N-CA-C 109.495 -0.558 . . . . 0.0 109.495 179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.586 ' O ' ' C ' ' A' ' 29' ' ' ALA . 36.8 p -50.18 -0.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.451 -0.34 . . . . 0.0 111.446 -179.2 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.663 ' H ' ' C ' ' A' ' 27' ' ' VAL . . . 6.9 64.14 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 115.946 -0.57 . . . . 0.0 112.43 179.326 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.537 ' N ' ' O ' ' A' ' 28' ' ' SER . 0.4 OUTLIER 164.67 -55.77 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.362 0 C-N-CA 120.879 -0.328 . . . . 0.0 111.288 179.115 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.44 ' CB ' ' O ' ' A' ' 30' ' ' SER . 7.0 t70 77.43 -32.27 0.18 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.155 -0.475 . . . . 0.0 110.265 -179.286 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.44 ' H ' ' C ' ' A' ' 30' ' ' SER . 43.0 p -81.13 0.03 38.07 Favored 'General case' 0 N--CA 1.455 -0.179 0 CA-C-O 121.304 0.573 . . . . 0.0 109.545 178.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.734 HG11 ' CZ ' ' A' ' 36' ' ' PHE . 5.3 p -60.86 138.92 21.01 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.458 0 CA-C-N 115.28 -0.873 . . . . 0.0 110.374 -179.752 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.518 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.3 m -95.46 -12.96 25.01 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 179.418 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.606 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.24 177.26 46.01 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.973 -1.251 . . . . 0.0 109.973 179.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.734 ' CZ ' HG11 ' A' ' 33' ' ' VAL . 92.4 m-85 -129.26 151.51 49.84 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-O 120.924 0.392 . . . . 0.0 110.288 179.343 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.671 ' NE ' HE22 ' A' ' 85' ' ' GLN . 27.8 ttp180 -129.71 126.09 37.47 Favored 'General case' 0 C--N 1.323 -0.572 0 N-CA-C 109.398 -0.593 . . . . 0.0 109.398 179.057 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.595 HG21 HG11 ' A' ' 61' ' ' VAL . 27.0 t -107.56 134.66 48.65 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-N 115.757 -0.656 . . . . 0.0 110.523 -179.501 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 68.5 tt0 -126.35 127.45 45.54 Favored 'General case' 0 C--N 1.323 -0.56 0 C-N-CA 120.316 -0.554 . . . . 0.0 110.529 179.581 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.465 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 27.0 p90 -136.63 140.86 43.09 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-O 121.286 0.565 . . . . 0.0 111.104 179.109 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.3 pt-20 -148.33 161.94 40.53 Favored 'General case' 0 C--N 1.325 -0.487 0 CA-C-N 115.164 -0.926 . . . . 0.0 110.17 -179.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.72 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 50.9 mt -75.63 127.75 33.75 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.104 0.478 . . . . 0.0 111.503 -179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.409 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 20.3 p -75.81 -9.73 58.85 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.738 -0.664 . . . . 0.0 109.812 179.042 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -102.35 -75.13 0.61 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.765 -0.652 . . . . 0.0 112.15 -178.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -64.07 -33.63 76.19 Favored 'General case' 0 C--N 1.33 -0.258 0 C-N-CA 120.827 -0.349 . . . . 0.0 111.112 -179.193 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 76.28 32.08 52.98 Favored Glycine 0 CA--C 1.524 0.609 0 N-CA-C 111.379 -0.688 . . . . 0.0 111.379 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.547 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 20.3 t0 -52.02 179.34 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.291 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 179.546 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.547 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -71.25 142.0 86.63 Favored Pre-proline 0 C--N 1.324 -0.515 0 C-N-CA 120.055 -0.658 . . . . 0.0 109.612 179.723 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 44.7 Cg_endo -69.46 146.42 61.99 Favored 'Trans proline' 0 C--N 1.302 -1.901 0 C-N-CA 122.344 2.029 . . . . 0.0 111.83 -179.624 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.465 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 13.8 mt-30 -114.31 147.03 39.72 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.915 -0.584 . . . . 0.0 109.586 179.764 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.431 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 91.4 m-85 -122.65 136.89 55.01 Favored 'General case' 0 C--N 1.324 -0.535 0 C-N-CA 119.932 -0.707 . . . . 0.0 111.841 -179.376 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.5 mt -124.8 127.15 46.73 Favored 'General case' 0 C--N 1.326 -0.428 0 N-CA-C 108.633 -0.877 . . . . 0.0 108.633 178.116 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.6 m-20 -99.06 131.96 44.72 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 116.034 -0.53 . . . . 0.0 111.956 -178.348 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -127.87 154.29 78.16 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.82 179.787 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 36.6 Cg_endo -69.58 159.64 52.78 Favored 'Trans proline' 0 N--CA 1.492 1.43 0 C-N-CA 122.619 2.213 . . . . 0.0 112.216 -179.32 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.441 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 12.2 p -60.61 -14.6 21.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 115.928 -0.578 . . . . 0.0 111.194 -179.521 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.3 p -90.15 -5.44 56.46 Favored 'General case' 0 C--N 1.326 -0.438 0 C-N-CA 120.699 -0.4 . . . . 0.0 111.328 -178.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -85.43 139.29 31.64 Favored 'General case' 0 C--N 1.33 -0.241 0 C-N-CA 120.995 -0.282 . . . . 0.0 111.498 -179.662 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 19.6 p -129.72 9.54 5.46 Favored 'General case' 0 CA--C 1.529 0.166 0 CA-C-N 116.428 -0.351 . . . . 0.0 111.265 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 12.9 p -167.55 150.2 5.95 Favored 'General case' 0 N--CA 1.464 0.255 0 N-CA-C 110.298 -0.26 . . . . 0.0 110.298 -179.97 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.595 HG11 HG21 ' A' ' 38' ' ' VAL . 8.1 p -150.29 147.49 15.97 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.222 0 C-N-CA 119.975 -0.69 . . . . 0.0 111.838 -179.371 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.429 HD21 ' CB ' ' A' ' 21' ' ' SER . 17.6 t-20 -103.04 127.56 50.25 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.322 -0.854 . . . . 0.0 109.379 178.593 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.1 mt -102.74 102.1 24.65 Favored Pre-proline 0 C--N 1.33 -0.252 0 CA-C-N 116.557 -0.292 . . . . 0.0 110.322 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.428 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 77.3 Cg_endo -86.8 -175.2 1.59 Allowed 'Trans proline' 0 C--N 1.307 -1.651 0 C-N-CA 122.8 2.333 . . . . 0.0 113.278 -179.548 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 57.87 39.15 27.09 Favored 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 114.848 -1.069 . . . . 0.0 111.611 179.439 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' CD1' ' A' ' 22' ' ' PHE . 25.8 mt -90.96 152.53 20.67 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 116.118 -0.492 . . . . 0.0 110.536 179.212 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 19.0 mt -95.41 108.13 37.29 Favored Pre-proline 0 CA--C 1.53 0.175 0 CA-C-N 116.524 -0.307 . . . . 0.0 111.297 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.403 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 39.3 Cg_exo -51.51 140.66 44.1 Favored 'Trans proline' 0 C--N 1.309 -1.548 0 C-N-CA 122.295 1.997 . . . . 0.0 111.647 179.124 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.425 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 83.33 14.76 73.35 Favored Glycine 0 CA--C 1.527 0.783 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 179.978 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 7.3 mmm-85 -124.69 143.69 50.62 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.807 0.336 . . . . 0.0 110.385 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.409 ' HB3' ' OG ' ' A' ' 43' ' ' SER . 74.7 tttt -99.19 134.88 41.4 Favored 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 109.138 -0.69 . . . . 0.0 109.138 178.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.72 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 83.8 m-85 -121.84 147.93 45.35 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.145 -0.479 . . . . 0.0 111.301 -179.612 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 61.6 mt -106.04 128.05 60.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.416 0 N-CA-C 107.417 -1.327 . . . . 0.0 107.417 176.857 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -116.64 136.49 53.54 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.726 0 CA-C-O 121.149 0.499 . . . . 0.0 111.588 -178.346 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 9.3 m-80 -135.36 125.81 26.73 Favored 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.483 -0.781 . . . . 0.0 110.179 179.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.442 HG11 ' CD2' ' A' ' 26' ' ' TRP . 11.9 t -104.97 131.77 53.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 C-N-CA 120.436 -0.506 . . . . 0.0 110.635 179.912 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 55.0 m-85 -120.6 140.87 50.91 Favored 'General case' 0 C--N 1.325 -0.495 0 CA-C-N 115.707 -0.679 . . . . 0.0 109.489 179.502 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.483 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 0.5 OUTLIER -105.92 135.42 47.39 Favored 'General case' 0 C--N 1.32 -0.709 0 N-CA-C 108.766 -0.827 . . . . 0.0 108.766 178.715 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.518 ' O ' ' N ' ' A' ' 34' ' ' SER . 36.0 mt -100.23 121.6 51.15 Favored 'Isoleucine or valine' 0 CA--C 1.511 -0.532 0 C-N-CA 120.188 -0.605 . . . . 0.0 110.439 -179.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.621 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 44.4 p -82.49 171.91 13.59 Favored 'General case' 0 C--N 1.317 -0.817 0 CA-C-N 115.206 -0.906 . . . . 0.0 109.782 179.724 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 92.0 mt-10 -60.06 -19.65 54.07 Favored 'General case' 0 C--N 1.32 -0.677 0 CA-C-N 115.943 -0.572 . . . . 0.0 111.398 -179.177 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.621 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 45.4 p30 -91.25 -2.8 57.37 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.503 -0.479 . . . . 0.0 110.389 179.476 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.89 13.17 67.23 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 121.23 -0.51 . . . . 0.0 112.319 179.167 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.514 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.2 mm-40 -83.33 145.23 29.18 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.828 0.347 . . . . 0.0 110.809 179.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.671 HE22 ' NE ' ' A' ' 37' ' ' ARG . 57.4 mt-30 -111.69 140.73 46.08 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 121.075 0.464 . . . . 0.0 110.832 179.466 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.4 t -137.79 135.27 36.14 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.637 179.78 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.403 HD21 ' HB2' ' A' ' 90' ' ' SER . 21.5 tp -71.64 119.29 15.59 Favored 'General case' 0 C--N 1.326 -0.436 0 C-N-CA 120.473 -0.491 . . . . 0.0 110.419 -179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.9 pt -109.36 -26.12 3.34 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.081 -0.509 . . . . 0.0 111.038 -179.808 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.505 HD22 ' HB3' ' A' ' 26' ' ' TRP . 13.9 tp -156.94 122.77 4.78 Favored 'General case' 0 C--N 1.331 -0.229 0 C-N-CA 120.419 -0.512 . . . . 0.0 111.48 -179.497 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.403 ' HB2' HD21 ' A' ' 87' ' ' LEU . 34.8 t -134.22 121.1 20.87 Favored 'General case' 0 C--N 1.327 -0.385 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 178.518 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -150.73 162.35 40.88 Favored 'General case' 0 C--N 1.331 -0.206 0 C-N-CA 120.743 -0.383 . . . . 0.0 110.972 -179.373 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 10.7 p -121.18 152.12 39.15 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.264 -0.425 . . . . 0.0 110.289 179.58 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.506 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 23.2 mt-30 -144.56 160.26 41.44 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.234 0.54 . . . . 0.0 110.585 179.261 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.456 ' O ' ' C ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -120.27 109.44 15.39 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.536 -0.757 . . . . 0.0 109.875 179.464 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.557 HG22 ' CE1' ' A' ' 22' ' ' PHE . 69.3 p . . . . . 0 C--O 1.219 -0.5 0 CA-C-O 117.843 -1.075 . . . . 0.0 110.042 -179.573 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.334 0 N-CA-C 109.554 -1.419 . . . . 0.0 109.554 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 42.7 Cg_exo -51.12 -35.54 51.94 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.913 2.409 . . . . 0.0 112.575 -179.807 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 16.4 tp -90.81 140.27 29.96 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.448 -0.342 . . . . 0.0 110.74 -179.812 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -135.79 174.2 21.46 Favored Glycine 0 CA--C 1.524 0.653 0 N-CA-C 111.161 -0.775 . . . . 0.0 111.161 -179.728 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 51.4 p -68.89 165.02 20.78 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.859 0.361 . . . . 0.0 110.58 179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.545 ' C ' HD13 ' A' ' 7' ' ' LEU . 26.8 m80 -121.64 139.13 53.93 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.342 179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 1.061 HD22 ' H ' ' A' ' 7' ' ' LEU . 0.0 OUTLIER -86.25 6.18 30.87 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.477 -0.328 . . . . 0.0 110.476 179.969 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.442 ' O ' ' C ' ' A' ' 9' ' ' ALA . 18.5 m -68.76 0.83 0.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 120.967 0.413 . . . . 0.0 110.345 -179.785 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.523 ' C ' ' H ' ' A' ' 11' ' ' SER . . . 33.15 39.39 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.529 179.294 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.431 ' H ' HG23 ' A' ' 8' ' ' VAL . 3.4 m 68.24 -38.19 0.36 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.813 0.339 . . . . 0.0 111.2 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.523 ' H ' ' C ' ' A' ' 9' ' ' ALA . 9.9 t -62.83 172.85 1.52 Allowed 'General case' 0 C--N 1.323 -0.559 0 CA-C-N 116.287 -0.415 . . . . 0.0 110.78 -179.829 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.2 mm-40 -53.49 142.15 23.08 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.321 -0.399 . . . . 0.0 110.362 -179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 21.8 t -59.71 -39.42 84.59 Favored 'General case' 0 C--N 1.332 -0.177 0 CA-C-N 116.34 -0.391 . . . . 0.0 110.845 -179.685 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 83.1 t -147.63 118.04 1.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.169 -0.469 . . . . 0.0 110.631 179.76 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.838 HG22 ' N ' ' A' ' 16' ' ' GLU . 14.5 m -117.87 -98.09 0.46 Allowed 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.311 179.739 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.838 ' N ' HG22 ' A' ' 15' ' ' THR . 24.5 pt-20 31.78 27.98 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 CA-C-N 116.043 -0.526 . . . . 0.0 110.662 179.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 15' ' ' THR . 15.0 mt -78.52 -85.27 0.04 OUTLIER 'Isoleucine or valine' 0 C--N 1.332 -0.152 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.318 -179.46 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.626 ' C ' ' O ' ' A' ' 17' ' ' ILE . 30.1 p 7.1 109.11 0.0 OUTLIER 'General case' 0 N--CA 1.467 0.386 0 O-C-N 123.626 0.579 . . . . 0.0 110.886 -179.091 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.517 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 69.88 23.41 5.56 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.746 -0.465 . . . . 0.0 109.746 -179.032 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.539 ' O ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER 56.96 20.91 5.72 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.907 -179.98 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.605 ' O ' ' O ' ' A' ' 16' ' ' GLU . 3.6 p -58.34 -178.8 0.05 OUTLIER 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 115.481 -0.781 . . . . 0.0 111.22 -179.584 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.494 ' CD1' ' O ' ' A' ' 21' ' ' SER . 16.1 m-85 -147.2 149.3 32.68 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.343 -0.844 . . . . 0.0 110.033 178.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.683 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 37.8 t -123.4 102.73 11.83 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 108.355 -0.979 . . . . 0.0 108.355 176.742 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.6 t -110.45 135.59 49.06 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-N 116.143 -0.481 . . . . 0.0 110.777 -178.832 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 96.4 p -129.09 153.73 47.37 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.411 179.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.702 ' CD2' HG11 ' A' ' 76' ' ' VAL . 37.4 p90 -144.24 -171.61 3.61 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 115.937 -0.574 . . . . 0.0 110.148 179.944 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 21.9 t -124.37 128.42 73.72 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 C-N-CA 120.747 -0.381 . . . . 0.0 110.1 179.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -47.85 124.54 7.5 Favored 'General case' 0 C--N 1.326 -0.415 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 179.862 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.441 ' C ' HE22 ' A' ' 78' ' ' GLN . . . -112.42 28.68 8.56 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.482 -0.327 . . . . 0.0 111.243 -179.403 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.664 ' C ' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER -152.44 -36.81 0.11 Allowed 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.539 -0.465 . . . . 0.0 111.109 -179.702 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.2 t0 67.21 -28.96 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 109.767 -0.457 . . . . 0.0 109.767 -179.101 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.664 ' H ' ' C ' ' A' ' 30' ' ' SER . 2.6 m -93.44 1.09 56.97 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 108.808 -0.812 . . . . 0.0 108.808 178.629 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.448 ' H ' HG12 ' A' ' 33' ' ' VAL . 1.2 p -54.65 143.18 7.36 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 CA-C-N 115.035 -0.984 . . . . 0.0 110.375 -179.962 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 39.4 m -95.01 -18.53 20.97 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.342 0.591 . . . . 0.0 109.413 179.691 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.28 179.65 47.68 Favored Glycine 0 CA--C 1.521 0.46 0 N-CA-C 109.796 -1.322 . . . . 0.0 109.796 179.471 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 92.2 m-85 -124.77 151.17 45.46 Favored 'General case' 0 C--N 1.32 -0.689 0 CA-C-O 120.834 0.35 . . . . 0.0 110.073 179.104 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.556 ' NE ' HE22 ' A' ' 85' ' ' GLN . 26.1 ttp180 -130.83 124.71 31.89 Favored 'General case' 0 C--N 1.32 -0.7 0 N-CA-C 109.315 -0.624 . . . . 0.0 109.315 179.393 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.493 HG21 HG11 ' A' ' 61' ' ' VAL . 60.2 t -109.1 131.21 60.52 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.341 -0.544 . . . . 0.0 110.43 179.912 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.431 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.11 128.81 52.92 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-N 115.997 -0.547 . . . . 0.0 109.636 179.41 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CE1' ' OE1' ' A' ' 50' ' ' GLN . 51.5 p90 -136.96 140.29 42.11 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-O 121.203 0.525 . . . . 0.0 111.035 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -149.16 164.05 35.85 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 115.401 -0.818 . . . . 0.0 109.983 -179.527 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.726 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 34.5 mt -73.96 128.59 35.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.012 0.434 . . . . 0.0 111.104 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.4 p -71.05 -21.55 62.24 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.915 -179.783 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 96.6 mt-10 -96.35 -63.81 1.11 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 121.056 0.455 . . . . 0.0 111.019 -179.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.499 ' HG3' HH21 ' A' ' 70' ' ' ARG . 78.6 mm-40 -63.62 -34.86 78.77 Favored 'General case' 0 C--N 1.322 -0.605 0 CA-C-N 115.526 -0.761 . . . . 0.0 110.696 -179.328 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 64.72 22.73 68.43 Favored Glycine 0 CA--C 1.522 0.522 0 N-CA-C 110.568 -1.013 . . . . 0.0 110.568 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.581 ' O ' ' O ' ' A' ' 46' ' ' GLY . 36.4 t0 -47.7 -170.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.838 0.352 . . . . 0.0 110.567 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.577 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 1.6 pt-20 -73.03 139.1 79.37 Favored Pre-proline 0 C--N 1.326 -0.453 0 CA-C-N 116.047 -0.524 . . . . 0.0 109.993 179.775 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -73.65 150.58 45.47 Favored 'Trans proline' 0 C--N 1.304 -1.773 0 C-N-CA 122.554 2.169 . . . . 0.0 112.314 -179.895 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.538 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 18.0 mp0 -114.85 150.61 35.28 Favored 'General case' 0 C--N 1.326 -0.446 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 178.905 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 55.8 m-85 -124.12 136.81 54.48 Favored 'General case' 0 C--N 1.326 -0.425 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.926 -178.808 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 48.8 mt -122.49 127.26 49.35 Favored 'General case' 0 C--N 1.33 -0.269 0 N-CA-C 108.785 -0.82 . . . . 0.0 108.785 178.178 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.9 m-20 -102.49 131.42 49.2 Favored 'General case' 0 C--N 1.324 -0.542 0 C-N-CA 120.473 -0.491 . . . . 0.0 111.584 -178.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.5 mt -128.69 155.51 79.0 Favored Pre-proline 0 C--N 1.329 -0.296 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.539 -179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.28 160.49 49.63 Favored 'Trans proline' 0 C--N 1.308 -1.592 0 C-N-CA 122.227 1.952 . . . . 0.0 112.572 179.976 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.459 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 20.7 p -60.19 -17.03 38.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.982 -0.553 . . . . 0.0 110.643 179.869 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 31.6 p -89.0 -9.54 50.97 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.728 -0.389 . . . . 0.0 110.066 179.748 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 130.26 35.05 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.098 -0.501 . . . . 0.0 110.167 179.513 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.5 p -127.02 13.07 7.26 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 116.461 -0.336 . . . . 0.0 110.467 179.537 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 57.8 p -165.06 148.09 8.3 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.393 -0.367 . . . . 0.0 110.267 179.616 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.493 HG11 HG21 ' A' ' 38' ' ' VAL . 12.6 p -149.89 148.13 15.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.29 0 CA-C-O 121.106 0.479 . . . . 0.0 111.494 -179.758 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.816 HD22 ' N ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -104.42 127.29 52.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.713 -0.676 . . . . 0.0 109.842 179.224 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.816 ' N ' HD22 ' A' ' 62' ' ' ASN . 1.7 mt -101.92 103.69 30.86 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.158 -0.217 . . . . 0.0 111.114 -179.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 97.2 Cg_endo -90.52 -179.81 1.7 Allowed 'Trans proline' 0 C--N 1.31 -1.457 0 C-N-CA 122.733 2.289 . . . . 0.0 112.342 179.508 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 92.0 m-20 59.98 38.13 21.02 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.434 -0.803 . . . . 0.0 111.69 179.556 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.539 HD12 ' O ' ' A' ' 20' ' ' SER . 33.2 mt -87.59 156.93 19.27 Favored 'General case' 0 C--N 1.329 -0.324 0 N-CA-C 109.277 -0.638 . . . . 0.0 109.277 178.364 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.585 HD12 ' OH ' ' A' ' 72' ' ' TYR . 28.7 mt -94.04 108.33 34.69 Favored Pre-proline 0 C--N 1.327 -0.38 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.151 -179.083 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.427 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 30.7 Cg_exo -55.1 138.98 80.07 Favored 'Trans proline' 0 C--N 1.312 -1.359 0 C-N-CA 122.064 1.843 . . . . 0.0 111.874 179.146 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 82.12 14.75 76.31 Favored Glycine 0 CA--C 1.524 0.606 0 N-CA-C 111.262 -0.735 . . . . 0.0 111.262 179.463 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.499 HH21 ' HG3' ' A' ' 45' ' ' GLU . 11.1 mmm-85 -126.36 148.95 49.49 Favored 'General case' 0 C--N 1.326 -0.418 0 N-CA-C 110.116 -0.327 . . . . 0.0 110.116 179.788 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.9 tttt -100.66 133.77 44.62 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.054 0.454 . . . . 0.0 110.431 179.988 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.726 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 77.5 m-85 -122.53 153.0 39.8 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.665 -0.698 . . . . 0.0 110.582 179.321 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.414 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.3 mt -111.05 128.82 67.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.57 0 N-CA-C 107.876 -1.157 . . . . 0.0 107.876 177.212 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.3 t -115.44 130.03 70.72 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.614 0 C-N-CA 120.429 -0.508 . . . . 0.0 110.878 -178.868 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 14.7 m-80 -131.09 122.72 27.2 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 115.429 -0.805 . . . . 0.0 109.036 179.216 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.702 HG11 ' CD2' ' A' ' 26' ' ' TRP . 11.1 t -102.93 126.0 57.24 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.574 0 C-N-CA 120.333 -0.547 . . . . 0.0 110.07 -179.495 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.481 ' HB2' HE21 ' A' ' 85' ' ' GLN . 63.0 m-85 -116.4 140.6 49.18 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-N 115.677 -0.692 . . . . 0.0 109.473 179.687 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.441 HE22 ' C ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -101.77 133.64 46.19 Favored 'General case' 0 C--N 1.321 -0.633 0 N-CA-C 108.04 -1.096 . . . . 0.0 108.04 178.774 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.407 HD11 ' HB2' ' A' ' 37' ' ' ARG . 54.0 mt -97.61 122.29 49.04 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 CA-C-O 121.244 0.545 . . . . 0.0 110.591 -178.408 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.593 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 73.2 p -82.18 168.0 18.13 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-N 115.253 -0.885 . . . . 0.0 110.307 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 96.5 mt-10 -58.22 -19.59 34.89 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.344 -179.352 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.593 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 40.0 p30 -93.86 -0.42 55.76 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 120.639 -0.425 . . . . 0.0 111.472 -179.675 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.15 12.04 66.26 Favored Glycine 0 CA--C 1.528 0.889 0 C-N-CA 120.989 -0.625 . . . . 0.0 111.993 179.283 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.515 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.5 mm-40 -83.84 138.94 32.97 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.851 179.438 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.556 HE22 ' NE ' ' A' ' 37' ' ' ARG . 37.4 mt-30 -103.44 142.82 33.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.619 179.326 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.9 t -136.36 127.38 27.79 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.039 -0.528 . . . . 0.0 109.871 179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.419 HD13 ' CE1' ' A' ' 77' ' ' TYR . 13.7 tp -72.69 118.07 15.15 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.576 -0.45 . . . . 0.0 109.969 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.484 HD11 ' CD1' ' A' ' 26' ' ' TRP . 34.4 pt -112.26 -20.3 6.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.098 -179.357 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 31.1 tp -154.98 124.86 6.59 Favored 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.467 -0.493 . . . . 0.0 111.347 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 28.5 t -135.25 112.26 10.29 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.709 . . . . 0.0 109.743 178.883 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -145.9 153.18 40.55 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 116.415 -0.357 . . . . 0.0 110.37 -179.612 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.3 p -113.42 153.08 29.2 Favored 'General case' 0 C--N 1.326 -0.42 0 N-CA-C 109.872 -0.418 . . . . 0.0 109.872 179.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.441 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 24.5 mt-30 -140.64 158.91 43.28 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.18 0.514 . . . . 0.0 110.906 -179.917 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -120.26 106.14 11.62 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 115.491 -0.777 . . . . 0.0 109.452 179.035 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.427 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 70.9 p . . . . . 0 C--O 1.219 -0.504 0 CA-C-O 117.913 -1.041 . . . . 0.0 110.74 -179.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.492 2.379 0 N-CA-C 109.369 -1.492 . . . . 0.0 109.369 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.553 ' O ' ' O ' ' A' ' 3' ' ' LEU . 10.7 Cg_endo -56.72 138.05 83.64 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.794 2.33 . . . . 0.0 111.933 -179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.553 ' O ' ' O ' ' A' ' 2' ' ' PRO . 0.9 OUTLIER -47.08 -175.28 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.353 179.928 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 89.64 23.65 32.87 Favored Glycine 0 CA--C 1.527 0.795 0 N-CA-C 111.355 -0.698 . . . . 0.0 111.355 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 44.5 p -79.29 8.41 6.09 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.814 0.34 . . . . 0.0 110.334 179.814 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.421 ' C ' HD12 ' A' ' 7' ' ' LEU . 86.2 m-70 -113.73 142.56 45.89 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.051 -0.522 . . . . 0.0 111.316 -179.293 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.82 ' N ' HD12 ' A' ' 7' ' ' LEU . 4.2 mp -86.96 152.59 22.27 Favored 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.825 179.853 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 66.0 t -99.84 135.02 37.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.257 0 CA-C-N 116.245 -0.434 . . . . 0.0 110.106 179.297 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -55.12 143.24 27.85 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.238 -0.437 . . . . 0.0 110.653 -179.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.508 ' OG1' ' N ' ' A' ' 11' ' ' SER . 9.2 t -179.08 -157.9 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.848 -179.726 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.508 ' N ' ' OG1' ' A' ' 10' ' ' THR . 24.0 p -63.11 -171.13 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.865 -0.607 . . . . 0.0 110.498 179.883 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' C ' ' H ' ' A' ' 14' ' ' VAL . 95.5 mt-10 -58.29 -31.56 67.6 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.821 -179.59 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 66.21 -42.29 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.964 0.411 . . . . 0.0 110.638 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.542 ' H ' ' C ' ' A' ' 12' ' ' GLU . 10.6 p -121.84 144.16 31.99 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.408 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.599 -179.785 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.81 HG22 ' N ' ' A' ' 16' ' ' GLU . 1.3 m -84.96 -82.25 0.18 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.102 -0.499 . . . . 0.0 111.005 -179.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.81 ' N ' HG22 ' A' ' 15' ' ' THR . 10.0 pt-20 32.09 105.18 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 121.216 0.531 . . . . 0.0 111.115 -179.353 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.66 ' O ' ' N ' ' A' ' 20' ' ' SER . 46.1 mt -152.41 -77.42 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 C-N-CA 120.426 -0.509 . . . . 0.0 111.79 179.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.622 ' C ' ' O ' ' A' ' 17' ' ' ILE . 5.6 p -11.34 126.01 0.01 OUTLIER 'General case' 0 N--CA 1.468 0.436 0 O-C-N 123.539 0.525 . . . . 0.0 110.681 -178.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.582 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 58.05 23.41 10.0 Favored 'General case' 0 C--N 1.327 -0.373 0 N-CA-C 109.278 -0.638 . . . . 0.0 109.278 -178.899 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.66 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.3 OUTLIER 59.16 29.58 19.17 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 115.672 -0.695 . . . . 0.0 110.124 -179.529 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 17' ' ' ILE . 4.3 p -63.51 163.32 11.21 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.865 -0.607 . . . . 0.0 111.136 -179.363 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.585 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 18.2 m-30 -130.38 152.93 49.24 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.353 -0.839 . . . . 0.0 110.46 178.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.674 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 41.5 t -126.84 106.16 15.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 176.732 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 82.0 t -115.65 134.84 57.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.905 -178.89 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 79.1 p -124.68 150.2 46.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.997 179.524 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 42.2 p90 -144.4 -179.5 6.58 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 120.908 0.385 . . . . 0.0 110.351 -179.915 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 59.5 t -118.92 128.45 75.74 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.542 179.988 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 40.5 t -50.08 133.86 22.61 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.69 -0.485 . . . . 0.0 109.69 179.484 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.677 ' H ' ' NE2' ' A' ' 78' ' ' GLN . . . -114.98 27.8 9.16 Favored 'General case' 0 C--N 1.329 -0.294 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.598 -179.003 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.65 ' C ' ' H ' ' A' ' 32' ' ' THR . 1.3 m -159.55 -25.28 0.07 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.307 -0.557 . . . . 0.0 111.315 -179.809 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 43.6 m-20 63.63 -40.13 0.21 Allowed 'General case' 0 C--N 1.327 -0.38 0 N-CA-C 109.434 -0.58 . . . . 0.0 109.434 -179.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.65 ' H ' ' C ' ' A' ' 30' ' ' SER . 43.9 p -79.24 1.06 26.1 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 115.774 -0.648 . . . . 0.0 109.76 179.244 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.47 ' O ' ' CB ' ' A' ' 56' ' ' SER . 0.9 OUTLIER -53.19 142.01 6.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.473 0 CA-C-N 115.626 -0.715 . . . . 0.0 109.93 179.903 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.599 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.7 m -94.58 -16.85 22.89 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 121.243 0.544 . . . . 0.0 109.743 -179.967 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.424 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.45 179.02 47.52 Favored Glycine 0 CA--C 1.522 0.484 0 N-CA-C 109.996 -1.242 . . . . 0.0 109.996 179.418 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.26 151.38 46.03 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.109 0.481 . . . . 0.0 110.448 179.296 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.447 ' HD3' ' NE2' ' A' ' 85' ' ' GLN . 60.8 ttt180 -130.89 124.4 31.08 Favored 'General case' 0 C--N 1.319 -0.753 0 CA-C-N 115.886 -0.597 . . . . 0.0 109.933 179.494 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.48 HG21 HG11 ' A' ' 61' ' ' VAL . 20.4 t -107.01 131.11 57.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.988 -0.551 . . . . 0.0 109.924 179.627 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -123.1 122.8 39.35 Favored 'General case' 0 C--N 1.322 -0.601 0 CA-C-N 115.918 -0.583 . . . . 0.0 109.932 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.552 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.1 p90 -135.7 138.17 42.49 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.384 0.612 . . . . 0.0 111.251 179.77 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -147.4 168.57 21.5 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 115.111 -0.95 . . . . 0.0 109.723 -179.812 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.759 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -74.3 127.77 33.85 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-O 121.032 0.444 . . . . 0.0 111.535 -179.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.2 p -69.23 -21.06 63.95 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 115.555 -0.748 . . . . 0.0 109.719 179.327 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 85.7 mt-10 -99.5 -74.29 0.6 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.464 -0.789 . . . . 0.0 110.255 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.645 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 70.6 mt-10 -66.76 150.73 48.69 Favored 'General case' 0 N--CA 1.45 -0.448 0 CA-C-N 115.622 -0.717 . . . . 0.0 109.557 179.747 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -99.7 43.1 1.86 Allowed Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.08 -1.057 . . . . 0.0 111.509 -179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.4 ' OD2' HD12 ' A' ' 42' ' ' LEU . 93.1 m-20 -59.89 172.25 0.79 Allowed 'General case' 0 C--N 1.328 -0.346 0 N-CA-C 109.622 -0.51 . . . . 0.0 109.622 179.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -74.01 136.7 76.25 Favored Pre-proline 0 C--N 1.325 -0.493 0 C-N-CA 120.379 -0.529 . . . . 0.0 110.548 -179.657 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 37.1 Cg_endo -68.82 151.68 74.11 Favored 'Trans proline' 0 C--N 1.306 -1.682 0 C-N-CA 122.562 2.174 . . . . 0.0 111.628 179.657 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.552 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 17.2 mt-30 -116.93 146.82 42.74 Favored 'General case' 0 C--N 1.327 -0.398 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 6.3 m-85 -125.04 136.7 53.94 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.256 -0.578 . . . . 0.0 110.803 -179.282 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.421 ' O ' ' HA ' ' A' ' 37' ' ' ARG . 61.5 mt -126.09 128.76 47.86 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 109.374 -0.602 . . . . 0.0 109.374 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.4 m-20 -104.44 134.12 48.17 Favored 'General case' 0 C--N 1.323 -0.544 0 C-N-CA 120.531 -0.468 . . . . 0.0 111.643 -179.3 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.1 mt -130.71 156.53 79.71 Favored Pre-proline 0 CA--C 1.531 0.23 0 CA-C-N 115.668 -0.697 . . . . 0.0 109.854 -179.583 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -66.53 156.38 65.77 Favored 'Trans proline' 0 C--N 1.311 -1.423 0 C-N-CA 122.236 1.958 . . . . 0.0 112.326 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.47 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 62.9 p -58.79 -13.3 5.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 115.776 -0.647 . . . . 0.0 111.115 -179.764 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 15.9 p -92.79 -8.02 44.83 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.448 -0.501 . . . . 0.0 110.197 179.772 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.27 130.72 35.16 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.346 179.677 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.3 p -130.6 14.73 5.44 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.863 -0.335 . . . . 0.0 110.365 179.277 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 56.2 p -163.65 140.31 6.95 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.211 -0.449 . . . . 0.0 109.88 179.483 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.48 HG11 HG21 ' A' ' 38' ' ' VAL . 4.8 p -150.09 143.92 17.51 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.393 0 CA-C-O 120.938 0.399 . . . . 0.0 110.792 -179.828 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.826 HD22 ' N ' ' A' ' 63' ' ' ILE . 0.2 OUTLIER -102.79 128.34 49.58 Favored 'General case' 0 C--N 1.322 -0.595 0 N-CA-C 109.098 -0.704 . . . . 0.0 109.098 179.025 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.826 ' N ' HD22 ' A' ' 62' ' ' ASN . 1.9 mt -97.82 105.09 24.79 Favored Pre-proline 0 C--N 1.331 -0.229 0 CA-C-N 116.715 -0.22 . . . . 0.0 110.49 -179.54 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.443 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.7 Cg_endo -91.16 177.35 2.02 Favored 'Trans proline' 0 C--N 1.31 -1.482 0 C-N-CA 122.589 2.193 . . . . 0.0 112.318 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.4 m-20 59.68 36.94 22.5 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 115.171 -0.922 . . . . 0.0 111.728 179.255 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.558 ' O ' ' OG ' ' A' ' 20' ' ' SER . 78.4 mt -89.48 146.1 24.86 Favored 'General case' 0 C--N 1.33 -0.275 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 178.623 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.455 ' O ' ' O ' ' A' ' 68' ' ' PRO . 34.4 mt -80.7 122.49 82.27 Favored Pre-proline 0 C--N 1.328 -0.34 0 C-N-CA 121.018 -0.273 . . . . 0.0 111.141 -179.387 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.695 ' O ' ' N ' ' A' ' 70' ' ' ARG . 45.6 Cg_exo -48.69 -174.04 0.0 OUTLIER 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.994 1.796 . . . . 0.0 111.82 178.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.456 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 21.82 33.91 0.01 OUTLIER Glycine 0 CA--C 1.534 1.274 0 CA-C-N 115.696 -0.684 . . . . 0.0 113.838 178.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.695 ' N ' ' O ' ' A' ' 68' ' ' PRO . 10.7 mmm-85 -126.89 144.54 50.96 Favored 'General case' 0 N--CA 1.465 0.321 0 CA-C-N 117.758 0.779 . . . . 0.0 110.612 179.035 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -100.11 131.82 45.84 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.814 -0.439 . . . . 0.0 109.814 179.087 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.759 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 83.6 m-85 -121.75 149.86 42.66 Favored 'General case' 0 C--N 1.321 -0.667 0 CA-C-N 116.021 -0.536 . . . . 0.0 111.286 179.983 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.452 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 85.4 mt -104.78 126.78 59.61 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.546 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 176.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 21.7 t -115.37 132.56 64.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.719 0 C-N-CA 120.188 -0.605 . . . . 0.0 111.224 -178.562 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.1 m-80 -133.86 123.64 25.11 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.361 -0.836 . . . . 0.0 109.17 179.236 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 21.3 t -103.16 126.85 57.43 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.493 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.53 -179.376 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -118.45 138.03 52.76 Favored 'General case' 0 C--N 1.326 -0.448 0 CA-C-N 116.026 -0.533 . . . . 0.0 109.756 179.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.677 ' NE2' ' H ' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -100.05 135.86 40.84 Favored 'General case' 0 C--N 1.321 -0.647 0 N-CA-C 108.384 -0.969 . . . . 0.0 108.384 178.489 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.599 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.1 mt -98.88 122.07 50.17 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.281 0.562 . . . . 0.0 110.711 -178.694 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.607 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 100.0 p -84.02 167.5 16.81 Favored 'General case' 0 N--CA 1.448 -0.56 0 CA-C-N 115.188 -0.914 . . . . 0.0 110.755 -179.745 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -58.14 -23.3 54.61 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.925 -179.554 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.607 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 38.6 p30 -90.97 -0.8 57.83 Favored 'General case' 0 C--N 1.329 -0.299 0 C-N-CA 120.561 -0.456 . . . . 0.0 110.747 -179.834 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.66 11.62 70.79 Favored Glycine 0 CA--C 1.527 0.836 0 C-N-CA 121.186 -0.53 . . . . 0.0 112.165 179.023 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -83.01 136.47 34.5 Favored 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 120.663 -0.415 . . . . 0.0 110.886 179.665 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.447 ' NE2' ' HD3' ' A' ' 37' ' ' ARG . 92.4 mt-30 -105.92 144.29 32.85 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.025 -0.534 . . . . 0.0 111.151 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.8 t -139.87 133.05 29.72 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.413 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.504 HD21 ' HB2' ' A' ' 90' ' ' SER . 15.0 tp -71.51 117.56 13.21 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 109.549 -0.537 . . . . 0.0 109.549 179.211 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 31.6 pt -108.9 -22.31 5.09 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.462 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.846 -179.447 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.2 tp -156.14 121.18 4.72 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.335 -179.982 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.504 ' HB2' HD21 ' A' ' 87' ' ' LEU . 40.3 t -127.03 122.99 35.98 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.01 -0.541 . . . . 0.0 109.583 178.71 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.3 t -154.28 157.78 39.21 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 120.737 -0.385 . . . . 0.0 110.575 -179.692 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 97.8 p -115.73 153.26 31.69 Favored 'General case' 0 C--N 1.326 -0.429 0 N-CA-C 109.801 -0.444 . . . . 0.0 109.801 179.145 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.437 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 31.6 mt-30 -138.06 157.29 46.64 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.215 0.531 . . . . 0.0 111.071 -179.946 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -128.69 108.19 10.29 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.181 178.91 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.41 HG22 ' CE1' ' A' ' 22' ' ' PHE . 44.5 p . . . . . 0 C--O 1.221 -0.429 0 CA-C-O 118.002 -0.999 . . . . 0.0 110.465 -179.369 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.415 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.323 0 N-CA-C 109.783 -1.327 . . . . 0.0 109.783 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.415 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 24.5 Cg_exo -57.79 148.6 74.08 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.733 2.289 . . . . 0.0 112.179 -179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.775 HD23 ' H ' ' A' ' 3' ' ' LEU . 0.1 OUTLIER -57.39 -36.81 71.75 Favored 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 116.48 -0.327 . . . . 0.0 110.729 -179.957 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 87.9 5.18 77.86 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 111.42 -0.672 . . . . 0.0 111.42 179.52 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.3 t -107.67 121.97 45.76 Favored 'General case' 0 C--N 1.327 -0.372 0 C-N-CA 120.478 -0.489 . . . . 0.0 110.693 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 53.0 m-70 -118.86 1.58 11.53 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.83 -0.623 . . . . 0.0 109.5 179.335 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 77.3 mt -68.07 174.61 3.69 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 115.336 -0.847 . . . . 0.0 110.13 179.145 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.563 ' O ' ' O ' ' A' ' 9' ' ' ALA . 42.0 t -54.2 144.95 4.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.387 -0.369 . . . . 0.0 110.077 179.337 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.563 ' O ' ' O ' ' A' ' 8' ' ' VAL . . . -32.52 155.94 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.405 179.885 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 22.8 m -66.09 136.19 55.65 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 121.032 0.444 . . . . 0.0 110.412 -179.711 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 36.9 p -163.25 175.98 10.4 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.715 -0.675 . . . . 0.0 109.675 -179.759 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.687 ' O ' ' N ' ' A' ' 14' ' ' VAL . 48.7 tt0 -80.58 7.37 10.18 Favored 'General case' 0 C--N 1.328 -0.344 0 N-CA-C 109.386 -0.598 . . . . 0.0 109.386 179.683 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 54.6 -73.21 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 115.986 -0.552 . . . . 0.0 110.213 -179.765 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.687 ' N ' ' O ' ' A' ' 12' ' ' GLU . 12.7 m -100.91 140.64 19.27 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 115.84 -0.618 . . . . 0.0 110.652 179.666 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.865 HG22 ' N ' ' A' ' 16' ' ' GLU . 94.1 m -133.77 -119.05 0.19 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.083 -0.508 . . . . 0.0 110.463 -179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.865 ' N ' HG22 ' A' ' 15' ' ' THR . 72.7 mm-40 5.08 55.63 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 115.022 -0.99 . . . . 0.0 112.098 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.728 ' N ' ' O ' ' A' ' 15' ' ' THR . 86.6 mt -61.14 -29.17 45.22 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.23 0 N-CA-C 109.037 -0.727 . . . . 0.0 109.037 178.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.416 ' C ' ' O ' ' A' ' 17' ' ' ILE . 7.7 t -40.56 144.18 0.27 Allowed 'General case' 0 N--CA 1.454 -0.245 0 CA-C-N 115.697 -0.683 . . . . 0.0 109.505 179.539 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.556 ' C ' ' OG ' ' A' ' 20' ' ' SER . . . 52.98 17.76 0.96 Allowed 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.447 -0.501 . . . . 0.0 109.841 -179.49 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.556 ' OG ' ' C ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 59.38 28.03 17.29 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.113 0.482 . . . . 0.0 110.016 179.968 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.556 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.0 OUTLIER -60.67 172.79 0.84 Allowed 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.45 -179.289 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.551 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 24.0 m-85 -135.61 151.91 50.72 Favored 'General case' 0 CA--C 1.515 -0.378 0 CA-C-N 115.38 -0.827 . . . . 0.0 110.375 178.576 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.8 t -122.25 105.98 17.12 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.796 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 176.127 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.1 t -114.12 136.34 50.97 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.42 -177.509 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -124.59 152.2 43.85 Favored 'General case' 0 CA--C 1.52 -0.182 0 CA-C-N 115.978 -0.556 . . . . 0.0 110.281 179.672 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.593 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.2 p90 -145.83 -165.29 2.16 Favored 'General case' 0 C--N 1.328 -0.342 0 C-N-CA 120.65 -0.42 . . . . 0.0 110.932 -179.913 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.591 HG12 ' H ' ' A' ' 29' ' ' ALA . 21.7 t -118.54 131.56 70.97 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 N-CA-C 108.967 -0.753 . . . . 0.0 108.967 179.273 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 30' ' ' SER . 19.3 m -52.36 -31.25 32.81 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 120.089 -0.644 . . . . 0.0 109.656 -179.555 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.591 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 55.16 -8.95 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 115.769 -0.651 . . . . 0.0 112.047 178.588 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.775 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER -158.36 127.4 5.61 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.424 -0.51 . . . . 0.0 111.15 -179.357 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 32.7 t70 -86.99 4.66 40.91 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.899 0.38 . . . . 0.0 110.132 179.375 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -95.49 1.8 54.14 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.065 -0.516 . . . . 0.0 109.689 179.502 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.775 HG12 ' O ' ' A' ' 30' ' ' SER . 2.6 p -75.34 136.36 25.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.589 -179.74 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.497 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.4 m -95.63 -13.5 24.28 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.848 -0.615 . . . . 0.0 109.549 179.76 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.519 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.01 179.59 47.48 Favored Glycine 0 CA--C 1.522 0.524 0 N-CA-C 110.056 -1.218 . . . . 0.0 110.056 -179.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.2 m-85 -126.94 151.53 48.37 Favored 'General case' 0 CA--C 1.511 -0.528 0 CA-C-O 120.925 0.393 . . . . 0.0 110.681 179.252 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.478 ' NH2' HE22 ' A' ' 85' ' ' GLN . 18.6 ttp180 -130.5 122.16 27.13 Favored 'General case' 0 C--N 1.318 -0.784 0 CA-C-N 115.872 -0.604 . . . . 0.0 109.416 177.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.479 HG21 HG11 ' A' ' 61' ' ' VAL . 84.8 t -108.9 132.58 56.54 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.788 0 CA-C-N 115.389 -0.823 . . . . 0.0 110.271 -179.774 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.46 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 20.0 tt0 -120.87 127.37 51.82 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.935 -0.575 . . . . 0.0 109.852 179.629 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.432 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 52.6 p90 -131.89 132.5 43.66 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-O 121.09 0.472 . . . . 0.0 110.019 178.84 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.9 pt-20 -148.68 165.15 32.22 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-N 115.527 -0.76 . . . . 0.0 109.739 -179.101 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.612 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 94.3 mt -73.27 128.54 35.77 Favored 'General case' 0 C--N 1.329 -0.303 0 C-N-CA 120.391 -0.524 . . . . 0.0 110.942 179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -70.82 -24.82 62.62 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.641 -0.708 . . . . 0.0 109.857 179.615 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 72.4 mm-40 -92.24 -73.75 0.54 Allowed 'General case' 0 CA--C 1.519 -0.231 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.744 179.563 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.471 ' CD ' HH12 ' A' ' 70' ' ' ARG . 87.8 mt-10 -67.9 146.24 53.82 Favored 'General case' 0 N--CA 1.447 -0.614 0 CA-C-N 115.595 -0.729 . . . . 0.0 109.635 179.246 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -95.26 38.01 3.25 Favored Glycine 0 CA--C 1.525 0.679 0 C-N-CA 120.276 -0.964 . . . . 0.0 111.477 -179.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 30.3 m-20 -53.75 170.39 0.12 Allowed 'General case' 0 CA--C 1.518 -0.27 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 179.142 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -72.5 133.02 83.18 Favored Pre-proline 0 C--N 1.324 -0.521 0 C-N-CA 119.986 -0.685 . . . . 0.0 110.4 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.4 Cg_endo -69.56 150.25 69.19 Favored 'Trans proline' 0 C--N 1.308 -1.577 0 C-N-CA 122.601 2.201 . . . . 0.0 112.167 -179.917 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -116.66 147.78 41.61 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.124 179.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.46 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 52.6 m-85 -125.66 141.69 51.89 Favored 'General case' 0 C--N 1.331 -0.228 0 C-N-CA 120.721 -0.391 . . . . 0.0 111.819 -179.143 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -127.91 134.65 49.36 Favored 'General case' 0 C--N 1.332 -0.168 0 N-CA-C 109.564 -0.532 . . . . 0.0 109.564 178.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 38.4 m-20 -106.92 134.12 50.55 Favored 'General case' 0 C--N 1.326 -0.427 0 C-N-CA 120.71 -0.396 . . . . 0.0 111.164 -179.793 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -130.45 155.93 80.33 Favored Pre-proline 0 N--CA 1.463 0.214 0 CA-C-N 115.932 -0.576 . . . . 0.0 110.044 -179.425 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 9.4 Cg_endo -66.25 154.12 75.41 Favored 'Trans proline' 0 C--N 1.309 -1.508 0 C-N-CA 121.945 1.763 . . . . 0.0 112.357 179.461 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.473 ' HB2' HG13 ' A' ' 33' ' ' VAL . 62.0 p -57.19 -15.75 6.46 Favored 'General case' 0 N--CA 1.465 0.3 0 CA-C-N 116.12 -0.491 . . . . 0.0 110.995 -179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 57.5 p -91.06 -8.0 50.2 Favored 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.527 -0.469 . . . . 0.0 110.438 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.37 133.1 35.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.968 -0.56 . . . . 0.0 109.853 179.428 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 70.8 p -130.41 17.98 5.37 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 116.199 -0.455 . . . . 0.0 110.612 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.4 p -164.96 144.38 6.89 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.269 -179.749 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.479 HG11 HG21 ' A' ' 38' ' ' VAL . 9.8 p -149.13 147.02 16.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-O 121.232 0.539 . . . . 0.0 111.624 -179.18 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.407 ' HA ' ' O ' ' A' ' 22' ' ' PHE . 2.2 t-20 -102.83 124.3 48.1 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.431 178.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.409 HG21 ' CG ' ' A' ' 40' ' ' TYR . 1.8 mt -95.44 109.9 47.9 Favored Pre-proline 0 N--CA 1.467 0.378 0 C-N-CA 120.904 -0.318 . . . . 0.0 111.317 -179.236 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -90.99 178.9 1.77 Allowed 'Trans proline' 0 C--N 1.312 -1.38 0 C-N-CA 122.88 2.387 . . . . 0.0 112.778 179.565 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 89.0 m-20 58.3 37.9 26.01 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.396 -0.82 . . . . 0.0 112.083 179.319 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.556 HD12 ' HA ' ' A' ' 21' ' ' SER . 76.4 mt -91.11 143.94 26.16 Favored 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.957 -0.297 . . . . 0.0 110.213 178.665 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.571 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 17.9 mt -90.1 112.79 54.45 Favored Pre-proline 0 CA--C 1.532 0.25 0 N-CA-C 111.778 0.288 . . . . 0.0 111.778 -179.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_exo -56.34 142.28 88.35 Favored 'Trans proline' 0 N--CA 1.491 1.368 0 C-N-CA 122.257 1.971 . . . . 0.0 111.86 179.05 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 77.51 14.58 82.32 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 110.765 -0.934 . . . . 0.0 110.765 179.628 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.471 HH12 ' CD ' ' A' ' 45' ' ' GLU . 14.6 mmt85 -121.9 150.94 41.26 Favored 'General case' 0 C--N 1.332 -0.178 0 N-CA-C 110.013 -0.365 . . . . 0.0 110.013 179.56 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 70.8 tttt -100.75 130.84 46.84 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-O 120.95 0.405 . . . . 0.0 110.107 179.393 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.612 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 59.8 m-85 -116.77 153.43 32.45 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.036 -0.529 . . . . 0.0 111.206 180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.534 HG22 ' ND2' ' A' ' 75' ' ' ASN . 84.4 mt -108.51 122.8 63.58 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 N-CA-C 107.582 -1.266 . . . . 0.0 107.582 176.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.3 t -113.21 131.63 64.33 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.672 -179.313 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.534 ' ND2' HG22 ' A' ' 73' ' ' ILE . 44.8 m-80 -137.49 126.53 24.34 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.591 179.53 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.593 HG11 ' CD2' ' A' ' 26' ' ' TRP . 15.6 t -103.35 130.85 52.99 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.423 0 CA-C-O 121.013 0.435 . . . . 0.0 110.506 -179.72 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 71.7 m-85 -120.23 142.98 48.53 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.824 -0.625 . . . . 0.0 110.217 179.644 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.439 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 0.5 OUTLIER -106.64 133.12 51.8 Favored 'General case' 0 C--N 1.317 -0.828 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 177.642 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.497 ' O ' ' N ' ' A' ' 34' ' ' SER . 63.2 mt -96.23 122.83 48.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.47 0 C-N-CA 120.64 -0.424 . . . . 0.0 110.61 -178.667 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.597 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 20.7 p -81.19 168.11 18.89 Favored 'General case' 0 N--CA 1.446 -0.641 0 CA-C-N 115.807 -0.633 . . . . 0.0 110.015 179.874 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 87.6 mt-10 -58.75 -17.87 26.86 Favored 'General case' 0 C--N 1.322 -0.606 0 CA-C-N 115.967 -0.561 . . . . 0.0 111.379 -179.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.597 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.3 p30 -93.4 0.01 56.69 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.606 -0.438 . . . . 0.0 111.572 -179.564 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 10.63 67.98 Favored Glycine 0 CA--C 1.529 0.933 0 C-N-CA 120.943 -0.646 . . . . 0.0 112.38 179.162 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.509 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.3 mm-40 -88.34 144.74 26.22 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 117.068 0.434 . . . . 0.0 110.652 178.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.478 HE22 ' NH2' ' A' ' 37' ' ' ARG . 29.7 mt-30 -103.47 143.32 32.86 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.306 -0.407 . . . . 0.0 110.656 179.154 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -128.96 125.21 36.97 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.996 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 25.1 tp -73.02 115.4 12.29 Favored 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.306 -0.557 . . . . 0.0 109.904 179.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 34.9 pt -109.66 -23.52 4.44 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.445 0 CA-C-N 116.135 -0.484 . . . . 0.0 111.581 -178.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.4 tp -156.61 128.08 7.08 Favored 'General case' 0 N--CA 1.466 0.346 0 C-N-CA 120.099 -0.641 . . . . 0.0 111.977 179.732 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 27.6 t -131.66 125.65 32.67 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.607 -0.724 . . . . 0.0 109.735 178.735 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.0 t -153.97 156.4 37.36 Favored 'General case' 0 C--N 1.331 -0.204 0 C-N-CA 120.782 -0.367 . . . . 0.0 110.49 179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 90.0 p -116.25 155.48 28.27 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.309 -0.405 . . . . 0.0 110.144 179.41 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.551 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 25.5 mt-30 -142.31 157.96 44.23 Favored 'General case' 0 C--N 1.326 -0.43 0 CA-C-O 121.324 0.583 . . . . 0.0 111.184 -179.955 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -122.64 104.81 9.58 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 115.185 -0.916 . . . . 0.0 108.911 179.045 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.43 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 46.6 p . . . . . 0 C--O 1.219 -0.549 0 CA-C-O 117.978 -1.011 . . . . 0.0 110.536 -179.179 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.477 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.287 0 N-CA-C 109.584 -1.406 . . . . 0.0 109.584 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -62.76 3.35 0.52 Allowed 'Trans proline' 0 C--N 1.305 -1.737 0 C-N-CA 122.9 2.4 . . . . 0.0 111.541 179.962 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.477 ' H ' ' C ' ' A' ' 1' ' ' GLY . 18.7 mt -77.06 146.66 37.15 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.873 -0.603 . . . . 0.0 109.748 179.853 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -176.57 -88.03 0.07 OUTLIER Glycine 0 CA--C 1.519 0.317 0 N-CA-C 110.292 -1.123 . . . . 0.0 110.292 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 29.1 t -60.02 -26.81 66.38 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 179.256 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 22.9 m170 60.8 158.17 0.04 OUTLIER 'General case' 0 C--N 1.333 -0.14 0 CA-C-N 115.874 -0.603 . . . . 0.0 110.476 179.881 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.789 HD22 ' H ' ' A' ' 7' ' ' LEU . 1.8 mm? -74.43 -3.48 30.83 Favored 'General case' 0 C--N 1.328 -0.336 0 C-N-CA 120.738 -0.385 . . . . 0.0 110.153 179.821 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 11.3 p -119.0 139.63 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.194 0 CA-C-N 116.411 -0.359 . . . . 0.0 110.631 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -90.41 129.6 36.59 Favored 'General case' 0 C--N 1.333 -0.147 0 CA-C-N 116.181 -0.463 . . . . 0.0 111.285 -179.59 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.586 ' C ' ' H ' ' A' ' 12' ' ' GLU . 2.4 t -132.65 154.49 50.05 Favored 'General case' 0 N--CA 1.462 0.158 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.737 179.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.573 ' O ' ' O ' ' A' ' 12' ' ' GLU . 36.1 t 49.94 6.35 0.02 OUTLIER 'General case' 0 C--O 1.232 0.142 0 CA-C-O 121.077 0.465 . . . . 0.0 110.133 -179.649 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.586 ' H ' ' C ' ' A' ' 10' ' ' THR . 67.7 tt0 53.16 150.71 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.85 -0.614 . . . . 0.0 110.4 -179.314 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.404 ' N ' ' HG2' ' A' ' 12' ' ' GLU . 7.7 m -57.6 -54.15 50.15 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.136 -0.484 . . . . 0.0 111.342 -179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 3.5 m -104.49 132.7 50.51 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-N 115.962 -0.563 . . . . 0.0 111.175 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.66 HG22 ' N ' ' A' ' 16' ' ' GLU . 46.5 m -111.7 169.38 8.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.084 -0.507 . . . . 0.0 110.026 179.349 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.66 ' N ' HG22 ' A' ' 15' ' ' THR . 32.1 mm-40 62.75 17.41 9.81 Favored 'General case' 0 CA--C 1.517 -0.312 0 N-CA-C 107.956 -1.127 . . . . 0.0 107.956 -177.95 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.604 ' O ' ' N ' ' A' ' 20' ' ' SER . 0.1 OUTLIER -37.94 -80.03 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.325 -0.457 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.465 -178.712 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.689 ' OG1' ' N ' ' A' ' 19' ' ' ALA . 13.0 p 29.47 -99.57 0.01 OUTLIER 'General case' 0 C--O 1.232 0.168 0 N-CA-C 110.058 -0.349 . . . . 0.0 110.058 -179.081 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.689 ' N ' ' OG1' ' A' ' 18' ' ' THR . . . -69.11 32.77 0.03 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 0.0 109.85 179.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.616 ' H ' ' C ' ' A' ' 18' ' ' THR . 79.4 p 57.99 33.73 23.5 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 115.877 -0.601 . . . . 0.0 110.219 -179.675 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.517 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 4.3 p -60.34 149.41 33.76 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.852 -179.532 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.551 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 22.2 m-30 -110.16 145.81 36.59 Favored 'General case' 0 C--N 1.324 -0.531 0 CA-C-N 115.48 -0.782 . . . . 0.0 110.282 178.566 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 44.5 t -117.32 104.84 17.04 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 N-CA-C 108.41 -0.959 . . . . 0.0 108.41 177.076 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 71.8 t -112.93 139.1 39.81 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.444 0 CA-C-N 116.004 -0.544 . . . . 0.0 111.809 -178.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.8 p -128.19 153.54 46.79 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.634 -0.712 . . . . 0.0 110.129 179.394 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.546 ' CE3' HG21 ' A' ' 76' ' ' VAL . 39.8 p90 -147.22 -166.32 2.48 Favored 'General case' 0 C--N 1.325 -0.481 0 C-N-CA 120.265 -0.574 . . . . 0.0 111.079 -179.608 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.705 HG12 ' H ' ' A' ' 29' ' ' ALA . 49.0 t -118.06 133.1 65.92 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.454 0 CA-C-N 115.525 -0.761 . . . . 0.0 109.256 179.175 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.582 ' C ' ' H ' ' A' ' 30' ' ' SER . 53.3 m -50.38 -30.91 13.35 Favored 'General case' 0 C--N 1.321 -0.639 0 C-N-CA 120.283 -0.567 . . . . 0.0 110.277 -179.4 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.705 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 51.07 2.65 0.01 OUTLIER 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 116.2 -0.455 . . . . 0.0 111.366 179.267 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.582 ' H ' ' C ' ' A' ' 28' ' ' SER . 0.9 OUTLIER -164.74 145.77 7.83 Favored 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.48 -179.875 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.546 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 54.9 t0 -103.25 -12.38 17.33 Favored 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.974 -0.557 . . . . 0.0 110.077 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 34.5 p -86.78 -4.94 59.24 Favored 'General case' 0 N--CA 1.455 -0.207 0 CA-C-N 115.889 -0.596 . . . . 0.0 111.456 -179.474 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.432 ' H ' HG12 ' A' ' 33' ' ' VAL . 0.6 OUTLIER -62.58 136.58 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 N-CA-C 109.869 -0.419 . . . . 0.0 109.869 179.697 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 37.5 m -96.16 -14.2 22.96 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 121.141 0.495 . . . . 0.0 110.24 -179.364 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.431 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.53 174.92 43.43 Favored Glycine 0 CA--C 1.521 0.464 0 N-CA-C 109.865 -1.294 . . . . 0.0 109.865 -179.884 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 84.0 m-85 -123.33 150.73 43.26 Favored 'General case' 0 C--N 1.325 -0.492 0 CA-C-O 121.168 0.509 . . . . 0.0 111.063 179.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.834 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 37.7 ttp180 -130.51 122.52 27.78 Favored 'General case' 0 C--N 1.323 -0.569 0 N-CA-C 108.926 -0.768 . . . . 0.0 108.926 178.385 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.73 HG21 HG11 ' A' ' 61' ' ' VAL . 91.9 t -106.27 132.45 53.38 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.77 0 CA-C-N 115.976 -0.556 . . . . 0.0 109.824 179.634 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.465 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 81.4 tt0 -122.75 132.94 54.46 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 120.475 -0.49 . . . . 0.0 110.52 -179.98 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.484 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 46.9 p90 -140.09 141.08 36.19 Favored 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 120.279 -0.568 . . . . 0.0 111.179 178.83 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.4 pt-20 -150.57 163.82 37.54 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.438 -0.801 . . . . 0.0 109.772 -179.513 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.557 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 50.8 mt -75.35 131.98 40.64 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.137 0.494 . . . . 0.0 111.246 -179.99 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 17.3 p -78.78 -14.99 58.96 Favored 'General case' 0 C--N 1.331 -0.205 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.483 179.895 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 80.0 mm-40 -102.14 -73.37 0.66 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 115.891 -0.595 . . . . 0.0 111.853 -178.259 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.7 mt-10 -59.64 -28.33 67.13 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.913 -0.585 . . . . 0.0 110.473 -179.22 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 68.43 40.13 86.91 Favored Glycine 0 CA--C 1.517 0.214 0 N-CA-C 110.207 -1.157 . . . . 0.0 110.207 -179.756 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 46.8 p30 -60.36 -179.55 0.12 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 120.892 0.377 . . . . 0.0 110.408 -179.743 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -74.11 143.33 80.31 Favored Pre-proline 0 C--N 1.322 -0.605 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.138 179.797 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 57.7 Cg_endo -71.7 151.76 58.19 Favored 'Trans proline' 0 C--N 1.301 -1.941 0 C-N-CA 122.696 2.264 . . . . 0.0 112.756 -179.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.484 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 24.7 mt-30 -122.75 148.2 45.61 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 179.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.7 m-85 -126.37 137.03 53.41 Favored 'General case' 0 C--N 1.326 -0.455 0 C-N-CA 119.605 -0.838 . . . . 0.0 112.188 -179.135 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 64.7 mt -122.32 127.84 50.3 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 108.815 -0.809 . . . . 0.0 108.815 178.026 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 73.4 m-20 -102.99 133.45 48.09 Favored 'General case' 0 C--N 1.32 -0.703 0 CA-C-O 121.353 0.597 . . . . 0.0 112.17 -178.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.4 mt -131.38 157.2 78.79 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 115.17 -0.923 . . . . 0.0 108.917 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.3 160.5 48.65 Favored 'Trans proline' 0 C--N 1.309 -1.509 0 C-N-CA 121.789 1.66 . . . . 0.0 112.219 -179.771 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.431 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 50.9 p -57.05 -11.82 1.76 Allowed 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.183 179.632 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 51.2 p -91.49 -7.5 50.3 Favored 'General case' 0 C--N 1.332 -0.196 0 CA-C-N 116.226 -0.443 . . . . 0.0 111.435 -179.891 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.3 134.17 35.54 Favored 'General case' 0 C--N 1.331 -0.226 0 C-N-CA 120.608 -0.437 . . . . 0.0 110.403 179.581 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 37.6 p -126.73 7.62 6.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.839 179.666 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -162.21 154.17 18.89 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.532 -0.304 . . . . 0.0 110.332 179.549 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.73 HG11 HG21 ' A' ' 38' ' ' VAL . 9.1 p -153.2 146.97 14.57 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.066 0.46 . . . . 0.0 111.311 -179.246 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.421 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 30.4 t30 -103.83 128.93 51.25 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 115.79 -0.641 . . . . 0.0 109.44 178.806 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -105.67 99.6 22.51 Favored Pre-proline 0 C--N 1.331 -0.234 0 CA-C-O 120.513 0.197 . . . . 0.0 111.055 -179.559 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.421 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 66.9 Cg_endo -89.61 -169.41 0.37 Allowed 'Trans proline' 0 C--N 1.308 -1.59 0 C-N-CA 122.921 2.414 . . . . 0.0 112.162 179.718 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.4 m-20 57.63 36.69 26.99 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.538 179.595 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.513 ' HB2' ' HG ' ' A' ' 20' ' ' SER . 42.7 mt -94.33 138.21 32.57 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.85 -0.614 . . . . 0.0 109.946 179.584 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.673 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 18.6 mt -84.71 113.96 52.54 Favored Pre-proline 0 C--N 1.333 -0.147 0 C-N-CA 120.7 -0.4 . . . . 0.0 111.131 -179.218 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_exo -54.08 138.07 70.47 Favored 'Trans proline' 0 C--N 1.31 -1.465 0 C-N-CA 121.92 1.747 . . . . 0.0 111.534 179.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 84.32 14.95 70.18 Favored Glycine 0 CA--C 1.528 0.862 0 C-N-CA 121.086 -0.578 . . . . 0.0 111.861 179.109 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -124.87 148.61 48.17 Favored 'General case' 0 C--N 1.331 -0.22 0 N-CA-C 110.175 -0.305 . . . . 0.0 110.175 179.728 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 76.9 tttt -98.98 134.78 41.33 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 120.387 -0.525 . . . . 0.0 110.361 179.617 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.673 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 64.9 m-85 -121.5 153.55 37.8 Favored 'General case' 0 C--N 1.323 -0.587 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.588 -179.508 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.608 HG22 HD21 ' A' ' 75' ' ' ASN . 85.7 mt -109.38 125.63 66.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.565 0 N-CA-C 107.696 -1.224 . . . . 0.0 107.696 177.138 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.7 t -114.5 129.02 71.29 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.638 0 CA-C-O 121.044 0.45 . . . . 0.0 110.673 -178.703 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.608 HD21 HG22 ' A' ' 73' ' ' ILE . 14.3 m-80 -135.71 124.42 23.83 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.171 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.546 HG21 ' CE3' ' A' ' 26' ' ' TRP . 17.6 t -103.47 128.01 56.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.361 0 C-N-CA 120.318 -0.553 . . . . 0.0 109.983 179.394 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 72.9 m-85 -117.37 142.21 47.39 Favored 'General case' 0 C--N 1.324 -0.53 0 N-CA-C 109.657 -0.497 . . . . 0.0 109.657 179.445 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -103.41 133.75 47.94 Favored 'General case' 0 C--N 1.323 -0.546 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.865 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 47.0 mt -98.3 126.17 51.43 Favored 'Isoleucine or valine' 0 CA--C 1.512 -0.5 0 CA-C-O 121.384 0.611 . . . . 0.0 110.789 -178.649 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.604 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 30.0 p -82.87 168.55 16.98 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.156 -0.929 . . . . 0.0 109.974 179.788 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.7 mt-10 -62.16 -19.3 62.93 Favored 'General case' 0 C--N 1.321 -0.636 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.147 -179.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.604 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 36.3 p30 -93.69 2.8 56.2 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 120.564 -0.455 . . . . 0.0 111.451 -179.439 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.34 11.8 66.18 Favored Glycine 0 CA--C 1.529 0.962 0 C-N-CA 121.227 -0.511 . . . . 0.0 112.425 179.121 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.448 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 70.5 mm-40 -87.34 142.6 27.76 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.833 0.349 . . . . 0.0 110.979 179.481 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.834 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 83.7 mt-30 -105.2 147.23 28.24 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.046 -0.525 . . . . 0.0 111.018 179.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -137.05 124.37 21.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.677 -0.692 . . . . 0.0 110.614 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.423 HD21 ' HB2' ' A' ' 90' ' ' SER . 14.4 tp -73.71 115.57 13.29 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.444 -0.344 . . . . 0.0 110.147 179.469 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 47.2 pt -109.87 -20.26 6.35 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-N 116.23 -0.441 . . . . 0.0 110.795 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 14.7 tp -155.17 123.12 5.78 Favored 'General case' 0 C--N 1.327 -0.371 0 C-N-CA 120.481 -0.488 . . . . 0.0 111.657 179.867 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.423 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.0 t -131.87 119.13 20.77 Favored 'General case' 0 C--N 1.328 -0.359 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.399 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -153.37 162.26 41.47 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.456 -0.497 . . . . 0.0 110.601 -179.484 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 29.7 p -120.33 153.1 36.91 Favored 'General case' 0 C--N 1.322 -0.59 0 C-N-CA 120.59 -0.444 . . . . 0.0 110.347 179.744 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.551 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 20.7 mt-30 -138.13 157.1 47.0 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.945 179.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 1.4 m -123.09 115.7 22.25 Favored 'General case' 0 C--N 1.322 -0.625 0 N-CA-C 109.113 -0.699 . . . . 0.0 109.113 179.108 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 40.2 p . . . . . 0 C--N 1.323 -0.556 0 CA-C-O 117.904 -1.046 . . . . 0.0 110.781 -179.199 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.299 0 N-CA-C 109.665 -1.374 . . . . 0.0 109.665 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 52.4 Cg_exo -50.1 150.22 10.71 Favored 'Trans proline' 0 C--N 1.31 -1.471 0 C-N-CA 122.641 2.227 . . . . 0.0 112.24 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 24.9 mt -90.68 143.34 26.83 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.971 -179.759 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -95.89 -168.03 34.87 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.823 -0.911 . . . . 0.0 110.823 179.629 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.523 ' O ' ' OG ' ' A' ' 5' ' ' SER . 0.0 OUTLIER 65.45 20.49 11.74 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-O 120.829 0.347 . . . . 0.0 110.873 179.776 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 29.4 m170 -93.45 10.9 30.44 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.099 -0.5 . . . . 0.0 110.648 179.672 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.693 ' O ' ' N ' ' A' ' 9' ' ' ALA . 23.1 mt -44.13 160.54 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.451 -0.34 . . . . 0.0 110.621 -179.232 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.579 ' C ' ' O ' ' A' ' 7' ' ' LEU . 47.2 t -1.99 -60.54 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.468 0.428 0 CA-C-N 115.753 -0.658 . . . . 0.0 112.288 -179.472 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.693 ' N ' ' O ' ' A' ' 7' ' ' LEU . . . -52.54 129.42 28.97 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 120.536 -0.466 . . . . 0.0 110.254 -179.62 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.534 ' O ' ' C ' ' A' ' 11' ' ' SER . 4.4 t -138.12 164.81 28.21 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.268 -179.81 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.534 ' C ' ' O ' ' A' ' 10' ' ' THR . 17.7 m 32.36 -119.68 0.06 Allowed 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.684 -0.487 . . . . 0.0 109.684 -179.776 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 96.9 mt-10 -107.37 119.32 39.08 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.77 -0.372 . . . . 0.0 110.114 179.015 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 52.8 p -92.12 6.42 46.61 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.274 -179.52 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.634 ' O ' ' N ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -86.12 -75.72 0.27 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 C-N-CA 120.726 -0.39 . . . . 0.0 111.559 -179.15 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.687 ' O ' ' N ' ' A' ' 17' ' ' ILE . 1.7 m 61.13 -45.75 0.12 Allowed 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.584 -179.221 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.634 ' N ' ' O ' ' A' ' 14' ' ' VAL . 1.8 pt-20 -62.1 43.78 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.012 -0.54 . . . . 0.0 109.701 179.767 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.687 ' N ' ' O ' ' A' ' 15' ' ' THR . 0.3 OUTLIER -103.6 -11.67 9.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 115.724 -0.671 . . . . 0.0 111.833 -178.71 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.461 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 26.4 m -46.4 113.01 0.56 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.047 -0.661 . . . . 0.0 109.235 -179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.606 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 65.01 27.32 12.63 Favored 'General case' 0 C--N 1.327 -0.413 0 N-CA-C 108.886 -0.783 . . . . 0.0 108.886 -178.294 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.677 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.0 OUTLIER 64.34 29.06 13.73 Favored 'General case' 0 C--N 1.332 -0.154 0 CA-C-N 115.468 -0.787 . . . . 0.0 110.859 -179.988 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.567 ' O ' ' O ' ' A' ' 16' ' ' GLU . 0.3 OUTLIER -62.96 -177.69 0.17 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 121.832 0.825 . . . . 0.0 112.059 -179.147 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.564 ' CD1' ' O ' ' A' ' 21' ' ' SER . 16.1 m-85 -151.53 140.38 20.94 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.283 -1.326 . . . . 0.0 109.278 178.611 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.2 t -117.46 101.62 12.25 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.785 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 176.755 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.5 t -110.89 137.06 44.94 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 CA-C-N 115.769 -0.651 . . . . 0.0 111.222 -177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.6 p -124.03 151.41 43.79 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.114 179.689 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.466 ' CD2' HG11 ' A' ' 76' ' ' VAL . 40.6 p90 -145.04 -175.39 4.67 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-N 116.193 -0.458 . . . . 0.0 110.465 -179.775 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.582 HG12 ' H ' ' A' ' 29' ' ' ALA . 41.3 t -112.42 133.36 58.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 N-CA-C 109.409 -0.589 . . . . 0.0 109.409 179.266 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.685 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 45.2 t -49.79 -34.59 19.89 Favored 'General case' 0 C--N 1.324 -0.525 0 C-N-CA 120.581 -0.448 . . . . 0.0 110.353 -179.47 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.582 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 58.34 -0.13 0.12 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.11 -0.496 . . . . 0.0 111.428 179.371 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.532 ' O ' HG12 ' A' ' 33' ' ' VAL . 3.2 m -170.99 133.63 0.91 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.522 -0.471 . . . . 0.0 111.118 -179.576 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 31.2 p-10 -89.68 1.66 55.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.376 -0.375 . . . . 0.0 110.742 179.569 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 67.0 p -92.37 1.55 57.17 Favored 'General case' 0 N--CA 1.454 -0.26 0 CA-C-N 116.442 -0.344 . . . . 0.0 110.301 179.753 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.532 HG12 ' O ' ' A' ' 30' ' ' SER . 2.5 p -70.09 136.03 26.95 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 116.056 -0.52 . . . . 0.0 111.083 -179.634 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.589 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.6 m -97.0 -14.52 21.59 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 115.826 -0.625 . . . . 0.0 109.421 179.275 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.412 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.94 178.54 46.77 Favored Glycine 0 CA--C 1.522 0.507 0 N-CA-C 109.716 -1.354 . . . . 0.0 109.716 179.757 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 94.3 m-85 -127.44 153.04 46.76 Favored 'General case' 0 C--N 1.321 -0.67 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.483 179.371 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.701 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 42.5 ttp180 -131.07 129.25 41.7 Favored 'General case' 0 C--N 1.323 -0.55 0 C-N-CA 120.307 -0.557 . . . . 0.0 109.834 178.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 22.0 t -112.37 133.65 57.44 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.635 0 CA-C-N 115.891 -0.595 . . . . 0.0 110.526 -179.766 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 19.8 tt0 -122.16 127.71 50.38 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-N 115.924 -0.58 . . . . 0.0 110.091 179.668 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.431 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 48.8 p90 -135.25 130.63 35.48 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.32 0.581 . . . . 0.0 110.66 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.6 pt-20 -143.98 165.1 28.71 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.234 -0.894 . . . . 0.0 109.721 -179.42 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.611 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 35.5 mt -74.78 127.14 32.45 Favored 'General case' 0 C--N 1.325 -0.49 0 CA-C-O 121.084 0.469 . . . . 0.0 111.505 -179.319 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 19.9 p -69.9 -37.85 76.12 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.599 -0.728 . . . . 0.0 109.49 179.128 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.8 mt-10 -78.93 -56.6 4.27 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.555 -0.748 . . . . 0.0 110.226 179.598 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.675 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 81.9 mt-10 -85.85 152.45 22.99 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.409 -0.814 . . . . 0.0 109.973 179.91 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.433 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -99.5 26.78 23.03 Favored Glycine 0 CA--C 1.523 0.541 0 N-CA-C 111.157 -0.777 . . . . 0.0 111.157 -179.831 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.513 ' CG ' ' N ' ' A' ' 48' ' ' GLU . 25.4 t70 -46.37 172.5 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.425 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.578 ' H ' ' CD ' ' A' ' 48' ' ' GLU . 1.3 pm0 -72.43 139.37 81.3 Favored Pre-proline 0 C--N 1.323 -0.56 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.594 -179.714 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 58.8 Cg_endo -74.1 153.13 46.36 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.69 2.26 . . . . 0.0 112.291 179.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.425 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 9.2 mt-30 -118.88 143.82 46.75 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.124 -0.489 . . . . 0.0 109.711 179.212 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 32.6 m-85 -123.07 136.64 54.9 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.328 -0.549 . . . . 0.0 111.092 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 78.0 mt -124.93 131.72 53.39 Favored 'General case' 0 C--N 1.328 -0.342 0 N-CA-C 109.077 -0.712 . . . . 0.0 109.077 178.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 69.0 m-20 -106.18 136.07 46.53 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-O 121.091 0.472 . . . . 0.0 111.457 -179.277 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.8 mt -130.21 157.24 77.78 Favored Pre-proline 0 C--N 1.328 -0.363 0 CA-C-N 115.659 -0.701 . . . . 0.0 109.576 -179.555 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -69.97 158.7 55.83 Favored 'Trans proline' 0 C--N 1.309 -1.52 0 C-N-CA 121.939 1.759 . . . . 0.0 112.098 179.508 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.434 ' HB2' HG13 ' A' ' 33' ' ' VAL . 36.7 p -59.31 -12.95 6.44 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.019 -0.537 . . . . 0.0 111.114 -179.66 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 22.2 p -92.05 -8.56 45.57 Favored 'General case' 0 C--N 1.327 -0.39 0 C-N-CA 120.697 -0.401 . . . . 0.0 110.792 -179.656 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.13 133.91 35.02 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.372 -0.377 . . . . 0.0 110.69 179.813 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -131.02 11.21 5.06 Favored 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 120.764 -0.375 . . . . 0.0 110.902 179.754 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 37.0 p -164.43 143.89 7.47 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 109.978 -0.378 . . . . 0.0 109.978 179.557 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 5.3 p -149.01 149.22 15.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.206 -0.598 . . . . 0.0 111.703 -179.765 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.5 HD22 ' N ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -103.9 123.41 47.08 Favored 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 115.262 -0.881 . . . . 0.0 109.069 178.832 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.5 ' N ' HD22 ' A' ' 62' ' ' ASN . 2.0 mt -100.38 102.82 19.96 Favored Pre-proline 0 N--CA 1.464 0.226 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.003 -179.554 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.445 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 63.1 Cg_endo -92.87 179.98 1.07 Allowed 'Trans proline' 0 C--N 1.309 -1.539 0 C-N-CA 122.909 2.406 . . . . 0.0 113.207 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 62.31 37.3 14.03 Favored 'General case' 0 C--N 1.326 -0.44 0 CA-C-N 114.94 -1.027 . . . . 0.0 111.901 179.3 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.563 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -92.47 152.34 19.73 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.408 -0.36 . . . . 0.0 110.291 178.747 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.408 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 19.3 mt -82.96 119.85 75.05 Favored Pre-proline 0 C--N 1.332 -0.179 0 C-N-CA 120.688 -0.405 . . . . 0.0 109.969 179.501 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.52 144.89 62.62 Favored 'Trans proline' 0 C--N 1.312 -1.362 0 C-N-CA 121.867 1.711 . . . . 0.0 112.082 -179.953 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 81.76 15.45 75.45 Favored Glycine 0 CA--C 1.525 0.693 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.889 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.675 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 0.1 OUTLIER -124.81 153.4 42.57 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 120.848 0.356 . . . . 0.0 110.731 -179.702 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 67.2 tttt -102.6 133.86 46.91 Favored 'General case' 0 N--CA 1.454 -0.258 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.29 179.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.611 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 86.9 m-85 -120.4 151.12 39.72 Favored 'General case' 0 C--N 1.323 -0.553 0 CA-C-N 115.951 -0.568 . . . . 0.0 111.74 -179.936 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.431 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 77.1 mt -108.53 123.94 64.6 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 N-CA-C 107.157 -1.423 . . . . 0.0 107.157 176.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 50.5 t -116.11 134.68 58.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.587 0 CA-C-O 121.161 0.505 . . . . 0.0 111.644 -178.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.6 m-80 -135.2 129.65 34.06 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.482 -0.781 . . . . 0.0 109.714 179.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.466 HG11 ' CD2' ' A' ' 26' ' ' TRP . 28.6 t -106.61 128.92 60.87 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.425 0 C-N-CA 120.537 -0.465 . . . . 0.0 110.355 179.919 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -120.55 139.53 52.79 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 116.022 -0.535 . . . . 0.0 109.869 179.435 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.685 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -101.11 133.33 45.8 Favored 'General case' 0 C--N 1.32 -0.711 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 178.391 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.589 ' O ' ' N ' ' A' ' 34' ' ' SER . 52.2 mt -98.33 122.69 50.28 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.639 0 CA-C-O 121.292 0.567 . . . . 0.0 110.448 -178.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.601 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 42.0 p -83.79 169.11 15.53 Favored 'General case' 0 C--N 1.322 -0.59 0 CA-C-N 115.306 -0.861 . . . . 0.0 110.124 -179.815 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.524 ' CD ' ' HG ' ' A' ' 34' ' ' SER . 77.6 mm-40 -58.19 -20.81 44.24 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-N 115.753 -0.658 . . . . 0.0 111.09 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.601 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.5 p30 -91.35 -2.61 57.31 Favored 'General case' 0 C--N 1.331 -0.215 0 C-N-CA 120.689 -0.404 . . . . 0.0 110.945 -179.612 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.01 12.71 67.73 Favored Glycine 0 CA--C 1.527 0.802 0 C-N-CA 121.025 -0.607 . . . . 0.0 112.136 179.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.587 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.7 mm-40 -84.0 141.04 31.49 Favored 'General case' 0 C--N 1.326 -0.421 0 C-N-CA 120.613 -0.435 . . . . 0.0 110.627 179.341 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.701 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 93.3 mt-30 -105.19 140.92 37.62 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.514 179.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 38.3 t -134.02 127.86 33.13 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-N 115.901 -0.591 . . . . 0.0 110.107 179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 23.0 tp -72.06 116.28 12.28 Favored 'General case' 0 C--N 1.324 -0.526 0 C-N-CA 120.345 -0.542 . . . . 0.0 109.553 179.549 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.3 pt -107.4 -23.1 4.62 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.556 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 23.4 tp -159.08 124.81 4.35 Favored 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 120.303 -0.559 . . . . 0.0 112.054 -179.702 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 37.4 t -128.48 126.71 41.05 Favored 'General case' 0 C--N 1.33 -0.256 0 N-CA-C 109.257 -0.645 . . . . 0.0 109.257 178.306 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.9 t -153.77 159.03 41.78 Favored 'General case' 0 C--N 1.33 -0.249 0 C-N-CA 120.361 -0.536 . . . . 0.0 111.196 -179.016 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.9 p -120.58 152.26 38.35 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.084 179.216 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.427 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 23.1 mt-30 -143.65 158.12 43.91 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-O 121.233 0.54 . . . . 0.0 110.996 179.707 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -123.21 114.88 20.86 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 115.266 -0.879 . . . . 0.0 108.906 178.598 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.553 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 33.4 p . . . . . 0 C--N 1.326 -0.446 0 CA-C-O 117.936 -1.031 . . . . 0.0 110.647 -179.01 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.254 0 N-CA-C 109.64 -1.384 . . . . 0.0 109.64 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.0 Cg_exo -59.63 153.32 56.25 Favored 'Trans proline' 0 C--N 1.304 -1.767 0 C-N-CA 122.899 2.399 . . . . 0.0 111.96 179.787 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 55.3 mt -78.6 143.8 36.09 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.036 179.691 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 98.4 -136.66 12.83 Favored Glycine 0 CA--C 1.529 0.912 0 N-CA-C 110.519 -1.032 . . . . 0.0 110.519 -179.271 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 38.78 56.45 1.92 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.889 0.376 . . . . 0.0 110.846 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.692 ' CD2' ' H ' ' A' ' 6' ' ' HIS . 0.0 OUTLIER -68.68 -46.84 68.01 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.196 -0.456 . . . . 0.0 110.493 179.873 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.525 ' CD2' ' N ' ' A' ' 7' ' ' LEU . 3.0 mm? -81.57 -154.68 0.12 Allowed 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.065 -0.516 . . . . 0.0 110.274 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.438 ' H ' ' HB3' ' A' ' 7' ' ' LEU . 6.1 m -48.46 132.73 6.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.764 0.316 . . . . 0.0 110.253 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -58.14 151.85 18.12 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 109.717 -0.475 . . . . 0.0 109.717 179.714 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 74.2 p -67.19 2.65 1.48 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.72 -0.392 . . . . 0.0 111.06 -179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.2 t -99.55 138.18 37.0 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.959 0.409 . . . . 0.0 110.864 179.615 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 39.4 tp10 -76.93 150.23 35.96 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.994 -0.548 . . . . 0.0 109.929 179.677 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.57 ' O ' ' O ' ' A' ' 23' ' ' VAL . 61.8 m -71.45 -6.92 43.98 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.06 -179.34 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 7.4 p -126.6 143.34 40.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-O 121.111 0.481 . . . . 0.0 111.076 179.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.672 ' O ' ' N ' ' A' ' 17' ' ' ILE . 1.0 OUTLIER -144.16 -52.88 0.33 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.199 179.164 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.437 ' N ' HG22 ' A' ' 15' ' ' THR . 74.5 mm-40 -64.3 45.75 0.02 OUTLIER 'General case' 0 C--N 1.323 -0.559 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -179.81 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.672 ' N ' ' O ' ' A' ' 15' ' ' THR . 80.4 mt -43.64 -37.0 1.05 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 115.256 -0.884 . . . . 0.0 110.365 -179.263 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.604 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 0.5 OUTLIER -43.26 124.99 3.57 Favored 'General case' 0 C--N 1.327 -0.412 0 N-CA-C 109.49 -0.559 . . . . 0.0 109.49 179.34 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.604 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 74.84 20.13 2.33 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.529 -0.305 . . . . 0.0 110.471 -179.376 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.541 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 0.3 OUTLIER 56.51 25.76 10.14 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.96 0.409 . . . . 0.0 110.455 179.878 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.521 ' OG ' ' N ' ' A' ' 22' ' ' PHE . 0.0 OUTLIER -63.29 -174.73 0.09 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 121.496 0.665 . . . . 0.0 112.15 -179.16 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.759 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 21.1 m-85 -149.67 148.24 29.05 Favored 'General case' 0 CA--C 1.517 -0.297 0 CA-C-N 114.763 -1.108 . . . . 0.0 110.165 178.373 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.57 ' O ' ' O ' ' A' ' 13' ' ' SER . 43.4 t -118.75 103.96 15.32 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 N-CA-C 107.714 -1.217 . . . . 0.0 107.714 176.482 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 72.5 t -112.28 135.53 51.34 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 CA-C-N 116.06 -0.518 . . . . 0.0 111.409 -178.009 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.6 p -123.07 151.51 41.93 Favored 'General case' 0 CA--C 1.519 -0.245 0 CA-C-N 115.927 -0.579 . . . . 0.0 110.293 179.617 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.405 ' CD2' HG11 ' A' ' 76' ' ' VAL . 41.0 p90 -143.47 179.92 6.81 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 116.036 -0.529 . . . . 0.0 110.341 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 40.1 t -117.38 129.27 74.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 CA-C-N 116.204 -0.453 . . . . 0.0 110.239 179.831 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.2 p -50.39 133.12 24.77 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 116.262 -0.426 . . . . 0.0 110.227 -179.903 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.467 ' C ' HE22 ' A' ' 78' ' ' GLN . . . -111.44 11.96 21.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.793 -179.921 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.938 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.5 m -169.94 98.0 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.291 -0.413 . . . . 0.0 110.607 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.453 ' O ' ' OD1' ' A' ' 31' ' ' ASP . 66.0 t0 -50.28 -23.78 2.5 Favored 'General case' 0 C--N 1.328 -0.333 0 N-CA-C 109.678 -0.49 . . . . 0.0 109.678 179.59 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 62.2 p -74.94 1.52 12.61 Favored 'General case' 0 N--CA 1.45 -0.438 0 CA-C-N 115.837 -0.62 . . . . 0.0 110.341 179.786 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.938 HG12 ' O ' ' A' ' 30' ' ' SER . 2.1 p -64.14 134.77 28.69 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 CA-C-N 116.292 -0.413 . . . . 0.0 110.43 -179.922 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.47 ' OG ' ' CD ' ' A' ' 81' ' ' GLU . 70.8 m -95.36 -15.46 23.06 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.832 -0.622 . . . . 0.0 109.747 179.813 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.88 179.66 47.4 Favored Glycine 0 CA--C 1.522 0.513 0 N-CA-C 110.159 -1.177 . . . . 0.0 110.159 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.6 m-85 -125.9 152.88 44.99 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-O 120.992 0.425 . . . . 0.0 110.602 179.458 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.47 ' NH2' ' CD2' ' A' ' 51' ' ' TYR . 55.2 ttt180 -133.9 127.65 32.94 Favored 'General case' 0 C--N 1.32 -0.691 0 CA-C-N 116.035 -0.53 . . . . 0.0 109.9 179.565 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.586 HG21 HG11 ' A' ' 61' ' ' VAL . 47.0 t -108.29 132.78 55.17 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 CA-C-N 115.912 -0.585 . . . . 0.0 110.075 179.843 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -124.34 125.59 44.59 Favored 'General case' 0 C--N 1.323 -0.585 0 CA-C-N 115.87 -0.604 . . . . 0.0 109.801 -179.619 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.538 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 42.5 p90 -141.35 140.33 33.72 Favored 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 119.98 -0.688 . . . . 0.0 111.897 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.0 pt-20 -149.38 169.99 19.57 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 115.027 -0.988 . . . . 0.0 109.39 179.586 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.72 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 92.3 mt -74.28 126.66 31.13 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.448 -0.501 . . . . 0.0 111.16 179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.5 p -62.05 -33.92 75.3 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.75 -0.659 . . . . 0.0 110.388 179.64 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -86.19 -75.41 0.38 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.829 -0.623 . . . . 0.0 110.647 -179.862 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.0 mm-40 -67.03 145.22 55.6 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.967 179.892 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -94.28 41.96 2.53 Favored Glycine 0 CA--C 1.524 0.646 0 C-N-CA 120.466 -0.873 . . . . 0.0 111.56 -179.341 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 23.2 m-20 -57.91 165.75 1.7 Allowed 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -64.7 139.06 97.66 Favored Pre-proline 0 C--N 1.325 -0.494 0 C-N-CA 120.458 -0.497 . . . . 0.0 110.186 -179.878 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.4 Cg_endo -71.74 155.97 57.79 Favored 'Trans proline' 0 C--N 1.306 -1.68 0 C-N-CA 122.674 2.249 . . . . 0.0 111.824 -179.971 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.538 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 32.5 mt-30 -119.91 140.78 50.34 Favored 'General case' 0 C--N 1.325 -0.499 0 CA-C-N 115.953 -0.567 . . . . 0.0 109.778 -179.91 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.47 ' CD2' ' NH2' ' A' ' 37' ' ' ARG . 6.1 m-85 -121.64 141.28 51.28 Favored 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.588 -179.088 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 49.5 mt -131.15 123.44 28.55 Favored 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 109.2 -0.666 . . . . 0.0 109.2 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 78.0 m-20 -101.61 135.72 42.65 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-O 121.134 0.492 . . . . 0.0 111.578 -179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -132.86 159.43 72.63 Favored Pre-proline 0 CA--C 1.532 0.274 0 CA-C-N 115.453 -0.794 . . . . 0.0 109.842 -179.03 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -72.52 160.17 47.31 Favored 'Trans proline' 0 N--CA 1.493 1.447 0 C-N-CA 122.094 1.863 . . . . 0.0 112.624 179.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.477 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 61.1 p -61.69 -15.48 40.7 Favored 'General case' 0 C--N 1.331 -0.213 0 CA-C-N 115.719 -0.673 . . . . 0.0 110.696 -179.839 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 26.5 p -88.34 -1.14 57.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.322 -0.399 . . . . 0.0 110.691 -179.618 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.908 ' O ' HG23 ' A' ' 59' ' ' THR . . . -75.86 -146.54 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.412 -0.358 . . . . 0.0 110.595 -179.636 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.908 HG23 ' O ' ' A' ' 58' ' ' ALA . 1.9 p 143.45 4.53 0.0 OUTLIER 'General case' 0 N--CA 1.466 0.348 0 CA-C-N 115.406 -0.815 . . . . 0.0 110.809 -179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.8 p -163.75 141.89 7.54 Favored 'General case' 0 N--CA 1.454 -0.243 0 N-CA-C 109.898 -0.408 . . . . 0.0 109.898 179.467 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.586 HG11 HG21 ' A' ' 38' ' ' VAL . 8.8 p -150.74 155.35 7.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.394 0 CA-C-O 121.356 0.598 . . . . 0.0 112.174 -178.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.642 HD22 ' N ' ' A' ' 63' ' ' ILE . 0.7 OUTLIER -106.1 122.88 47.09 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 115.108 -0.951 . . . . 0.0 109.217 178.748 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.642 ' N ' HD22 ' A' ' 62' ' ' ASN . 2.1 mt -95.87 106.67 29.26 Favored Pre-proline 0 CA--C 1.531 0.248 0 C-N-CA 121.202 -0.199 . . . . 0.0 111.175 -179.205 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.415 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 64.7 Cg_endo -92.74 177.33 1.5 Allowed 'Trans proline' 0 C--N 1.316 -1.171 0 C-N-CA 123.115 2.544 . . . . 0.0 113.393 -179.593 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 72.9 m-20 60.19 38.33 20.2 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 114.944 -1.026 . . . . 0.0 111.958 179.236 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.541 ' O ' ' OG ' ' A' ' 20' ' ' SER . 39.8 mt -91.76 143.15 26.83 Favored 'General case' 0 C--N 1.329 -0.297 0 N-CA-C 109.689 -0.485 . . . . 0.0 109.689 178.563 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.473 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 64.2 mt -83.86 112.82 43.3 Favored Pre-proline 0 CA--C 1.533 0.305 0 C-N-CA 121.206 -0.198 . . . . 0.0 111.194 -179.16 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.9 Cg_exo -55.29 143.12 77.43 Favored 'Trans proline' 0 N--CA 1.493 1.488 0 C-N-CA 122.383 2.056 . . . . 0.0 112.366 179.356 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.51 17.37 79.98 Favored Glycine 0 CA--C 1.523 0.534 0 N-CA-C 111.328 -0.709 . . . . 0.0 111.328 179.283 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.479 ' HB3' HD22 ' A' ' 42' ' ' LEU . 8.9 mmm-85 -123.98 152.79 42.13 Favored 'General case' 0 C--N 1.327 -0.403 0 C-N-CA 120.9 -0.32 . . . . 0.0 110.153 179.862 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 43.3 tttp -100.97 130.96 47.04 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 120.486 -0.486 . . . . 0.0 110.451 179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.72 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 65.1 m-85 -118.5 144.59 45.92 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.689 -0.687 . . . . 0.0 111.091 179.77 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.437 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 80.2 mt -104.11 125.5 58.84 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.523 0 N-CA-C 107.023 -1.473 . . . . 0.0 107.023 176.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 62.0 t -113.0 132.54 61.51 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.853 0 CA-C-O 121.243 0.544 . . . . 0.0 111.154 -178.683 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 27.7 m-80 -134.78 128.13 32.23 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.462 -0.79 . . . . 0.0 109.514 179.654 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.405 HG11 ' CD2' ' A' ' 26' ' ' TRP . 21.3 t -104.11 128.45 57.5 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.58 0 C-N-CA 120.575 -0.45 . . . . 0.0 110.416 -179.743 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 79.6 m-85 -119.54 138.53 53.12 Favored 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 109.288 -0.634 . . . . 0.0 109.288 179.179 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.467 HE22 ' C ' ' A' ' 29' ' ' ALA . 1.6 pt20 -101.13 136.87 40.27 Favored 'General case' 0 C--N 1.32 -0.68 0 N-CA-C 108.587 -0.894 . . . . 0.0 108.587 178.768 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 55.6 mt -100.03 123.32 52.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.641 0 CA-C-O 121.263 0.554 . . . . 0.0 110.795 -178.685 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.591 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 84.3 p -83.31 171.99 12.99 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.191 -0.913 . . . . 0.0 110.32 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.47 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 76.1 mm-40 -58.77 -19.96 45.33 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-N 116.017 -0.538 . . . . 0.0 111.496 -179.014 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.591 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 48.8 p30 -95.08 -0.22 53.76 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.749 -0.38 . . . . 0.0 111.43 -179.614 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.19 15.12 65.23 Favored Glycine 0 CA--C 1.528 0.904 0 C-N-CA 120.768 -0.729 . . . . 0.0 111.564 179.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.55 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 67.3 mm-40 -83.82 143.79 29.7 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.849 0.357 . . . . 0.0 110.53 179.45 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 38.4 mt-30 -113.91 142.78 45.7 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 121.017 0.437 . . . . 0.0 111.686 -179.548 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 9.7 t -138.24 134.54 34.54 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 115.644 -0.707 . . . . 0.0 109.86 179.191 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.586 HD21 ' HB2' ' A' ' 90' ' ' SER . 53.5 tp -73.34 117.44 15.09 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.298 -0.561 . . . . 0.0 110.3 179.784 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 33.8 pt -109.0 -21.84 5.37 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.363 0 CA-C-N 116.152 -0.476 . . . . 0.0 110.992 -179.515 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.7 tp -156.84 125.44 5.78 Favored 'General case' 0 C--N 1.328 -0.33 0 C-N-CA 120.55 -0.46 . . . . 0.0 111.325 179.542 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.586 ' HB2' HD21 ' A' ' 87' ' ' LEU . 38.2 t -132.13 122.53 25.49 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 115.865 -0.607 . . . . 0.0 109.819 179.035 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 13.8 t -151.7 158.69 43.75 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.454 -0.339 . . . . 0.0 110.75 -179.577 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -118.04 152.55 35.32 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.739 -0.384 . . . . 0.0 110.221 179.438 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.759 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 23.6 mt-30 -140.51 156.77 46.22 Favored 'General case' 0 CA--C 1.513 -0.457 0 CA-C-O 121.268 0.556 . . . . 0.0 110.313 179.167 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.473 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -123.13 104.81 9.42 Favored 'General case' 0 C--N 1.318 -0.778 0 CA-C-N 115.325 -0.852 . . . . 0.0 109.629 179.468 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.473 ' OXT' ' O ' ' A' ' 94' ' ' THR . 81.0 p . . . . . 0 C--O 1.22 -0.483 0 CA-C-O 118.051 -0.975 . . . . 0.0 110.435 -179.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.33 0 N-CA-C 109.583 -1.407 . . . . 0.0 109.583 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.546 ' O ' ' O ' ' A' ' 3' ' ' LEU . 1.0 OUTLIER -48.5 147.1 9.59 Favored 'Trans proline' 0 C--N 1.304 -1.777 0 C-N-CA 122.919 2.412 . . . . 0.0 111.978 179.715 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.546 ' O ' ' O ' ' A' ' 2' ' ' PRO . 47.4 mt 54.2 128.35 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.616 -179.749 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.695 ' O ' ' N ' ' A' ' 6' ' ' HIS . . . -170.16 152.36 18.92 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 111.079 -0.809 . . . . 0.0 111.079 179.887 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 3.6 t 55.35 -67.86 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.8 0.334 . . . . 0.0 110.704 179.992 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.695 ' N ' ' O ' ' A' ' 4' ' ' GLY . 1.8 p80 -80.75 152.86 28.12 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.235 -0.439 . . . . 0.0 110.249 179.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 39.3 mt 56.26 15.0 1.72 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.927 0.394 . . . . 0.0 110.369 -179.94 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 12.7 p -56.52 135.67 19.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 115.871 -0.604 . . . . 0.0 110.839 -179.736 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -162.44 16.59 0.09 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.21 -0.45 . . . . 0.0 110.442 179.744 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 14.9 t -99.52 -0.33 40.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.213 -0.449 . . . . 0.0 110.634 -179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.557 ' O ' ' CB ' ' A' ' 12' ' ' GLU . 42.3 t -51.36 160.04 0.61 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.047 -0.524 . . . . 0.0 110.678 -179.723 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.669 ' C ' ' H ' ' A' ' 14' ' ' VAL . 41.6 tt0 87.53 -3.93 0.59 Allowed 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.485 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.6 p 60.09 -23.19 0.03 OUTLIER 'General case' 0 N--CA 1.463 0.191 0 CA-C-N 116.082 -0.508 . . . . 0.0 111.724 179.324 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.669 ' H ' ' C ' ' A' ' 12' ' ' GLU . 14.2 p -107.04 139.52 28.32 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.504 -0.316 . . . . 0.0 111.322 -178.958 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.839 HG22 ' N ' ' A' ' 16' ' ' GLU . 1.2 m -93.08 -79.67 0.4 Allowed 'General case' 0 C--N 1.331 -0.198 0 CA-C-N 116.177 -0.465 . . . . 0.0 111.089 179.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.839 ' N ' HG22 ' A' ' 15' ' ' THR . 60.1 mp0 -49.1 134.52 17.43 Favored 'General case' 0 CA--C 1.516 -0.327 0 CA-C-O 121.24 0.543 . . . . 0.0 110.399 -178.113 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.581 ' O ' ' N ' ' A' ' 20' ' ' SER . 5.9 mt -127.82 -25.25 1.34 Allowed 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 115.39 -0.823 . . . . 0.0 110.401 -179.112 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.415 ' C ' ' O ' ' A' ' 17' ' ' ILE . 35.8 p -39.86 138.28 0.8 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.19 -0.459 . . . . 0.0 109.77 -179.759 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 51.53 23.94 2.07 Favored 'General case' 0 C--N 1.328 -0.357 0 N-CA-C 109.475 -0.565 . . . . 0.0 109.475 -179.109 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 94.5 p 61.35 45.28 8.78 Favored 'General case' 0 C--N 1.331 -0.208 0 CA-C-N 115.853 -0.612 . . . . 0.0 109.715 -178.776 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.539 ' OG ' ' C ' ' A' ' 16' ' ' GLU . 2.6 p -63.16 158.51 19.69 Favored 'General case' 0 C--N 1.331 -0.201 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.556 -179.415 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.627 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 21.6 m-30 -125.69 155.92 40.14 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 115.7 -0.682 . . . . 0.0 110.776 178.812 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.546 ' CG2' ' OE1' ' A' ' 16' ' ' GLU . 71.4 t -128.83 106.3 14.1 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.661 0 N-CA-C 108.187 -1.042 . . . . 0.0 108.187 176.757 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 69.7 t -111.94 137.48 44.48 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-N 116.09 -0.505 . . . . 0.0 110.71 -178.718 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 94.1 p -129.14 153.56 47.57 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.89 -0.596 . . . . 0.0 110.355 179.788 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.64 ' CD2' HG11 ' A' ' 76' ' ' VAL . 34.0 p90 -143.41 -165.88 2.19 Favored 'General case' 0 C--N 1.32 -0.705 0 CA-C-N 115.504 -0.771 . . . . 0.0 110.023 179.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 34.0 t -127.73 124.5 63.37 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.59 0 N-CA-C 109.747 -0.464 . . . . 0.0 109.747 179.712 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -48.79 101.21 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.483 -0.487 . . . . 0.0 109.902 -179.852 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.43 ' HB3' HE22 ' A' ' 78' ' ' GLN . . . -76.3 3.55 10.69 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.706 -179.59 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.888 ' O ' HG12 ' A' ' 33' ' ' VAL . 3.3 m -168.92 116.96 0.66 Allowed 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 116.112 -0.495 . . . . 0.0 110.781 -179.875 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.8 m-20 -71.73 -10.5 59.87 Favored 'General case' 0 C--N 1.327 -0.391 0 C-N-CA 120.777 -0.369 . . . . 0.0 110.256 179.676 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 68.8 p -82.4 -0.68 47.15 Favored 'General case' 0 N--CA 1.452 -0.346 0 CA-C-N 116.024 -0.535 . . . . 0.0 110.456 179.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.888 HG12 ' O ' ' A' ' 30' ' ' SER . 2.4 p -64.04 137.84 24.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 115.979 -0.555 . . . . 0.0 110.25 179.712 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.688 ' N ' ' O ' ' A' ' 79' ' ' ILE . 53.1 m -94.0 -15.48 24.81 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-O 121.213 0.53 . . . . 0.0 109.803 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.459 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.2 176.46 45.32 Favored Glycine 0 CA--C 1.521 0.419 0 N-CA-C 109.785 -1.326 . . . . 0.0 109.785 179.51 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 81.2 m-85 -125.41 152.91 44.21 Favored 'General case' 0 C--N 1.324 -0.516 0 CA-C-O 120.906 0.384 . . . . 0.0 110.673 179.286 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.7 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.4 ttp180 -131.5 124.33 29.9 Favored 'General case' 0 C--N 1.322 -0.591 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 178.7 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.53 HG21 HG11 ' A' ' 61' ' ' VAL . 74.4 t -109.03 133.67 53.45 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.529 0 CA-C-N 115.98 -0.555 . . . . 0.0 110.554 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 74.1 tt0 -124.6 132.65 53.43 Favored 'General case' 0 C--N 1.323 -0.546 0 CA-C-N 116.068 -0.515 . . . . 0.0 110.341 179.471 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.578 ' CE2' ' OE1' ' A' ' 50' ' ' GLN . 22.8 p90 -137.82 130.28 29.45 Favored 'General case' 0 C--N 1.325 -0.471 0 CA-C-O 121.095 0.474 . . . . 0.0 110.284 179.106 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.4 pt-20 -146.71 166.61 26.09 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.549 -0.75 . . . . 0.0 109.504 -179.578 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.833 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 87.1 mt -73.65 128.59 35.93 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 121.413 0.625 . . . . 0.0 111.969 -179.236 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.2 p -68.23 -27.84 66.72 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 114.994 -1.003 . . . . 0.0 109.568 179.071 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.469 ' HG3' HH22 ' A' ' 70' ' ' ARG . 88.1 mt-10 -93.53 -75.19 0.51 Allowed 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.529 -0.759 . . . . 0.0 110.131 179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 69.3 mt-10 -64.73 144.0 57.54 Favored 'General case' 0 N--CA 1.449 -0.506 0 N-CA-C 108.783 -0.821 . . . . 0.0 108.783 179.043 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -96.05 41.31 2.44 Favored Glycine 0 CA--C 1.521 0.408 0 C-N-CA 120.159 -1.02 . . . . 0.0 111.343 -179.457 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 87.7 m-20 -59.26 169.72 1.1 Allowed 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 109.86 -0.422 . . . . 0.0 109.86 179.273 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.449 ' OE1' ' N ' ' A' ' 48' ' ' GLU . 3.4 pm0 -69.17 137.17 89.24 Favored Pre-proline 0 C--N 1.324 -0.537 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.577 -179.634 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -73.82 156.2 48.47 Favored 'Trans proline' 0 C--N 1.305 -1.713 0 C-N-CA 122.783 2.322 . . . . 0.0 112.085 179.87 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.578 ' OE1' ' CE2' ' A' ' 40' ' ' TYR . 11.4 mt-30 -120.29 144.0 48.04 Favored 'General case' 0 C--N 1.325 -0.473 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 179.344 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 40.8 m-85 -124.41 140.38 53.01 Favored 'General case' 0 C--N 1.328 -0.359 0 C-N-CA 120.238 -0.585 . . . . 0.0 111.506 -179.25 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.6 mt -124.71 129.38 50.39 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.616 -0.72 . . . . 0.0 109.13 178.662 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 57.6 m-20 -101.48 131.78 47.43 Favored 'General case' 0 C--N 1.322 -0.602 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.905 -179.355 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.4 mt -130.08 155.64 80.42 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 115.544 -0.753 . . . . 0.0 109.636 -179.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.4 ' C ' ' N ' ' A' ' 57' ' ' THR . 22.7 Cg_endo -68.94 156.65 64.69 Favored 'Trans proline' 0 C--N 1.305 -1.747 0 C-N-CA 122.38 2.053 . . . . 0.0 112.5 -179.74 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.459 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 30.4 p -55.74 -11.6 1.01 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.952 -0.567 . . . . 0.0 109.958 179.521 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.4 ' N ' ' C ' ' A' ' 55' ' ' PRO . 29.5 p -92.0 -7.29 49.32 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.593 -179.893 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -81.61 132.28 35.3 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.431 -0.349 . . . . 0.0 110.843 -179.783 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.7 p -130.32 9.32 5.17 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.182 179.284 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 68.9 p -164.12 146.8 9.27 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.983 -0.553 . . . . 0.0 109.62 179.487 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.53 HG11 HG21 ' A' ' 38' ' ' VAL . 5.2 p -151.0 152.69 11.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.772 -179.103 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.627 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 11.7 t-20 -106.68 126.63 52.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.573 179.111 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.513 HG21 ' CG ' ' A' ' 40' ' ' TYR . 2.3 mt -100.94 104.94 35.36 Favored Pre-proline 0 C--N 1.331 -0.199 0 CA-C-N 116.075 -0.511 . . . . 0.0 111.148 -179.77 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -91.35 -179.34 1.37 Allowed 'Trans proline' 0 C--N 1.311 -1.431 0 C-N-CA 122.779 2.319 . . . . 0.0 112.372 179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 58.66 39.03 24.95 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.602 179.373 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.509 ' O ' ' O ' ' A' ' 19' ' ' ALA . 41.5 mt -90.41 143.91 26.31 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 109.974 -0.38 . . . . 0.0 109.974 178.792 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 47.3 mt -78.02 129.81 74.65 Favored Pre-proline 0 CA--C 1.531 0.234 0 C-N-CA 120.744 -0.382 . . . . 0.0 110.043 179.924 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 39.5 Cg_endo -69.49 140.94 44.98 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.529 2.153 . . . . 0.0 112.873 -179.422 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 70.38 27.99 71.91 Favored Glycine 0 CA--C 1.524 0.597 0 N-CA-C 110.83 -0.908 . . . . 0.0 110.83 179.702 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.773 ' HE ' HD22 ' A' ' 42' ' ' LEU . 4.9 mmm180 -126.48 148.13 49.72 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-O 120.704 0.288 . . . . 0.0 111.22 -179.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.685 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 75.7 tttt -100.26 131.15 46.36 Favored 'General case' 0 N--CA 1.452 -0.341 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 178.797 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.833 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 64.4 m-85 -119.82 151.26 39.11 Favored 'General case' 0 C--N 1.32 -0.679 0 CA-C-N 116.015 -0.539 . . . . 0.0 111.106 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 70.4 mt -104.99 123.7 59.23 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.609 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.5 t -111.69 131.15 63.83 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.774 0 CA-C-N 115.996 -0.547 . . . . 0.0 110.51 -178.787 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 35.7 m-80 -133.98 125.86 29.07 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 115.636 -0.711 . . . . 0.0 109.507 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.64 HG11 ' CD2' ' A' ' 26' ' ' TRP . 5.7 t -104.42 126.57 59.15 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 C-N-CA 120.454 -0.498 . . . . 0.0 110.03 -179.716 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 81.4 m-85 -118.82 141.91 48.2 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.05 179.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.43 HE22 ' HB3' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -105.23 135.58 46.33 Favored 'General case' 0 C--N 1.321 -0.668 0 N-CA-C 108.96 -0.756 . . . . 0.0 108.96 178.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.688 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.9 mt -98.38 122.22 49.81 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.569 0 CA-C-O 121.172 0.511 . . . . 0.0 110.634 -178.57 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.726 ' HG ' ' CG ' ' A' ' 82' ' ' ASP . 47.2 p -82.52 169.53 16.23 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 115.578 -0.737 . . . . 0.0 110.811 -179.403 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 48.9 mt-10 -58.3 -20.47 43.14 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.126 179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.726 ' CG ' ' HG ' ' A' ' 80' ' ' SER . 2.0 p-10 -92.04 -2.32 56.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.158 -0.473 . . . . 0.0 111.14 -179.799 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.51 14.46 65.77 Favored Glycine 0 CA--C 1.53 1.023 0 C-N-CA 121.053 -0.594 . . . . 0.0 112.452 178.768 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.467 ' CG ' ' OD2' ' A' ' 82' ' ' ASP . 60.2 mm-40 -86.2 144.17 27.6 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 117.121 0.46 . . . . 0.0 111.211 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.7 HE22 ' NE ' ' A' ' 37' ' ' ARG . 93.2 mt-30 -109.18 139.61 43.87 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.158 -0.473 . . . . 0.0 110.914 179.477 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 13.1 t -137.81 136.1 36.89 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.089 -0.505 . . . . 0.0 110.392 179.584 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.437 HD21 ' HB2' ' A' ' 90' ' ' SER . 19.3 tp -72.88 116.73 13.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.693 -179.914 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 39.7 pt -108.87 -22.28 5.1 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.434 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.29 179.513 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 42.1 tp -156.32 125.81 6.25 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.62 -179.859 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.437 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.5 t -133.44 122.43 23.67 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 115.834 -0.621 . . . . 0.0 109.508 178.857 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.5 t -149.7 156.54 42.03 Favored 'General case' 0 C--N 1.33 -0.282 0 C-N-CA 120.873 -0.331 . . . . 0.0 110.461 -179.531 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 59.8 p -117.58 153.03 33.94 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.83 -0.433 . . . . 0.0 109.83 179.561 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.42 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 24.1 mt-30 -140.98 158.36 44.04 Favored 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 121.181 0.515 . . . . 0.0 111.216 -179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -115.71 108.23 16.1 Favored 'General case' 0 C--N 1.324 -0.533 0 CA-C-N 115.347 -0.842 . . . . 0.0 109.576 179.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 6.1 p . . . . . 0 C--O 1.22 -0.47 0 CA-C-O 117.937 -1.03 . . . . 0.0 110.344 -179.468 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.271 0 N-CA-C 109.545 -1.422 . . . . 0.0 109.545 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_exo -55.38 144.53 72.0 Favored 'Trans proline' 0 C--N 1.305 -1.724 0 C-N-CA 122.657 2.238 . . . . 0.0 112.006 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.424 HD23 ' HA ' ' A' ' 3' ' ' LEU . 88.9 mt -80.86 -4.26 54.15 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.167 179.923 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.605 ' O ' ' O ' ' A' ' 5' ' ' SER . . . 130.35 145.77 5.81 Favored Glycine 0 CA--C 1.526 0.733 0 N-CA-C 111.2 -0.76 . . . . 0.0 111.2 179.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.622 ' OG ' ' N ' ' A' ' 6' ' ' HIS . 3.6 t 38.16 -171.09 0.0 OUTLIER 'General case' 0 C--N 1.332 -0.19 0 CA-C-O 120.752 0.31 . . . . 0.0 110.612 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.622 ' N ' ' OG ' ' A' ' 5' ' ' SER . 35.6 m170 -136.28 160.89 37.32 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.806 -0.358 . . . . 0.0 110.732 -179.716 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 17.2 tp -83.75 139.8 32.5 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.698 -179.647 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 5.6 t -87.82 139.93 16.59 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.214 0 CA-C-O 120.943 0.401 . . . . 0.0 110.699 -179.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.516 ' O ' ' OG1' ' A' ' 10' ' ' THR . . . -44.72 147.55 0.61 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.625 -179.84 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.516 ' OG1' ' O ' ' A' ' 9' ' ' ALA . 48.4 p 55.54 98.24 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.97 -0.559 . . . . 0.0 110.162 -179.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 50.4 m -63.86 -76.46 0.07 Allowed 'General case' 0 C--N 1.328 -0.339 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 179.743 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 94.4 mt-10 -57.08 143.45 38.5 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.109 179.448 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.4 p -63.22 -13.04 33.09 Favored 'General case' 0 C--N 1.328 -0.362 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 179.455 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 91.6 t -115.68 131.62 67.53 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.219 0 CA-C-N 115.268 -0.878 . . . . 0.0 110.535 179.687 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.836 HG22 ' N ' ' A' ' 16' ' ' GLU . 2.2 m -104.35 -86.37 0.46 Allowed 'General case' 0 C--O 1.223 -0.309 0 C-N-CA 120.391 -0.524 . . . . 0.0 111.086 179.555 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.836 ' N ' HG22 ' A' ' 15' ' ' THR . 76.7 mm-40 -45.04 130.95 7.58 Favored 'General case' 0 N--CA 1.453 -0.31 0 CA-C-N 115.81 -0.632 . . . . 0.0 110.314 -177.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.467 HG13 ' O ' ' A' ' 15' ' ' THR . 6.0 mt -126.67 -24.16 1.66 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.441 0 CA-C-N 115.37 -0.832 . . . . 0.0 110.664 -179.055 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.447 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 59.6 m -54.34 136.79 43.11 Favored 'General case' 0 CA--C 1.519 -0.247 0 CA-C-N 116.188 -0.46 . . . . 0.0 109.812 -179.714 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.588 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 63.53 22.06 13.03 Favored 'General case' 0 C--N 1.326 -0.448 0 N-CA-C 108.972 -0.751 . . . . 0.0 108.972 -178.957 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.588 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 4.7 p 56.69 37.23 28.66 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.401 -0.818 . . . . 0.0 110.154 -179.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.529 ' OG ' ' CB ' ' A' ' 16' ' ' GLU . 1.4 p -60.45 165.56 3.62 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 115.999 -0.546 . . . . 0.0 110.524 -179.679 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.536 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 15.8 m-30 -133.51 154.76 50.57 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.738 -0.664 . . . . 0.0 110.818 179.078 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 53.6 t -131.43 104.32 8.66 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.628 0 N-CA-C 108.464 -0.939 . . . . 0.0 108.464 177.096 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.4 t -113.43 136.8 48.66 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.847 -178.748 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.9 p -123.43 150.92 43.2 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.188 -0.46 . . . . 0.0 110.446 179.766 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.463 ' CE3' HG21 ' A' ' 76' ' ' VAL . 36.9 p90 -145.26 -174.15 4.3 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.254 -0.43 . . . . 0.0 110.373 179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.749 HG12 ' H ' ' A' ' 29' ' ' ALA . 44.5 t -109.55 135.38 48.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.453 0 CA-C-N 116.004 -0.544 . . . . 0.0 109.824 179.944 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.61 ' O ' ' N ' ' A' ' 30' ' ' SER . 85.2 p -53.53 -20.6 5.16 Favored 'General case' 0 C--N 1.324 -0.512 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.544 -179.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.749 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 31.53 30.94 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.077 -0.51 . . . . 0.0 111.495 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.692 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.4 OUTLIER 164.71 122.18 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 120.61 -0.436 . . . . 0.0 110.907 179.739 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 -87.18 -8.1 57.26 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.371 179.624 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 45.3 p -84.71 -4.4 59.01 Favored 'General case' 0 N--CA 1.453 -0.294 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.437 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.692 HG12 ' O ' ' A' ' 30' ' ' SER . 3.0 p -64.64 136.45 26.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.122 -0.49 . . . . 0.0 110.275 179.885 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.575 ' N ' ' O ' ' A' ' 79' ' ' ILE . 67.5 m -94.86 -14.65 24.37 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.27 0.557 . . . . 0.0 109.541 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.515 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.36 -179.87 47.93 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 109.806 -1.317 . . . . 0.0 109.806 179.773 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 91.8 m-85 -127.31 150.57 49.52 Favored 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 121.003 0.43 . . . . 0.0 110.75 179.622 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 18.8 ttp180 -129.2 124.81 35.53 Favored 'General case' 0 N--CA 1.449 -0.521 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.471 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 39.2 t -110.84 131.2 62.67 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.667 0 CA-C-N 116.007 -0.542 . . . . 0.0 110.121 -179.7 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.442 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 80.9 tt0 -123.27 133.57 54.17 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.26 179.818 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.579 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.7 p90 -140.65 138.7 34.54 Favored 'General case' 0 N--CA 1.451 -0.388 0 C-N-CA 120.344 -0.542 . . . . 0.0 111.446 179.573 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.7 pt-20 -148.02 165.54 30.47 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.467 -0.788 . . . . 0.0 109.706 179.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.533 HD13 ' HE ' ' A' ' 70' ' ' ARG . 56.3 mt -73.13 127.61 33.09 Favored 'General case' 0 C--N 1.326 -0.433 0 C-N-CA 120.668 -0.413 . . . . 0.0 111.028 -179.601 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.405 ' OG ' ' HB3' ' A' ' 71' ' ' LYS . 18.6 p -70.34 -34.62 72.88 Favored 'General case' 0 C--N 1.33 -0.247 0 N-CA-C 109.561 -0.533 . . . . 0.0 109.561 179.287 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 98.2 mt-10 -80.05 -50.91 9.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 115.383 -0.826 . . . . 0.0 110.825 -179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.621 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 90.5 mt-10 -94.39 144.99 25.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.651 -179.491 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.581 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -84.96 23.88 7.39 Favored Glycine 0 CA--C 1.524 0.63 0 N-CA-C 110.966 -0.854 . . . . 0.0 110.966 179.954 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.69 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 52.3 t0 -43.61 177.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-O 120.993 0.425 . . . . 0.0 110.258 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.69 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 4.0 pm0 -83.11 143.06 44.91 Favored Pre-proline 0 C--N 1.324 -0.531 0 CA-C-N 115.819 -0.628 . . . . 0.0 111.089 -179.341 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo -75.43 153.57 39.86 Favored 'Trans proline' 0 C--N 1.305 -1.735 0 C-N-CA 122.838 2.359 . . . . 0.0 112.036 179.411 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.494 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 16.2 mt-30 -123.36 146.02 48.28 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 108.925 -0.768 . . . . 0.0 108.925 179.361 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.434 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 80.4 m-85 -124.86 139.17 54.08 Favored 'General case' 0 C--N 1.331 -0.225 0 C-N-CA 119.808 -0.757 . . . . 0.0 112.046 -179.269 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 97.7 mt -123.2 129.16 51.02 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.231 177.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 -102.21 130.92 48.99 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.678 -0.409 . . . . 0.0 110.831 -179.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.2 mt -129.25 154.72 80.62 Favored Pre-proline 0 C--N 1.329 -0.319 0 CA-C-N 115.856 -0.611 . . . . 0.0 109.795 -179.689 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -68.15 156.76 64.59 Favored 'Trans proline' 0 C--N 1.308 -1.559 0 C-N-CA 122.143 1.895 . . . . 0.0 112.374 -179.626 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 33' ' ' VAL . 14.5 p -56.56 -11.34 1.26 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 115.848 -0.615 . . . . 0.0 110.666 -179.763 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 70.4 p -93.76 -9.17 38.47 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.382 -0.372 . . . . 0.0 110.698 -179.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -80.91 131.8 35.38 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.433 -0.349 . . . . 0.0 110.485 179.759 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 45.1 p -130.19 12.22 5.55 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.37 -0.377 . . . . 0.0 110.319 179.313 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 54.0 p -164.38 143.13 7.21 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.514 -0.55 . . . . 0.0 109.514 179.532 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.5 p -147.95 149.81 14.98 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 C-N-CA 120.507 -0.477 . . . . 0.0 111.62 -179.181 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.536 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 8.9 t-20 -105.16 128.02 53.19 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.869 -0.605 . . . . 0.0 110.26 179.215 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.7 mt -104.84 101.34 28.66 Favored Pre-proline 0 C--N 1.332 -0.173 0 CA-C-N 116.339 -0.392 . . . . 0.0 111.449 -179.462 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 85.5 Cg_endo -89.47 -174.58 0.93 Allowed 'Trans proline' 0 C--N 1.308 -1.568 0 C-N-CA 122.773 2.315 . . . . 0.0 112.439 179.356 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.3 m-20 59.72 37.01 22.38 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.316 -0.856 . . . . 0.0 111.386 179.683 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.567 HD12 ' O ' ' A' ' 20' ' ' SER . 45.9 mt -90.36 151.88 21.25 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.341 178.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.648 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 30.4 mt -95.37 108.35 38.62 Favored Pre-proline 0 CA--C 1.532 0.267 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.977 -179.473 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 32.1 Cg_exo -55.28 139.78 81.31 Favored 'Trans proline' 0 N--CA 1.494 1.536 0 C-N-CA 122.432 2.088 . . . . 0.0 111.839 179.192 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 85.58 14.69 67.54 Favored Glycine 0 CA--C 1.522 0.53 0 N-CA-C 110.376 -1.09 . . . . 0.0 110.376 -179.643 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.621 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 5.7 mmm-85 -127.21 141.44 51.73 Favored 'General case' 0 C--N 1.329 -0.314 0 N-CA-C 110.104 -0.332 . . . . 0.0 110.104 -179.859 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.431 ' NZ ' ' HB2' ' A' ' 92' ' ' SER . 14.0 tttp -96.19 134.86 38.75 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 120.629 -0.429 . . . . 0.0 109.938 179.397 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.648 ' OH ' ' N ' ' A' ' 67' ' ' LEU . 4.0 m-85 -117.85 151.79 36.66 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.232 0.539 . . . . 0.0 111.718 -179.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.454 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.5 mt -110.07 124.36 66.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.581 0 N-CA-C 107.037 -1.468 . . . . 0.0 107.037 176.648 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.8 t -112.84 132.51 61.43 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.854 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.929 -178.665 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 13.1 m-80 -133.61 124.49 26.92 Favored 'General case' 0 C--N 1.324 -0.525 0 CA-C-N 115.577 -0.738 . . . . 0.0 109.371 179.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.463 HG21 ' CE3' ' A' ' 26' ' ' TRP . 21.9 t -106.74 127.76 61.99 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 C-N-CA 120.506 -0.478 . . . . 0.0 110.875 -179.415 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.3 m-85 -119.01 137.36 53.58 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.882 -0.599 . . . . 0.0 109.682 179.095 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.488 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 0.6 OUTLIER -100.65 136.25 40.82 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 108.576 -0.898 . . . . 0.0 108.576 178.973 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.575 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.0 mt -100.12 125.49 53.83 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.469 0 CA-C-O 121.384 0.611 . . . . 0.0 110.934 -178.44 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.597 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 89.7 p -84.89 165.2 17.88 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-N 115.136 -0.938 . . . . 0.0 110.206 179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -58.31 -20.31 42.03 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.357 -179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.631 ' OD1' ' N ' ' A' ' 82' ' ' ASP . 2.0 p-10 -91.98 -1.54 57.2 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.47 -0.332 . . . . 0.0 110.786 179.652 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.97 13.01 65.12 Favored Glycine 0 CA--C 1.526 0.761 0 C-N-CA 121.103 -0.57 . . . . 0.0 112.243 178.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.455 ' CG ' ' OD2' ' A' ' 82' ' ' ASP . 75.8 mm-40 -83.2 135.34 34.82 Favored 'General case' 0 C--N 1.327 -0.386 0 C-N-CA 120.533 -0.467 . . . . 0.0 110.898 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 91.4 mt-30 -104.98 140.66 37.86 Favored 'General case' 0 C--N 1.332 -0.194 0 CA-C-N 116.241 -0.436 . . . . 0.0 110.749 179.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 24.3 t -136.72 132.9 35.49 Favored 'General case' 0 C--N 1.326 -0.446 0 CA-C-N 115.86 -0.609 . . . . 0.0 110.114 179.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.613 HD21 ' HB2' ' A' ' 90' ' ' SER . 57.0 tp -71.83 118.98 15.35 Favored 'General case' 0 C--N 1.326 -0.417 0 C-N-CA 120.472 -0.491 . . . . 0.0 109.736 179.43 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 24.5 pt -108.92 -22.97 4.71 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.473 0 CA-C-N 116.134 -0.484 . . . . 0.0 110.899 -179.545 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 43.2 tp -157.01 125.67 5.77 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.5 -0.48 . . . . 0.0 111.597 179.742 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.613 ' HB2' HD21 ' A' ' 87' ' ' LEU . 15.2 t -132.66 112.66 12.21 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 115.796 -0.638 . . . . 0.0 109.417 179.043 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.3 t -146.25 159.62 43.08 Favored 'General case' 0 C--O 1.225 -0.205 0 C-N-CA 120.863 -0.335 . . . . 0.0 111.0 -179.22 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . 0.431 ' HB2' ' NZ ' ' A' ' 71' ' ' LYS . 95.7 p -117.25 153.8 32.28 Favored 'General case' 0 C--N 1.326 -0.413 0 CA-C-N 116.237 -0.438 . . . . 0.0 110.321 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.518 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 26.8 mt-30 -139.52 156.04 47.16 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.29 0.567 . . . . 0.0 110.902 179.626 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.3 OUTLIER -122.71 107.83 12.37 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-N 115.195 -0.911 . . . . 0.0 109.434 179.584 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.505 ' O ' ' O ' ' A' ' 94' ' ' THR . 45.6 p . . . . . 0 C--O 1.22 -0.492 0 CA-C-O 118.048 -0.977 . . . . 0.0 110.715 -179.15 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.279 0 N-CA-C 109.385 -1.486 . . . . 0.0 109.385 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.1 Cg_endo -58.12 149.26 73.0 Favored 'Trans proline' 0 C--N 1.308 -1.556 0 C-N-CA 122.639 2.226 . . . . 0.0 111.735 179.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.732 ' H ' HD12 ' A' ' 3' ' ' LEU . 4.9 mp -76.56 134.38 39.43 Favored 'General case' 0 C--N 1.326 -0.436 0 CA-C-N 116.099 -0.501 . . . . 0.0 110.301 -179.971 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 168.66 62.22 0.03 OUTLIER Glycine 0 CA--C 1.525 0.686 0 N-CA-C 110.636 -0.985 . . . . 0.0 110.636 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 91.1 p -80.36 -5.34 56.26 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.836 0.351 . . . . 0.0 110.675 -179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 14.6 p80 -124.93 -168.36 1.81 Allowed 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.948 -0.569 . . . . 0.0 109.799 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 45.4 mt -66.13 123.6 20.32 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.406 -0.518 . . . . 0.0 110.537 -179.542 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 9.8 p -128.55 146.33 34.14 Favored 'Isoleucine or valine' 0 N--CA 1.462 0.148 0 CA-C-N 115.831 -0.622 . . . . 0.0 111.482 -178.937 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -91.2 -116.93 0.07 Allowed 'General case' 0 N--CA 1.463 0.223 0 CA-C-N 116.041 -0.527 . . . . 0.0 110.259 179.059 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -105.15 -4.94 21.21 Favored 'General case' 0 CA--C 1.53 0.21 0 CA-C-N 115.921 -0.581 . . . . 0.0 109.762 179.694 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 41.6 t 33.58 81.07 0.02 OUTLIER 'General case' 0 N--CA 1.464 0.263 0 CA-C-N 115.709 -0.678 . . . . 0.0 112.421 179.708 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 56.0 mt-10 -67.52 144.74 55.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.224 -0.444 . . . . 0.0 110.051 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 41.3 p -78.85 -8.06 58.46 Favored 'General case' 0 C--N 1.33 -0.272 0 N-CA-C 109.664 -0.495 . . . . 0.0 109.664 179.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 48.9 t -109.12 132.35 57.43 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.205 0 CA-C-N 115.839 -0.619 . . . . 0.0 111.147 -179.933 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.882 HG22 ' N ' ' A' ' 16' ' ' GLU . 85.6 m -104.59 -118.82 0.21 Allowed 'General case' 0 N--CA 1.465 0.302 0 CA-C-N 116.348 -0.387 . . . . 0.0 110.675 179.15 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.882 ' N ' HG22 ' A' ' 15' ' ' THR . 67.8 mm-40 -1.48 77.15 0.0 OUTLIER 'General case' 0 CA--C 1.521 -0.15 0 CA-C-N 115.786 -0.643 . . . . 0.0 111.717 -178.918 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.735 ' O ' ' N ' ' A' ' 20' ' ' SER . 60.1 mt -88.89 -78.01 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 115.918 -0.583 . . . . 0.0 110.598 179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.563 ' C ' ' H ' ' A' ' 20' ' ' SER . 42.8 p 33.78 -97.71 0.01 OUTLIER 'General case' 0 N--CA 1.461 0.117 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 -178.791 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.56 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . -77.14 30.78 0.14 Allowed 'General case' 0 C--N 1.328 -0.356 0 N-CA-C 108.435 -0.95 . . . . 0.0 108.435 178.382 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.735 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.2 p 57.2 38.11 28.69 Favored 'General case' 0 CA--C 1.52 -0.208 0 CA-C-N 114.93 -1.032 . . . . 0.0 110.003 -178.574 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.697 ' OG ' ' ND2' ' A' ' 62' ' ' ASN . 0.0 OUTLIER -67.61 135.93 53.65 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.973 -179.32 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.635 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 23.9 m-85 -96.12 148.04 23.11 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.64 -0.709 . . . . 0.0 110.351 179.263 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 24.9 t -120.59 101.34 10.63 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.778 0 N-CA-C 107.539 -1.282 . . . . 0.0 107.539 176.039 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.1 t -111.53 137.59 43.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.485 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.665 -178.616 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.5 p -128.1 155.84 43.77 Favored 'General case' 0 C--N 1.323 -0.566 0 CA-C-N 115.322 -0.854 . . . . 0.0 110.129 179.94 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.465 ' CE3' HG21 ' A' ' 76' ' ' VAL . 33.6 p90 -146.9 -164.95 2.11 Favored 'General case' 0 C--N 1.324 -0.528 0 C-N-CA 120.444 -0.502 . . . . 0.0 111.049 -179.239 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 97.0 t -117.08 129.62 73.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.129 -0.487 . . . . 0.0 110.531 179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -69.69 89.75 0.56 Allowed 'General case' 0 C--N 1.324 -0.543 0 N-CA-C 109.319 -0.623 . . . . 0.0 109.319 178.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.733 ' O ' ' NE2' ' A' ' 78' ' ' GLN . . . -89.92 104.31 16.89 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.17 -0.468 . . . . 0.0 111.018 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.649 ' CB ' ' O ' ' A' ' 29' ' ' ALA . 5.4 m 104.84 97.34 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.297 0 O-C-N 123.54 0.525 . . . . 0.0 110.337 179.941 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 40.3 t0 -58.99 -16.15 16.67 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.821 -0.627 . . . . 0.0 111.227 -179.689 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.0 p -71.08 2.29 4.69 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.459 -0.337 . . . . 0.0 111.062 -179.517 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.578 HG12 ' O ' ' A' ' 30' ' ' SER . 2.7 p -71.96 133.19 32.27 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.374 0 CA-C-N 116.17 -0.468 . . . . 0.0 110.365 -179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.552 ' N ' ' O ' ' A' ' 79' ' ' ILE . 4.8 m -93.84 -15.4 25.11 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.667 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.535 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 175.62 -178.3 47.22 Favored Glycine 0 C--O 1.224 -0.508 0 N-CA-C 109.784 -1.326 . . . . 0.0 109.784 -179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 85.2 m-85 -126.61 153.81 44.8 Favored 'General case' 0 C--N 1.324 -0.532 0 CA-C-O 120.96 0.41 . . . . 0.0 110.376 178.903 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . . . . . . . . . 17.8 ttp180 -132.44 123.01 25.84 Favored 'General case' 0 C--N 1.322 -0.629 0 CA-C-N 116.104 -0.498 . . . . 0.0 110.083 179.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.617 HG21 HG11 ' A' ' 61' ' ' VAL . 77.7 t -107.48 132.43 55.04 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.637 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.504 179.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.422 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 68.3 tt0 -127.17 131.34 50.74 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 115.815 -0.629 . . . . 0.0 110.233 -179.583 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.534 ' CZ ' ' OE1' ' A' ' 50' ' ' GLN . 18.9 p90 -144.29 137.63 27.37 Favored 'General case' 0 C--N 1.325 -0.493 0 CA-C-O 121.273 0.558 . . . . 0.0 111.259 179.377 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -144.36 167.91 21.34 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-N 115.211 -0.904 . . . . 0.0 109.149 179.807 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.764 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 76.7 mt -74.81 126.42 30.88 Favored 'General case' 0 C--N 1.323 -0.547 0 C-N-CA 120.144 -0.622 . . . . 0.0 110.688 179.932 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 p -67.24 -25.03 65.89 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.816 -0.629 . . . . 0.0 110.458 179.915 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 93.8 mt-10 -92.29 -73.4 0.55 Allowed 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 115.868 -0.605 . . . . 0.0 111.979 -178.932 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.69 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 83.3 mt-10 -62.06 -31.23 71.63 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 115.953 -0.567 . . . . 0.0 111.944 -178.548 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.619 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 83.34 -37.83 2.75 Favored Glycine 0 CA--C 1.526 0.756 0 N-CA-C 110.009 -1.236 . . . . 0.0 110.009 -179.035 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.619 ' O ' ' O ' ' A' ' 46' ' ' GLY . 32.3 t0 24.73 -150.67 0.0 OUTLIER 'General case' 0 N--CA 1.462 0.144 0 CA-C-O 120.803 0.335 . . . . 0.0 111.044 179.853 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.511 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 1.0 OUTLIER -104.37 138.57 19.56 Favored Pre-proline 0 C--N 1.327 -0.411 0 C-N-CA 120.546 -0.462 . . . . 0.0 110.424 -179.716 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 45.8 Cg_endo -72.11 142.74 38.72 Favored 'Trans proline' 0 C--N 1.305 -1.726 0 C-N-CA 121.982 1.788 . . . . 0.0 111.269 179.619 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.534 ' OE1' ' CZ ' ' A' ' 40' ' ' TYR . 21.6 mt-30 -112.71 146.15 39.24 Favored 'General case' 0 C--N 1.326 -0.427 0 N-CA-C 109.573 -0.528 . . . . 0.0 109.573 -179.567 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 24.7 m-85 -124.78 137.06 54.34 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.739 -0.784 . . . . 0.0 111.672 -179.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 24.2 mt -129.68 130.48 45.59 Favored 'General case' 0 C--O 1.233 0.186 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 178.186 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 23.6 m-20 -104.71 132.75 50.58 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 120.32 -0.552 . . . . 0.0 111.477 -179.765 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.6 mt -126.18 152.54 73.63 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-N 115.803 -0.635 . . . . 0.0 109.636 179.175 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 10.9 Cg_endo -64.36 154.48 71.15 Favored 'Trans proline' 0 C--N 1.303 -1.82 0 C-N-CA 122.441 2.094 . . . . 0.0 112.777 179.959 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.535 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 24.9 p -57.8 -14.31 5.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.115 179.79 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 69.6 p -92.12 -6.7 50.32 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 115.875 -0.602 . . . . 0.0 111.234 -179.134 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -86.82 138.78 31.29 Favored 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 120.924 -0.31 . . . . 0.0 110.336 179.599 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 77.3 p -130.71 13.98 5.37 Favored 'General case' 0 C--N 1.325 -0.462 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.424 -179.868 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.2 p -163.68 148.68 10.81 Favored 'General case' 0 C--N 1.329 -0.301 0 C-N-CA 120.652 -0.419 . . . . 0.0 110.577 -179.862 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.617 HG11 HG21 ' A' ' 38' ' ' VAL . 9.4 p -149.18 144.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.52 -0.186 0 C-N-CA 120.479 -0.488 . . . . 0.0 111.856 -179.175 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.697 ' ND2' ' OG ' ' A' ' 21' ' ' SER . 2.4 t-20 -102.85 126.5 50.02 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.676 -0.861 . . . . 0.0 108.676 178.029 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -97.96 112.55 62.05 Favored Pre-proline 0 N--CA 1.466 0.337 0 C-N-CA 120.976 -0.29 . . . . 0.0 111.468 -178.606 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 60.8 Cg_endo -93.23 175.71 1.56 Allowed 'Trans proline' 0 C--N 1.317 -1.095 0 C-N-CA 122.997 2.465 . . . . 0.0 113.637 -179.73 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 47.0 m-20 59.91 38.4 21.09 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 114.715 -1.13 . . . . 0.0 111.619 179.249 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.481 HD12 ' O ' ' A' ' 20' ' ' SER . 15.1 mt -87.72 145.17 26.26 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.592 -0.443 . . . . 0.0 109.82 178.679 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.406 ' HB2' ' OH ' ' A' ' 72' ' ' TYR . 16.4 mt -86.73 112.12 44.69 Favored Pre-proline 0 C--O 1.232 0.148 0 N-CA-C 111.749 0.277 . . . . 0.0 111.749 -179.19 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.402 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 32.1 Cg_exo -55.28 134.26 62.8 Favored 'Trans proline' 0 C--N 1.308 -1.588 0 C-N-CA 121.963 1.775 . . . . 0.0 111.159 178.378 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 83.63 13.93 74.52 Favored Glycine 0 CA--C 1.53 1.024 0 C-N-CA 120.787 -0.721 . . . . 0.0 111.424 179.719 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.69 ' NH2' ' OE2' ' A' ' 45' ' ' GLU . 13.0 mmt85 -121.13 152.17 39.04 Favored 'General case' 0 N--CA 1.463 0.205 0 C-N-CA 120.955 -0.298 . . . . 0.0 110.682 -179.947 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 80.0 tttt -103.89 127.71 51.39 Favored 'General case' 0 C--O 1.233 0.188 0 N-CA-C 109.909 -0.404 . . . . 0.0 109.909 179.537 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.764 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 84.5 m-85 -115.36 156.98 24.53 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 116.076 -0.511 . . . . 0.0 110.096 179.149 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.438 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 61.9 mt -110.49 132.99 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.669 0 N-CA-C 107.445 -1.317 . . . . 0.0 107.445 177.408 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.4 t -120.46 130.82 74.03 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.786 0 C-N-CA 119.863 -0.735 . . . . 0.0 111.582 -178.216 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.5 m-80 -135.02 121.69 20.77 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.607 179.095 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.465 HG21 ' CE3' ' A' ' 26' ' ' TRP . 48.5 t -103.17 127.73 56.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.388 0 C-N-CA 120.633 -0.427 . . . . 0.0 110.467 -179.728 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 21.5 m-85 -121.68 136.27 54.95 Favored 'General case' 0 C--O 1.223 -0.315 0 CA-C-N 116.121 -0.49 . . . . 0.0 110.861 179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.733 ' NE2' ' O ' ' A' ' 29' ' ' ALA . 1.4 pt20 -96.59 132.75 41.88 Favored 'General case' 0 C--N 1.321 -0.631 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 177.466 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.552 ' O ' ' N ' ' A' ' 34' ' ' SER . 56.0 mt -97.18 125.94 50.1 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.572 0 CA-C-O 121.346 0.593 . . . . 0.0 110.787 -178.681 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.595 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 90.0 p -85.62 168.66 14.23 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.794 -1.094 . . . . 0.0 111.197 -179.418 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.447 ' CD ' ' OG ' ' A' ' 34' ' ' SER . 81.7 mm-40 -61.75 -18.43 59.75 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 115.769 -0.65 . . . . 0.0 110.385 179.976 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.595 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 32.8 p30 -92.87 -0.72 57.18 Favored 'General case' 0 N--CA 1.463 0.201 0 C-N-CA 120.636 -0.426 . . . . 0.0 111.033 -179.873 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.06 10.24 75.45 Favored Glycine 0 CA--C 1.528 0.856 0 C-N-CA 121.003 -0.617 . . . . 0.0 112.424 179.027 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.566 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 55.2 mm-40 -82.43 145.3 29.93 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 117.206 0.503 . . . . 0.0 110.971 179.624 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . . . . . . . . . 96.7 mt-30 -109.87 139.16 45.26 Favored 'General case' 0 C--N 1.331 -0.229 0 CA-C-O 121.106 0.479 . . . . 0.0 110.722 179.149 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 28.1 t -133.88 130.39 37.76 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.782 -0.644 . . . . 0.0 110.187 179.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 17.5 tp -73.45 121.72 20.98 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-O 121.042 0.449 . . . . 0.0 111.43 -179.472 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.459 HD11 ' CG1' ' A' ' 76' ' ' VAL . 35.6 pt -109.59 -22.55 4.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.837 179.797 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 44.5 tp -157.57 127.68 6.24 Favored 'General case' 0 N--CA 1.464 0.248 0 CA-C-O 121.098 0.475 . . . . 0.0 111.769 179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 11.6 t -133.56 120.41 20.72 Favored 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.335 -0.617 . . . . 0.0 109.335 178.718 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 9.1 t -156.0 153.35 29.37 Favored 'General case' 0 C--N 1.324 -0.508 0 C-N-CA 120.573 -0.451 . . . . 0.0 110.832 -179.519 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 53.0 p -111.39 157.92 19.67 Favored 'General case' 0 CA--C 1.517 -0.305 0 N-CA-C 109.624 -0.51 . . . . 0.0 109.624 179.289 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.635 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 26.4 mt-30 -145.84 163.01 36.39 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-O 121.123 0.487 . . . . 0.0 111.112 179.798 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -131.84 105.23 7.33 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.427 -0.806 . . . . 0.0 110.149 179.318 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.402 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 81.3 p . . . . . 0 C--N 1.324 -0.54 0 CA-C-O 117.956 -1.021 . . . . 0.0 110.315 -179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.365 0 N-CA-C 109.528 -1.429 . . . . 0.0 109.528 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.696 ' O ' ' N ' ' A' ' 4' ' ' GLY . 13.1 Cg_endo -57.93 137.71 82.33 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.942 2.428 . . . . 0.0 112.134 -179.983 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.475 ' C ' ' O ' ' A' ' 2' ' ' PRO . 4.7 mp 31.92 26.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.116 -0.493 . . . . 0.0 110.969 179.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.696 ' N ' ' O ' ' A' ' 2' ' ' PRO . . . -108.86 154.36 16.51 Favored Glycine 0 CA--C 1.525 0.658 0 C-N-CA 120.71 -0.757 . . . . 0.0 111.378 -179.699 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.597 ' OG ' ' N ' ' A' ' 6' ' ' HIS . 0.6 OUTLIER 48.99 -178.03 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 121.134 0.493 . . . . 0.0 111.284 179.641 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.597 ' N ' ' OG ' ' A' ' 5' ' ' SER . 81.9 m-70 57.79 -131.93 1.33 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.57 -0.741 . . . . 0.0 110.976 179.762 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.694 ' N ' HD12 ' A' ' 7' ' ' LEU . 6.6 mp -90.82 130.95 36.74 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.179 -0.464 . . . . 0.0 111.382 -179.175 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 3.3 p -158.84 130.95 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.241 0 CA-C-N 115.712 -0.677 . . . . 0.0 110.331 179.352 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -95.66 132.83 40.42 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.328 -0.396 . . . . 0.0 110.93 -179.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.61 ' O ' ' O ' ' A' ' 11' ' ' SER . 1.5 t -109.27 -0.98 18.91 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.283 -0.417 . . . . 0.0 110.355 179.535 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.61 ' O ' ' O ' ' A' ' 10' ' ' THR . 0.1 OUTLIER 25.05 104.88 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 115.981 -0.554 . . . . 0.0 111.15 179.994 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.578 ' O ' ' O ' ' A' ' 11' ' ' SER . 42.0 mp0 38.2 101.02 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.05 -0.523 . . . . 0.0 110.205 179.761 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 69.4 m -78.04 -1.29 31.54 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.952 0.406 . . . . 0.0 110.019 179.775 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.2 t -120.48 132.08 71.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 115.973 -0.558 . . . . 0.0 110.92 179.953 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.865 HG22 ' N ' ' A' ' 16' ' ' GLU . 54.3 m -123.27 -113.48 0.31 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.425 -0.352 . . . . 0.0 110.276 179.303 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.865 ' N ' HG22 ' A' ' 15' ' ' THR . 47.8 mp0 -13.69 75.55 0.0 OUTLIER 'General case' 0 N--CA 1.463 0.225 0 O-C-N 123.628 0.58 . . . . 0.0 111.06 -179.401 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.712 ' N ' ' O ' ' A' ' 15' ' ' THR . 35.0 mt -76.33 -9.45 12.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.364 0 C-N-CA 120.477 -0.489 . . . . 0.0 109.698 -179.753 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.638 ' O ' ' N ' ' A' ' 20' ' ' SER . 62.7 p -52.54 149.6 5.73 Favored 'General case' 0 CA--C 1.518 -0.258 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 179.526 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.482 ' C ' ' O ' ' A' ' 18' ' ' THR . . . 43.75 17.62 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 N-CA-C 107.618 -1.253 . . . . 0.0 107.618 -178.122 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.638 ' N ' ' O ' ' A' ' 18' ' ' THR . 4.3 p 79.33 -55.63 0.42 Allowed 'General case' 0 CA--C 1.519 -0.235 0 CA-C-N 114.64 -1.164 . . . . 0.0 109.519 -178.557 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.691 ' O ' ' CD1' ' A' ' 22' ' ' PHE . 0.0 OUTLIER 38.81 -178.26 0.0 OUTLIER 'General case' 0 C--N 1.325 -0.483 0 CA-C-O 121.915 0.864 . . . . 0.0 112.023 179.204 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.698 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 25.2 m-85 -156.72 150.65 24.89 Favored 'General case' 0 C--N 1.322 -0.617 0 CA-C-N 114.371 -1.286 . . . . 0.0 109.741 178.33 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.65 ' CG2' ' OE1' ' A' ' 16' ' ' GLU . 42.4 t -119.66 102.26 12.5 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.86 0 N-CA-C 107.532 -1.284 . . . . 0.0 107.532 176.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 94.5 t -110.25 132.53 58.33 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.5 0 CA-C-N 115.823 -0.626 . . . . 0.0 110.324 -178.72 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 90.4 p -126.63 154.36 44.11 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.704 -0.68 . . . . 0.0 109.906 179.569 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.414 ' CE3' HG21 ' A' ' 76' ' ' VAL . 33.9 p90 -143.43 -165.48 2.1 Favored 'General case' 0 C--N 1.32 -0.69 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.724 -179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 41.5 t -130.68 128.48 63.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.646 0 C-N-CA 120.494 -0.482 . . . . 0.0 110.286 179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 p -49.67 111.61 0.53 Allowed 'General case' 0 C--N 1.326 -0.422 0 C-N-CA 120.459 -0.496 . . . . 0.0 109.692 179.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -82.96 5.27 22.6 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.106 -0.497 . . . . 0.0 111.116 -179.329 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.654 ' O ' HG12 ' A' ' 33' ' ' VAL . 4.0 m -174.46 140.71 0.64 Allowed 'General case' 0 C--N 1.326 -0.414 0 C-N-CA 120.682 -0.407 . . . . 0.0 110.781 -179.755 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.45 ' C ' ' OD1' ' A' ' 31' ' ' ASP . 51.3 p30 -87.23 2.36 50.32 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 116.328 -0.397 . . . . 0.0 110.253 179.589 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 57.3 p -93.22 1.07 57.24 Favored 'General case' 0 N--CA 1.452 -0.328 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.356 179.638 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.654 HG12 ' O ' ' A' ' 30' ' ' SER . 2.5 p -71.37 135.87 27.04 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.051 -0.522 . . . . 0.0 110.798 -179.776 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.457 ' N ' ' O ' ' A' ' 79' ' ' ILE . 30.6 m -94.86 -14.83 24.21 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.818 -0.628 . . . . 0.0 109.53 179.637 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.462 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 176.1 179.05 46.36 Favored Glycine 0 CA--C 1.522 0.502 0 N-CA-C 109.835 -1.306 . . . . 0.0 109.835 179.901 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 93.2 m-85 -126.12 152.25 46.16 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 120.904 0.383 . . . . 0.0 110.19 179.081 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.499 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 25.2 ttp180 -131.4 128.31 39.31 Favored 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 109.189 -0.671 . . . . 0.0 109.189 178.839 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.6 t -112.63 133.61 57.88 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.713 0 C-N-CA 120.306 -0.558 . . . . 0.0 110.721 -179.693 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.443 ' HG3' ' CE1' ' A' ' 51' ' ' TYR . 38.6 tt0 -123.1 130.67 53.08 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.167 -0.469 . . . . 0.0 109.794 179.375 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.623 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 0.7 OUTLIER -133.69 135.78 44.28 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.378 -0.529 . . . . 0.0 110.709 179.426 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 20.9 pt-20 -144.96 161.52 39.16 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 115.298 -0.865 . . . . 0.0 109.239 179.816 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.772 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 43.8 mt -71.15 130.39 41.36 Favored 'General case' 0 C--N 1.321 -0.66 0 CA-C-O 121.142 0.496 . . . . 0.0 111.332 -178.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 52.6 p -65.32 -24.5 67.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.952 179.642 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.486 ' HB2' HH22 ' A' ' 70' ' ' ARG . 60.8 mm-40 -97.44 -73.85 0.59 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.581 -0.736 . . . . 0.0 110.384 -179.792 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.913 ' H ' HH22 ' A' ' 70' ' ' ARG . 80.5 mm-40 -68.72 147.1 52.32 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-N 115.189 -0.914 . . . . 0.0 110.282 -179.971 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.574 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -93.07 28.42 9.59 Favored Glycine 0 CA--C 1.524 0.636 0 C-N-CA 120.462 -0.875 . . . . 0.0 111.104 -179.511 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.574 ' O ' ' O ' ' A' ' 46' ' ' GLY . 13.7 t70 -41.64 171.45 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.319 0 C-N-CA 120.44 -0.504 . . . . 0.0 109.733 179.483 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.521 ' N ' ' CG ' ' A' ' 47' ' ' ASP . 0.0 OUTLIER -73.42 134.93 79.26 Favored Pre-proline 0 C--N 1.323 -0.555 0 C-N-CA 120.304 -0.558 . . . . 0.0 110.747 -179.684 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 36.2 Cg_endo -68.64 148.99 73.29 Favored 'Trans proline' 0 C--N 1.307 -1.644 0 C-N-CA 122.486 2.124 . . . . 0.0 111.116 179.457 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.7 mt-30 -119.57 144.09 47.27 Favored 'General case' 0 C--N 1.325 -0.487 0 N-CA-C 109.802 -0.444 . . . . 0.0 109.802 -179.962 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.443 ' CE1' ' HG3' ' A' ' 39' ' ' GLU . 59.2 m-85 -122.91 141.9 51.39 Favored 'General case' 0 C--N 1.33 -0.247 0 C-N-CA 120.29 -0.564 . . . . 0.0 112.114 -178.787 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 85.5 mt -128.06 130.79 48.79 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 115.223 -0.898 . . . . 0.0 108.687 177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 45.9 m-20 -102.21 133.41 47.13 Favored 'General case' 0 C--N 1.325 -0.473 0 C-N-CA 120.291 -0.564 . . . . 0.0 111.567 -178.897 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.2 mt -128.67 156.39 77.54 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-N 115.653 -0.703 . . . . 0.0 109.55 -179.717 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 34.2 Cg_endo -71.51 159.3 51.72 Favored 'Trans proline' 0 C--N 1.31 -1.497 0 C-N-CA 122.228 1.952 . . . . 0.0 112.522 179.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.462 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 47.4 p -60.2 -16.36 32.58 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 115.864 -0.607 . . . . 0.0 111.114 -179.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 81.0 p -91.19 -7.92 50.01 Favored 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 120.735 -0.386 . . . . 0.0 110.704 -179.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.69 133.74 34.8 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.222 179.483 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 32.9 p -128.84 11.36 6.11 Favored 'General case' 0 C--N 1.327 -0.396 0 C-N-CA 120.868 -0.333 . . . . 0.0 110.584 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.6 p -163.62 144.22 8.83 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.482 -0.326 . . . . 0.0 110.284 179.602 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.0 p -151.24 147.83 15.25 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 CA-C-N 116.288 -0.414 . . . . 0.0 111.172 -179.487 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.459 ' OD1' ' OE1' ' A' ' 16' ' ' GLU . 18.6 t30 -101.4 126.23 48.15 Favored 'General case' 0 C--N 1.325 -0.472 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.358 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.6 mt -98.66 105.65 31.76 Favored Pre-proline 0 C--N 1.33 -0.249 0 C-N-CA 121.152 -0.219 . . . . 0.0 110.894 -179.159 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.413 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.6 Cg_endo -90.08 -176.77 1.2 Allowed 'Trans proline' 0 C--N 1.312 -1.364 0 C-N-CA 123.015 2.477 . . . . 0.0 112.773 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 81.8 m-20 56.41 35.92 26.69 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 115.261 -0.881 . . . . 0.0 111.441 179.429 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.52 HD13 ' CE2' ' A' ' 22' ' ' PHE . 44.4 mt -90.23 140.55 29.57 Favored 'General case' 0 C--N 1.328 -0.334 0 N-CA-C 109.831 -0.433 . . . . 0.0 109.831 178.667 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 76.5 mt -68.35 111.58 8.41 Favored Pre-proline 0 CA--C 1.53 0.176 0 N-CA-C 111.441 0.163 . . . . 0.0 111.441 -179.405 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.409 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 25.3 Cg_exo -57.71 138.67 87.22 Favored 'Trans proline' 0 N--CA 1.491 1.371 0 C-N-CA 122.191 1.928 . . . . 0.0 112.015 178.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.1 22.09 74.61 Favored Glycine 0 CA--C 1.527 0.843 0 C-N-CA 121.282 -0.485 . . . . 0.0 111.917 179.065 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.913 HH22 ' H ' ' A' ' 45' ' ' GLU . 22.2 mmm180 -126.56 154.66 43.58 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.984 0.421 . . . . 0.0 111.548 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 75.1 tttt -100.05 132.44 45.41 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.891 -0.595 . . . . 0.0 109.694 178.752 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.772 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 52.4 m-85 -121.81 153.59 38.13 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.961 -0.563 . . . . 0.0 111.701 -179.523 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.425 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 69.8 mt -108.1 125.41 64.74 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.515 0 N-CA-C 107.272 -1.381 . . . . 0.0 107.272 177.127 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.5 t -113.87 133.87 58.49 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.859 0 C-N-CA 120.495 -0.482 . . . . 0.0 111.044 -178.536 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.4 m-80 -136.36 124.25 22.7 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.659 -0.7 . . . . 0.0 109.751 179.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.414 HG21 ' CE3' ' A' ' 26' ' ' TRP . 34.0 t -105.06 129.75 57.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-O 121.145 0.497 . . . . 0.0 110.599 -179.689 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 60.8 m-85 -121.57 137.7 54.63 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.803 179.51 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.447 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 3.5 pt20 -99.77 134.53 42.52 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 178.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.457 ' O ' ' N ' ' A' ' 34' ' ' SER . 49.0 mt -98.27 125.13 51.65 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-O 121.399 0.619 . . . . 0.0 110.392 -178.938 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.598 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 80.6 p -82.85 169.11 16.45 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-N 115.122 -0.945 . . . . 0.0 110.553 -179.588 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.71 -22.32 57.08 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.936 -179.676 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.598 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.4 p30 -93.72 0.02 56.2 Favored 'General case' 0 C--N 1.33 -0.254 0 C-N-CA 120.777 -0.369 . . . . 0.0 111.303 -179.592 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 89.04 12.51 63.51 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.421 179.022 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.484 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.35 144.45 29.66 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.995 0.397 . . . . 0.0 110.653 179.38 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.499 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 86.2 mt-30 -111.19 144.77 39.82 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-O 121.042 0.449 . . . . 0.0 111.431 -179.882 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 30.8 t -138.02 132.04 31.6 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 115.785 -0.643 . . . . 0.0 110.314 179.302 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 26.3 tp -72.61 118.22 15.27 Favored 'General case' 0 C--N 1.328 -0.369 0 C-N-CA 120.441 -0.503 . . . . 0.0 109.905 179.662 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.3 pt -109.65 -25.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.465 0 C-N-CA 120.647 -0.421 . . . . 0.0 110.822 -179.724 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 41.7 tp -156.15 125.0 5.99 Favored 'General case' 0 C--N 1.327 -0.379 0 C-N-CA 120.438 -0.505 . . . . 0.0 111.842 -179.39 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 48.1 t -133.07 117.7 17.88 Favored 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.121 -0.696 . . . . 0.0 109.121 178.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.4 t -148.36 153.88 39.19 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.753 -0.379 . . . . 0.0 110.698 -179.25 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.8 p -112.17 151.49 29.46 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 109.9 -0.407 . . . . 0.0 109.9 179.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.698 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 22.3 mt-30 -139.41 155.59 47.52 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-O 121.187 0.518 . . . . 0.0 110.974 179.937 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.472 ' O ' ' OXT' ' A' ' 95' ' ' THR . 0.2 OUTLIER -114.14 111.58 21.81 Favored 'General case' 0 C--N 1.322 -0.609 0 CA-C-N 115.411 -0.813 . . . . 0.0 109.202 178.83 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.57 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 6.9 p . . . . . 0 C--O 1.221 -0.427 0 CA-C-O 117.916 -1.04 . . . . 0.0 110.535 -179.288 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.698 ' N ' ' CD ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.312 0 N-CA-C 109.735 -1.346 . . . . 0.0 109.735 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.698 ' CD ' ' N ' ' A' ' 1' ' ' GLY . 6.6 Cg_endo -53.15 139.16 63.0 Favored 'Trans proline' 0 C--N 1.303 -1.823 0 C-N-CA 122.637 2.224 . . . . 0.0 111.749 179.707 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.551 ' O ' ' O ' ' A' ' 2' ' ' PRO . 85.1 mt 51.11 162.56 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.144 -0.48 . . . . 0.0 110.386 -179.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 99.22 2.76 56.8 Favored Glycine 0 CA--C 1.526 0.738 0 N-CA-C 110.735 -0.946 . . . . 0.0 110.735 -179.644 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 43.7 m -80.9 15.02 1.94 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.852 0.358 . . . . 0.0 110.375 179.699 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.64 ' C ' ' H ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER -113.03 167.08 10.82 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.865 -179.562 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.402 ' HG ' ' O ' ' A' ' 7' ' ' LEU . 17.4 tp 61.24 -5.5 0.12 Allowed 'General case' 0 C--O 1.232 0.137 0 CA-C-O 121.456 0.646 . . . . 0.0 109.485 -179.376 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.64 ' H ' ' C ' ' A' ' 6' ' ' HIS . 6.2 m -120.74 22.13 5.22 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.469 179.911 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -51.26 175.27 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.318 -0.401 . . . . 0.0 110.242 -179.846 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.478 ' O ' ' OG ' ' A' ' 11' ' ' SER . 26.4 p -80.53 169.63 17.42 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 121.003 0.43 . . . . 0.0 111.389 -179.209 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.493 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 76.1 p 60.29 -122.27 0.99 Allowed 'General case' 0 C--N 1.332 -0.161 0 CA-C-N 115.762 -0.654 . . . . 0.0 110.914 -179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.495 ' O ' ' N ' ' A' ' 14' ' ' VAL . 44.1 mp0 -59.99 -23.73 63.89 Favored 'General case' 0 C--N 1.33 -0.239 0 CA-C-N 116.235 -0.438 . . . . 0.0 110.525 -179.867 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.493 ' OG ' HG23 ' A' ' 14' ' ' VAL . 1.3 p 69.03 -55.65 0.55 Allowed 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 108.997 -0.742 . . . . 0.0 108.997 -179.086 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.495 ' N ' ' O ' ' A' ' 12' ' ' GLU . 63.1 t -111.98 129.64 67.08 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.363 -0.835 . . . . 0.0 109.965 179.009 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.702 HG22 ' N ' ' A' ' 16' ' ' GLU . 53.4 m -133.89 -101.52 0.25 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.966 0.413 . . . . 0.0 110.664 179.939 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.702 ' N ' HG22 ' A' ' 15' ' ' THR . 0.6 OUTLIER 35.78 73.36 0.09 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.801 -0.636 . . . . 0.0 110.952 -179.926 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.579 ' O ' ' O ' ' A' ' 18' ' ' THR . 19.5 mt -129.03 -116.88 0.02 OUTLIER 'Isoleucine or valine' 0 CA--C 1.531 0.214 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.612 179.482 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.631 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 2.5 m 34.11 95.95 0.0 OUTLIER 'General case' 0 CA--C 1.52 -0.198 0 N-CA-C 109.502 -0.555 . . . . 0.0 109.502 -179.616 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.631 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 74.76 26.46 1.37 Allowed 'General case' 0 C--N 1.326 -0.453 0 N-CA-C 108.309 -0.997 . . . . 0.0 108.309 -178.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.707 ' O ' HD12 ' A' ' 66' ' ' LEU . 5.1 p 56.08 23.16 6.58 Favored 'General case' 0 N--CA 1.456 -0.173 0 CA-C-N 115.151 -0.931 . . . . 0.0 109.77 -178.94 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.551 ' N ' ' O ' ' A' ' 17' ' ' ILE . 2.4 p -57.59 136.69 56.8 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 115.824 -0.625 . . . . 0.0 111.392 -179.217 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.584 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.3 m-30 -101.66 147.03 26.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.586 -0.733 . . . . 0.0 110.876 178.917 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.695 ' N ' ' OE1' ' A' ' 16' ' ' GLU . 16.1 t -130.45 103.77 8.71 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 N-CA-C 109.709 -0.478 . . . . 0.0 109.709 178.005 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 70.0 t -113.78 138.26 44.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-O 121.059 0.456 . . . . 0.0 110.97 -179.772 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 71.8 p -127.58 151.54 48.78 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-N 115.609 -0.723 . . . . 0.0 109.725 179.303 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.639 ' CE3' HG21 ' A' ' 76' ' ' VAL . 32.4 p90 -144.37 -165.38 2.12 Favored 'General case' 0 C--N 1.326 -0.419 0 C-N-CA 120.496 -0.482 . . . . 0.0 111.009 -179.557 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 20.7 t -130.93 125.84 58.77 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.954 -0.566 . . . . 0.0 109.967 -179.753 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 12.6 p -46.01 117.27 1.46 Allowed 'General case' 0 C--N 1.327 -0.409 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.402 -179.787 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -85.02 4.04 35.72 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.363 179.666 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.618 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.7 m -169.09 139.34 2.25 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-N 115.679 -0.692 . . . . 0.0 110.052 -179.633 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 89.1 m-20 -88.06 -2.21 58.47 Favored 'General case' 0 C--N 1.322 -0.626 0 C-N-CA 120.573 -0.451 . . . . 0.0 109.805 179.429 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 36.4 p -92.56 -1.37 56.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 115.778 -0.646 . . . . 0.0 110.631 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.618 HG12 ' O ' ' A' ' 30' ' ' SER . 2.3 p -61.14 137.52 23.33 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.117 -0.492 . . . . 0.0 110.802 -179.832 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . . . . . . . . . 18.5 m -96.19 -15.99 21.73 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.46 179.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.467 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.54 177.14 46.16 Favored Glycine 0 CA--C 1.525 0.688 0 N-CA-C 109.938 -1.265 . . . . 0.0 109.938 179.651 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 82.2 m-85 -125.24 153.02 43.81 Favored 'General case' 0 C--N 1.326 -0.434 0 CA-C-O 120.859 0.362 . . . . 0.0 110.54 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.803 ' NE ' HE22 ' A' ' 85' ' ' GLN . 42.3 ttp180 -132.18 132.09 42.83 Favored 'General case' 0 C--N 1.324 -0.534 0 C-N-CA 120.497 -0.481 . . . . 0.0 109.728 178.661 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.645 HG21 HG11 ' A' ' 61' ' ' VAL . 12.4 t -113.0 135.09 53.58 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.586 0 CA-C-N 116.054 -0.521 . . . . 0.0 110.53 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -126.8 133.5 50.78 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.503 -179.865 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.523 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 4.4 p90 -143.56 143.05 31.35 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.282 0.563 . . . . 0.0 111.729 179.533 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 17.8 pt-20 -150.36 163.56 38.05 Favored 'General case' 0 C--N 1.326 -0.442 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.114 179.337 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.869 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 90.5 mt -74.07 125.47 28.38 Favored 'General case' 0 C--N 1.326 -0.441 0 C-N-CA 120.365 -0.534 . . . . 0.0 110.875 179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.6 p -64.3 -33.77 76.59 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 115.749 -0.66 . . . . 0.0 110.44 179.919 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 97.1 mt-10 -86.87 -71.07 0.57 Allowed 'General case' 0 C--N 1.323 -0.562 0 CA-C-N 115.447 -0.797 . . . . 0.0 111.545 -178.948 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.662 ' CD ' HH21 ' A' ' 70' ' ' ARG . 89.1 mt-10 -62.73 -35.76 80.82 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.545 -0.752 . . . . 0.0 112.076 -178.428 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.583 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 85.35 -42.31 3.14 Favored Glycine 0 CA--C 1.524 0.646 0 N-CA-C 110.69 -0.964 . . . . 0.0 110.69 -179.439 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.684 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 19.3 t70 28.98 -151.69 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-O 120.806 0.336 . . . . 0.0 110.242 179.833 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.684 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 4.9 pt-20 -108.71 135.11 20.11 Favored Pre-proline 0 N--CA 1.45 -0.445 0 CA-C-N 116.277 -0.42 . . . . 0.0 110.601 179.904 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -64.36 149.78 89.48 Favored 'Trans proline' 0 C--N 1.304 -1.795 0 C-N-CA 122.203 1.935 . . . . 0.0 111.826 179.754 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 19.2 mt-30 -121.36 151.05 40.57 Favored 'General case' 0 C--N 1.327 -0.391 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 179.454 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.0 m-85 -126.68 139.46 53.14 Favored 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 119.995 -0.682 . . . . 0.0 112.259 -178.544 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 87.6 mt -129.42 129.92 45.3 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 115.449 -0.796 . . . . 0.0 109.343 178.154 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 50.5 m-20 -106.02 134.43 49.15 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 121.146 0.498 . . . . 0.0 111.963 -179.096 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.454 ' HB3' ' CB ' ' A' ' 58' ' ' ALA . 7.4 mt -129.71 155.75 79.89 Favored Pre-proline 0 CA--C 1.53 0.208 0 CA-C-N 115.623 -0.717 . . . . 0.0 109.686 179.541 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 17.6 Cg_endo -68.06 159.89 51.06 Favored 'Trans proline' 0 C--N 1.307 -1.623 0 C-N-CA 122.195 1.93 . . . . 0.0 111.995 179.374 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.467 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 21.0 p -56.25 -12.83 1.75 Allowed 'General case' 0 N--CA 1.466 0.331 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.241 -179.627 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 42.7 p -93.58 -7.11 45.03 Favored 'General case' 0 C--N 1.328 -0.347 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.531 179.989 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.454 ' CB ' ' HB3' ' A' ' 54' ' ' LEU . . . -79.6 130.13 35.09 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.351 -0.386 . . . . 0.0 110.248 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.4 p -130.98 12.65 5.2 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.861 179.849 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 61.2 p -165.13 147.56 8.01 Favored 'General case' 0 C--N 1.332 -0.18 0 N-CA-C 109.899 -0.408 . . . . 0.0 109.899 179.221 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.645 HG11 HG21 ' A' ' 38' ' ' VAL . 6.2 p -149.87 147.16 16.44 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.211 0 C-N-CA 120.399 -0.521 . . . . 0.0 111.81 -178.782 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.548 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 4.7 t-20 -107.72 127.98 54.17 Favored 'General case' 0 C--N 1.328 -0.353 0 N-CA-C 109.16 -0.681 . . . . 0.0 109.16 178.224 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -101.76 105.65 42.47 Favored Pre-proline 0 C--N 1.328 -0.363 0 C-N-CA 121.012 -0.275 . . . . 0.0 111.126 -179.029 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 86.5 Cg_endo -88.24 175.55 4.01 Favored 'Trans proline' 0 C--N 1.312 -1.363 0 C-N-CA 122.896 2.398 . . . . 0.0 112.715 -179.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 77.0 m-20 60.48 39.1 18.7 Favored 'General case' 0 C--N 1.322 -0.604 0 CA-C-N 114.823 -1.08 . . . . 0.0 111.994 179.356 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.707 HD12 ' O ' ' A' ' 20' ' ' SER . 56.9 mt -88.95 153.51 20.97 Favored 'General case' 0 C--N 1.329 -0.292 0 N-CA-C 109.874 -0.417 . . . . 0.0 109.874 178.521 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.466 HD13 ' NH2' ' A' ' 70' ' ' ARG . 46.7 mt -90.72 110.56 42.36 Favored Pre-proline 0 CA--C 1.537 0.455 0 CA-C-N 116.873 -0.148 . . . . 0.0 110.836 -179.698 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.5 Cg_exo -58.95 145.1 98.47 Favored 'Trans proline' 0 N--CA 1.495 1.598 0 C-N-CA 122.307 2.005 . . . . 0.0 112.204 179.138 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.509 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 80.3 17.77 73.16 Favored Glycine 0 CA--C 1.523 0.593 0 N-CA-C 110.667 -0.973 . . . . 0.0 110.667 179.716 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.662 HH21 ' CD ' ' A' ' 45' ' ' GLU . 4.9 mmm-85 -128.78 147.54 50.79 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-O 120.547 0.213 . . . . 0.0 110.597 -179.442 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.8 tttt -98.43 135.09 40.5 Favored 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 121.005 0.431 . . . . 0.0 110.491 179.552 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.869 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 67.9 m-85 -121.02 152.87 38.09 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-N 115.84 -0.618 . . . . 0.0 111.378 179.547 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.442 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 79.0 mt -111.7 131.23 63.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.429 0 N-CA-C 107.724 -1.213 . . . . 0.0 107.724 177.14 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.8 t -118.28 134.74 60.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.595 0 C-N-CA 120.267 -0.573 . . . . 0.0 111.507 -178.403 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.9 m-80 -135.21 123.76 23.52 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.488 -0.778 . . . . 0.0 109.3 178.81 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.639 HG21 ' CE3' ' A' ' 26' ' ' TRP . 17.2 t -103.62 130.96 53.22 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.517 0 C-N-CA 120.273 -0.571 . . . . 0.0 110.551 -179.636 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 49.7 m-85 -122.56 139.06 54.33 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 116.085 -0.507 . . . . 0.0 110.433 179.873 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.448 HE22 ' N ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -100.91 135.04 42.99 Favored 'General case' 0 C--N 1.321 -0.637 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 178.098 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . . . . . . . . . 54.0 mt -98.15 123.75 50.82 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.534 0 CA-C-O 121.208 0.527 . . . . 0.0 110.634 -178.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.613 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 59.3 p -83.76 166.18 18.24 Favored 'General case' 0 N--CA 1.448 -0.555 0 CA-C-N 115.398 -0.819 . . . . 0.0 110.498 -179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 55.1 mt-10 -57.48 -18.8 20.53 Favored 'General case' 0 C--N 1.324 -0.543 0 CA-C-N 115.7 -0.682 . . . . 0.0 111.017 -179.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.613 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 37.4 p30 -91.95 -1.1 57.44 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 120.725 -0.39 . . . . 0.0 110.747 -179.797 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.75 13.7 66.63 Favored Glycine 0 CA--C 1.531 1.04 0 C-N-CA 121.241 -0.504 . . . . 0.0 112.032 179.395 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.578 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 63.8 mm-40 -85.47 143.3 28.64 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.863 0.363 . . . . 0.0 111.65 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.803 HE22 ' NE ' ' A' ' 37' ' ' ARG . 78.5 mt-30 -108.06 140.41 41.28 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.067 -0.515 . . . . 0.0 110.742 178.935 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 14.4 t -135.15 132.68 38.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.101 -0.5 . . . . 0.0 110.035 179.607 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.7 tp -73.45 118.98 17.06 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 120.422 -0.511 . . . . 0.0 110.707 -179.962 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 30.2 pt -112.09 -21.48 5.55 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.495 0 CA-C-N 115.966 -0.561 . . . . 0.0 111.111 -179.585 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.8 tp -157.04 124.41 5.28 Favored 'General case' 0 N--CA 1.466 0.36 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.905 179.731 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 35.8 t -132.18 120.82 22.77 Favored 'General case' 0 C--N 1.332 -0.191 0 N-CA-C 109.75 -0.463 . . . . 0.0 109.75 178.211 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.7 t -153.56 155.51 36.3 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.797 -0.361 . . . . 0.0 110.908 -179.757 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 96.4 p -121.63 154.27 37.0 Favored 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.181 0.515 . . . . 0.0 111.042 179.814 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.461 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.7 mt-30 -146.69 157.93 43.8 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.501 -0.772 . . . . 0.0 111.07 179.296 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -109.53 118.3 36.24 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.29 -0.868 . . . . 0.0 109.249 178.71 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.584 HG22 ' CE1' ' A' ' 22' ' ' PHE . 39.2 p . . . . . 0 C--O 1.219 -0.532 0 CA-C-O 118.077 -0.963 . . . . 0.0 110.788 -179.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.489 2.215 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 16.8 Cg_exo -63.81 133.59 39.76 Favored 'Trans proline' 0 C--N 1.309 -1.533 0 C-N-CA 122.453 2.102 . . . . 0.0 111.536 179.809 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 28.6 mt -126.93 -134.87 0.25 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.272 -0.422 . . . . 0.0 110.292 -179.983 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.502 ' O ' ' C ' ' A' ' 5' ' ' SER . . . -115.96 37.18 3.52 Favored Glycine 0 CA--C 1.523 0.565 0 N-CA-C 110.639 -0.984 . . . . 0.0 110.639 179.622 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.559 ' O ' ' OG ' ' A' ' 5' ' ' SER . 4.7 p 33.31 63.73 0.33 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-O 121.016 0.436 . . . . 0.0 110.018 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.508 ' C ' ' ND1' ' A' ' 6' ' ' HIS . 0.1 OUTLIER -97.62 -179.2 4.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 115.848 -0.614 . . . . 0.0 110.793 -179.502 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.787 ' H ' HD12 ' A' ' 7' ' ' LEU . 5.2 mp -65.9 145.48 55.87 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.164 -0.471 . . . . 0.0 110.535 -179.863 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 7.2 p -135.68 -15.62 0.75 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.115 -0.493 . . . . 0.0 110.45 -179.865 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.533 ' C ' ' H ' ' A' ' 11' ' ' SER . . . -176.98 150.15 0.75 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.849 -0.614 . . . . 0.0 109.792 -179.937 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.605 ' O ' ' N ' ' A' ' 12' ' ' GLU . 1.8 m -67.94 10.66 0.19 Allowed 'General case' 0 C--N 1.327 -0.397 0 C-N-CA 120.568 -0.453 . . . . 0.0 110.266 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.541 ' O ' ' OG ' ' A' ' 11' ' ' SER . 1.2 p -35.11 89.69 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.022 179.688 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.605 ' N ' ' O ' ' A' ' 10' ' ' THR . 61.7 tt0 -94.55 116.98 29.42 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.257 -0.429 . . . . 0.0 110.8 -179.323 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 59.9 p -93.6 -10.38 34.86 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.895 -0.593 . . . . 0.0 110.588 179.824 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.612 ' O ' ' O ' ' A' ' 15' ' ' THR . 88.3 t -70.25 -21.31 23.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.138 -0.483 . . . . 0.0 111.093 -179.442 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.807 HG22 ' N ' ' A' ' 16' ' ' GLU . 27.5 m -33.28 -103.09 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.208 0 CA-C-O 121.015 0.436 . . . . 0.0 111.027 -179.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.807 ' N ' HG22 ' A' ' 15' ' ' THR . 9.9 pt-20 32.41 28.48 0.0 OUTLIER 'General case' 0 C--N 1.324 -0.508 0 CA-C-N 116.222 -0.445 . . . . 0.0 110.442 -179.6 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.661 ' N ' ' O ' ' A' ' 15' ' ' THR . 8.9 mt -82.66 -81.25 0.1 OUTLIER 'Isoleucine or valine' 0 C--O 1.231 0.119 0 C-N-CA 120.666 -0.413 . . . . 0.0 111.027 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.601 ' C ' ' O ' ' A' ' 17' ' ' ILE . 1.5 p 11.43 100.85 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.226 0 O-C-N 123.474 0.484 . . . . 0.0 111.187 -179.629 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 71.05 29.75 2.87 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-O 120.961 0.41 . . . . 0.0 109.922 -179.438 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.587 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 1.6 p 55.56 23.47 6.04 Favored 'General case' 0 C--N 1.332 -0.193 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.476 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.622 ' N ' ' O ' ' A' ' 17' ' ' ILE . 3.8 p -63.04 -177.58 0.17 Allowed 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 115.887 -0.597 . . . . 0.0 111.378 -179.532 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.465 ' CZ ' HG22 ' A' ' 95' ' ' THR . 17.7 m-85 -147.67 144.33 28.27 Favored 'General case' 0 CA--C 1.516 -0.347 0 CA-C-N 115.309 -0.86 . . . . 0.0 109.953 178.888 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 14.9 t -116.16 101.67 12.56 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.672 0 N-CA-C 107.689 -1.226 . . . . 0.0 107.689 176.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 80.6 t -111.17 135.16 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.544 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.357 -178.361 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 91.2 p -125.5 154.26 42.34 Favored 'General case' 0 N--CA 1.453 -0.291 0 CA-C-N 115.769 -0.651 . . . . 0.0 110.403 179.666 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.623 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.2 p90 -143.8 -179.19 6.31 Favored 'General case' 0 N--CA 1.448 -0.528 0 CA-C-N 115.896 -0.593 . . . . 0.0 110.01 -179.586 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 33.9 t -118.8 129.36 75.12 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.476 0 CA-C-N 116.352 -0.385 . . . . 0.0 110.045 179.713 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 49.0 p -49.88 126.92 15.17 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.681 -0.408 . . . . 0.0 110.422 -179.859 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . . . . . . . . . . . -90.63 3.31 54.49 Favored 'General case' 0 C--N 1.331 -0.224 0 CA-C-O 121.059 0.457 . . . . 0.0 110.461 179.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.444 ' N ' HE22 ' A' ' 78' ' ' GLN . 5.9 m -174.22 153.7 2.06 Favored 'General case' 0 C--N 1.323 -0.586 0 CA-C-N 115.821 -0.627 . . . . 0.0 110.002 -179.515 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 78.5 m-20 -98.07 1.68 47.92 Favored 'General case' 0 C--N 1.326 -0.426 0 CA-C-O 120.898 0.38 . . . . 0.0 110.288 179.892 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 69.6 p -95.35 -1.76 50.54 Favored 'General case' 0 N--CA 1.453 -0.302 0 CA-C-N 116.0 -0.546 . . . . 0.0 110.745 -179.996 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.502 ' CG2' ' O ' ' A' ' 35' ' ' GLY . 2.5 p -60.04 138.77 20.54 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.459 0 CA-C-N 115.987 -0.551 . . . . 0.0 110.507 179.904 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.686 ' N ' ' O ' ' A' ' 79' ' ' ILE . 18.8 m -93.05 -15.99 25.51 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-O 121.273 0.558 . . . . 0.0 109.507 179.648 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.502 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.41 -177.82 47.2 Favored Glycine 0 CA--C 1.521 0.423 0 N-CA-C 109.798 -1.321 . . . . 0.0 109.798 179.762 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 58' ' ' ALA . 73.8 m-85 -122.73 149.4 44.13 Favored 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 120.96 0.41 . . . . 0.0 110.523 178.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.631 ' NH2' HE22 ' A' ' 85' ' ' GLN . 13.7 ttp180 -127.49 118.71 24.53 Favored 'General case' 0 C--N 1.321 -0.635 0 N-CA-C 108.703 -0.851 . . . . 0.0 108.703 178.691 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 72.9 t -103.49 132.39 49.93 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.591 0 CA-C-N 115.779 -0.646 . . . . 0.0 110.209 -179.481 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.455 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 80.8 tt0 -122.03 134.9 54.79 Favored 'General case' 0 C--N 1.327 -0.38 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.03 -179.573 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.506 ' CE1' ' NE2' ' A' ' 50' ' ' GLN . 54.3 p90 -140.86 137.08 32.97 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.031 -0.531 . . . . 0.0 110.836 178.992 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -149.08 160.86 42.96 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.203 -179.441 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.69 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 47.3 mt -74.32 127.39 32.87 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.704 -0.398 . . . . 0.0 110.691 179.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.7 p -70.87 -24.01 62.42 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-O 121.268 0.556 . . . . 0.0 109.849 179.576 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 79.1 mt-10 -86.6 -74.41 0.43 Allowed 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.429 -0.805 . . . . 0.0 111.027 -179.182 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 79.4 mt-10 -57.95 -35.3 70.93 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 115.985 -0.552 . . . . 0.0 110.93 -179.085 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 70.24 17.33 73.99 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.549 -1.02 . . . . 0.0 110.549 -179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.613 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 27.2 t70 -46.5 -178.47 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.258 0 CA-C-O 120.732 0.301 . . . . 0.0 110.591 -179.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.613 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 2.8 pt-20 -68.8 139.18 90.82 Favored Pre-proline 0 C--N 1.327 -0.389 0 CA-C-N 116.251 -0.431 . . . . 0.0 110.76 -179.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.437 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 37.3 Cg_endo -70.43 153.63 65.72 Favored 'Trans proline' 0 C--N 1.307 -1.641 0 C-N-CA 122.626 2.218 . . . . 0.0 112.851 179.806 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.506 ' NE2' ' CE1' ' A' ' 40' ' ' TYR . 6.1 mt-30 -114.88 145.0 42.65 Favored 'General case' 0 C--N 1.327 -0.396 0 N-CA-C 108.651 -0.87 . . . . 0.0 108.651 178.891 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.404 ' CE1' ' CG ' ' A' ' 39' ' ' GLU . 92.9 m-85 -124.09 136.41 54.22 Favored 'General case' 0 C--N 1.326 -0.442 0 C-N-CA 119.833 -0.747 . . . . 0.0 112.153 -179.204 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.409 HD23 ' HA ' ' A' ' 52' ' ' LEU . 88.6 mt -119.92 131.37 55.2 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 108.668 -0.864 . . . . 0.0 108.668 177.676 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 60.0 m-20 -103.6 132.03 50.22 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.272 -0.571 . . . . 0.0 111.521 -179.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.3 mt -129.72 155.5 80.29 Favored Pre-proline 0 C--N 1.33 -0.243 0 CA-C-N 115.589 -0.732 . . . . 0.0 109.467 179.712 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -66.68 160.42 46.39 Favored 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.232 1.955 . . . . 0.0 112.539 -179.69 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.427 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 15.9 p -57.53 -14.19 4.78 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.667 179.936 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 66.5 p -90.82 -9.47 46.32 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.876 0.369 . . . . 0.0 110.345 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.44 ' O ' ' CD2' ' A' ' 36' ' ' PHE . . . -83.41 128.81 34.81 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.059 -0.518 . . . . 0.0 110.938 -179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.9 p -132.81 14.22 4.36 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.209 -0.451 . . . . 0.0 110.339 179.112 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.8 p -163.16 141.62 8.19 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.31 -0.404 . . . . 0.0 110.152 -179.804 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 4.3 p -150.22 146.43 16.66 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.654 -179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.406 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 9.1 t-20 -103.05 127.2 50.4 Favored 'General case' 0 C--N 1.329 -0.309 0 N-CA-C 108.825 -0.806 . . . . 0.0 108.825 178.23 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mt -102.4 103.65 32.64 Favored Pre-proline 0 C--N 1.331 -0.234 0 C-N-CA 120.944 -0.302 . . . . 0.0 111.34 -179.003 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.406 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 95.0 Cg_endo -90.65 -179.12 1.53 Allowed 'Trans proline' 0 C--N 1.311 -1.426 0 C-N-CA 122.919 2.413 . . . . 0.0 112.622 179.528 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 79.8 m-20 61.58 35.69 17.18 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 114.99 -1.005 . . . . 0.0 111.96 179.503 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 30.5 mt -89.51 152.88 21.21 Favored 'General case' 0 C--N 1.326 -0.439 0 N-CA-C 109.324 -0.621 . . . . 0.0 109.324 178.236 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 22.6 mt -86.11 111.73 40.57 Favored Pre-proline 0 C--N 1.331 -0.235 0 C-N-CA 120.927 -0.309 . . . . 0.0 110.508 -179.987 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.416 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 23.5 Cg_exo -56.29 139.78 86.9 Favored 'Trans proline' 0 C--N 1.31 -1.456 0 C-N-CA 121.933 1.755 . . . . 0.0 111.358 179.34 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 80.83 18.83 69.2 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.384 -0.686 . . . . 0.0 111.384 179.665 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.695 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -125.02 148.74 48.33 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 110.24 -0.281 . . . . 0.0 110.24 179.813 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 53.3 tttt -99.35 132.51 44.62 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.151 179.142 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.69 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 90.3 m-85 -121.56 150.92 40.96 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.189 179.787 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.44 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 87.4 mt -107.71 123.65 63.25 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.64 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 176.856 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 36.4 t -109.95 131.39 61.05 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 CA-C-O 121.009 0.433 . . . . 0.0 110.815 -178.657 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 6.2 m-80 -135.14 129.08 33.3 Favored 'General case' 0 C--N 1.326 -0.432 0 CA-C-N 115.749 -0.66 . . . . 0.0 109.603 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.623 HG11 ' CD2' ' A' ' 26' ' ' TRP . 5.6 t -109.99 131.46 60.91 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 C-N-CA 120.599 -0.44 . . . . 0.0 110.923 -179.471 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 26.4 m-85 -123.47 143.37 50.2 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.288 179.553 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.444 HE22 ' N ' ' A' ' 30' ' ' SER . 0.6 OUTLIER -99.6 136.58 39.32 Favored 'General case' 0 C--N 1.325 -0.483 0 N-CA-C 107.828 -1.175 . . . . 0.0 107.828 177.806 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.686 ' O ' ' N ' ' A' ' 34' ' ' SER . 54.5 mt -100.72 123.97 54.02 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.298 -177.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.606 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 51.9 p -85.44 172.36 11.08 Favored 'General case' 0 C--N 1.324 -0.515 0 CA-C-N 115.282 -0.872 . . . . 0.0 111.003 -179.63 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.549 ' OE2' ' OG ' ' A' ' 34' ' ' SER . 78.1 mm-40 -61.48 -23.96 66.25 Favored 'General case' 0 C--N 1.325 -0.457 0 CA-C-N 115.5 -0.773 . . . . 0.0 111.03 -179.978 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.606 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.9 p30 -93.57 -1.66 55.18 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 120.658 -0.417 . . . . 0.0 111.35 -179.49 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.1 15.97 60.05 Favored Glycine 0 CA--C 1.528 0.89 0 C-N-CA 120.992 -0.623 . . . . 0.0 112.411 179.139 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.459 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.4 mm-40 -84.79 131.82 34.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 117.14 0.47 . . . . 0.0 110.596 179.285 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.631 HE22 ' NH2' ' A' ' 37' ' ' ARG . 27.3 mt-30 -105.26 141.11 37.36 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 116.27 -0.423 . . . . 0.0 110.794 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.6 t -136.29 133.56 37.07 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.576 179.115 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.76 HD21 ' HB2' ' A' ' 90' ' ' SER . 28.0 tp -72.3 118.41 15.16 Favored 'General case' 0 C--N 1.327 -0.409 0 C-N-CA 120.291 -0.564 . . . . 0.0 110.3 -179.679 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 21.5 pt -110.06 -20.58 6.14 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.475 0 CA-C-N 115.646 -0.706 . . . . 0.0 110.523 -179.755 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.457 HD22 ' HB3' ' A' ' 26' ' ' TRP . 15.0 tp -155.0 124.89 6.59 Favored 'General case' 0 C--N 1.331 -0.239 0 C-N-CA 120.553 -0.459 . . . . 0.0 111.422 -179.817 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.76 ' HB2' HD21 ' A' ' 87' ' ' LEU . 12.9 t -131.93 123.03 26.59 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.978 -0.555 . . . . 0.0 109.562 178.903 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.7 t -154.14 152.76 30.78 Favored 'General case' 0 C--O 1.225 -0.22 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.034 -179.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 79.6 p -118.19 153.37 33.97 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-O 120.927 0.394 . . . . 0.0 110.075 179.077 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 20.9 mt-30 -142.59 160.5 40.18 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-N 116.011 -0.541 . . . . 0.0 110.838 179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.47 115.92 25.61 Favored 'General case' 0 C--N 1.322 -0.593 0 CA-C-N 115.283 -0.871 . . . . 0.0 109.015 179.203 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.465 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 81.9 p . . . . . 0 C--O 1.22 -0.459 0 CA-C-O 117.958 -1.02 . . . . 0.0 110.662 -179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 2.357 0 N-CA-C 109.617 -1.393 . . . . 0.0 109.617 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 55.4 Cg_endo -72.11 34.11 0.29 Allowed 'Trans proline' 0 C--N 1.305 -1.723 0 C-N-CA 122.978 2.452 . . . . 0.0 112.467 -179.904 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 32.1 tp 44.35 84.55 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.75 0.31 . . . . 0.0 110.511 -179.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -118.57 -131.27 4.33 Favored Glycine 0 CA--C 1.525 0.68 0 N-CA-C 111.468 -0.653 . . . . 0.0 111.468 -179.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 4.7 p -82.78 2.13 35.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.464 0.173 . . . . 0.0 110.94 -179.462 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 15.1 m-70 -58.85 -57.69 11.91 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.623 -0.431 . . . . 0.0 110.697 -179.631 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.636 ' O ' ' O ' ' A' ' 8' ' ' VAL . 47.2 mt -95.05 0.07 54.12 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.247 -0.433 . . . . 0.0 110.298 179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.636 ' O ' ' O ' ' A' ' 7' ' ' LEU . 0.3 OUTLIER 41.55 175.88 0.0 OUTLIER 'Isoleucine or valine' 0 N--CA 1.462 0.138 0 CA-C-N 115.802 -0.635 . . . . 0.0 110.787 -179.33 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.478 ' H ' HG22 ' A' ' 8' ' ' VAL . . . -70.43 147.39 49.54 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.258 -0.428 . . . . 0.0 110.856 -179.43 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.658 ' O ' ' N ' ' A' ' 12' ' ' GLU . 40.8 p -80.02 3.87 18.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.151 -0.477 . . . . 0.0 110.3 179.711 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.59 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 0.0 OUTLIER 55.99 -69.35 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.822 -0.626 . . . . 0.0 110.759 179.748 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.658 ' N ' ' O ' ' A' ' 10' ' ' THR . 24.4 tp10 -108.92 -137.41 0.37 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.479 -0.328 . . . . 0.0 110.31 -179.788 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.566 ' O ' ' O ' ' A' ' 14' ' ' VAL . 1.4 t 178.68 69.55 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.491 -0.322 . . . . 0.0 110.986 -179.865 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.763 ' CG1' ' H ' ' A' ' 23' ' ' VAL . 2.0 t 53.39 129.34 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.267 0 CA-C-N 116.276 -0.42 . . . . 0.0 110.904 179.615 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.911 HG22 ' H ' ' A' ' 16' ' ' GLU . 7.4 m -81.95 -140.27 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.079 -0.51 . . . . 0.0 110.828 179.887 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.911 ' H ' HG22 ' A' ' 15' ' ' THR . 81.0 mm-40 26.04 47.53 0.01 OUTLIER 'General case' 0 CA--C 1.52 -0.194 0 CA-C-O 121.034 0.445 . . . . 0.0 110.029 -179.534 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.503 ' O ' HG22 ' A' ' 17' ' ' ILE . 43.9 mt -65.6 -5.36 2.69 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.44 0 CA-C-N 115.771 -0.649 . . . . 0.0 110.253 -179.429 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.466 ' O ' ' N ' ' A' ' 20' ' ' SER . 68.8 p -62.63 151.09 39.05 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 179.806 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.559 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 43.34 23.82 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.35 -0.54 . . . . 0.0 109.672 -179.272 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.559 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 60.56 27.57 17.24 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.781 -0.645 . . . . 0.0 110.383 179.738 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.562 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -55.08 -178.16 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 121.596 0.712 . . . . 0.0 111.862 -179.338 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.488 ' CD1' ' NE2' ' A' ' 93' ' ' GLN . 18.7 m-85 -146.34 146.51 30.7 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 114.696 -1.138 . . . . 0.0 109.744 178.465 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.763 ' H ' ' CG1' ' A' ' 14' ' ' VAL . 54.1 t -119.04 103.19 14.1 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 176.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.3 t -109.04 134.57 50.62 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 115.997 -0.547 . . . . 0.0 111.191 -178.453 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 60.1 p -128.05 150.52 49.91 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.909 -0.587 . . . . 0.0 110.757 179.857 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 41.4 p90 -145.01 178.62 7.91 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 115.628 -0.715 . . . . 0.0 109.949 179.91 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 35.8 t -117.01 128.48 74.41 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.76 0 N-CA-C 109.006 -0.739 . . . . 0.0 109.006 178.673 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 1.3 m -48.1 148.98 1.55 Allowed 'General case' 0 C--N 1.325 -0.466 0 C-N-CA 120.162 -0.615 . . . . 0.0 109.422 -179.447 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.654 ' C ' HE22 ' A' ' 78' ' ' GLN . . . -138.51 55.15 1.75 Allowed 'General case' 0 C--N 1.329 -0.288 0 C-N-CA 120.513 -0.475 . . . . 0.0 111.659 -178.808 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.73 ' C ' ' H ' ' A' ' 32' ' ' THR . 0.4 OUTLIER 178.21 -27.29 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.364 -0.38 . . . . 0.0 110.614 179.334 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 98.3 m-20 60.86 -26.32 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 120.893 0.378 . . . . 0.0 110.128 -179.164 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.73 ' H ' ' C ' ' A' ' 30' ' ' SER . 1.9 m -92.04 -0.85 57.46 Favored 'General case' 0 N--CA 1.453 -0.322 0 N-CA-C 108.605 -0.887 . . . . 0.0 108.605 178.726 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.448 HG13 ' HB2' ' A' ' 56' ' ' SER . 1.5 p -52.78 137.08 13.19 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.531 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.656 179.509 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.553 ' N ' ' O ' ' A' ' 79' ' ' ILE . 50.5 m -94.62 -14.77 24.62 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-O 121.295 0.569 . . . . 0.0 109.648 -179.795 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 174.9 177.3 43.9 Favored Glycine 0 CA--C 1.521 0.445 0 N-CA-C 110.14 -1.184 . . . . 0.0 110.14 179.827 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -124.77 152.86 43.3 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-O 120.927 0.394 . . . . 0.0 110.624 179.06 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.781 ' NH1' ' CD1' ' A' ' 51' ' ' TYR . 14.8 ttp85 -128.59 126.06 39.51 Favored 'General case' 0 C--N 1.323 -0.576 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 178.641 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.657 HG21 HG11 ' A' ' 61' ' ' VAL . 41.6 t -105.72 132.34 52.95 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.625 0 CA-C-N 116.096 -0.502 . . . . 0.0 110.734 -179.373 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.453 ' OE2' ' CB ' ' A' ' 49' ' ' PRO . 73.3 tt0 -127.95 133.25 49.21 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 120.504 -0.479 . . . . 0.0 110.72 179.65 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.581 ' CD1' ' N ' ' A' ' 40' ' ' TYR . 1.6 p90 -140.43 133.74 29.77 Favored 'General case' 0 C--N 1.326 -0.443 0 CA-C-N 115.969 -0.56 . . . . 0.0 110.222 179.126 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.2 pt-20 -143.59 162.09 36.79 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.247 -0.649 . . . . 0.0 109.247 179.546 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.726 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 47.2 mt -72.9 134.95 45.01 Favored 'General case' 0 C--N 1.322 -0.587 0 C-N-CA 120.306 -0.557 . . . . 0.0 110.997 -179.994 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.7 p -73.55 -19.38 60.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.07 -0.514 . . . . 0.0 110.213 179.629 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . 0.404 ' HG2' HH22 ' A' ' 70' ' ' ARG . 73.5 mm-40 -98.5 -65.0 0.99 Allowed 'General case' 0 C--N 1.331 -0.207 0 CA-C-N 116.037 -0.529 . . . . 0.0 110.936 -179.568 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 88.5 mt-10 -64.16 -31.07 72.13 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.423 -179.432 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.546 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 55.27 22.72 30.96 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.423 -1.071 . . . . 0.0 110.423 179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.546 ' O ' ' O ' ' A' ' 46' ' ' GLY . 34.1 t0 -49.59 -169.2 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.432 0 CA-C-O 120.929 0.395 . . . . 0.0 110.297 -179.783 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.498 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 1.7 pt-20 -68.7 138.13 90.69 Favored Pre-proline 0 C--N 1.324 -0.515 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.217 179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.453 ' CB ' ' OE2' ' A' ' 39' ' ' GLU . 61.2 Cg_endo -73.43 151.09 47.45 Favored 'Trans proline' 0 C--N 1.305 -1.757 0 C-N-CA 122.62 2.213 . . . . 0.0 111.94 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . . . . . . . . . 15.3 mt-30 -112.27 141.0 46.5 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 178.917 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.781 ' CD1' ' NH1' ' A' ' 37' ' ' ARG . 78.6 m-85 -123.43 138.8 54.51 Favored 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 119.705 -0.798 . . . . 0.0 112.872 -178.226 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 79.6 mt -126.6 132.18 51.33 Favored 'General case' 0 C--N 1.328 -0.352 0 N-CA-C 108.178 -1.045 . . . . 0.0 108.178 177.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 80.9 m-20 -100.91 134.38 43.98 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.364 -0.534 . . . . 0.0 111.882 -178.636 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.4 mt -128.64 154.7 79.69 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-N 115.339 -0.846 . . . . 0.0 109.558 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -69.08 159.39 54.12 Favored 'Trans proline' 0 C--N 1.305 -1.762 0 C-N-CA 122.245 1.963 . . . . 0.0 111.957 179.513 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.475 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 25.4 p -59.72 -11.99 6.2 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.075 -0.511 . . . . 0.0 110.672 -179.622 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 52.3 p -91.23 -6.4 53.4 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.766 179.911 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.69 132.97 35.17 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.465 -0.334 . . . . 0.0 110.682 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 4.2 p -130.65 6.84 4.78 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.175 -0.466 . . . . 0.0 110.267 179.474 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 89.4 p -164.92 141.38 5.8 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.422 179.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.657 HG11 HG21 ' A' ' 38' ' ' VAL . 8.0 p -148.11 148.96 15.7 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.161 0 CA-C-O 121.162 0.506 . . . . 0.0 111.667 -179.324 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.534 ' ND2' ' CB ' ' A' ' 16' ' ' GLU . 10.1 t-20 -102.63 125.45 49.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 115.571 -0.74 . . . . 0.0 109.908 178.935 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.8 mt -99.03 108.17 47.95 Favored Pre-proline 0 CA--C 1.531 0.242 0 CA-C-N 116.338 -0.392 . . . . 0.0 111.351 -179.324 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 41.6 Cg_endo -93.36 -176.92 0.61 Allowed 'Trans proline' 0 C--N 1.312 -1.376 0 C-N-CA 123.168 2.579 . . . . 0.0 112.705 179.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 66.8 m-20 59.59 35.55 22.57 Favored 'General case' 0 C--N 1.324 -0.53 0 CA-C-N 115.266 -0.879 . . . . 0.0 111.233 179.161 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . . . . . . . . . 26.8 mt -89.6 148.11 23.53 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.81 -0.356 . . . . 0.0 110.191 179.299 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 30.0 mt -86.49 113.31 51.97 Favored Pre-proline 0 CA--C 1.535 0.377 0 CA-C-N 116.575 -0.284 . . . . 0.0 111.034 -179.093 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -57.66 140.95 95.14 Favored 'Trans proline' 0 N--CA 1.495 1.605 0 C-N-CA 122.236 1.957 . . . . 0.0 112.334 179.484 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.2 21.42 67.6 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 111.121 -0.791 . . . . 0.0 111.121 179.563 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.682 ' HE ' HD22 ' A' ' 42' ' ' LEU . 7.3 mmm180 -125.67 149.0 48.83 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 121.068 0.461 . . . . 0.0 111.945 -179.546 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . 0.4 ' H ' ' CZ ' ' A' ' 70' ' ' ARG . 67.9 tttt -102.34 130.52 49.09 Favored 'General case' 0 C--N 1.332 -0.195 0 CA-C-N 115.687 -0.688 . . . . 0.0 109.775 178.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.726 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 90.4 m-85 -122.72 154.05 38.63 Favored 'General case' 0 C--N 1.323 -0.562 0 CA-C-O 121.091 0.472 . . . . 0.0 111.246 179.667 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 63.3 mt -108.22 125.88 64.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.542 0 N-CA-C 107.43 -1.322 . . . . 0.0 107.43 177.018 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 22.2 t -113.98 133.83 58.74 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.745 0 CA-C-O 121.205 0.526 . . . . 0.0 111.401 -178.503 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 40.7 m-80 -134.63 126.08 28.46 Favored 'General case' 0 C--N 1.322 -0.589 0 CA-C-N 115.324 -0.853 . . . . 0.0 109.354 179.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 16.0 t -103.93 128.3 57.37 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.651 0 C-N-CA 120.202 -0.599 . . . . 0.0 109.848 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 25.2 m-85 -121.36 137.94 54.48 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.124 -0.489 . . . . 0.0 110.103 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.654 HE22 ' C ' ' A' ' 29' ' ' ALA . 0.5 OUTLIER -101.01 136.0 41.56 Favored 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 108.465 -0.939 . . . . 0.0 108.465 178.476 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.553 ' O ' ' N ' ' A' ' 34' ' ' SER . 62.3 mt -98.68 120.95 48.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.702 0 CA-C-O 121.253 0.549 . . . . 0.0 110.808 -178.28 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 29.2 p -82.4 168.53 17.4 Favored 'General case' 0 N--CA 1.448 -0.538 0 CA-C-N 115.245 -0.889 . . . . 0.0 110.22 -179.838 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . 0.555 ' HG2' HG22 ' A' ' 32' ' ' THR . 73.5 mm-40 -59.28 -18.22 35.61 Favored 'General case' 0 C--N 1.323 -0.571 0 CA-C-N 115.88 -0.6 . . . . 0.0 110.825 -179.143 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.63 ' OD1' ' N ' ' A' ' 84' ' ' GLU . 38.7 p30 -93.07 -1.51 56.45 Favored 'General case' 0 CA--C 1.531 0.222 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.243 -179.682 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.61 12.8 68.72 Favored Glycine 0 CA--C 1.529 0.923 0 C-N-CA 120.878 -0.677 . . . . 0.0 111.575 179.963 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.63 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.0 mm-40 -84.69 141.89 30.26 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.981 0.419 . . . . 0.0 111.082 179.617 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.484 HE22 ' NE ' ' A' ' 37' ' ' ARG . 94.4 mt-30 -110.12 141.93 42.32 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 115.992 -0.549 . . . . 0.0 110.702 179.471 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 10.4 t -136.5 131.22 33.65 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 116.014 -0.539 . . . . 0.0 110.034 179.339 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.569 HD21 ' HB2' ' A' ' 90' ' ' SER . 30.4 tp -72.3 116.96 13.36 Favored 'General case' 0 C--N 1.325 -0.465 0 C-N-CA 120.499 -0.481 . . . . 0.0 110.157 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 36.5 pt -110.31 -21.69 5.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 CA-C-N 116.056 -0.52 . . . . 0.0 110.939 -179.424 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 20.0 tp -154.75 122.03 5.63 Favored 'General case' 0 C--N 1.328 -0.354 0 C-N-CA 120.373 -0.531 . . . . 0.0 111.185 -179.852 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.569 ' HB2' HD21 ' A' ' 87' ' ' LEU . 22.6 t -131.19 117.88 19.67 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.868 -0.605 . . . . 0.0 109.433 179.096 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -150.63 155.71 39.91 Favored 'General case' 0 C--N 1.329 -0.283 0 C-N-CA 120.677 -0.409 . . . . 0.0 110.637 -179.523 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 87.6 p -114.85 156.04 25.68 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.242 -0.435 . . . . 0.0 110.427 179.651 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.488 ' NE2' ' CD1' ' A' ' 22' ' ' PHE . 25.4 mt-30 -144.28 153.3 41.88 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.753 179.741 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.26 106.68 14.91 Favored 'General case' 0 C--N 1.324 -0.509 0 CA-C-N 115.631 -0.713 . . . . 0.0 109.2 178.738 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . . . . . . . . . 20.6 p . . . . . 0 C--O 1.221 -0.397 0 CA-C-O 118.051 -0.976 . . . . 0.0 110.595 -179.24 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.466 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.246 0 N-CA-C 109.429 -1.468 . . . . 0.0 109.429 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -67.69 6.7 0.69 Allowed 'Trans proline' 0 C--N 1.307 -1.614 0 C-N-CA 122.24 1.96 . . . . 0.0 111.317 179.792 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.509 ' O ' HD23 ' A' ' 3' ' ' LEU . 2.3 tt 73.19 -55.23 0.68 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.494 -0.776 . . . . 0.0 110.659 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 88.67 -148.95 20.73 Favored Glycine 0 CA--C 1.524 0.614 0 C-N-CA 120.86 -0.686 . . . . 0.0 111.44 179.625 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 1.8 t 71.34 15.22 6.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.846 0.355 . . . . 0.0 110.195 -179.501 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -52.41 -40.24 61.9 Favored 'General case' 0 C--N 1.331 -0.202 0 CA-C-N 116.092 -0.504 . . . . 0.0 109.674 179.678 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.537 ' HG ' ' H ' ' A' ' 9' ' ' ALA . 12.2 tp -90.35 124.69 35.13 Favored 'General case' 0 C--N 1.327 -0.407 0 N-CA-C 109.271 -0.64 . . . . 0.0 109.271 179.044 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.601 HG21 ' HB2' ' A' ' 13' ' ' SER . 3.6 t -82.95 -13.32 12.06 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.431 0 CA-C-N 116.13 -0.486 . . . . 0.0 110.872 -178.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.577 ' HB3' ' O ' ' A' ' 8' ' ' VAL . . . 74.98 -37.74 0.36 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.265 -0.425 . . . . 0.0 111.555 179.211 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.753 ' O ' ' N ' ' A' ' 12' ' ' GLU . 88.8 m -79.28 136.83 37.15 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.886 -0.325 . . . . 0.0 110.198 179.952 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.544 ' C ' ' O ' ' A' ' 10' ' ' THR . 7.0 t -26.25 80.15 0.0 OUTLIER 'General case' 0 C--N 1.333 -0.152 0 O-C-N 123.341 0.4 . . . . 0.0 110.672 -179.837 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.753 ' N ' ' O ' ' A' ' 10' ' ' THR . 50.9 mt-10 59.45 150.41 0.02 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.219 -0.446 . . . . 0.0 110.783 -179.898 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.601 ' HB2' HG21 ' A' ' 8' ' ' VAL . 15.4 t -60.92 -36.41 79.23 Favored 'General case' 0 C--N 1.332 -0.167 0 CA-C-O 121.029 0.442 . . . . 0.0 110.112 179.527 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 15.5 m -121.69 143.76 33.11 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.847 -0.615 . . . . 0.0 110.331 179.651 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.849 HG22 ' N ' ' A' ' 16' ' ' GLU . 3.1 m -91.07 -93.45 0.13 Allowed 'General case' 0 C--O 1.224 -0.261 0 C-N-CA 120.413 -0.515 . . . . 0.0 110.146 179.324 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.849 ' N ' HG22 ' A' ' 15' ' ' THR . 74.3 mm-40 -30.86 114.01 0.11 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.868 0.366 . . . . 0.0 110.195 -179.728 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.503 HG13 ' O ' ' A' ' 15' ' ' THR . 11.7 mt -112.05 -18.19 7.82 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.228 0 CA-C-N 115.98 -0.554 . . . . 0.0 111.225 -179.205 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.464 ' C ' ' N ' ' A' ' 20' ' ' SER . 71.8 p -58.48 156.37 10.56 Favored 'General case' 0 C--N 1.329 -0.295 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 -179.688 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.526 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 46.35 21.61 0.13 Allowed 'General case' 0 N--CA 1.451 -0.405 0 N-CA-C 109.055 -0.721 . . . . 0.0 109.055 -178.631 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.526 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.1 OUTLIER 57.97 36.3 26.04 Favored 'General case' 0 N--CA 1.455 -0.186 0 CA-C-N 115.487 -0.779 . . . . 0.0 110.241 -179.604 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.544 ' OG ' ' CB ' ' A' ' 16' ' ' GLU . 0.4 OUTLIER -61.97 159.9 13.37 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 115.933 -0.576 . . . . 0.0 111.41 -179.161 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.486 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 22.5 m-30 -127.23 151.97 48.01 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.538 -0.755 . . . . 0.0 110.806 178.899 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.0 t -126.76 106.56 15.75 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.559 0 N-CA-C 108.33 -0.989 . . . . 0.0 108.33 176.166 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 93.6 t -115.24 145.48 20.93 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.46 0 CA-C-O 121.109 0.48 . . . . 0.0 111.006 -179.133 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 84.2 p -131.4 153.82 49.29 Favored 'General case' 0 N--CA 1.445 -0.696 0 CA-C-N 115.585 -0.734 . . . . 0.0 109.69 179.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.479 ' CD2' HG11 ' A' ' 76' ' ' VAL . 33.0 p90 -143.35 -166.38 2.3 Favored 'General case' 0 C--N 1.32 -0.675 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.332 -179.74 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.565 HG12 ' H ' ' A' ' 29' ' ' ALA . 25.4 t -117.45 129.23 74.25 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.531 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 179.146 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 54.3 m -50.55 -33.98 23.8 Favored 'General case' 0 C--N 1.325 -0.471 0 C-N-CA 119.855 -0.738 . . . . 0.0 109.079 -179.802 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.565 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 51.11 12.54 0.13 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 115.754 -0.657 . . . . 0.0 111.909 178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.463 ' OG ' ' O ' ' A' ' 29' ' ' ALA . 5.3 m -175.57 148.34 0.9 Allowed 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 119.646 -0.822 . . . . 0.0 111.89 -179.578 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 75.3 m-20 -103.79 -12.36 16.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 115.589 -0.732 . . . . 0.0 110.387 179.228 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 72.3 p -79.68 -1.12 36.92 Favored 'General case' 0 N--CA 1.452 -0.325 0 CA-C-O 121.075 0.464 . . . . 0.0 109.827 179.598 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.418 ' O ' ' HB3' ' A' ' 56' ' ' SER . 3.9 p -73.72 130.42 35.86 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 CA-C-N 115.612 -0.722 . . . . 0.0 110.226 179.559 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.687 ' N ' ' O ' ' A' ' 79' ' ' ILE . 39.0 m -95.45 -12.98 24.99 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 121.218 0.532 . . . . 0.0 109.739 179.359 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.443 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.17 -179.88 47.82 Favored Glycine 0 CA--C 1.523 0.588 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.88 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 97.0 m-85 -127.86 151.53 48.94 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-O 120.749 0.309 . . . . 0.0 110.433 179.615 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.889 ' NE ' HE22 ' A' ' 85' ' ' GLN . 25.3 ttp180 -129.35 122.83 30.32 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 109.252 -0.647 . . . . 0.0 109.252 178.317 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.486 HG21 HG11 ' A' ' 61' ' ' VAL . 80.8 t -108.2 133.82 51.96 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.518 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.542 -179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.416 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 59.3 tt0 -124.46 137.06 54.47 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 116.146 -0.479 . . . . 0.0 110.548 -179.777 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.447 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 24.9 p90 -141.81 130.66 22.98 Favored 'General case' 0 C--N 1.328 -0.327 0 C-N-CA 120.43 -0.508 . . . . 0.0 110.937 178.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -143.11 164.29 30.54 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 115.53 -0.759 . . . . 0.0 109.324 -179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.82 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 83.0 mt -75.69 123.89 26.33 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.166 0.507 . . . . 0.0 111.491 -179.434 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 24.0 p -66.14 -26.04 67.25 Favored 'General case' 0 C--N 1.331 -0.211 0 CA-C-N 115.714 -0.675 . . . . 0.0 110.423 179.657 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -87.88 -73.54 0.48 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.674 -0.694 . . . . 0.0 110.299 -179.162 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.547 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 81.3 mt-10 -83.54 148.56 27.13 Favored 'General case' 0 N--CA 1.445 -0.702 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 179.049 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.627 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . -61.4 -23.54 62.57 Favored Glycine 0 CA--C 1.523 0.583 0 C-N-CA 120.139 -1.029 . . . . 0.0 111.415 -179.138 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.684 ' HB2' HD12 ' A' ' 42' ' ' LEU . 16.1 t70 33.01 -161.14 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.872 0.368 . . . . 0.0 110.093 -179.637 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.644 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.4 OUTLIER -119.07 126.01 27.31 Favored Pre-proline 0 C--N 1.326 -0.446 0 N-CA-C 109.896 -0.409 . . . . 0.0 109.896 179.291 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_endo -71.15 137.2 31.0 Favored 'Trans proline' 0 C--N 1.305 -1.763 0 C-N-CA 121.815 1.677 . . . . 0.0 111.163 -179.918 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.447 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 5.2 mt-30 -120.61 150.93 40.12 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.903 -0.406 . . . . 0.0 109.903 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 25.5 m-85 -124.78 136.13 53.58 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.329 -0.548 . . . . 0.0 110.95 -179.751 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 90.8 mt -122.09 130.19 53.04 Favored 'General case' 0 C--N 1.327 -0.406 0 N-CA-C 109.222 -0.658 . . . . 0.0 109.222 178.372 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.479 ' O ' HD23 ' A' ' 54' ' ' LEU . 67.3 m-20 -104.29 133.53 49.04 Favored 'General case' 0 C--N 1.323 -0.586 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.39 -179.43 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.479 HD23 ' O ' ' A' ' 53' ' ' ASP . 7.2 mt -129.41 155.77 79.58 Favored Pre-proline 0 C--N 1.324 -0.527 0 CA-C-N 115.408 -0.815 . . . . 0.0 109.278 -179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.466 ' HD2' ' HB2' ' A' ' 58' ' ' ALA . 22.2 Cg_endo -69.49 151.24 70.59 Favored 'Trans proline' 0 C--N 1.306 -1.707 0 C-N-CA 121.63 1.553 . . . . 0.0 112.059 -179.538 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.443 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 3.3 p -52.16 -13.03 0.28 Allowed 'General case' 0 C--N 1.326 -0.416 0 CA-C-N 115.683 -0.689 . . . . 0.0 110.491 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . 0.406 ' N ' ' C ' ' A' ' 55' ' ' PRO . 78.1 p -93.01 -7.06 46.87 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.315 -0.402 . . . . 0.0 110.57 179.685 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.466 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . . . -80.45 136.79 36.4 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.427 -0.351 . . . . 0.0 110.352 179.754 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -129.62 8.9 5.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.342 -0.39 . . . . 0.0 111.055 179.877 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 52.5 p -164.57 149.84 10.01 Favored 'General case' 0 C--N 1.332 -0.162 0 C-N-CA 120.815 -0.354 . . . . 0.0 110.702 179.653 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.486 HG11 HG21 ' A' ' 38' ' ' VAL . 9.9 p -151.85 153.06 10.18 Favored 'Isoleucine or valine' 0 C--O 1.232 0.136 0 CA-C-O 121.244 0.545 . . . . 0.0 111.944 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.451 ' OD1' ' O ' ' A' ' 22' ' ' PHE . 50.8 t30 -105.51 128.5 53.6 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 115.466 -0.788 . . . . 0.0 109.927 178.764 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.415 HG22 HD21 ' A' ' 66' ' ' LEU . 2.0 mt -102.13 103.36 29.61 Favored Pre-proline 0 C--N 1.329 -0.299 0 CA-C-N 116.377 -0.374 . . . . 0.0 110.808 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.411 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 64.2 Cg_endo -89.95 -175.21 0.95 Allowed 'Trans proline' 0 C--N 1.31 -1.468 0 C-N-CA 123.177 2.585 . . . . 0.0 112.211 179.782 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 87.4 m-20 58.86 36.63 24.75 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.647 -0.706 . . . . 0.0 111.234 179.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.472 HD12 ' O ' ' A' ' 20' ' ' SER . 16.4 mt -89.2 149.66 23.01 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.435 -0.348 . . . . 0.0 110.313 179.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.597 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 21.8 mt -92.67 112.06 53.91 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-N 116.085 -0.507 . . . . 0.0 112.076 -178.54 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_exo -59.34 132.84 48.74 Favored 'Trans proline' 0 C--N 1.311 -1.408 0 C-N-CA 121.875 1.717 . . . . 0.0 110.703 178.153 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 86.48 10.72 73.13 Favored Glycine 0 CA--C 1.526 0.728 0 N-CA-C 110.79 -0.924 . . . . 0.0 110.79 -179.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.547 ' NH2' ' OE2' ' A' ' 45' ' ' GLU . 19.4 mmt85 -123.77 145.9 48.7 Favored 'General case' 0 C--N 1.331 -0.2 0 N-CA-C 109.908 -0.404 . . . . 0.0 109.908 179.108 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.2 tttt -97.22 133.16 42.21 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.087 -0.506 . . . . 0.0 110.02 179.873 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.82 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 20.7 m-85 -115.27 156.19 25.87 Favored 'General case' 0 C--N 1.325 -0.5 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.225 -179.8 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.564 HG22 HD21 ' A' ' 75' ' ' ASN . 62.5 mt -113.47 122.14 67.02 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.494 0 N-CA-C 107.595 -1.261 . . . . 0.0 107.595 177.085 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 35.0 t -110.84 128.12 67.45 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.762 0 CA-C-O 121.067 0.461 . . . . 0.0 110.948 -178.774 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.564 HD21 HG22 ' A' ' 73' ' ' ILE . 39.7 m-80 -133.86 127.17 32.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.761 -0.654 . . . . 0.0 109.599 179.52 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.479 HG11 ' CD2' ' A' ' 26' ' ' TRP . 19.5 t -106.99 128.25 61.99 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.668 0 C-N-CA 120.343 -0.543 . . . . 0.0 110.732 -179.468 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 67.9 m-85 -117.32 139.0 51.39 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 0.0 109.876 179.314 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . . . . . . . . . 0.4 OUTLIER -100.76 135.13 42.7 Favored 'General case' 0 C--N 1.326 -0.451 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.687 ' O ' ' N ' ' A' ' 34' ' ' SER . 60.0 mt -99.26 121.94 50.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.45 0 CA-C-O 120.916 0.388 . . . . 0.0 110.984 -178.587 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.593 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 93.0 p -85.2 168.98 14.28 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.608 -0.724 . . . . 0.0 111.008 179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.8 mt-10 -57.25 -20.8 29.87 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.718 -0.674 . . . . 0.0 111.643 -179.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.593 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 50.0 p30 -93.38 2.67 56.44 Favored 'General case' 0 C--N 1.327 -0.382 0 C-N-CA 120.357 -0.537 . . . . 0.0 111.17 -179.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 84.29 13.95 72.62 Favored Glycine 0 CA--C 1.525 0.681 0 C-N-CA 121.077 -0.583 . . . . 0.0 111.944 179.181 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.412 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 69.7 mm-40 -85.13 144.35 28.26 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-O 120.984 0.421 . . . . 0.0 111.4 179.965 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.889 HE22 ' NE ' ' A' ' 37' ' ' ARG . 53.5 mt-30 -109.51 140.03 43.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 115.902 -0.59 . . . . 0.0 110.719 179.115 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 5.9 t -135.72 132.36 36.78 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.894 -0.594 . . . . 0.0 109.867 179.279 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.448 HD21 ' HB2' ' A' ' 90' ' ' SER . 22.0 tp -73.16 117.07 14.45 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.478 -0.328 . . . . 0.0 110.424 179.905 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 23.0 pt -107.43 -22.84 4.75 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 C-N-CA 120.679 -0.408 . . . . 0.0 111.096 -179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 21.4 tp -156.73 125.26 5.77 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 119.996 -0.681 . . . . 0.0 111.812 -179.689 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.448 ' HB2' HD21 ' A' ' 87' ' ' LEU . 47.8 t -127.7 123.66 35.98 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 115.82 -0.627 . . . . 0.0 109.33 178.424 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 10.4 t -155.0 156.72 36.47 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.613 -179.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 81.3 p -116.96 156.1 28.0 Favored 'General case' 0 C--N 1.328 -0.341 0 C-N-CA 120.83 -0.348 . . . . 0.0 110.413 179.811 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.486 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 20.0 mt-30 -140.38 160.16 40.6 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.3 0.571 . . . . 0.0 111.122 179.456 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.69 112.65 17.0 Favored 'General case' 0 C--N 1.324 -0.51 0 CA-C-N 115.177 -0.92 . . . . 0.0 109.236 179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.408 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 43.9 p . . . . . 0 C--N 1.325 -0.496 0 CA-C-O 118.102 -0.951 . . . . 0.0 110.601 -179.414 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.528 ' O ' ' O ' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.363 0 N-CA-C 109.52 -1.432 . . . . 0.0 109.52 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.528 ' O ' ' O ' ' A' ' 1' ' ' GLY . 37.9 Cg_exo -52.82 -136.02 0.0 OUTLIER 'Trans proline' 0 C--N 1.305 -1.736 0 C-N-CA 122.877 2.385 . . . . 0.0 112.134 -179.795 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 11.5 tp -92.96 125.64 37.66 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.46 -0.336 . . . . 0.0 110.733 -179.694 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . -89.24 -175.08 46.41 Favored Glycine 0 CA--C 1.525 0.713 0 N-CA-C 111.239 -0.744 . . . . 0.0 111.239 -179.925 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 58.4 p -71.86 157.6 37.58 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.939 0.399 . . . . 0.0 110.8 -180.0 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.683 ' O ' ' N ' ' A' ' 8' ' ' VAL . 80.5 m-70 -133.71 -64.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 115.908 -0.587 . . . . 0.0 110.374 179.754 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.612 ' N ' HD12 ' A' ' 7' ' ' LEU . 6.1 mp 30.98 30.38 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.926 -0.579 . . . . 0.0 110.057 -179.929 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.683 ' N ' ' O ' ' A' ' 6' ' ' HIS . 2.1 t 48.53 13.4 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 115.792 -0.64 . . . . 0.0 110.64 -179.895 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.467 ' N ' ' C ' ' A' ' 7' ' ' LEU . . . -78.3 -3.27 42.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.143 -0.48 . . . . 0.0 110.089 179.622 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.842 HG22 ' H ' ' A' ' 11' ' ' SER . 1.5 m -78.39 -169.98 1.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.851 -0.613 . . . . 0.0 110.322 -179.979 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.842 ' H ' HG22 ' A' ' 10' ' ' THR . 7.2 p -60.04 170.05 1.34 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.183 -0.462 . . . . 0.0 110.13 -179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 76.8 mm-40 -56.74 126.93 29.05 Favored 'General case' 0 C--N 1.328 -0.363 0 C-N-CA 120.687 -0.405 . . . . 0.0 110.399 -179.76 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 66.8 m -90.07 1.33 56.47 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 0.0 110.227 179.721 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 12.5 p -124.83 143.78 37.16 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 115.934 -0.575 . . . . 0.0 110.793 -179.688 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.813 HG22 ' H ' ' A' ' 16' ' ' GLU . 59.4 m -132.42 -125.56 0.18 Allowed 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.702 179.543 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.813 ' H ' HG22 ' A' ' 15' ' ' THR . 47.4 mp0 15.25 48.73 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.233 0 CA-C-N 116.36 -0.382 . . . . 0.0 111.128 -179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.685 ' N ' ' O ' ' A' ' 15' ' ' THR . 77.7 mt -69.87 -4.25 3.83 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.383 -0.371 . . . . 0.0 110.756 -179.6 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.47 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 79.6 m -67.21 139.58 57.4 Favored 'General case' 0 C--N 1.33 -0.282 0 N-CA-C 108.666 -0.865 . . . . 0.0 108.666 178.792 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.575 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 63.74 15.95 9.39 Favored 'General case' 0 C--N 1.325 -0.482 0 N-CA-C 108.303 -0.999 . . . . 0.0 108.303 -178.211 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.575 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.9 OUTLIER 59.38 34.11 22.66 Favored 'General case' 0 C--N 1.333 -0.11 0 CA-C-N 115.08 -0.964 . . . . 0.0 110.683 -179.57 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.607 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -64.49 164.3 11.86 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-O 121.164 0.507 . . . . 0.0 111.605 -179.509 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 19.7 m-30 -128.71 144.26 51.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 115.227 -0.897 . . . . 0.0 110.58 178.665 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 21.4 t -119.7 101.96 12.04 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.584 0 N-CA-C 107.878 -1.156 . . . . 0.0 107.878 176.499 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 58.4 t -112.27 136.59 48.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.054 -0.521 . . . . 0.0 111.509 -178.316 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.8 p -124.41 152.76 42.87 Favored 'General case' 0 C--N 1.326 -0.433 0 CA-C-N 115.496 -0.775 . . . . 0.0 109.497 178.962 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 38.8 p90 -144.28 -165.88 2.24 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-O 121.059 0.457 . . . . 0.0 110.639 -179.318 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.75 HG12 ' H ' ' A' ' 29' ' ' ALA . 57.7 t -120.27 131.28 72.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.386 0 CA-C-N 115.94 -0.573 . . . . 0.0 109.765 179.751 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.661 ' O ' ' N ' ' A' ' 30' ' ' SER . 73.0 p -52.66 -27.45 17.33 Favored 'General case' 0 C--N 1.326 -0.427 0 CA-C-O 120.975 0.417 . . . . 0.0 110.542 -179.597 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.75 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 45.53 5.63 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.022 -0.535 . . . . 0.0 111.006 179.698 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.836 ' O ' HG12 ' A' ' 33' ' ' VAL . 1.6 m -168.34 110.77 0.57 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.85 0.357 . . . . 0.0 110.685 -179.78 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.0 m-20 -76.43 -7.04 54.23 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.714 -0.476 . . . . 0.0 109.714 179.496 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 32.3 p -87.31 -3.27 59.03 Favored 'General case' 0 N--CA 1.453 -0.301 0 CA-C-N 115.944 -0.571 . . . . 0.0 110.195 179.787 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.836 HG12 ' O ' ' A' ' 30' ' ' SER . 3.2 p -62.33 138.24 22.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.294 0 CA-C-N 115.919 -0.582 . . . . 0.0 110.17 179.788 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.59 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.0 m -93.68 -16.52 24.19 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 121.156 0.503 . . . . 0.0 109.761 179.877 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.438 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 176.97 178.82 47.01 Favored Glycine 0 CA--C 1.521 0.411 0 N-CA-C 109.822 -1.311 . . . . 0.0 109.822 179.464 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -127.73 150.82 49.62 Favored 'General case' 0 C--N 1.325 -0.5 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.658 179.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.722 ' NE ' HE22 ' A' ' 85' ' ' GLN . 31.0 ttp180 -130.09 122.26 27.95 Favored 'General case' 0 C--N 1.325 -0.492 0 N-CA-C 109.195 -0.669 . . . . 0.0 109.195 178.521 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 23.3 t -107.98 131.17 59.06 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.62 0 CA-C-N 116.104 -0.498 . . . . 0.0 109.806 179.888 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.432 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.6 tt0 -122.29 132.52 54.45 Favored 'General case' 0 C--N 1.326 -0.443 0 C-N-CA 120.521 -0.471 . . . . 0.0 110.774 -179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.418 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 54.1 p90 -138.1 137.2 37.49 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-O 121.272 0.558 . . . . 0.0 111.129 179.358 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 22.4 pt-20 -146.43 159.01 43.95 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.248 -0.887 . . . . 0.0 109.438 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.71 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 58.3 mt -73.91 124.43 26.14 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 120.343 -0.543 . . . . 0.0 111.197 -179.646 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -67.14 -28.66 68.32 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.595 179.899 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 78.1 mm-40 -86.41 -69.1 0.69 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.757 -0.656 . . . . 0.0 111.393 -179.193 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 91.0 mt-10 -60.3 -35.95 76.75 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 115.829 -0.623 . . . . 0.0 111.882 -178.54 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.22 30.92 64.37 Favored Glycine 0 CA--C 1.525 0.674 0 N-CA-C 110.454 -1.059 . . . . 0.0 110.454 -179.465 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.414 ' OD2' HD12 ' A' ' 42' ' ' LEU . 76.1 m-20 -58.48 171.48 0.6 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.747 0.308 . . . . 0.0 110.719 -179.669 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -61.7 141.37 95.05 Favored Pre-proline 0 N--CA 1.452 -0.328 0 N-CA-C 109.673 -0.491 . . . . 0.0 109.673 179.571 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 56.0 Cg_endo -72.13 147.71 48.89 Favored 'Trans proline' 0 C--N 1.3 -2.02 0 C-N-CA 122.391 2.061 . . . . 0.0 112.47 -179.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.414 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 1.2 mt-30 -114.59 146.38 40.87 Favored 'General case' 0 C--N 1.327 -0.395 0 N-CA-C 108.617 -0.882 . . . . 0.0 108.617 178.945 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.432 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.3 m-85 -123.32 137.2 54.9 Favored 'General case' 0 C--N 1.327 -0.4 0 C-N-CA 119.988 -0.685 . . . . 0.0 112.324 -178.644 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . 0.419 HD23 ' HA ' ' A' ' 52' ' ' LEU . 91.3 mt -121.93 126.81 49.48 Favored 'General case' 0 C--N 1.329 -0.323 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 177.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 51.5 m-20 -100.69 130.62 46.76 Favored 'General case' 0 C--N 1.323 -0.557 0 C-N-CA 120.449 -0.5 . . . . 0.0 111.146 -179.049 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 4.9 mt -127.78 154.72 78.02 Favored Pre-proline 0 C--N 1.327 -0.385 0 CA-C-N 115.665 -0.698 . . . . 0.0 109.577 -179.693 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -69.35 155.44 67.29 Favored 'Trans proline' 0 C--N 1.307 -1.613 0 C-N-CA 122.188 1.925 . . . . 0.0 112.503 -179.786 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.426 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 5.3 p -56.89 -12.57 2.03 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.788 -0.642 . . . . 0.0 110.528 179.888 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 32.8 p -94.21 -9.45 36.21 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.388 -0.369 . . . . 0.0 110.848 -179.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.1 136.05 34.16 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-O 120.869 0.366 . . . . 0.0 110.67 179.764 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 27.0 p -129.34 12.6 6.01 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.295 -0.411 . . . . 0.0 110.89 179.432 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 84.2 p -164.32 149.32 10.11 Favored 'General case' 0 C--N 1.331 -0.217 0 C-N-CA 120.765 -0.374 . . . . 0.0 110.516 179.715 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -152.41 150.35 12.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 121.178 0.514 . . . . 0.0 111.575 -179.745 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -103.47 127.11 50.93 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.571 178.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 mt -100.6 105.01 34.63 Favored Pre-proline 0 CA--C 1.534 0.334 0 C-N-CA 120.967 -0.293 . . . . 0.0 110.88 -179.542 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -90.66 -178.54 1.41 Allowed 'Trans proline' 0 C--N 1.312 -1.365 0 C-N-CA 122.922 2.414 . . . . 0.0 113.253 -179.877 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.1 m-20 60.47 36.86 20.08 Favored 'General case' 0 C--N 1.324 -0.503 0 CA-C-N 114.807 -1.088 . . . . 0.0 111.771 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.51 ' O ' ' OG ' ' A' ' 20' ' ' SER . 47.6 mt -92.62 144.88 24.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.446 -0.343 . . . . 0.0 110.603 179.107 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.541 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 19.4 mt -88.71 112.17 48.76 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-N 116.363 -0.381 . . . . 0.0 111.063 -179.491 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_exo -53.92 141.67 66.29 Favored 'Trans proline' 0 C--N 1.311 -1.402 0 C-N-CA 122.102 1.868 . . . . 0.0 111.897 179.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.412 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 81.0 17.08 73.17 Favored Glycine 0 CA--C 1.526 0.761 0 N-CA-C 111.201 -0.759 . . . . 0.0 111.201 179.681 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.424 ' HB3' HD22 ' A' ' 42' ' ' LEU . 7.7 mmt-85 -124.01 146.39 48.56 Favored 'General case' 0 C--N 1.329 -0.298 0 N-CA-C 110.08 -0.341 . . . . 0.0 110.08 179.741 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -98.94 132.41 44.28 Favored 'General case' 0 N--CA 1.451 -0.423 0 C-N-CA 120.476 -0.489 . . . . 0.0 109.827 179.231 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.71 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 55.6 m-85 -118.89 155.6 30.97 Favored 'General case' 0 C--N 1.323 -0.563 0 CA-C-N 115.965 -0.561 . . . . 0.0 110.762 -179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.468 HG22 HD21 ' A' ' 75' ' ' ASN . 70.8 mt -109.13 126.99 66.16 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 N-CA-C 107.967 -1.123 . . . . 0.0 107.967 177.354 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -112.47 131.31 64.33 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.732 0 CA-C-O 121.0 0.428 . . . . 0.0 111.075 -178.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.468 HD21 HG22 ' A' ' 73' ' ' ILE . 32.7 m-80 -138.05 125.68 22.21 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-N 115.864 -0.607 . . . . 0.0 109.898 179.489 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.471 ' O ' HD12 ' A' ' 87' ' ' LEU . 46.5 t -105.04 127.85 59.3 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.484 0 CA-C-O 120.893 0.378 . . . . 0.0 110.413 180.0 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.7 m-85 -119.45 136.07 54.47 Favored 'General case' 0 C--N 1.324 -0.502 0 N-CA-C 109.648 -0.501 . . . . 0.0 109.648 179.459 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.618 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -101.57 135.18 43.51 Favored 'General case' 0 C--N 1.321 -0.667 0 N-CA-C 108.35 -0.981 . . . . 0.0 108.35 178.82 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.59 ' O ' ' N ' ' A' ' 34' ' ' SER . 64.0 mt -97.08 120.51 46.5 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.607 0 CA-C-O 121.385 0.612 . . . . 0.0 110.549 -178.169 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.587 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.2 p -81.39 172.32 13.69 Favored 'General case' 0 N--CA 1.446 -0.658 0 CA-C-N 115.361 -0.836 . . . . 0.0 110.652 -179.4 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.5 mt-10 -58.78 -22.82 59.12 Favored 'General case' 0 C--N 1.323 -0.581 0 CA-C-N 115.491 -0.777 . . . . 0.0 111.642 -179.058 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.587 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 49.2 p30 -92.18 0.68 57.47 Favored 'General case' 0 C--N 1.329 -0.3 0 C-N-CA 120.61 -0.436 . . . . 0.0 111.235 -179.425 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 85.98 11.21 73.79 Favored Glycine 0 CA--C 1.525 0.71 0 C-N-CA 120.875 -0.678 . . . . 0.0 111.814 179.475 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.496 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 72.9 mm-40 -84.02 140.08 32.1 Favored 'General case' 0 C--N 1.326 -0.437 0 C-N-CA 120.826 -0.349 . . . . 0.0 110.53 179.311 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.722 HE22 ' NE ' ' A' ' 37' ' ' ARG . 90.8 mt-30 -103.08 142.62 33.81 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 121.007 0.432 . . . . 0.0 110.899 179.761 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.7 t -136.58 128.24 28.86 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.914 -0.584 . . . . 0.0 110.15 179.683 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.711 HD21 ' HB2' ' A' ' 90' ' ' SER . 61.3 tp -73.14 119.16 17.0 Favored 'General case' 0 C--N 1.326 -0.428 0 C-N-CA 120.634 -0.427 . . . . 0.0 110.418 179.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.577 HD12 ' O ' ' A' ' 27' ' ' VAL . 45.0 pt -110.83 -20.89 5.96 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 CA-C-N 116.122 -0.49 . . . . 0.0 111.099 -179.808 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.0 tp -155.46 120.18 4.75 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.564 -0.454 . . . . 0.0 111.512 -179.642 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.711 ' HB2' HD21 ' A' ' 87' ' ' LEU . 33.7 t -127.13 123.66 37.32 Favored 'General case' 0 C--N 1.328 -0.365 0 N-CA-C 108.899 -0.778 . . . . 0.0 108.899 178.384 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 8.6 t -156.08 149.58 24.77 Favored 'General case' 0 C--N 1.326 -0.435 0 C-N-CA 120.717 -0.393 . . . . 0.0 110.685 -179.302 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 93.2 p -111.95 155.44 23.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.024 179.388 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 21.2 mt-30 -140.93 156.67 46.04 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-O 121.237 0.541 . . . . 0.0 110.954 179.814 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.2 OUTLIER -119.14 110.94 17.64 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.302 -0.863 . . . . 0.0 109.252 178.908 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.439 ' O ' ' O ' ' A' ' 94' ' ' THR . 75.6 p . . . . . 0 C--O 1.219 -0.515 0 CA-C-O 118.013 -0.994 . . . . 0.0 110.583 -179.251 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.476 ' N ' ' HD3' ' A' ' 2' ' ' PRO . . . . . . . . 0 N--CA 1.491 2.347 0 N-CA-C 109.486 -1.445 . . . . 0.0 109.486 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.476 ' HD3' ' N ' ' A' ' 1' ' ' GLY . 22.2 Cg_exo -56.79 146.0 80.34 Favored 'Trans proline' 0 C--N 1.306 -1.668 0 C-N-CA 122.652 2.234 . . . . 0.0 111.998 -179.848 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 37.8 mt -82.66 137.78 34.36 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.755 -0.461 . . . . 0.0 109.755 179.397 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.549 ' O ' ' C ' ' A' ' 5' ' ' SER . . . 171.52 -176.68 44.68 Favored Glycine 0 CA--C 1.523 0.564 0 N-CA-C 111.047 -0.821 . . . . 0.0 111.047 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.549 ' C ' ' O ' ' A' ' 4' ' ' GLY . 0.9 OUTLIER 27.85 85.53 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.889 0.376 . . . . 0.0 110.227 179.861 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 21.2 p80 -159.06 134.36 8.43 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.032 -0.531 . . . . 0.0 110.556 -179.593 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 83.0 mt -84.96 133.56 34.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.029 179.436 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . . . . . . . . . 60.6 t -111.33 123.79 67.51 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.404 -0.362 . . . . 0.0 110.342 179.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . -135.94 -85.97 0.36 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.226 -0.443 . . . . 0.0 110.595 -179.843 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 41.2 m -105.01 138.02 41.86 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.168 -0.469 . . . . 0.0 110.849 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -107.6 -31.01 8.28 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.124 -0.489 . . . . 0.0 111.131 -179.912 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.577 ' O ' ' N ' ' A' ' 14' ' ' VAL . 25.5 tt0 -89.22 5.84 42.95 Favored 'General case' 0 C--N 1.331 -0.217 0 CA-C-O 120.858 0.361 . . . . 0.0 110.764 -179.473 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER 56.56 -78.7 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 C-N-CA 120.713 -0.395 . . . . 0.0 110.364 -179.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.584 HG12 ' O ' ' A' ' 23' ' ' VAL . 11.0 m -101.5 133.83 43.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.354 179.552 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.807 HG22 ' N ' ' A' ' 16' ' ' GLU . 1.1 m -88.18 -77.23 0.36 Allowed 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.479 -0.488 . . . . 0.0 110.534 179.658 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.807 ' N ' HG22 ' A' ' 15' ' ' THR . 51.3 mp0 -49.71 132.37 21.8 Favored 'General case' 0 N--CA 1.45 -0.433 0 C-N-CA 120.276 -0.57 . . . . 0.0 110.065 -178.537 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.512 ' O ' ' N ' ' A' ' 20' ' ' SER . 2.1 mt -131.01 -22.37 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.323 -0.571 0 CA-C-N 115.541 -0.754 . . . . 0.0 110.445 -178.961 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.497 ' C ' ' O ' ' A' ' 17' ' ' ILE . 44.0 p -35.01 140.92 0.07 Allowed 'General case' 0 C--N 1.33 -0.254 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 179.899 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.601 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 38.98 38.9 0.33 Allowed 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 120.496 -0.482 . . . . 0.0 109.707 -179.328 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.601 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 18.7 p 56.92 43.69 24.32 Favored 'General case' 0 C--N 1.333 -0.142 0 CA-C-N 115.59 -0.732 . . . . 0.0 111.05 179.972 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.546 ' OG ' ' C ' ' A' ' 16' ' ' GLU . 1.2 p -61.65 131.59 50.48 Favored 'General case' 0 C--N 1.33 -0.259 0 C-N-CA 120.668 -0.413 . . . . 0.0 110.264 179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.632 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 6.6 m-30 -95.03 146.48 24.24 Favored 'General case' 0 C--N 1.324 -0.505 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.735 179.728 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.584 ' O ' HG12 ' A' ' 14' ' ' VAL . 37.1 t -131.49 103.99 8.08 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.612 0 C-N-CA 120.434 -0.506 . . . . 0.0 109.903 178.376 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 88.6 t -116.05 138.11 47.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.097 -0.501 . . . . 0.0 110.866 -179.723 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 70.0 p -124.71 152.58 43.56 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.88 -0.6 . . . . 0.0 109.821 179.303 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.621 ' CE3' HG21 ' A' ' 76' ' ' VAL . 42.1 p90 -146.24 -165.49 2.23 Favored 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 120.569 -0.452 . . . . 0.0 110.36 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 18.5 t -130.81 129.59 63.89 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.526 0 CA-C-N 116.029 -0.532 . . . . 0.0 109.826 179.785 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 59.4 p -50.02 155.38 0.93 Allowed 'General case' 0 C--N 1.324 -0.52 0 C-N-CA 120.47 -0.492 . . . . 0.0 109.801 -179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.563 ' H ' HE22 ' A' ' 78' ' ' GLN . . . -142.46 44.65 1.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 C-N-CA 120.849 -0.34 . . . . 0.0 111.113 -179.424 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.664 ' C ' ' H ' ' A' ' 32' ' ' THR . 0.2 OUTLIER -170.93 -30.71 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.817 -0.353 . . . . 0.0 110.897 179.841 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 36.5 t0 64.49 -33.43 0.15 Allowed 'General case' 0 C--N 1.328 -0.335 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 -179.311 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.664 ' H ' ' C ' ' A' ' 30' ' ' SER . 81.0 p -86.85 2.33 49.42 Favored 'General case' 0 N--CA 1.451 -0.382 0 CA-C-N 116.107 -0.497 . . . . 0.0 109.665 179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.618 HG13 ' HB2' ' A' ' 56' ' ' SER . 0.9 OUTLIER -55.56 142.2 10.66 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.41 0 CA-C-N 115.624 -0.717 . . . . 0.0 109.836 179.715 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.487 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.6 m -94.72 -18.74 21.01 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 121.209 0.528 . . . . 0.0 109.805 179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . . . . . . . . . . . 176.85 178.36 46.54 Favored Glycine 0 CA--C 1.52 0.403 0 N-CA-C 109.873 -1.291 . . . . 0.0 109.873 179.711 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 79.1 m-85 -123.1 150.26 43.43 Favored 'General case' 0 C--N 1.322 -0.595 0 C-N-CA 120.62 -0.432 . . . . 0.0 110.486 179.158 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.685 ' NE ' HE22 ' A' ' 85' ' ' GLN . 29.4 ttp180 -129.21 120.93 26.62 Favored 'General case' 0 C--N 1.322 -0.621 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 178.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.527 HG21 HG11 ' A' ' 61' ' ' VAL . 13.7 t -106.56 131.22 56.9 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.752 0 C-N-CA 120.271 -0.572 . . . . 0.0 109.89 -179.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.408 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.7 tt0 -121.05 132.83 55.13 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.477 -0.489 . . . . 0.0 110.132 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.519 ' CE1' ' NE2' ' A' ' 50' ' ' GLN . 54.7 p90 -140.73 136.45 32.57 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-O 121.38 0.609 . . . . 0.0 111.267 179.645 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -146.0 164.72 31.19 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.072 -0.967 . . . . 0.0 108.989 179.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.768 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 79.3 mt -72.45 125.11 26.59 Favored 'General case' 0 C--N 1.325 -0.498 0 C-N-CA 120.583 -0.447 . . . . 0.0 110.82 -179.621 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 p -62.08 -32.95 73.55 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.511 179.816 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 71.8 mm-40 -87.41 -75.07 0.42 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.232 -0.894 . . . . 0.0 110.033 179.735 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.68 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 90.4 mt-10 -63.84 143.59 57.73 Favored 'General case' 0 N--CA 1.448 -0.549 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.39 179.159 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -93.14 29.57 8.02 Favored Glycine 0 CA--C 1.521 0.429 0 C-N-CA 120.187 -1.006 . . . . 0.0 111.43 -179.336 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.502 ' CG ' ' N ' ' A' ' 48' ' ' GLU . 21.8 t70 -46.93 170.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 C-N-CA 120.455 -0.498 . . . . 0.0 110.51 179.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.502 ' N ' ' CG ' ' A' ' 47' ' ' ASP . 2.5 pt-20 -70.69 139.4 86.12 Favored Pre-proline 0 C--N 1.322 -0.6 0 CA-C-N 115.756 -0.656 . . . . 0.0 110.542 -179.565 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_endo -69.64 153.29 69.68 Favored 'Trans proline' 0 C--N 1.308 -1.598 0 C-N-CA 122.693 2.262 . . . . 0.0 111.952 179.884 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.519 ' NE2' ' CE1' ' A' ' 40' ' ' TYR . 2.2 mt-30 -119.87 145.46 46.65 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.59 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 60.2 m-85 -126.15 138.92 53.71 Favored 'General case' 0 C--N 1.33 -0.256 0 C-N-CA 120.414 -0.515 . . . . 0.0 111.763 -179.078 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 66.6 mt -127.06 133.05 50.54 Favored 'General case' 0 C--N 1.329 -0.304 0 N-CA-C 109.074 -0.713 . . . . 0.0 109.074 178.146 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . 0.406 ' O ' HD23 ' A' ' 54' ' ' LEU . 56.1 m-20 -106.65 134.29 50.02 Favored 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 120.498 -0.481 . . . . 0.0 111.693 -179.059 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.406 HD23 ' O ' ' A' ' 53' ' ' ASP . 7.2 mt -131.83 156.14 80.49 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 115.731 -0.668 . . . . 0.0 109.669 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -67.25 158.13 58.45 Favored 'Trans proline' 0 C--N 1.31 -1.467 0 C-N-CA 122.05 1.834 . . . . 0.0 112.294 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.618 ' HB2' HG13 ' A' ' 33' ' ' VAL . 87.3 p -58.67 -13.04 4.89 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.208 -179.448 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 62.7 p -92.97 -6.97 47.22 Favored 'General case' 0 C--N 1.327 -0.394 0 C-N-CA 120.58 -0.448 . . . . 0.0 110.861 -179.802 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.12 134.56 34.99 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.389 -0.368 . . . . 0.0 110.606 179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 25.3 p -131.9 15.41 4.76 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.29 -0.414 . . . . 0.0 110.482 179.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.6 p -163.28 144.02 9.23 Favored 'General case' 0 C--N 1.331 -0.202 0 N-CA-C 109.926 -0.398 . . . . 0.0 109.926 179.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.527 HG11 HG21 ' A' ' 38' ' ' VAL . 9.5 p -149.28 148.26 15.83 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 C-N-CA 120.346 -0.542 . . . . 0.0 111.533 -179.486 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.632 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 5.0 t-20 -106.04 127.13 52.96 Favored 'General case' 0 C--N 1.325 -0.498 0 CA-C-N 115.543 -0.753 . . . . 0.0 109.546 178.533 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.411 HG22 HD21 ' A' ' 66' ' ' LEU . 1.7 mt -98.34 104.77 25.15 Favored Pre-proline 0 C--N 1.331 -0.222 0 N-CA-C 109.715 -0.476 . . . . 0.0 109.715 -179.893 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.422 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 94.3 Cg_endo -90.18 172.5 3.57 Favored 'Trans proline' 0 C--N 1.308 -1.56 0 C-N-CA 122.535 2.157 . . . . 0.0 112.587 -179.307 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 80.8 m-20 62.45 39.53 11.82 Favored 'General case' 0 C--N 1.32 -0.688 0 CA-C-N 115.152 -0.931 . . . . 0.0 111.725 179.306 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.547 HD12 ' CD1' ' A' ' 22' ' ' PHE . 32.9 mt -89.44 138.68 31.24 Favored 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 120.529 -0.468 . . . . 0.0 110.291 178.789 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.565 HD13 ' NH2' ' A' ' 70' ' ' ARG . 28.5 mt -68.76 129.34 92.51 Favored Pre-proline 0 C--N 1.331 -0.239 0 CA-C-N 116.28 -0.418 . . . . 0.0 110.851 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 60.0 Cg_endo -73.05 138.06 27.53 Favored 'Trans proline' 0 N--CA 1.493 1.449 0 C-N-CA 122.508 2.139 . . . . 0.0 112.012 179.315 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 76.26 22.23 73.91 Favored Glycine 0 CA--C 1.526 0.753 0 N-CA-C 111.128 -0.789 . . . . 0.0 111.128 179.808 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.68 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 5.5 mmm-85 -125.71 148.59 49.0 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.739 0.304 . . . . 0.0 110.53 179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 68.0 tttt -98.64 134.03 42.15 Favored 'General case' 0 N--CA 1.45 -0.45 0 CA-C-O 121.183 0.516 . . . . 0.0 110.858 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.768 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 49.9 m-85 -120.81 149.5 42.47 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.404 -0.816 . . . . 0.0 110.846 179.633 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.478 HG22 HD21 ' A' ' 75' ' ' ASN . 66.3 mt -108.18 128.71 63.42 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.657 0 N-CA-C 107.285 -1.376 . . . . 0.0 107.285 176.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 34.9 t -116.58 129.26 73.35 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.838 0 C-N-CA 120.21 -0.596 . . . . 0.0 111.42 -178.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.478 HD21 HG22 ' A' ' 73' ' ' ILE . 33.4 m-80 -134.43 124.41 25.62 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-N 115.424 -0.807 . . . . 0.0 109.712 179.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.621 HG21 ' CE3' ' A' ' 26' ' ' TRP . 21.9 t -100.96 128.14 53.43 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 C-N-CA 120.336 -0.546 . . . . 0.0 110.496 -179.656 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . 0.468 ' HB2' HE21 ' A' ' 85' ' ' GLN . 61.2 m-85 -120.12 136.59 54.55 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.698 179.616 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.563 HE22 ' H ' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -101.88 137.5 40.1 Favored 'General case' 0 C--N 1.324 -0.532 0 C-N-CA 119.759 -0.776 . . . . 0.0 108.969 178.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.487 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.8 mt -100.58 127.7 53.39 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.489 0 CA-C-O 121.09 0.471 . . . . 0.0 111.4 -178.405 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.605 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 28.4 p -84.53 173.06 11.13 Favored 'General case' 0 N--CA 1.449 -0.495 0 CA-C-N 115.554 -0.748 . . . . 0.0 110.231 179.514 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.1 mt-10 -60.43 -18.06 48.46 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 116.123 -0.489 . . . . 0.0 110.868 -179.746 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.605 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.3 p30 -94.56 -4.04 48.65 Favored 'General case' 0 N--CA 1.463 0.179 0 C-N-CA 120.722 -0.391 . . . . 0.0 111.498 -179.618 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 88.68 13.75 62.41 Favored Glycine 0 CA--C 1.53 0.975 0 C-N-CA 120.898 -0.668 . . . . 0.0 112.262 179.382 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.585 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 69.4 mm-40 -84.56 147.3 27.09 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.898 0.349 . . . . 0.0 110.335 178.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.685 HE22 ' NE ' ' A' ' 37' ' ' ARG . 50.0 mt-30 -112.44 147.7 35.93 Favored 'General case' 0 C--N 1.331 -0.239 0 CA-C-O 121.124 0.488 . . . . 0.0 111.77 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 23.3 t -139.14 128.63 24.38 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 115.434 -0.803 . . . . 0.0 109.93 179.144 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 15.9 tp -73.3 118.96 16.89 Favored 'General case' 0 C--N 1.33 -0.265 0 C-N-CA 120.402 -0.519 . . . . 0.0 109.964 179.528 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 41.2 pt -111.72 -22.69 4.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.547 0 CA-C-N 116.184 -0.462 . . . . 0.0 111.186 -179.425 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . 0.453 HD22 ' HB3' ' A' ' 26' ' ' TRP . 16.6 tp -154.85 127.1 7.79 Favored 'General case' 0 C--N 1.328 -0.353 0 C-N-CA 120.232 -0.587 . . . . 0.0 111.907 -179.427 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.468 ' OG ' ' OD1' ' A' ' 75' ' ' ASN . 48.1 t -135.6 119.05 16.84 Favored 'General case' 0 C--O 1.232 0.156 0 CA-C-N 115.912 -0.586 . . . . 0.0 110.133 178.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 6.2 t -145.77 159.57 42.99 Favored 'General case' 0 C--N 1.332 -0.192 0 CA-C-N 116.413 -0.358 . . . . 0.0 110.779 -179.879 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 54.7 p -126.32 152.49 46.14 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.968 0.413 . . . . 0.0 110.584 179.623 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.447 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.2 mt-30 -145.94 163.02 36.46 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 115.938 -0.574 . . . . 0.0 110.598 179.38 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.03 108.67 16.5 Favored 'General case' 0 C--N 1.323 -0.551 0 CA-C-N 115.583 -0.735 . . . . 0.0 109.864 179.499 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.482 ' HG1' ' H ' ' A' ' 70' ' ' ARG . 37.9 p . . . . . 0 C--O 1.22 -0.469 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.631 -179.533 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.253 0 N-CA-C 109.492 -1.443 . . . . 0.0 109.492 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 46.6 Cg_endo -73.64 8.21 2.01 Favored 'Trans proline' 0 C--N 1.306 -1.69 0 C-N-CA 122.737 2.291 . . . . 0.0 111.981 -179.995 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 64.0 mt -54.3 -23.68 16.1 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.125 -0.489 . . . . 0.0 110.276 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.621 ' O ' ' N ' ' A' ' 6' ' ' HIS . . . -163.43 15.39 0.11 Allowed Glycine 0 CA--C 1.524 0.604 0 N-CA-C 110.832 -0.907 . . . . 0.0 110.832 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.513 ' C ' ' O ' ' A' ' 4' ' ' GLY . 41.4 t 28.6 35.59 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 120.679 0.276 . . . . 0.0 110.886 -179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.621 ' N ' ' O ' ' A' ' 4' ' ' GLY . 91.3 m-70 -52.52 -39.22 61.11 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.443 -0.344 . . . . 0.0 110.513 179.811 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.583 ' O ' ' O ' ' A' ' 6' ' ' HIS . 7.7 mp 31.1 102.08 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.186 -0.461 . . . . 0.0 111.078 179.874 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.755 ' O ' ' HB2' ' A' ' 9' ' ' ALA . 94.2 t -100.55 125.57 54.35 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.171 -0.468 . . . . 0.0 109.817 178.967 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.755 ' HB2' ' O ' ' A' ' 8' ' ' VAL . . . 150.28 80.7 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.434 -0.348 . . . . 0.0 110.685 -179.622 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 96.9 m -90.93 130.09 36.9 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.467 -0.333 . . . . 0.0 110.608 179.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 45.2 p -76.4 161.96 28.25 Favored 'General case' 0 C--N 1.331 -0.2 0 CA-C-N 116.285 -0.416 . . . . 0.0 110.373 179.845 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 77.0 mm-40 -58.39 133.21 55.54 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 120.858 -0.337 . . . . 0.0 110.578 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 6.8 m -100.24 -6.33 26.19 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.862 179.929 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.406 ' C ' ' CG2' ' A' ' 15' ' ' THR . 33.7 m -74.32 -10.07 13.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-O 121.093 0.473 . . . . 0.0 110.483 -179.799 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.63 ' OG1' ' N ' ' A' ' 16' ' ' GLU . 0.1 OUTLIER 33.39 -112.12 0.05 OUTLIER 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.832 178.944 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.653 ' C ' ' H ' ' A' ' 18' ' ' THR . 95.1 mt-10 -61.85 -33.48 74.26 Favored 'General case' 0 N--CA 1.465 0.316 0 CA-C-N 115.665 -0.698 . . . . 0.0 112.561 -177.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.591 ' O ' ' C ' ' A' ' 18' ' ' THR . 6.0 mt 63.44 -27.24 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 120.965 -0.294 . . . . 0.0 110.934 -179.529 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.653 ' H ' ' C ' ' A' ' 16' ' ' GLU . 13.2 t -19.96 116.05 0.03 OUTLIER 'General case' 0 N--CA 1.464 0.266 0 CA-C-O 120.837 0.351 . . . . 0.0 110.676 -179.28 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.477 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 67.08 34.57 5.02 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.144 -0.48 . . . . 0.0 109.756 -179.151 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.578 ' N ' ' O ' ' A' ' 17' ' ' ILE . 1.7 p 47.18 24.97 0.47 Allowed 'General case' 0 C--N 1.332 -0.17 0 CA-C-N 116.076 -0.511 . . . . 0.0 109.962 -179.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . . . . . . . . . 60.3 p -61.16 142.37 56.79 Favored 'General case' 0 C--N 1.331 -0.219 0 CA-C-N 116.043 -0.526 . . . . 0.0 111.37 -179.222 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.552 ' CE1' HG22 ' A' ' 95' ' ' THR . 6.3 m-30 -96.78 148.38 22.97 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 115.43 -0.805 . . . . 0.0 111.316 179.699 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 46.7 t -128.34 107.02 15.38 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 N-CA-C 109.184 -0.672 . . . . 0.0 109.184 177.194 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 40.9 t -119.21 135.54 59.26 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 C-N-CA 120.671 -0.412 . . . . 0.0 111.051 -179.385 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -123.35 150.58 43.47 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 116.075 -0.511 . . . . 0.0 109.693 178.903 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . . . . . . . . . 43.0 p90 -146.88 -168.24 2.98 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 120.635 -0.426 . . . . 0.0 110.301 -179.523 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.533 HG12 ' H ' ' A' ' 29' ' ' ALA . 34.1 t -120.63 132.76 69.35 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 115.86 -0.609 . . . . 0.0 109.521 179.035 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.689 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 32.2 t -45.49 -33.11 2.51 Favored 'General case' 0 C--N 1.323 -0.575 0 C-N-CA 120.637 -0.425 . . . . 0.0 110.416 -179.347 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.533 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 56.69 5.22 0.2 Allowed 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.387 -0.37 . . . . 0.0 111.661 178.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.544 ' O ' ' CB ' ' A' ' 31' ' ' ASP . 1.4 t -143.36 -59.38 0.42 Allowed 'General case' 0 C--N 1.328 -0.366 0 C-N-CA 120.378 -0.529 . . . . 0.0 111.445 -179.484 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . 0.544 ' CB ' ' O ' ' A' ' 30' ' ' SER . 2.9 m-20 86.39 -22.54 0.17 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.889 -179.27 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 1.8 m -95.21 -3.82 47.02 Favored 'General case' 0 C--N 1.331 -0.227 0 N-CA-C 109.142 -0.688 . . . . 0.0 109.142 178.874 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.452 ' H ' HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -54.11 144.15 5.45 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.482 0 CA-C-N 115.156 -0.929 . . . . 0.0 110.167 179.769 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.595 ' N ' ' O ' ' A' ' 79' ' ' ILE . 8.4 m -94.83 -16.13 23.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 121.304 0.573 . . . . 0.0 109.682 -179.86 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.447 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.05 175.29 45.08 Favored Glycine 0 CA--C 1.523 0.537 0 N-CA-C 109.961 -1.256 . . . . 0.0 109.961 179.447 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . 0.442 ' CZ ' HG11 ' A' ' 33' ' ' VAL . 93.9 m-85 -124.28 152.25 43.26 Favored 'General case' 0 C--N 1.323 -0.573 0 C-N-CA 120.474 -0.49 . . . . 0.0 110.613 179.545 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.534 ' HE ' ' HB3' ' A' ' 51' ' ' TYR . 70.7 ttt180 -132.78 122.87 25.15 Favored 'General case' 0 C--N 1.322 -0.619 0 CA-C-N 115.806 -0.634 . . . . 0.0 109.756 179.138 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 32.2 t -109.58 130.41 62.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 CA-C-N 115.808 -0.633 . . . . 0.0 109.886 179.888 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.51 ' C ' ' OE1' ' A' ' 39' ' ' GLU . 13.1 tm-20 -123.68 129.59 51.35 Favored 'General case' 0 C--N 1.322 -0.608 0 N-CA-C 109.672 -0.492 . . . . 0.0 109.672 179.579 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.406 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 34.9 p90 -143.52 144.74 32.1 Favored 'General case' 0 C--N 1.322 -0.588 0 CA-C-O 121.213 0.53 . . . . 0.0 111.599 -179.578 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.5 pt-20 -148.65 168.14 23.64 Favored 'General case' 0 C--N 1.327 -0.406 0 CA-C-N 115.417 -0.81 . . . . 0.0 109.464 179.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.745 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 67.3 mt -73.86 129.76 38.56 Favored 'General case' 0 C--N 1.324 -0.512 0 CA-C-O 121.191 0.52 . . . . 0.0 111.532 -179.312 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.3 p -70.83 -18.74 62.72 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.608 -0.724 . . . . 0.0 110.21 179.514 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 70.4 mm-40 -101.06 -75.01 0.6 Allowed 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 115.854 -0.612 . . . . 0.0 111.221 -179.339 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.677 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 89.0 mt-10 -62.2 -36.71 82.75 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.055 -0.521 . . . . 0.0 111.262 -178.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.601 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 83.6 -39.18 2.8 Favored Glycine 0 CA--C 1.524 0.645 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 -179.689 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.601 ' O ' ' O ' ' A' ' 46' ' ' GLY . 35.4 t0 27.98 -151.39 0.0 OUTLIER 'General case' 0 C--O 1.232 0.171 0 CA-C-O 120.865 0.364 . . . . 0.0 110.41 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.557 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.8 OUTLIER -101.62 134.13 20.39 Favored Pre-proline 0 C--N 1.328 -0.356 0 CA-C-N 116.259 -0.428 . . . . 0.0 109.897 179.508 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 30.4 Cg_endo -66.27 144.05 73.0 Favored 'Trans proline' 0 C--N 1.307 -1.653 0 C-N-CA 122.129 1.886 . . . . 0.0 111.858 -179.614 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.401 ' HB2' ' CZ ' ' A' ' 40' ' ' TYR . 22.6 mt-30 -116.67 144.14 44.78 Favored 'General case' 0 C--N 1.325 -0.466 0 N-CA-C 109.382 -0.599 . . . . 0.0 109.382 179.678 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.534 ' HB3' ' HE ' ' A' ' 37' ' ' ARG . 3.2 m-85 -123.7 139.22 54.21 Favored 'General case' 0 C--N 1.324 -0.506 0 C-N-CA 120.199 -0.601 . . . . 0.0 110.909 -179.416 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 80.1 mt -127.35 127.67 44.63 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.236 179.163 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 63.2 m-20 -100.86 132.1 46.43 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.026 -0.534 . . . . 0.0 111.354 -179.706 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 6.3 mt -128.0 155.5 77.67 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-N 115.837 -0.619 . . . . 0.0 109.456 179.822 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.9 Cg_endo -68.33 155.98 67.31 Favored 'Trans proline' 0 C--N 1.308 -1.561 0 C-N-CA 122.037 1.824 . . . . 0.0 112.303 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . . . . . . . . . 31.4 p -56.67 -12.59 1.91 Allowed 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 115.87 -0.605 . . . . 0.0 110.896 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 37.7 p -91.84 -8.66 45.94 Favored 'General case' 0 C--N 1.329 -0.289 0 C-N-CA 120.666 -0.414 . . . . 0.0 110.79 -179.71 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.51 132.06 34.96 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.782 0.325 . . . . 0.0 110.848 -179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.8 p -128.5 11.31 6.28 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.244 -0.435 . . . . 0.0 110.503 179.491 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 86.6 p -164.2 145.89 8.72 Favored 'General case' 0 C--N 1.329 -0.311 0 N-CA-C 109.684 -0.488 . . . . 0.0 109.684 179.45 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 7.2 p -149.09 145.49 17.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 C-N-CA 120.383 -0.527 . . . . 0.0 111.361 -179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -104.23 127.84 51.9 Favored 'General case' 0 C--N 1.326 -0.453 0 CA-C-N 115.629 -0.714 . . . . 0.0 109.236 178.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 1.6 mt -99.84 105.94 37.66 Favored Pre-proline 0 C--N 1.327 -0.376 0 N-CA-C 110.021 -0.362 . . . . 0.0 110.021 -180.0 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -87.78 179.52 2.88 Favored 'Trans proline' 0 C--N 1.309 -1.522 0 C-N-CA 122.571 2.181 . . . . 0.0 112.492 -179.613 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 90.4 m-20 58.37 38.58 25.82 Favored 'General case' 0 C--N 1.321 -0.646 0 CA-C-N 115.004 -0.998 . . . . 0.0 111.299 179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.519 HD12 ' O ' ' A' ' 20' ' ' SER . 28.8 mt -87.77 150.23 23.7 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.534 -0.543 . . . . 0.0 109.534 178.552 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.8 mt -94.21 109.32 41.69 Favored Pre-proline 0 C--N 1.327 -0.378 0 CA-C-N 116.567 -0.288 . . . . 0.0 111.112 -179.092 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_exo -54.63 139.56 76.29 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.137 1.891 . . . . 0.0 111.627 179.407 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.574 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 84.95 15.92 66.36 Favored Glycine 0 CA--C 1.524 0.637 0 N-CA-C 110.958 -0.857 . . . . 0.0 110.958 179.993 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.677 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 7.6 mmm-85 -125.35 143.75 50.82 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.685 0.279 . . . . 0.0 110.574 -179.898 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 64.8 tttt -100.81 132.0 46.43 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.95 -0.389 . . . . 0.0 109.95 179.156 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.745 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 80.1 m-85 -119.6 151.41 38.72 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-N 116.035 -0.53 . . . . 0.0 110.894 179.871 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.406 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 70.3 mt -108.54 131.46 59.06 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.51 0 N-CA-C 107.169 -1.419 . . . . 0.0 107.169 176.928 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.6 t -119.68 134.18 64.07 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.728 0 C-N-CA 120.092 -0.643 . . . . 0.0 111.827 -178.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 20.6 m-80 -133.02 125.7 30.27 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 115.281 -0.872 . . . . 0.0 109.48 179.389 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . . . . . . . . . 20.1 t -104.15 128.95 57.14 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.446 0 C-N-CA 120.476 -0.49 . . . . 0.0 110.765 -179.489 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 92.2 m-85 -119.08 138.96 52.51 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.929 -0.578 . . . . 0.0 109.544 179.394 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.689 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.5 OUTLIER -104.98 137.15 43.17 Favored 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.736 -0.839 . . . . 0.0 108.736 179.03 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.595 ' O ' ' N ' ' A' ' 34' ' ' SER . 55.6 mt -100.1 121.75 51.19 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.564 0 CA-C-O 121.195 0.521 . . . . 0.0 110.382 -179.361 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.61 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 83.6 p -82.48 167.67 18.18 Favored 'General case' 0 C--N 1.322 -0.613 0 CA-C-N 115.447 -0.797 . . . . 0.0 110.597 -179.828 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -57.55 -19.91 28.53 Favored 'General case' 0 C--N 1.324 -0.537 0 CA-C-N 115.779 -0.646 . . . . 0.0 111.244 -179.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.61 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.9 p30 -92.24 0.04 57.43 Favored 'General case' 0 C--N 1.332 -0.191 0 C-N-CA 120.68 -0.408 . . . . 0.0 111.188 -179.598 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.4 9.2 73.06 Favored Glycine 0 CA--C 1.53 0.974 0 C-N-CA 120.981 -0.628 . . . . 0.0 112.054 179.561 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.58 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 68.5 mm-40 -82.71 143.93 30.57 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-O 120.82 0.343 . . . . 0.0 111.074 179.745 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.484 ' NE2' HG12 ' A' ' 79' ' ' ILE . 3.1 mm-40 -109.53 141.91 41.33 Favored 'General case' 0 C--N 1.331 -0.214 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.575 179.665 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 22.5 t -138.27 133.95 33.76 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.557 179.814 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 22.9 tp -73.56 118.55 16.65 Favored 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 120.648 -0.421 . . . . 0.0 109.947 179.527 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 45.3 pt -109.92 -23.25 4.56 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.436 0 C-N-CA 120.701 -0.399 . . . . 0.0 111.211 -179.531 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 34.9 tp -157.03 126.6 6.13 Favored 'General case' 0 C--N 1.33 -0.276 0 C-N-CA 120.043 -0.663 . . . . 0.0 112.119 -179.773 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . . . . . . . . . 26.1 t -132.81 122.36 24.34 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 115.797 -0.638 . . . . 0.0 109.495 178.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.8 t -152.38 159.94 43.36 Favored 'General case' 0 C--N 1.33 -0.251 0 C-N-CA 120.661 -0.416 . . . . 0.0 111.257 -179.415 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.2 p -121.59 153.03 38.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.113 -0.494 . . . . 0.0 110.29 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.505 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 26.4 mt-30 -145.64 161.32 40.11 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.459 179.323 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -124.13 114.17 19.32 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.771 -0.65 . . . . 0.0 109.705 179.015 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.574 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 59.5 p . . . . . 0 C--O 1.219 -0.519 0 CA-C-O 118.098 -0.953 . . . . 0.0 110.418 -179.472 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.446 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.49 2.24 0 N-CA-C 109.465 -1.454 . . . . 0.0 109.465 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 10.5 Cg_endo -57.58 -2.73 0.74 Allowed 'Trans proline' 0 C--N 1.303 -1.863 0 C-N-CA 122.79 2.327 . . . . 0.0 112.016 179.744 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.624 ' C ' ' H ' ' A' ' 5' ' ' SER . 50.3 mt -103.97 -38.72 6.87 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 0.0 110.991 -179.811 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 61.88 -31.21 0.06 OUTLIER Glycine 0 CA--C 1.528 0.849 0 N-CA-C 111.567 -0.613 . . . . 0.0 111.567 179.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.624 ' H ' ' C ' ' A' ' 3' ' ' LEU . 94.0 p -76.68 -7.71 55.84 Favored 'General case' 0 C--N 1.331 -0.218 0 CA-C-O 120.75 0.31 . . . . 0.0 111.028 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.516 ' NE2' ' CD1' ' A' ' 3' ' ' LEU . 6.0 m-70 -76.21 -24.54 54.66 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.336 -0.393 . . . . 0.0 110.454 179.703 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.891 ' N ' HD12 ' A' ' 7' ' ' LEU . 4.1 mp -90.57 134.56 34.3 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.137 -0.483 . . . . 0.0 110.632 179.97 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 8' ' ' VAL . 27.6 m -135.12 69.83 0.32 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.223 -0.444 . . . . 0.0 110.282 179.641 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.673 ' O ' ' N ' ' A' ' 11' ' ' SER . . . -63.5 -48.63 76.79 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.253 -0.43 . . . . 0.0 111.311 -179.235 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.572 ' C ' ' O ' ' A' ' 9' ' ' ALA . 20.1 p 26.51 36.95 0.0 OUTLIER 'General case' 0 C--N 1.331 -0.225 0 CA-C-O 120.924 0.392 . . . . 0.0 110.25 -179.729 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.673 ' N ' ' O ' ' A' ' 9' ' ' ALA . 66.8 m -78.26 2.18 19.2 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.049 -0.523 . . . . 0.0 111.363 -179.223 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.63 ' C ' ' H ' ' A' ' 14' ' ' VAL . 48.6 mt-10 60.96 -11.1 0.05 Allowed 'General case' 0 C--N 1.328 -0.344 0 C-N-CA 120.603 -0.439 . . . . 0.0 110.356 -179.989 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . 0.655 ' H ' ' C ' ' A' ' 11' ' ' SER . 0.6 OUTLIER 68.36 -22.42 0.13 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.149 -0.478 . . . . 0.0 109.97 -179.374 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.63 ' H ' ' C ' ' A' ' 12' ' ' GLU . 39.4 t -135.0 133.97 53.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 115.992 -0.549 . . . . 0.0 111.112 -179.849 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.717 ' C ' ' H ' ' A' ' 17' ' ' ILE . 1.4 m -130.14 -56.98 1.1 Allowed 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.25 178.937 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.573 ' O ' ' OG ' ' A' ' 21' ' ' SER . 61.2 mp0 -66.04 32.88 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.384 0 N-CA-C 109.015 -0.735 . . . . 0.0 109.015 179.576 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.717 ' H ' ' C ' ' A' ' 15' ' ' THR . 49.1 mt -31.48 -35.84 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 CA-C-N 115.203 -0.908 . . . . 0.0 110.886 -179.011 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.555 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 5.2 t -44.35 127.67 5.87 Favored 'General case' 0 C--N 1.327 -0.386 0 N-CA-C 109.402 -0.592 . . . . 0.0 109.402 179.497 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.555 ' HB3' ' O ' ' A' ' 18' ' ' THR . . . 70.68 26.8 3.82 Favored 'General case' 0 C--N 1.327 -0.389 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 -179.009 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 66' ' ' LEU . 23.7 p 52.57 35.55 18.27 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 115.89 -0.595 . . . . 0.0 110.691 -179.815 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.573 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 4.9 p -62.46 164.05 7.89 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.961 -0.563 . . . . 0.0 110.735 -179.68 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.579 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 20.8 m-30 -129.37 147.9 51.24 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 115.742 -0.663 . . . . 0.0 110.47 178.495 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.556 ' CG2' ' OE1' ' A' ' 16' ' ' GLU . 38.9 t -124.04 101.9 10.0 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.685 0 N-CA-C 108.426 -0.953 . . . . 0.0 108.426 176.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 81.0 t -112.09 137.76 43.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.368 0 CA-C-N 116.023 -0.535 . . . . 0.0 111.394 -178.561 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 95.8 p -124.55 152.27 43.68 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 115.615 -0.72 . . . . 0.0 109.883 179.356 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.473 ' CD2' HG11 ' A' ' 76' ' ' VAL . 39.0 p90 -143.35 -177.93 5.62 Favored 'General case' 0 C--N 1.326 -0.419 0 CA-C-N 116.259 -0.428 . . . . 0.0 110.5 -179.489 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.619 HG12 ' H ' ' A' ' 29' ' ' ALA . 55.8 t -108.02 132.54 55.47 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.871 179.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.644 ' C ' ' H ' ' A' ' 30' ' ' SER . 98.3 p -54.68 -33.21 60.52 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-O 120.959 0.409 . . . . 0.0 110.49 -179.459 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.619 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 54.69 -6.3 0.02 OUTLIER 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 116.008 -0.542 . . . . 0.0 111.528 179.608 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.787 ' O ' HG12 ' A' ' 33' ' ' VAL . 2.2 m -166.05 122.88 1.37 Allowed 'General case' 0 C--N 1.327 -0.37 0 C-N-CA 120.446 -0.502 . . . . 0.0 111.07 -179.633 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 88.3 m-20 -80.34 -4.07 52.02 Favored 'General case' 0 C--N 1.327 -0.379 0 N-CA-C 109.81 -0.441 . . . . 0.0 109.81 179.129 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 21.8 p -85.14 -5.58 59.33 Favored 'General case' 0 N--CA 1.451 -0.395 0 CA-C-N 115.8 -0.637 . . . . 0.0 110.59 -179.984 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.787 HG12 ' O ' ' A' ' 30' ' ' SER . 2.4 p -63.3 138.83 22.28 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.256 0 N-CA-C 109.852 -0.425 . . . . 0.0 109.852 179.57 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.572 ' N ' ' O ' ' A' ' 79' ' ' ILE . 7.2 m -94.5 -17.14 22.71 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.248 0.547 . . . . 0.0 109.559 -179.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.434 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 178.06 178.51 47.59 Favored Glycine 0 CA--C 1.521 0.432 0 N-CA-C 109.898 -1.281 . . . . 0.0 109.898 179.39 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 95.1 m-85 -126.9 151.6 48.22 Favored 'General case' 0 C--N 1.323 -0.561 0 CA-C-O 121.056 0.455 . . . . 0.0 110.596 179.463 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.455 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 21.2 ttp180 -130.8 121.26 25.02 Favored 'General case' 0 C--N 1.322 -0.593 0 N-CA-C 109.262 -0.644 . . . . 0.0 109.262 178.984 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 58.0 t -107.1 132.01 55.61 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.608 0 CA-C-N 115.752 -0.658 . . . . 0.0 109.935 180.0 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.594 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 79.6 tt0 -121.07 133.65 55.24 Favored 'General case' 0 C--N 1.324 -0.529 0 C-N-CA 120.24 -0.584 . . . . 0.0 110.61 -179.628 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.465 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 52.4 p90 -139.04 130.48 27.09 Favored 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 116.091 -0.504 . . . . 0.0 110.657 179.155 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.6 pt-20 -142.72 161.63 37.58 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 115.639 -0.71 . . . . 0.0 109.573 179.961 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.654 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 56.8 mt -75.15 132.61 41.3 Favored 'General case' 0 C--N 1.326 -0.456 0 CA-C-O 121.052 0.453 . . . . 0.0 111.85 -179.418 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 21.4 p -77.86 -14.67 59.49 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 115.558 -0.746 . . . . 0.0 110.124 179.435 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 89.9 mt-10 -100.19 -74.91 0.59 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.117 -0.492 . . . . 0.0 111.059 -179.494 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.658 ' OE1' ' NH2' ' A' ' 70' ' ' ARG . 89.3 mt-10 -63.65 -34.57 78.14 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.915 -0.584 . . . . 0.0 110.93 -179.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.585 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 84.75 -39.6 2.95 Favored Glycine 0 CA--C 1.523 0.587 0 N-CA-C 110.21 -1.156 . . . . 0.0 110.21 -179.323 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.64 ' CG ' ' H ' ' A' ' 48' ' ' GLU . 32.4 t0 29.43 -153.65 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.246 0 CA-C-O 120.888 0.375 . . . . 0.0 110.45 179.619 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.64 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.6 OUTLIER -102.6 134.93 19.63 Favored Pre-proline 0 C--N 1.326 -0.42 0 N-CA-C 109.629 -0.508 . . . . 0.0 109.629 179.429 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 31.3 Cg_endo -66.66 142.13 62.93 Favored 'Trans proline' 0 C--N 1.305 -1.746 0 C-N-CA 122.166 1.911 . . . . 0.0 111.511 -179.703 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.465 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 21.3 mt-30 -118.08 144.9 45.24 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 109.507 -0.553 . . . . 0.0 109.507 179.738 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.594 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 97.9 m-85 -125.17 137.37 54.15 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 120.455 -0.498 . . . . 0.0 111.627 -179.469 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 75.5 mt -117.03 127.41 54.14 Favored 'General case' 0 C--N 1.326 -0.421 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 178.303 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 74.5 m-20 -100.49 131.15 46.56 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-O 121.127 0.489 . . . . 0.0 111.093 -179.024 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.419 HD21 HG21 ' A' ' 61' ' ' VAL . 4.5 mt -129.12 155.79 79.26 Favored Pre-proline 0 C--N 1.327 -0.391 0 CA-C-N 115.4 -0.818 . . . . 0.0 109.59 -179.474 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -70.69 158.61 55.24 Favored 'Trans proline' 0 C--N 1.308 -1.587 0 C-N-CA 122.118 1.879 . . . . 0.0 112.167 179.818 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.433 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 27.8 p -58.69 -12.95 4.78 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 115.825 -0.625 . . . . 0.0 110.714 -179.897 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 29.5 p -90.31 -10.23 44.91 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.31 -0.405 . . . . 0.0 110.664 -179.637 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -83.32 134.74 34.9 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.93 0.395 . . . . 0.0 110.788 179.927 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.7 p -126.83 7.51 6.75 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.039 -0.528 . . . . 0.0 110.563 179.445 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 83.6 p -165.76 147.08 7.05 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.314 -0.403 . . . . 0.0 110.232 179.661 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.419 HG21 HD21 ' A' ' 54' ' ' LEU . 5.7 p -148.91 150.43 14.03 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-O 121.043 0.449 . . . . 0.0 111.371 -179.516 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.439 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 8.1 t-20 -101.49 130.48 47.76 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 115.709 -0.678 . . . . 0.0 109.925 178.901 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.0 mt -107.29 97.01 17.16 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-N 116.323 -0.399 . . . . 0.0 110.534 179.995 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.439 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 85.3 Cg_endo -87.46 -171.52 0.73 Allowed 'Trans proline' 0 C--N 1.305 -1.73 0 C-N-CA 122.664 2.243 . . . . 0.0 112.541 -179.822 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 86.9 m-20 58.42 35.63 24.87 Favored 'General case' 0 C--N 1.323 -0.56 0 CA-C-N 115.117 -0.947 . . . . 0.0 111.219 179.787 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.573 ' O ' ' OG ' ' A' ' 20' ' ' SER . 50.0 mt -90.53 142.01 28.18 Favored 'General case' 0 C--N 1.328 -0.364 0 N-CA-C 109.78 -0.452 . . . . 0.0 109.78 178.792 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 27.2 mt -82.75 113.16 43.15 Favored Pre-proline 0 CA--C 1.532 0.274 0 C-N-CA 120.976 -0.29 . . . . 0.0 110.266 -179.939 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 21.9 Cg_exo -54.4 141.42 72.32 Favored 'Trans proline' 0 C--N 1.312 -1.39 0 C-N-CA 122.226 1.95 . . . . 0.0 112.204 -179.803 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 79.26 20.09 70.43 Favored Glycine 0 CA--C 1.525 0.695 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 179.553 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.658 ' NH2' ' OE1' ' A' ' 45' ' ' GLU . 13.3 mmm-85 -123.05 146.91 47.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.887 0.375 . . . . 0.0 110.716 -179.959 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 78.6 tttt -100.15 131.54 46.04 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.055 -0.521 . . . . 0.0 109.674 179.225 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.654 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 76.9 m-85 -121.13 153.93 36.85 Favored 'General case' 0 C--N 1.324 -0.507 0 CA-C-O 121.214 0.531 . . . . 0.0 111.625 -179.707 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.433 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 74.0 mt -108.31 124.08 64.4 Favored 'Isoleucine or valine' 0 CA--C 1.515 -0.378 0 N-CA-C 107.635 -1.246 . . . . 0.0 107.635 177.206 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.1 t -112.97 131.54 64.29 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.75 0 CA-C-O 121.251 0.548 . . . . 0.0 111.084 -178.601 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 31.4 m-80 -134.54 126.1 28.64 Favored 'General case' 0 C--N 1.326 -0.451 0 CA-C-N 115.465 -0.789 . . . . 0.0 109.552 179.517 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.473 HG11 ' CD2' ' A' ' 26' ' ' TRP . 38.8 t -106.33 130.74 57.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.452 0 C-N-CA 120.662 -0.415 . . . . 0.0 110.904 -179.461 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 57.6 m-85 -123.5 136.59 54.65 Favored 'General case' 0 C--N 1.325 -0.459 0 CA-C-N 115.981 -0.554 . . . . 0.0 110.025 179.179 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.62 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -100.93 134.74 43.46 Favored 'General case' 0 C--N 1.321 -0.663 0 N-CA-C 108.078 -1.082 . . . . 0.0 108.078 178.207 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.572 ' O ' ' N ' ' A' ' 34' ' ' SER . 59.2 mt -97.5 123.64 50.01 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.616 0 CA-C-O 121.356 0.598 . . . . 0.0 110.957 -178.4 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.579 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 52.1 p -83.34 170.97 14.0 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 115.206 -0.906 . . . . 0.0 110.517 -179.832 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.6 mt-10 -61.97 -21.41 64.8 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.737 -0.665 . . . . 0.0 110.868 -179.692 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.579 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 0.5 OUTLIER -91.3 -0.8 57.72 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.413 -0.358 . . . . 0.0 111.478 -179.569 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.56 10.18 70.86 Favored Glycine 0 CA--C 1.526 0.765 0 C-N-CA 120.885 -0.674 . . . . 0.0 112.335 178.825 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.419 ' HG2' ' OD1' ' A' ' 82' ' ' ASP . 78.3 mm-40 -84.67 140.8 31.06 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 120.661 -0.416 . . . . 0.0 110.791 179.687 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.455 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 91.4 mt-30 -106.12 143.16 34.65 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.531 179.504 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 33.2 t -136.59 132.15 34.73 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.111 -0.495 . . . . 0.0 110.261 179.666 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.575 HD21 ' HB2' ' A' ' 90' ' ' SER . 24.1 tp -72.96 118.37 15.82 Favored 'General case' 0 C--N 1.326 -0.439 0 C-N-CA 120.731 -0.388 . . . . 0.0 110.349 179.853 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.435 HD11 ' CD1' ' A' ' 26' ' ' TRP . 41.5 pt -109.42 -22.87 4.76 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 CA-C-N 116.207 -0.451 . . . . 0.0 110.401 179.913 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 22.7 tp -154.88 121.81 5.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-O 121.085 0.469 . . . . 0.0 111.459 179.764 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.575 ' HB2' HD21 ' A' ' 87' ' ' LEU . 39.3 t -132.08 113.24 13.11 Favored 'General case' 0 C--N 1.328 -0.329 0 N-CA-C 109.069 -0.715 . . . . 0.0 109.069 178.666 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 3.8 t -150.87 162.76 40.16 Favored 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.826 -0.35 . . . . 0.0 110.443 -179.03 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 89.5 p -116.49 154.3 30.61 Favored 'General case' 0 C--N 1.327 -0.399 0 C-N-CA 120.74 -0.384 . . . . 0.0 110.331 179.459 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.579 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 23.7 mt-30 -136.56 155.82 49.42 Favored 'General case' 0 C--N 1.326 -0.449 0 CA-C-N 116.102 -0.499 . . . . 0.0 110.529 179.553 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -121.93 109.51 14.71 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.13 -0.693 . . . . 0.0 109.13 178.594 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.4 ' CG2' ' HB2' ' A' ' 20' ' ' SER . 18.4 p . . . . . 0 C--O 1.22 -0.456 0 CA-C-O 117.978 -1.01 . . . . 0.0 110.499 -179.203 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.257 0 N-CA-C 109.592 -1.403 . . . . 0.0 109.592 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 25.7 Cg_exo -58.41 141.51 97.13 Favored 'Trans proline' 0 C--N 1.303 -1.834 0 C-N-CA 122.778 2.318 . . . . 0.0 111.518 179.913 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 4.0 tt -91.29 121.8 33.35 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.278 -0.419 . . . . 0.0 110.505 -179.852 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.685 ' O ' ' N ' ' A' ' 6' ' ' HIS . . . 154.67 179.44 29.91 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 110.776 -0.93 . . . . 0.0 110.776 -179.867 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.425 ' O ' ' HB2' ' A' ' 6' ' ' HIS . 35.3 t 49.54 -73.9 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.301 0 CA-C-O 120.568 0.223 . . . . 0.0 110.972 179.897 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.685 ' N ' ' O ' ' A' ' 4' ' ' GLY . 27.8 m80 76.51 -60.93 0.46 Allowed 'General case' 0 N--CA 1.467 0.407 0 CA-C-N 115.905 -0.588 . . . . 0.0 111.463 179.642 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.479 ' C ' ' O ' ' A' ' 6' ' ' HIS . 3.1 mt 33.02 63.77 0.31 Allowed 'General case' 0 C--N 1.328 -0.329 0 C-N-CA 120.711 -0.396 . . . . 0.0 110.666 -179.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.546 ' O ' ' C ' ' A' ' 9' ' ' ALA . 14.7 p -84.23 150.22 4.16 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.374 0 CA-C-N 116.08 -0.509 . . . . 0.0 110.674 -179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.546 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . -28.3 113.51 0.07 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.166 -0.47 . . . . 0.0 110.005 179.67 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 24.5 m -112.59 141.01 46.86 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-N 116.372 -0.376 . . . . 0.0 111.645 -178.91 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 31.1 t -82.18 155.65 24.84 Favored 'General case' 0 C--N 1.332 -0.187 0 CA-C-N 115.914 -0.585 . . . . 0.0 110.465 179.381 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . . . . . . . . . 36.7 mp0 -54.46 137.51 42.4 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 120.947 0.403 . . . . 0.0 110.606 179.88 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -107.91 -18.71 13.73 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 115.869 -0.605 . . . . 0.0 111.505 -179.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . . . . . . . . . 25.8 t -103.71 122.28 56.2 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-O 121.125 0.488 . . . . 0.0 111.108 -179.238 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.949 HG22 ' H ' ' A' ' 16' ' ' GLU . 2.5 m -111.69 -167.52 1.19 Allowed 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.871 -0.604 . . . . 0.0 109.983 179.108 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.949 ' H ' HG22 ' A' ' 15' ' ' THR . 3.1 mp0 33.37 28.34 0.0 OUTLIER 'General case' 0 CA--C 1.517 -0.298 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 -179.324 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.706 ' N ' ' O ' ' A' ' 15' ' ' THR . 80.1 mt -37.14 -21.94 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 115.252 -0.885 . . . . 0.0 109.584 -179.372 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.66 ' N ' ' O ' ' A' ' 16' ' ' GLU . 69.8 p -58.34 151.97 18.58 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.091 -0.504 . . . . 0.0 109.682 179.191 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.567 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 55.58 21.75 4.72 Favored 'General case' 0 C--N 1.325 -0.488 0 C-N-CA 120.484 -0.487 . . . . 0.0 109.947 -179.647 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.567 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.2 OUTLIER 58.03 33.84 23.61 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.205 -0.452 . . . . 0.0 110.234 -179.879 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.569 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 3.5 p -61.18 165.87 4.1 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.855 -0.611 . . . . 0.0 111.24 -179.212 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.675 ' O ' ' ND2' ' A' ' 62' ' ' ASN . 17.3 m-30 -136.12 151.06 49.4 Favored 'General case' 0 CA--C 1.517 -0.295 0 CA-C-N 115.477 -0.783 . . . . 0.0 110.281 178.765 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.8 t -126.96 102.2 9.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 108.104 -1.073 . . . . 0.0 108.104 176.677 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 99.3 t -112.63 136.51 48.67 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.418 0 CA-C-N 116.238 -0.437 . . . . 0.0 111.306 -178.557 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 89.8 p -121.88 153.18 38.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.003 -0.544 . . . . 0.0 109.687 179.128 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.62 ' CD2' HG11 ' A' ' 76' ' ' VAL . 29.0 p90 -143.58 -168.9 2.95 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-O 121.12 0.486 . . . . 0.0 110.933 -179.138 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.841 HG12 ' H ' ' A' ' 29' ' ' ALA . 79.7 t -115.1 133.05 62.52 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.217 179.635 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.625 ' C ' ' H ' ' A' ' 30' ' ' SER . 98.2 p -51.9 -29.69 21.04 Favored 'General case' 0 C--N 1.326 -0.435 0 CA-C-N 116.1 -0.5 . . . . 0.0 110.422 -179.833 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.841 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 50.77 0.33 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.445 0 CA-C-N 115.902 -0.59 . . . . 0.0 111.251 179.844 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.625 ' H ' ' C ' ' A' ' 28' ' ' SER . 3.0 m -173.03 134.82 0.57 Allowed 'General case' 0 C--N 1.329 -0.298 0 C-N-CA 120.545 -0.462 . . . . 0.0 110.912 179.916 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 84.3 m-20 -88.54 -8.39 54.86 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.57 179.722 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 44.6 p -83.35 -2.83 56.69 Favored 'General case' 0 N--CA 1.453 -0.312 0 CA-C-N 116.357 -0.383 . . . . 0.0 110.632 -179.818 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.58 HG12 ' O ' ' A' ' 30' ' ' SER . 2.6 p -65.09 135.56 28.08 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.397 0 CA-C-O 120.907 0.384 . . . . 0.0 110.297 179.895 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.603 ' N ' ' O ' ' A' ' 79' ' ' ILE . 59.7 m -95.37 -15.07 23.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 115.842 -0.617 . . . . 0.0 109.525 179.666 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.468 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 177.54 -178.89 48.37 Favored Glycine 0 CA--C 1.52 0.381 0 N-CA-C 109.718 -1.353 . . . . 0.0 109.718 179.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.9 m-85 -128.34 152.73 47.82 Favored 'General case' 0 C--N 1.323 -0.585 0 C-N-CA 120.595 -0.442 . . . . 0.0 110.549 179.254 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.793 ' NH2' HE22 ' A' ' 85' ' ' GLN . 27.4 ttp180 -130.8 122.68 27.59 Favored 'General case' 0 C--N 1.32 -0.684 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.594 179.396 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . . . . . . . . . 57.2 t -109.32 134.32 51.72 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 CA-C-N 115.921 -0.582 . . . . 0.0 110.948 -179.709 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.419 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 83.2 tt0 -121.47 126.95 50.51 Favored 'General case' 0 C--N 1.326 -0.452 0 CA-C-N 116.081 -0.508 . . . . 0.0 110.202 179.537 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.457 ' CE1' ' OE1' ' A' ' 50' ' ' GLN . 54.0 p90 -133.6 131.29 39.47 Favored 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 121.238 0.542 . . . . 0.0 110.502 179.613 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.4 pt-20 -147.44 161.56 40.79 Favored 'General case' 0 C--N 1.325 -0.494 0 CA-C-N 115.45 -0.796 . . . . 0.0 109.442 -179.61 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.78 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 67.6 mt -75.78 130.45 38.64 Favored 'General case' 0 C--N 1.325 -0.469 0 CA-C-O 120.941 0.401 . . . . 0.0 111.702 -179.974 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.0 p -74.87 -23.23 58.37 Favored 'General case' 0 C--N 1.332 -0.172 0 CA-C-N 115.921 -0.581 . . . . 0.0 110.106 179.018 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 48.4 mt-10 -89.63 -71.04 0.63 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 115.904 -0.589 . . . . 0.0 110.533 -179.972 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.407 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 94.1 mt-10 -59.11 -37.98 78.48 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 115.758 -0.655 . . . . 0.0 110.698 -179.431 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.55 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 70.4 21.91 77.56 Favored Glycine 0 CA--C 1.521 0.463 0 N-CA-C 110.461 -1.056 . . . . 0.0 110.461 -179.819 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.55 ' O ' ' O ' ' A' ' 46' ' ' GLY . 27.1 t0 -46.29 -176.74 0.0 OUTLIER 'General case' 0 CA--C 1.514 -0.412 0 CA-C-O 120.963 0.411 . . . . 0.0 110.333 179.971 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.511 ' H ' ' CG ' ' A' ' 47' ' ' ASP . 0.3 OUTLIER -69.76 140.2 89.01 Favored Pre-proline 0 C--N 1.322 -0.619 0 CA-C-N 115.844 -0.616 . . . . 0.0 109.93 179.773 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -72.44 148.78 49.04 Favored 'Trans proline' 0 C--N 1.304 -1.77 0 C-N-CA 122.483 2.122 . . . . 0.0 111.856 -179.825 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.457 ' OE1' ' CE1' ' A' ' 40' ' ' TYR . 32.7 mt-30 -116.81 147.82 41.77 Favored 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 109.036 -0.728 . . . . 0.0 109.036 179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -123.95 139.59 53.81 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 119.857 -0.737 . . . . 0.0 111.943 -178.797 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 65.7 mt -124.76 128.55 48.93 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 115.422 -0.808 . . . . 0.0 109.056 178.348 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 48.6 m-20 -103.36 132.02 49.96 Favored 'General case' 0 C--N 1.32 -0.681 0 C-N-CA 120.653 -0.419 . . . . 0.0 110.977 -179.419 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . 0.449 HD21 HG21 ' A' ' 61' ' ' VAL . 4.4 mt -128.91 155.15 80.02 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-N 115.838 -0.619 . . . . 0.0 109.916 -179.391 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -67.9 155.77 68.48 Favored 'Trans proline' 0 C--N 1.309 -1.542 0 C-N-CA 122.087 1.858 . . . . 0.0 112.031 179.661 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.413 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 26.7 p -58.06 -14.66 7.1 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 115.79 -0.641 . . . . 0.0 110.639 179.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 49.8 p -89.41 -11.12 44.07 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.686 -0.406 . . . . 0.0 110.367 179.918 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.99 131.44 35.19 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.181 -0.463 . . . . 0.0 110.479 179.452 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 40.4 p -125.28 10.2 8.01 Favored 'General case' 0 C--N 1.328 -0.35 0 C-N-CA 120.718 -0.393 . . . . 0.0 110.617 179.485 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 49.8 p -164.85 146.4 7.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.06 179.358 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.449 HG21 HD21 ' A' ' 54' ' ' LEU . 5.1 p -149.05 152.21 12.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 C-N-CA 120.484 -0.486 . . . . 0.0 111.514 -179.45 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.675 ' ND2' ' O ' ' A' ' 22' ' ' PHE . 13.2 t-20 -102.42 124.76 48.57 Favored 'General case' 0 C--N 1.326 -0.423 0 CA-C-N 115.477 -0.783 . . . . 0.0 109.762 178.86 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.4 mt -97.26 107.0 35.76 Favored Pre-proline 0 C--N 1.329 -0.298 0 N-CA-C 110.032 -0.358 . . . . 0.0 110.032 -179.971 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 46.7 Cg_endo -92.21 -178.65 1.03 Allowed 'Trans proline' 0 C--N 1.308 -1.604 0 C-N-CA 122.802 2.335 . . . . 0.0 113.145 -179.273 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 75.6 m-20 58.7 38.05 25.04 Favored 'General case' 0 C--N 1.327 -0.4 0 CA-C-N 115.013 -0.994 . . . . 0.0 111.531 179.272 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.525 ' O ' ' OG ' ' A' ' 20' ' ' SER . 56.7 mt -90.69 146.53 23.94 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.394 -0.366 . . . . 0.0 110.094 178.988 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.493 ' N ' ' OH ' ' A' ' 72' ' ' TYR . 30.2 mt -86.44 123.77 70.73 Favored Pre-proline 0 CA--C 1.532 0.252 0 C-N-CA 120.719 -0.392 . . . . 0.0 110.249 179.951 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . . . . . . . . . 34.0 Cg_endo -68.81 143.36 55.29 Favored 'Trans proline' 0 C--N 1.313 -1.307 0 C-N-CA 122.226 1.95 . . . . 0.0 112.523 -179.7 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 78.56 19.53 73.49 Favored Glycine 0 CA--C 1.524 0.648 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 179.899 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.673 ' CG ' HH11 ' A' ' 70' ' ' ARG . 0.0 OUTLIER -126.44 151.55 47.59 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.733 0.302 . . . . 0.0 110.64 -179.758 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.7 tttt -100.37 130.65 46.49 Favored 'General case' 0 N--CA 1.451 -0.409 0 CA-C-O 121.029 0.442 . . . . 0.0 110.236 179.232 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.78 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 68.1 m-85 -117.25 158.52 24.19 Favored 'General case' 0 C--N 1.323 -0.544 0 CA-C-N 115.825 -0.625 . . . . 0.0 111.017 179.814 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . . . . . . . . . 76.4 mt -113.37 126.08 70.74 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.555 0 N-CA-C 107.987 -1.116 . . . . 0.0 107.987 176.943 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.6 t -112.74 128.83 69.23 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.674 0 CA-C-O 121.031 0.443 . . . . 0.0 110.642 -179.091 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 11.1 m-80 -133.36 125.76 29.85 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 115.649 -0.705 . . . . 0.0 109.421 179.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.62 HG11 ' CD2' ' A' ' 26' ' ' TRP . 14.3 t -104.65 128.51 58.22 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.483 0 C-N-CA 120.483 -0.487 . . . . 0.0 110.583 -179.502 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 54.0 m-85 -120.75 139.37 53.19 Favored 'General case' 0 C--N 1.325 -0.471 0 N-CA-C 109.542 -0.54 . . . . 0.0 109.542 179.262 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.518 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -101.62 134.52 44.63 Favored 'General case' 0 C--N 1.32 -0.677 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 178.963 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.603 ' O ' ' N ' ' A' ' 34' ' ' SER . 58.4 mt -99.06 119.39 46.98 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.575 0 CA-C-O 121.39 0.614 . . . . 0.0 110.621 -178.685 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.6 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 24.7 p -82.56 169.64 16.08 Favored 'General case' 0 C--N 1.321 -0.651 0 CA-C-N 115.071 -0.968 . . . . 0.0 110.078 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.8 mt-10 -59.98 -19.3 51.51 Favored 'General case' 0 C--N 1.323 -0.577 0 CA-C-N 116.033 -0.53 . . . . 0.0 111.48 -179.307 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.6 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 47.3 p30 -93.14 -1.41 56.4 Favored 'General case' 0 C--N 1.33 -0.243 0 C-N-CA 120.305 -0.558 . . . . 0.0 111.144 -179.789 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.51 12.28 67.36 Favored Glycine 0 CA--C 1.527 0.81 0 C-N-CA 120.928 -0.654 . . . . 0.0 111.926 179.297 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.537 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 73.8 mm-40 -83.7 139.26 32.88 Favored 'General case' 0 C--N 1.326 -0.451 0 C-N-CA 120.852 -0.339 . . . . 0.0 110.474 179.673 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.793 HE22 ' NH2' ' A' ' 37' ' ' ARG . 28.7 mt-30 -110.41 139.43 45.63 Favored 'General case' 0 C--N 1.332 -0.169 0 CA-C-N 116.303 -0.408 . . . . 0.0 110.876 179.791 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 8.0 t -136.82 135.92 38.37 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.119 -0.491 . . . . 0.0 109.937 179.302 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.819 HD21 ' HB2' ' A' ' 90' ' ' SER . 32.3 tp -73.28 118.45 16.25 Favored 'General case' 0 C--N 1.328 -0.356 0 C-N-CA 120.638 -0.425 . . . . 0.0 110.577 -179.989 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.652 HD12 ' O ' ' A' ' 27' ' ' VAL . 44.1 pt -109.05 -22.37 5.06 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.612 179.949 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 15.6 tp -154.87 122.19 5.62 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 120.663 -0.415 . . . . 0.0 111.106 179.99 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.819 ' HB2' HD21 ' A' ' 87' ' ' LEU . 35.2 t -130.61 122.21 27.04 Favored 'General case' 0 C--N 1.33 -0.266 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 178.886 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.9 t -154.34 158.59 40.33 Favored 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 120.68 -0.408 . . . . 0.0 110.323 -179.447 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 92.2 p -117.15 152.69 34.23 Favored 'General case' 0 C--N 1.323 -0.563 0 C-N-CA 120.551 -0.459 . . . . 0.0 110.445 179.535 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.463 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 27.0 mt-30 -138.94 157.47 45.97 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 115.964 -0.562 . . . . 0.0 110.661 179.809 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -118.6 112.66 20.13 Favored 'General case' 0 C--N 1.322 -0.605 0 N-CA-C 108.921 -0.77 . . . . 0.0 108.921 178.829 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.425 HG22 ' CZ ' ' A' ' 22' ' ' PHE . 53.8 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 117.894 -1.05 . . . . 0.0 110.498 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . 0.554 ' C ' ' H ' ' A' ' 3' ' ' LEU . . . . . . . . 0 N--CA 1.493 2.438 0 N-CA-C 109.4 -1.48 . . . . 0.0 109.4 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -65.23 18.01 0.08 OUTLIER 'Trans proline' 0 C--N 1.305 -1.748 0 C-N-CA 122.851 2.368 . . . . 0.0 111.653 179.743 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.554 ' H ' ' C ' ' A' ' 1' ' ' GLY . 1.0 OUTLIER -70.28 144.14 51.86 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 115.803 -0.635 . . . . 0.0 111.013 -179.713 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . . . . . . . . . . . 82.55 11.48 81.81 Favored Glycine 0 CA--C 1.523 0.58 0 N-CA-C 111.035 -0.826 . . . . 0.0 111.035 179.757 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . . . . . . . . . 56.7 p -84.95 -4.06 58.99 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.692 0.282 . . . . 0.0 110.915 -179.866 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.612 ' O ' ' N ' ' A' ' 8' ' ' VAL . 76.6 m-70 -73.36 -113.5 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.285 0 CA-C-O 121.105 0.478 . . . . 0.0 110.552 179.929 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.533 ' N ' HD12 ' A' ' 7' ' ' LEU . 6.5 mp 36.31 23.55 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.675 -0.693 . . . . 0.0 110.991 179.852 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.69 ' C ' ' H ' ' A' ' 10' ' ' THR . 36.9 t -70.05 -11.71 15.24 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.236 0 N-CA-C 109.77 -0.455 . . . . 0.0 109.77 179.683 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . . . . . . . . . . . 63.98 -27.95 0.09 Allowed 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 115.971 -0.559 . . . . 0.0 110.363 -179.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.69 ' H ' ' C ' ' A' ' 8' ' ' VAL . 63.8 m -103.91 139.21 39.4 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 115.993 -0.549 . . . . 0.0 110.937 -179.879 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 11.8 p -130.85 -90.87 0.44 Allowed 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 115.724 -0.671 . . . . 0.0 109.446 179.144 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.476 ' C ' ' H ' ' A' ' 14' ' ' VAL . 39.4 tp10 -72.69 -44.03 62.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-O 121.165 0.507 . . . . 0.0 109.899 178.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 1.1 m 69.8 -40.64 0.46 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 115.58 -0.736 . . . . 0.0 110.947 179.925 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.476 ' H ' ' C ' ' A' ' 12' ' ' GLU . 47.3 t -115.01 131.34 67.53 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.978 0.418 . . . . 0.0 111.94 -179.28 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.964 HG22 ' H ' ' A' ' 16' ' ' GLU . 9.5 m -134.67 -143.09 0.2 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.08 -0.509 . . . . 0.0 109.954 178.615 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.964 ' H ' HG22 ' A' ' 15' ' ' THR . 77.4 mm-40 8.14 56.88 0.0 OUTLIER 'General case' 0 N--CA 1.464 0.258 0 O-C-N 123.529 0.518 . . . . 0.0 110.777 -179.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.711 ' N ' ' O ' ' A' ' 15' ' ' THR . 67.4 mt -64.1 -21.5 29.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 CA-C-N 115.956 -0.565 . . . . 0.0 110.991 -178.73 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.439 ' O ' ' HB3' ' A' ' 19' ' ' ALA . 18.4 m -53.33 135.0 39.63 Favored 'General case' 0 C--N 1.329 -0.29 0 N-CA-C 109.046 -0.724 . . . . 0.0 109.046 179.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.597 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 65.4 17.38 10.95 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 108.998 -0.741 . . . . 0.0 108.998 -178.393 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.597 ' OG ' ' O ' ' A' ' 19' ' ' ALA . 0.3 OUTLIER 60.41 29.14 18.78 Favored 'General case' 0 C--N 1.332 -0.171 0 CA-C-N 115.426 -0.806 . . . . 0.0 111.313 -179.879 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.607 ' OG ' ' O ' ' A' ' 16' ' ' GLU . 0.0 OUTLIER -60.77 129.57 42.17 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 121.182 0.515 . . . . 0.0 110.626 -179.994 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.553 ' CG ' ' NE2' ' A' ' 93' ' ' GLN . 19.0 m-30 -95.65 144.87 25.71 Favored 'General case' 0 C--N 1.325 -0.46 0 CA-C-N 115.555 -0.748 . . . . 0.0 111.266 179.408 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 39.0 t -120.31 102.87 13.2 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.634 0 N-CA-C 107.996 -1.113 . . . . 0.0 107.996 176.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 97.6 t -113.87 137.88 45.57 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.433 0 CA-C-O 121.079 0.466 . . . . 0.0 111.504 -178.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 99.4 p -126.52 153.02 45.73 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.606 -0.725 . . . . 0.0 109.711 179.32 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.577 ' CD2' HG11 ' A' ' 76' ' ' VAL . 32.2 p90 -144.65 -172.52 3.83 Favored 'General case' 0 C--N 1.323 -0.556 0 CA-C-N 116.139 -0.482 . . . . 0.0 110.538 -179.243 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.537 HG12 ' H ' ' A' ' 29' ' ' ALA . 39.4 t -113.76 131.15 66.45 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 CA-C-N 115.926 -0.579 . . . . 0.0 109.629 179.235 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.678 ' O ' ' NE2' ' A' ' 78' ' ' GLN . 27.3 t -52.76 -34.64 54.02 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.392 -0.367 . . . . 0.0 110.683 -179.376 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.537 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 60.59 -7.74 0.08 Allowed 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.412 -0.358 . . . . 0.0 111.082 179.507 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.592 ' H ' ' C ' ' A' ' 28' ' ' SER . 3.1 m -167.48 132.77 1.98 Allowed 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.308 -0.405 . . . . 0.0 110.798 -179.504 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 -90.06 6.55 41.87 Favored 'General case' 0 C--N 1.326 -0.425 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.483 179.633 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -94.49 -4.39 48.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.171 -0.468 . . . . 0.0 110.231 179.872 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.572 HG12 ' O ' ' A' ' 30' ' ' SER . 2.1 p -63.29 138.49 22.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.26 0 CA-C-N 116.023 -0.535 . . . . 0.0 110.106 179.836 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.663 ' N ' ' O ' ' A' ' 79' ' ' ILE . 5.8 m -95.31 -13.31 24.91 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-O 121.346 0.593 . . . . 0.0 109.831 -179.934 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.475 ' O ' ' CG2' ' A' ' 33' ' ' VAL . . . 175.96 177.02 44.65 Favored Glycine 0 CA--C 1.523 0.566 0 N-CA-C 109.812 -1.315 . . . . 0.0 109.812 179.667 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 83.9 m-85 -125.57 151.71 46.06 Favored 'General case' 0 C--N 1.323 -0.557 0 CA-C-O 120.904 0.383 . . . . 0.0 110.369 178.991 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.708 ' CZ ' HE22 ' A' ' 85' ' ' GLN . 46.0 ttp180 -128.66 121.74 29.25 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-N 116.008 -0.542 . . . . 0.0 109.682 178.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.466 HG21 HG11 ' A' ' 61' ' ' VAL . 47.9 t -106.72 132.87 52.89 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.558 0 CA-C-N 115.907 -0.588 . . . . 0.0 110.381 -179.679 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.44 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 69.3 tt0 -123.46 134.28 53.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 CA-C-N 116.093 -0.503 . . . . 0.0 110.763 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.485 ' CZ ' ' HB2' ' A' ' 50' ' ' GLN . 54.6 p90 -140.14 137.18 34.24 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 121.097 0.475 . . . . 0.0 110.714 178.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 21.2 pt-20 -147.62 158.94 44.23 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 115.669 -0.696 . . . . 0.0 109.907 -179.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.685 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 39.9 mt -74.25 132.4 42.09 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.947 0.403 . . . . 0.0 110.845 179.763 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.5 p -77.64 -13.67 59.84 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.834 -0.621 . . . . 0.0 110.317 179.802 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 83.4 mt-10 -98.8 -73.19 0.63 Allowed 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.03 -0.532 . . . . 0.0 110.976 -179.539 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 77.7 mm-40 -60.1 -34.4 73.44 Favored 'General case' 0 C--N 1.326 -0.414 0 CA-C-N 115.768 -0.651 . . . . 0.0 111.155 -179.217 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.573 ' O ' ' O ' ' A' ' 47' ' ' ASP . . . 74.96 18.48 80.18 Favored Glycine 0 CA--C 1.521 0.459 0 N-CA-C 110.294 -1.122 . . . . 0.0 110.294 -179.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.677 ' OD1' ' N ' ' A' ' 48' ' ' GLU . 37.8 t0 -41.32 173.45 0.0 OUTLIER 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.929 0.395 . . . . 0.0 110.462 -179.803 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . 0.677 ' N ' ' OD1' ' A' ' 47' ' ' ASP . 0.7 OUTLIER -67.18 140.23 95.51 Favored Pre-proline 0 C--N 1.325 -0.489 0 CA-C-N 116.024 -0.534 . . . . 0.0 110.125 -179.744 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.538 ' C ' ' OE1' ' A' ' 50' ' ' GLN . 57.7 Cg_endo -73.3 146.35 40.11 Favored 'Trans proline' 0 C--N 1.306 -1.693 0 C-N-CA 122.575 2.183 . . . . 0.0 111.997 -179.895 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.655 ' N ' ' CD ' ' A' ' 50' ' ' GLN . 2.4 mp0 -113.11 147.9 36.37 Favored 'General case' 0 C--N 1.328 -0.358 0 N-CA-C 108.898 -0.779 . . . . 0.0 108.898 179.173 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 28.9 m-85 -122.72 136.16 54.79 Favored 'General case' 0 C--N 1.325 -0.494 0 C-N-CA 119.953 -0.699 . . . . 0.0 111.146 -179.536 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 72.7 mt -120.58 128.28 52.91 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 108.755 -0.832 . . . . 0.0 108.755 178.465 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 56.4 m-20 -100.66 130.61 46.73 Favored 'General case' 0 C--N 1.323 -0.583 0 C-N-CA 120.382 -0.527 . . . . 0.0 111.201 -178.928 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 7.5 mt -127.82 155.95 76.61 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-N 115.572 -0.74 . . . . 0.0 109.468 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -68.21 156.16 66.77 Favored 'Trans proline' 0 C--N 1.307 -1.611 0 C-N-CA 122.274 1.983 . . . . 0.0 112.269 -179.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.505 ' CB ' ' O ' ' A' ' 33' ' ' VAL . 53.4 p -58.8 -14.11 7.91 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.027 -0.533 . . . . 0.0 110.738 -179.885 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 61.3 p -90.01 -8.83 50.66 Favored 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.298 -0.41 . . . . 0.0 110.217 179.932 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -84.71 132.96 34.39 Favored 'General case' 0 C--N 1.334 -0.101 0 CA-C-N 116.274 -0.421 . . . . 0.0 110.689 179.612 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 p -128.9 12.73 6.25 Favored 'General case' 0 C--N 1.329 -0.296 0 C-N-CA 120.756 -0.378 . . . . 0.0 111.032 179.697 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 94.5 p -164.61 148.62 9.23 Favored 'General case' 0 C--N 1.329 -0.312 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 179.403 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.466 HG11 HG21 ' A' ' 38' ' ' VAL . 5.3 p -152.63 147.17 14.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.472 0 C-N-CA 120.356 -0.537 . . . . 0.0 111.514 -179.571 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.42 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 15.9 t-20 -102.88 127.96 49.86 Favored 'General case' 0 C--N 1.326 -0.45 0 CA-C-N 115.784 -0.644 . . . . 0.0 109.366 178.723 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.455 HG22 HD21 ' A' ' 66' ' ' LEU . 1.9 mt -99.21 104.6 27.33 Favored Pre-proline 0 C--N 1.332 -0.177 0 N-CA-C 110.26 -0.274 . . . . 0.0 110.26 -179.684 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.42 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 91.5 Cg_endo -89.42 174.66 3.49 Favored 'Trans proline' 0 C--N 1.312 -1.357 0 C-N-CA 122.785 2.323 . . . . 0.0 113.103 -179.35 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 84.8 m-20 61.38 38.31 16.24 Favored 'General case' 0 C--N 1.324 -0.514 0 CA-C-N 114.641 -1.163 . . . . 0.0 111.708 179.524 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.517 ' O ' ' OG ' ' A' ' 20' ' ' SER . 26.3 mt -90.51 142.44 27.74 Favored 'General case' 0 C--N 1.329 -0.285 0 N-CA-C 110.106 -0.331 . . . . 0.0 110.106 178.793 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.417 HD13 ' NH2' ' A' ' 70' ' ' ARG . 24.9 mt -78.66 130.8 69.69 Favored Pre-proline 0 CA--C 1.53 0.176 0 C-N-CA 121.145 -0.222 . . . . 0.0 111.287 -179.405 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.709 ' O ' ' N ' ' A' ' 70' ' ' ARG . 39.0 Cg_exo -51.35 -174.92 0.01 OUTLIER 'Trans proline' 0 C--N 1.31 -1.474 0 C-N-CA 122.206 1.937 . . . . 0.0 111.812 178.392 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.501 ' C ' ' O ' ' A' ' 68' ' ' PRO . . . 17.02 40.29 0.01 OUTLIER Glycine 0 CA--C 1.532 1.14 0 CA-C-N 115.686 -0.688 . . . . 0.0 113.373 179.068 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.709 ' N ' ' O ' ' A' ' 68' ' ' PRO . 16.2 mmm-85 -127.22 142.76 51.4 Favored 'General case' 0 C--N 1.327 -0.395 0 CA-C-N 117.346 0.573 . . . . 0.0 110.417 179.0 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 77.4 tttt -101.19 132.4 46.7 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-O 120.988 0.423 . . . . 0.0 110.217 179.441 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.685 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 67.8 m-85 -121.28 155.72 34.07 Favored 'General case' 0 C--N 1.321 -0.64 0 CA-C-N 115.942 -0.572 . . . . 0.0 111.192 179.828 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.43 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 72.2 mt -110.68 123.77 66.87 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.508 0 N-CA-C 107.109 -1.441 . . . . 0.0 107.109 176.816 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.414 ' HA ' ' O ' ' A' ' 39' ' ' GLU . 62.7 t -114.13 134.22 57.69 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.653 0 CA-C-O 121.304 0.573 . . . . 0.0 111.565 -178.27 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . 0.496 ' OD1' ' OG ' ' A' ' 90' ' ' SER . 21.4 m-80 -133.07 126.14 31.15 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 115.331 -0.85 . . . . 0.0 109.523 179.409 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.577 HG11 ' CD2' ' A' ' 26' ' ' TRP . 6.6 t -107.57 131.36 57.97 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.405 0 C-N-CA 120.335 -0.546 . . . . 0.0 110.535 -179.802 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 46.2 m-85 -122.12 142.29 50.54 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 115.967 -0.561 . . . . 0.0 110.116 179.657 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.678 ' NE2' ' O ' ' A' ' 28' ' ' SER . 0.6 OUTLIER -102.88 137.47 41.04 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 107.863 -1.162 . . . . 0.0 107.863 177.804 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.663 ' O ' ' N ' ' A' ' 34' ' ' SER . 45.2 mt -100.93 121.56 51.89 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.593 0 CA-C-O 121.074 0.464 . . . . 0.0 110.437 -178.587 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.614 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 71.4 p -82.11 168.13 18.05 Favored 'General case' 0 N--CA 1.45 -0.468 0 CA-C-N 115.618 -0.719 . . . . 0.0 110.945 -179.287 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 98.0 mt-10 -57.62 -22.25 44.26 Favored 'General case' 0 C--N 1.325 -0.466 0 CA-C-N 115.546 -0.752 . . . . 0.0 111.03 -179.504 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.614 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 42.5 p30 -92.82 -0.49 57.24 Favored 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 120.585 -0.446 . . . . 0.0 110.723 179.942 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.76 11.95 67.32 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 121.186 -0.531 . . . . 0.0 112.495 179.131 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.519 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.6 mm-40 -83.21 138.69 33.51 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 117.195 0.498 . . . . 0.0 111.037 179.796 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.708 HE22 ' CZ ' ' A' ' 37' ' ' ARG . 94.0 mt-30 -107.03 142.24 36.97 Favored 'General case' 0 C--N 1.332 -0.183 0 CA-C-N 116.157 -0.474 . . . . 0.0 111.224 179.971 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 31.7 t -138.3 135.34 35.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.856 -0.611 . . . . 0.0 110.135 179.448 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.614 HD21 ' HB2' ' A' ' 90' ' ' SER . 36.8 tp -73.42 118.6 16.57 Favored 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 120.508 -0.477 . . . . 0.0 110.228 179.672 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.403 HD13 HG21 ' A' ' 88' ' ' ILE . 32.6 pt -110.99 -22.43 5.02 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.448 0 CA-C-N 116.13 -0.487 . . . . 0.0 110.555 -179.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 27.6 tp -155.19 124.86 6.47 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.562 179.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.614 ' HB2' HD21 ' A' ' 87' ' ' LEU . 7.2 t -135.66 119.22 16.99 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 115.671 -0.695 . . . . 0.0 109.345 178.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 4.8 t -149.88 158.27 44.0 Favored 'General case' 0 C--N 1.33 -0.274 0 C-N-CA 120.624 -0.431 . . . . 0.0 110.902 -179.321 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 69.1 p -115.74 154.65 29.2 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.414 -0.357 . . . . 0.0 110.137 179.394 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.553 ' NE2' ' CG ' ' A' ' 22' ' ' PHE . 27.1 mt-30 -142.18 159.81 41.49 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 121.106 0.479 . . . . 0.0 111.23 179.974 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.17 114.84 23.07 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 115.604 -0.726 . . . . 0.0 109.477 178.597 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.586 ' OG1' ' N ' ' A' ' 70' ' ' ARG . 31.1 p . . . . . 0 C--O 1.219 -0.514 0 CA-C-O 117.951 -1.023 . . . . 0.0 110.607 -179.191 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.493 2.463 0 N-CA-C 109.404 -1.478 . . . . 0.0 109.404 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . . . . . . . . . 95.8 Cg_endo -88.34 -9.8 4.94 Favored 'Trans proline' 0 C--N 1.304 -1.796 0 C-N-CA 123.475 2.783 . . . . 0.0 113.9 -179.239 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . . . . . . . . . 31.1 mt -59.51 -36.22 75.66 Favored 'General case' 0 C--N 1.329 -0.302 0 C-N-CA 120.331 -0.548 . . . . 0.0 111.093 -178.778 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.454 ' O ' ' O ' ' A' ' 5' ' ' SER . . . -108.44 -140.73 9.31 Favored Glycine 0 CA--C 1.525 0.69 0 N-CA-C 110.772 -0.931 . . . . 0.0 110.772 179.912 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.454 ' O ' ' O ' ' A' ' 4' ' ' GLY . 13.2 m 36.5 -157.57 0.0 OUTLIER 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.732 0.301 . . . . 0.0 110.667 179.838 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . . . . . . . . . 79.5 m-70 60.66 45.46 10.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 121.007 0.432 . . . . 0.0 110.048 -179.672 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . . . . . . . . . 9.0 tt -53.44 -37.74 62.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 115.715 -0.675 . . . . 0.0 111.487 -179.365 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.531 ' O ' HG22 ' A' ' 10' ' ' THR . 7.4 p -137.96 -42.37 0.35 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.41 0 C-N-CA 120.56 -0.456 . . . . 0.0 111.512 -179.415 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.653 ' C ' HG22 ' A' ' 10' ' ' THR . . . -61.95 148.1 44.81 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 121.09 0.471 . . . . 0.0 110.809 -179.641 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . 0.653 HG22 ' C ' ' A' ' 9' ' ' ALA . 0.0 OUTLIER 166.63 -33.63 0.0 OUTLIER 'General case' 0 C--N 1.327 -0.374 0 CA-C-O 121.478 0.656 . . . . 0.0 109.484 -179.709 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . 0.542 ' OG ' ' N ' ' A' ' 12' ' ' GLU . 8.0 p -163.62 -138.62 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.473 0 CA-C-N 115.157 -0.929 . . . . 0.0 109.408 179.549 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.542 ' N ' ' OG ' ' A' ' 11' ' ' SER . 85.6 mt-10 -67.95 -31.86 71.89 Favored 'General case' 0 C--N 1.324 -0.541 0 C-N-CA 120.518 -0.473 . . . . 0.0 110.877 179.832 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 51.37 4.21 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.381 -0.372 . . . . 0.0 111.241 179.834 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.537 ' H ' ' C ' ' A' ' 12' ' ' GLU . 39.2 t -135.02 -59.54 0.53 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-O 120.905 0.384 . . . . 0.0 110.837 -179.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.7 HG22 ' N ' ' A' ' 16' ' ' GLU . 59.6 m 45.89 -102.64 0.07 Allowed 'General case' 0 C--N 1.326 -0.454 0 CA-C-N 115.892 -0.595 . . . . 0.0 110.711 -179.727 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.7 ' N ' HG22 ' A' ' 15' ' ' THR . 17.4 pt-20 46.79 43.47 13.16 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 115.939 -0.573 . . . . 0.0 110.7 -179.542 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.675 HG22 ' N ' ' A' ' 18' ' ' THR . 30.3 mt -110.05 -118.39 0.02 OUTLIER 'Isoleucine or valine' 0 C--N 1.333 -0.147 0 C-N-CA 120.612 -0.435 . . . . 0.0 110.571 179.659 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.675 ' N ' HG22 ' A' ' 17' ' ' ILE . 71.3 p 36.15 102.89 0.0 OUTLIER 'General case' 0 N--CA 1.465 0.322 0 N-CA-C 109.902 -0.407 . . . . 0.0 109.902 -179.457 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.565 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . 68.16 22.64 8.19 Favored 'General case' 0 C--N 1.327 -0.382 0 N-CA-C 108.287 -1.005 . . . . 0.0 108.287 -178.297 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.64 ' O ' HD12 ' A' ' 66' ' ' LEU . 2.6 p 55.26 22.59 4.87 Favored 'General case' 0 N--CA 1.454 -0.257 0 CA-C-N 115.479 -0.782 . . . . 0.0 109.324 -178.923 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.625 ' O ' ' O ' ' A' ' 16' ' ' GLU . 2.3 p -61.59 127.92 33.78 Favored 'General case' 0 C--N 1.332 -0.168 0 CA-C-N 115.632 -0.713 . . . . 0.0 110.584 -179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.524 ' CE1' HG22 ' A' ' 95' ' ' THR . 5.5 m-30 -92.34 140.41 29.62 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-N 115.812 -0.631 . . . . 0.0 112.126 -179.878 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 99.0 t -122.32 107.65 20.1 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.524 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 176.547 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 87.5 t -117.47 135.15 58.78 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.509 0 C-N-CA 120.255 -0.578 . . . . 0.0 110.847 -179.226 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 88.9 p -124.34 150.79 45.1 Favored 'General case' 0 C--N 1.326 -0.432 0 N-CA-C 109.208 -0.664 . . . . 0.0 109.208 179.142 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.57 ' CD2' HG11 ' A' ' 76' ' ' VAL . 38.9 p90 -145.04 -164.99 2.05 Favored 'General case' 0 C--N 1.321 -0.65 0 C-N-CA 120.553 -0.459 . . . . 0.0 110.493 -179.497 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . 0.654 HG12 ' H ' ' A' ' 29' ' ' ALA . 47.0 t -118.75 133.37 65.81 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.61 0 CA-C-N 115.749 -0.659 . . . . 0.0 109.345 179.392 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . 0.666 ' O ' ' N ' ' A' ' 30' ' ' SER . 61.1 p -50.56 -28.83 9.36 Favored 'General case' 0 C--N 1.324 -0.501 0 CA-C-N 116.214 -0.448 . . . . 0.0 110.595 -179.196 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.654 ' H ' HG12 ' A' ' 27' ' ' VAL . . . 42.81 9.19 0.0 OUTLIER 'General case' 0 C--N 1.326 -0.422 0 CA-C-N 116.141 -0.481 . . . . 0.0 111.1 179.486 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.678 ' O ' HG12 ' A' ' 33' ' ' VAL . 0.7 OUTLIER -169.08 116.96 0.64 Allowed 'General case' 0 C--N 1.328 -0.358 0 C-N-CA 120.816 -0.354 . . . . 0.0 110.82 -179.896 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 90.5 m-20 -84.44 -7.46 59.28 Favored 'General case' 0 C--N 1.327 -0.403 0 N-CA-C 109.555 -0.535 . . . . 0.0 109.555 179.089 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . . . . . . . . . 35.8 p -88.25 -0.7 57.42 Favored 'General case' 0 N--CA 1.452 -0.364 0 CA-C-N 115.564 -0.743 . . . . 0.0 110.017 179.305 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.678 HG12 ' O ' ' A' ' 30' ' ' SER . 7.5 p -66.94 137.22 25.27 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.354 0 CA-C-N 115.759 -0.655 . . . . 0.0 110.8 -179.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.681 ' N ' ' O ' ' A' ' 79' ' ' ILE . 70.2 m -95.11 -16.51 22.57 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 115.93 -0.577 . . . . 0.0 109.651 179.622 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.477 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.83 178.34 47.29 Favored Glycine 0 CA--C 1.521 0.446 0 N-CA-C 109.699 -1.36 . . . . 0.0 109.699 179.538 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 96.5 m-85 -126.19 151.27 47.58 Favored 'General case' 0 C--N 1.324 -0.513 0 CA-C-O 120.895 0.379 . . . . 0.0 110.118 179.124 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.819 ' NE ' HE22 ' A' ' 85' ' ' GLN . 26.9 ttp180 -130.46 125.62 34.86 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 109.254 -0.647 . . . . 0.0 109.254 179.557 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.525 HG21 HG11 ' A' ' 61' ' ' VAL . 46.2 t -109.13 131.49 59.78 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.67 0 CA-C-N 116.095 -0.502 . . . . 0.0 110.396 -179.662 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.403 ' HA ' ' O ' ' A' ' 50' ' ' GLN . 78.2 tt0 -120.99 126.21 49.34 Favored 'General case' 0 C--N 1.325 -0.493 0 N-CA-C 109.321 -0.622 . . . . 0.0 109.321 179.48 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.489 ' HA ' ' O ' ' A' ' 73' ' ' ILE . 49.6 p90 -137.61 137.05 38.1 Favored 'General case' 0 C--N 1.325 -0.458 0 C-N-CA 120.222 -0.591 . . . . 0.0 111.239 -179.688 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 16.5 pt-20 -147.2 167.53 23.96 Favored 'General case' 0 C--N 1.332 -0.191 0 CA-C-N 115.748 -0.66 . . . . 0.0 110.211 179.871 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.811 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 57.9 mt -77.1 128.59 34.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-O 120.942 0.401 . . . . 0.0 111.213 179.291 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.4 p -76.4 -16.09 59.79 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 115.993 -0.548 . . . . 0.0 110.145 179.684 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 65.3 mm-40 -92.31 -74.82 0.5 Allowed 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.083 -178.86 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . . . . . . . . . 74.4 mm-40 -62.84 -34.29 77.02 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-N 115.859 -0.609 . . . . 0.0 110.998 -179.43 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 72.68 34.96 59.28 Favored Glycine 0 CA--C 1.524 0.615 0 N-CA-C 110.934 -0.867 . . . . 0.0 110.934 179.824 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . . . . . . . . . 67.2 m-20 -57.56 169.92 0.62 Allowed 'General case' 0 C--N 1.329 -0.313 0 N-CA-C 110.063 -0.347 . . . . 0.0 110.063 179.882 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.3 pm0 -61.11 137.47 94.15 Favored Pre-proline 0 C--N 1.327 -0.39 0 C-N-CA 120.386 -0.526 . . . . 0.0 109.85 -179.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 27.4 Cg_endo -64.71 152.47 81.84 Favored 'Trans proline' 0 C--N 1.307 -1.626 0 C-N-CA 122.603 2.202 . . . . 0.0 112.846 -179.281 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.403 ' O ' ' HA ' ' A' ' 39' ' ' GLU . 42.9 mt-30 -118.65 144.7 46.0 Favored 'General case' 0 C--N 1.327 -0.41 0 CA-C-N 115.338 -0.847 . . . . 0.0 108.904 179.372 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . . . . . . . . . 89.1 m-85 -121.1 143.04 49.3 Favored 'General case' 0 C--N 1.327 -0.377 0 C-N-CA 120.054 -0.659 . . . . 0.0 112.203 -178.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 61.0 mt -129.38 125.74 37.27 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 115.069 -0.969 . . . . 0.0 108.869 177.933 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -100.54 133.52 44.85 Favored 'General case' 0 C--N 1.324 -0.504 0 C-N-CA 120.384 -0.527 . . . . 0.0 111.367 -179.051 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.3 mt -128.96 160.43 63.52 Favored Pre-proline 0 C--N 1.329 -0.317 0 CA-C-N 115.476 -0.783 . . . . 0.0 109.512 -179.496 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . 0.467 ' HD2' ' HB2' ' A' ' 58' ' ' ALA . 35.9 Cg_endo -75.61 158.99 39.57 Favored 'Trans proline' 0 C--N 1.309 -1.517 0 C-N-CA 121.989 1.793 . . . . 0.0 112.129 179.794 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.477 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 7.7 p -57.45 -12.23 2.47 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 115.752 -0.658 . . . . 0.0 111.296 -179.672 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 30.4 p -93.8 -8.11 41.47 Favored 'General case' 0 C--N 1.328 -0.351 0 C-N-CA 120.594 -0.443 . . . . 0.0 111.09 -179.583 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . 0.467 ' HB2' ' HD2' ' A' ' 55' ' ' PRO . . . -82.07 138.53 34.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.839 0.352 . . . . 0.0 110.989 -179.752 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 24.0 p -130.27 5.69 4.85 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.993 179.7 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 73.3 p -163.31 146.82 10.57 Favored 'General case' 0 C--N 1.329 -0.325 0 N-CA-C 109.995 -0.372 . . . . 0.0 109.995 179.647 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.525 HG11 HG21 ' A' ' 38' ' ' VAL . 9.7 p -146.85 146.76 18.38 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 C-N-CA 120.563 -0.455 . . . . 0.0 111.407 -179.171 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . 0.436 ' O ' ' HD3' ' A' ' 64' ' ' PRO . 14.1 t-20 -103.51 128.49 50.71 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 115.761 -0.654 . . . . 0.0 110.296 179.315 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.457 HD13 ' CD1' ' A' ' 40' ' ' TYR . 1.4 mt -105.47 99.49 21.23 Favored Pre-proline 0 C--N 1.331 -0.214 0 CA-C-N 116.038 -0.528 . . . . 0.0 109.925 179.681 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . 0.436 ' HD3' ' O ' ' A' ' 62' ' ' ASN . 96.7 Cg_endo -88.83 174.46 3.92 Favored 'Trans proline' 0 C--N 1.302 -1.916 0 C-N-CA 122.579 2.186 . . . . 0.0 112.162 -179.551 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 64.9 m-20 66.56 37.73 4.39 Favored 'General case' 0 C--N 1.319 -0.752 0 CA-C-N 114.874 -1.057 . . . . 0.0 111.431 179.775 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.64 HD12 ' O ' ' A' ' 20' ' ' SER . 39.4 mt -89.74 157.42 17.97 Favored 'General case' 0 C--N 1.327 -0.378 0 N-CA-C 109.66 -0.496 . . . . 0.0 109.66 178.451 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . . . . . . . . . 33.4 mt -91.1 110.09 39.85 Favored Pre-proline 0 C--N 1.331 -0.205 0 C-N-CA 121.143 -0.223 . . . . 0.0 110.793 -179.704 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.41 ' HD3' ' O ' ' A' ' 66' ' ' LEU . 22.1 Cg_exo -56.39 143.33 87.05 Favored 'Trans proline' 0 C--N 1.312 -1.379 0 C-N-CA 122.192 1.928 . . . . 0.0 111.699 179.427 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . 0.602 ' N ' ' OG1' ' A' ' 95' ' ' THR . . . 79.05 17.78 76.14 Favored Glycine 0 CA--C 1.525 0.689 0 N-CA-C 111.27 -0.732 . . . . 0.0 111.27 179.555 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . . . . . . . . . 12.7 mmm-85 -125.15 151.2 46.1 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-O 120.758 0.313 . . . . 0.0 110.466 179.93 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 66.1 tttt -99.85 131.86 45.55 Favored 'General case' 0 N--CA 1.449 -0.488 0 CA-C-N 116.234 -0.439 . . . . 0.0 109.866 179.353 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.811 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 72.2 m-85 -118.84 153.05 35.14 Favored 'General case' 0 C--N 1.324 -0.52 0 CA-C-N 116.116 -0.493 . . . . 0.0 111.457 -179.699 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.489 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 75.0 mt -110.1 126.81 67.33 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.419 0 N-CA-C 108.093 -1.077 . . . . 0.0 108.093 177.369 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 43.1 t -117.92 133.88 63.3 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.663 0 C-N-CA 120.074 -0.65 . . . . 0.0 111.115 -179.479 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 30.9 m-80 -133.98 126.87 31.19 Favored 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 115.364 -0.835 . . . . 0.0 109.545 179.475 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.57 HG11 ' CD2' ' A' ' 26' ' ' TRP . 23.9 t -105.44 126.96 60.58 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.596 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.393 -179.969 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 69.3 m-85 -119.35 139.74 51.48 Favored 'General case' 0 N--CA 1.45 -0.455 0 N-CA-C 109.29 -0.633 . . . . 0.0 109.29 178.938 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.496 ' NE2' ' HB2' ' A' ' 30' ' ' SER . 0.5 OUTLIER -105.13 136.61 44.31 Favored 'General case' 0 C--N 1.32 -0.692 0 N-CA-C 108.845 -0.798 . . . . 0.0 108.845 179.35 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.681 ' O ' ' N ' ' A' ' 34' ' ' SER . 46.4 mt -100.66 124.78 54.45 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.561 0 CA-C-N 116.183 -0.462 . . . . 0.0 111.216 -178.276 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 25.6 p -85.43 171.99 11.38 Favored 'General case' 0 C--N 1.323 -0.578 0 CA-C-N 115.528 -0.76 . . . . 0.0 110.3 179.748 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 94.6 mt-10 -58.82 -19.45 41.47 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 116.202 -0.454 . . . . 0.0 111.012 179.916 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 39.8 p30 -92.34 -2.32 56.47 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 120.567 -0.453 . . . . 0.0 111.203 -179.619 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 86.08 13.52 68.73 Favored Glycine 0 CA--C 1.529 0.919 0 C-N-CA 121.09 -0.576 . . . . 0.0 112.272 179.231 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.543 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 65.6 mm-40 -84.48 142.07 30.32 Favored 'General case' 0 C--N 1.327 -0.376 0 CA-C-N 117.135 0.468 . . . . 0.0 111.097 179.667 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.819 HE22 ' NE ' ' A' ' 37' ' ' ARG . 81.2 mt-30 -108.64 139.81 42.9 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.066 -0.515 . . . . 0.0 110.832 179.68 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 7.1 t -136.92 137.81 39.98 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.013 -0.539 . . . . 0.0 109.866 179.363 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.605 HD21 ' HB2' ' A' ' 90' ' ' SER . 43.2 tp -74.07 118.46 17.06 Favored 'General case' 0 C--N 1.327 -0.385 0 C-N-CA 120.69 -0.404 . . . . 0.0 111.377 -179.503 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . 0.487 HG21 ' NE2' ' A' ' 78' ' ' GLN . 43.3 pt -110.91 -23.14 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 115.983 -0.553 . . . . 0.0 110.44 179.616 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 28.0 tp -155.82 125.02 6.18 Favored 'General case' 0 C--N 1.329 -0.306 0 C-N-CA 120.511 -0.476 . . . . 0.0 111.666 179.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.605 ' HB2' HD21 ' A' ' 87' ' ' LEU . 25.9 t -134.37 118.97 18.06 Favored 'General case' 0 C--N 1.326 -0.436 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 178.494 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 7.0 t -153.79 154.39 33.91 Favored 'General case' 0 C--N 1.329 -0.322 0 C-N-CA 120.441 -0.504 . . . . 0.0 111.447 -178.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 82.7 p -116.52 155.11 29.22 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 115.866 -0.606 . . . . 0.0 110.107 179.486 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . 0.448 ' HB2' ' CE2' ' A' ' 22' ' ' PHE . 24.7 mt-30 -145.48 164.65 30.94 Favored 'General case' 0 C--N 1.325 -0.497 0 CA-C-N 116.002 -0.545 . . . . 0.0 110.238 179.088 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -122.35 109.52 14.52 Favored 'General case' 0 C--N 1.321 -0.649 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.72 179.516 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.602 ' OG1' ' N ' ' A' ' 69' ' ' GLY . 72.7 p . . . . . 0 C--O 1.22 -0.464 0 CA-C-O 118.008 -0.996 . . . . 0.0 110.389 -179.4 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.49 2.242 0 N-CA-C 109.515 -1.434 . . . . 0.0 109.515 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PRO . . . . . 0.618 ' C ' ' H ' ' A' ' 4' ' ' GLY . 10.9 Cg_endo -57.24 149.5 63.87 Favored 'Trans proline' 0 C--N 1.307 -1.617 0 C-N-CA 122.519 2.146 . . . . 0.0 111.829 -179.997 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' LEU . . . . . 0.404 ' HA ' HD22 ' A' ' 3' ' ' LEU . 1.1 mm? -64.14 16.4 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.176 -0.466 . . . . 0.0 110.866 -179.696 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLY . . . . . 0.618 ' H ' ' C ' ' A' ' 2' ' ' PRO . . . -57.4 136.79 50.28 Favored Glycine 0 CA--C 1.525 0.692 0 N-CA-C 110.675 -0.97 . . . . 0.0 110.675 179.816 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' SER . . . . . 0.54 ' O ' ' C ' ' A' ' 6' ' ' HIS . 60.0 p -86.32 -2.64 58.58 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 121.23 -0.188 . . . . 0.0 111.272 -179.601 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' HIS . . . . . 0.699 ' O ' ' N ' ' A' ' 8' ' ' VAL . 0.0 OUTLIER 29.46 55.06 0.13 Allowed 'General case' 0 C--N 1.33 -0.271 0 N-CA-C 110.068 -0.345 . . . . 0.0 110.068 -179.605 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' LEU . . . . . 0.419 HD23 ' H ' ' A' ' 7' ' ' LEU . 0.5 OUTLIER -52.34 71.25 0.0 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.285 -0.416 . . . . 0.0 111.147 -179.408 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' VAL . . . . . 0.699 ' N ' ' O ' ' A' ' 6' ' ' HIS . 18.8 m -111.28 5.59 8.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.057 -0.519 . . . . 0.0 109.81 179.364 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' ALA . . . . . 0.413 ' C ' ' O ' ' A' ' 8' ' ' VAL . . . 37.29 -121.29 0.19 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.926 179.926 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' THR . . . . . . . . . . . . . 15.0 t -103.86 175.05 5.61 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 115.974 -0.557 . . . . 0.0 111.051 -179.557 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' SER . . . . . . . . . . . . . 4.4 p -60.63 -163.54 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 115.963 -0.562 . . . . 0.0 110.126 179.591 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' GLU . . . . . 0.676 ' C ' ' H ' ' A' ' 14' ' ' VAL . 97.0 mt-10 -57.89 -35.94 71.71 Favored 'General case' 0 C--N 1.33 -0.277 0 C-N-CA 120.719 -0.393 . . . . 0.0 110.547 -179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' SER . . . . . . . . . . . . . 51.2 p 60.45 -19.66 0.03 OUTLIER 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.297 -0.41 . . . . 0.0 111.074 179.861 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' VAL . . . . . 0.676 ' H ' ' C ' ' A' ' 12' ' ' GLU . 63.4 t -107.53 132.03 56.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.565 -0.289 . . . . 0.0 110.715 -179.936 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' THR . . . . . 0.443 ' O ' HG13 ' A' ' 17' ' ' ILE . 1.0 OUTLIER -109.49 -43.73 4.03 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.399 -0.364 . . . . 0.0 110.939 179.675 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' GLU . . . . . 0.56 ' OE1' HG21 ' A' ' 23' ' ' VAL . 43.8 mp0 -74.78 92.57 2.51 Favored 'General case' 0 C--N 1.327 -0.372 0 N-CA-C 109.441 -0.577 . . . . 0.0 109.441 -179.176 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ILE . . . . . 0.678 ' O ' ' N ' ' A' ' 20' ' ' SER . 12.6 mt -112.88 -22.92 4.62 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.456 0 CA-C-N 115.429 -0.805 . . . . 0.0 110.431 -179.056 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' THR . . . . . 0.505 ' OG1' ' N ' ' A' ' 19' ' ' ALA . 35.0 p -32.66 -71.27 0.06 Allowed 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.22 -0.445 . . . . 0.0 110.03 -179.92 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.578 ' O ' ' OG ' ' A' ' 20' ' ' SER . . . -81.71 26.53 0.49 Allowed 'General case' 0 C--N 1.326 -0.455 0 CA-C-N 115.775 -0.648 . . . . 0.0 109.39 179.019 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.678 ' N ' ' O ' ' A' ' 17' ' ' ILE . 0.1 OUTLIER 60.91 21.47 11.69 Favored 'General case' 0 N--CA 1.454 -0.255 0 CA-C-N 115.769 -0.65 . . . . 0.0 109.957 -179.834 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' SER . . . . . 0.485 ' HA ' HD12 ' A' ' 66' ' ' LEU . 0.1 OUTLIER -61.22 172.1 1.17 Allowed 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 115.551 -0.75 . . . . 0.0 111.801 -179.134 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.448 ' CZ ' HG22 ' A' ' 95' ' ' THR . 23.3 m-85 -135.58 146.06 47.58 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 114.974 -1.012 . . . . 0.0 109.913 178.166 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.56 HG21 ' OE1' ' A' ' 16' ' ' GLU . 41.5 t -117.28 102.2 13.12 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.743 0 N-CA-C 107.586 -1.264 . . . . 0.0 107.586 176.515 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' VAL . . . . . . . . . . . . . 73.6 t -108.76 134.9 49.26 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.479 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.075 -178.135 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' SER . . . . . . . . . . . . . 93.0 p -126.66 151.66 47.76 Favored 'General case' 0 N--CA 1.45 -0.444 0 CA-C-N 115.791 -0.641 . . . . 0.0 110.167 179.77 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' TRP . . . . . 0.565 ' CD2' HG11 ' A' ' 76' ' ' VAL . 36.9 p90 -144.37 -174.64 4.36 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 115.966 -0.561 . . . . 0.0 109.977 179.776 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' VAL . . . . . . . . . . . . . 32.9 t -122.79 127.66 74.95 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.554 0 CA-C-N 116.326 -0.397 . . . . 0.0 109.961 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -45.62 129.08 8.8 Favored 'General case' 0 C--N 1.326 -0.431 0 N-CA-C 109.418 -0.586 . . . . 0.0 109.418 -179.958 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' ALA . . . . . 0.417 ' CA ' HE22 ' A' ' 78' ' ' GLN . . . -111.71 28.17 8.99 Favored 'General case' 0 C--N 1.328 -0.331 0 C-N-CA 120.906 -0.317 . . . . 0.0 111.745 -178.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' SER . . . . . 0.681 ' O ' ' N ' ' A' ' 32' ' ' THR . 1.0 OUTLIER -163.47 -23.04 0.04 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 C-N-CA 120.3 -0.56 . . . . 0.0 111.392 179.974 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' ASP . . . . . . . . . . . . . 91.2 m-20 61.51 -41.78 0.13 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.828 0.347 . . . . 0.0 110.073 -179.438 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' THR . . . . . 0.681 ' N ' ' O ' ' A' ' 30' ' ' SER . 40.1 p -74.19 5.24 4.61 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 109.489 -0.56 . . . . 0.0 109.489 179.053 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' VAL . . . . . 0.46 ' H ' HG12 ' A' ' 33' ' ' VAL . 0.8 OUTLIER -60.1 138.1 21.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.497 0 CA-C-N 115.496 -0.775 . . . . 0.0 110.006 179.635 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' SER . . . . . 0.594 ' N ' ' O ' ' A' ' 79' ' ' ILE . 32.1 m -94.46 -15.74 23.98 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 121.392 0.615 . . . . 0.0 109.612 179.873 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' GLY . . . . . 0.464 ' HA2' ' N ' ' A' ' 56' ' ' SER . . . 177.04 176.68 45.37 Favored Glycine 0 CA--C 1.523 0.547 0 N-CA-C 109.839 -1.304 . . . . 0.0 109.839 179.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' PHE . . . . . . . . . . . . . 87.4 m-85 -124.33 151.48 44.27 Favored 'General case' 0 C--N 1.321 -0.666 0 C-N-CA 120.632 -0.427 . . . . 0.0 110.29 179.239 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' ARG . . . . . 0.855 ' NE ' HE22 ' A' ' 85' ' ' GLN . 40.6 ttp180 -131.78 125.06 30.98 Favored 'General case' 0 C--N 1.32 -0.714 0 N-CA-C 109.21 -0.663 . . . . 0.0 109.21 178.817 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' VAL . . . . . 0.529 HG21 HG11 ' A' ' 61' ' ' VAL . 48.2 t -110.8 133.64 55.63 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.693 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.621 -179.626 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLU . . . . . 0.436 ' CD ' ' CE1' ' A' ' 51' ' ' TYR . 80.9 tt0 -123.82 132.24 53.74 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-N 116.263 -0.426 . . . . 0.0 110.446 179.837 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' TYR . . . . . 0.52 ' OH ' ' OE1' ' A' ' 50' ' ' GLN . 53.4 p90 -140.04 136.26 33.49 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 121.19 0.519 . . . . 0.0 111.001 179.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLU . . . . . . . . . . . . . 19.7 pt-20 -146.66 161.79 39.82 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 115.433 -0.803 . . . . 0.0 109.551 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' LEU . . . . . 0.786 HD21 ' CZ ' ' A' ' 72' ' ' TYR . 36.6 mt -75.0 125.14 28.29 Favored 'General case' 0 C--N 1.326 -0.418 0 C-N-CA 120.49 -0.484 . . . . 0.0 110.848 179.706 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 20.2 p -69.57 -18.91 63.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 115.776 -0.647 . . . . 0.0 110.928 -179.918 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLU . . . . . . . . . . . . . 68.6 mm-40 -94.23 -73.4 0.57 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.239 -0.437 . . . . 0.0 111.318 -179.002 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' GLU . . . . . 0.573 ' OE2' ' NH2' ' A' ' 70' ' ' ARG . 94.8 mt-10 -57.55 -34.59 69.32 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 115.953 -0.567 . . . . 0.0 110.993 -178.992 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 70.25 34.23 69.26 Favored Glycine 0 CA--C 1.524 0.631 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 -179.81 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' ASP . . . . . 0.454 ' C ' ' OD1' ' A' ' 47' ' ' ASP . 48.5 p30 -58.22 -175.34 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.901 0.382 . . . . 0.0 110.417 -179.738 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -71.54 135.95 83.71 Favored Pre-proline 0 C--N 1.325 -0.485 0 CA-C-N 116.142 -0.481 . . . . 0.0 110.053 179.912 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 35.2 Cg_endo -68.3 146.45 69.32 Favored 'Trans proline' 0 C--N 1.305 -1.759 0 C-N-CA 122.267 1.978 . . . . 0.0 111.703 179.957 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' GLN . . . . . 0.52 ' OE1' ' OH ' ' A' ' 40' ' ' TYR . 30.8 mt-30 -114.33 144.01 43.96 Favored 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.97 -0.752 . . . . 0.0 108.97 179.617 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' TYR . . . . . 0.436 ' CE1' ' CD ' ' A' ' 39' ' ' GLU . 95.8 m-85 -120.94 140.33 51.99 Favored 'General case' 0 C--N 1.327 -0.389 0 C-N-CA 120.117 -0.633 . . . . 0.0 111.965 -178.761 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' LEU . . . . . . . . . . . . . 37.3 mt -125.76 128.08 47.17 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 115.356 -0.838 . . . . 0.0 108.916 178.612 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' ASP . . . . . . . . . . . . . 58.2 m-20 -103.12 130.72 50.38 Favored 'General case' 0 C--N 1.323 -0.582 0 CA-C-O 121.081 0.467 . . . . 0.0 111.43 -179.185 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' LEU . . . . . . . . . . . . . 5.1 mt -129.77 154.55 81.04 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-N 115.722 -0.672 . . . . 0.0 109.651 -179.575 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' PRO . . . . . . . . . . . . . 23.5 Cg_endo -69.54 157.73 59.77 Favored 'Trans proline' 0 C--N 1.307 -1.645 0 C-N-CA 122.371 2.047 . . . . 0.0 112.724 -179.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' SER . . . . . 0.464 ' N ' ' HA2' ' A' ' 35' ' ' GLY . 58.3 p -58.13 -14.65 7.3 Favored 'General case' 0 C--N 1.332 -0.186 0 CA-C-N 115.805 -0.634 . . . . 0.0 110.701 -179.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' THR . . . . . . . . . . . . . 44.4 p -89.61 -9.67 48.83 Favored 'General case' 0 C--N 1.328 -0.345 0 C-N-CA 120.53 -0.468 . . . . 0.0 110.03 179.776 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' ALA . . . . . . . . . . . . . . . -82.53 131.94 35.21 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.045 -0.525 . . . . 0.0 110.603 179.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 10.0 p -130.14 13.74 5.67 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.184 -0.462 . . . . 0.0 110.432 179.533 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 59.5 p -163.58 146.06 9.77 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.302 -0.408 . . . . 0.0 110.219 179.619 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.529 HG11 HG21 ' A' ' 38' ' ' VAL . 7.6 p -149.21 145.63 17.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.998 0.428 . . . . 0.0 111.487 -179.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' ASN . . . . . . . . . . . . . 2.5 t-20 -103.12 125.14 49.69 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 115.795 -0.639 . . . . 0.0 109.391 178.962 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.426 ' HB ' HD11 ' A' ' 66' ' ' LEU . 1.8 mt -97.98 107.59 41.59 Favored Pre-proline 0 CA--C 1.532 0.266 0 C-N-CA 120.948 -0.301 . . . . 0.0 111.179 -179.326 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' PRO . . . . . . . . . . . . . 83.2 Cg_endo -89.23 177.19 2.92 Favored 'Trans proline' 0 C--N 1.312 -1.358 0 C-N-CA 122.856 2.37 . . . . 0.0 112.682 179.626 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ASP . . . . . . . . . . . . . 85.5 m-20 60.47 38.18 19.33 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.095 -0.957 . . . . 0.0 111.717 179.505 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' LEU . . . . . 0.587 ' O ' ' OG ' ' A' ' 20' ' ' SER . 34.1 mt -90.92 147.74 22.92 Favored 'General case' 0 C--N 1.328 -0.327 0 N-CA-C 109.843 -0.429 . . . . 0.0 109.843 178.779 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LEU . . . . . 0.428 ' O ' ' OG1' ' A' ' 95' ' ' THR . 17.1 mt -89.09 114.25 59.44 Favored Pre-proline 0 C--N 1.33 -0.257 0 N-CA-C 112.103 0.409 . . . . 0.0 112.103 -178.893 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' PRO . . . . . 0.489 ' HA ' ' OG1' ' A' ' 95' ' ' THR . 31.6 Cg_exo -54.33 136.41 68.8 Favored 'Trans proline' 0 C--N 1.312 -1.356 0 C-N-CA 122.276 1.984 . . . . 0.0 111.465 178.031 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' GLY . . . . . . . . . . . . . . . 74.73 26.75 66.47 Favored Glycine 0 CA--C 1.53 0.972 0 C-N-CA 120.969 -0.634 . . . . 0.0 111.864 179.238 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' ARG . . . . . 0.573 ' NH2' ' OE2' ' A' ' 45' ' ' GLU . 7.0 mmt180 -128.89 149.14 50.9 Favored 'General case' 0 C--N 1.327 -0.375 0 N-CA-C 110.096 -0.335 . . . . 0.0 110.096 179.654 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' LYS . . . . . . . . . . . . . 73.2 tttt -98.34 127.97 44.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 121.17 0.51 . . . . 0.0 110.599 179.674 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' TYR . . . . . 0.786 ' CZ ' HD21 ' A' ' 42' ' ' LEU . 74.6 m-85 -119.02 147.99 43.49 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.566 -0.743 . . . . 0.0 110.22 179.429 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ILE . . . . . 0.418 ' O ' ' HA ' ' A' ' 40' ' ' TYR . 76.2 mt -103.87 124.83 58.47 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 N-CA-C 107.994 -1.113 . . . . 0.0 107.994 177.585 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 28.9 t -111.17 130.57 64.4 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.69 0 C-N-CA 120.438 -0.505 . . . . 0.0 110.671 -178.981 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' ASN . . . . . . . . . . . . . 21.4 m-80 -133.91 123.08 24.08 Favored 'General case' 0 C--N 1.325 -0.485 0 CA-C-N 115.619 -0.719 . . . . 0.0 109.507 179.598 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' VAL . . . . . 0.565 HG11 ' CD2' ' A' ' 26' ' ' TRP . 17.7 t -104.28 126.57 58.96 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.491 0 C-N-CA 120.516 -0.474 . . . . 0.0 110.156 -179.74 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' TYR . . . . . . . . . . . . . 66.0 m-85 -120.02 138.3 53.59 Favored 'General case' 0 C--N 1.326 -0.418 0 CA-C-N 116.17 -0.468 . . . . 0.0 109.878 179.584 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' GLN . . . . . 0.417 HE22 ' CA ' ' A' ' 29' ' ' ALA . 0.6 OUTLIER -102.27 135.96 42.96 Favored 'General case' 0 C--N 1.321 -0.641 0 N-CA-C 108.362 -0.977 . . . . 0.0 108.362 178.896 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' ILE . . . . . 0.594 ' O ' ' N ' ' A' ' 34' ' ' SER . 57.5 mt -99.26 122.26 50.82 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.6 0 CA-C-O 121.229 0.537 . . . . 0.0 110.613 -178.739 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' SER . . . . . 0.603 ' OG ' ' OD1' ' A' ' 82' ' ' ASP . 94.5 p -83.5 169.45 15.47 Favored 'General case' 0 N--CA 1.447 -0.591 0 CA-C-N 115.3 -0.864 . . . . 0.0 110.361 -179.801 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' GLU . . . . . . . . . . . . . 97.3 mt-10 -59.61 -21.15 59.99 Favored 'General case' 0 C--N 1.323 -0.583 0 CA-C-N 115.806 -0.634 . . . . 0.0 110.878 -179.551 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ASP . . . . . 0.603 ' OD1' ' OG ' ' A' ' 80' ' ' SER . 41.5 p30 -91.74 -0.91 57.58 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 120.637 -0.425 . . . . 0.0 111.009 -179.73 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . 87.58 11.37 68.73 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 120.986 -0.626 . . . . 0.0 112.011 179.294 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' GLU . . . . . 0.575 ' N ' ' OD1' ' A' ' 82' ' ' ASP . 66.0 mm-40 -82.81 140.39 32.98 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-O 120.901 0.381 . . . . 0.0 111.18 179.792 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLN . . . . . 0.855 HE22 ' NE ' ' A' ' 37' ' ' ARG . 59.4 mt-30 -108.81 141.03 41.44 Favored 'General case' 0 C--N 1.331 -0.203 0 CA-C-N 116.044 -0.525 . . . . 0.0 110.728 179.293 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' SER . . . . . . . . . . . . . 29.3 t -137.26 133.05 34.62 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 115.899 -0.591 . . . . 0.0 110.0 179.154 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . 0.743 HD21 ' HB2' ' A' ' 90' ' ' SER . 13.7 tp -71.31 119.05 14.89 Favored 'General case' 0 C--N 1.326 -0.43 0 C-N-CA 120.298 -0.561 . . . . 0.0 109.695 179.72 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ILE . . . . . . . . . . . . . 40.9 pt -108.12 -24.08 4.2 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.454 0 CA-C-N 116.161 -0.472 . . . . 0.0 110.652 -179.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' LEU . . . . . . . . . . . . . 24.7 tp -156.07 121.33 4.79 Favored 'General case' 0 C--N 1.327 -0.387 0 C-N-CA 120.661 -0.415 . . . . 0.0 111.176 179.574 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' SER . . . . . 0.743 ' HB2' HD21 ' A' ' 87' ' ' LEU . 15.7 t -131.1 118.39 20.46 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.44 178.94 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' THR . . . . . . . . . . . . . 5.2 t -149.42 153.73 37.78 Favored 'General case' 0 C--N 1.328 -0.346 0 C-N-CA 120.724 -0.39 . . . . 0.0 110.724 -179.552 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' SER . . . . . . . . . . . . . 99.5 p -115.89 149.25 38.98 Favored 'General case' 0 C--N 1.327 -0.391 0 CA-C-N 116.358 -0.383 . . . . 0.0 110.101 179.409 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' GLN . . . . . . . . . . . . . 23.7 mt-30 -147.45 158.9 44.17 Favored 'General case' 0 C--N 1.326 -0.428 0 CA-C-N 116.197 -0.456 . . . . 0.0 111.154 179.707 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' THR . . . . . 0.481 ' O ' ' O ' ' A' ' 95' ' ' THR . 0.6 OUTLIER -119.04 111.5 18.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 115.769 -0.651 . . . . 0.0 109.739 178.318 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' THR . . . . . 0.489 ' OG1' ' HA ' ' A' ' 68' ' ' PRO . 73.8 p . . . . . 0 C--N 1.321 -0.651 0 CA-C-O 117.954 -1.022 . . . . 0.0 110.787 -179.68 . . . . . . . . 1 1 . 1 stop_ save_